data_1pdx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pdx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.637 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 121.931 0.872 . . . . 0.0 110.472 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.719 ' HA ' HG21 ' A' ' 97' ' ' ILE . 54.9 t -140.99 135.59 33.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 121.121 -0.987 . . . . 0.0 110.902 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 47.3 t -142.4 90.96 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.804 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 73.1 m-85 -67.86 134.84 51.58 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 121.714 -0.616 . . . . 0.0 109.81 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 99' ' ' VAL . 91.1 t -99.82 166.95 2.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 O-C-N 120.052 -1.655 . . . . 0.0 109.467 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 11' ' ' THR . 86.1 p -101.8 -155.86 0.54 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.096 -1.003 . . . . 0.0 108.819 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.589 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.24 -29.83 17.93 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.8 -6.26 52.05 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.436 0.636 . . . . 0.0 109.878 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.38 -25.55 10.38 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.57 130.18 31.27 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.628 -1.513 . . . . 0.0 108.066 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.527 ' CD ' HG22 ' A' ' 6' ' ' VAL . 17.3 mtm-85 -121.26 -176.38 3.27 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 122.374 1.083 . . . . 0.0 112.883 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.552 ' CD ' HG12 ' A' ' 32' ' ' ILE 0.28 0.2 OUTLIER -128.78 178.73 6.15 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.687 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 84.1 mt-10 -152.9 114.17 4.21 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 117.324 -1.751 . . . . 0.0 111.142 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.587 ' CD2' HD11 ' A' ' 32' ' ' ILE . 6.6 mt -108.71 -156.16 0.58 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.475 1.131 . . . . 0.0 110.095 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.5 71.91 0.96 Allowed 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.709 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 1.4 t -89.14 127.58 41.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.866 0.841 . . . . 0.0 109.431 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.94 -175.06 4.47 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.675 1.226 . . . . 0.0 112.867 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 11.6 p30 -63.2 115.89 4.93 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.792 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.98 -22.39 18.74 Favored Glycine 0 C--N 1.287 -2.185 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.763 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.709 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 90.8 t -88.34 147.93 4.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 119.938 1.869 . . . . 0.0 109.746 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -96.63 131.79 42.93 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.591 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 8.8 mt -44.54 -26.11 0.33 Allowed 'General case' 0 C--O 1.201 -1.464 0 O-C-N 120.899 -1.126 . . . . 0.0 109.292 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.588 ' O ' ' HB ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -69.04 -42.4 76.37 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 118.206 -1.398 . . . . 0.0 107.77 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.5 tt0 -59.68 -70.8 0.15 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.744 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.612 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.97 -54.3 10.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.981 -1.075 . . . . 0.0 110.512 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.595 ' HB1' ' CZ ' ' A' ' 5' ' ' TYR . . . -47.41 -51.15 20.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.787 -1.195 . . . . 0.0 110.098 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -69.05 -1.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.622 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.12 -27.47 12.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.334 -0.853 . . . . 0.0 109.863 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.511 ' CB ' HD21 ' A' ' 15' ' ' LEU . 3.5 m-80 -97.31 -0.8 45.89 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.11 21.17 33.68 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.587 HD11 ' CD2' ' A' ' 15' ' ' LEU . 1.8 mt . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.221 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.505 0.669 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.5 ' O ' HG11 ' A' ' 50' ' ' VAL . 25.1 p -88.53 28.41 1.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.531 -0.731 . . . . 0.0 110.151 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.69 ' CD2' ' CG ' ' A' ' 102' ' ' PRO . 4.0 t60 -70.21 126.37 29.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.433 -0.792 . . . . 0.0 110.219 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.579 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 1.3 m -156.39 -173.94 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-O 122.12 0.962 . . . . 0.0 110.246 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.683 ' CE2' ' CE1' ' A' ' 49' ' ' HIS 0.268 77.1 m-85 -141.08 111.76 7.0 Favored 'General case' 0 C--O 1.197 -1.687 0 CA-C-O 121.557 0.694 . . . . 0.0 110.563 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.566 HG23 ' CB ' ' A' ' 83' ' ' ARG . 2.4 t -78.4 131.46 34.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 O-C-N 120.31 -1.494 . . . . 0.0 110.689 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.585 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 3.4 t30 -47.44 146.67 1.96 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.495 -1.378 . . . . 0.0 108.778 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -58.71 -8.09 1.19 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.065 -1.022 . . . . 0.0 112.135 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.571 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . . . -95.99 8.24 44.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.547 -1.345 . . . . 0.0 110.56 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.69 ' CG ' HD12 ' A' ' 97' ' ' ILE . 87.5 m-85 -140.16 3.77 2.0 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.23 -0.918 . . . . 0.0 109.846 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.561 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 8.7 p -90.45 -42.61 10.77 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.027 -1.046 . . . . 0.0 108.358 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -1.34 57.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.751 0.786 . . . . 0.0 110.486 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.667 ' HB2' HD21 ' A' ' 94' ' ' LEU 0.259 0.1 OUTLIER -99.35 -46.79 5.39 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 123.073 1.416 . . . . 0.0 107.314 179.659 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.735 ' CG1' ' HD2' ' A' ' 61' ' ' PRO 0.338 1.0 OUTLIER -78.07 -179.8 1.43 Allowed Pre-proline 0 C--N 1.289 -2.06 0 CA-C-N 113.797 -1.547 . . . . 0.0 107.123 178.966 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.735 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 37.9 Cg_endo -68.39 107.54 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 CA-C-O 122.874 1.114 . . . . 0.0 112.42 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.625 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -75.46 71.54 2.41 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.016 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -38.65 170.92 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.604 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -111.9 -164.25 0.9 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.91 -1.118 . . . . 0.0 112.543 -178.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 64' ' ' ASN . 8.8 pt-20 -28.71 -39.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -52.9 -63.01 1.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.543 -1.348 . . . . 0.0 108.833 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.67 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -59.14 -30.06 67.86 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.52 -0.737 . . . . 0.0 110.5 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.541 ' O ' ' CB ' ' A' ' 72' ' ' GLU . 1.8 mp -77.12 -8.87 12.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.434 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -88.17 -76.68 1.28 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.67 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -44.04 -40.29 4.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.165 -1.197 . . . . 0.0 108.481 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.667 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 0.6 OUTLIER -64.67 -50.96 64.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 12.0 tp10 -56.91 -19.35 17.37 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.967 -1.083 . . . . 0.0 108.398 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -75.64 -47.88 24.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 110.156 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.557 ' HA ' ' NE1' ' A' ' 106' ' ' TRP . 6.1 m -40.78 161.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 0.0 109.279 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.539 ' O ' ' CG2' ' A' ' 75' ' ' THR . 27.8 m -120.36 34.06 5.36 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 120.971 -1.081 . . . . 0.0 109.257 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.613 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -114.81 -165.19 0.99 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.595 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.748 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -54.05 63.26 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.167 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.797 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.35 153.02 16.37 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 118.842 -2.411 . . . . 0.0 111.67 -177.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.65 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.389 2.2 mmtt -135.42 177.45 2.22 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.409 -173.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 43.6 Cg_endo -74.76 -28.73 9.36 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 N-CA-C 107.514 -1.764 . . . . 0.0 107.514 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.54 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -106.02 15.18 26.84 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.873 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.797 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -44.17 148.83 0.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.989 . . . . 0.0 109.507 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.625 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 1.3 mmt85 -162.03 155.93 21.51 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 117.436 -1.706 . . . . 0.0 113.293 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.616 ' O ' ' N ' ' A' ' 86' ' ' CYS . 7.8 mt -114.73 98.32 6.79 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 174.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.512 ' HB3' ' N ' ' A' ' 24' ' ' MET . 60.7 m -28.85 -28.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -39.76 -26.35 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.502 -1.373 . . . . 0.0 112.442 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.594 ' NE2' ' CG ' ' A' ' 67' ' ' GLU . 8.8 pm0 -125.74 0.25 7.42 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.208 -1.557 . . . . 0.0 112.934 -178.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.539 HD12 ' CG1' ' A' ' 60' ' ' VAL . 12.6 mm -78.64 99.97 3.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.366 -1.459 . . . . 0.0 107.518 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.597 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -81.92 130.88 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.208 -0.933 . . . . 0.0 110.578 -177.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.598 ' HE1' HG23 ' A' ' 97' ' ' ILE . 1.3 tpt -82.58 120.71 25.88 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.809 -0.557 . . . . 0.0 111.375 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.579 ' OG1' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -106.18 174.3 2.68 Favored Pre-proline 0 N--CA 1.494 1.767 0 C-N-CA 118.481 -1.288 . . . . 0.0 109.77 178.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 44.3 Cg_endo -73.94 -10.51 23.08 Favored 'Trans proline' 0 C--N 1.292 -2.427 0 O-C-N 124.651 1.869 . . . . 0.0 110.074 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.579 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -92.48 -30.49 15.68 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 59' ' ' LYS . 97.8 mt -90.07 25.04 2.26 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.865 0.841 . . . . 0.0 110.28 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.522 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 5.9 p-10 -63.11 104.2 0.55 Allowed 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.287 177.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.637 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.99 18.43 2.6 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.333 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.719 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -53.42 141.8 7.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.539 -0.977 . . . . 0.0 111.39 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.597 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 2.1 t -115.49 112.49 40.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.543 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -98.33 155.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.782 -1.199 . . . . 0.0 108.977 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -122.86 124.84 44.17 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.396 -0.815 . . . . 0.0 110.476 -178.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.569 HG13 ' CE1' ' A' ' 8' ' ' HIS . 63.4 t -99.22 137.4 20.39 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.879 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.69 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 57.2 Cg_endo -89.25 170.64 4.74 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 C-N-CA 121.809 1.673 . . . . 0.0 111.813 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.51 -16.36 27.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.522 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -111.09 75.08 0.9 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.514 ' NE2' HG11 ' A' ' 101' ' ' VAL . 18.3 mt-30 -98.94 56.75 1.07 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.327 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.571 ' OXT' ' CD2' ' A' ' 106' ' ' TRP . 1.6 p-90 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.787 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.611 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 13.9 mtmt . . . . . 0 C--O 1.205 -1.253 0 CA-C-O 121.522 0.677 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.717 ' HA ' HG21 ' A' ' 97' ' ' ILE . 41.5 t -138.51 134.29 43.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 O-C-N 120.897 -1.127 . . . . 0.0 110.516 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 50.5 t -142.61 93.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.078 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.63 ' CD1' ' CD1' ' A' ' 32' ' ' ILE . 50.2 m-85 -69.67 162.45 27.68 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 109.464 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 87.3 t -127.89 168.56 20.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.096 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.56 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 6.1 p -103.12 -154.77 0.5 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 109.616 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.57 ' CE1' HG13 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -92.12 -29.84 16.3 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -91.93 -11.86 35.05 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.515 0.674 . . . . 0.0 109.251 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.5 7.23 18.67 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.234 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.6 OUTLIER -71.64 131.12 42.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.355 -1.673 . . . . 0.0 107.451 178.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -120.77 173.47 7.19 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.124 0.964 . . . . 0.0 112.896 -177.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.567 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -134.44 -179.08 5.36 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 37.0 mt-10 -151.78 112.93 4.28 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 117.844 -1.542 . . . . 0.0 110.729 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.622 ' CD1' ' HA ' ' A' ' 27' ' ' ALA . 3.9 mt -109.83 -151.11 0.47 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.482 1.134 . . . . 0.0 111.111 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.19 70.54 0.92 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.703 HG11 ' HB ' ' A' ' 21' ' ' VAL . 18.3 t -86.46 113.51 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.21 -170.8 2.89 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.87 0.843 . . . . 0.0 111.608 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.526 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 2.5 p30 -61.18 110.07 1.29 Allowed 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.19 -18.68 23.33 Favored Glycine 0 C--N 1.289 -2.029 0 C-N-CA 119.349 -1.405 . . . . 0.0 111.116 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.703 ' HB ' HG11 ' A' ' 17' ' ' VAL . 45.0 t -94.24 139.32 18.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 O-C-N 120.088 -1.831 . . . . 0.0 107.099 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.573 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -95.9 142.49 28.08 Favored 'General case' 0 C--N 1.275 -2.674 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.625 HD21 HG21 ' A' ' 3' ' ' VAL . 11.0 mt -49.67 -27.03 4.21 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.082 -1.447 . . . . 0.0 107.78 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.533 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -71.62 -17.31 62.28 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.832 0.825 . . . . 0.0 108.821 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -89.7 -70.21 0.67 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.612 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -48.43 -49.67 34.28 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.301 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.622 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . . . -47.76 -49.43 28.48 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.384 -1.448 . . . . 0.0 110.295 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -72.13 0.12 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.61 -0.681 . . . . 0.0 109.537 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.503 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.25 0.0 OUTLIER -103.58 -29.75 10.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.481 -0.762 . . . . 0.0 110.513 -179.773 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.445 ' HB2' HD21 ' A' ' 15' ' ' LEU . 4.1 m-80 -97.73 -2.99 40.01 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.38 29.03 15.22 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.63 ' CD1' ' CD1' ' A' ' 5' ' ' TYR . 3.1 mt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.272 -1.134 . . . . 0.0 108.58 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.528 ' O ' ' CG1' ' A' ' 50' ' ' VAL . 25.8 p -86.84 25.4 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.438 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.736 ' CD2' ' CG ' ' A' ' 102' ' ' PRO . 13.5 t60 -61.87 110.71 1.62 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.093 -1.005 . . . . 0.0 109.962 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.588 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -140.0 -169.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.624 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.677 ' CE1' ' CE1' ' A' ' 49' ' ' HIS 0.258 62.0 m-85 -141.0 103.67 4.51 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.954 0.883 . . . . 0.0 111.041 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.59 ' CG2' ' CB ' ' A' ' 83' ' ' ARG . 6.2 t -75.01 131.73 34.52 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 O-C-N 120.67 -1.268 . . . . 0.0 110.135 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.59 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 3.7 t30 -47.24 147.75 1.45 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.082 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.52 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.5 pt-20 -59.47 -8.74 1.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.212 -0.93 . . . . 0.0 111.966 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.587 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -96.69 10.01 39.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.701 -1.249 . . . . 0.0 110.725 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.688 ' CG ' HD12 ' A' ' 97' ' ' ILE . 91.0 m-85 -140.72 1.13 1.68 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.073 -1.017 . . . . 0.0 110.288 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.585 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 11.3 p -90.41 -40.81 11.84 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.946 -1.096 . . . . 0.0 108.465 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.26 -1.12 54.51 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.671 0.748 . . . . 0.0 110.592 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.627 ' HB2' HD21 ' A' ' 94' ' ' LEU 0.256 0.2 OUTLIER -99.13 -47.09 5.34 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.618 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.628 ' HB ' ' O ' ' A' ' 56' ' ' PHE 0.327 1.0 OUTLIER -78.43 176.0 4.09 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.39 178.92 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.594 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 39.1 Cg_endo -72.7 103.27 1.53 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 CA-C-O 122.538 0.974 . . . . 0.0 111.314 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.512 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.26 73.09 1.8 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.052 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.521 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -37.76 161.26 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.337 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 66' ' ' ARG . 45.1 p-10 -86.95 -160.12 0.56 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.572 1.177 . . . . 0.0 113.125 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.0 pm0 -33.67 -27.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.477 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -53.17 -70.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.321 -1.487 . . . . 0.0 107.66 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.573 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -64.63 -30.67 71.69 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.801 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.524 ' CD1' ' HG2' ' A' ' 67' ' ' GLU . 1.2 mp -77.45 -16.66 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.176 -0.953 . . . . 0.0 110.853 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -90.61 -73.95 1.28 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.573 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -42.11 -29.12 0.22 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.599 -0.942 . . . . 0.0 108.566 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.594 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 0.9 OUTLIER -80.01 -47.58 14.69 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 7.3 tp10 -64.12 -12.71 42.12 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.199 -0.938 . . . . 0.0 109.339 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.27 -18.33 27.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.362 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.674 ' HA ' ' CD1' ' A' ' 106' ' ' TRP . 8.0 m -70.17 145.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.096 -1.003 . . . . 0.0 110.456 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.532 ' O ' ' CG2' ' A' ' 75' ' ' THR . 55.4 m -99.52 28.46 4.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.741 -0.6 . . . . 0.0 109.699 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.595 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -97.15 -148.81 0.32 Allowed 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.094 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.744 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.47 63.48 5.79 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 122.333 1.063 . . . . 0.0 110.918 -178.46 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.82 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.14 154.4 13.05 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 118.923 -2.36 . . . . 0.0 111.61 -177.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.625 ' HG3' ' CD2' ' A' ' 51' ' ' TYR 0.379 2.4 mmtt -133.86 177.31 2.31 Favored Pre-proline 0 C--N 1.289 -2.059 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.774 -173.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 42.0 Cg_endo -73.31 -25.57 15.44 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 N-CA-C 107.583 -1.737 . . . . 0.0 107.583 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.553 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 8.2 p-10 -114.66 21.37 14.53 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.251 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.82 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -45.85 158.08 0.1 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.802 -1.186 . . . . 0.0 109.094 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.59 ' CB ' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -166.28 150.15 7.57 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 117.011 -1.876 . . . . 0.0 112.276 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 86' ' ' CYS . 79.7 mt -104.67 102.83 12.41 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 24' ' ' MET . 1.9 t -24.05 -37.18 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.554 ' N ' ' O ' ' A' ' 84' ' ' LEU . 27.6 p -70.58 2.92 3.48 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.134 -1.604 . . . . 0.0 111.554 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.539 ' HG3' ' CB ' ' A' ' 67' ' ' GLU . 76.9 mm-40 -125.2 19.43 8.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.882 -1.136 . . . . 0.0 110.514 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.541 ' CD1' HG13 ' A' ' 60' ' ' VAL . 5.1 mm -120.34 100.49 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.105 -0.997 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.572 ' HB ' ' CG ' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -90.04 127.04 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.794 -1.191 . . . . 0.0 108.106 178.329 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.58 ' CG ' ' HB ' ' A' ' 17' ' ' VAL . 26.3 mmm -82.73 137.42 34.41 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.334 -0.854 . . . . 0.0 110.626 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.571 ' OG1' ' CG ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -114.7 170.27 5.66 Favored Pre-proline 0 C--N 1.291 -1.952 0 O-C-N 120.936 -1.102 . . . . 0.0 110.033 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 19' ' ' ASP . 40.6 Cg_endo -67.14 -10.31 28.14 Favored 'Trans proline' 0 C--N 1.292 -2.446 0 O-C-N 124.498 1.789 . . . . 0.0 110.859 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.571 ' CG ' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -92.57 -30.78 15.47 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 117.628 -1.629 . . . . 0.0 107.646 177.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.627 HD21 ' HB2' ' A' ' 59' ' ' LYS . 83.7 mt -89.8 28.53 1.33 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.096 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 34.8 p-10 -63.19 106.02 0.81 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 118.465 -1.294 . . . . 0.0 108.281 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.611 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.87 23.01 1.89 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.717 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -57.61 138.39 18.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.327 -1.102 . . . . 0.0 111.237 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.615 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 2.1 t -111.39 114.49 47.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.584 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -99.75 152.87 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.78 -1.2 . . . . 0.0 109.755 -178.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.629 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -123.06 128.59 50.35 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.318 -0.864 . . . . 0.0 110.71 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.57 HG13 ' CE1' ' A' ' 8' ' ' HIS . 64.9 t -101.45 134.69 20.11 Favored Pre-proline 0 C--N 1.292 -1.93 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.107 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.736 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 56.8 Cg_endo -87.79 175.67 4.29 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.512 2.141 . . . . 0.0 112.807 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -91.86 -17.05 25.83 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.601 0.715 . . . . 0.0 109.193 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.574 ' CB ' ' CB ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.92 70.46 0.71 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.328 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.53 ' CG ' ' HG2' ' A' ' 102' ' ' PRO . 2.5 mt-30 -97.63 62.89 1.7 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 122.004 0.907 . . . . 0.0 110.219 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.674 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 5.8 p-90 . . . . . 0 C--N 1.294 -1.827 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.179 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.619 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 6.9 mtmm . . . . . 0 C--O 1.21 -0.977 0 CA-C-O 121.999 0.904 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.721 ' HA ' HG21 ' A' ' 97' ' ' ILE . 53.8 t -140.77 135.35 34.01 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 O-C-N 121.351 -0.843 . . . . 0.0 111.024 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 20.8 t -142.49 90.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 C-N-CA 118.711 -1.196 . . . . 0.0 110.386 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 55.8 m-85 -69.57 136.16 50.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.448 -0.782 . . . . 0.0 109.817 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 99' ' ' VAL . 62.2 t -100.03 167.69 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 O-C-N 120.723 -1.236 . . . . 0.0 109.297 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.526 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 89.1 p -103.84 -155.92 0.55 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.103 -0.998 . . . . 0.0 109.246 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.595 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -87.7 -31.34 19.76 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -91.7 -6.65 51.63 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.364 0.602 . . . . 0.0 109.806 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.536 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.24 -23.46 12.56 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.523 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.76 129.11 28.81 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.691 -1.476 . . . . 0.0 108.223 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.536 ' CG ' ' O ' ' A' ' 10' ' ' GLY . 20.8 mtt180 -121.73 -175.45 3.1 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 122.191 0.996 . . . . 0.0 112.65 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -133.76 179.7 6.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 177.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.669 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -151.78 111.15 3.94 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 117.704 -1.598 . . . . 0.0 110.972 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.608 ' CD1' ' HA ' ' A' ' 27' ' ' ALA . 7.6 mt -103.86 -157.04 0.59 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.527 1.156 . . . . 0.0 110.595 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -152.54 69.58 0.87 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.709 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 1.4 t -89.41 127.18 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.033 0.921 . . . . 0.0 109.783 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.23 177.05 6.71 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.21 1.005 . . . . 0.0 113.229 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.559 ' HB3' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -53.14 120.63 6.16 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.222 177.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.54 -24.08 26.67 Favored Glycine 0 C--N 1.28 -2.53 0 C-N-CA 119.308 -1.425 . . . . 0.0 112.218 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.709 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 85.9 t -84.43 152.23 3.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.513 0 CA-C-N 120.286 2.043 . . . . 0.0 109.381 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.479 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -96.6 131.24 43.44 Favored 'General case' 0 C--N 1.274 -2.682 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.636 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 7.5 mt -47.11 -26.99 1.23 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.47 -1.394 . . . . 0.0 108.707 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.585 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -73.74 -14.76 61.18 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.657 0.741 . . . . 0.0 109.445 -178.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 22' ' ' SER . 0.7 OUTLIER -90.2 -62.1 1.54 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 177.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.592 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -51.47 -55.65 17.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.128 -0.982 . . . . 0.0 110.385 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.608 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . . . -47.62 -50.8 23.34 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.534 -1.353 . . . . 0.0 110.263 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.7 OUTLIER -66.92 -4.25 2.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.439 -0.788 . . . . 0.0 109.456 178.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.256 0.0 OUTLIER -103.44 -24.72 13.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.373 -0.829 . . . . 0.0 110.36 179.954 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.447 ' HB2' HD21 ' A' ' 15' ' ' LEU . 3.8 m-80 -97.05 2.8 51.81 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.99 9.8 67.31 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.587 ' CD1' ' CD2' ' A' ' 15' ' ' LEU . 9.0 mt . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.439 -1.036 . . . . 0.0 108.757 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.629 0.728 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.527 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 25.9 p -89.92 29.96 1.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.659 -0.651 . . . . 0.0 109.678 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.677 ' CE1' ' CZ ' ' A' ' 51' ' ' TYR . 5.9 t60 -69.97 128.78 37.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.566 -0.709 . . . . 0.0 110.732 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.589 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 1.1 m -157.09 -172.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 O-C-N 121.297 -0.877 . . . . 0.0 109.468 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.677 ' CZ ' ' CE1' ' A' ' 49' ' ' HIS 0.252 81.4 m-85 -140.49 106.49 5.19 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.901 0.857 . . . . 0.0 110.823 178.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.595 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 9.6 t -76.33 130.83 35.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.498 0 O-C-N 120.621 -1.299 . . . . 0.0 109.897 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.585 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 4.4 t30 -45.52 150.0 0.52 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.033 -1.042 . . . . 0.0 109.418 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 pt-20 -59.95 -8.46 2.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.255 -0.903 . . . . 0.0 111.888 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.58 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -97.24 9.15 43.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.671 -1.268 . . . . 0.0 110.779 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.691 ' CG ' HD12 ' A' ' 97' ' ' ILE . 90.5 m-85 -140.68 2.72 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 109.919 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.595 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 24.9 p -90.82 -40.48 11.76 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.979 -1.076 . . . . 0.0 108.375 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.55 -0.9 51.54 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.711 0.767 . . . . 0.0 110.664 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.607 ' CB ' ' CD2' ' A' ' 94' ' ' LEU 0.26 0.0 OUTLIER -99.26 -47.95 5.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.479 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.671 ' CG1' ' HD2' ' A' ' 61' ' ' PRO 0.334 0.9 OUTLIER -74.88 179.52 1.33 Allowed Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 113.529 -1.669 . . . . 0.0 106.751 178.585 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.671 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 36.9 Cg_endo -70.74 115.22 4.14 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 CA-C-O 122.951 1.146 . . . . 0.0 111.796 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.33 69.8 1.63 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.833 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -37.5 159.48 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.223 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -105.6 -154.79 0.52 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.201 -0.937 . . . . 0.0 111.362 -178.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 64' ' ' ASN . 6.2 pt-20 -31.98 -31.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.023 -0.423 . . . . 0.0 111.841 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 64' ' ' ASN . 3.5 mtm180 -52.84 -71.68 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.701 -1.25 . . . . 0.0 107.812 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.623 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 2.5 tm-20 -61.25 -48.65 80.5 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.349 -0.844 . . . . 0.0 109.321 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.545 ' O ' ' CB ' ' A' ' 72' ' ' GLU . 1.1 mp -54.19 -16.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.367 -0.833 . . . . 0.0 110.421 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -89.23 -75.99 1.3 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.623 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.81 -40.27 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.272 -1.134 . . . . 0.0 108.486 178.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.638 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 0.7 OUTLIER -65.3 -51.49 60.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.545 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -57.39 -22.4 42.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.951 -1.093 . . . . 0.0 108.646 178.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.542 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.79 -43.31 30.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.626 -0.671 . . . . 0.0 110.615 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.561 HG13 ' CG ' ' A' ' 49' ' ' HIS . 4.7 m -39.2 161.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.571 -0.705 . . . . 0.0 109.892 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.551 ' O ' ' CG2' ' A' ' 75' ' ' THR . 21.6 m -120.39 30.91 6.71 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.103 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.604 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -114.18 -166.5 1.11 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.701 -1.2 . . . . 0.0 112.493 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.75 63.27 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.616 -178.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.776 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.44 154.03 14.66 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 118.805 -2.434 . . . . 0.0 111.243 -177.003 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.517 ' CE ' ' HG3' ' A' ' 77' ' ' GLU 0.347 0.4 OUTLIER -131.43 179.65 1.3 Allowed Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.275 -174.794 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 45.7 Cg_endo -77.37 -27.94 6.05 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 N-CA-C 106.96 -1.977 . . . . 0.0 106.96 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.537 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 19.3 p-10 -107.89 16.9 23.06 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.166 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.776 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -45.61 152.62 0.31 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.155 -0.966 . . . . 0.0 109.309 179.006 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.584 ' NE ' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -165.11 144.59 6.8 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.139 -1.424 . . . . 0.0 111.237 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -97.62 109.3 22.08 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.585 ' SG ' ' N ' ' A' ' 24' ' ' MET . 7.2 t -28.68 -32.79 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' A' ' 84' ' ' LEU . 26.0 p -71.99 1.31 7.46 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.383 -1.448 . . . . 0.0 110.703 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 84' ' ' LEU . 33.2 mm-40 -125.22 20.49 8.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.994 -1.066 . . . . 0.0 110.52 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.584 ' CD1' ' NE ' ' A' ' 83' ' ' ARG . 6.8 mm -119.94 99.91 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.029 -1.044 . . . . 0.0 110.305 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.586 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -82.71 129.39 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.844 -1.16 . . . . 0.0 109.563 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.645 ' HG2' ' CG2' ' A' ' 3' ' ' VAL . 1.4 tpt -82.68 125.78 31.61 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.583 -0.698 . . . . 0.0 110.422 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.475 ' OG1' ' HG3' ' A' ' 93' ' ' GLU . 2.0 p -114.09 162.17 24.37 Favored Pre-proline 0 C--N 1.292 -1.913 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.903 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.559 ' CD ' ' HB3' ' A' ' 19' ' ' ASP . 37.9 Cg_endo -64.33 -13.69 39.71 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 O-C-N 124.658 1.873 . . . . 0.0 108.372 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.475 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.8 OUTLIER -84.76 -38.69 19.33 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.624 ' CD1' HG23 ' A' ' 60' ' ' VAL . 68.5 mt -90.5 31.09 1.06 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.725 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.445 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 6.3 p-10 -63.59 107.19 1.09 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.922 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.619 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.93 22.32 1.98 Allowed Glycine 0 N--CA 1.498 2.799 0 O-C-N 120.817 -1.177 . . . . 0.0 110.328 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.721 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -59.0 140.67 17.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.634 -0.921 . . . . 0.0 111.497 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.613 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 2.2 t -114.75 111.47 36.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -98.89 154.83 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.631 -1.293 . . . . 0.0 109.764 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 1.3 m-20 -122.43 123.11 40.56 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.243 -0.911 . . . . 0.0 110.087 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 72.2 t -102.27 121.55 49.82 Favored Pre-proline 0 C--N 1.289 -2.063 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.3 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.62 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 53.6 Cg_endo -75.51 172.83 15.57 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.835 1.69 . . . . 0.0 112.048 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.51 -18.17 24.55 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.425 0.631 . . . . 0.0 109.371 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.429 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.95 73.51 0.82 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.463 ' CG ' ' HG2' ' A' ' 102' ' ' PRO . 1.2 mt-30 -98.63 56.26 1.11 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.266 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.591 ' OXT' ' CD2' ' A' ' 106' ' ' TRP . 1.5 p-90 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.852 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.622 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.941 0.401 . . . . 0.0 110.097 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.699 ' HA ' HG21 ' A' ' 97' ' ' ILE . 43.4 t -140.23 135.59 36.73 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 O-C-N 121.436 -0.79 . . . . 0.0 110.767 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 39.2 t -141.81 91.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.77 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.646 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 42.3 m-85 -68.41 136.15 52.85 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 99' ' ' VAL . 98.7 t -98.91 163.82 2.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 11' ' ' THR . 81.9 p -98.59 -150.99 0.37 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.983 -1.073 . . . . 0.0 108.608 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.642 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -92.84 -30.53 15.4 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 119.763 -1.835 . . . . 0.0 107.815 178.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 3.1 p-10 -92.39 2.45 56.65 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.629 -0.67 . . . . 0.0 111.244 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.487 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 103.43 -8.39 52.15 Favored Glycine 0 N--CA 1.502 3.074 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.889 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -70.87 130.94 42.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.611 -1.523 . . . . 0.0 107.31 178.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -121.05 -172.33 2.38 Favored 'General case' 0 C--N 1.273 -2.758 0 O-C-N 120.862 -1.149 . . . . 0.0 112.567 -178.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.3 179.9 6.04 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 177.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.689 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 6.7 mt-10 -150.45 105.3 3.31 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.182 -1.574 . . . . 0.0 110.687 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.596 ' CD1' HD11 ' A' ' 32' ' ' ILE 0.256 8.4 mt -99.5 -156.2 0.54 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.889 0.852 . . . . 0.0 110.357 178.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -146.74 72.78 1.29 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.749 HG11 ' HB ' ' A' ' 21' ' ' VAL 0.255 14.7 t -86.5 120.15 35.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.56 -172.86 3.74 Favored 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.35 1.072 . . . . 0.0 111.969 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -68.65 117.1 9.94 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 177.18 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.487 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 112.8 -16.39 23.45 Favored Glycine 0 C--N 1.275 -2.855 0 C-N-CA 118.977 -1.582 . . . . 0.0 109.719 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.749 ' HB ' HG11 ' A' ' 17' ' ' VAL . 43.1 t -97.01 144.09 11.23 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.006 0 C-N-CA 117.144 -1.822 . . . . 0.0 108.564 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER -96.4 134.79 39.12 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.104 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.646 ' HB3' ' CE2' ' A' ' 5' ' ' TYR 0.27 7.6 mt -46.09 -30.1 1.76 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 123.833 1.778 . . . . 0.0 108.198 178.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.58 ' HB2' ' HB3' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -73.65 -12.28 60.69 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.721 -179.245 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.648 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.2 tt0 -95.52 -59.9 1.78 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.534 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -56.76 -49.43 75.29 Favored 'General case' 0 C--O 1.199 -1.559 0 C-N-CA 118.022 -1.471 . . . . 0.0 110.572 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.608 ' CA ' ' HB ' ' A' ' 32' ' ' ILE . . . -47.0 -53.43 12.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.611 -1.305 . . . . 0.0 109.802 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -3.76 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 121.352 0.596 . . . . 0.0 110.268 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 26' ' ' ALA 0.265 0.0 OUTLIER -105.44 -29.22 10.36 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.482 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.498 ' HB2' HD21 ' A' ' 15' ' ' LEU . 3.3 m-80 -96.37 4.27 52.34 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.57 62.72 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 118.416 -1.85 . . . . 0.0 110.315 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.608 ' HB ' ' CA ' ' A' ' 27' ' ' ALA . 11.2 mt . . . . . 0 C--N 1.3 -1.577 0 O-C-N 121.492 -1.005 . . . . 0.0 108.652 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.4 p . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.286 0.565 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.512 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 23.8 p -91.78 29.97 1.45 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 110.886 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.718 ' CE1' ' CE2' ' A' ' 51' ' ' TYR . 5.3 t60 -68.5 134.84 50.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.441 -1.412 . . . . 0.0 110.959 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.598 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 2.0 m -159.74 179.89 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.641 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.718 ' CE2' ' CE1' ' A' ' 49' ' ' HIS 0.275 65.8 m-85 -138.53 113.19 8.99 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 121.596 0.712 . . . . 0.0 110.959 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.599 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 3.9 t -82.61 131.35 33.96 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 O-C-N 120.869 -1.144 . . . . 0.0 109.346 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.705 HD22 ' HB2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -44.58 155.17 0.1 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.076 -1.049 . . . . 0.0 108.727 177.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -67.45 -1.07 4.3 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.839 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.626 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.45 5.31 48.16 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.564 -1.335 . . . . 0.0 111.393 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.705 ' HB2' HD22 ' A' ' 53' ' ' ASN . 70.6 m-85 -140.17 2.2 1.88 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.328 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.599 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 17.7 p -89.08 -30.28 18.78 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.318 -1.489 . . . . 0.0 107.748 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -107.8 20.74 18.39 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.015 -178.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.638 ' HB3' HD23 ' A' ' 94' ' ' LEU 0.302 0.3 OUTLIER -125.93 -47.62 1.65 Allowed 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 124.455 2.074 . . . . 0.0 106.72 179.535 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.795 ' CG1' ' HD2' ' A' ' 61' ' ' PRO 0.347 0.6 OUTLIER -75.68 -176.65 0.6 Allowed Pre-proline 0 C--N 1.273 -2.727 0 CA-C-N 113.093 -1.867 . . . . 0.0 107.153 179.244 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.795 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 37.5 Cg_endo -59.6 122.73 11.95 Favored 'Trans proline' 0 C--N 1.294 -2.307 0 CA-C-O 122.621 1.009 . . . . 0.0 111.354 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -70.77 67.93 0.4 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.041 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.561 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -37.34 151.89 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.143 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.425 ' OD1' ' HB2' ' A' ' 66' ' ' ARG . 48.7 p-10 -92.55 -164.21 1.15 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.033 0.92 . . . . 0.0 111.744 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 69' ' ' GLY . 24.6 pt-20 -55.56 -25.48 38.15 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.519 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.498 ' O ' ' HG2' ' A' ' 70' ' ' MET . 0.2 OUTLIER -55.71 -61.57 2.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 119.785 -1.822 . . . . 0.0 107.049 177.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.614 ' HA ' ' HE3' ' A' ' 70' ' ' MET . 1.0 OUTLIER -57.76 -49.41 76.67 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.701 -0.624 . . . . 0.0 109.922 177.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 58.0 mt -73.77 -0.9 2.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.058 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -94.25 -76.45 1.33 Allowed Glycine 0 C--O 1.202 -1.871 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.614 ' HE3' ' HA ' ' A' ' 67' ' ' GLU . 1.6 ptt? -46.81 -25.81 0.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.615 ' CD1' ' HB3' ' A' ' 82' ' ' SER . 0.7 OUTLIER -74.56 -48.38 27.19 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -57.71 -16.01 9.63 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 119.972 -1.705 . . . . 0.0 108.328 177.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.585 ' O ' ' NE1' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -86.57 -30.34 21.94 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 120.509 -0.476 . . . . 0.0 112.033 -177.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.58 HG13 ' ND1' ' A' ' 49' ' ' HIS . 22.3 m -48.83 170.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.575 ' O ' ' CG2' ' A' ' 75' ' ' THR . 23.5 m -120.15 16.93 12.41 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 109.534 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 78' ' ' LEU . . . -105.76 -164.97 1.06 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.849 1.309 . . . . 0.0 113.589 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.811 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -52.39 61.8 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.573 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.819 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -56.34 154.21 8.56 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 114.911 -2.716 . . . . 0.0 110.142 -177.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.667 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.402 1.0 OUTLIER -135.19 174.34 4.71 Favored Pre-proline 0 C--N 1.277 -2.584 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.152 -173.704 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.94 -26.24 22.24 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 N-CA-C 107.782 -1.661 . . . . 0.0 107.782 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.579 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 15.6 p-10 -110.27 16.29 21.79 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.716 0.769 . . . . 0.0 110.555 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.819 ' OG ' ' HG ' ' A' ' 78' ' ' LEU 0.256 0.5 OUTLIER -45.24 158.36 0.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.066 -1.021 . . . . 0.0 110.675 178.597 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.493 ' HB2' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -168.56 153.26 6.1 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 117.475 -1.69 . . . . 0.0 114.315 -179.039 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.563 ' HB2' ' HE3' ' A' ' 70' ' ' MET . 0.1 OUTLIER -105.94 88.65 2.86 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 24' ' ' MET . 1.5 t -12.32 -52.02 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.545 ' N ' ' O ' ' A' ' 84' ' ' LEU . 8.7 p -50.92 -9.65 0.06 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.084 -1.01 . . . . 0.0 111.636 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.484 ' NE2' ' HE1' ' A' ' 70' ' ' MET . 0.0 OUTLIER -119.15 20.45 12.64 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 119.707 -1.871 . . . . 0.0 111.375 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.545 HD12 ' CG1' ' A' ' 60' ' ' VAL . 8.7 mm -118.91 117.64 55.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.71 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.574 ' HB ' ' HG3' ' A' ' 61' ' ' PRO . 3.6 mm -100.21 131.69 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.451 -0.781 . . . . 0.0 109.364 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.627 ' CE ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -82.04 129.71 34.87 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.36 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.691 ' OG1' ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -110.96 163.51 17.13 Favored Pre-proline 0 C--N 1.288 -2.072 0 C-N-CA 118.265 -1.374 . . . . 0.0 109.858 179.053 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.503 ' HD3' ' OD1' ' A' ' 19' ' ' ASP . 43.2 Cg_endo -65.18 -9.3 21.33 Favored 'Trans proline' 0 C--N 1.283 -2.883 0 O-C-N 124.641 1.864 . . . . 0.0 110.285 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.691 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.6 OUTLIER -93.69 -28.63 15.85 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 116.992 -1.883 . . . . 0.0 107.853 177.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.638 HD23 ' HB3' ' A' ' 59' ' ' LYS . 70.7 mt -91.71 33.94 1.01 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.09 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.452 ' O ' ' CG ' ' A' ' 95' ' ' ASP . 19.4 p-10 -64.29 103.72 0.67 Allowed 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.931 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.622 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 125.26 17.68 2.66 Favored Glycine 0 N--CA 1.504 3.212 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.716 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.699 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -51.07 144.3 2.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.322 0.582 . . . . 0.0 109.526 178.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.643 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.5 t -122.07 113.24 38.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.549 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -98.07 160.41 3.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 119.958 -1.714 . . . . 0.0 110.497 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.694 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -123.18 120.4 33.09 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 109.55 -178.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 76.5 t -96.27 126.95 42.08 Favored Pre-proline 0 C--N 1.291 -1.954 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.807 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.598 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 43.9 Cg_endo -79.65 166.04 22.08 Favored 'Trans proline' 0 C--N 1.295 -2.238 0 O-C-N 123.695 1.366 . . . . 0.0 110.797 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -89.42 -15.96 31.99 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.42 83.8 1.82 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.48 ' HG2' ' HG2' ' A' ' 102' ' ' PRO . 42.9 mt-30 -102.03 57.46 0.81 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.576 -1.25 . . . . 0.0 111.072 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.624 ' OXT' ' CG ' ' A' ' 106' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 O-C-N 121.244 -0.91 . . . . 0.0 110.601 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.594 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.211 -0.941 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.776 ' HA ' HG21 ' A' ' 97' ' ' ILE . 19.9 t -136.67 136.33 48.31 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.186 0 O-C-N 121.055 -1.028 . . . . 0.0 111.735 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 59.9 t -141.3 89.89 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.696 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 29.5 m-85 -67.54 133.97 50.42 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 99' ' ' VAL . 61.9 t -99.58 172.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 120.956 -1.09 . . . . 0.0 109.576 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.493 ' HB3' HG21 ' A' ' 11' ' ' THR . 5.4 p -106.45 -145.78 0.39 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.243 -0.911 . . . . 0.0 109.623 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.575 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -96.28 -32.34 12.46 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -92.02 -8.19 46.74 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.848 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.82 -12.4 20.46 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.157 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -57.02 131.57 50.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.368 -1.666 . . . . 0.0 108.229 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -121.08 174.66 6.52 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 122.123 0.964 . . . . 0.0 112.957 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.62 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -129.13 178.84 6.13 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.665 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -151.93 109.76 3.66 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.041 -1.864 . . . . 0.0 111.289 178.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.619 ' CD1' ' HA ' ' A' ' 27' ' ' ALA . 3.6 mt -103.72 -157.98 0.64 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.449 1.119 . . . . 0.0 110.842 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 16' ' ' ASP . 27.2 t0 -149.5 67.91 1.02 Allowed 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.711 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -88.85 124.62 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.108 0.956 . . . . 0.0 110.008 -177.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.05 179.81 5.86 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.243 1.021 . . . . 0.0 113.112 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -57.42 117.6 4.29 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.644 177.134 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.58 -25.06 14.02 Favored Glycine 0 C--N 1.286 -2.197 0 C-N-CA 119.425 -1.369 . . . . 0.0 111.381 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.711 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 91.2 t -85.63 149.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 120.082 1.941 . . . . 0.0 109.742 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -96.05 125.32 40.5 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.651 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 8.6 mt -41.77 -27.84 0.13 Allowed 'General case' 0 C--O 1.201 -1.461 0 O-C-N 121.084 -1.01 . . . . 0.0 109.258 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.51 ' SD ' ' HB3' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -59.32 -49.44 77.81 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 177.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.5 tt0 -57.98 -68.79 0.21 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.714 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.592 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.77 -55.95 7.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.971 -1.08 . . . . 0.0 111.052 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.619 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . . . -47.65 -48.14 28.96 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.293 -1.504 . . . . 0.0 110.196 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -70.72 -1.46 2.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.502 179.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -102.05 -29.3 11.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 0.0 109.674 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.451 ' CG ' HD22 ' A' ' 15' ' ' LEU . 4.5 m-80 -97.73 -3.15 39.71 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.79 32.98 9.43 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.119 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.608 HD11 ' CD2' ' A' ' 15' ' ' LEU . 5.2 mt . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.218 -1.166 . . . . 0.0 109.276 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.513 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 28.6 p -101.24 29.93 4.45 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.716 -0.615 . . . . 0.0 110.243 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.716 ' CD2' ' HB ' ' A' ' 74' ' ' VAL . 2.0 t60 -65.47 104.24 0.96 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.523 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.546 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 0.8 OUTLIER -140.75 -173.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.454 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.716 ' CZ ' ' CE1' ' A' ' 49' ' ' HIS 0.275 84.2 m-85 -140.63 107.21 5.32 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 121.838 0.827 . . . . 0.0 110.617 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.638 HG23 ' HB2' ' A' ' 83' ' ' ARG . 3.5 t -70.88 134.29 30.29 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 O-C-N 120.222 -1.549 . . . . 0.0 109.162 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.635 ' ND2' ' HB2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -44.8 151.44 0.29 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.683 -1.207 . . . . 0.0 109.305 178.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -61.82 -8.51 4.97 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.216 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.611 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -92.64 5.06 52.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.019 -1.051 . . . . 0.0 111.379 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.741 ' CD2' ' HB ' ' A' ' 97' ' ' ILE . 42.0 m-85 -140.75 4.63 1.93 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.78 -1.2 . . . . 0.0 109.715 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.558 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 14.7 p -89.67 -33.16 16.73 Favored 'General case' 0 C--N 1.288 -2.066 0 O-C-N 120.746 -1.221 . . . . 0.0 108.023 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.25 -1.91 35.18 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.863 0.84 . . . . 0.0 109.968 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.611 ' CD ' ' O ' ' A' ' 55' ' ' ALA 0.268 1.5 mtpt -99.38 -48.64 4.72 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 123.07 1.414 . . . . 0.0 107.601 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.695 ' CG1' ' HD2' ' A' ' 61' ' ' PRO 0.33 0.8 OUTLIER -72.09 -178.28 0.61 Allowed Pre-proline 0 C--N 1.288 -2.068 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.053 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.695 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 33.1 Cg_endo -67.61 128.0 17.33 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 CA-C-O 123.1 1.208 . . . . 0.0 111.922 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -73.23 69.4 1.08 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.107 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.496 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -38.02 157.94 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.594 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.447 ' O ' HD12 ' A' ' 68' ' ' ILE . 49.9 p30 -127.37 -149.7 0.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.762 -1.211 . . . . 0.0 112.48 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -36.45 -30.78 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.215 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.471 ' NH1' ' HG3' ' A' ' 66' ' ' ARG . 5.9 mtm-85 -53.79 -73.2 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.699 -1.251 . . . . 0.0 109.458 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.619 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -67.98 -38.82 83.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.094 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.552 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 0.5 OUTLIER -47.52 -19.83 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.22 -0.925 . . . . 0.0 109.618 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 67' ' ' GLU . . . -90.18 -70.13 1.22 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.619 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -50.3 -30.26 11.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.847 -1.384 . . . . 0.0 108.384 178.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.629 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 0.5 OUTLIER -74.13 -50.06 21.08 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -57.13 -18.4 14.85 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.727 -1.233 . . . . 0.0 108.39 178.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -83.54 -34.32 25.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.719 . . . . 0.0 111.533 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.716 ' HB ' ' CD2' ' A' ' 49' ' ' HIS . 33.3 m -42.63 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.016 -1.052 . . . . 0.0 109.851 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.521 ' O ' ' CG2' ' A' ' 75' ' ' THR . 38.2 m -121.08 11.57 10.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.936 -1.102 . . . . 0.0 110.521 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.57 ' HB2' ' CD2' ' A' ' 49' ' ' HIS . . . -99.59 -154.87 0.48 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 123.041 1.4 . . . . 0.0 113.063 -177.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.757 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.252 0.0 OUTLIER -64.96 63.79 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.575 -178.384 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.631 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.03 145.05 37.64 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 115.078 -2.649 . . . . 0.0 110.529 -176.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.546 ' CE ' ' HG3' ' A' ' 77' ' ' GLU 0.362 0.1 OUTLIER -119.01 177.28 1.38 Allowed Pre-proline 0 C--N 1.288 -2.103 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.787 -175.238 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.438 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 42.7 Cg_endo -75.39 -25.2 11.5 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 N-CA-C 106.36 -2.208 . . . . 0.0 106.36 175.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.513 ' HB2' ' CB ' ' A' ' 57' ' ' THR . 14.6 p-10 -112.79 22.37 14.56 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.931 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.631 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -46.14 156.57 0.15 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.658 -1.276 . . . . 0.0 109.347 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.638 ' HB2' HG23 ' A' ' 52' ' ' VAL . 2.1 mmt85 -153.02 155.1 36.26 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.347 -1.341 . . . . 0.0 111.603 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -111.84 100.72 9.15 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.537 ' SG ' ' CG1' ' A' ' 50' ' ' VAL . 88.2 m -30.37 -31.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.572 ' N ' ' O ' ' A' ' 84' ' ' LEU . 28.0 p -73.21 1.87 8.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.394 -1.442 . . . . 0.0 110.621 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' A' ' 84' ' ' LEU . 1.2 tp-100 -126.29 -8.9 6.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.037 -1.04 . . . . 0.0 111.685 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.497 HG23 ' HG ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -89.87 118.84 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.769 -1.207 . . . . 0.0 110.39 -179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.56 ' HB ' ' HG3' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -102.65 135.01 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.074 -1.016 . . . . 0.0 109.607 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.608 ' O ' ' HA ' ' A' ' 19' ' ' ASP . 2.0 tpt -83.61 121.15 26.85 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.702 -0.624 . . . . 0.0 110.66 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.591 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.6 OUTLIER -95.83 -176.9 0.58 Allowed Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 117.879 -1.528 . . . . 0.0 109.172 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 46.1 Cg_endo -90.06 -8.04 4.23 Favored 'Trans proline' 0 C--N 1.284 -2.842 0 O-C-N 124.204 1.634 . . . . 0.0 108.883 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.548 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.9 pt-20 -91.96 -30.53 16.05 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.767 1.27 . . . . 0.0 107.577 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.629 ' CD1' HG23 ' A' ' 60' ' ' VAL . 62.6 mt -90.1 29.35 1.23 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.333 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.483 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 17.9 p-10 -62.87 104.01 0.5 Allowed 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.932 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.594 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.37 22.88 2.02 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.051 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.776 HG21 ' HA ' ' A' ' 3' ' ' VAL . 3.5 tt -63.12 161.3 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.462 1.125 . . . . 0.0 112.307 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.635 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 t -134.56 116.43 21.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -99.24 156.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.647 -1.283 . . . . 0.0 109.47 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.682 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.95 111.61 16.83 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.079 -1.013 . . . . 0.0 110.637 -178.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 6' ' ' VAL . 58.7 t -91.83 127.94 47.93 Favored Pre-proline 0 C--N 1.288 -2.081 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.75 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.546 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 58.4 Cg_endo -79.06 -179.9 5.87 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.083 1.57 . . . . 0.0 112.715 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -91.01 -14.89 30.56 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.51 ' HG2' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -110.37 82.66 1.63 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.458 ' NE2' ' CG1' ' A' ' 101' ' ' VAL . 3.7 tt0 -98.64 50.54 0.98 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 117.381 -1.728 . . . . 0.0 110.478 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.57 ' CE3' ' O ' ' A' ' 106' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.117 -0.989 . . . . 0.0 109.888 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.597 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 1.0 OUTLIER . . . . . 0 C--O 1.207 -1.158 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.746 HG22 ' CG2' ' A' ' 97' ' ' ILE . 53.7 t -138.05 135.67 45.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 O-C-N 120.85 -1.156 . . . . 0.0 111.929 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 47.5 t -143.18 92.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.717 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.644 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 34.6 m-85 -70.7 136.92 49.33 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.232 -0.917 . . . . 0.0 108.982 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.528 HG22 ' CD ' ' A' ' 12' ' ' ARG . 61.5 t -99.92 167.55 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 O-C-N 120.51 -1.369 . . . . 0.0 109.335 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.529 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 91.2 p -103.17 -155.83 0.54 Allowed 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.15 -0.969 . . . . 0.0 109.014 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.594 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -88.51 -30.41 19.37 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -91.83 -6.08 52.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.38 0.609 . . . . 0.0 109.909 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.03 -24.65 11.5 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.71 129.55 29.95 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.671 -1.488 . . . . 0.0 108.453 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.528 ' CD ' HG22 ' A' ' 6' ' ' VAL . 1.6 mtm180 -121.53 -172.34 2.4 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-O 122.113 0.958 . . . . 0.0 112.514 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.73 -178.22 5.03 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.233 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.674 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 49.9 mt-10 -151.85 112.1 4.1 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 117.717 -1.593 . . . . 0.0 110.959 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.633 HD13 ' CD1' ' A' ' 32' ' ' ILE 0.254 6.5 mt -108.19 -153.38 0.5 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 122.573 1.178 . . . . 0.0 111.493 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.16 68.77 0.99 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.692 HG11 ' HB ' ' A' ' 21' ' ' VAL . 20.9 t -86.05 114.32 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.98 -170.57 2.84 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 122.098 0.951 . . . . 0.0 111.786 -177.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.499 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 2.1 p-10 -63.67 110.53 2.05 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.4 -16.83 24.21 Favored Glycine 0 C--N 1.286 -2.227 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.606 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.692 ' HB ' HG11 ' A' ' 17' ' ' VAL . 42.0 t -96.73 136.28 28.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 O-C-N 120.203 -1.763 . . . . 0.0 106.909 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.593 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -93.1 140.27 29.68 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.277 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.644 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 8.2 mt -47.96 -25.36 1.33 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.664 -1.273 . . . . 0.0 108.055 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.596 ' CB ' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -69.91 -29.68 66.92 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.316 -0.865 . . . . 0.0 108.667 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 22' ' ' SER . 3.5 tt0 -75.46 -70.84 0.4 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.609 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -46.79 -49.99 18.99 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.136 -1.426 . . . . 0.0 110.601 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.625 ' HA ' HD13 ' A' ' 15' ' ' LEU . . . -47.3 -41.55 19.31 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.211 -1.556 . . . . 0.0 110.796 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.413 ' O ' HG11 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -79.68 2.1 2.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.32 -0.863 . . . . 0.0 109.646 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.261 0.0 OUTLIER -103.9 -30.38 10.37 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.4 1.095 . . . . 0.0 110.206 -179.817 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.63 ' OD1' ' CD1' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -99.08 -6.48 28.35 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.28 32.79 15.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.633 ' CD1' HD13 ' A' ' 15' ' ' LEU . 4.0 mt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 0.0 109.166 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.477 HG22 ' N ' ' A' ' 48' ' ' CYS . 14.8 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.627 0.727 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.498 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 20.7 p -88.23 26.56 1.38 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.607 -0.683 . . . . 0.0 110.26 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.67 ' CE1' ' CZ ' ' A' ' 51' ' ' TYR . 4.5 t60 -70.26 125.49 26.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.431 -0.793 . . . . 0.0 109.899 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.586 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -153.37 -171.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.823 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.67 ' CZ ' ' CE1' ' A' ' 49' ' ' HIS 0.263 81.6 m-85 -140.81 113.27 8.04 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.734 0.778 . . . . 0.0 110.95 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.548 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 5.6 t -80.39 132.44 31.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 O-C-N 120.426 -1.422 . . . . 0.0 109.796 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.672 ' OD1' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -43.88 158.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.544 -1.262 . . . . 0.0 108.772 177.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.18 1.53 7.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.759 -1.213 . . . . 0.0 110.144 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.594 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.06 5.59 46.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.663 ' HB2' HD22 ' A' ' 53' ' ' ASN . 57.7 m-85 -140.27 4.9 2.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.92 -1.112 . . . . 0.0 109.35 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.548 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 33.8 p -89.35 -39.67 13.28 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.26 -1.79 47.33 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.755 0.788 . . . . 0.0 110.661 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.597 ' CB ' ' CD2' ' A' ' 94' ' ' LEU 0.26 0.8 OUTLIER -99.31 -47.68 5.08 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 123.207 1.48 . . . . 0.0 107.559 179.877 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.642 ' CG1' ' HD2' ' A' ' 61' ' ' PRO 0.329 0.7 OUTLIER -78.31 -179.91 1.49 Allowed Pre-proline 0 C--N 1.286 -2.177 0 CA-C-N 113.624 -1.626 . . . . 0.0 107.921 179.811 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.642 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 37.9 Cg_endo -69.97 106.75 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 CA-C-O 122.655 1.023 . . . . 0.0 111.836 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.515 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -60.21 74.45 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.766 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 87' ' ' GLN . . . -36.78 153.2 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.951 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 66' ' ' ARG . 1.1 p-10 -108.1 -159.75 0.7 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.165 -0.959 . . . . 0.0 111.858 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 7.4 pt-20 -29.68 -34.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.099 -0.375 . . . . 0.0 111.918 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 64' ' ' ASN . 5.7 mmt180 -53.09 -66.23 0.42 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 120.78 -1.2 . . . . 0.0 107.772 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -61.09 -49.08 78.78 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.14 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.542 ' N ' ' HG3' ' A' ' 67' ' ' GLU . 1.1 mp -57.73 -12.69 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.337 -0.852 . . . . 0.0 111.183 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -89.91 -79.76 1.34 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.585 ' CE ' ' CG ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -43.88 -38.77 3.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -1.177 . . . . 0.0 108.846 179.216 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.621 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 1.0 OUTLIER -64.99 -50.74 65.15 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -57.17 -22.19 38.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.224 -0.923 . . . . 0.0 108.844 178.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.542 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -80.18 -42.29 23.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.477 -0.764 . . . . 0.0 110.744 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.571 HG13 ' CG ' ' A' ' 49' ' ' HIS . 4.7 m -39.0 161.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.526 -0.734 . . . . 0.0 110.089 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.544 ' O ' ' CG2' ' A' ' 75' ' ' THR . 24.2 m -120.52 29.49 7.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 109.245 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.602 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -112.91 -166.38 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.45 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.6 63.36 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.493 -178.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.779 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.47 152.42 18.03 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 118.848 -2.407 . . . . 0.0 111.389 -176.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.502 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.35 0.0 OUTLIER -128.73 -175.97 0.49 Allowed Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.526 -174.824 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 47.0 Cg_endo -80.67 -30.0 2.03 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 N-CA-C 106.987 -1.967 . . . . 0.0 106.987 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.534 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.7 OUTLIER -105.28 13.21 30.81 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.381 178.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.779 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -44.27 147.54 0.54 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.221 -0.924 . . . . 0.0 109.702 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.541 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 4.6 mtt180 -166.74 153.71 9.02 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 117.798 -1.561 . . . . 0.0 112.534 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -102.63 119.08 38.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 24' ' ' MET . 28.8 p -33.53 -28.91 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.876 -0.515 . . . . 0.0 112.349 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.596 ' HA ' ' CB ' ' A' ' 24' ' ' MET . 31.8 p -77.17 8.16 4.3 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.551 -1.343 . . . . 0.0 111.075 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.585 ' CG ' ' CE ' ' A' ' 70' ' ' MET . 19.4 mm-40 -125.68 8.73 7.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.052 -1.03 . . . . 0.0 110.384 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.541 ' CD1' HG13 ' A' ' 60' ' ' VAL . 3.9 mm -120.5 119.72 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.969 -1.082 . . . . 0.0 111.47 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.546 ' HB ' ' HG3' ' A' ' 61' ' ' PRO . 4.7 mm -102.06 131.36 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.085 -1.009 . . . . 0.0 108.967 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.608 ' HE1' HG23 ' A' ' 97' ' ' ILE . 20.2 mmm -84.13 141.1 31.32 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.899 -1.126 . . . . 0.0 110.289 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.597 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -114.14 -175.43 0.32 Allowed Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.843 -1.16 . . . . 0.0 109.988 179.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 44.2 Cg_endo -84.98 -9.94 8.43 Favored 'Trans proline' 0 C--N 1.285 -2.8 0 O-C-N 123.705 1.371 . . . . 0.0 108.603 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.4 pt-20 -92.16 -35.12 14.03 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.616 ' CD1' HG23 ' A' ' 60' ' ' VAL . 55.7 mt -89.77 32.22 0.9 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.726 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.469 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 6.8 p-10 -63.46 108.04 1.26 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 118.319 -1.352 . . . . 0.0 108.788 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.597 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.39 24.11 1.83 Allowed Glycine 0 N--CA 1.498 2.794 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.24 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.746 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -58.59 135.79 22.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.53 -0.983 . . . . 0.0 110.644 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.672 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.5 t -113.53 113.6 44.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.508 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -99.46 155.86 4.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.762 -1.211 . . . . 0.0 109.973 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.19 120.09 33.17 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.739 0.78 . . . . 0.0 109.842 -179.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.529 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 72.8 t -99.61 123.02 49.46 Favored Pre-proline 0 C--N 1.289 -2.06 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.3 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.628 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 55.8 Cg_endo -76.44 173.53 14.33 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.301 1.685 . . . . 0.0 112.21 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.463 ' OD1' ' CD2' ' A' ' 8' ' ' HIS . 1.3 t0 -91.57 -17.84 25.0 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.515 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.81 72.35 0.78 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.1 OUTLIER -98.42 56.02 1.13 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.285 -177.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.585 ' CD2' ' O ' ' A' ' 106' ' ' TRP . 1.7 p-90 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.886 -1.054 . . . . 0.0 109.807 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.56 ' H ' ' HA ' ' A' ' 95' ' ' ASP . 4.4 mmtt . . . . . 0 C--O 1.209 -1.029 0 CA-C-O 121.556 0.694 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.674 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 35.4 t -141.35 139.24 32.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 O-C-N 121.623 -0.673 . . . . 0.0 111.466 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 45.6 t -143.18 89.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.602 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 46.9 m-85 -67.63 156.67 36.29 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.368 -0.832 . . . . 0.0 109.463 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.549 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 86.3 t -122.36 170.1 12.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.25 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.537 ' HB3' HG21 ' A' ' 11' ' ' THR . 12.0 p -105.45 -154.63 0.52 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.066 -1.021 . . . . 0.0 109.738 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.567 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.91 -30.25 17.0 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.68 -10.63 39.54 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.483 0.659 . . . . 0.0 109.428 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.531 ' O ' ' CD ' ' A' ' 12' ' ' ARG . . . 114.31 -4.33 23.53 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 120.297 -0.954 . . . . 0.0 110.758 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.537 HG21 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -63.77 130.18 43.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.557 -1.555 . . . . 0.0 107.847 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.531 ' CD ' ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -121.08 175.67 5.96 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 122.245 1.022 . . . . 0.0 112.791 -177.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.551 ' HG2' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -132.83 179.31 6.24 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 177.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 42.0 mt-10 -151.57 108.1 3.48 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 117.54 -1.664 . . . . 0.0 110.954 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.61 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 4.9 mt -99.93 -164.19 1.1 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.804 1.288 . . . . 0.0 110.976 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -143.82 68.23 1.28 Allowed 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.708 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 1.1 t -88.06 125.41 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.908 0.861 . . . . 0.0 109.247 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 90' ' ' MET . . . -89.31 -176.98 5.26 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.746 1.26 . . . . 0.0 113.268 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 90' ' ' MET . 3.1 p-10 -62.12 118.26 7.11 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.569 177.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.409 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 111.9 -22.93 17.98 Favored Glycine 0 C--N 1.284 -2.34 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.593 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.708 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 80.9 t -88.94 149.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 119.818 1.809 . . . . 0.0 110.314 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 25' ' ' GLN . 1.6 p -96.14 128.64 43.22 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.63 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 8.0 mt -41.07 -31.22 0.17 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.201 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.51 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -68.84 -39.29 80.04 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 118.116 -1.434 . . . . 0.0 108.658 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.4 tt0 -56.83 -65.01 0.69 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -50.73 -56.02 13.92 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.683 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.588 ' HA ' ' OD1' ' A' ' 30' ' ' ASN . . . -47.0 -41.45 16.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.513 -1.367 . . . . 0.0 110.835 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -78.94 0.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.325 -0.859 . . . . 0.0 109.435 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.516 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.259 0.0 OUTLIER -104.03 -30.01 10.54 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.232 1.015 . . . . 0.0 110.333 -179.781 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.588 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -98.97 -2.66 36.84 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 24.97 44.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.593 ' CD1' ' CD2' ' A' ' 15' ' ' LEU . 4.4 mt . . . . . 0 C--N 1.302 -1.484 0 O-C-N 121.244 -1.151 . . . . 0.0 109.435 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.36 0.6 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.488 ' O ' HG12 ' A' ' 50' ' ' VAL . 7.9 p -115.14 24.33 11.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.409 -0.807 . . . . 0.0 110.082 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.701 ' CE1' ' CZ ' ' A' ' 51' ' ' TYR . 6.5 t60 -65.11 122.97 18.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.493 -0.754 . . . . 0.0 110.297 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.581 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -148.42 -173.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.981 0.896 . . . . 0.0 109.89 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.75 ' CE1' ' OG ' ' A' ' 82' ' ' SER 0.27 75.6 m-85 -140.69 110.63 6.52 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.713 0.768 . . . . 0.0 110.855 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.536 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 4.0 t -79.01 136.14 24.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 O-C-N 120.421 -1.425 . . . . 0.0 110.038 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.684 ' OD1' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -46.01 158.33 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.523 -1.271 . . . . 0.0 108.858 177.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' N ' ' OE2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -72.16 0.22 10.25 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.775 178.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.594 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.28 4.26 48.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.059 -1.026 . . . . 0.0 110.584 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.739 ' CE2' ' HA ' ' A' ' 97' ' ' ILE . 35.3 m-85 -140.19 6.72 2.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.06 . . . . 0.0 109.299 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 45.6 p -89.39 -39.86 13.13 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.9 -2.47 53.27 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.827 0.822 . . . . 0.0 110.335 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.611 ' CB ' ' CD2' ' A' ' 94' ' ' LEU 0.261 0.0 OUTLIER -99.56 -47.88 4.95 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 122.971 1.367 . . . . 0.0 107.636 -179.961 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.702 ' HB ' ' O ' ' A' ' 56' ' ' PHE 0.33 0.9 OUTLIER -77.54 177.97 2.4 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.113 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.63 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 38.2 Cg_endo -71.38 110.02 2.75 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 CA-C-O 122.565 0.985 . . . . 0.0 112.276 -176.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -60.21 70.95 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.108 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' PRO . . . -37.21 134.25 0.6 Allowed 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.88 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' ARG . 43.1 p-10 -88.76 -150.11 0.19 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.111 0.958 . . . . 0.0 112.252 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 64' ' ' ASN . 11.7 pt-20 -37.97 -26.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.573 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.521 ' HA ' ' NE ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -53.0 -70.91 0.08 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.752 -1.218 . . . . 0.0 108.025 179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.595 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -67.38 -51.5 51.27 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.53 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 0.9 OUTLIER -44.65 -24.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.465 -0.772 . . . . 0.0 110.108 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.488 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -84.07 -83.08 0.97 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.137 -1.985 . . . . 0.0 108.137 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.595 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 1.7 ptt? -39.65 -40.52 0.92 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.578 -0.954 . . . . 0.0 108.934 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.648 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 0.9 OUTLIER -61.71 -53.49 55.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.53 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 3.8 tp10 -56.22 -21.95 26.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.542 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.97 -45.65 23.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.648 -0.657 . . . . 0.0 110.377 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.565 HG13 ' CG ' ' A' ' 49' ' ' HIS . 4.3 m -38.94 159.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.556 -0.715 . . . . 0.0 109.733 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.545 ' O ' ' CG2' ' A' ' 75' ' ' THR . 20.5 m -120.56 34.53 5.18 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.075 -1.015 . . . . 0.0 108.96 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.614 ' HB2' ' CD2' ' A' ' 49' ' ' HIS . . . -115.88 -164.37 0.95 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.628 1.204 . . . . 0.0 112.649 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.751 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.251 0.0 OUTLIER -56.79 62.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.391 -178.843 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.675 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.11 153.65 14.38 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 118.845 -2.409 . . . . 0.0 111.081 -176.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.668 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.387 2.4 mmtt -131.93 177.48 2.22 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.151 -173.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 42.9 Cg_endo -73.4 -27.56 13.14 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 176.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.538 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.9 OUTLIER -109.38 13.88 23.94 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.041 179.362 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.75 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -45.04 147.29 0.7 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.954 -1.091 . . . . 0.0 109.649 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.56 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 1.1 mtt180 -167.47 163.11 14.84 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 117.765 -1.574 . . . . 0.0 113.01 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 3.4 mm? -99.22 122.63 42.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 48' ' ' CYS . 1.9 p -42.92 -23.25 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.167 -0.958 . . . . 0.0 110.713 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.51 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 30.4 p -81.49 4.85 19.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.811 -1.181 . . . . 0.0 110.496 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.519 ' HB3' ' CB ' ' A' ' 63' ' ' ALA . 18.7 mm-40 -125.22 9.0 7.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 110.827 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.547 HD13 ' NE ' ' A' ' 83' ' ' ARG . 30.1 mm -113.71 106.96 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.038 -1.039 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.594 ' HB ' ' HG3' ' A' ' 61' ' ' PRO . 4.2 mm -84.88 131.52 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.976 -1.078 . . . . 0.0 110.046 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.553 ' HG2' ' CG2' ' A' ' 3' ' ' VAL . 2.8 tpt -82.62 113.74 20.52 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.359 -0.838 . . . . 0.0 110.823 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.591 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -91.5 -177.34 0.73 Allowed Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 117.516 -1.674 . . . . 0.0 108.642 178.386 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 46.9 Cg_endo -87.11 -12.61 4.82 Favored 'Trans proline' 0 C--N 1.287 -2.67 0 O-C-N 124.412 1.743 . . . . 0.0 108.651 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.523 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.1 pt-20 -85.2 -32.67 22.54 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.613 ' CD1' HG23 ' A' ' 60' ' ' VAL . 57.7 mt -89.33 36.54 0.83 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.68 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.56 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 12.8 p-10 -62.3 99.82 0.15 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.036 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.558 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 120.67 29.52 1.54 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.268 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.739 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 9.5 tt -60.19 163.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.496 -1.591 . . . . 0.0 112.3 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.684 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.3 t -133.1 114.1 20.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -102.18 154.7 5.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 120.92 -1.113 . . . . 0.0 109.992 -178.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.635 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -122.63 122.91 39.94 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.764 0.792 . . . . 0.0 110.487 -178.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.532 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 73.6 t -98.45 136.33 20.88 Favored Pre-proline 0 C--N 1.289 -2.045 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.631 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.672 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 56.0 Cg_endo -89.76 173.59 3.58 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 121.716 1.61 . . . . 0.0 111.818 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 18.3 p-10 -91.2 -17.15 26.52 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.535 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.98 74.92 0.89 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.499 ' HG2' ' HG2' ' A' ' 102' ' ' PRO . 10.9 mt-30 -98.49 54.08 1.05 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.299 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.578 ' OXT' ' CD2' ' A' ' 106' ' ' TRP . 1.4 p-90 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.082 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.601 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 11.3 mtmt . . . . . 0 C--O 1.206 -1.187 0 CA-C-O 121.547 0.689 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.723 ' HA ' HG21 ' A' ' 97' ' ' ILE . 44.9 t -137.94 135.01 45.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 O-C-N 121.119 -0.988 . . . . 0.0 111.024 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 48.8 t -142.29 92.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.154 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.627 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 36.6 m-85 -70.87 137.3 49.25 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.502 -0.749 . . . . 0.0 109.326 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 99' ' ' VAL . 74.7 t -99.86 166.49 2.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 O-C-N 120.807 -1.183 . . . . 0.0 109.035 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 11' ' ' THR . 82.8 p -102.21 -154.88 0.5 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.066 -1.021 . . . . 0.0 108.925 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.594 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -89.52 -31.25 17.72 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.485 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 6.1 p-10 -92.01 -5.1 53.6 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.313 0.577 . . . . 0.0 109.792 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.4 -24.65 11.16 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.526 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.76 129.31 29.4 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.567 -1.549 . . . . 0.0 108.38 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 10' ' ' GLY . 5.4 mtt180 -121.53 -172.47 2.43 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 122.187 0.994 . . . . 0.0 112.563 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.572 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -136.7 -178.85 5.36 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.652 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 35.3 mt-10 -151.86 112.23 4.13 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 117.788 -1.565 . . . . 0.0 110.711 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.614 ' CD1' ' HA ' ' A' ' 27' ' ' ALA 0.253 3.5 mt -107.86 -152.3 0.48 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.464 1.126 . . . . 0.0 111.207 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -150.37 70.36 1.02 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.692 HG11 ' HB ' ' A' ' 21' ' ' VAL . 12.7 t -86.8 113.7 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.541 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.17 -169.89 2.58 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.03 0.919 . . . . 0.0 111.504 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -63.86 110.53 2.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.28 -17.2 24.24 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.558 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.692 ' HB ' HG11 ' A' ' 17' ' ' VAL . 42.9 t -95.58 137.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 O-C-N 120.134 -1.804 . . . . 0.0 107.358 178.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -95.56 144.03 26.36 Favored 'General case' 0 C--N 1.274 -2.69 0 C-N-CA 118.647 -1.221 . . . . 0.0 108.032 178.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.627 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 12.2 mt -49.81 -25.98 3.55 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.09 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.567 ' CB ' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -72.21 -18.67 61.82 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 22' ' ' SER . 3.7 tt0 -88.48 -71.96 0.56 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.61 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -47.2 -50.09 21.52 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.166 -1.413 . . . . 0.0 110.349 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.614 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . . . -47.81 -48.21 30.69 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.354 -1.466 . . . . 0.0 110.361 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -72.97 0.55 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.594 -0.691 . . . . 0.0 109.627 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.502 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.34 -29.25 11.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.393 -0.817 . . . . 0.0 110.016 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.435 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.9 m-80 -97.73 -0.97 44.46 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.72 22.39 43.21 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.559 HD12 ' CD1' ' A' ' 15' ' ' LEU . 4.9 mt . . . . . 0 C--N 1.301 -1.509 0 O-C-N 121.295 -1.121 . . . . 0.0 109.237 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.521 0.676 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.495 ' O ' HG12 ' A' ' 50' ' ' VAL . 24.9 p -89.13 28.2 1.25 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.472 -0.767 . . . . 0.0 109.879 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.684 ' CE1' ' CE2' ' A' ' 51' ' ' TYR . 3.6 t60 -70.32 126.55 29.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.379 -0.826 . . . . 0.0 110.14 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.572 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -156.14 -173.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.05 -1.031 . . . . 0.0 110.102 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.684 ' CE2' ' CE1' ' A' ' 49' ' ' HIS 0.269 76.9 m-85 -140.92 109.9 6.12 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.656 0.741 . . . . 0.0 110.773 179.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.563 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 4.1 t -76.58 131.64 34.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 O-C-N 120.225 -1.547 . . . . 0.0 110.773 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.584 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 3.7 t30 -47.82 146.28 2.46 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.608 -1.237 . . . . 0.0 108.668 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -59.0 -8.0 1.27 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.058 -1.026 . . . . 0.0 112.072 -178.393 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.573 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . . . -94.76 8.1 43.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.469 -1.394 . . . . 0.0 110.532 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.681 ' CG ' HD12 ' A' ' 97' ' ' ILE . 87.3 m-85 -140.14 3.5 1.98 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 109.754 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.563 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 23.7 p -90.43 -40.54 11.98 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.1 -1.0 . . . . 0.0 108.467 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.92 -0.87 55.4 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.782 0.801 . . . . 0.0 110.438 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.659 ' HB2' HD21 ' A' ' 94' ' ' LEU 0.259 0.2 OUTLIER -99.46 -48.17 4.87 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 123.199 1.476 . . . . 0.0 107.419 179.655 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.77 ' CG1' ' HD2' ' A' ' 61' ' ' PRO 0.337 0.8 OUTLIER -77.36 -176.82 0.69 Allowed Pre-proline 0 C--N 1.289 -2.039 0 CA-C-N 113.602 -1.635 . . . . 0.0 107.225 179.31 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.77 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 35.5 Cg_endo -61.99 127.45 21.37 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 CA-C-O 122.885 1.119 . . . . 0.0 111.448 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.519 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -74.05 60.4 0.77 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.824 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' A' ' 67' ' ' GLU . . . -38.43 107.29 0.06 Allowed 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.476 0.655 . . . . 0.0 109.915 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -87.73 -142.38 0.12 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.31 -0.869 . . . . 0.0 111.996 -178.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.505 ' HG2' ' ND2' ' A' ' 64' ' ' ASN . 15.7 pt-20 -29.14 -37.34 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 64' ' ' ASN . 4.3 mtm-85 -53.35 -70.37 0.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.872 -1.142 . . . . 0.0 108.99 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -59.78 -52.58 64.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 110.188 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.538 ' O ' ' CB ' ' A' ' 72' ' ' GLU . 1.4 mp -45.54 -20.88 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.566 -0.709 . . . . 0.0 111.111 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -86.6 -80.21 1.19 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.55 ' HG3' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -44.06 -39.06 3.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -1.162 . . . . 0.0 108.653 178.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.695 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 0.5 OUTLIER -63.41 -51.96 63.57 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.538 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -54.63 -24.21 20.5 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -71.23 -50.79 29.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.666 -0.647 . . . . 0.0 110.326 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.569 HG13 ' CG ' ' A' ' 49' ' ' HIS . 4.6 m -39.7 160.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.374 -0.828 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.555 ' O ' ' CG2' ' A' ' 75' ' ' THR . 20.9 m -120.66 35.27 4.93 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.033 -1.042 . . . . 0.0 109.26 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.617 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -114.98 -163.89 0.91 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.841 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.747 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.13 63.21 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.739 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.741 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.08 152.58 16.38 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 118.989 -2.32 . . . . 0.0 111.763 -177.177 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.662 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.392 1.5 mmtt -133.96 177.73 2.11 Favored Pre-proline 0 C--N 1.292 -1.926 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.662 -173.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 44.3 Cg_endo -75.93 -29.38 6.86 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 N-CA-C 107.329 -1.835 . . . . 0.0 107.329 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.529 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.6 OUTLIER -103.82 12.4 34.56 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.631 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.741 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -44.46 148.03 0.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.123 -0.986 . . . . 0.0 109.838 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.519 ' NH1' ' HA ' ' A' ' 62' ' ' ALA . 1.1 mtt180 -169.67 157.74 7.21 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.733 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 86' ' ' CYS . 4.4 mt -106.97 116.09 31.32 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 24' ' ' MET . 7.4 p -35.35 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.567 ' HA ' ' CB ' ' A' ' 24' ' ' MET . 4.5 p -65.41 -6.1 9.37 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.294 -1.504 . . . . 0.0 112.127 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.543 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . 6.5 tp-100 -125.53 3.24 7.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.421 -1.424 . . . . 0.0 111.655 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.516 ' CD1' ' NE ' ' A' ' 83' ' ' ARG . 35.9 mm -100.99 103.4 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.753 -1.217 . . . . 0.0 110.312 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.57 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -90.17 128.63 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.073 -1.017 . . . . 0.0 108.465 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.58 ' HG3' ' CG2' ' A' ' 3' ' ' VAL . 22.3 mmm -83.22 134.49 34.95 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.546 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.573 ' OG1' ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -112.15 170.67 5.03 Favored Pre-proline 0 C--N 1.291 -1.935 0 O-C-N 120.833 -1.167 . . . . 0.0 109.507 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 38.9 Cg_endo -65.86 -11.71 32.04 Favored 'Trans proline' 0 C--N 1.289 -2.58 0 O-C-N 124.525 1.803 . . . . 0.0 110.892 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.573 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.3 OUTLIER -92.37 -29.33 16.38 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 117.729 -1.588 . . . . 0.0 107.835 177.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 59' ' ' LYS . 96.7 mt -89.96 27.48 1.58 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.707 0.765 . . . . 0.0 110.935 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.446 ' OD1' ' HG3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -63.23 104.79 0.63 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.51 -1.276 . . . . 0.0 107.958 177.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.601 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.78 22.74 1.95 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.723 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -57.83 138.05 19.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.399 -1.059 . . . . 0.0 111.069 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.606 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 2.1 t -111.36 114.14 46.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -98.81 155.17 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.732 -1.23 . . . . 0.0 109.209 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.664 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.93 120.32 33.08 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.358 -0.839 . . . . 0.0 110.251 -178.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 69.8 t -96.32 136.79 21.76 Favored Pre-proline 0 C--N 1.287 -2.115 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.789 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.675 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 57.3 Cg_endo -89.48 171.28 4.39 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.063 1.559 . . . . 0.0 111.585 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -91.2 -17.24 26.39 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.453 ' HB3' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.82 73.9 0.85 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.05 57.13 1.07 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.435 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.583 ' OXT' ' CD2' ' A' ' 106' ' ' TRP . 1.7 p-90 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.714 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.639 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 9.1 mtmm . . . . . 0 C--O 1.211 -0.936 0 CA-C-O 121.828 0.823 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.715 ' HA ' HG21 ' A' ' 97' ' ' ILE . 56.0 t -141.17 135.04 31.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 O-C-N 121.152 -0.968 . . . . 0.0 110.983 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 23.6 t -142.6 89.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 118.732 -1.187 . . . . 0.0 110.415 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.637 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 46.2 m-85 -67.92 157.04 35.89 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.466 -0.772 . . . . 0.0 109.331 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.547 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 99.7 t -122.54 169.98 13.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 O-C-N 121.178 -0.951 . . . . 0.0 109.291 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 11' ' ' THR . 9.9 p -102.61 -153.26 0.46 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.06 -1.025 . . . . 0.0 109.217 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.574 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -93.51 -29.44 15.53 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 178.093 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -91.81 -9.97 41.54 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.498 0.666 . . . . 0.0 109.452 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.529 ' O ' ' CD ' ' A' ' 12' ' ' ARG . . . 114.57 -5.69 22.83 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 120.3 -0.953 . . . . 0.0 111.145 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.6 OUTLIER -63.54 130.56 44.87 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.288 -1.713 . . . . 0.0 107.924 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -120.74 176.08 5.7 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 122.257 1.027 . . . . 0.0 112.927 -177.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.555 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -133.02 178.9 6.53 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 177.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 46.2 mp0 -151.75 110.32 3.8 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 117.56 -1.656 . . . . 0.0 111.109 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.601 ' CD1' ' HA ' ' A' ' 27' ' ' ALA . 8.3 mt -103.17 -156.33 0.56 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.592 1.187 . . . . 0.0 110.618 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -153.02 70.35 0.87 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.702 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -89.66 127.84 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.003 0.906 . . . . 0.0 109.627 -177.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.25 -179.27 5.84 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.259 1.028 . . . . 0.0 112.858 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -62.24 119.18 8.52 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.05 -22.14 19.01 Favored Glycine 0 C--N 1.288 -2.119 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.555 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.702 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 65.8 t -90.77 150.64 3.68 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.209 0 O-C-N 120.116 -1.814 . . . . 0.0 109.505 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 25' ' ' GLN . 1.2 p -96.61 132.14 42.54 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.637 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 7.9 mt -46.96 -28.44 1.62 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.705 -1.247 . . . . 0.0 108.436 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.553 ' CB ' ' O ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -73.91 -12.02 60.53 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.323 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.0 OUTLIER -91.84 -61.22 1.68 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.598 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -54.39 -55.53 27.72 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.375 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.601 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . . . -47.42 -51.0 21.38 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.561 -1.337 . . . . 0.0 110.446 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -65.41 -5.61 2.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 109.333 179.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 26' ' ' ALA 0.256 0.0 OUTLIER -103.3 -24.0 13.55 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.731 0.777 . . . . 0.0 110.065 179.838 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.468 ' CB ' HD21 ' A' ' 15' ' ' LEU . 3.6 m-80 -96.75 5.45 50.59 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.72 78.44 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.591 ' CD1' ' CD2' ' A' ' 15' ' ' LEU . 10.5 mt . . . . . 0 C--N 1.303 -1.444 0 O-C-N 121.317 -1.107 . . . . 0.0 109.213 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.444 0.64 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.581 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -107.06 14.73 26.02 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.475 -0.765 . . . . 0.0 109.66 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.7 ' CD2' ' CG ' ' A' ' 102' ' ' PRO . 13.4 t60 -70.23 123.76 22.47 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.276 -0.89 . . . . 0.0 111.714 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.58 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 1.5 m -158.34 -174.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.729 0.776 . . . . 0.0 109.129 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.69 ' CE1' ' CE1' ' A' ' 49' ' ' HIS 0.252 68.0 m-85 -140.84 102.57 4.31 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.019 0.914 . . . . 0.0 110.66 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.583 HG23 ' CB ' ' A' ' 83' ' ' ARG . 2.7 t -74.19 134.13 30.18 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 O-C-N 120.69 -1.256 . . . . 0.0 110.491 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.581 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 3.7 t30 -48.8 150.33 1.5 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.302 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.6 pt-20 -60.35 -8.1 2.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.246 -0.909 . . . . 0.0 111.909 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.578 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.78 9.41 43.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.628 -1.295 . . . . 0.0 110.758 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.693 ' CG ' HD12 ' A' ' 97' ' ' ILE . 88.0 m-85 -140.51 2.03 1.8 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.051 -1.03 . . . . 0.0 110.119 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.578 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 7.6 p -90.45 -40.21 12.16 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.015 -1.053 . . . . 0.0 108.36 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.39 -0.31 52.69 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.688 0.756 . . . . 0.0 110.699 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.646 ' HB2' HD21 ' A' ' 94' ' ' LEU 0.265 1.1 mtpp -99.22 -48.49 4.81 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 123.303 1.525 . . . . 0.0 107.085 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.665 ' CG1' ' HD2' ' A' ' 61' ' ' PRO 0.334 0.9 OUTLIER -72.8 179.48 1.09 Allowed Pre-proline 0 C--N 1.288 -2.083 0 CA-C-N 113.436 -1.711 . . . . 0.0 106.472 178.431 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.665 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 36.6 Cg_endo -70.21 113.07 3.33 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 CA-C-O 122.834 1.098 . . . . 0.0 111.155 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.3 67.61 1.42 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.225 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.566 ' CB ' ' CG ' ' A' ' 87' ' ' GLN . . . -37.45 156.6 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.954 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 66' ' ' ARG . 2.3 p-10 -92.37 -161.96 0.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.017 -1.052 . . . . 0.0 112.399 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 4.0 pt-20 -38.1 -24.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.987 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -52.76 -72.3 0.06 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.65 -1.281 . . . . 0.0 107.949 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.597 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -68.36 -40.88 81.33 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.554 -0.716 . . . . 0.0 109.298 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.483 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.1 mp -57.94 -16.89 7.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.111 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.495 ' HA2' ' OE1' ' A' ' 72' ' ' GLU . . . -97.01 -68.35 0.96 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.597 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -42.44 -38.9 2.04 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.126 -1.22 . . . . 0.0 108.065 179.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.698 ' CD1' ' HB3' ' A' ' 82' ' ' SER 0.261 0.0 OUTLIER -65.34 -50.51 65.31 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.883 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.515 ' OE2' ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -67.04 -29.84 69.75 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.515 ' N ' ' OE2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -61.11 -38.92 88.04 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.023 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.635 ' CG2' ' CE1' ' A' ' 49' ' ' HIS . 1.4 m -53.2 168.81 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.594 ' O ' ' CG2' ' A' ' 75' ' ' THR . 17.0 m -120.74 54.48 1.07 Allowed 'General case' 0 C--N 1.287 -2.145 0 O-C-N 120.483 -1.386 . . . . 0.0 110.014 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.652 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -126.17 -154.64 0.64 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 115.151 -2.62 . . . . 0.0 112.211 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.733 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.262 0.0 OUTLIER -63.88 60.38 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 122.702 1.239 . . . . 0.0 108.472 -179.558 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.626 HD12 ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -59.23 132.72 54.85 Favored 'General case' 0 C--N 1.288 -2.09 0 O-C-N 119.63 -1.919 . . . . 0.0 110.375 -177.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.546 ' CD ' ' O ' ' A' ' 77' ' ' GLU 0.365 0.0 OUTLIER -116.01 -179.4 0.62 Allowed Pre-proline 0 C--N 1.291 -1.975 0 CA-C-N 112.666 -2.061 . . . . 0.0 111.798 -174.13 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -79.12 -28.79 3.58 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 N-CA-C 106.82 -2.031 . . . . 0.0 106.82 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.532 ' O ' ' O ' ' A' ' 82' ' ' SER . 14.8 p-10 -108.68 14.68 24.26 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.98 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.698 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . 2.7 m -47.8 -175.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.537 -0.727 . . . . 0.0 109.68 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.583 ' CB ' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -174.89 169.27 3.47 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 116.434 -2.106 . . . . 0.0 114.72 178.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.554 ' CD1' ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -115.72 103.12 10.37 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.661 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 48' ' ' CYS . 0.7 OUTLIER -31.92 -31.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 84' ' ' LEU . 29.6 p -84.48 12.07 7.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.053 -1.654 . . . . 0.0 112.247 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.566 ' CG ' ' CB ' ' A' ' 63' ' ' ALA . 1.5 tp-100 -126.33 21.62 7.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.588 -1.32 . . . . 0.0 111.836 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.561 HD12 ' CG1' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -120.12 105.15 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.736 -1.227 . . . . 0.0 110.678 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.57 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -90.76 132.39 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.923 -1.11 . . . . 0.0 109.37 179.085 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.611 ' HG2' ' CG2' ' A' ' 3' ' ' VAL . 1.3 tpt -82.83 117.56 22.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.653 -0.654 . . . . 0.0 111.348 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.573 ' OG1' ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -98.77 176.15 2.13 Favored Pre-proline 0 N--CA 1.496 1.849 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.779 178.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 45.3 Cg_endo -78.56 -9.0 16.09 Favored 'Trans proline' 0 C--N 1.293 -2.353 0 O-C-N 124.564 1.823 . . . . 0.0 110.262 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.573 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.6 OUTLIER -92.72 -29.72 15.91 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 59' ' ' LYS . 85.9 mt -89.68 28.47 1.31 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.738 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.525 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 17.9 p-10 -63.45 105.73 0.81 Allowed 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 118.513 -1.275 . . . . 0.0 108.621 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.639 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 125.04 16.99 2.83 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.523 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.715 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -51.71 142.17 4.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.606 -0.938 . . . . 0.0 111.715 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.604 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 2.1 t -115.67 111.43 35.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -99.06 153.05 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 120.735 -1.228 . . . . 0.0 109.853 -178.542 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.76 127.88 49.74 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.791 -179.118 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.572 HG13 ' CE1' ' A' ' 8' ' ' HIS . 54.5 t -98.24 139.8 21.45 Favored Pre-proline 0 C--N 1.288 -2.07 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.722 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.7 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 56.2 Cg_endo -90.53 174.81 2.83 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.818 1.679 . . . . 0.0 111.886 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 11.1 p-10 -91.3 -17.72 25.48 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.533 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -111.34 67.86 0.65 Allowed 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -97.5 49.88 1.05 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.326 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.571 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 11.0 p-90 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.282 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.659 ' O ' HG21 ' A' ' 97' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.204 -1.318 0 CA-C-O 121.356 0.598 . . . . 0.0 110.057 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.775 ' HA ' HG21 ' A' ' 97' ' ' ILE . 44.8 t -134.39 133.07 55.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.843 0.83 . . . . 0.0 111.073 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 56.4 t -142.29 89.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.531 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.656 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 40.9 m-85 -67.79 135.82 53.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.53 HG22 ' CD ' ' A' ' 12' ' ' ARG . 59.3 t -99.65 167.09 2.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 O-C-N 120.546 -1.346 . . . . 0.0 109.664 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 11' ' ' THR . 89.6 p -102.3 -153.99 0.48 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 109.335 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.594 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -88.99 -33.09 17.31 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.478 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 10.5 p-10 -91.63 -3.88 55.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.736 -0.603 . . . . 0.0 109.883 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.11 -24.42 11.67 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.79 128.83 28.02 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.609 -1.524 . . . . 0.0 108.38 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.53 ' CD ' HG22 ' A' ' 6' ' ' VAL . 20.8 mtm180 -121.35 -171.77 2.28 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 122.162 0.982 . . . . 0.0 112.474 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.36 -179.08 5.42 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 178.296 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -152.0 109.58 3.62 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 117.447 -1.701 . . . . 0.0 111.201 178.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.603 ' CD1' ' N ' ' A' ' 27' ' ' ALA . 6.6 mt -105.06 -157.07 0.59 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.639 1.209 . . . . 0.0 110.583 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -153.27 70.81 0.87 Allowed 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.701 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 1.2 t -88.34 127.39 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.736 0.779 . . . . 0.0 109.592 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.0 -178.16 5.63 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.618 1.199 . . . . 0.0 112.987 -177.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.498 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 1.5 p30 -61.15 116.12 4.31 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.829 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.89 -20.86 21.57 Favored Glycine 0 C--N 1.287 -2.162 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.524 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.701 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 90.3 t -89.21 150.5 3.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 120.1 -1.823 . . . . 0.0 109.306 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 25' ' ' GLN . 1.6 p -96.01 125.61 40.67 Favored 'General case' 0 C--N 1.274 -2.684 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.656 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 4.4 mt -43.05 -24.33 0.07 Allowed 'General case' 0 C--O 1.203 -1.382 0 O-C-N 120.73 -1.231 . . . . 0.0 109.265 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.594 ' O ' ' HB ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -64.43 -47.58 78.58 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.9 tt0 -59.84 -65.51 0.67 Allowed 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.57 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -46.61 -60.04 2.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.911 -1.118 . . . . 0.0 110.581 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.603 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -47.72 -54.69 11.42 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.751 -1.218 . . . . 0.0 110.848 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.594 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -63.92 -6.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.544 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.254 0.0 OUTLIER -99.25 -25.97 14.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.303 -0.873 . . . . 0.0 109.817 179.708 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 26' ' ' ALA . 3.5 m-80 -96.93 3.93 51.84 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.81 72.81 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.574 HD11 ' CD1' ' A' ' 15' ' ' LEU . 9.0 mt . . . . . 0 C--N 1.302 -1.495 0 O-C-N 121.479 -1.012 . . . . 0.0 109.488 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.448 0.642 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.524 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 9.4 p -115.32 29.69 7.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.456 -0.777 . . . . 0.0 109.895 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.668 ' HE1' ' CZ ' ' A' ' 51' ' ' TYR . 4.7 t60 -70.21 125.98 28.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.745 . . . . 0.0 110.116 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.577 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 0.9 OUTLIER -155.3 -173.66 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.0 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.694 ' O ' ' N ' ' A' ' 100' ' ' ASP 0.269 82.9 m-85 -140.41 114.13 8.82 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.624 0.726 . . . . 0.0 110.754 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.547 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 5.5 t -85.19 130.66 35.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 O-C-N 120.28 -1.513 . . . . 0.0 109.504 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.672 HD22 ' HB2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -40.75 157.2 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.675 -1.265 . . . . 0.0 109.294 177.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.1 0.37 7.79 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.844 -1.16 . . . . 0.0 110.209 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.59 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.1 5.29 47.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.948 -1.095 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.681 ' CD2' ' HA ' ' A' ' 97' ' ' ILE . 55.0 m-85 -140.48 5.44 2.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.901 -1.124 . . . . 0.0 109.443 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.547 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 30.4 p -89.58 -38.02 14.27 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -2.45 44.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.828 0.823 . . . . 0.0 110.39 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.623 ' CB ' ' CD2' ' A' ' 94' ' ' LEU 0.259 0.2 OUTLIER -99.21 -47.96 5.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 179.708 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.672 ' HB ' ' O ' ' A' ' 56' ' ' PHE 0.334 1.1 t -80.4 175.03 5.22 Favored Pre-proline 0 C--N 1.288 -2.071 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 177.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.593 ' CG ' ' HB ' ' A' ' 89' ' ' ILE . 38.3 Cg_endo -74.54 110.79 3.17 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 CA-C-O 122.877 1.115 . . . . 0.0 112.934 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.524 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -75.43 75.55 2.5 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.356 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . . . -37.04 160.32 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.874 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -96.99 -160.7 0.82 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.247 -0.908 . . . . 0.0 112.336 -178.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -28.74 -39.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 122.025 -0.422 . . . . 0.0 112.074 -178.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 64' ' ' ASN . 3.6 mtt180 -53.19 -66.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.569 -1.332 . . . . 0.0 108.488 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.592 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.8 OUTLIER -59.25 -35.13 73.14 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.579 -0.701 . . . . 0.0 109.86 178.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.7 mp -77.24 -9.04 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.224 -0.922 . . . . 0.0 110.278 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -84.23 -80.81 1.05 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.592 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.82 -36.56 2.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.164 -1.198 . . . . 0.0 108.728 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.641 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 0.9 OUTLIER -64.62 -48.54 74.5 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 3.1 tp10 -61.36 -16.18 43.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.49 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -85.72 -40.51 16.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.695 -0.628 . . . . 0.0 110.459 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.575 HG13 ' CG ' ' A' ' 49' ' ' HIS . 8.1 m -40.38 162.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.387 -0.821 . . . . 0.0 109.639 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.539 ' O ' ' CG2' ' A' ' 75' ' ' THR . 23.0 m -120.48 30.0 7.16 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.193 -0.942 . . . . 0.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.605 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -113.85 -167.96 1.28 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.755 -1.178 . . . . 0.0 112.465 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.738 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.14 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.819 -179.012 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.796 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.48 153.56 15.71 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 118.903 -2.373 . . . . 0.0 111.165 -177.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.506 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.347 0.0 OUTLIER -128.46 -178.18 0.75 Allowed Pre-proline 0 C--N 1.297 -1.703 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.329 -174.792 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -78.75 -28.36 4.22 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 N-CA-C 106.985 -1.967 . . . . 0.0 106.985 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.56 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER -108.11 16.24 23.5 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.089 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.796 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -43.72 149.37 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.922 -1.111 . . . . 0.0 108.932 -179.388 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.589 ' CZ ' ' CD1' ' A' ' 88' ' ' ILE . 2.3 mmt85 -154.55 146.07 23.14 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.604 -1.638 . . . . 0.0 112.403 -177.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -103.67 88.71 3.13 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 177.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 24' ' ' MET . 5.7 t -17.03 -45.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.578 ' N ' ' O ' ' A' ' 84' ' ' LEU . 1.6 p -44.26 -19.31 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.611 -1.305 . . . . 0.0 112.236 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.469 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 1.3 mp0 -118.88 -4.72 10.64 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.254 -1.529 . . . . 0.0 112.081 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.589 ' CD1' ' CZ ' ' A' ' 83' ' ' ARG . 3.2 mm -79.76 98.25 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.779 -1.201 . . . . 0.0 109.046 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.593 ' HB ' ' CG ' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -84.11 130.42 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.002 -1.061 . . . . 0.0 109.02 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.586 ' HE3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -83.31 125.16 31.33 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.692 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.61 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -101.42 -177.67 0.58 Allowed Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 118.111 -1.436 . . . . 0.0 109.005 177.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.61 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 47.6 Cg_endo -89.07 -14.71 2.67 Favored 'Trans proline' 0 C--N 1.291 -2.453 0 O-C-N 124.483 1.781 . . . . 0.0 108.713 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.5 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.1 pt-20 -82.26 -31.47 30.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.632 ' CD1' HG23 ' A' ' 60' ' ' VAL . 52.4 mt -89.72 34.85 0.83 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.053 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.525 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 6.7 p-10 -62.65 107.16 0.9 Allowed 'General case' 0 C--N 1.29 -2.013 0 O-C-N 120.365 -1.459 . . . . 0.0 109.092 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.433 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 122.24 25.67 1.98 Allowed Glycine 0 N--CA 1.497 2.761 0 O-C-N 120.835 -1.165 . . . . 0.0 110.71 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.775 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -59.1 135.97 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.971 -1.311 . . . . 0.0 110.6 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.672 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.4 t -115.77 111.74 36.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -99.5 156.5 3.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.88 -178.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.694 ' N ' ' O ' ' A' ' 51' ' ' TYR . 1.1 m-20 -122.9 125.95 46.34 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.306 -0.871 . . . . 0.0 110.413 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.532 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 56.1 t -103.61 130.31 23.75 Favored Pre-proline 0 C--N 1.289 -2.039 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.692 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.653 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 56.7 Cg_endo -84.23 173.84 8.55 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 124.296 1.682 . . . . 0.0 112.077 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 1.3 m-20 -91.34 -18.31 24.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.529 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.91 73.75 0.84 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.466 ' HG2' ' HD2' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -98.64 55.63 1.08 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 118.994 -1.083 . . . . 0.0 110.132 -177.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.563 ' CD2' ' O ' ' A' ' 106' ' ' TRP . 1.4 p-90 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.92 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.655 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.202 -1.429 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.734 ' CG2' HG23 ' A' ' 17' ' ' VAL . 78.6 t -137.69 130.08 41.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 122.287 1.042 . . . . 0.0 110.711 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 85.8 t -141.42 96.5 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.917 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.294 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.652 ' HB2' ' CG ' ' A' ' 13' ' ' ARG . 21.6 m-85 -76.89 151.63 35.72 Favored 'General case' 0 C--O 1.201 -1.486 0 O-C-N 121.64 -0.663 . . . . 0.0 109.747 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 89.9 t -111.31 166.85 5.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 O-C-N 121.046 -1.034 . . . . 0.0 110.368 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 11' ' ' THR . 85.8 p -103.77 -157.21 0.6 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.131 -0.98 . . . . 0.0 109.261 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.613 ' CE1' HG13 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -91.04 -27.13 18.82 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.442 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 6.3 p-10 -92.1 -8.23 46.37 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.734 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 113.47 -9.35 24.22 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.58 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.6 OUTLIER -66.54 136.17 55.25 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 119.914 -1.933 . . . . 0.0 108.758 179.599 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -120.5 179.66 4.25 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.251 1.024 . . . . 0.0 112.974 -176.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.652 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -134.58 173.27 11.84 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 179.589 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 16.3 mt-10 -150.15 114.84 5.27 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 117.111 -1.836 . . . . 0.0 111.047 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.625 ' CD1' ' HA ' ' A' ' 27' ' ' ALA 0.28 4.6 mt -107.92 -154.03 0.52 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.462 1.125 . . . . 0.0 109.845 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.32 72.04 0.92 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.734 HG23 ' CG2' ' A' ' 3' ' ' VAL . 1.4 t -88.31 126.41 41.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-O 121.786 0.803 . . . . 0.0 109.022 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.629 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.44 -179.51 5.84 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.817 0.817 . . . . 0.0 112.777 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.653 ' HB3' ' CD ' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -56.75 112.44 1.3 Allowed 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.56 177.091 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.81 -21.54 18.31 Favored Glycine 0 C--N 1.282 -2.464 0 C-N-CA 118.702 -1.713 . . . . 0.0 113.003 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.678 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 66.7 t -86.2 147.87 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 120.677 2.239 . . . . 0.0 108.059 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -95.38 130.34 42.21 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.612 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 11.0 mt -44.87 -25.79 0.34 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.015 -1.678 . . . . 0.0 109.782 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.564 ' CB ' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -67.41 -23.18 65.53 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.3 tt0 -88.09 -65.43 1.02 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.613 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -46.42 -49.86 17.51 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.281 -1.368 . . . . 0.0 111.383 178.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.649 ' HB1' ' CZ ' ' A' ' 5' ' ' TYR . . . -55.2 -50.0 70.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.184 -1.573 . . . . 0.0 110.173 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.7 OUTLIER -67.32 -1.19 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.73 -1.231 . . . . 0.0 110.569 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . 0.265 0.0 OUTLIER -104.33 -31.15 9.68 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.311 1.053 . . . . 0.0 109.655 -178.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.514 ' HB2' HD21 ' A' ' 15' ' ' LEU . 6.8 m-80 -95.82 4.16 53.1 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.17 12.58 63.2 Favored Glycine 0 N--CA 1.505 3.273 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.536 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.568 HD13 ' CD2' ' A' ' 15' ' ' LEU . 7.9 mt . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.564 -0.962 . . . . 0.0 109.681 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.683 0.754 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.51 ' O ' HG11 ' A' ' 50' ' ' VAL . 6.8 p -99.68 30.04 3.82 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.616 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.675 ' CE1' ' CZ ' ' A' ' 51' ' ' TYR . 5.3 t60 -69.81 123.25 20.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.518 -0.739 . . . . 0.0 110.842 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -155.32 -172.35 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 120.808 -1.182 . . . . 0.0 108.399 178.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.675 ' CZ ' ' CE1' ' A' ' 49' ' ' HIS 0.301 79.8 m-85 -139.78 109.13 6.14 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.351 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.557 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 7.1 t -76.94 129.42 37.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 O-C-N 120.566 -1.334 . . . . 0.0 110.553 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.683 HD22 ' HB2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -42.75 146.22 0.39 Allowed 'General case' 0 C--N 1.307 -1.251 0 O-C-N 120.163 -1.586 . . . . 0.0 109.411 176.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.14 -9.48 0.92 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.361 -0.837 . . . . 0.0 111.956 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.631 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -92.15 7.77 40.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.041 -1.662 . . . . 0.0 112.281 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.692 ' O ' ' HB ' ' A' ' 60' ' ' VAL . 77.1 m-85 -141.08 3.71 1.81 Allowed 'General case' 0 N--CA 1.516 2.857 0 O-C-N 120.535 -1.353 . . . . 0.0 108.759 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.557 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 17.0 p -89.4 -33.25 16.92 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.157 -0.965 . . . . 0.0 108.618 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.38 -1.76 24.67 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.94 0.876 . . . . 0.0 111.084 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.631 ' CD ' ' O ' ' A' ' 55' ' ' ALA 0.286 0.1 OUTLIER -97.63 -48.31 5.29 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 179.187 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.692 ' HB ' ' O ' ' A' ' 56' ' ' PHE 0.339 1.0 OUTLIER -77.44 177.75 2.52 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.699 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.64 ' HD2' HG11 ' A' ' 60' ' ' VAL . 32.5 Cg_endo -71.6 122.56 8.69 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 CA-C-O 122.632 1.013 . . . . 0.0 111.731 -177.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -77.17 73.57 3.75 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.36 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.497 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . . . -37.71 157.59 0.01 OUTLIER 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.326 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 66' ' ' ARG . 48.1 p30 -90.0 -168.7 2.2 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 123.157 1.456 . . . . 0.0 112.49 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -37.4 -30.43 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.237 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.46 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -55.28 -63.43 1.16 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.365 -1.459 . . . . 0.0 107.568 179.247 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.592 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 8.0 tp10 -60.72 -41.0 94.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.823 -0.548 . . . . 0.0 110.421 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.9 mt -79.75 -5.22 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.933 . . . . 0.0 110.906 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -86.93 -75.71 1.27 Allowed Glycine 0 N--CA 1.482 1.753 0 N-CA-C 107.629 -2.188 . . . . 0.0 107.629 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.603 ' HG3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -43.52 -43.36 5.44 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.629 -1.228 . . . . 0.0 107.913 178.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.57 ' CD2' HD12 ' A' ' 78' ' ' LEU 0.25 0.6 OUTLIER -56.96 -53.78 54.13 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.34 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -56.0 -24.94 41.92 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.707 -1.245 . . . . 0.0 108.358 178.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.488 ' O ' ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -74.05 -47.16 38.6 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.704 -179.362 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 71' ' ' LEU . 3.3 m -36.19 161.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 121.972 0.891 . . . . 0.0 111.186 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.566 ' O ' ' CG2' ' A' ' 75' ' ' THR . 30.2 m -118.45 25.9 9.97 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.456 -1.403 . . . . 0.0 109.973 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.6 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -103.46 -153.66 0.48 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.102 -1.624 . . . . 0.0 113.283 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.753 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.25 0.0 OUTLIER -71.05 63.15 0.31 Allowed 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.897 -178.41 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.75 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -57.39 154.97 9.86 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 116.218 -2.193 . . . . 0.0 110.317 -176.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.66 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.375 20.4 mmtt -134.02 178.89 1.55 Allowed Pre-proline 0 C--N 1.294 -1.831 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.253 -173.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 55.2 Cg_endo -77.3 -28.38 5.76 Favored 'Trans proline' 0 C--N 1.295 -2.27 0 N-CA-C 104.742 -2.83 . . . . 0.0 104.742 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.517 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 13.3 p-10 -105.13 14.57 28.96 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.611 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.75 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -47.26 146.6 1.85 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.853 -1.155 . . . . 0.0 109.499 178.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.608 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 mmm-85 -169.1 122.8 0.81 Allowed 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 117.661 -1.616 . . . . 0.0 111.99 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.603 HD13 ' HG3' ' A' ' 70' ' ' MET . 0.7 OUTLIER -80.72 112.97 18.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.041 -1.662 . . . . 0.0 108.298 176.44 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 24' ' ' MET . 5.5 m -35.09 -23.55 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.564 ' HA ' ' CB ' ' A' ' 24' ' ' MET . 9.7 p -64.08 -12.71 41.6 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 119.222 -2.174 . . . . 0.0 111.056 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.58 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -120.67 18.36 11.95 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.731 -1.188 . . . . 0.0 111.366 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.419 HD12 ' CG1' ' A' ' 60' ' ' VAL . 3.5 mm -110.07 102.75 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.126 -0.984 . . . . 0.0 110.406 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.574 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -84.25 126.55 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 120.967 -1.083 . . . . 0.0 110.418 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.632 ' HA ' ' CE ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -82.53 123.47 29.22 Favored 'General case' 0 C--O 1.2 -1.526 0 O-C-N 120.81 -1.181 . . . . 0.0 109.236 177.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.549 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -113.92 157.39 42.05 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.181 178.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.653 ' CD ' ' HB3' ' A' ' 19' ' ' ASP . 33.8 Cg_endo -58.06 -27.45 79.69 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 124.444 1.76 . . . . 0.0 109.07 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.549 ' HG2' ' HB ' ' A' ' 91' ' ' THR . 3.0 pt-20 -64.4 -42.85 95.86 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.176 176.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.646 ' CD1' HG23 ' A' ' 60' ' ' VAL . 50.8 mt -88.51 38.79 0.88 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.729 0.776 . . . . 0.0 112.469 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.53 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 3.3 p-10 -64.6 111.1 2.57 Favored 'General case' 0 C--N 1.286 -2.185 0 O-C-N 119.867 -1.771 . . . . 0.0 109.167 177.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.655 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.44 21.69 2.2 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.176 -1.488 . . . . 0.0 110.425 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.725 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -60.34 136.98 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.054 -1.262 . . . . 0.0 110.297 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.65 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.5 t -117.15 113.2 42.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.57 HG23 ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -101.16 156.67 4.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 120.262 -1.524 . . . . 0.0 109.886 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.625 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.48 130.05 52.65 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 122.571 1.177 . . . . 0.0 111.276 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.613 HG13 ' CE1' ' A' ' 8' ' ' HIS . 87.2 t -104.89 136.65 19.13 Favored Pre-proline 0 C--N 1.283 -2.307 0 O-C-N 120.743 -1.223 . . . . 0.0 109.833 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.565 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 73.8 Cg_endo -92.61 166.85 2.75 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.807 1.671 . . . . 0.0 111.126 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -86.94 -18.09 31.59 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.706 0.765 . . . . 0.0 109.248 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.529 ' HB3' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -109.47 73.09 0.83 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.26 57.92 0.81 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.975 -1.078 . . . . 0.0 109.695 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.6 ' CD2' ' O ' ' A' ' 106' ' ' TRP . 3.3 p-90 . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.618 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.598 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.204 -1.318 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.765 ' HA ' HG21 ' A' ' 97' ' ' ILE . 40.4 t -135.47 135.83 51.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-O 121.748 0.785 . . . . 0.0 111.914 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 47.4 t -142.67 88.5 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.496 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.655 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 46.4 m-85 -67.53 136.0 53.88 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.414 -0.804 . . . . 0.0 109.336 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.532 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 60.7 t -99.77 166.62 2.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 O-C-N 120.662 -1.274 . . . . 0.0 109.513 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.553 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 87.9 p -100.53 -155.28 0.5 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.141 -0.975 . . . . 0.0 109.029 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.595 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -89.7 -30.17 18.25 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.79 -6.18 52.21 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.388 0.613 . . . . 0.0 109.81 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.37 -24.92 10.91 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.71 129.16 28.77 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.689 -1.477 . . . . 0.0 108.237 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.53 ' CD ' HG22 ' A' ' 6' ' ' VAL . 2.5 mtm180 -121.42 -173.13 2.56 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-O 122.211 1.005 . . . . 0.0 112.528 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -134.94 -177.65 4.73 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 80.0 mt-10 -151.83 109.41 3.62 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.495 -1.682 . . . . 0.0 111.518 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.613 ' CD1' ' HA ' ' A' ' 27' ' ' ALA . 7.7 mt -106.63 -173.9 2.41 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.452 1.12 . . . . 0.0 110.889 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.62 68.86 1.44 Allowed 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.705 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 1.6 t -87.72 126.33 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.096 0.95 . . . . 0.0 109.311 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.514 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.29 178.47 6.33 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.124 0.964 . . . . 0.0 112.887 -177.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.566 ' HB3' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -52.21 129.94 29.21 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.215 1.007 . . . . 0.0 109.288 177.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.406 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 94.68 -20.93 46.07 Favored Glycine 0 C--N 1.276 -2.802 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.551 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.705 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 84.9 t -83.96 149.81 4.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 CA-C-N 120.843 2.322 . . . . 0.0 109.523 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -96.01 122.85 39.27 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.648 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 1.9 mt -46.33 -24.73 0.52 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.277 -1.514 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.553 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -70.33 -11.6 61.02 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.928 0.871 . . . . 0.0 108.756 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -97.83 -63.41 1.13 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.039 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.572 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -47.36 -58.96 3.55 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.975 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.613 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . . . -47.76 -53.04 16.49 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.581 -1.324 . . . . 0.0 110.474 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -66.1 -3.52 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 109.526 179.091 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.255 0.0 OUTLIER -103.15 -24.99 13.54 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.833 0.825 . . . . 0.0 110.149 179.851 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 26' ' ' ALA . 3.6 m-80 -97.02 4.94 51.22 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.61 11.12 75.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.588 ' CD1' ' CD2' ' A' ' 15' ' ' LEU . 9.2 mt . . . . . 0 C--N 1.302 -1.492 0 O-C-N 121.364 -1.08 . . . . 0.0 109.309 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 105' ' ' GLN . 8.6 t . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.386 0.612 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.482 ' O ' HG12 ' A' ' 50' ' ' VAL . 25.4 p -88.64 26.41 1.5 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.476 -0.765 . . . . 0.0 110.12 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.702 ' CE1' ' CE2' ' A' ' 51' ' ' TYR . 5.7 t60 -70.12 123.26 21.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.427 -0.796 . . . . 0.0 109.878 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.589 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 0.8 OUTLIER -150.13 -170.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.095 -1.003 . . . . 0.0 109.807 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.807 ' CE1' ' OG ' ' A' ' 82' ' ' SER . 75.2 m-85 -140.45 107.62 5.49 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.938 0.875 . . . . 0.0 110.762 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.56 ' CG2' ' CB ' ' A' ' 83' ' ' ARG . 6.2 t -80.92 131.96 32.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 O-C-N 120.699 -1.251 . . . . 0.0 109.698 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.679 ' OD1' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -42.88 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.089 177.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -72.05 0.03 10.5 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.038 -1.039 . . . . 0.0 110.148 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.605 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.09 5.34 47.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.094 -1.004 . . . . 0.0 111.088 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.659 ' HB2' HD22 ' A' ' 53' ' ' ASN . 59.4 m-85 -140.62 5.12 1.99 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.762 -1.211 . . . . 0.0 109.415 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.548 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 35.3 p -89.74 -38.27 13.96 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -2.24 39.39 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.737 0.78 . . . . 0.0 110.76 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.605 ' CD ' ' O ' ' A' ' 55' ' ' ALA 0.262 0.1 OUTLIER -99.06 -47.46 5.22 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.659 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.654 ' HB ' ' O ' ' A' ' 56' ' ' PHE 0.338 1.0 OUTLIER -78.25 176.76 3.3 Favored Pre-proline 0 C--N 1.285 -2.196 0 CA-C-N 113.371 -1.741 . . . . 0.0 106.392 178.312 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.595 ' N ' HG11 ' A' ' 60' ' ' VAL . 39.9 Cg_endo -73.83 96.27 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 CA-C-O 122.59 0.996 . . . . 0.0 112.155 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.522 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -66.54 67.49 0.06 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.428 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.535 ' CB ' ' HB3' ' A' ' 67' ' ' GLU . . . -37.17 152.93 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.281 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -88.17 -147.6 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.127 -0.983 . . . . 0.0 111.868 -178.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 69' ' ' GLY . 17.7 pt-20 -28.98 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.193 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -53.29 -70.5 0.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.807 -1.183 . . . . 0.0 108.982 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.545 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -59.26 -32.42 69.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.577 -0.702 . . . . 0.0 109.269 178.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.534 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.2 mp -77.64 -10.82 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 110.826 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -89.24 -79.27 1.32 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.559 ' HG3' ' CG ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -43.27 -30.14 0.47 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -1.177 . . . . 0.0 108.668 179.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.596 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 1.1 tm? -74.84 -50.73 16.08 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.534 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 8.1 tp10 -58.44 -22.72 55.39 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 108.777 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.524 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -80.99 -40.78 23.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.675 -0.641 . . . . 0.0 110.686 -179.487 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.569 HG13 ' CG ' ' A' ' 49' ' ' HIS . 4.7 m -40.06 162.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.436 -0.79 . . . . 0.0 109.754 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.559 ' O ' ' CG2' ' A' ' 75' ' ' THR . 21.7 m -120.63 32.38 6.02 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.114 -0.991 . . . . 0.0 108.965 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.607 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -115.27 -167.24 1.21 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.686 1.231 . . . . 0.0 112.728 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.761 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.19 62.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.996 -178.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.646 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.43 154.86 12.97 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 118.729 -2.482 . . . . 0.0 110.997 -177.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.803 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.382 0.5 OUTLIER -133.15 177.17 2.38 Favored Pre-proline 0 C--N 1.288 -2.077 0 CA-C-N 113.61 -1.632 . . . . 0.0 111.07 -173.79 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 41.0 Cg_endo -71.96 -25.91 19.19 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 N-CA-C 106.99 -1.965 . . . . 0.0 106.99 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.525 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 13.6 p-10 -114.53 18.76 16.58 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.913 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.807 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -45.88 149.59 0.63 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.805 -1.185 . . . . 0.0 108.139 178.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.57 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -155.65 152.3 28.5 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.388 -1.725 . . . . 0.0 112.313 -178.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.592 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -106.43 103.29 12.71 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 24' ' ' MET . 5.7 t -27.82 -34.09 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.552 ' N ' ' O ' ' A' ' 84' ' ' LEU . 26.5 p -71.65 1.97 5.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.3 -1.5 . . . . 0.0 110.784 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.539 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 38.1 mm-40 -125.03 14.94 8.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.877 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.555 ' CD1' HG13 ' A' ' 60' ' ' VAL . 5.7 mm -116.46 99.0 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.272 -0.892 . . . . 0.0 110.285 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.601 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 1.7 mm -82.82 131.15 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.899 -1.125 . . . . 0.0 110.048 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.565 ' HG2' ' CG2' ' A' ' 3' ' ' VAL . 2.1 tpt -82.42 123.14 28.86 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.279 -0.888 . . . . 0.0 110.349 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.493 ' HB ' ' CG ' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -113.22 159.33 35.36 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 118.151 -1.42 . . . . 0.0 110.319 179.29 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.566 ' CD ' ' HB3' ' A' ' 19' ' ' ASP . 37.2 Cg_endo -62.24 -14.23 37.08 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 O-C-N 124.481 1.779 . . . . 0.0 109.569 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.493 ' CG ' ' HB ' ' A' ' 91' ' ' THR . 1.8 pt-20 -82.52 -36.93 25.91 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.33 1.062 . . . . 0.0 108.42 177.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.63 ' CD1' HG23 ' A' ' 60' ' ' VAL . 50.3 mt -90.23 35.76 0.87 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.576 -178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 20.9 p30 -63.61 108.02 1.29 Allowed 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.823 177.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.598 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.36 23.79 1.88 Allowed Glycine 0 N--CA 1.496 2.695 0 O-C-N 120.755 -1.216 . . . . 0.0 110.7 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.765 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -59.62 136.83 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -1.087 . . . . 0.0 111.097 179.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.679 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.5 t -115.76 110.31 31.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.527 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -100.0 154.99 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.834 -1.166 . . . . 0.0 110.039 -178.552 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.606 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.46 128.43 50.86 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.268 -0.895 . . . . 0.0 110.249 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.575 HG11 ' CE1' ' A' ' 8' ' ' HIS . 55.1 t -103.54 123.54 41.1 Favored Pre-proline 0 C--N 1.291 -1.972 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.669 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.642 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 54.8 Cg_endo -76.37 171.19 18.53 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.096 1.864 . . . . 0.0 111.949 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.5 -18.93 23.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.699 -0.626 . . . . 0.0 109.468 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.53 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -111.0 74.62 0.88 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 47' ' ' THR . 3.1 pt20 -98.81 56.1 1.07 Allowed 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.436 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.589 ' OXT' ' CD2' ' A' ' 106' ' ' TRP . 1.5 p-90 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.765 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.593 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 4.1 mptt . . . . . 0 C--O 1.209 -1.072 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.723 ' HA ' HG21 ' A' ' 97' ' ' ILE . 65.4 t -140.56 134.05 33.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 O-C-N 121.382 -0.824 . . . . 0.0 110.959 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 45.9 t -142.7 90.2 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 C-N-CA 118.634 -1.226 . . . . 0.0 110.803 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.632 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 70.3 m-85 -67.64 134.65 51.53 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.674 -0.641 . . . . 0.0 109.464 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.535 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 97.3 t -99.62 169.36 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 O-C-N 120.113 -1.617 . . . . 0.0 109.717 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 11' ' ' THR . 95.9 p -104.46 -155.9 0.55 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 109.386 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.584 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.02 -29.69 18.25 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -91.83 -8.59 46.15 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.339 0.59 . . . . 0.0 109.713 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.21 -16.08 20.26 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -59.44 132.51 54.21 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.728 -1.454 . . . . 0.0 107.872 179.184 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -120.98 179.92 4.22 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 122.368 1.08 . . . . 0.0 113.02 -178.154 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.555 ' CD ' HG12 ' A' ' 32' ' ' ILE 0.277 0.9 OUTLIER -127.25 179.03 5.66 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 178.682 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 68.5 mt-10 -152.87 116.02 4.63 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 117.129 -1.828 . . . . 0.0 111.518 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.606 ' CD2' HD11 ' A' ' 32' ' ' ILE . 5.7 mt -112.63 -156.79 0.6 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.459 1.123 . . . . 0.0 110.194 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -153.08 68.24 0.81 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.732 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -88.29 124.24 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.083 0.944 . . . . 0.0 109.463 -177.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -87.34 176.25 7.61 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.087 0.946 . . . . 0.0 112.851 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.557 ' HB3' ' CD ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -51.02 127.85 19.95 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.318 1.056 . . . . 0.0 109.187 177.357 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.403 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 99.04 -23.82 34.84 Favored Glycine 0 C--N 1.276 -2.805 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.474 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.732 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 95.1 t -84.44 153.61 3.65 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.656 0 CA-C-N 120.61 2.205 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -96.98 134.71 39.99 Favored 'General case' 0 C--N 1.273 -2.728 0 C-N-CA 118.797 -1.161 . . . . 0.0 107.886 176.206 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.63 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 9.2 mt -50.24 -23.65 2.39 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.299 -1.501 . . . . 0.0 108.028 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.547 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -74.5 -15.0 60.89 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.599 -0.688 . . . . 0.0 109.211 179.175 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.504 ' HG2' ' CG1' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -89.14 -63.5 1.28 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.575 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -56.04 -50.07 71.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.065 -1.022 . . . . 0.0 110.196 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.604 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . . . -47.66 -48.66 28.89 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.527 -1.358 . . . . 0.0 109.706 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -70.78 -0.74 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.605 -0.684 . . . . 0.0 109.679 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.509 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.08 -27.18 12.73 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.813 0.816 . . . . 0.0 109.569 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.502 ' CB ' HD21 ' A' ' 15' ' ' LEU . 3.7 m-80 -97.36 -0.72 45.91 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.68 21.47 36.83 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.606 HD11 ' CD2' ' A' ' 15' ' ' LEU . 2.1 mt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.392 -1.063 . . . . 0.0 109.66 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.533 0.682 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 11.3 p -115.18 28.53 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.48 -0.763 . . . . 0.0 109.625 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.692 ' CE1' ' CE2' ' A' ' 51' ' ' TYR . 5.2 t60 -69.86 128.7 37.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.537 -0.727 . . . . 0.0 110.402 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.564 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -156.78 -174.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.971 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.71 ' O ' ' N ' ' A' ' 100' ' ' ASP 0.272 81.9 m-85 -140.41 113.85 8.62 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.634 0.73 . . . . 0.0 110.323 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.564 ' CG2' ' HB2' ' A' ' 83' ' ' ARG . 6.3 t -82.36 132.45 31.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 O-C-N 120.329 -1.482 . . . . 0.0 110.654 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.577 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 3.3 t30 -47.1 145.47 2.16 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.709 -1.244 . . . . 0.0 108.583 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.523 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -58.16 -8.37 1.07 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.159 -0.963 . . . . 0.0 112.077 -178.337 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.575 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . . . -93.97 7.76 43.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.532 -1.355 . . . . 0.0 110.731 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.691 ' CG ' HD12 ' A' ' 97' ' ' ILE . 86.9 m-85 -140.54 4.65 1.97 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.125 -0.984 . . . . 0.0 109.622 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.556 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 31.5 p -90.29 -41.19 11.68 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 120.946 -1.096 . . . . 0.0 108.068 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.34 -2.09 52.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.826 0.822 . . . . 0.0 110.56 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.614 ' CB ' ' CD2' ' A' ' 94' ' ' LEU 0.255 0.1 OUTLIER -99.22 -47.77 5.07 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.531 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.672 ' HB ' ' O ' ' A' ' 56' ' ' PHE 0.331 1.1 t -78.99 175.76 4.4 Favored Pre-proline 0 C--N 1.288 -2.065 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.186 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.585 ' N ' HG11 ' A' ' 60' ' ' VAL . 40.0 Cg_endo -75.05 109.2 2.88 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 CA-C-O 122.702 1.042 . . . . 0.0 112.293 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.531 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -75.23 66.71 1.76 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.551 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.531 ' CB ' ' HG2' ' A' ' 87' ' ' GLN . . . -37.19 155.94 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.25 0.547 . . . . 0.0 110.226 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 66' ' ' ARG . 45.0 p-10 -96.06 -145.79 0.28 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.155 -0.966 . . . . 0.0 112.493 -177.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 64' ' ' ASN . 8.2 pt-20 -30.92 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.349 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 64' ' ' ASN . 2.3 mtm-85 -52.96 -71.2 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.608 -1.308 . . . . 0.0 108.365 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.599 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -62.89 -45.8 90.82 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 109.18 178.363 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.558 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.1 mp -55.77 -12.97 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.348 -0.845 . . . . 0.0 111.424 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -91.2 -78.41 1.37 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.599 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -45.37 -35.57 3.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.976 -1.308 . . . . 0.0 108.538 179.493 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.618 ' CD1' ' HB3' ' A' ' 82' ' ' SER . 0.8 OUTLIER -67.77 -43.96 78.57 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 177.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.558 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -60.44 -25.79 66.24 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 108.699 178.168 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.591 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.94 -42.76 31.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.781 -0.574 . . . . 0.0 111.111 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.6 HG13 ' CG ' ' A' ' 49' ' ' HIS . 4.5 m -39.87 151.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.564 ' O ' ' CG2' ' A' ' 75' ' ' THR . 18.7 m -121.03 30.47 6.84 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.083 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 49' ' ' HIS . . . -92.67 -82.5 0.33 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.492 -1.283 . . . . 0.0 113.344 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.721 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.288 0.0 OUTLIER -153.86 64.58 0.72 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 122.291 1.043 . . . . 0.0 108.683 -175.579 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.799 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -57.0 150.71 16.33 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 119.382 -2.074 . . . . 0.0 113.24 -173.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.51 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.36 0.0 OUTLIER -124.97 -174.14 0.32 Allowed Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.312 -174.889 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 46.6 Cg_endo -81.98 -28.86 1.87 Allowed 'Trans proline' 0 C--N 1.302 -1.92 0 N-CA-C 107.222 -1.876 . . . . 0.0 107.222 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.535 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.9 OUTLIER -107.47 15.33 24.97 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.113 179.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.799 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -44.65 146.68 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.952 -1.093 . . . . 0.0 109.611 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.59 ' NH1' ' CD1' ' A' ' 88' ' ' ILE . 30.7 mmm-85 -158.43 152.91 24.44 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.888 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -105.26 107.03 17.79 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 24' ' ' MET . 6.1 p -32.07 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.553 ' N ' ' O ' ' A' ' 84' ' ' LEU . 16.3 p -70.05 -1.24 9.31 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.425 -1.422 . . . . 0.0 111.03 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.531 ' HG2' ' CB ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -125.4 -1.92 7.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.91 -1.119 . . . . 0.0 110.938 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.59 ' CD1' ' NH1' ' A' ' 83' ' ' ARG . 3.2 mm -97.15 108.78 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.084 -1.01 . . . . 0.0 110.281 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.592 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 2.9 mm -87.72 129.36 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.896 -1.128 . . . . 0.0 109.959 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.591 ' HG2' ' CG2' ' A' ' 3' ' ' VAL . 2.4 tpt -83.03 122.94 28.97 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 121.42 -0.8 . . . . 0.0 110.379 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -114.11 159.22 37.14 Favored Pre-proline 0 C--N 1.292 -1.922 0 C-N-CA 118.233 -1.387 . . . . 0.0 109.682 178.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.557 ' CD ' ' HB3' ' A' ' 19' ' ' ASP . 35.2 Cg_endo -58.66 -36.67 96.89 Favored 'Trans proline' 0 C--N 1.297 -2.149 0 O-C-N 124.334 1.702 . . . . 0.0 110.045 -178.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -58.9 -36.83 75.34 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.797 -1.161 . . . . 0.0 108.558 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.632 ' CD1' HG23 ' A' ' 60' ' ' VAL . 65.9 mt -90.59 35.12 0.88 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.937 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.478 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 19.6 p-10 -63.75 107.03 1.09 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.575 -1.25 . . . . 0.0 109.391 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.593 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 123.75 19.83 2.69 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 120.458 -1.401 . . . . 0.0 110.733 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.723 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -55.77 140.33 13.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.228 -1.16 . . . . 0.0 111.119 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.603 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 2.0 t -115.53 112.15 38.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -98.61 156.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.786 -1.196 . . . . 0.0 109.346 -178.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.71 ' N ' ' O ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -122.85 124.21 42.75 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.742 0.782 . . . . 0.0 110.323 -178.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.527 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 68.2 t -100.32 135.55 20.24 Favored Pre-proline 0 C--N 1.289 -2.064 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.679 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 54.5 Cg_endo -88.9 176.09 3.39 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 121.765 1.643 . . . . 0.0 111.885 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -91.14 -20.45 21.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.572 -0.705 . . . . 0.0 109.36 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.542 ' HB3' ' CA ' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -110.76 77.86 1.07 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.492 ' NE2' HG12 ' A' ' 101' ' ' VAL . 12.9 mt-30 -98.34 52.07 1.02 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.72 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.591 ' CZ2' ' HB3' ' A' ' 73' ' ' CYS . 3.0 p-90 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.18 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.627 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.205 -1.257 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.726 ' HA ' HG21 ' A' ' 97' ' ' ILE . 41.6 t -136.27 133.82 49.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 O-C-N 121.326 -0.859 . . . . 0.0 110.137 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 58.2 t -141.85 91.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.619 0 C-N-CA 118.804 -1.158 . . . . 0.0 110.411 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.637 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 40.8 m-85 -69.03 154.64 41.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.577 -0.702 . . . . 0.0 109.169 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.527 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 87.0 t -118.35 172.7 5.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.215 178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.525 ' HB3' HG21 ' A' ' 11' ' ' THR . 46.3 p -107.97 -158.4 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.104 -0.998 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.561 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -88.04 -29.67 20.51 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 178.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -91.76 -11.18 37.44 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.437 0.637 . . . . 0.0 109.575 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.29 -4.31 23.56 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.335 -0.936 . . . . 0.0 110.785 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -65.09 131.41 46.48 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.646 -1.502 . . . . 0.0 107.784 179.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -120.93 178.51 4.69 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 122.229 1.014 . . . . 0.0 112.905 -177.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.4 177.71 7.61 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 9.2 mp0 -150.3 113.47 4.87 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.975 -1.49 . . . . 0.0 110.397 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.629 ' CD1' ' HA ' ' A' ' 27' ' ' ALA 0.262 2.8 mt -109.21 -151.53 0.47 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 122.603 1.192 . . . . 0.0 111.084 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -152.94 75.98 1.11 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.699 HG11 ' HB ' ' A' ' 21' ' ' VAL . 17.4 t -88.41 118.87 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.64 -175.4 4.66 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.595 -0.691 . . . . 0.0 110.892 -177.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -65.45 114.39 4.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.36 -15.84 24.82 Favored Glycine 0 C--N 1.288 -2.085 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.351 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.699 ' HB ' HG11 ' A' ' 17' ' ' VAL . 41.6 t -97.81 136.37 28.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 120.441 -1.623 . . . . 0.0 106.776 177.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -95.15 143.71 26.36 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.378 -1.329 . . . . 0.0 107.721 178.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.637 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 13.8 mt -47.04 -26.6 1.08 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.281 -1.367 . . . . 0.0 107.434 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.537 ' CB ' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -59.41 -39.27 82.91 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.362 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.564 ' N ' ' O ' ' A' ' 22' ' ' SER . 4.8 tt0 -75.24 -72.37 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.796 -0.565 . . . . 0.0 110.532 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.6 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -46.6 -50.54 17.31 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 117.986 -1.486 . . . . 0.0 111.014 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.629 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . . . -47.95 -46.02 31.77 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.343 -1.473 . . . . 0.0 110.443 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -74.08 0.57 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.555 -0.716 . . . . 0.0 109.654 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.501 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.18 -29.18 11.47 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.736 0.779 . . . . 0.0 109.687 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.447 ' HB2' HD21 ' A' ' 15' ' ' LEU . 3.8 m-80 -97.56 -1.57 43.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.65 19.58 51.21 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.562 HD12 ' CD1' ' A' ' 15' ' ' LEU . 8.5 mt . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.306 -1.114 . . . . 0.0 109.434 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.568 0.699 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.482 ' O ' HG12 ' A' ' 50' ' ' VAL . 25.4 p -88.38 29.98 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.636 -0.665 . . . . 0.0 110.048 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.667 ' CE1' ' CE2' ' A' ' 51' ' ' TYR . 4.1 t60 -70.24 126.27 29.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.417 -0.802 . . . . 0.0 110.667 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.572 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 1.1 m -156.33 -174.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.251 -0.905 . . . . 0.0 109.99 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.672 ' CD1' ' HG3' ' A' ' 79' ' ' LYS 0.254 78.2 m-85 -141.01 108.22 5.5 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.659 0.743 . . . . 0.0 110.669 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.575 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 2.4 t -75.01 133.84 30.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 O-C-N 120.34 -1.475 . . . . 0.0 110.583 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.579 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 3.8 t30 -48.42 147.29 2.45 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.744 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.2 pt-20 -58.77 -8.41 1.32 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.169 -0.957 . . . . 0.0 111.972 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.577 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . . . -96.01 7.91 45.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.475 -1.391 . . . . 0.0 111.057 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.684 ' CG ' HD12 ' A' ' 97' ' ' ILE . 87.7 m-85 -140.37 3.01 1.91 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.059 . . . . 0.0 109.898 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.575 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 3.2 p -90.55 -41.22 11.5 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -93.76 -0.94 55.67 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.737 0.779 . . . . 0.0 110.526 -178.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.611 ' CB ' ' CD2' ' A' ' 94' ' ' LEU 0.253 1.2 mtpp -99.23 -46.91 5.38 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 123.135 1.445 . . . . 0.0 107.355 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.781 ' CG1' ' HD2' ' A' ' 61' ' ' PRO 0.334 0.9 OUTLIER -74.86 -177.68 0.71 Allowed Pre-proline 0 C--N 1.287 -2.114 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.197 178.975 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.781 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 34.1 Cg_endo -61.59 122.34 10.91 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 CA-C-O 123.001 1.167 . . . . 0.0 111.941 -177.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.32 62.95 0.99 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.635 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -38.22 157.88 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.937 -0.477 . . . . 0.0 109.999 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 66' ' ' ARG . 29.8 p30 -118.0 -154.47 0.56 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.061 -1.024 . . . . 0.0 111.432 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 64' ' ' ASN . 4.3 pt-20 -31.24 -33.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.028 -0.42 . . . . 0.0 111.726 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -53.0 -71.05 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.773 -1.204 . . . . 0.0 108.195 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.596 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -59.7 -50.41 73.94 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 108.906 178.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.541 ' N ' ' HG3' ' A' ' 67' ' ' GLU . 1.2 mp -51.52 -19.32 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 110.302 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -88.17 -75.69 1.28 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.596 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -45.04 -38.78 5.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -1.215 . . . . 0.0 108.674 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.699 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 0.4 OUTLIER -65.74 -51.7 57.05 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.208 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 11.0 tp10 -55.39 -19.62 9.61 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.081 -1.012 . . . . 0.0 108.417 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -76.21 -46.98 25.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.604 -0.685 . . . . 0.0 110.552 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.576 HG13 ' CG ' ' A' ' 49' ' ' HIS . 8.1 m -40.71 163.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.266 -0.896 . . . . 0.0 109.725 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.524 ' O ' ' CG2' ' A' ' 75' ' ' THR . 45.8 m -120.4 37.4 4.27 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.977 -1.077 . . . . 0.0 109.599 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.613 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -122.44 -167.78 1.62 Allowed 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.281 -1.368 . . . . 0.0 112.968 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.744 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -50.77 63.42 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.662 -178.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.761 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.42 153.65 15.35 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 118.767 -2.458 . . . . 0.0 111.809 -177.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.672 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.385 0.2 OUTLIER -133.96 176.86 2.57 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 113.294 -1.775 . . . . 0.0 111.308 -173.826 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 43.7 Cg_endo -75.34 -27.58 9.36 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 176.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.524 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 15.5 p-10 -108.5 17.01 22.52 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.255 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.761 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -45.81 149.91 0.59 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.181 -0.949 . . . . 0.0 110.126 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.569 ' CG ' HG23 ' A' ' 52' ' ' VAL . 7.9 mmt85 -158.62 160.22 36.29 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.255 -1.378 . . . . 0.0 112.192 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 86' ' ' CYS . 2.2 mt -112.85 114.98 27.75 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 24' ' ' MET . 12.6 p -30.67 -30.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.572 ' N ' ' O ' ' A' ' 84' ' ' LEU . 27.8 p -77.07 4.24 10.64 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.611 -1.306 . . . . 0.0 111.43 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.506 ' HG2' ' CB ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -125.34 11.94 8.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.819 -1.175 . . . . 0.0 111.357 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.522 HD12 ' CG1' ' A' ' 60' ' ' VAL . 21.4 mm -120.34 107.12 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.83 -1.169 . . . . 0.0 110.978 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.544 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 3.9 mm -89.83 128.81 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.144 -0.973 . . . . 0.0 108.895 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.576 ' HE2' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -83.86 124.77 31.31 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.414 -0.804 . . . . 0.0 111.238 -178.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.558 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -98.97 179.69 1.01 Allowed Pre-proline 0 C--N 1.295 -1.769 0 C-N-CA 117.673 -1.611 . . . . 0.0 109.181 177.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.558 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 45.6 Cg_endo -82.21 -12.88 10.33 Favored 'Trans proline' 0 C--N 1.289 -2.599 0 O-C-N 124.368 1.72 . . . . 0.0 108.705 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.558 ' HG2' ' OG1' ' A' ' 91' ' ' THR . 3.4 pt-20 -84.89 -33.69 22.73 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.613 ' CD1' HG23 ' A' ' 60' ' ' VAL . 66.1 mt -89.64 29.77 1.11 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.498 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -63.22 111.38 2.22 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 120.3 -1.5 . . . . 0.0 109.056 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.627 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 123.87 17.04 3.17 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.726 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -53.75 141.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.377 -1.073 . . . . 0.0 111.668 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.594 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 2.0 t -117.46 113.63 43.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.542 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -99.41 155.41 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.838 -1.163 . . . . 0.0 109.773 -178.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.635 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.34 121.07 35.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.677 0.751 . . . . 0.0 109.783 -179.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.525 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 90.8 t -99.51 123.58 47.6 Favored Pre-proline 0 C--N 1.289 -2.025 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.432 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.644 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 52.6 Cg_endo -75.58 170.83 19.42 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.002 1.801 . . . . 0.0 112.028 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.413 ' OD2' ' HG2' ' A' ' 104' ' ' ARG . 11.6 p-10 -91.32 -17.45 25.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.677 -0.639 . . . . 0.0 109.402 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.523 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -110.75 70.89 0.73 Allowed 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.423 ' CD ' ' O ' ' A' ' 105' ' ' GLN . 0.0 OUTLIER -98.73 58.81 1.21 Allowed 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.466 -177.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.558 ' CD2' ' O ' ' A' ' 106' ' ' TRP . 1.8 p-90 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.885 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.56 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.236 0.541 . . . . 0.0 110.345 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.637 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 0.5 OUTLIER -87.55 147.79 25.17 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.172 -0.955 . . . . 0.0 110.472 179.231 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.719 ' HA ' HG21 ' A' ' 97' ' ' ILE . 54.9 t -140.99 135.59 33.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 121.121 -0.987 . . . . 0.0 110.902 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 47.3 t -142.4 90.96 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.804 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 73.1 m-85 -67.86 134.84 51.58 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 121.714 -0.616 . . . . 0.0 109.81 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 99' ' ' VAL . 91.1 t -99.82 166.95 2.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 O-C-N 120.052 -1.655 . . . . 0.0 109.467 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 11' ' ' THR . 86.1 p -101.8 -155.86 0.54 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.096 -1.003 . . . . 0.0 108.819 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.589 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.24 -29.83 17.93 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.8 -6.26 52.05 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.436 0.636 . . . . 0.0 109.878 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.38 -25.55 10.38 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.57 130.18 31.27 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.628 -1.513 . . . . 0.0 108.066 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.527 ' CD ' HG22 ' A' ' 6' ' ' VAL . 17.3 mtm-85 -121.26 -176.38 3.27 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 122.374 1.083 . . . . 0.0 112.883 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.552 ' CD ' HG12 ' A' ' 32' ' ' ILE 0.28 0.2 OUTLIER -128.78 178.73 6.15 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.687 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 84.1 mt-10 -152.9 114.17 4.21 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 117.324 -1.751 . . . . 0.0 111.142 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.587 ' CD2' HD11 ' A' ' 32' ' ' ILE . 6.6 mt -108.71 -156.16 0.58 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.475 1.131 . . . . 0.0 110.095 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 1' ' ' SER . 0.7 OUTLIER -152.5 71.91 0.96 Allowed 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 177.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.709 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 1.4 t -89.14 127.58 41.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.866 0.841 . . . . 0.0 109.431 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.94 -175.06 4.47 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.675 1.226 . . . . 0.0 112.867 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 11.6 p30 -63.2 115.89 4.93 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.792 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.98 -22.39 18.74 Favored Glycine 0 C--N 1.287 -2.185 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.763 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.709 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 90.8 t -88.34 147.93 4.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 119.938 1.869 . . . . 0.0 109.746 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -96.63 131.79 42.93 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.591 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 8.8 mt -44.54 -26.11 0.33 Allowed 'General case' 0 C--O 1.201 -1.464 0 O-C-N 120.899 -1.126 . . . . 0.0 109.292 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.613 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -69.04 -42.4 76.37 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 118.206 -1.398 . . . . 0.0 107.77 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.5 tt0 -59.68 -70.8 0.15 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.744 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.612 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.97 -54.3 10.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.981 -1.075 . . . . 0.0 110.512 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.595 ' HB1' ' CZ ' ' A' ' 5' ' ' TYR . . . -47.41 -51.15 20.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.787 -1.195 . . . . 0.0 110.098 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -69.05 -1.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.622 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.12 -27.47 12.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.334 -0.853 . . . . 0.0 109.863 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.511 ' CB ' HD21 ' A' ' 15' ' ' LEU . 3.5 m-80 -97.31 -0.8 45.89 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.11 21.17 33.68 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.587 HD11 ' CD2' ' A' ' 15' ' ' LEU . 1.8 mt -72.69 -62.75 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.221 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.613 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 13.2 m-30 -80.36 48.96 1.07 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.614 -0.679 . . . . 0.0 110.377 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -49.75 -20.66 0.88 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.434 -0.791 . . . . 0.0 110.469 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.573 ' CD1' ' CG2' ' A' ' 47' ' ' THR . 4.1 tt -66.91 179.0 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.158 -0.964 . . . . 0.0 110.1 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.81 65.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.15 -0.969 . . . . 0.0 110.375 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.472 ' HA3' ' CB ' ' A' ' 47' ' ' THR . . . -120.03 72.13 0.34 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 9.8 p30 -120.06 115.18 23.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -1.153 . . . . 0.0 110.344 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 42' ' ' SER . 23.1 p -100.03 25.0 7.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.187 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.07 50.06 40.61 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.37 19.83 9.37 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 11.1 m -92.62 0.63 57.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -1.106 . . . . 0.0 110.194 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.518 ' CB ' ' SD ' ' A' ' 70' ' ' MET . . . 53.14 60.1 3.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 110.264 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -139.63 24.77 2.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.371 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 2.1 p -129.9 -174.29 3.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.054 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.637 ' CB ' ' CZ3' ' A' ' 106' ' ' TRP . . . -150.06 9.9 0.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.981 . . . . 0.0 110.955 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.573 ' CG2' ' CD1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -84.85 -18.79 33.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.917 -1.114 . . . . 0.0 109.86 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.5 ' O ' HG11 ' A' ' 50' ' ' VAL . 25.1 p -88.53 28.41 1.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.531 -0.731 . . . . 0.0 110.151 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.69 ' CD2' ' CG ' ' A' ' 102' ' ' PRO . 4.0 t60 -70.21 126.37 29.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.433 -0.792 . . . . 0.0 110.219 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.579 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 1.3 m -156.39 -173.94 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-O 122.12 0.962 . . . . 0.0 110.246 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.683 ' CE2' ' CE1' ' A' ' 49' ' ' HIS 0.268 77.1 m-85 -141.08 111.76 7.0 Favored 'General case' 0 C--O 1.197 -1.687 0 CA-C-O 121.557 0.694 . . . . 0.0 110.563 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.566 HG23 ' CB ' ' A' ' 83' ' ' ARG . 2.4 t -78.4 131.46 34.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 O-C-N 120.31 -1.494 . . . . 0.0 110.689 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.585 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 3.4 t30 -47.44 146.67 1.96 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.495 -1.378 . . . . 0.0 108.778 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -58.71 -8.09 1.19 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.065 -1.022 . . . . 0.0 112.135 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.571 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . . . -95.99 8.24 44.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.547 -1.345 . . . . 0.0 110.56 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.69 ' CG ' HD12 ' A' ' 97' ' ' ILE . 87.5 m-85 -140.16 3.77 2.0 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.23 -0.918 . . . . 0.0 109.846 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.561 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 8.7 p -90.45 -42.61 10.77 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.027 -1.046 . . . . 0.0 108.358 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -1.34 57.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.751 0.786 . . . . 0.0 110.486 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.667 ' HB2' HD21 ' A' ' 94' ' ' LEU 0.259 0.1 OUTLIER -99.35 -46.79 5.39 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 123.073 1.416 . . . . 0.0 107.314 179.659 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.735 ' CG1' ' HD2' ' A' ' 61' ' ' PRO 0.338 1.0 OUTLIER -78.07 -179.8 1.43 Allowed Pre-proline 0 C--N 1.289 -2.06 0 CA-C-N 113.797 -1.547 . . . . 0.0 107.123 178.966 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.735 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 37.9 Cg_endo -68.39 107.54 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 CA-C-O 122.874 1.114 . . . . 0.0 112.42 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.625 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -75.46 71.54 2.41 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.016 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -38.65 170.92 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.604 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -111.9 -164.25 0.9 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.91 -1.118 . . . . 0.0 112.543 -178.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 64' ' ' ASN . 8.8 pt-20 -28.71 -39.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -52.9 -63.01 1.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.543 -1.348 . . . . 0.0 108.833 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.67 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -59.14 -30.06 67.86 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.52 -0.737 . . . . 0.0 110.5 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.541 ' O ' ' CB ' ' A' ' 72' ' ' GLU . 1.8 mp -77.12 -8.87 12.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.434 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -88.17 -76.68 1.28 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.67 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -44.04 -40.29 4.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.165 -1.197 . . . . 0.0 108.481 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.667 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 0.6 OUTLIER -64.67 -50.96 64.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 12.0 tp10 -56.91 -19.35 17.37 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.967 -1.083 . . . . 0.0 108.398 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -75.64 -47.88 24.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 110.156 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.557 ' HA ' ' NE1' ' A' ' 106' ' ' TRP . 6.1 m -40.78 161.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 0.0 109.279 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.539 ' O ' ' CG2' ' A' ' 75' ' ' THR . 27.8 m -120.36 34.06 5.36 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 120.971 -1.081 . . . . 0.0 109.257 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.613 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -114.81 -165.19 0.99 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.595 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.748 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -54.05 63.26 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.167 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.797 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.35 153.02 16.37 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 118.842 -2.411 . . . . 0.0 111.67 -177.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.65 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.389 2.2 mmtt -135.42 177.45 2.22 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.409 -173.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 43.6 Cg_endo -74.76 -28.73 9.36 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 N-CA-C 107.514 -1.764 . . . . 0.0 107.514 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.54 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -106.02 15.18 26.84 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.873 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.797 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -44.17 148.83 0.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.989 . . . . 0.0 109.507 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.625 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 1.3 mmt85 -162.03 155.93 21.51 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 117.436 -1.706 . . . . 0.0 113.293 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.616 ' O ' ' N ' ' A' ' 86' ' ' CYS . 7.8 mt -114.73 98.32 6.79 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 174.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.512 ' HB3' ' N ' ' A' ' 24' ' ' MET . 60.7 m -28.85 -28.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -39.76 -26.35 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.502 -1.373 . . . . 0.0 112.442 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.594 ' NE2' ' CG ' ' A' ' 67' ' ' GLU . 8.8 pm0 -125.74 0.25 7.42 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.208 -1.557 . . . . 0.0 112.934 -178.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.539 HD12 ' CG1' ' A' ' 60' ' ' VAL . 12.6 mm -78.64 99.97 3.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.366 -1.459 . . . . 0.0 107.518 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.597 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -81.92 130.88 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.208 -0.933 . . . . 0.0 110.578 -177.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.598 ' HE1' HG23 ' A' ' 97' ' ' ILE . 1.3 tpt -82.58 120.71 25.88 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.809 -0.557 . . . . 0.0 111.375 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.579 ' OG1' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -106.18 174.3 2.68 Favored Pre-proline 0 N--CA 1.494 1.767 0 C-N-CA 118.481 -1.288 . . . . 0.0 109.77 178.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 44.3 Cg_endo -73.94 -10.51 23.08 Favored 'Trans proline' 0 C--N 1.292 -2.427 0 O-C-N 124.651 1.869 . . . . 0.0 110.074 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.579 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -92.48 -30.49 15.68 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 59' ' ' LYS . 97.8 mt -90.07 25.04 2.26 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.865 0.841 . . . . 0.0 110.28 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.522 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 5.9 p-10 -63.11 104.2 0.55 Allowed 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.287 177.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.637 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.99 18.43 2.6 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.333 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.719 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -53.42 141.8 7.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.539 -0.977 . . . . 0.0 111.39 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.597 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 2.1 t -115.49 112.49 40.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.543 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -98.33 155.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.782 -1.199 . . . . 0.0 108.977 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -122.86 124.84 44.17 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.396 -0.815 . . . . 0.0 110.476 -178.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.569 HG13 ' CE1' ' A' ' 8' ' ' HIS . 63.4 t -99.22 137.4 20.39 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.879 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.69 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 57.2 Cg_endo -89.25 170.64 4.74 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 C-N-CA 121.809 1.673 . . . . 0.0 111.813 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.51 -16.36 27.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.522 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -111.09 75.08 0.9 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.514 ' NE2' HG11 ' A' ' 101' ' ' VAL . 18.3 mt-30 -98.94 56.75 1.07 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.327 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.637 ' CZ3' ' CB ' ' A' ' 46' ' ' ALA . 1.6 p-90 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.787 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.46 ' S2 ' ' HB3' ' A' ' 86' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 91' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.143 0.497 . . . . 0.0 110.225 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.611 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 13.9 mtmt -69.7 148.12 49.67 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.139 -0.976 . . . . 0.0 109.873 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.717 ' HA ' HG21 ' A' ' 97' ' ' ILE . 41.5 t -138.51 134.29 43.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 O-C-N 120.897 -1.127 . . . . 0.0 110.516 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 50.5 t -142.61 93.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.078 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.63 ' CD1' ' CD1' ' A' ' 32' ' ' ILE . 50.2 m-85 -69.67 162.45 27.68 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 109.464 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 87.3 t -127.89 168.56 20.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.096 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.56 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 6.1 p -103.12 -154.77 0.5 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 109.616 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.57 ' CE1' HG13 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -92.12 -29.84 16.3 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -91.93 -11.86 35.05 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.515 0.674 . . . . 0.0 109.251 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.5 7.23 18.67 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.234 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.6 OUTLIER -71.64 131.12 42.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.355 -1.673 . . . . 0.0 107.451 178.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -120.77 173.47 7.19 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.124 0.964 . . . . 0.0 112.896 -177.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.567 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -134.44 -179.08 5.36 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 37.0 mt-10 -151.78 112.93 4.28 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 117.844 -1.542 . . . . 0.0 110.729 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.622 ' CD1' ' HA ' ' A' ' 27' ' ' ALA . 3.9 mt -109.83 -151.11 0.47 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.482 1.134 . . . . 0.0 111.111 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.19 70.54 0.92 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.703 HG11 ' HB ' ' A' ' 21' ' ' VAL . 18.3 t -86.46 113.51 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.21 -170.8 2.89 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.87 0.843 . . . . 0.0 111.608 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.526 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 2.5 p30 -61.18 110.07 1.29 Allowed 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.19 -18.68 23.33 Favored Glycine 0 C--N 1.289 -2.029 0 C-N-CA 119.349 -1.405 . . . . 0.0 111.116 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.703 ' HB ' HG11 ' A' ' 17' ' ' VAL . 45.0 t -94.24 139.32 18.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 O-C-N 120.088 -1.831 . . . . 0.0 107.099 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.573 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -95.9 142.49 28.08 Favored 'General case' 0 C--N 1.275 -2.674 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.625 HD21 HG21 ' A' ' 3' ' ' VAL . 11.0 mt -49.67 -27.03 4.21 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.082 -1.447 . . . . 0.0 107.78 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.533 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -71.62 -17.31 62.28 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.832 0.825 . . . . 0.0 108.821 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -89.7 -70.21 0.67 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.612 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -48.43 -49.67 34.28 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.301 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.622 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . . . -47.76 -49.43 28.48 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.384 -1.448 . . . . 0.0 110.295 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -72.13 0.12 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.61 -0.681 . . . . 0.0 109.537 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.503 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.25 0.0 OUTLIER -103.58 -29.75 10.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.481 -0.762 . . . . 0.0 110.513 -179.773 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.445 ' HB2' HD21 ' A' ' 15' ' ' LEU . 4.1 m-80 -97.73 -2.99 40.01 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.38 29.03 15.22 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.63 ' CD1' ' CD1' ' A' ' 5' ' ' TYR . 3.1 mt -72.43 -60.13 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -1.134 . . . . 0.0 108.58 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.509 ' OH ' ' SG ' ' A' ' 85' ' ' CYS . 20.8 m-30 -81.05 46.48 0.91 Allowed 'General case' 0 C--N 1.288 -2.085 0 O-C-N 121.584 -0.698 . . . . 0.0 110.835 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 9.8 p-10 -55.93 -28.12 55.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.413 -0.804 . . . . 0.0 110.364 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.416 HD11 ' HA3' ' A' ' 37' ' ' GLY . 1.1 pt -66.94 161.05 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.12 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 m -79.92 51.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.925 . . . . 0.0 110.13 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' CA ' ' HB ' ' A' ' 47' ' ' THR . . . -118.08 37.53 3.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.524 ' OD1' ' CE ' ' A' ' 24' ' ' MET . 2.5 t70 -120.16 121.93 39.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -1.179 . . . . 0.0 110.187 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.89 18.64 19.02 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.026 -1.046 . . . . 0.0 110.089 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.95 21.64 65.28 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.46 ' HA2' ' S1 ' ' A' ' 107' ' ' FES . . . 50.0 40.07 34.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -87.42 25.52 1.41 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -1.141 . . . . 0.0 110.31 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' CB ' ' HD2' ' A' ' 66' ' ' ARG . . . 42.86 36.59 0.89 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.206 -0.934 . . . . 0.0 110.146 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 p -140.09 30.24 2.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 110.177 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.521 ' O ' ' S2 ' ' A' ' 107' ' ' FES . 0.5 OUTLIER -161.42 -170.72 2.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.948 . . . . 0.0 110.669 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.634 ' CB ' ' CZ2' ' A' ' 106' ' ' TRP . . . -150.28 9.15 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.415 -1.428 . . . . 0.0 111.753 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.537 ' HB ' ' CA ' ' A' ' 37' ' ' GLY . 13.9 p -57.37 -20.09 27.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.761 -1.212 . . . . 0.0 107.944 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.528 ' O ' ' CG1' ' A' ' 50' ' ' VAL . 25.8 p -86.84 25.4 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.438 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.736 ' CD2' ' CG ' ' A' ' 102' ' ' PRO . 13.5 t60 -61.87 110.71 1.62 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.093 -1.005 . . . . 0.0 109.962 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.588 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -140.0 -169.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.624 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.677 ' CE1' ' CE1' ' A' ' 49' ' ' HIS 0.258 62.0 m-85 -141.0 103.67 4.51 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.954 0.883 . . . . 0.0 111.041 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.59 ' CG2' ' CB ' ' A' ' 83' ' ' ARG . 6.2 t -75.01 131.73 34.52 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 O-C-N 120.67 -1.268 . . . . 0.0 110.135 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.59 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 3.7 t30 -47.24 147.75 1.45 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.082 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.52 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.5 pt-20 -59.47 -8.74 1.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.212 -0.93 . . . . 0.0 111.966 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.587 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -96.69 10.01 39.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.701 -1.249 . . . . 0.0 110.725 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.688 ' CG ' HD12 ' A' ' 97' ' ' ILE . 91.0 m-85 -140.72 1.13 1.68 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.073 -1.017 . . . . 0.0 110.288 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.585 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 11.3 p -90.41 -40.81 11.84 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.946 -1.096 . . . . 0.0 108.465 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.26 -1.12 54.51 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.671 0.748 . . . . 0.0 110.592 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.627 ' HB2' HD21 ' A' ' 94' ' ' LEU 0.256 0.2 OUTLIER -99.13 -47.09 5.34 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.618 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.628 ' HB ' ' O ' ' A' ' 56' ' ' PHE 0.327 1.0 OUTLIER -78.43 176.0 4.09 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.39 178.92 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.594 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 39.1 Cg_endo -72.7 103.27 1.53 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 CA-C-O 122.538 0.974 . . . . 0.0 111.314 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.512 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.26 73.09 1.8 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.052 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.521 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -37.76 161.26 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.337 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 66' ' ' ARG . 45.1 p-10 -86.95 -160.12 0.56 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.572 1.177 . . . . 0.0 113.125 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.0 pm0 -33.67 -27.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.477 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -53.17 -70.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.321 -1.487 . . . . 0.0 107.66 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.573 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -64.63 -30.67 71.69 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.801 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.524 ' CD1' ' HG2' ' A' ' 67' ' ' GLU . 1.2 mp -77.45 -16.66 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.176 -0.953 . . . . 0.0 110.853 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -90.61 -73.95 1.28 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.834 ' SD ' ' S2 ' ' A' ' 107' ' ' FES . 0.0 OUTLIER -42.11 -29.12 0.22 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.599 -0.942 . . . . 0.0 108.566 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.594 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 0.9 OUTLIER -80.01 -47.58 14.69 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 7.3 tp10 -64.12 -12.71 42.12 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.199 -0.938 . . . . 0.0 109.339 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.27 -18.33 27.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.362 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.674 ' HA ' ' CD1' ' A' ' 106' ' ' TRP . 8.0 m -70.17 145.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.096 -1.003 . . . . 0.0 110.456 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.532 ' O ' ' CG2' ' A' ' 75' ' ' THR . 55.4 m -99.52 28.46 4.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.741 -0.6 . . . . 0.0 109.699 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.595 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -97.15 -148.81 0.32 Allowed 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.094 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.744 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.47 63.48 5.79 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 122.333 1.063 . . . . 0.0 110.918 -178.46 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.82 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.14 154.4 13.05 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 118.923 -2.36 . . . . 0.0 111.61 -177.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.625 ' HG3' ' CD2' ' A' ' 51' ' ' TYR 0.379 2.4 mmtt -133.86 177.31 2.31 Favored Pre-proline 0 C--N 1.289 -2.059 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.774 -173.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 42.0 Cg_endo -73.31 -25.57 15.44 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 N-CA-C 107.583 -1.737 . . . . 0.0 107.583 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.553 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 8.2 p-10 -114.66 21.37 14.53 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.251 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.82 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -45.85 158.08 0.1 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.802 -1.186 . . . . 0.0 109.094 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.59 ' CB ' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -166.28 150.15 7.57 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 117.011 -1.876 . . . . 0.0 112.276 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 86' ' ' CYS . 79.7 mt -104.67 102.83 12.41 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 24' ' ' MET . 1.9 t -24.05 -37.18 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.554 ' N ' ' O ' ' A' ' 84' ' ' LEU . 27.6 p -70.58 2.92 3.48 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.134 -1.604 . . . . 0.0 111.554 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.539 ' HG3' ' CB ' ' A' ' 67' ' ' GLU . 76.9 mm-40 -125.2 19.43 8.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.882 -1.136 . . . . 0.0 110.514 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.541 ' CD1' HG13 ' A' ' 60' ' ' VAL . 5.1 mm -120.34 100.49 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.105 -0.997 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.572 ' HB ' ' CG ' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -90.04 127.04 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.794 -1.191 . . . . 0.0 108.106 178.329 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.58 ' CG ' ' HB ' ' A' ' 17' ' ' VAL . 26.3 mmm -82.73 137.42 34.41 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.334 -0.854 . . . . 0.0 110.626 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.571 ' OG1' ' CG ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -114.7 170.27 5.66 Favored Pre-proline 0 C--N 1.291 -1.952 0 O-C-N 120.936 -1.102 . . . . 0.0 110.033 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 19' ' ' ASP . 40.6 Cg_endo -67.14 -10.31 28.14 Favored 'Trans proline' 0 C--N 1.292 -2.446 0 O-C-N 124.498 1.789 . . . . 0.0 110.859 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.571 ' CG ' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -92.57 -30.78 15.47 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 117.628 -1.629 . . . . 0.0 107.646 177.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.627 HD21 ' HB2' ' A' ' 59' ' ' LYS . 83.7 mt -89.8 28.53 1.33 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.096 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 34.8 p-10 -63.19 106.02 0.81 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 118.465 -1.294 . . . . 0.0 108.281 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.611 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.87 23.01 1.89 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.717 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -57.61 138.39 18.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.327 -1.102 . . . . 0.0 111.237 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.615 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 2.1 t -111.39 114.49 47.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.584 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -99.75 152.87 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.78 -1.2 . . . . 0.0 109.755 -178.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.629 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -123.06 128.59 50.35 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.318 -0.864 . . . . 0.0 110.71 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.57 HG13 ' CE1' ' A' ' 8' ' ' HIS . 64.9 t -101.45 134.69 20.11 Favored Pre-proline 0 C--N 1.292 -1.93 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.107 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.736 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 56.8 Cg_endo -87.79 175.67 4.29 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.512 2.141 . . . . 0.0 112.807 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -91.86 -17.05 25.83 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.601 0.715 . . . . 0.0 109.193 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.574 ' CB ' ' CB ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.92 70.46 0.71 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.328 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.53 ' CG ' ' HG2' ' A' ' 102' ' ' PRO . 2.5 mt-30 -97.63 62.89 1.7 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 122.004 0.907 . . . . 0.0 110.219 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.674 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 5.8 p-90 . . . . . 0 C--N 1.294 -1.827 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.179 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.834 ' S2 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.17 0.51 . . . . 0.0 110.344 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.619 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 6.9 mtmm -84.85 146.4 27.33 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.999 0.904 . . . . 0.0 110.555 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.721 ' HA ' HG21 ' A' ' 97' ' ' ILE . 53.8 t -140.77 135.35 34.01 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 O-C-N 121.351 -0.843 . . . . 0.0 111.024 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 20.8 t -142.49 90.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 C-N-CA 118.711 -1.196 . . . . 0.0 110.386 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 55.8 m-85 -69.57 136.16 50.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.448 -0.782 . . . . 0.0 109.817 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 99' ' ' VAL . 62.2 t -100.03 167.69 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 O-C-N 120.723 -1.236 . . . . 0.0 109.297 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.526 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 89.1 p -103.84 -155.92 0.55 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.103 -0.998 . . . . 0.0 109.246 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.595 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -87.7 -31.34 19.76 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -91.7 -6.65 51.63 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.364 0.602 . . . . 0.0 109.806 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.536 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.24 -23.46 12.56 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.523 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.76 129.11 28.81 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.691 -1.476 . . . . 0.0 108.223 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.536 ' CG ' ' O ' ' A' ' 10' ' ' GLY . 20.8 mtt180 -121.73 -175.45 3.1 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 122.191 0.996 . . . . 0.0 112.65 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -133.76 179.7 6.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 177.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.669 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -151.78 111.15 3.94 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 117.704 -1.598 . . . . 0.0 110.972 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.608 ' CD1' ' HA ' ' A' ' 27' ' ' ALA . 7.6 mt -103.86 -157.04 0.59 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.527 1.156 . . . . 0.0 110.595 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.523 ' HA ' ' O ' ' A' ' 1' ' ' SER . 62.0 t0 -152.54 69.58 0.87 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.709 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 1.4 t -89.41 127.18 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.033 0.921 . . . . 0.0 109.783 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.23 177.05 6.71 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.21 1.005 . . . . 0.0 113.229 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.559 ' HB3' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -53.14 120.63 6.16 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.222 177.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.54 -24.08 26.67 Favored Glycine 0 C--N 1.28 -2.53 0 C-N-CA 119.308 -1.425 . . . . 0.0 112.218 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.709 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 85.9 t -84.43 152.23 3.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.513 0 CA-C-N 120.286 2.043 . . . . 0.0 109.381 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.479 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -96.6 131.24 43.44 Favored 'General case' 0 C--N 1.274 -2.682 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.636 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 7.5 mt -47.11 -26.99 1.23 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.47 -1.394 . . . . 0.0 108.707 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.64 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -73.74 -14.76 61.18 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.657 0.741 . . . . 0.0 109.445 -178.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 22' ' ' SER . 0.7 OUTLIER -90.2 -62.1 1.54 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 177.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.592 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -51.47 -55.65 17.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.128 -0.982 . . . . 0.0 110.385 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.608 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . . . -47.62 -50.8 23.34 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.534 -1.353 . . . . 0.0 110.263 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.585 ' CG2' ' CB ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -66.92 -4.25 2.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.439 -0.788 . . . . 0.0 109.456 178.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.256 0.0 OUTLIER -103.44 -24.72 13.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.373 -0.829 . . . . 0.0 110.36 179.954 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.447 ' HB2' HD21 ' A' ' 15' ' ' LEU . 3.8 m-80 -97.05 2.8 51.81 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.99 9.8 67.31 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.587 ' CD1' ' CD2' ' A' ' 15' ' ' LEU . 9.0 mt -72.59 -59.13 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.439 -1.036 . . . . 0.0 108.757 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.64 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 6.9 m-30 -80.82 53.18 1.87 Allowed 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.567 0.699 . . . . 0.0 110.246 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -48.99 -22.55 0.89 Allowed 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.488 -0.757 . . . . 0.0 109.724 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 tp -95.06 135.35 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.731 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.4 t -79.88 156.67 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.309 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.45 ' HA2' HG21 ' A' ' 47' ' ' THR . . . -79.84 -171.62 42.58 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 45' ' ' CYS . 4.7 t0 -112.58 -26.44 8.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -1.124 . . . . 0.0 110.353 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 5.8 p -99.99 -15.12 18.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.108 -0.995 . . . . 0.0 110.404 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.75 43.98 94.34 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.42 1.53 80.98 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 5.6 t -83.12 10.57 7.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.11 -1.23 . . . . 0.0 110.186 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.481 ' CB ' ' HG2' ' A' ' 66' ' ' ARG . . . 43.58 53.89 5.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 44' ' ' SER . 0.3 OUTLIER -140.03 16.33 2.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.375 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 70' ' ' MET . 1.1 p -130.05 -175.4 3.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.948 . . . . 0.0 110.216 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.527 ' CB ' ' OXT' ' A' ' 106' ' ' TRP . . . -143.99 9.31 1.49 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.29 -0.881 . . . . 0.0 110.411 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.45 HG21 ' HA2' ' A' ' 37' ' ' GLY . 15.1 t -71.37 -20.92 62.09 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.074 -1.016 . . . . 0.0 109.275 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.527 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 25.9 p -89.92 29.96 1.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.659 -0.651 . . . . 0.0 109.678 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.677 ' CE1' ' CZ ' ' A' ' 51' ' ' TYR . 5.9 t60 -69.97 128.78 37.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.566 -0.709 . . . . 0.0 110.732 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.589 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 1.1 m -157.09 -172.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 O-C-N 121.297 -0.877 . . . . 0.0 109.468 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.677 ' CZ ' ' CE1' ' A' ' 49' ' ' HIS 0.252 81.4 m-85 -140.49 106.49 5.19 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.901 0.857 . . . . 0.0 110.823 178.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.595 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 9.6 t -76.33 130.83 35.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.498 0 O-C-N 120.621 -1.299 . . . . 0.0 109.897 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.585 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 4.4 t30 -45.52 150.0 0.52 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.033 -1.042 . . . . 0.0 109.418 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 pt-20 -59.95 -8.46 2.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.255 -0.903 . . . . 0.0 111.888 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.58 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -97.24 9.15 43.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.671 -1.268 . . . . 0.0 110.779 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.691 ' CG ' HD12 ' A' ' 97' ' ' ILE . 90.5 m-85 -140.68 2.72 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 109.919 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.595 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 24.9 p -90.82 -40.48 11.76 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.979 -1.076 . . . . 0.0 108.375 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.55 -0.9 51.54 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.711 0.767 . . . . 0.0 110.664 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.607 ' CB ' ' CD2' ' A' ' 94' ' ' LEU 0.26 0.0 OUTLIER -99.26 -47.95 5.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.479 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.671 ' CG1' ' HD2' ' A' ' 61' ' ' PRO 0.334 0.9 OUTLIER -74.88 179.52 1.33 Allowed Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 113.529 -1.669 . . . . 0.0 106.751 178.585 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.671 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 36.9 Cg_endo -70.74 115.22 4.14 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 CA-C-O 122.951 1.146 . . . . 0.0 111.796 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.33 69.8 1.63 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.833 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -37.5 159.48 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.223 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -105.6 -154.79 0.52 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.201 -0.937 . . . . 0.0 111.362 -178.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 64' ' ' ASN . 6.2 pt-20 -31.98 -31.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.023 -0.423 . . . . 0.0 111.841 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 64' ' ' ASN . 3.5 mtm180 -52.84 -71.68 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.701 -1.25 . . . . 0.0 107.812 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.623 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 2.5 tm-20 -61.25 -48.65 80.5 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.349 -0.844 . . . . 0.0 109.321 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.545 ' O ' ' CB ' ' A' ' 72' ' ' GLU . 1.1 mp -54.19 -16.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.367 -0.833 . . . . 0.0 110.421 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -89.23 -75.99 1.3 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.642 ' SD ' ' S1 ' ' A' ' 107' ' ' FES . 0.0 OUTLIER -43.81 -40.27 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.272 -1.134 . . . . 0.0 108.486 178.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.638 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 0.7 OUTLIER -65.3 -51.49 60.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.545 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -57.39 -22.4 42.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.951 -1.093 . . . . 0.0 108.646 178.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.542 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.79 -43.31 30.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.626 -0.671 . . . . 0.0 110.615 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.561 HG13 ' CG ' ' A' ' 49' ' ' HIS . 4.7 m -39.2 161.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.571 -0.705 . . . . 0.0 109.892 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.551 ' O ' ' CG2' ' A' ' 75' ' ' THR . 21.6 m -120.39 30.91 6.71 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.103 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.604 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -114.18 -166.5 1.11 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.701 -1.2 . . . . 0.0 112.493 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.75 63.27 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.616 -178.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.776 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.44 154.03 14.66 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 118.805 -2.434 . . . . 0.0 111.243 -177.003 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.517 ' CE ' ' HG3' ' A' ' 77' ' ' GLU 0.347 0.4 OUTLIER -131.43 179.65 1.3 Allowed Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.275 -174.794 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 45.7 Cg_endo -77.37 -27.94 6.05 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 N-CA-C 106.96 -1.977 . . . . 0.0 106.96 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.537 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 19.3 p-10 -107.89 16.9 23.06 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.166 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.776 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -45.61 152.62 0.31 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.155 -0.966 . . . . 0.0 109.309 179.006 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.584 ' NE ' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -165.11 144.59 6.8 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.139 -1.424 . . . . 0.0 111.237 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -97.62 109.3 22.08 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.585 ' SG ' ' N ' ' A' ' 24' ' ' MET . 7.2 t -28.68 -32.79 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' A' ' 84' ' ' LEU . 26.0 p -71.99 1.31 7.46 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.383 -1.448 . . . . 0.0 110.703 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 84' ' ' LEU . 33.2 mm-40 -125.22 20.49 8.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.994 -1.066 . . . . 0.0 110.52 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.584 ' CD1' ' NE ' ' A' ' 83' ' ' ARG . 6.8 mm -119.94 99.91 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.029 -1.044 . . . . 0.0 110.305 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.586 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -82.71 129.39 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.844 -1.16 . . . . 0.0 109.563 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.645 ' HG2' ' CG2' ' A' ' 3' ' ' VAL . 1.4 tpt -82.68 125.78 31.61 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.583 -0.698 . . . . 0.0 110.422 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.475 ' OG1' ' HG3' ' A' ' 93' ' ' GLU . 2.0 p -114.09 162.17 24.37 Favored Pre-proline 0 C--N 1.292 -1.913 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.903 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.559 ' CD ' ' HB3' ' A' ' 19' ' ' ASP . 37.9 Cg_endo -64.33 -13.69 39.71 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 O-C-N 124.658 1.873 . . . . 0.0 108.372 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.475 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.8 OUTLIER -84.76 -38.69 19.33 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.624 ' CD1' HG23 ' A' ' 60' ' ' VAL . 68.5 mt -90.5 31.09 1.06 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.725 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.445 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 6.3 p-10 -63.59 107.19 1.09 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.922 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.619 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.93 22.32 1.98 Allowed Glycine 0 N--CA 1.498 2.799 0 O-C-N 120.817 -1.177 . . . . 0.0 110.328 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.721 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -59.0 140.67 17.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.634 -0.921 . . . . 0.0 111.497 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.613 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 2.2 t -114.75 111.47 36.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -98.89 154.83 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.631 -1.293 . . . . 0.0 109.764 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 1.3 m-20 -122.43 123.11 40.56 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.243 -0.911 . . . . 0.0 110.087 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 72.2 t -102.27 121.55 49.82 Favored Pre-proline 0 C--N 1.289 -2.063 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.3 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.62 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 53.6 Cg_endo -75.51 172.83 15.57 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.835 1.69 . . . . 0.0 112.048 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.51 -18.17 24.55 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.425 0.631 . . . . 0.0 109.371 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.429 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.95 73.51 0.82 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.463 ' CG ' ' HG2' ' A' ' 102' ' ' PRO . 1.2 mt-30 -98.63 56.26 1.11 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.266 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.591 ' OXT' ' CD2' ' A' ' 106' ' ' TRP . 1.5 p-90 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.852 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.642 ' S1 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 91' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.622 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -78.32 150.61 33.24 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.097 178.511 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.699 ' HA ' HG21 ' A' ' 97' ' ' ILE . 43.4 t -140.23 135.59 36.73 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 O-C-N 121.436 -0.79 . . . . 0.0 110.767 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 39.2 t -141.81 91.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.77 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.646 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 42.3 m-85 -68.41 136.15 52.85 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 99' ' ' VAL . 98.7 t -98.91 163.82 2.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 11' ' ' THR . 81.9 p -98.59 -150.99 0.37 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.983 -1.073 . . . . 0.0 108.608 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.642 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -92.84 -30.53 15.4 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 119.763 -1.835 . . . . 0.0 107.815 178.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 3.1 p-10 -92.39 2.45 56.65 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.629 -0.67 . . . . 0.0 111.244 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.487 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 103.43 -8.39 52.15 Favored Glycine 0 N--CA 1.502 3.074 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.889 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -70.87 130.94 42.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.611 -1.523 . . . . 0.0 107.31 178.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -121.05 -172.33 2.38 Favored 'General case' 0 C--N 1.273 -2.758 0 O-C-N 120.862 -1.149 . . . . 0.0 112.567 -178.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.3 179.9 6.04 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 177.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.689 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 6.7 mt-10 -150.45 105.3 3.31 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.182 -1.574 . . . . 0.0 110.687 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.596 ' CD1' HD11 ' A' ' 32' ' ' ILE 0.256 8.4 mt -99.5 -156.2 0.54 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.889 0.852 . . . . 0.0 110.357 178.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -146.74 72.78 1.29 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.749 HG11 ' HB ' ' A' ' 21' ' ' VAL 0.255 14.7 t -86.5 120.15 35.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.56 -172.86 3.74 Favored 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.35 1.072 . . . . 0.0 111.969 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -68.65 117.1 9.94 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 177.18 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.487 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 112.8 -16.39 23.45 Favored Glycine 0 C--N 1.275 -2.855 0 C-N-CA 118.977 -1.582 . . . . 0.0 109.719 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.749 ' HB ' HG11 ' A' ' 17' ' ' VAL . 43.1 t -97.01 144.09 11.23 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.006 0 C-N-CA 117.144 -1.822 . . . . 0.0 108.564 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER -96.4 134.79 39.12 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.104 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.646 ' HB3' ' CE2' ' A' ' 5' ' ' TYR 0.27 7.6 mt -46.09 -30.1 1.76 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 123.833 1.778 . . . . 0.0 108.198 178.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.636 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -73.65 -12.28 60.69 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.721 -179.245 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.648 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.2 tt0 -95.52 -59.9 1.78 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.534 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -56.76 -49.43 75.29 Favored 'General case' 0 C--O 1.199 -1.559 0 C-N-CA 118.022 -1.471 . . . . 0.0 110.572 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.608 ' CA ' ' HB ' ' A' ' 32' ' ' ILE . . . -47.0 -53.43 12.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.611 -1.305 . . . . 0.0 109.802 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.599 HG23 ' HB3' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -63.52 -3.76 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 121.352 0.596 . . . . 0.0 110.268 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 26' ' ' ALA 0.265 0.0 OUTLIER -105.44 -29.22 10.36 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.482 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.498 ' HB2' HD21 ' A' ' 15' ' ' LEU . 3.3 m-80 -96.37 4.27 52.34 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.57 62.72 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 118.416 -1.85 . . . . 0.0 110.315 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.608 ' HB ' ' CA ' ' A' ' 27' ' ' ALA . 11.2 mt -77.08 -60.83 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.492 -1.005 . . . . 0.0 108.652 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.636 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 3.8 m-30 -82.0 54.43 2.48 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 121.982 0.896 . . . . 0.0 110.571 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -46.97 -31.28 3.07 Favored 'General case' 0 C--N 1.271 -2.808 0 O-C-N 120.514 -1.366 . . . . 0.0 111.114 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 35' ' ' ILE . 11.5 mm -69.46 130.78 34.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.563 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 6.1 p -92.24 58.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.945 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.26 69.88 3.08 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -99.52 86.09 3.28 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 121.061 -1.259 . . . . 0.0 111.623 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.578 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 7.4 p -61.05 -9.15 3.98 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.0 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 53.77 46.13 68.09 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.728 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.34 28.76 62.29 Favored Glycine 0 N--CA 1.507 3.378 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 43' ' ' ALA . 45.8 t -99.82 12.98 35.31 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 118.046 0.923 . . . . 0.0 108.977 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 42' ' ' SER . . . 41.99 54.28 4.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.364 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.74 9.0 6.39 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.444 -0.902 . . . . 0.0 112.005 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.578 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -130.57 168.81 16.48 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 118.208 -1.397 . . . . 0.0 112.474 -178.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.522 ' O ' ' OXT' ' A' ' 106' ' ' TRP . . . -150.25 10.28 0.68 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.4 p -87.16 -4.35 59.11 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.031 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.512 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 23.8 p -91.78 29.97 1.45 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 110.886 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.718 ' CE1' ' CE2' ' A' ' 51' ' ' TYR . 5.3 t60 -68.5 134.84 50.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.441 -1.412 . . . . 0.0 110.959 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.598 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 2.0 m -159.74 179.89 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.641 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.718 ' CE2' ' CE1' ' A' ' 49' ' ' HIS 0.275 65.8 m-85 -138.53 113.19 8.99 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 121.596 0.712 . . . . 0.0 110.959 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.599 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 3.9 t -82.61 131.35 33.96 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 O-C-N 120.869 -1.144 . . . . 0.0 109.346 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.705 HD22 ' HB2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -44.58 155.17 0.1 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.076 -1.049 . . . . 0.0 108.727 177.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -67.45 -1.07 4.3 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.839 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.626 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.45 5.31 48.16 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.564 -1.335 . . . . 0.0 111.393 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.705 ' HB2' HD22 ' A' ' 53' ' ' ASN . 70.6 m-85 -140.17 2.2 1.88 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.328 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.599 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 17.7 p -89.08 -30.28 18.78 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.318 -1.489 . . . . 0.0 107.748 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -107.8 20.74 18.39 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.015 -178.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.638 ' HB3' HD23 ' A' ' 94' ' ' LEU 0.302 0.3 OUTLIER -125.93 -47.62 1.65 Allowed 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 124.455 2.074 . . . . 0.0 106.72 179.535 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.795 ' CG1' ' HD2' ' A' ' 61' ' ' PRO 0.347 0.6 OUTLIER -75.68 -176.65 0.6 Allowed Pre-proline 0 C--N 1.273 -2.727 0 CA-C-N 113.093 -1.867 . . . . 0.0 107.153 179.244 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.795 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 37.5 Cg_endo -59.6 122.73 11.95 Favored 'Trans proline' 0 C--N 1.294 -2.307 0 CA-C-O 122.621 1.009 . . . . 0.0 111.354 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -70.77 67.93 0.4 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.041 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.561 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -37.34 151.89 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.143 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.425 ' OD1' ' HB2' ' A' ' 66' ' ' ARG . 48.7 p-10 -92.55 -164.21 1.15 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.033 0.92 . . . . 0.0 111.744 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 69' ' ' GLY . 24.6 pt-20 -55.56 -25.48 38.15 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.519 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.498 ' O ' ' HG2' ' A' ' 70' ' ' MET . 0.2 OUTLIER -55.71 -61.57 2.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 119.785 -1.822 . . . . 0.0 107.049 177.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.614 ' HA ' ' HE3' ' A' ' 70' ' ' MET . 1.0 OUTLIER -57.76 -49.41 76.67 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.701 -0.624 . . . . 0.0 109.922 177.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 58.0 mt -73.77 -0.9 2.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.058 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -94.25 -76.45 1.33 Allowed Glycine 0 C--O 1.202 -1.871 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.979 ' SD ' ' S1 ' ' A' ' 107' ' ' FES . 1.6 ptt? -46.81 -25.81 0.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.615 ' CD1' ' HB3' ' A' ' 82' ' ' SER . 0.7 OUTLIER -74.56 -48.38 27.19 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -57.71 -16.01 9.63 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 119.972 -1.705 . . . . 0.0 108.328 177.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.585 ' O ' ' NE1' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -86.57 -30.34 21.94 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 120.509 -0.476 . . . . 0.0 112.033 -177.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.58 HG13 ' ND1' ' A' ' 49' ' ' HIS . 22.3 m -48.83 170.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.575 ' O ' ' CG2' ' A' ' 75' ' ' THR . 23.5 m -120.15 16.93 12.41 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 109.534 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 78' ' ' LEU . . . -105.76 -164.97 1.06 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.849 1.309 . . . . 0.0 113.589 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.811 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -52.39 61.8 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.573 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.819 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -56.34 154.21 8.56 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 114.911 -2.716 . . . . 0.0 110.142 -177.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.667 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.402 1.0 OUTLIER -135.19 174.34 4.71 Favored Pre-proline 0 C--N 1.277 -2.584 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.152 -173.704 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.94 -26.24 22.24 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 N-CA-C 107.782 -1.661 . . . . 0.0 107.782 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.579 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 15.6 p-10 -110.27 16.29 21.79 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.716 0.769 . . . . 0.0 110.555 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.819 ' OG ' ' HG ' ' A' ' 78' ' ' LEU 0.256 0.5 OUTLIER -45.24 158.36 0.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.066 -1.021 . . . . 0.0 110.675 178.597 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.493 ' HB2' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -168.56 153.26 6.1 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 117.475 -1.69 . . . . 0.0 114.315 -179.039 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.563 ' HB2' ' HE3' ' A' ' 70' ' ' MET . 0.1 OUTLIER -105.94 88.65 2.86 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 24' ' ' MET . 1.5 t -12.32 -52.02 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.545 ' N ' ' O ' ' A' ' 84' ' ' LEU . 8.7 p -50.92 -9.65 0.06 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.084 -1.01 . . . . 0.0 111.636 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.484 ' NE2' ' HE1' ' A' ' 70' ' ' MET . 0.0 OUTLIER -119.15 20.45 12.64 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 119.707 -1.871 . . . . 0.0 111.375 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.545 HD12 ' CG1' ' A' ' 60' ' ' VAL . 8.7 mm -118.91 117.64 55.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.71 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.574 ' HB ' ' HG3' ' A' ' 61' ' ' PRO . 3.6 mm -100.21 131.69 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.451 -0.781 . . . . 0.0 109.364 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.627 ' CE ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -82.04 129.71 34.87 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.36 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.691 ' OG1' ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -110.96 163.51 17.13 Favored Pre-proline 0 C--N 1.288 -2.072 0 C-N-CA 118.265 -1.374 . . . . 0.0 109.858 179.053 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.503 ' HD3' ' OD1' ' A' ' 19' ' ' ASP . 43.2 Cg_endo -65.18 -9.3 21.33 Favored 'Trans proline' 0 C--N 1.283 -2.883 0 O-C-N 124.641 1.864 . . . . 0.0 110.285 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.691 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.6 OUTLIER -93.69 -28.63 15.85 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 116.992 -1.883 . . . . 0.0 107.853 177.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.638 HD23 ' HB3' ' A' ' 59' ' ' LYS . 70.7 mt -91.71 33.94 1.01 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.09 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.452 ' O ' ' CG ' ' A' ' 95' ' ' ASP . 19.4 p-10 -64.29 103.72 0.67 Allowed 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.931 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.622 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 125.26 17.68 2.66 Favored Glycine 0 N--CA 1.504 3.212 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.716 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.699 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -51.07 144.3 2.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.322 0.582 . . . . 0.0 109.526 178.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.643 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.5 t -122.07 113.24 38.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.549 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -98.07 160.41 3.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 119.958 -1.714 . . . . 0.0 110.497 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.694 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -123.18 120.4 33.09 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 109.55 -178.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 76.5 t -96.27 126.95 42.08 Favored Pre-proline 0 C--N 1.291 -1.954 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.807 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.598 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 43.9 Cg_endo -79.65 166.04 22.08 Favored 'Trans proline' 0 C--N 1.295 -2.238 0 O-C-N 123.695 1.366 . . . . 0.0 110.797 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -89.42 -15.96 31.99 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.42 83.8 1.82 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.48 ' HG2' ' HG2' ' A' ' 102' ' ' PRO . 42.9 mt-30 -102.03 57.46 0.81 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.576 -1.25 . . . . 0.0 111.072 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.624 ' OXT' ' CG ' ' A' ' 106' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 O-C-N 121.244 -0.91 . . . . 0.0 110.601 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.979 ' S1 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.622 ' CB ' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.356 0.598 . . . . 0.0 110.361 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.594 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -78.04 146.67 35.16 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.275 -0.89 . . . . 0.0 108.999 177.461 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.776 ' HA ' HG21 ' A' ' 97' ' ' ILE . 19.9 t -136.67 136.33 48.31 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.186 0 O-C-N 121.055 -1.028 . . . . 0.0 111.735 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 59.9 t -141.3 89.89 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.696 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 29.5 m-85 -67.54 133.97 50.42 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 99' ' ' VAL . 61.9 t -99.58 172.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 120.956 -1.09 . . . . 0.0 109.576 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.493 ' HB3' HG21 ' A' ' 11' ' ' THR . 5.4 p -106.45 -145.78 0.39 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.243 -0.911 . . . . 0.0 109.623 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.575 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -96.28 -32.34 12.46 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -92.02 -8.19 46.74 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.848 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.82 -12.4 20.46 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.157 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -57.02 131.57 50.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.368 -1.666 . . . . 0.0 108.229 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -121.08 174.66 6.52 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 122.123 0.964 . . . . 0.0 112.957 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.62 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -129.13 178.84 6.13 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.665 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -151.93 109.76 3.66 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.041 -1.864 . . . . 0.0 111.289 178.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.619 ' CD1' ' HA ' ' A' ' 27' ' ' ALA . 3.6 mt -103.72 -157.98 0.64 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.449 1.119 . . . . 0.0 110.842 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 16' ' ' ASP . 27.2 t0 -149.5 67.91 1.02 Allowed 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.711 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -88.85 124.62 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.108 0.956 . . . . 0.0 110.008 -177.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.05 179.81 5.86 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.243 1.021 . . . . 0.0 113.112 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -57.42 117.6 4.29 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.644 177.134 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.58 -25.06 14.02 Favored Glycine 0 C--N 1.286 -2.197 0 C-N-CA 119.425 -1.369 . . . . 0.0 111.381 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.711 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 91.2 t -85.63 149.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 120.082 1.941 . . . . 0.0 109.742 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -96.05 125.32 40.5 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.651 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 8.6 mt -41.77 -27.84 0.13 Allowed 'General case' 0 C--O 1.201 -1.461 0 O-C-N 121.084 -1.01 . . . . 0.0 109.258 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.551 ' HA ' ' HE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -59.32 -49.44 77.81 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 177.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.5 tt0 -57.98 -68.79 0.21 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.714 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.592 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.77 -55.95 7.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.971 -1.08 . . . . 0.0 111.052 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.619 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . . . -47.65 -48.14 28.96 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.293 -1.504 . . . . 0.0 110.196 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.512 HG22 ' HB2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -70.72 -1.46 2.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.502 179.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -102.05 -29.3 11.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 0.0 109.674 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.451 ' CG ' HD22 ' A' ' 15' ' ' LEU . 4.5 m-80 -97.73 -3.15 39.71 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.455 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . 89.79 32.98 9.43 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.119 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.608 HD11 ' CD2' ' A' ' 15' ' ' LEU . 5.2 mt -80.42 -65.27 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -1.166 . . . . 0.0 109.276 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.589 ' OH ' ' CD2' ' A' ' 5' ' ' TYR . 19.7 m-85 -80.49 11.22 3.84 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.561 -0.712 . . . . 0.0 111.036 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 31' ' ' GLY . 41.8 p-10 -79.68 45.04 0.66 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.049 -1.032 . . . . 0.0 111.163 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.0 mt -100.58 -48.32 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.134 -0.979 . . . . 0.0 109.958 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.529 ' CG1' ' N ' ' A' ' 37' ' ' GLY . 2.2 p -117.22 -146.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.335 -0.853 . . . . 0.0 109.809 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.529 ' N ' ' CG1' ' A' ' 36' ' ' VAL . . . -90.16 -161.69 37.67 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -98.33 170.08 9.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.285 -1.127 . . . . 0.0 110.184 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -100.08 24.13 9.01 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.853 1.311 . . . . 0.0 109.003 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 41' ' ' GLY . . . 65.55 6.65 29.83 Favored Glycine 0 N--CA 1.495 2.63 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.438 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 46.61 22.35 1.05 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.334 -1.412 . . . . 0.0 109.847 177.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 43' ' ' ALA . 4.7 p -91.81 22.99 3.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.877 -1.367 . . . . 0.0 111.316 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 42' ' ' SER . . . 44.05 26.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.142 -0.974 . . . . 0.0 109.256 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 42' ' ' SER . 5.5 t -125.75 18.04 8.0 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.485 -0.76 . . . . 0.0 109.556 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.465 ' O ' ' S2 ' ' A' ' 107' ' ' FES . 12.2 p -129.62 -174.06 3.19 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.993 0.902 . . . . 0.0 111.017 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.555 ' CB ' ' OXT' ' A' ' 106' ' ' TRP . . . -141.17 21.38 2.25 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.449 ' HB ' ' CB ' ' A' ' 39' ' ' CYS . 3.0 m -55.19 -19.44 7.94 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.171 -1.011 . . . . 0.0 108.797 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.513 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 28.6 p -101.24 29.93 4.45 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.716 -0.615 . . . . 0.0 110.243 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.716 ' CD2' ' HB ' ' A' ' 74' ' ' VAL . 2.0 t60 -65.47 104.24 0.96 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.523 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.546 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 0.8 OUTLIER -140.75 -173.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.454 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.716 ' CZ ' ' CE1' ' A' ' 49' ' ' HIS 0.275 84.2 m-85 -140.63 107.21 5.32 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 121.838 0.827 . . . . 0.0 110.617 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.638 HG23 ' HB2' ' A' ' 83' ' ' ARG . 3.5 t -70.88 134.29 30.29 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 O-C-N 120.222 -1.549 . . . . 0.0 109.162 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.635 ' ND2' ' HB2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -44.8 151.44 0.29 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.683 -1.207 . . . . 0.0 109.305 178.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -61.82 -8.51 4.97 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.216 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.611 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -92.64 5.06 52.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.019 -1.051 . . . . 0.0 111.379 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.741 ' CD2' ' HB ' ' A' ' 97' ' ' ILE . 42.0 m-85 -140.75 4.63 1.93 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.78 -1.2 . . . . 0.0 109.715 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.558 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 14.7 p -89.67 -33.16 16.73 Favored 'General case' 0 C--N 1.288 -2.066 0 O-C-N 120.746 -1.221 . . . . 0.0 108.023 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.25 -1.91 35.18 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.863 0.84 . . . . 0.0 109.968 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.611 ' CD ' ' O ' ' A' ' 55' ' ' ALA 0.268 1.5 mtpt -99.38 -48.64 4.72 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 123.07 1.414 . . . . 0.0 107.601 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.695 ' CG1' ' HD2' ' A' ' 61' ' ' PRO 0.33 0.8 OUTLIER -72.09 -178.28 0.61 Allowed Pre-proline 0 C--N 1.288 -2.068 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.053 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.695 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 33.1 Cg_endo -67.61 128.0 17.33 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 CA-C-O 123.1 1.208 . . . . 0.0 111.922 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -73.23 69.4 1.08 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.107 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.496 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -38.02 157.94 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.594 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.447 ' O ' HD12 ' A' ' 68' ' ' ILE . 49.9 p30 -127.37 -149.7 0.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.762 -1.211 . . . . 0.0 112.48 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -36.45 -30.78 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.215 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.471 ' NH1' ' HG3' ' A' ' 66' ' ' ARG . 5.9 mtm-85 -53.79 -73.2 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.699 -1.251 . . . . 0.0 109.458 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.619 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -67.98 -38.82 83.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.094 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.552 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 0.5 OUTLIER -47.52 -19.83 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.22 -0.925 . . . . 0.0 109.618 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 67' ' ' GLU . . . -90.18 -70.13 1.22 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.619 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -50.3 -30.26 11.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.847 -1.384 . . . . 0.0 108.384 178.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.629 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 0.5 OUTLIER -74.13 -50.06 21.08 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -57.13 -18.4 14.85 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.727 -1.233 . . . . 0.0 108.39 178.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -83.54 -34.32 25.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.719 . . . . 0.0 111.533 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.716 ' HB ' ' CD2' ' A' ' 49' ' ' HIS . 33.3 m -42.63 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.016 -1.052 . . . . 0.0 109.851 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.521 ' O ' ' CG2' ' A' ' 75' ' ' THR . 38.2 m -121.08 11.57 10.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.936 -1.102 . . . . 0.0 110.521 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.57 ' HB2' ' CD2' ' A' ' 49' ' ' HIS . . . -99.59 -154.87 0.48 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 123.041 1.4 . . . . 0.0 113.063 -177.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.757 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.252 0.0 OUTLIER -64.96 63.79 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.575 -178.384 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.631 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.03 145.05 37.64 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 115.078 -2.649 . . . . 0.0 110.529 -176.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.546 ' CE ' ' HG3' ' A' ' 77' ' ' GLU 0.362 0.1 OUTLIER -119.01 177.28 1.38 Allowed Pre-proline 0 C--N 1.288 -2.103 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.787 -175.238 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.438 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 42.7 Cg_endo -75.39 -25.2 11.5 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 N-CA-C 106.36 -2.208 . . . . 0.0 106.36 175.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.513 ' HB2' ' CB ' ' A' ' 57' ' ' THR . 14.6 p-10 -112.79 22.37 14.56 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.931 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.631 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -46.14 156.57 0.15 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.658 -1.276 . . . . 0.0 109.347 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.638 ' HB2' HG23 ' A' ' 52' ' ' VAL . 2.1 mmt85 -153.02 155.1 36.26 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.347 -1.341 . . . . 0.0 111.603 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -111.84 100.72 9.15 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.537 ' SG ' ' CG1' ' A' ' 50' ' ' VAL . 88.2 m -30.37 -31.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.572 ' N ' ' O ' ' A' ' 84' ' ' LEU . 28.0 p -73.21 1.87 8.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.394 -1.442 . . . . 0.0 110.621 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' A' ' 84' ' ' LEU . 1.2 tp-100 -126.29 -8.9 6.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.037 -1.04 . . . . 0.0 111.685 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.497 HG23 ' HG ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -89.87 118.84 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.769 -1.207 . . . . 0.0 110.39 -179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.56 ' HB ' ' HG3' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -102.65 135.01 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.074 -1.016 . . . . 0.0 109.607 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.608 ' O ' ' HA ' ' A' ' 19' ' ' ASP . 2.0 tpt -83.61 121.15 26.85 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.702 -0.624 . . . . 0.0 110.66 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.622 ' O ' ' CB ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -95.83 -176.9 0.58 Allowed Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 117.879 -1.528 . . . . 0.0 109.172 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 46.1 Cg_endo -90.06 -8.04 4.23 Favored 'Trans proline' 0 C--N 1.284 -2.842 0 O-C-N 124.204 1.634 . . . . 0.0 108.883 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.548 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.9 pt-20 -91.96 -30.53 16.05 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.767 1.27 . . . . 0.0 107.577 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.629 ' CD1' HG23 ' A' ' 60' ' ' VAL . 62.6 mt -90.1 29.35 1.23 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.333 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.578 ' HA ' ' CB ' ' A' ' 1' ' ' SER . 17.9 p-10 -62.87 104.01 0.5 Allowed 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.932 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.594 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.37 22.88 2.02 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.051 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.776 HG21 ' HA ' ' A' ' 3' ' ' VAL . 3.5 tt -63.12 161.3 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.462 1.125 . . . . 0.0 112.307 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.635 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 t -134.56 116.43 21.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -99.24 156.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.647 -1.283 . . . . 0.0 109.47 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.682 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.95 111.61 16.83 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.079 -1.013 . . . . 0.0 110.637 -178.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 6' ' ' VAL . 58.7 t -91.83 127.94 47.93 Favored Pre-proline 0 C--N 1.288 -2.081 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.75 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.546 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 58.4 Cg_endo -79.06 -179.9 5.87 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.083 1.57 . . . . 0.0 112.715 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -91.01 -14.89 30.56 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.51 ' HG2' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -110.37 82.66 1.63 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.458 ' NE2' ' CG1' ' A' ' 101' ' ' VAL . 3.7 tt0 -98.64 50.54 0.98 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 117.381 -1.728 . . . . 0.0 110.478 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.57 ' CE3' ' O ' ' A' ' 106' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.117 -0.989 . . . . 0.0 109.888 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.465 ' S2 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.61 ' CB ' ' O ' ' A' ' 91' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.179 0.514 . . . . 0.0 110.68 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.597 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 1.0 OUTLIER -62.08 148.85 42.89 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.746 HG22 ' CG2' ' A' ' 97' ' ' ILE . 53.7 t -138.05 135.67 45.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 O-C-N 120.85 -1.156 . . . . 0.0 111.929 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 47.5 t -143.18 92.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.717 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.644 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 34.6 m-85 -70.7 136.92 49.33 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.232 -0.917 . . . . 0.0 108.982 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.528 HG22 ' CD ' ' A' ' 12' ' ' ARG . 61.5 t -99.92 167.55 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 O-C-N 120.51 -1.369 . . . . 0.0 109.335 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.529 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 91.2 p -103.17 -155.83 0.54 Allowed 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.15 -0.969 . . . . 0.0 109.014 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.594 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -88.51 -30.41 19.37 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -91.83 -6.08 52.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.38 0.609 . . . . 0.0 109.909 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.03 -24.65 11.5 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.71 129.55 29.95 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.671 -1.488 . . . . 0.0 108.453 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.528 ' CD ' HG22 ' A' ' 6' ' ' VAL . 1.6 mtm180 -121.53 -172.34 2.4 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-O 122.113 0.958 . . . . 0.0 112.514 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.73 -178.22 5.03 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.233 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.674 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 49.9 mt-10 -151.85 112.1 4.1 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 117.717 -1.593 . . . . 0.0 110.959 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.633 HD13 ' CD1' ' A' ' 32' ' ' ILE 0.254 6.5 mt -108.19 -153.38 0.5 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 122.573 1.178 . . . . 0.0 111.493 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.16 68.77 0.99 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.692 HG11 ' HB ' ' A' ' 21' ' ' VAL . 20.9 t -86.05 114.32 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.98 -170.57 2.84 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 122.098 0.951 . . . . 0.0 111.786 -177.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.499 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 2.1 p-10 -63.67 110.53 2.05 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.4 -16.83 24.21 Favored Glycine 0 C--N 1.286 -2.227 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.606 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.692 ' HB ' HG11 ' A' ' 17' ' ' VAL . 42.0 t -96.73 136.28 28.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 O-C-N 120.203 -1.763 . . . . 0.0 106.909 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.593 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -93.1 140.27 29.68 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.277 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.644 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 8.2 mt -47.96 -25.36 1.33 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.664 -1.273 . . . . 0.0 108.055 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.596 ' CB ' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -69.91 -29.68 66.92 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.316 -0.865 . . . . 0.0 108.667 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 22' ' ' SER . 3.5 tt0 -75.46 -70.84 0.4 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.609 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -46.79 -49.99 18.99 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.136 -1.426 . . . . 0.0 110.601 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.625 ' HA ' HD13 ' A' ' 15' ' ' LEU . . . -47.3 -41.55 19.31 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.211 -1.556 . . . . 0.0 110.796 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.413 ' O ' HG11 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -79.68 2.1 2.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.32 -0.863 . . . . 0.0 109.646 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.261 0.0 OUTLIER -103.9 -30.38 10.37 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.4 1.095 . . . . 0.0 110.206 -179.817 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.63 ' OD1' ' CD1' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -99.08 -6.48 28.35 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.28 32.79 15.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.633 ' CD1' HD13 ' A' ' 15' ' ' LEU . 4.0 mt -72.75 -55.21 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 0.0 109.166 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.578 ' HE2' ' HA ' ' A' ' 24' ' ' MET . 22.3 m-30 -81.25 55.97 2.72 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.735 0.779 . . . . 0.0 110.145 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 20.1 p-10 -49.25 -19.58 0.5 Allowed 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.725 -0.609 . . . . 0.0 110.693 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -66.81 167.43 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.974 -1.079 . . . . 0.0 109.866 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 t -103.35 51.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 110.452 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.525 ' O ' ' CG2' ' A' ' 47' ' ' THR . . . -120.14 70.45 0.36 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -120.15 118.53 30.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.112 -1.228 . . . . 0.0 110.342 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 23.2 p -100.13 22.24 11.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.21 -0.931 . . . . 0.0 110.153 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.05 39.99 97.74 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.02 34.36 23.41 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.498 ' O ' ' NH2' ' A' ' 66' ' ' ARG . 37.7 p -102.75 12.05 36.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 110.136 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.58 ' CB ' ' CZ ' ' A' ' 66' ' ' ARG . . . 55.88 60.13 3.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.132 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -135.93 7.01 3.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.312 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 1.8 p -134.15 -175.34 3.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.976 . . . . 0.0 110.318 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.575 ' HB3' ' CE3' ' A' ' 106' ' ' TRP . . . -143.94 9.35 1.5 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 110.297 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 37' ' ' GLY . 14.8 t -77.04 -15.55 59.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.06 -1.025 . . . . 0.0 109.437 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.498 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 20.7 p -88.23 26.56 1.38 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.607 -0.683 . . . . 0.0 110.26 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.67 ' CE1' ' CZ ' ' A' ' 51' ' ' TYR . 4.5 t60 -70.26 125.49 26.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.431 -0.793 . . . . 0.0 109.899 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.586 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -153.37 -171.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.823 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.67 ' CZ ' ' CE1' ' A' ' 49' ' ' HIS 0.263 81.6 m-85 -140.81 113.27 8.04 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.734 0.778 . . . . 0.0 110.95 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.548 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 5.6 t -80.39 132.44 31.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 O-C-N 120.426 -1.422 . . . . 0.0 109.796 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.672 ' OD1' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -43.88 158.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.544 -1.262 . . . . 0.0 108.772 177.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.18 1.53 7.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.759 -1.213 . . . . 0.0 110.144 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.594 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.06 5.59 46.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.663 ' HB2' HD22 ' A' ' 53' ' ' ASN . 57.7 m-85 -140.27 4.9 2.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.92 -1.112 . . . . 0.0 109.35 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.548 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 33.8 p -89.35 -39.67 13.28 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.26 -1.79 47.33 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.755 0.788 . . . . 0.0 110.661 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.597 ' CB ' ' CD2' ' A' ' 94' ' ' LEU 0.26 0.8 OUTLIER -99.31 -47.68 5.08 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 123.207 1.48 . . . . 0.0 107.559 179.877 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.642 ' CG1' ' HD2' ' A' ' 61' ' ' PRO 0.329 0.7 OUTLIER -78.31 -179.91 1.49 Allowed Pre-proline 0 C--N 1.286 -2.177 0 CA-C-N 113.624 -1.626 . . . . 0.0 107.921 179.811 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.642 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 37.9 Cg_endo -69.97 106.75 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 CA-C-O 122.655 1.023 . . . . 0.0 111.836 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.515 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -60.21 74.45 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.766 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 87' ' ' GLN . . . -36.78 153.2 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.951 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 66' ' ' ARG . 1.1 p-10 -108.1 -159.75 0.7 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.165 -0.959 . . . . 0.0 111.858 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 7.4 pt-20 -29.68 -34.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.099 -0.375 . . . . 0.0 111.918 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.58 ' CZ ' ' CB ' ' A' ' 43' ' ' ALA . 5.7 mmt180 -53.09 -66.23 0.42 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 120.78 -1.2 . . . . 0.0 107.772 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -61.09 -49.08 78.78 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.14 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.542 ' N ' ' HG3' ' A' ' 67' ' ' GLU . 1.1 mp -57.73 -12.69 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.337 -0.852 . . . . 0.0 111.183 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -89.91 -79.76 1.34 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.585 ' CE ' ' CG ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -43.88 -38.77 3.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -1.177 . . . . 0.0 108.846 179.216 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.621 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 1.0 OUTLIER -64.99 -50.74 65.15 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -57.17 -22.19 38.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.224 -0.923 . . . . 0.0 108.844 178.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.542 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -80.18 -42.29 23.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.477 -0.764 . . . . 0.0 110.744 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.571 HG13 ' CG ' ' A' ' 49' ' ' HIS . 4.7 m -39.0 161.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.526 -0.734 . . . . 0.0 110.089 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.544 ' O ' ' CG2' ' A' ' 75' ' ' THR . 24.2 m -120.52 29.49 7.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 109.245 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.602 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -112.91 -166.38 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.45 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.6 63.36 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.493 -178.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.779 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.47 152.42 18.03 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 118.848 -2.407 . . . . 0.0 111.389 -176.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.502 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.35 0.0 OUTLIER -128.73 -175.97 0.49 Allowed Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.526 -174.824 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 47.0 Cg_endo -80.67 -30.0 2.03 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 N-CA-C 106.987 -1.967 . . . . 0.0 106.987 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.534 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.7 OUTLIER -105.28 13.21 30.81 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.381 178.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.779 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -44.27 147.54 0.54 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.221 -0.924 . . . . 0.0 109.702 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.541 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 4.6 mtt180 -166.74 153.71 9.02 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 117.798 -1.561 . . . . 0.0 112.534 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -102.63 119.08 38.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 33' ' ' TYR . 28.8 p -33.53 -28.91 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.876 -0.515 . . . . 0.0 112.349 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.596 ' HA ' ' CB ' ' A' ' 24' ' ' MET . 31.8 p -77.17 8.16 4.3 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.551 -1.343 . . . . 0.0 111.075 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.585 ' CG ' ' CE ' ' A' ' 70' ' ' MET . 19.4 mm-40 -125.68 8.73 7.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.052 -1.03 . . . . 0.0 110.384 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.541 ' CD1' HG13 ' A' ' 60' ' ' VAL . 3.9 mm -120.5 119.72 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.969 -1.082 . . . . 0.0 111.47 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.546 ' HB ' ' HG3' ' A' ' 61' ' ' PRO . 4.7 mm -102.06 131.36 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.085 -1.009 . . . . 0.0 108.967 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.608 ' HE1' HG23 ' A' ' 97' ' ' ILE . 20.2 mmm -84.13 141.1 31.32 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.899 -1.126 . . . . 0.0 110.289 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.61 ' O ' ' CB ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -114.14 -175.43 0.32 Allowed Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.843 -1.16 . . . . 0.0 109.988 179.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 44.2 Cg_endo -84.98 -9.94 8.43 Favored 'Trans proline' 0 C--N 1.285 -2.8 0 O-C-N 123.705 1.371 . . . . 0.0 108.603 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.518 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.4 pt-20 -92.16 -35.12 14.03 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.616 ' CD1' HG23 ' A' ' 60' ' ' VAL . 55.7 mt -89.77 32.22 0.9 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.726 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.469 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 6.8 p-10 -63.46 108.04 1.26 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 118.319 -1.352 . . . . 0.0 108.788 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.597 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.39 24.11 1.83 Allowed Glycine 0 N--CA 1.498 2.794 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.24 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.746 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -58.59 135.79 22.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.53 -0.983 . . . . 0.0 110.644 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.672 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.5 t -113.53 113.6 44.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.508 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -99.46 155.86 4.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.762 -1.211 . . . . 0.0 109.973 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.19 120.09 33.17 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.739 0.78 . . . . 0.0 109.842 -179.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.529 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 72.8 t -99.61 123.02 49.46 Favored Pre-proline 0 C--N 1.289 -2.06 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.3 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.628 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 55.8 Cg_endo -76.44 173.53 14.33 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.301 1.685 . . . . 0.0 112.21 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.463 ' OD1' ' CD2' ' A' ' 8' ' ' HIS . 1.3 t0 -91.57 -17.84 25.0 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.515 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.81 72.35 0.78 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.1 OUTLIER -98.42 56.02 1.13 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.285 -177.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.585 ' CD2' ' O ' ' A' ' 106' ' ' TRP . 1.7 p-90 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.886 -1.054 . . . . 0.0 109.807 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.453 ' S1 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.581 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.972 0.891 . . . . 0.0 110.851 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.56 ' H ' ' HA ' ' A' ' 95' ' ' ASP . 4.4 mmtt -98.81 149.64 22.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.556 0.694 . . . . 0.0 109.982 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.674 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 35.4 t -141.35 139.24 32.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 O-C-N 121.623 -0.673 . . . . 0.0 111.466 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 45.6 t -143.18 89.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.602 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 46.9 m-85 -67.63 156.67 36.29 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.368 -0.832 . . . . 0.0 109.463 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.549 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 86.3 t -122.36 170.1 12.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.25 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.537 ' HB3' HG21 ' A' ' 11' ' ' THR . 12.0 p -105.45 -154.63 0.52 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.066 -1.021 . . . . 0.0 109.738 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.567 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.91 -30.25 17.0 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.68 -10.63 39.54 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.483 0.659 . . . . 0.0 109.428 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.531 ' O ' ' CD ' ' A' ' 12' ' ' ARG . . . 114.31 -4.33 23.53 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 120.297 -0.954 . . . . 0.0 110.758 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.537 HG21 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -63.77 130.18 43.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.557 -1.555 . . . . 0.0 107.847 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.531 ' CD ' ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -121.08 175.67 5.96 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 122.245 1.022 . . . . 0.0 112.791 -177.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.551 ' HG2' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -132.83 179.31 6.24 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 177.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 42.0 mt-10 -151.57 108.1 3.48 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 117.54 -1.664 . . . . 0.0 110.954 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.61 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 4.9 mt -99.93 -164.19 1.1 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.804 1.288 . . . . 0.0 110.976 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 1' ' ' SER . 51.4 t0 -143.82 68.23 1.28 Allowed 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.708 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 1.1 t -88.06 125.41 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.908 0.861 . . . . 0.0 109.247 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.513 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -89.31 -176.98 5.26 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.746 1.26 . . . . 0.0 113.268 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 90' ' ' MET . 3.1 p-10 -62.12 118.26 7.11 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.569 177.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.409 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 111.9 -22.93 17.98 Favored Glycine 0 C--N 1.284 -2.34 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.593 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.708 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 80.9 t -88.94 149.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 119.818 1.809 . . . . 0.0 110.314 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 25' ' ' GLN . 1.6 p -96.14 128.64 43.22 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.63 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 8.0 mt -41.07 -31.22 0.17 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.201 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.606 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -68.84 -39.29 80.04 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 118.116 -1.434 . . . . 0.0 108.658 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.4 tt0 -56.83 -65.01 0.69 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -50.73 -56.02 13.92 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.683 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.588 ' HA ' ' OD1' ' A' ' 30' ' ' ASN . . . -47.0 -41.45 16.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.513 -1.367 . . . . 0.0 110.835 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -78.94 0.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.325 -0.859 . . . . 0.0 109.435 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.516 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.259 0.0 OUTLIER -104.03 -30.01 10.54 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.232 1.015 . . . . 0.0 110.333 -179.781 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.588 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -98.97 -2.66 36.84 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 24.97 44.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.593 ' CD1' ' CD2' ' A' ' 15' ' ' LEU . 4.4 mt -72.78 -51.64 26.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.244 -1.151 . . . . 0.0 109.435 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.606 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 15.2 m-30 -80.08 54.11 1.86 Allowed 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.766 0.793 . . . . 0.0 110.125 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -60.4 -7.29 1.95 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.726 -0.609 . . . . 0.0 111.201 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.556 ' N ' ' CD1' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -66.1 -149.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.852 -1.155 . . . . 0.0 110.278 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.554 ' N ' HG12 ' A' ' 35' ' ' ILE . 22.1 m -79.32 175.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.01 -1.056 . . . . 0.0 110.387 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.87 172.41 54.83 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.527 ' OD1' ' CE ' ' A' ' 24' ' ' MET . 8.0 p-10 -120.12 -141.27 0.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -1.064 . . . . 0.0 110.346 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.463 ' O ' ' OG ' ' A' ' 42' ' ' SER . 26.3 p -92.81 7.33 44.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.185 -0.947 . . . . 0.0 110.256 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.03 24.7 75.79 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.01 8.5 66.87 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 39' ' ' CYS . 4.1 m -84.63 7.79 19.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -1.142 . . . . 0.0 110.138 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.536 ' CB ' ' HD2' ' A' ' 66' ' ' ARG . . . 46.76 55.07 8.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.289 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 t -140.11 19.2 2.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.96 . . . . 0.0 110.389 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 1.7 p -129.99 -173.49 3.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 110.404 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.579 ' HB3' ' CE3' ' A' ' 106' ' ' TRP . . . -144.01 9.78 1.51 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 110.199 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.447 HG23 ' CG2' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -82.07 7.93 12.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 110.028 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.488 ' O ' HG12 ' A' ' 50' ' ' VAL . 7.9 p -115.14 24.33 11.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.409 -0.807 . . . . 0.0 110.082 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.701 ' CE1' ' CZ ' ' A' ' 51' ' ' TYR . 6.5 t60 -65.11 122.97 18.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.493 -0.754 . . . . 0.0 110.297 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.581 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -148.42 -173.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.981 0.896 . . . . 0.0 109.89 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.75 ' CE1' ' OG ' ' A' ' 82' ' ' SER 0.27 75.6 m-85 -140.69 110.63 6.52 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.713 0.768 . . . . 0.0 110.855 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.536 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 4.0 t -79.01 136.14 24.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 O-C-N 120.421 -1.425 . . . . 0.0 110.038 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.684 ' OD1' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -46.01 158.33 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.523 -1.271 . . . . 0.0 108.858 177.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' N ' ' OE2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -72.16 0.22 10.25 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.775 178.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.594 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.28 4.26 48.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.059 -1.026 . . . . 0.0 110.584 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.739 ' CE2' ' HA ' ' A' ' 97' ' ' ILE . 35.3 m-85 -140.19 6.72 2.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.06 . . . . 0.0 109.299 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 45.6 p -89.39 -39.86 13.13 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.9 -2.47 53.27 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.827 0.822 . . . . 0.0 110.335 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.611 ' CB ' ' CD2' ' A' ' 94' ' ' LEU 0.261 0.0 OUTLIER -99.56 -47.88 4.95 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 122.971 1.367 . . . . 0.0 107.636 -179.961 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.702 ' HB ' ' O ' ' A' ' 56' ' ' PHE 0.33 0.9 OUTLIER -77.54 177.97 2.4 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.113 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.63 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 38.2 Cg_endo -71.38 110.02 2.75 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 CA-C-O 122.565 0.985 . . . . 0.0 112.276 -176.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -60.21 70.95 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.108 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' PRO . . . -37.21 134.25 0.6 Allowed 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.88 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' ARG . 43.1 p-10 -88.76 -150.11 0.19 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.111 0.958 . . . . 0.0 112.252 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 64' ' ' ASN . 11.7 pt-20 -37.97 -26.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.573 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.536 ' HD2' ' CB ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -53.0 -70.91 0.08 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.752 -1.218 . . . . 0.0 108.025 179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.595 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -67.38 -51.5 51.27 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.53 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 0.9 OUTLIER -44.65 -24.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.465 -0.772 . . . . 0.0 110.108 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.488 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -84.07 -83.08 0.97 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.137 -1.985 . . . . 0.0 108.137 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.595 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 1.7 ptt? -39.65 -40.52 0.92 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.578 -0.954 . . . . 0.0 108.934 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.648 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 0.9 OUTLIER -61.71 -53.49 55.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.53 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 3.8 tp10 -56.22 -21.95 26.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.542 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.97 -45.65 23.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.648 -0.657 . . . . 0.0 110.377 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.565 HG13 ' CG ' ' A' ' 49' ' ' HIS . 4.3 m -38.94 159.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.556 -0.715 . . . . 0.0 109.733 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.545 ' O ' ' CG2' ' A' ' 75' ' ' THR . 20.5 m -120.56 34.53 5.18 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.075 -1.015 . . . . 0.0 108.96 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.614 ' HB2' ' CD2' ' A' ' 49' ' ' HIS . . . -115.88 -164.37 0.95 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.628 1.204 . . . . 0.0 112.649 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.751 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.251 0.0 OUTLIER -56.79 62.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.391 -178.843 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.675 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.11 153.65 14.38 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 118.845 -2.409 . . . . 0.0 111.081 -176.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.668 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.387 2.4 mmtt -131.93 177.48 2.22 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.151 -173.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 42.9 Cg_endo -73.4 -27.56 13.14 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 176.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.538 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.9 OUTLIER -109.38 13.88 23.94 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.041 179.362 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.75 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -45.04 147.29 0.7 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.954 -1.091 . . . . 0.0 109.649 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.56 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 1.1 mtt180 -167.47 163.11 14.84 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 117.765 -1.574 . . . . 0.0 113.01 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 3.4 mm? -99.22 122.63 42.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.539 ' CB ' ' OH ' ' A' ' 33' ' ' TYR . 1.9 p -42.92 -23.25 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.167 -0.958 . . . . 0.0 110.713 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.51 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 30.4 p -81.49 4.85 19.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.811 -1.181 . . . . 0.0 110.496 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.519 ' HB3' ' CB ' ' A' ' 63' ' ' ALA . 18.7 mm-40 -125.22 9.0 7.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 110.827 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.547 HD13 ' NE ' ' A' ' 83' ' ' ARG . 30.1 mm -113.71 106.96 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.038 -1.039 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.594 ' HB ' ' HG3' ' A' ' 61' ' ' PRO . 4.2 mm -84.88 131.52 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.976 -1.078 . . . . 0.0 110.046 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.553 ' HG2' ' CG2' ' A' ' 3' ' ' VAL . 2.8 tpt -82.62 113.74 20.52 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.359 -0.838 . . . . 0.0 110.823 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.591 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -91.5 -177.34 0.73 Allowed Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 117.516 -1.674 . . . . 0.0 108.642 178.386 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 46.9 Cg_endo -87.11 -12.61 4.82 Favored 'Trans proline' 0 C--N 1.287 -2.67 0 O-C-N 124.412 1.743 . . . . 0.0 108.651 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.523 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.1 pt-20 -85.2 -32.67 22.54 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.613 ' CD1' HG23 ' A' ' 60' ' ' VAL . 57.7 mt -89.33 36.54 0.83 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.68 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.581 ' HA ' ' CB ' ' A' ' 1' ' ' SER . 12.8 p-10 -62.3 99.82 0.15 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.036 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.558 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 120.67 29.52 1.54 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.268 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.739 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 9.5 tt -60.19 163.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.496 -1.591 . . . . 0.0 112.3 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.684 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.3 t -133.1 114.1 20.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -102.18 154.7 5.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 120.92 -1.113 . . . . 0.0 109.992 -178.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.635 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -122.63 122.91 39.94 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.764 0.792 . . . . 0.0 110.487 -178.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.532 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 73.6 t -98.45 136.33 20.88 Favored Pre-proline 0 C--N 1.289 -2.045 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.631 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.672 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 56.0 Cg_endo -89.76 173.59 3.58 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 121.716 1.61 . . . . 0.0 111.818 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 18.3 p-10 -91.2 -17.15 26.52 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.535 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.98 74.92 0.89 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.499 ' HG2' ' HG2' ' A' ' 102' ' ' PRO . 10.9 mt-30 -98.49 54.08 1.05 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.299 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.579 ' CE3' ' HB3' ' A' ' 46' ' ' ALA . 1.4 p-90 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.082 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.574 ' S1 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.533 ' HB2' ' O ' ' A' ' 91' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.204 0.526 . . . . 0.0 110.22 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.601 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 11.3 mtmt -69.99 149.47 47.69 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.248 -0.908 . . . . 0.0 110.175 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.723 ' HA ' HG21 ' A' ' 97' ' ' ILE . 44.9 t -137.94 135.01 45.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 O-C-N 121.119 -0.988 . . . . 0.0 111.024 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 48.8 t -142.29 92.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.154 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.627 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 36.6 m-85 -70.87 137.3 49.25 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.502 -0.749 . . . . 0.0 109.326 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 99' ' ' VAL . 74.7 t -99.86 166.49 2.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 O-C-N 120.807 -1.183 . . . . 0.0 109.035 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 11' ' ' THR . 82.8 p -102.21 -154.88 0.5 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.066 -1.021 . . . . 0.0 108.925 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.594 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -89.52 -31.25 17.72 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.485 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 6.1 p-10 -92.01 -5.1 53.6 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.313 0.577 . . . . 0.0 109.792 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.4 -24.65 11.16 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.526 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.76 129.31 29.4 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.567 -1.549 . . . . 0.0 108.38 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 10' ' ' GLY . 5.4 mtt180 -121.53 -172.47 2.43 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 122.187 0.994 . . . . 0.0 112.563 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.572 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -136.7 -178.85 5.36 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.652 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 35.3 mt-10 -151.86 112.23 4.13 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 117.788 -1.565 . . . . 0.0 110.711 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.614 ' CD1' ' HA ' ' A' ' 27' ' ' ALA 0.253 3.5 mt -107.86 -152.3 0.48 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.464 1.126 . . . . 0.0 111.207 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -150.37 70.36 1.02 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.692 HG11 ' HB ' ' A' ' 21' ' ' VAL . 12.7 t -86.8 113.7 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.541 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.17 -169.89 2.58 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.03 0.919 . . . . 0.0 111.504 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -63.86 110.53 2.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.28 -17.2 24.24 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.558 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.692 ' HB ' HG11 ' A' ' 17' ' ' VAL . 42.9 t -95.58 137.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 O-C-N 120.134 -1.804 . . . . 0.0 107.358 178.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -95.56 144.03 26.36 Favored 'General case' 0 C--N 1.274 -2.69 0 C-N-CA 118.647 -1.221 . . . . 0.0 108.032 178.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.627 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 12.2 mt -49.81 -25.98 3.55 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.09 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.597 ' HA ' ' HE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -72.21 -18.67 61.82 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 22' ' ' SER . 3.7 tt0 -88.48 -71.96 0.56 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.61 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -47.2 -50.09 21.52 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.166 -1.413 . . . . 0.0 110.349 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.644 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -47.81 -48.21 30.69 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.354 -1.466 . . . . 0.0 110.361 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -72.97 0.55 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.594 -0.691 . . . . 0.0 109.627 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.502 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.34 -29.25 11.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.393 -0.817 . . . . 0.0 110.016 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.435 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.9 m-80 -97.73 -0.97 44.46 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.72 22.39 43.21 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.559 HD12 ' CD1' ' A' ' 15' ' ' LEU . 4.9 mt -72.64 -60.29 2.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.295 -1.121 . . . . 0.0 109.237 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.644 ' CE2' ' CB ' ' A' ' 27' ' ' ALA . 21.7 m-30 -80.79 50.73 1.4 Allowed 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.552 0.691 . . . . 0.0 110.58 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 13.3 p-10 -49.47 -21.45 0.93 Allowed 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.63 -0.669 . . . . 0.0 110.224 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.0 mm -67.13 176.16 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 0.0 109.979 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.438 ' O ' HG11 ' A' ' 36' ' ' VAL . 86.6 t -95.63 80.35 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 110.369 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.536 ' CA ' ' CG2' ' A' ' 47' ' ' THR . . . -120.08 62.86 0.48 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -120.09 71.23 0.89 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -1.144 . . . . 0.0 110.317 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 19.6 p -88.36 24.99 1.76 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 110.198 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.41 33.05 86.19 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.93 22.55 4.6 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 84.0 p -89.91 11.0 21.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -1.153 . . . . 0.0 110.174 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.513 ' CB ' ' SD ' ' A' ' 70' ' ' MET . . . 58.98 60.03 2.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 4.6 t -132.13 11.65 4.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 0.0 110.473 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 1.8 p -133.36 -173.64 3.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.124 -0.985 . . . . 0.0 110.338 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.63 ' CB ' ' CZ3' ' A' ' 106' ' ' TRP . . . -148.5 9.63 0.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.873 . . . . 0.0 110.672 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.536 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 12.6 t -82.55 -16.62 47.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.874 -1.141 . . . . 0.0 109.702 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.495 ' O ' HG12 ' A' ' 50' ' ' VAL . 24.9 p -89.13 28.2 1.25 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.472 -0.767 . . . . 0.0 109.879 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.684 ' CE1' ' CE2' ' A' ' 51' ' ' TYR . 3.6 t60 -70.32 126.55 29.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.379 -0.826 . . . . 0.0 110.14 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.572 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -156.14 -173.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.05 -1.031 . . . . 0.0 110.102 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.684 ' CE2' ' CE1' ' A' ' 49' ' ' HIS 0.269 76.9 m-85 -140.92 109.9 6.12 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.656 0.741 . . . . 0.0 110.773 179.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.563 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 4.1 t -76.58 131.64 34.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 O-C-N 120.225 -1.547 . . . . 0.0 110.773 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.584 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 3.7 t30 -47.82 146.28 2.46 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.608 -1.237 . . . . 0.0 108.668 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -59.0 -8.0 1.27 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.058 -1.026 . . . . 0.0 112.072 -178.393 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.573 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . . . -94.76 8.1 43.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.469 -1.394 . . . . 0.0 110.532 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.681 ' CG ' HD12 ' A' ' 97' ' ' ILE . 87.3 m-85 -140.14 3.5 1.98 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 109.754 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.563 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 23.7 p -90.43 -40.54 11.98 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.1 -1.0 . . . . 0.0 108.467 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.92 -0.87 55.4 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.782 0.801 . . . . 0.0 110.438 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.659 ' HB2' HD21 ' A' ' 94' ' ' LEU 0.259 0.2 OUTLIER -99.46 -48.17 4.87 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 123.199 1.476 . . . . 0.0 107.419 179.655 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.77 ' CG1' ' HD2' ' A' ' 61' ' ' PRO 0.337 0.8 OUTLIER -77.36 -176.82 0.69 Allowed Pre-proline 0 C--N 1.289 -2.039 0 CA-C-N 113.602 -1.635 . . . . 0.0 107.225 179.31 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.77 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 35.5 Cg_endo -61.99 127.45 21.37 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 CA-C-O 122.885 1.119 . . . . 0.0 111.448 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.519 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -74.05 60.4 0.77 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.824 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' A' ' 67' ' ' GLU . . . -38.43 107.29 0.06 Allowed 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.476 0.655 . . . . 0.0 109.915 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -87.73 -142.38 0.12 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.31 -0.869 . . . . 0.0 111.996 -178.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.505 ' HG2' ' ND2' ' A' ' 64' ' ' ASN . 15.7 pt-20 -29.14 -37.34 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 64' ' ' ASN . 4.3 mtm-85 -53.35 -70.37 0.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.872 -1.142 . . . . 0.0 108.99 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -59.78 -52.58 64.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 110.188 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.538 ' O ' ' CB ' ' A' ' 72' ' ' GLU . 1.4 mp -45.54 -20.88 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.566 -0.709 . . . . 0.0 111.111 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -86.6 -80.21 1.19 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.55 ' HG3' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -44.06 -39.06 3.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -1.162 . . . . 0.0 108.653 178.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.695 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 0.5 OUTLIER -63.41 -51.96 63.57 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.538 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -54.63 -24.21 20.5 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -71.23 -50.79 29.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.666 -0.647 . . . . 0.0 110.326 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.569 HG13 ' CG ' ' A' ' 49' ' ' HIS . 4.6 m -39.7 160.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.374 -0.828 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.555 ' O ' ' CG2' ' A' ' 75' ' ' THR . 20.9 m -120.66 35.27 4.93 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.033 -1.042 . . . . 0.0 109.26 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.617 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -114.98 -163.89 0.91 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.841 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.747 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.13 63.21 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.739 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.741 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.08 152.58 16.38 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 118.989 -2.32 . . . . 0.0 111.763 -177.177 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.662 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.392 1.5 mmtt -133.96 177.73 2.11 Favored Pre-proline 0 C--N 1.292 -1.926 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.662 -173.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 44.3 Cg_endo -75.93 -29.38 6.86 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 N-CA-C 107.329 -1.835 . . . . 0.0 107.329 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.529 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.6 OUTLIER -103.82 12.4 34.56 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.631 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.741 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -44.46 148.03 0.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.123 -0.986 . . . . 0.0 109.838 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.519 ' NH1' ' HA ' ' A' ' 62' ' ' ALA . 1.1 mtt180 -169.67 157.74 7.21 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.733 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 86' ' ' CYS . 4.4 mt -106.97 116.09 31.32 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.537 ' SG ' ' CE2' ' A' ' 33' ' ' TYR . 7.4 p -35.35 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.567 ' HA ' ' CB ' ' A' ' 24' ' ' MET . 4.5 p -65.41 -6.1 9.37 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.294 -1.504 . . . . 0.0 112.127 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.543 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . 6.5 tp-100 -125.53 3.24 7.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.421 -1.424 . . . . 0.0 111.655 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.516 ' CD1' ' NE ' ' A' ' 83' ' ' ARG . 35.9 mm -100.99 103.4 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.753 -1.217 . . . . 0.0 110.312 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.57 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -90.17 128.63 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.073 -1.017 . . . . 0.0 108.465 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.58 ' HG3' ' CG2' ' A' ' 3' ' ' VAL . 22.3 mmm -83.22 134.49 34.95 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.546 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.573 ' OG1' ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -112.15 170.67 5.03 Favored Pre-proline 0 C--N 1.291 -1.935 0 O-C-N 120.833 -1.167 . . . . 0.0 109.507 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 38.9 Cg_endo -65.86 -11.71 32.04 Favored 'Trans proline' 0 C--N 1.289 -2.58 0 O-C-N 124.525 1.803 . . . . 0.0 110.892 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.573 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.3 OUTLIER -92.37 -29.33 16.38 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 117.729 -1.588 . . . . 0.0 107.835 177.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 59' ' ' LYS . 96.7 mt -89.96 27.48 1.58 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.707 0.765 . . . . 0.0 110.935 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.463 ' HA ' ' CB ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -63.23 104.79 0.63 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.51 -1.276 . . . . 0.0 107.958 177.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.601 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.78 22.74 1.95 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.723 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -57.83 138.05 19.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.399 -1.059 . . . . 0.0 111.069 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.606 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 2.1 t -111.36 114.14 46.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -98.81 155.17 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.732 -1.23 . . . . 0.0 109.209 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.664 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.93 120.32 33.08 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.358 -0.839 . . . . 0.0 110.251 -178.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 69.8 t -96.32 136.79 21.76 Favored Pre-proline 0 C--N 1.287 -2.115 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.789 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.675 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 57.3 Cg_endo -89.48 171.28 4.39 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.063 1.559 . . . . 0.0 111.585 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -91.2 -17.24 26.39 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.453 ' HB3' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.82 73.9 0.85 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.05 57.13 1.07 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.435 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.63 ' CZ3' ' CB ' ' A' ' 46' ' ' ALA . 1.7 p-90 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.714 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.449 ' S1 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.536 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.085 0.469 . . . . 0.0 110.395 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.639 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 9.1 mtmm -86.51 148.36 25.56 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.298 -0.876 . . . . 0.0 110.173 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.715 ' HA ' HG21 ' A' ' 97' ' ' ILE . 56.0 t -141.17 135.04 31.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 O-C-N 121.152 -0.968 . . . . 0.0 110.983 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 23.6 t -142.6 89.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 118.732 -1.187 . . . . 0.0 110.415 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.637 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 46.2 m-85 -67.92 157.04 35.89 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.466 -0.772 . . . . 0.0 109.331 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.547 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 99.7 t -122.54 169.98 13.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 O-C-N 121.178 -0.951 . . . . 0.0 109.291 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 11' ' ' THR . 9.9 p -102.61 -153.26 0.46 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.06 -1.025 . . . . 0.0 109.217 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.574 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -93.51 -29.44 15.53 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 178.093 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -91.81 -9.97 41.54 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.498 0.666 . . . . 0.0 109.452 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.529 ' O ' ' CD ' ' A' ' 12' ' ' ARG . . . 114.57 -5.69 22.83 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 120.3 -0.953 . . . . 0.0 111.145 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.6 OUTLIER -63.54 130.56 44.87 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.288 -1.713 . . . . 0.0 107.924 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -120.74 176.08 5.7 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 122.257 1.027 . . . . 0.0 112.927 -177.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.555 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -133.02 178.9 6.53 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 177.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 46.2 mp0 -151.75 110.32 3.8 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 117.56 -1.656 . . . . 0.0 111.109 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.601 ' CD1' ' HA ' ' A' ' 27' ' ' ALA . 8.3 mt -103.17 -156.33 0.56 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.592 1.187 . . . . 0.0 110.618 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 1' ' ' SER . 1.1 t0 -153.02 70.35 0.87 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.702 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -89.66 127.84 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.003 0.906 . . . . 0.0 109.627 -177.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.25 -179.27 5.84 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.259 1.028 . . . . 0.0 112.858 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -62.24 119.18 8.52 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.05 -22.14 19.01 Favored Glycine 0 C--N 1.288 -2.119 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.555 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.702 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 65.8 t -90.77 150.64 3.68 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.209 0 O-C-N 120.116 -1.814 . . . . 0.0 109.505 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 25' ' ' GLN . 1.2 p -96.61 132.14 42.54 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.637 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 7.9 mt -46.96 -28.44 1.62 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.705 -1.247 . . . . 0.0 108.436 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.683 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -73.91 -12.02 60.53 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.323 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.0 OUTLIER -91.84 -61.22 1.68 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.598 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -54.39 -55.53 27.72 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.375 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.601 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . . . -47.42 -51.0 21.38 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.561 -1.337 . . . . 0.0 110.446 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.569 ' CG2' ' CB ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -65.41 -5.61 2.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 109.333 179.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 26' ' ' ALA 0.256 0.0 OUTLIER -103.3 -24.0 13.55 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.731 0.777 . . . . 0.0 110.065 179.838 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.468 ' CB ' HD21 ' A' ' 15' ' ' LEU . 3.6 m-80 -96.75 5.45 50.59 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.72 78.44 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.591 ' CD1' ' CD2' ' A' ' 15' ' ' LEU . 10.5 mt -72.63 -58.27 5.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.317 -1.107 . . . . 0.0 109.213 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.683 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 7.1 m-30 -80.59 50.51 1.33 Allowed 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.457 0.646 . . . . 0.0 110.489 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -49.52 -21.28 0.92 Allowed 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.533 -0.73 . . . . 0.0 110.242 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.6 mm -70.45 177.1 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.512 ' CG2' ' O ' ' A' ' 36' ' ' VAL . 18.5 m -116.23 80.25 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.121 -0.987 . . . . 0.0 110.338 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.521 ' CA ' ' OG1' ' A' ' 47' ' ' THR . . . -120.22 54.58 0.65 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 3.6 p-10 -120.16 84.27 2.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -1.223 . . . . 0.0 110.436 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.3 p -86.73 20.1 2.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.106 -0.996 . . . . 0.0 110.229 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.2 34.59 40.8 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.62 21.8 5.06 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.9 t -80.44 1.23 30.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -1.161 . . . . 0.0 110.292 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.457 ' HA ' ' S2 ' ' A' ' 107' ' ' FES . . . 61.13 59.93 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.215 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.8 p -140.05 15.99 2.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.361 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 5.5 p -137.12 -169.3 2.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 110.355 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.643 ' CB ' ' CZ3' ' A' ' 106' ' ' TRP . . . -145.58 11.71 1.29 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.89 . . . . 0.0 110.26 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.521 ' OG1' ' CA ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -83.3 10.5 8.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 0.0 109.952 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.581 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -107.06 14.73 26.02 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.475 -0.765 . . . . 0.0 109.66 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.7 ' CD2' ' CG ' ' A' ' 102' ' ' PRO . 13.4 t60 -70.23 123.76 22.47 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.276 -0.89 . . . . 0.0 111.714 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.58 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 1.5 m -158.34 -174.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.729 0.776 . . . . 0.0 109.129 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.69 ' CE1' ' CE1' ' A' ' 49' ' ' HIS 0.252 68.0 m-85 -140.84 102.57 4.31 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.019 0.914 . . . . 0.0 110.66 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.583 HG23 ' CB ' ' A' ' 83' ' ' ARG . 2.7 t -74.19 134.13 30.18 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 O-C-N 120.69 -1.256 . . . . 0.0 110.491 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.581 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 3.7 t30 -48.8 150.33 1.5 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.302 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.6 pt-20 -60.35 -8.1 2.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.246 -0.909 . . . . 0.0 111.909 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.578 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.78 9.41 43.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.628 -1.295 . . . . 0.0 110.758 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.693 ' CG ' HD12 ' A' ' 97' ' ' ILE . 88.0 m-85 -140.51 2.03 1.8 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.051 -1.03 . . . . 0.0 110.119 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.578 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 7.6 p -90.45 -40.21 12.16 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.015 -1.053 . . . . 0.0 108.36 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.39 -0.31 52.69 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.688 0.756 . . . . 0.0 110.699 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.646 ' HB2' HD21 ' A' ' 94' ' ' LEU 0.265 1.1 mtpp -99.22 -48.49 4.81 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 123.303 1.525 . . . . 0.0 107.085 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.665 ' CG1' ' HD2' ' A' ' 61' ' ' PRO 0.334 0.9 OUTLIER -72.8 179.48 1.09 Allowed Pre-proline 0 C--N 1.288 -2.083 0 CA-C-N 113.436 -1.711 . . . . 0.0 106.472 178.431 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.665 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 36.6 Cg_endo -70.21 113.07 3.33 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 CA-C-O 122.834 1.098 . . . . 0.0 111.155 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.3 67.61 1.42 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.225 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.566 ' CB ' ' CG ' ' A' ' 87' ' ' GLN . . . -37.45 156.6 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.954 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 66' ' ' ARG . 2.3 p-10 -92.37 -161.96 0.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.017 -1.052 . . . . 0.0 112.399 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 4.0 pt-20 -38.1 -24.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.987 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -52.76 -72.3 0.06 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.65 -1.281 . . . . 0.0 107.949 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.597 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -68.36 -40.88 81.33 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.554 -0.716 . . . . 0.0 109.298 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.483 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.1 mp -57.94 -16.89 7.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.111 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.495 ' HA2' ' OE1' ' A' ' 72' ' ' GLU . . . -97.01 -68.35 0.96 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.662 ' SD ' ' S2 ' ' A' ' 107' ' ' FES . 0.0 OUTLIER -42.44 -38.9 2.04 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.126 -1.22 . . . . 0.0 108.065 179.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.698 ' CD1' ' HB3' ' A' ' 82' ' ' SER 0.261 0.0 OUTLIER -65.34 -50.51 65.31 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.883 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.515 ' OE2' ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -67.04 -29.84 69.75 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.515 ' N ' ' OE2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -61.11 -38.92 88.04 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.023 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.635 ' CG2' ' CE1' ' A' ' 49' ' ' HIS . 1.4 m -53.2 168.81 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.594 ' O ' ' CG2' ' A' ' 75' ' ' THR . 17.0 m -120.74 54.48 1.07 Allowed 'General case' 0 C--N 1.287 -2.145 0 O-C-N 120.483 -1.386 . . . . 0.0 110.014 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.652 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -126.17 -154.64 0.64 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 115.151 -2.62 . . . . 0.0 112.211 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.733 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.262 0.0 OUTLIER -63.88 60.38 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 122.702 1.239 . . . . 0.0 108.472 -179.558 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.626 HD12 ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -59.23 132.72 54.85 Favored 'General case' 0 C--N 1.288 -2.09 0 O-C-N 119.63 -1.919 . . . . 0.0 110.375 -177.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.546 ' CD ' ' O ' ' A' ' 77' ' ' GLU 0.365 0.0 OUTLIER -116.01 -179.4 0.62 Allowed Pre-proline 0 C--N 1.291 -1.975 0 CA-C-N 112.666 -2.061 . . . . 0.0 111.798 -174.13 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -79.12 -28.79 3.58 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 N-CA-C 106.82 -2.031 . . . . 0.0 106.82 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.532 ' O ' ' O ' ' A' ' 82' ' ' SER . 14.8 p-10 -108.68 14.68 24.26 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.98 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.698 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . 2.7 m -47.8 -175.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.537 -0.727 . . . . 0.0 109.68 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.583 ' CB ' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -174.89 169.27 3.47 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 116.434 -2.106 . . . . 0.0 114.72 178.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.554 ' CD1' ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -115.72 103.12 10.37 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.661 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 48' ' ' CYS . 0.7 OUTLIER -31.92 -31.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 84' ' ' LEU . 29.6 p -84.48 12.07 7.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.053 -1.654 . . . . 0.0 112.247 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.566 ' CG ' ' CB ' ' A' ' 63' ' ' ALA . 1.5 tp-100 -126.33 21.62 7.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.588 -1.32 . . . . 0.0 111.836 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.561 HD12 ' CG1' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -120.12 105.15 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.736 -1.227 . . . . 0.0 110.678 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.57 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -90.76 132.39 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.923 -1.11 . . . . 0.0 109.37 179.085 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.611 ' HG2' ' CG2' ' A' ' 3' ' ' VAL . 1.3 tpt -82.83 117.56 22.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.653 -0.654 . . . . 0.0 111.348 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.573 ' OG1' ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -98.77 176.15 2.13 Favored Pre-proline 0 N--CA 1.496 1.849 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.779 178.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 45.3 Cg_endo -78.56 -9.0 16.09 Favored 'Trans proline' 0 C--N 1.293 -2.353 0 O-C-N 124.564 1.823 . . . . 0.0 110.262 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.573 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.6 OUTLIER -92.72 -29.72 15.91 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 59' ' ' LYS . 85.9 mt -89.68 28.47 1.31 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.738 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.525 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 17.9 p-10 -63.45 105.73 0.81 Allowed 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 118.513 -1.275 . . . . 0.0 108.621 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.639 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 125.04 16.99 2.83 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.523 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.715 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -51.71 142.17 4.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.606 -0.938 . . . . 0.0 111.715 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.604 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 2.1 t -115.67 111.43 35.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -99.06 153.05 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 120.735 -1.228 . . . . 0.0 109.853 -178.542 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.76 127.88 49.74 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.791 -179.118 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.572 HG13 ' CE1' ' A' ' 8' ' ' HIS . 54.5 t -98.24 139.8 21.45 Favored Pre-proline 0 C--N 1.288 -2.07 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.722 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.7 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 56.2 Cg_endo -90.53 174.81 2.83 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.818 1.679 . . . . 0.0 111.886 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 11.1 p-10 -91.3 -17.72 25.48 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.533 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -111.34 67.86 0.65 Allowed 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -97.5 49.88 1.05 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.326 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.643 ' CZ3' ' CB ' ' A' ' 46' ' ' ALA . 11.0 p-90 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.282 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.662 ' S2 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 91' ' ' THR . 1.4 p . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.146 0.498 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.659 ' O ' HG21 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -98.19 146.63 25.42 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.091 -1.006 . . . . 0.0 110.057 178.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.775 ' HA ' HG21 ' A' ' 97' ' ' ILE . 44.8 t -134.39 133.07 55.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.843 0.83 . . . . 0.0 111.073 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 56.4 t -142.29 89.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.531 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.656 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 40.9 m-85 -67.79 135.82 53.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.53 HG22 ' CD ' ' A' ' 12' ' ' ARG . 59.3 t -99.65 167.09 2.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 O-C-N 120.546 -1.346 . . . . 0.0 109.664 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 11' ' ' THR . 89.6 p -102.3 -153.99 0.48 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 109.335 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.594 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -88.99 -33.09 17.31 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 10.5 p-10 -91.63 -3.88 55.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.736 -0.603 . . . . 0.0 109.883 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.11 -24.42 11.67 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.79 128.83 28.02 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.609 -1.524 . . . . 0.0 108.38 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.53 ' CD ' HG22 ' A' ' 6' ' ' VAL . 20.8 mtm180 -121.35 -171.77 2.28 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 122.162 0.982 . . . . 0.0 112.474 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.36 -179.08 5.42 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 178.296 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -152.0 109.58 3.62 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 117.447 -1.701 . . . . 0.0 111.201 178.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.603 ' CD1' ' N ' ' A' ' 27' ' ' ALA . 6.6 mt -105.06 -157.07 0.59 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.639 1.209 . . . . 0.0 110.583 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -153.27 70.81 0.87 Allowed 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.701 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 1.2 t -88.34 127.39 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.736 0.779 . . . . 0.0 109.592 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.0 -178.16 5.63 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.618 1.199 . . . . 0.0 112.987 -177.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.498 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 1.5 p30 -61.15 116.12 4.31 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.829 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.89 -20.86 21.57 Favored Glycine 0 C--N 1.287 -2.162 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.524 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.701 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 90.3 t -89.21 150.5 3.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 120.1 -1.823 . . . . 0.0 109.306 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 25' ' ' GLN . 1.6 p -96.01 125.61 40.67 Favored 'General case' 0 C--N 1.274 -2.684 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.656 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 4.4 mt -43.05 -24.33 0.07 Allowed 'General case' 0 C--O 1.203 -1.382 0 O-C-N 120.73 -1.231 . . . . 0.0 109.265 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.655 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -64.43 -47.58 78.58 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.9 tt0 -59.84 -65.51 0.67 Allowed 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.57 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -46.61 -60.04 2.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.911 -1.118 . . . . 0.0 110.581 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.603 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -47.72 -54.69 11.42 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.751 -1.218 . . . . 0.0 110.848 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.594 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -63.92 -6.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.544 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.254 0.0 OUTLIER -99.25 -25.97 14.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.303 -0.873 . . . . 0.0 109.817 179.708 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 26' ' ' ALA . 3.5 m-80 -96.93 3.93 51.84 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.81 72.81 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.574 HD11 ' CD1' ' A' ' 15' ' ' LEU . 9.0 mt -72.85 -56.41 9.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.479 -1.012 . . . . 0.0 109.488 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.655 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 7.0 m-30 -80.22 50.62 1.27 Allowed 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.459 0.647 . . . . 0.0 110.272 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -49.36 -21.48 0.88 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.474 -0.766 . . . . 0.0 110.272 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 pp -74.62 134.63 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 109.974 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.453 ' O ' HG11 ' A' ' 36' ' ' VAL . 10.8 p -112.14 55.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.952 . . . . 0.0 110.443 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 47' ' ' THR . . . -120.13 36.4 3.44 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.455 ' HB2' ' S1 ' ' A' ' 107' ' ' FES . 6.8 p-10 -101.07 158.23 16.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -1.151 . . . . 0.0 110.441 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.456 ' HB2' ' CB ' ' A' ' 42' ' ' SER . 24.2 p -77.16 -9.16 58.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.31 -0.869 . . . . 0.0 110.233 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.15 35.71 26.37 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.07 4.72 71.45 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.456 ' CB ' ' HB2' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -83.63 4.32 28.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.209 -1.171 . . . . 0.0 110.209 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.477 ' CB ' ' HG2' ' A' ' 66' ' ' ARG . . . 42.26 49.0 4.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.318 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.5 p -140.07 24.48 2.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 110.581 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 2.1 p -130.12 -168.18 1.93 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.041 -1.037 . . . . 0.0 110.355 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HB3' ' CE3' ' A' ' 106' ' ' TRP . . . -149.44 9.86 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.935 . . . . 0.0 110.81 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 37' ' ' GLY . 15.0 p -83.31 4.05 28.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.004 -1.06 . . . . 0.0 109.995 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.524 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 9.4 p -115.32 29.69 7.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.456 -0.777 . . . . 0.0 109.895 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.668 ' HE1' ' CZ ' ' A' ' 51' ' ' TYR . 4.7 t60 -70.21 125.98 28.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.745 . . . . 0.0 110.116 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.577 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 0.9 OUTLIER -155.3 -173.66 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.0 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.694 ' O ' ' N ' ' A' ' 100' ' ' ASP 0.269 82.9 m-85 -140.41 114.13 8.82 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.624 0.726 . . . . 0.0 110.754 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.547 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 5.5 t -85.19 130.66 35.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 O-C-N 120.28 -1.513 . . . . 0.0 109.504 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.672 HD22 ' HB2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -40.75 157.2 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.675 -1.265 . . . . 0.0 109.294 177.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.1 0.37 7.79 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.844 -1.16 . . . . 0.0 110.209 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.59 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.1 5.29 47.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.948 -1.095 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.681 ' CD2' ' HA ' ' A' ' 97' ' ' ILE . 55.0 m-85 -140.48 5.44 2.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.901 -1.124 . . . . 0.0 109.443 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.547 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 30.4 p -89.58 -38.02 14.27 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -2.45 44.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.828 0.823 . . . . 0.0 110.39 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.623 ' CB ' ' CD2' ' A' ' 94' ' ' LEU 0.259 0.2 OUTLIER -99.21 -47.96 5.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 179.708 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.672 ' HB ' ' O ' ' A' ' 56' ' ' PHE 0.334 1.1 t -80.4 175.03 5.22 Favored Pre-proline 0 C--N 1.288 -2.071 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 177.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.593 ' CG ' ' HB ' ' A' ' 89' ' ' ILE . 38.3 Cg_endo -74.54 110.79 3.17 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 CA-C-O 122.877 1.115 . . . . 0.0 112.934 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.524 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -75.43 75.55 2.5 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.356 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . . . -37.04 160.32 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.874 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -96.99 -160.7 0.82 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.247 -0.908 . . . . 0.0 112.336 -178.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -28.74 -39.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 122.025 -0.422 . . . . 0.0 112.074 -178.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.477 ' HG2' ' CB ' ' A' ' 43' ' ' ALA . 3.6 mtt180 -53.19 -66.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.569 -1.332 . . . . 0.0 108.488 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.592 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.8 OUTLIER -59.25 -35.13 73.14 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.579 -0.701 . . . . 0.0 109.86 178.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.7 mp -77.24 -9.04 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.224 -0.922 . . . . 0.0 110.278 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -84.23 -80.81 1.05 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.592 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.82 -36.56 2.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.164 -1.198 . . . . 0.0 108.728 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.641 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 0.9 OUTLIER -64.62 -48.54 74.5 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 3.1 tp10 -61.36 -16.18 43.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.49 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -85.72 -40.51 16.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.695 -0.628 . . . . 0.0 110.459 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.575 HG13 ' CG ' ' A' ' 49' ' ' HIS . 8.1 m -40.38 162.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.387 -0.821 . . . . 0.0 109.639 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.539 ' O ' ' CG2' ' A' ' 75' ' ' THR . 23.0 m -120.48 30.0 7.16 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.193 -0.942 . . . . 0.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.605 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -113.85 -167.96 1.28 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.755 -1.178 . . . . 0.0 112.465 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.738 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.14 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.819 -179.012 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.796 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.48 153.56 15.71 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 118.903 -2.373 . . . . 0.0 111.165 -177.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.506 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.347 0.0 OUTLIER -128.46 -178.18 0.75 Allowed Pre-proline 0 C--N 1.297 -1.703 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.329 -174.792 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -78.75 -28.36 4.22 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 N-CA-C 106.985 -1.967 . . . . 0.0 106.985 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.56 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER -108.11 16.24 23.5 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.089 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.796 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -43.72 149.37 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.922 -1.111 . . . . 0.0 108.932 -179.388 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.589 ' CZ ' ' CD1' ' A' ' 88' ' ' ILE . 2.3 mmt85 -154.55 146.07 23.14 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.604 -1.638 . . . . 0.0 112.403 -177.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -103.67 88.71 3.13 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 177.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 24' ' ' MET . 5.7 t -17.03 -45.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.578 ' N ' ' O ' ' A' ' 84' ' ' LEU . 1.6 p -44.26 -19.31 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.611 -1.305 . . . . 0.0 112.236 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.469 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 1.3 mp0 -118.88 -4.72 10.64 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.254 -1.529 . . . . 0.0 112.081 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.589 ' CD1' ' CZ ' ' A' ' 83' ' ' ARG . 3.2 mm -79.76 98.25 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.779 -1.201 . . . . 0.0 109.046 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.593 ' HB ' ' CG ' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -84.11 130.42 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.002 -1.061 . . . . 0.0 109.02 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.586 ' HE3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -83.31 125.16 31.33 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.692 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.61 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -101.42 -177.67 0.58 Allowed Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 118.111 -1.436 . . . . 0.0 109.005 177.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.61 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 47.6 Cg_endo -89.07 -14.71 2.67 Favored 'Trans proline' 0 C--N 1.291 -2.453 0 O-C-N 124.483 1.781 . . . . 0.0 108.713 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.5 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.1 pt-20 -82.26 -31.47 30.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.632 ' CD1' HG23 ' A' ' 60' ' ' VAL . 52.4 mt -89.72 34.85 0.83 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.053 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.525 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 6.7 p-10 -62.65 107.16 0.9 Allowed 'General case' 0 C--N 1.29 -2.013 0 O-C-N 120.365 -1.459 . . . . 0.0 109.092 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.433 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 122.24 25.67 1.98 Allowed Glycine 0 N--CA 1.497 2.761 0 O-C-N 120.835 -1.165 . . . . 0.0 110.71 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.775 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -59.1 135.97 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.971 -1.311 . . . . 0.0 110.6 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.672 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.4 t -115.77 111.74 36.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -99.5 156.5 3.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.88 -178.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.694 ' N ' ' O ' ' A' ' 51' ' ' TYR . 1.1 m-20 -122.9 125.95 46.34 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.306 -0.871 . . . . 0.0 110.413 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.532 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 56.1 t -103.61 130.31 23.75 Favored Pre-proline 0 C--N 1.289 -2.039 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.692 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.653 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 56.7 Cg_endo -84.23 173.84 8.55 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 124.296 1.682 . . . . 0.0 112.077 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 1.3 m-20 -91.34 -18.31 24.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.529 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.91 73.75 0.84 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.466 ' HG2' ' HD2' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -98.64 55.63 1.08 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 118.994 -1.083 . . . . 0.0 110.132 -177.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.581 ' CE3' ' HB3' ' A' ' 46' ' ' ALA . 1.4 p-90 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.92 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.467 ' S2 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.504 ' OG ' ' HG3' ' A' ' 90' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.498 1.966 0 CA-C-O 121.197 0.523 . . . . 0.0 110.521 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.655 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -73.34 144.06 46.65 Favored 'General case' 0 C--O 1.202 -1.429 0 O-C-N 120.682 -1.261 . . . . 0.0 109.073 179.119 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.734 ' CG2' HG23 ' A' ' 17' ' ' VAL . 78.6 t -137.69 130.08 41.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 122.287 1.042 . . . . 0.0 110.711 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 85.8 t -141.42 96.5 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.917 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.294 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.652 ' HB2' ' CG ' ' A' ' 13' ' ' ARG . 21.6 m-85 -76.89 151.63 35.72 Favored 'General case' 0 C--O 1.201 -1.486 0 O-C-N 121.64 -0.663 . . . . 0.0 109.747 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 89.9 t -111.31 166.85 5.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 O-C-N 121.046 -1.034 . . . . 0.0 110.368 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 11' ' ' THR . 85.8 p -103.77 -157.21 0.6 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.131 -0.98 . . . . 0.0 109.261 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.613 ' CE1' HG13 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -91.04 -27.13 18.82 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.442 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 6.3 p-10 -92.1 -8.23 46.37 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.734 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 113.47 -9.35 24.22 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.58 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.6 OUTLIER -66.54 136.17 55.25 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 119.914 -1.933 . . . . 0.0 108.758 179.599 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -120.5 179.66 4.25 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.251 1.024 . . . . 0.0 112.974 -176.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.652 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -134.58 173.27 11.84 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 179.589 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 16.3 mt-10 -150.15 114.84 5.27 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 117.111 -1.836 . . . . 0.0 111.047 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.625 ' CD1' ' HA ' ' A' ' 27' ' ' ALA 0.28 4.6 mt -107.92 -154.03 0.52 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.462 1.125 . . . . 0.0 109.845 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.32 72.04 0.92 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.734 HG23 ' CG2' ' A' ' 3' ' ' VAL . 1.4 t -88.31 126.41 41.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-O 121.786 0.803 . . . . 0.0 109.022 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.629 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.44 -179.51 5.84 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.817 0.817 . . . . 0.0 112.777 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.653 ' HB3' ' CD ' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -56.75 112.44 1.3 Allowed 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.56 177.091 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.81 -21.54 18.31 Favored Glycine 0 C--N 1.282 -2.464 0 C-N-CA 118.702 -1.713 . . . . 0.0 113.003 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.678 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 66.7 t -86.2 147.87 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 120.677 2.239 . . . . 0.0 108.059 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -95.38 130.34 42.21 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.612 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 11.0 mt -44.87 -25.79 0.34 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.015 -1.678 . . . . 0.0 109.782 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.605 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -67.41 -23.18 65.53 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.3 tt0 -88.09 -65.43 1.02 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.613 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -46.42 -49.86 17.51 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.281 -1.368 . . . . 0.0 111.383 178.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.649 ' HB1' ' CZ ' ' A' ' 5' ' ' TYR . . . -55.2 -50.0 70.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.184 -1.573 . . . . 0.0 110.173 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.7 OUTLIER -67.32 -1.19 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.73 -1.231 . . . . 0.0 110.569 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . 0.265 0.0 OUTLIER -104.33 -31.15 9.68 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.311 1.053 . . . . 0.0 109.655 -178.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.514 ' HB2' HD21 ' A' ' 15' ' ' LEU . 6.8 m-80 -95.82 4.16 53.1 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.17 12.58 63.2 Favored Glycine 0 N--CA 1.505 3.273 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.536 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.568 HD13 ' CD2' ' A' ' 15' ' ' LEU . 7.9 mt -72.16 -58.34 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.564 -0.962 . . . . 0.0 109.681 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.605 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 6.1 m-30 -81.9 52.52 1.97 Allowed 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.3 -0.875 . . . . 0.0 109.902 178.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -49.06 -29.35 4.98 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.03 0.919 . . . . 0.0 109.448 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.548 ' O ' HG13 ' A' ' 35' ' ' ILE . 25.4 pt -82.78 100.53 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.526 0 O-C-N 120.362 -1.461 . . . . 0.0 108.354 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.2 t -79.88 73.71 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 O-C-N 120.92 -1.112 . . . . 0.0 110.642 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' OG1' ' A' ' 47' ' ' THR . . . -120.42 44.65 1.34 Allowed Glycine 0 N--CA 1.504 3.232 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.57 169.88 11.34 Favored 'General case' 0 C--O 1.193 -1.884 0 O-C-N 121.697 -0.884 . . . . 0.0 110.085 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.652 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 6.9 p -100.5 -4.97 27.7 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-O 122.3 1.048 . . . . 0.0 109.896 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.62 30.83 68.24 Favored Glycine 0 N--CA 1.499 2.867 0 O-C-N 120.297 -1.502 . . . . 0.0 111.321 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.19 17.88 70.73 Favored Glycine 0 N--CA 1.502 3.092 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 39' ' ' CYS . 1.6 t -96.84 -1.43 46.07 Favored 'General case' 0 C--N 1.286 -2.158 0 O-C-N 119.599 -2.118 . . . . 0.0 109.181 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 52.76 55.47 8.97 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.286 -0.884 . . . . 0.0 110.341 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.04 30.73 1.8 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 120.605 -1.31 . . . . 0.0 110.136 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.652 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -141.04 175.31 9.72 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 119.527 -1.983 . . . . 0.0 111.739 -178.556 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.24 17.07 0.94 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.463 0.649 . . . . 0.0 110.469 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -89.19 -2.38 58.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.276 -1.515 . . . . 0.0 109.333 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.51 ' O ' HG11 ' A' ' 50' ' ' VAL . 6.8 p -99.68 30.04 3.82 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.616 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.675 ' CE1' ' CZ ' ' A' ' 51' ' ' TYR . 5.3 t60 -69.81 123.25 20.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.518 -0.739 . . . . 0.0 110.842 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -155.32 -172.35 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 120.808 -1.182 . . . . 0.0 108.399 178.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.675 ' CZ ' ' CE1' ' A' ' 49' ' ' HIS 0.301 79.8 m-85 -139.78 109.13 6.14 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.351 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.557 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 7.1 t -76.94 129.42 37.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 O-C-N 120.566 -1.334 . . . . 0.0 110.553 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.683 HD22 ' HB2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -42.75 146.22 0.39 Allowed 'General case' 0 C--N 1.307 -1.251 0 O-C-N 120.163 -1.586 . . . . 0.0 109.411 176.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.14 -9.48 0.92 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.361 -0.837 . . . . 0.0 111.956 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.631 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -92.15 7.77 40.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.041 -1.662 . . . . 0.0 112.281 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.692 ' O ' ' HB ' ' A' ' 60' ' ' VAL . 77.1 m-85 -141.08 3.71 1.81 Allowed 'General case' 0 N--CA 1.516 2.857 0 O-C-N 120.535 -1.353 . . . . 0.0 108.759 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.557 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 17.0 p -89.4 -33.25 16.92 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.157 -0.965 . . . . 0.0 108.618 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.38 -1.76 24.67 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.94 0.876 . . . . 0.0 111.084 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.631 ' CD ' ' O ' ' A' ' 55' ' ' ALA 0.286 0.1 OUTLIER -97.63 -48.31 5.29 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 179.187 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.692 ' HB ' ' O ' ' A' ' 56' ' ' PHE 0.339 1.0 OUTLIER -77.44 177.75 2.52 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.699 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.64 ' HD2' HG11 ' A' ' 60' ' ' VAL . 32.5 Cg_endo -71.6 122.56 8.69 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 CA-C-O 122.632 1.013 . . . . 0.0 111.731 -177.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -77.17 73.57 3.75 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.36 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.497 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . . . -37.71 157.59 0.01 OUTLIER 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.326 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 66' ' ' ARG . 48.1 p30 -90.0 -168.7 2.2 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 123.157 1.456 . . . . 0.0 112.49 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -37.4 -30.43 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.237 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.46 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -55.28 -63.43 1.16 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.365 -1.459 . . . . 0.0 107.568 179.247 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.592 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 8.0 tp10 -60.72 -41.0 94.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.823 -0.548 . . . . 0.0 110.421 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.9 mt -79.75 -5.22 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.933 . . . . 0.0 110.906 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -86.93 -75.71 1.27 Allowed Glycine 0 N--CA 1.482 1.753 0 N-CA-C 107.629 -2.188 . . . . 0.0 107.629 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.717 ' SD ' ' S2 ' ' A' ' 107' ' ' FES . 0.0 OUTLIER -43.52 -43.36 5.44 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.629 -1.228 . . . . 0.0 107.913 178.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.57 ' CD2' HD12 ' A' ' 78' ' ' LEU 0.25 0.6 OUTLIER -56.96 -53.78 54.13 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.34 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -56.0 -24.94 41.92 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.707 -1.245 . . . . 0.0 108.358 178.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.488 ' O ' ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -74.05 -47.16 38.6 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.704 -179.362 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 71' ' ' LEU . 3.3 m -36.19 161.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 121.972 0.891 . . . . 0.0 111.186 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.566 ' O ' ' CG2' ' A' ' 75' ' ' THR . 30.2 m -118.45 25.9 9.97 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.456 -1.403 . . . . 0.0 109.973 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.6 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -103.46 -153.66 0.48 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.102 -1.624 . . . . 0.0 113.283 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.753 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.25 0.0 OUTLIER -71.05 63.15 0.31 Allowed 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.897 -178.41 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.75 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -57.39 154.97 9.86 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 116.218 -2.193 . . . . 0.0 110.317 -176.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.66 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.375 20.4 mmtt -134.02 178.89 1.55 Allowed Pre-proline 0 C--N 1.294 -1.831 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.253 -173.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 55.2 Cg_endo -77.3 -28.38 5.76 Favored 'Trans proline' 0 C--N 1.295 -2.27 0 N-CA-C 104.742 -2.83 . . . . 0.0 104.742 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.517 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 13.3 p-10 -105.13 14.57 28.96 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.611 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.75 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -47.26 146.6 1.85 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.853 -1.155 . . . . 0.0 109.499 178.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.608 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 mmm-85 -169.1 122.8 0.81 Allowed 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 117.661 -1.616 . . . . 0.0 111.99 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.603 HD13 ' HG3' ' A' ' 70' ' ' MET . 0.7 OUTLIER -80.72 112.97 18.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.041 -1.662 . . . . 0.0 108.298 176.44 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.534 ' HB2' ' OH ' ' A' ' 33' ' ' TYR . 5.5 m -35.09 -23.55 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.564 ' HA ' ' CB ' ' A' ' 24' ' ' MET . 9.7 p -64.08 -12.71 41.6 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 119.222 -2.174 . . . . 0.0 111.056 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.58 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -120.67 18.36 11.95 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.731 -1.188 . . . . 0.0 111.366 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.419 HD12 ' CG1' ' A' ' 60' ' ' VAL . 3.5 mm -110.07 102.75 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.126 -0.984 . . . . 0.0 110.406 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.574 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -84.25 126.55 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 120.967 -1.083 . . . . 0.0 110.418 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.632 ' HA ' ' CE ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -82.53 123.47 29.22 Favored 'General case' 0 C--O 1.2 -1.526 0 O-C-N 120.81 -1.181 . . . . 0.0 109.236 177.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.549 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -113.92 157.39 42.05 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.181 178.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.653 ' CD ' ' HB3' ' A' ' 19' ' ' ASP . 33.8 Cg_endo -58.06 -27.45 79.69 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 124.444 1.76 . . . . 0.0 109.07 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.549 ' HG2' ' HB ' ' A' ' 91' ' ' THR . 3.0 pt-20 -64.4 -42.85 95.86 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.176 176.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.646 ' CD1' HG23 ' A' ' 60' ' ' VAL . 50.8 mt -88.51 38.79 0.88 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.729 0.776 . . . . 0.0 112.469 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.53 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 3.3 p-10 -64.6 111.1 2.57 Favored 'General case' 0 C--N 1.286 -2.185 0 O-C-N 119.867 -1.771 . . . . 0.0 109.167 177.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.655 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.44 21.69 2.2 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.176 -1.488 . . . . 0.0 110.425 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.725 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -60.34 136.98 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.054 -1.262 . . . . 0.0 110.297 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.65 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.5 t -117.15 113.2 42.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.57 HG23 ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -101.16 156.67 4.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 120.262 -1.524 . . . . 0.0 109.886 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.625 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.48 130.05 52.65 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 122.571 1.177 . . . . 0.0 111.276 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.613 HG13 ' CE1' ' A' ' 8' ' ' HIS . 87.2 t -104.89 136.65 19.13 Favored Pre-proline 0 C--N 1.283 -2.307 0 O-C-N 120.743 -1.223 . . . . 0.0 109.833 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.565 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 73.8 Cg_endo -92.61 166.85 2.75 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.807 1.671 . . . . 0.0 111.126 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -86.94 -18.09 31.59 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.706 0.765 . . . . 0.0 109.248 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.529 ' HB3' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -109.47 73.09 0.83 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.26 57.92 0.81 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.975 -1.078 . . . . 0.0 109.695 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.6 ' CD2' ' O ' ' A' ' 106' ' ' TRP . 3.3 p-90 . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.618 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.717 ' S2 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.528 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.331 0.586 . . . . 0.0 110.242 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.598 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -69.25 143.43 53.93 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.357 -0.84 . . . . 0.0 109.841 179.186 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.765 ' HA ' HG21 ' A' ' 97' ' ' ILE . 40.4 t -135.47 135.83 51.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-O 121.748 0.785 . . . . 0.0 111.914 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 47.4 t -142.67 88.5 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.496 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.655 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 46.4 m-85 -67.53 136.0 53.88 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.414 -0.804 . . . . 0.0 109.336 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.532 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 60.7 t -99.77 166.62 2.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 O-C-N 120.662 -1.274 . . . . 0.0 109.513 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.553 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 87.9 p -100.53 -155.28 0.5 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.141 -0.975 . . . . 0.0 109.029 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.595 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -89.7 -30.17 18.25 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.79 -6.18 52.21 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.388 0.613 . . . . 0.0 109.81 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.37 -24.92 10.91 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.71 129.16 28.77 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.689 -1.477 . . . . 0.0 108.237 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.53 ' CD ' HG22 ' A' ' 6' ' ' VAL . 2.5 mtm180 -121.42 -173.13 2.56 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-O 122.211 1.005 . . . . 0.0 112.528 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -134.94 -177.65 4.73 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 80.0 mt-10 -151.83 109.41 3.62 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.495 -1.682 . . . . 0.0 111.518 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.613 ' CD1' ' HA ' ' A' ' 27' ' ' ALA . 7.7 mt -106.63 -173.9 2.41 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.452 1.12 . . . . 0.0 110.889 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.62 68.86 1.44 Allowed 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.705 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 1.6 t -87.72 126.33 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.096 0.95 . . . . 0.0 109.311 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.514 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.29 178.47 6.33 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.124 0.964 . . . . 0.0 112.887 -177.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.566 ' HB3' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -52.21 129.94 29.21 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.215 1.007 . . . . 0.0 109.288 177.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 94.68 -20.93 46.07 Favored Glycine 0 C--N 1.276 -2.802 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.551 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.705 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 84.9 t -83.96 149.81 4.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 CA-C-N 120.843 2.322 . . . . 0.0 109.523 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -96.01 122.85 39.27 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.648 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 1.9 mt -46.33 -24.73 0.52 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.277 -1.514 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.605 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -70.33 -11.6 61.02 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.928 0.871 . . . . 0.0 108.756 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -97.83 -63.41 1.13 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.039 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.572 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -47.36 -58.96 3.55 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.975 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.613 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . . . -47.76 -53.04 16.49 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.581 -1.324 . . . . 0.0 110.474 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.581 ' CG2' ' CB ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -66.1 -3.52 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 109.526 179.091 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.255 0.0 OUTLIER -103.15 -24.99 13.54 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.833 0.825 . . . . 0.0 110.149 179.851 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 26' ' ' ALA . 3.6 m-80 -97.02 4.94 51.22 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.61 11.12 75.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.588 ' CD1' ' CD2' ' A' ' 15' ' ' LEU . 9.2 mt -72.79 -57.72 6.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.364 -1.08 . . . . 0.0 109.309 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.605 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 6.0 m-30 -80.58 30.88 0.29 Allowed 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.748 -0.595 . . . . 0.0 111.504 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -87.99 29.14 0.96 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.944 -1.098 . . . . 0.0 110.311 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.442 HG21 HG11 ' A' ' 36' ' ' VAL . 94.7 mt -107.0 -47.95 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 110.249 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.523 HG23 ' CG2' ' A' ' 47' ' ' THR . 35.0 m -120.06 174.77 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 47' ' ' THR . . . -104.68 139.16 14.5 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.453 ' HB3' ' S2 ' ' A' ' 107' ' ' FES . 59.9 m-20 -104.55 177.35 4.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -1.187 . . . . 0.0 110.233 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 42' ' ' SER . 25.5 p -87.93 25.1 1.62 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 110.246 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.22 24.29 15.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.02 9.81 65.28 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 39' ' ' CYS . 1.5 t -81.4 8.21 9.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -1.164 . . . . 0.0 110.102 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.531 ' CB ' ' HD2' ' A' ' 66' ' ' ARG . . . 44.86 54.07 7.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 110.359 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 42' ' ' SER . 0.9 OUTLIER -140.04 22.63 2.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 110.257 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -135.3 -175.97 4.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.925 . . . . 0.0 110.285 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.575 ' HB3' ' CE3' ' A' ' 106' ' ' TRP . . . -147.58 9.74 0.93 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.562 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.523 ' CG2' HG23 ' A' ' 36' ' ' VAL . 8.6 t -78.37 -14.96 59.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.02 -1.05 . . . . 0.0 109.907 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.482 ' O ' HG12 ' A' ' 50' ' ' VAL . 25.4 p -88.64 26.41 1.5 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.476 -0.765 . . . . 0.0 110.12 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.702 ' CE1' ' CE2' ' A' ' 51' ' ' TYR . 5.7 t60 -70.12 123.26 21.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.427 -0.796 . . . . 0.0 109.878 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.589 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 0.8 OUTLIER -150.13 -170.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.095 -1.003 . . . . 0.0 109.807 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.807 ' CE1' ' OG ' ' A' ' 82' ' ' SER . 75.2 m-85 -140.45 107.62 5.49 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.938 0.875 . . . . 0.0 110.762 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.56 ' CG2' ' CB ' ' A' ' 83' ' ' ARG . 6.2 t -80.92 131.96 32.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 O-C-N 120.699 -1.251 . . . . 0.0 109.698 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.679 ' OD1' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -42.88 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.089 177.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -72.05 0.03 10.5 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.038 -1.039 . . . . 0.0 110.148 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.605 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.09 5.34 47.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.094 -1.004 . . . . 0.0 111.088 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.659 ' HB2' HD22 ' A' ' 53' ' ' ASN . 59.4 m-85 -140.62 5.12 1.99 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.762 -1.211 . . . . 0.0 109.415 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.548 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 35.3 p -89.74 -38.27 13.96 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -2.24 39.39 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.737 0.78 . . . . 0.0 110.76 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.605 ' CD ' ' O ' ' A' ' 55' ' ' ALA 0.262 0.1 OUTLIER -99.06 -47.46 5.22 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.659 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.654 ' HB ' ' O ' ' A' ' 56' ' ' PHE 0.338 1.0 OUTLIER -78.25 176.76 3.3 Favored Pre-proline 0 C--N 1.285 -2.196 0 CA-C-N 113.371 -1.741 . . . . 0.0 106.392 178.312 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.595 ' N ' HG11 ' A' ' 60' ' ' VAL . 39.9 Cg_endo -73.83 96.27 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 CA-C-O 122.59 0.996 . . . . 0.0 112.155 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.522 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -66.54 67.49 0.06 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.428 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.535 ' CB ' ' HB3' ' A' ' 67' ' ' GLU . . . -37.17 152.93 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.281 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -88.17 -147.6 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.127 -0.983 . . . . 0.0 111.868 -178.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 69' ' ' GLY . 17.7 pt-20 -28.98 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.193 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.531 ' HD2' ' CB ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -53.29 -70.5 0.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.807 -1.183 . . . . 0.0 108.982 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.545 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -59.26 -32.42 69.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.577 -0.702 . . . . 0.0 109.269 178.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.534 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.2 mp -77.64 -10.82 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 110.826 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -89.24 -79.27 1.32 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.559 ' HG3' ' CG ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -43.27 -30.14 0.47 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -1.177 . . . . 0.0 108.668 179.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.596 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 1.1 tm? -74.84 -50.73 16.08 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.534 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 8.1 tp10 -58.44 -22.72 55.39 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 108.777 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.524 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -80.99 -40.78 23.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.675 -0.641 . . . . 0.0 110.686 -179.487 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.569 HG13 ' CG ' ' A' ' 49' ' ' HIS . 4.7 m -40.06 162.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.436 -0.79 . . . . 0.0 109.754 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.559 ' O ' ' CG2' ' A' ' 75' ' ' THR . 21.7 m -120.63 32.38 6.02 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.114 -0.991 . . . . 0.0 108.965 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.607 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -115.27 -167.24 1.21 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.686 1.231 . . . . 0.0 112.728 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.761 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.19 62.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.996 -178.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.646 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.43 154.86 12.97 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 118.729 -2.482 . . . . 0.0 110.997 -177.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.803 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.382 0.5 OUTLIER -133.15 177.17 2.38 Favored Pre-proline 0 C--N 1.288 -2.077 0 CA-C-N 113.61 -1.632 . . . . 0.0 111.07 -173.79 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 41.0 Cg_endo -71.96 -25.91 19.19 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 N-CA-C 106.99 -1.965 . . . . 0.0 106.99 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.525 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 13.6 p-10 -114.53 18.76 16.58 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.913 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.807 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -45.88 149.59 0.63 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.805 -1.185 . . . . 0.0 108.139 178.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.57 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -155.65 152.3 28.5 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.388 -1.725 . . . . 0.0 112.313 -178.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.592 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -106.43 103.29 12.71 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 24' ' ' MET . 5.7 t -27.82 -34.09 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.552 ' N ' ' O ' ' A' ' 84' ' ' LEU . 26.5 p -71.65 1.97 5.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.3 -1.5 . . . . 0.0 110.784 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.539 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 38.1 mm-40 -125.03 14.94 8.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.877 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.555 ' CD1' HG13 ' A' ' 60' ' ' VAL . 5.7 mm -116.46 99.0 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.272 -0.892 . . . . 0.0 110.285 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.601 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 1.7 mm -82.82 131.15 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.899 -1.125 . . . . 0.0 110.048 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.565 ' HG2' ' CG2' ' A' ' 3' ' ' VAL . 2.1 tpt -82.42 123.14 28.86 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.279 -0.888 . . . . 0.0 110.349 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.501 ' O ' ' CB ' ' A' ' 1' ' ' SER . 0.1 OUTLIER -113.22 159.33 35.36 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 118.151 -1.42 . . . . 0.0 110.319 179.29 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.566 ' CD ' ' HB3' ' A' ' 19' ' ' ASP . 37.2 Cg_endo -62.24 -14.23 37.08 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 O-C-N 124.481 1.779 . . . . 0.0 109.569 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.493 ' CG ' ' HB ' ' A' ' 91' ' ' THR . 1.8 pt-20 -82.52 -36.93 25.91 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.33 1.062 . . . . 0.0 108.42 177.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.63 ' CD1' HG23 ' A' ' 60' ' ' VAL . 50.3 mt -90.23 35.76 0.87 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.576 -178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.528 ' HA ' ' CB ' ' A' ' 1' ' ' SER . 20.9 p30 -63.61 108.02 1.29 Allowed 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.823 177.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.598 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.36 23.79 1.88 Allowed Glycine 0 N--CA 1.496 2.695 0 O-C-N 120.755 -1.216 . . . . 0.0 110.7 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.765 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -59.62 136.83 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -1.087 . . . . 0.0 111.097 179.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.679 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.5 t -115.76 110.31 31.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.527 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -100.0 154.99 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.834 -1.166 . . . . 0.0 110.039 -178.552 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.606 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.46 128.43 50.86 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.268 -0.895 . . . . 0.0 110.249 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.575 HG11 ' CE1' ' A' ' 8' ' ' HIS . 55.1 t -103.54 123.54 41.1 Favored Pre-proline 0 C--N 1.291 -1.972 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.669 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.642 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 54.8 Cg_endo -76.37 171.19 18.53 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.096 1.864 . . . . 0.0 111.949 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.5 -18.93 23.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.699 -0.626 . . . . 0.0 109.468 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.53 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -111.0 74.62 0.88 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 47' ' ' THR . 3.1 pt20 -98.81 56.1 1.07 Allowed 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.436 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.589 ' OXT' ' CD2' ' A' ' 106' ' ' TRP . 1.5 p-90 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.765 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.453 ' S2 ' ' HB3' ' A' ' 38' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.564 ' OG ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.393 0.616 . . . . 0.0 110.467 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.593 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 4.1 mptt -61.97 149.51 40.51 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.458 -0.776 . . . . 0.0 109.115 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.723 ' HA ' HG21 ' A' ' 97' ' ' ILE . 65.4 t -140.56 134.05 33.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 O-C-N 121.382 -0.824 . . . . 0.0 110.959 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 45.9 t -142.7 90.2 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 C-N-CA 118.634 -1.226 . . . . 0.0 110.803 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.632 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 70.3 m-85 -67.64 134.65 51.53 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.674 -0.641 . . . . 0.0 109.464 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.535 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 97.3 t -99.62 169.36 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 O-C-N 120.113 -1.617 . . . . 0.0 109.717 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 11' ' ' THR . 95.9 p -104.46 -155.9 0.55 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 109.386 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.584 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.02 -29.69 18.25 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -91.83 -8.59 46.15 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.339 0.59 . . . . 0.0 109.713 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.21 -16.08 20.26 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -59.44 132.51 54.21 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.728 -1.454 . . . . 0.0 107.872 179.184 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -120.98 179.92 4.22 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 122.368 1.08 . . . . 0.0 113.02 -178.154 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.555 ' CD ' HG12 ' A' ' 32' ' ' ILE 0.277 0.9 OUTLIER -127.25 179.03 5.66 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 178.682 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 68.5 mt-10 -152.87 116.02 4.63 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 117.129 -1.828 . . . . 0.0 111.518 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.606 ' CD2' HD11 ' A' ' 32' ' ' ILE . 5.7 mt -112.63 -156.79 0.6 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.459 1.123 . . . . 0.0 110.194 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -153.08 68.24 0.81 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.732 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -88.29 124.24 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.083 0.944 . . . . 0.0 109.463 -177.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -87.34 176.25 7.61 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.087 0.946 . . . . 0.0 112.851 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.557 ' HB3' ' CD ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -51.02 127.85 19.95 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.318 1.056 . . . . 0.0 109.187 177.357 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.403 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 99.04 -23.82 34.84 Favored Glycine 0 C--N 1.276 -2.805 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.474 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.732 ' CG1' ' CG1' ' A' ' 17' ' ' VAL . 95.1 t -84.44 153.61 3.65 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.656 0 CA-C-N 120.61 2.205 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -96.98 134.71 39.99 Favored 'General case' 0 C--N 1.273 -2.728 0 C-N-CA 118.797 -1.161 . . . . 0.0 107.886 176.206 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.63 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 9.2 mt -50.24 -23.65 2.39 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.299 -1.501 . . . . 0.0 108.028 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.645 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -74.5 -15.0 60.89 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.599 -0.688 . . . . 0.0 109.211 179.175 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.504 ' HG2' ' CG1' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -89.14 -63.5 1.28 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.575 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -56.04 -50.07 71.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.065 -1.022 . . . . 0.0 110.196 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.642 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -47.66 -48.66 28.89 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.527 -1.358 . . . . 0.0 109.706 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -70.78 -0.74 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.605 -0.684 . . . . 0.0 109.679 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.509 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.08 -27.18 12.73 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.813 0.816 . . . . 0.0 109.569 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.502 ' CB ' HD21 ' A' ' 15' ' ' LEU . 3.7 m-80 -97.36 -0.72 45.91 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.68 21.47 36.83 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.606 HD11 ' CD2' ' A' ' 15' ' ' LEU . 2.1 mt -72.74 -68.06 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.392 -1.063 . . . . 0.0 109.66 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.645 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 21.8 m-85 -80.62 59.1 3.46 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.588 0.708 . . . . 0.0 110.595 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -66.48 48.93 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.024 0 O-C-N 121.573 -0.704 . . . . 0.0 110.619 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.533 HD13 ' N ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -107.55 158.56 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.301 -0.874 . . . . 0.0 109.771 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.401 ' N ' HG12 ' A' ' 35' ' ' ILE . 38.4 t -112.75 -33.7 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.124 -0.985 . . . . 0.0 110.75 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.533 ' N ' HD13 ' A' ' 35' ' ' ILE . . . -79.87 72.38 2.59 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . 8.8 p-10 -120.22 169.43 10.26 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.234 -1.157 . . . . 0.0 110.179 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 18.0 p -100.03 -12.45 19.71 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.04 47.6 6.98 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . 66.77 8.83 49.98 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 t -79.98 -2.02 42.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -1.178 . . . . 0.0 110.205 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HA ' ' S2 ' ' A' ' 107' ' ' FES . . . 60.06 53.78 4.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 0.0 110.275 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.07 11.69 2.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.578 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 1.9 p -129.92 -171.59 2.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.015 -1.053 . . . . 0.0 110.409 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.53 ' CB ' ' OXT' ' A' ' 106' ' ' TRP . . . -144.7 9.66 1.36 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 110.406 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.522 ' CG2' HG13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -81.36 6.43 14.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.114 -0.991 . . . . 0.0 109.88 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 11.3 p -115.18 28.53 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.48 -0.763 . . . . 0.0 109.625 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.692 ' CE1' ' CE2' ' A' ' 51' ' ' TYR . 5.2 t60 -69.86 128.7 37.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.537 -0.727 . . . . 0.0 110.402 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.564 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -156.78 -174.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.971 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.71 ' O ' ' N ' ' A' ' 100' ' ' ASP 0.272 81.9 m-85 -140.41 113.85 8.62 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.634 0.73 . . . . 0.0 110.323 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.564 ' CG2' ' HB2' ' A' ' 83' ' ' ARG . 6.3 t -82.36 132.45 31.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 O-C-N 120.329 -1.482 . . . . 0.0 110.654 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.577 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 3.3 t30 -47.1 145.47 2.16 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.709 -1.244 . . . . 0.0 108.583 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.523 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -58.16 -8.37 1.07 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.159 -0.963 . . . . 0.0 112.077 -178.337 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.575 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . . . -93.97 7.76 43.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.532 -1.355 . . . . 0.0 110.731 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.691 ' CG ' HD12 ' A' ' 97' ' ' ILE . 86.9 m-85 -140.54 4.65 1.97 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.125 -0.984 . . . . 0.0 109.622 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.556 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 31.5 p -90.29 -41.19 11.68 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 120.946 -1.096 . . . . 0.0 108.068 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.34 -2.09 52.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.826 0.822 . . . . 0.0 110.56 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.614 ' CB ' ' CD2' ' A' ' 94' ' ' LEU 0.255 0.1 OUTLIER -99.22 -47.77 5.07 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.531 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.672 ' HB ' ' O ' ' A' ' 56' ' ' PHE 0.331 1.1 t -78.99 175.76 4.4 Favored Pre-proline 0 C--N 1.288 -2.065 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.186 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.585 ' N ' HG11 ' A' ' 60' ' ' VAL . 40.0 Cg_endo -75.05 109.2 2.88 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 CA-C-O 122.702 1.042 . . . . 0.0 112.293 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.531 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -75.23 66.71 1.76 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.551 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.531 ' CB ' ' HG2' ' A' ' 87' ' ' GLN . . . -37.19 155.94 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.25 0.547 . . . . 0.0 110.226 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 66' ' ' ARG . 45.0 p-10 -96.06 -145.79 0.28 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.155 -0.966 . . . . 0.0 112.493 -177.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 64' ' ' ASN . 8.2 pt-20 -30.92 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.349 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 64' ' ' ASN . 2.3 mtm-85 -52.96 -71.2 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.608 -1.308 . . . . 0.0 108.365 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.599 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -62.89 -45.8 90.82 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 109.18 178.363 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.558 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.1 mp -55.77 -12.97 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.348 -0.845 . . . . 0.0 111.424 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -91.2 -78.41 1.37 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.599 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -45.37 -35.57 3.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.976 -1.308 . . . . 0.0 108.538 179.493 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.618 ' CD1' ' HB3' ' A' ' 82' ' ' SER . 0.8 OUTLIER -67.77 -43.96 78.57 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 177.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.558 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -60.44 -25.79 66.24 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 108.699 178.168 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.591 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.94 -42.76 31.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.781 -0.574 . . . . 0.0 111.111 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.6 HG13 ' CG ' ' A' ' 49' ' ' HIS . 4.5 m -39.87 151.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.564 ' O ' ' CG2' ' A' ' 75' ' ' THR . 18.7 m -121.03 30.47 6.84 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.083 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 49' ' ' HIS . . . -92.67 -82.5 0.33 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.492 -1.283 . . . . 0.0 113.344 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.721 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.288 0.0 OUTLIER -153.86 64.58 0.72 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 122.291 1.043 . . . . 0.0 108.683 -175.579 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.799 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -57.0 150.71 16.33 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 119.382 -2.074 . . . . 0.0 113.24 -173.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.51 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.36 0.0 OUTLIER -124.97 -174.14 0.32 Allowed Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.312 -174.889 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 46.6 Cg_endo -81.98 -28.86 1.87 Allowed 'Trans proline' 0 C--N 1.302 -1.92 0 N-CA-C 107.222 -1.876 . . . . 0.0 107.222 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.535 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.9 OUTLIER -107.47 15.33 24.97 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.113 179.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.799 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -44.65 146.68 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.952 -1.093 . . . . 0.0 109.611 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.59 ' NH1' ' CD1' ' A' ' 88' ' ' ILE . 30.7 mmm-85 -158.43 152.91 24.44 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.888 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -105.26 107.03 17.79 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 24' ' ' MET . 6.1 p -32.07 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.553 ' N ' ' O ' ' A' ' 84' ' ' LEU . 16.3 p -70.05 -1.24 9.31 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.425 -1.422 . . . . 0.0 111.03 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.531 ' HG2' ' CB ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -125.4 -1.92 7.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.91 -1.119 . . . . 0.0 110.938 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.59 ' CD1' ' NH1' ' A' ' 83' ' ' ARG . 3.2 mm -97.15 108.78 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.084 -1.01 . . . . 0.0 110.281 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.592 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 2.9 mm -87.72 129.36 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.896 -1.128 . . . . 0.0 109.959 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.591 ' HG2' ' CG2' ' A' ' 3' ' ' VAL . 2.4 tpt -83.03 122.94 28.97 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 121.42 -0.8 . . . . 0.0 110.379 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.544 ' O ' ' CB ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -114.11 159.22 37.14 Favored Pre-proline 0 C--N 1.292 -1.922 0 C-N-CA 118.233 -1.387 . . . . 0.0 109.682 178.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.557 ' CD ' ' HB3' ' A' ' 19' ' ' ASP . 35.2 Cg_endo -58.66 -36.67 96.89 Favored 'Trans proline' 0 C--N 1.297 -2.149 0 O-C-N 124.334 1.702 . . . . 0.0 110.045 -178.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -58.9 -36.83 75.34 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.797 -1.161 . . . . 0.0 108.558 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.632 ' CD1' HG23 ' A' ' 60' ' ' VAL . 65.9 mt -90.59 35.12 0.88 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.937 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.513 ' HA ' ' CB ' ' A' ' 1' ' ' SER . 19.6 p-10 -63.75 107.03 1.09 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.575 -1.25 . . . . 0.0 109.391 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.593 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 123.75 19.83 2.69 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 120.458 -1.401 . . . . 0.0 110.733 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.723 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -55.77 140.33 13.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.228 -1.16 . . . . 0.0 111.119 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.603 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 2.0 t -115.53 112.15 38.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -98.61 156.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.786 -1.196 . . . . 0.0 109.346 -178.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.71 ' N ' ' O ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -122.85 124.21 42.75 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.742 0.782 . . . . 0.0 110.323 -178.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.527 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 68.2 t -100.32 135.55 20.24 Favored Pre-proline 0 C--N 1.289 -2.064 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.679 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 54.5 Cg_endo -88.9 176.09 3.39 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 121.765 1.643 . . . . 0.0 111.885 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -91.14 -20.45 21.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.572 -0.705 . . . . 0.0 109.36 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.542 ' HB3' ' CA ' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -110.76 77.86 1.07 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.492 ' NE2' HG12 ' A' ' 101' ' ' VAL . 12.9 mt-30 -98.34 52.07 1.02 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.72 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.591 ' CZ2' ' HB3' ' A' ' 73' ' ' CYS . 3.0 p-90 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.18 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.45 ' S2 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.659 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.19 0.519 . . . . 0.0 110.437 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.627 ' HB2' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -79.21 142.18 36.5 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.257 178.041 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.726 ' HA ' HG21 ' A' ' 97' ' ' ILE . 41.6 t -136.27 133.82 49.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 O-C-N 121.326 -0.859 . . . . 0.0 110.137 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 58.2 t -141.85 91.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.619 0 C-N-CA 118.804 -1.158 . . . . 0.0 110.411 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.637 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 40.8 m-85 -69.03 154.64 41.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.577 -0.702 . . . . 0.0 109.169 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.527 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 87.0 t -118.35 172.7 5.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.215 178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.525 ' HB3' HG21 ' A' ' 11' ' ' THR . 46.3 p -107.97 -158.4 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.104 -0.998 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.561 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -88.04 -29.67 20.51 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 178.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -91.76 -11.18 37.44 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.437 0.637 . . . . 0.0 109.575 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.29 -4.31 23.56 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.335 -0.936 . . . . 0.0 110.785 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -65.09 131.41 46.48 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.646 -1.502 . . . . 0.0 107.784 179.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -120.93 178.51 4.69 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 122.229 1.014 . . . . 0.0 112.905 -177.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.4 177.71 7.61 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 9.2 mp0 -150.3 113.47 4.87 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.975 -1.49 . . . . 0.0 110.397 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.629 ' CD1' ' HA ' ' A' ' 27' ' ' ALA 0.262 2.8 mt -109.21 -151.53 0.47 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 122.603 1.192 . . . . 0.0 111.084 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 1' ' ' SER . 12.4 t0 -152.94 75.98 1.11 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.699 HG11 ' HB ' ' A' ' 21' ' ' VAL . 17.4 t -88.41 118.87 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.64 -175.4 4.66 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.595 -0.691 . . . . 0.0 110.892 -177.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -65.45 114.39 4.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.36 -15.84 24.82 Favored Glycine 0 C--N 1.288 -2.085 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.351 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.699 ' HB ' HG11 ' A' ' 17' ' ' VAL . 41.6 t -97.81 136.37 28.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 120.441 -1.623 . . . . 0.0 106.776 177.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -95.15 143.71 26.36 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.378 -1.329 . . . . 0.0 107.721 178.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.637 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 13.8 mt -47.04 -26.6 1.08 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.281 -1.367 . . . . 0.0 107.434 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.625 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -59.41 -39.27 82.91 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.362 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.564 ' N ' ' O ' ' A' ' 22' ' ' SER . 4.8 tt0 -75.24 -72.37 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.796 -0.565 . . . . 0.0 110.532 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.6 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -46.6 -50.54 17.31 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 117.986 -1.486 . . . . 0.0 111.014 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.629 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . . . -47.95 -46.02 31.77 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.343 -1.473 . . . . 0.0 110.443 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -74.08 0.57 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.555 -0.716 . . . . 0.0 109.654 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.501 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.18 -29.18 11.47 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.736 0.779 . . . . 0.0 109.687 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.447 ' HB2' HD21 ' A' ' 15' ' ' LEU . 3.8 m-80 -97.56 -1.57 43.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.65 19.58 51.21 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.562 HD12 ' CD1' ' A' ' 15' ' ' LEU . 8.5 mt -72.7 -57.37 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -1.114 . . . . 0.0 109.434 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.629 ' CE2' ' CB ' ' A' ' 27' ' ' ALA . 20.0 m-30 -81.16 56.01 2.7 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.533 0.682 . . . . 0.0 110.52 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.42 47.13 0.21 Allowed 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.651 -0.655 . . . . 0.0 110.443 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 tp -86.87 -169.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.868 . . . . 0.0 109.73 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.1 t -80.08 -90.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 110.191 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.12 155.93 15.89 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' OD1' ' S1 ' ' A' ' 107' ' ' FES . 0.4 OUTLIER -119.51 -175.15 2.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -1.111 . . . . 0.0 110.054 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 24.5 p -99.77 7.44 45.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.232 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 53.65 35.25 51.65 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.19 18.7 78.05 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 39' ' ' CYS . 12.1 t -87.12 13.12 9.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -1.129 . . . . 0.0 110.133 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 42' ' ' SER . . . 43.53 55.27 5.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 110.084 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.8 p -137.82 12.62 2.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.327 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -135.72 179.55 6.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.11 -0.993 . . . . 0.0 110.326 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.583 ' HB3' ' CE3' ' A' ' 106' ' ' TRP . . . -147.66 9.9 0.93 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 0.0 110.52 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -16.88 62.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.059 -1.026 . . . . 0.0 109.407 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.482 ' O ' HG12 ' A' ' 50' ' ' VAL . 25.4 p -88.38 29.98 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.636 -0.665 . . . . 0.0 110.048 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.667 ' CE1' ' CE2' ' A' ' 51' ' ' TYR . 4.1 t60 -70.24 126.27 29.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.417 -0.802 . . . . 0.0 110.667 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.572 ' CG2' ' N ' ' A' ' 51' ' ' TYR . 1.1 m -156.33 -174.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.251 -0.905 . . . . 0.0 109.99 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.672 ' CD1' ' HG3' ' A' ' 79' ' ' LYS 0.254 78.2 m-85 -141.01 108.22 5.5 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.659 0.743 . . . . 0.0 110.669 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.575 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 2.4 t -75.01 133.84 30.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 O-C-N 120.34 -1.475 . . . . 0.0 110.583 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.579 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 3.8 t30 -48.42 147.29 2.45 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.744 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.2 pt-20 -58.77 -8.41 1.32 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.169 -0.957 . . . . 0.0 111.972 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.577 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . . . -96.01 7.91 45.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.475 -1.391 . . . . 0.0 111.057 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.684 ' CG ' HD12 ' A' ' 97' ' ' ILE . 87.7 m-85 -140.37 3.01 1.91 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.059 . . . . 0.0 109.898 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.575 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 3.2 p -90.55 -41.22 11.5 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -93.76 -0.94 55.67 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.737 0.779 . . . . 0.0 110.526 -178.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.611 ' CB ' ' CD2' ' A' ' 94' ' ' LEU 0.253 1.2 mtpp -99.23 -46.91 5.38 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 123.135 1.445 . . . . 0.0 107.355 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.781 ' CG1' ' HD2' ' A' ' 61' ' ' PRO 0.334 0.9 OUTLIER -74.86 -177.68 0.71 Allowed Pre-proline 0 C--N 1.287 -2.114 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.197 178.975 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.781 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 34.1 Cg_endo -61.59 122.34 10.91 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 CA-C-O 123.001 1.167 . . . . 0.0 111.941 -177.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.32 62.95 0.99 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.635 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -38.22 157.88 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.937 -0.477 . . . . 0.0 109.999 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 66' ' ' ARG . 29.8 p30 -118.0 -154.47 0.56 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.061 -1.024 . . . . 0.0 111.432 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 64' ' ' ASN . 4.3 pt-20 -31.24 -33.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.028 -0.42 . . . . 0.0 111.726 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -53.0 -71.05 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.773 -1.204 . . . . 0.0 108.195 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.596 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -59.7 -50.41 73.94 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 108.906 178.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.541 ' N ' ' HG3' ' A' ' 67' ' ' GLU . 1.2 mp -51.52 -19.32 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 110.302 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -88.17 -75.69 1.28 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.596 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -45.04 -38.78 5.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -1.215 . . . . 0.0 108.674 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.699 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 0.4 OUTLIER -65.74 -51.7 57.05 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.208 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 11.0 tp10 -55.39 -19.62 9.61 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.081 -1.012 . . . . 0.0 108.417 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -76.21 -46.98 25.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.604 -0.685 . . . . 0.0 110.552 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.576 HG13 ' CG ' ' A' ' 49' ' ' HIS . 8.1 m -40.71 163.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.266 -0.896 . . . . 0.0 109.725 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.524 ' O ' ' CG2' ' A' ' 75' ' ' THR . 45.8 m -120.4 37.4 4.27 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.977 -1.077 . . . . 0.0 109.599 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.613 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -122.44 -167.78 1.62 Allowed 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.281 -1.368 . . . . 0.0 112.968 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.744 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -50.77 63.42 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.662 -178.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.761 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.42 153.65 15.35 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 118.767 -2.458 . . . . 0.0 111.809 -177.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.672 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.385 0.2 OUTLIER -133.96 176.86 2.57 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 113.294 -1.775 . . . . 0.0 111.308 -173.826 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 43.7 Cg_endo -75.34 -27.58 9.36 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 176.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.524 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 15.5 p-10 -108.5 17.01 22.52 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.255 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.761 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -45.81 149.91 0.59 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.181 -0.949 . . . . 0.0 110.126 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.569 ' CG ' HG23 ' A' ' 52' ' ' VAL . 7.9 mmt85 -158.62 160.22 36.29 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.255 -1.378 . . . . 0.0 112.192 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 86' ' ' CYS . 2.2 mt -112.85 114.98 27.75 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.517 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 12.6 p -30.67 -30.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.572 ' N ' ' O ' ' A' ' 84' ' ' LEU . 27.8 p -77.07 4.24 10.64 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.611 -1.306 . . . . 0.0 111.43 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.506 ' HG2' ' CB ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -125.34 11.94 8.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.819 -1.175 . . . . 0.0 111.357 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.522 HD12 ' CG1' ' A' ' 60' ' ' VAL . 21.4 mm -120.34 107.12 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.83 -1.169 . . . . 0.0 110.978 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.544 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 3.9 mm -89.83 128.81 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.144 -0.973 . . . . 0.0 108.895 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.659 ' HG3' ' HB2' ' A' ' 1' ' ' SER . 0.0 OUTLIER -83.86 124.77 31.31 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.414 -0.804 . . . . 0.0 111.238 -178.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.558 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -98.97 179.69 1.01 Allowed Pre-proline 0 C--N 1.295 -1.769 0 C-N-CA 117.673 -1.611 . . . . 0.0 109.181 177.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.558 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 45.6 Cg_endo -82.21 -12.88 10.33 Favored 'Trans proline' 0 C--N 1.289 -2.599 0 O-C-N 124.368 1.72 . . . . 0.0 108.705 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.558 ' HG2' ' OG1' ' A' ' 91' ' ' THR . 3.4 pt-20 -84.89 -33.69 22.73 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.613 ' CD1' HG23 ' A' ' 60' ' ' VAL . 66.1 mt -89.64 29.77 1.11 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.498 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -63.22 111.38 2.22 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 120.3 -1.5 . . . . 0.0 109.056 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.627 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 123.87 17.04 3.17 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.726 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -53.75 141.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.377 -1.073 . . . . 0.0 111.668 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.594 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 2.0 t -117.46 113.63 43.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.542 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -99.41 155.41 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.838 -1.163 . . . . 0.0 109.773 -178.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.635 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.34 121.07 35.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.677 0.751 . . . . 0.0 109.783 -179.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.525 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 90.8 t -99.51 123.58 47.6 Favored Pre-proline 0 C--N 1.289 -2.025 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.432 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.644 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 52.6 Cg_endo -75.58 170.83 19.42 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.002 1.801 . . . . 0.0 112.028 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.413 ' OD2' ' HG2' ' A' ' 104' ' ' ARG . 11.6 p-10 -91.32 -17.45 25.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.677 -0.639 . . . . 0.0 109.402 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.523 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -110.75 70.89 0.73 Allowed 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.423 ' CD ' ' O ' ' A' ' 105' ' ' GLN . 0.0 OUTLIER -98.73 58.81 1.21 Allowed 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.466 -177.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.583 ' CE3' ' HB3' ' A' ' 46' ' ' ALA . 1.8 p-90 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.885 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.406 ' S1 ' ' OD1' ' A' ' 38' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 121.931 0.872 . . . . 0.0 110.472 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.921 ' HA ' HG23 ' A' ' 97' ' ' ILE . 54.9 t -140.99 135.59 33.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 121.121 -0.987 . . . . 0.0 110.902 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.594 HG13 ' HG2' ' A' ' 14' ' ' GLU . 47.3 t -142.4 90.96 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.804 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 73.1 m-85 -67.86 134.84 51.58 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 121.714 -0.616 . . . . 0.0 109.81 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.562 HG22 ' CD ' ' A' ' 12' ' ' ARG . 91.1 t -99.82 166.95 2.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 O-C-N 120.052 -1.655 . . . . 0.0 109.467 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.591 ' HB3' HG22 ' A' ' 11' ' ' THR . 86.1 p -101.8 -155.86 0.54 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.096 -1.003 . . . . 0.0 108.819 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.589 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.24 -29.83 17.93 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.8 -6.26 52.05 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.436 0.636 . . . . 0.0 109.878 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.38 -25.55 10.38 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.591 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.57 130.18 31.27 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.628 -1.513 . . . . 0.0 108.066 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.562 ' CD ' HG22 ' A' ' 6' ' ' VAL . 17.3 mtm-85 -121.26 -176.38 3.27 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 122.374 1.083 . . . . 0.0 112.883 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.587 ' O ' ' HA ' ' A' ' 4' ' ' VAL 0.28 0.2 OUTLIER -128.78 178.73 6.15 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.687 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 84.1 mt-10 -152.9 114.17 4.21 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 117.324 -1.751 . . . . 0.0 111.142 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.879 HD22 ' CG ' ' A' ' 30' ' ' ASN . 6.6 mt -108.71 -156.16 0.58 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.475 1.131 . . . . 0.0 110.095 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.5 71.91 0.96 Allowed 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.003 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.4 t -89.14 127.58 41.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.866 0.841 . . . . 0.0 109.431 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.94 -175.06 4.47 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.675 1.226 . . . . 0.0 112.867 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.521 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 11.6 p30 -63.2 115.89 4.93 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.792 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.732 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 111.98 -22.39 18.74 Favored Glycine 0 C--N 1.287 -2.185 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.763 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.003 ' HB ' HG12 ' A' ' 17' ' ' VAL . 90.8 t -88.34 147.93 4.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 119.938 1.869 . . . . 0.0 109.746 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -96.63 131.79 42.93 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.727 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.751 HD22 HG11 ' A' ' 3' ' ' VAL . 8.8 mt -44.54 -26.11 0.33 Allowed 'General case' 0 C--O 1.201 -1.464 0 O-C-N 120.899 -1.126 . . . . 0.0 109.292 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.6 ' O ' ' HB ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -69.04 -42.4 76.37 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 118.206 -1.398 . . . . 0.0 107.77 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.563 ' CG ' HG13 ' A' ' 21' ' ' VAL . 6.8 tt0 -59.68 -70.8 0.15 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.744 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.759 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.97 -54.3 10.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.981 -1.075 . . . . 0.0 110.512 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.878 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.41 -51.15 20.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.787 -1.195 . . . . 0.0 110.098 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.6 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -69.05 -1.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.622 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.12 -27.47 12.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.334 -0.853 . . . . 0.0 109.863 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.879 ' CG ' HD22 ' A' ' 15' ' ' LEU . 8.3 m120 -97.31 -0.8 45.89 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.11 21.17 33.68 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.849 HD11 HD21 ' A' ' 15' ' ' LEU . 1.8 mt . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.221 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.505 0.669 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' VAL . 25.1 p -88.53 28.41 1.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.531 -0.731 . . . . 0.0 110.151 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.318 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 8.2 t-160 -70.21 126.37 29.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.433 -0.792 . . . . 0.0 110.219 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.812 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.3 m -156.39 -173.94 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-O 122.12 0.962 . . . . 0.0 110.246 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.812 ' N ' HG23 ' A' ' 50' ' ' VAL 0.268 77.1 m-85 -141.08 111.76 7.0 Favored 'General case' 0 C--O 1.197 -1.687 0 CA-C-O 121.557 0.694 . . . . 0.0 110.563 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.063 ' HB ' HG22 ' A' ' 57' ' ' THR . 2.4 t -78.4 131.46 34.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 O-C-N 120.31 -1.494 . . . . 0.0 110.689 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.838 ' O ' HG23 ' A' ' 57' ' ' THR . 3.4 t30 -47.44 146.67 1.96 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.495 -1.378 . . . . 0.0 108.778 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -58.71 -8.09 1.19 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.065 -1.022 . . . . 0.0 112.135 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.566 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -95.99 8.24 44.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.547 -1.345 . . . . 0.0 110.56 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 1.116 ' CB ' HD13 ' A' ' 97' ' ' ILE . 87.5 m-85 -140.16 3.77 2.0 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.23 -0.918 . . . . 0.0 109.846 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 1.063 HG22 ' HB ' ' A' ' 52' ' ' VAL . 8.7 p -90.45 -42.61 10.77 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.027 -1.046 . . . . 0.0 108.358 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -1.34 57.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.751 0.786 . . . . 0.0 110.486 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.033 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.259 0.1 OUTLIER -99.35 -46.79 5.39 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 123.073 1.416 . . . . 0.0 107.314 179.659 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.053 HG11 HG23 ' A' ' 88' ' ' ILE 0.338 1.0 OUTLIER -78.07 -179.8 1.43 Allowed Pre-proline 0 C--N 1.289 -2.06 0 CA-C-N 113.797 -1.547 . . . . 0.0 107.123 178.966 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 1.023 ' HD2' HG13 ' A' ' 60' ' ' VAL . 37.9 Cg_endo -68.39 107.54 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 CA-C-O 122.874 1.114 . . . . 0.0 112.42 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.632 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -75.46 71.54 2.41 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.016 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.613 ' HB1' ' OE1' ' A' ' 67' ' ' GLU . . . -38.65 170.92 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.604 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 66' ' ' ARG . 4.7 p30 -111.9 -164.25 0.9 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.91 -1.118 . . . . 0.0 112.543 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 68' ' ' ILE . 8.8 pt-20 -28.71 -39.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -52.9 -63.01 1.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.543 -1.348 . . . . 0.0 108.833 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.633 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -59.14 -30.06 67.86 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.52 -0.737 . . . . 0.0 110.5 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.564 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.8 mp -77.12 -8.87 12.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.434 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -88.17 -76.68 1.28 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.829 ' HG3' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -44.04 -40.29 4.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.165 -1.197 . . . . 0.0 108.481 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.058 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -64.67 -50.96 64.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.294 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 12.0 tp10 -56.91 -19.35 17.37 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.967 -1.083 . . . . 0.0 108.398 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -75.64 -47.88 24.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 110.156 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.058 HG22 ' O ' ' A' ' 71' ' ' LEU . 6.1 m -40.78 161.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 0.0 109.279 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.78 HG22 ' O ' ' A' ' 75' ' ' THR . 27.8 m -120.36 34.06 5.36 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 120.971 -1.081 . . . . 0.0 109.257 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.318 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -114.81 -165.19 0.99 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.595 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.748 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -54.05 63.26 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.167 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.84 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.35 153.02 16.37 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 118.842 -2.411 . . . . 0.0 111.67 -177.651 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.674 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.389 2.2 mmtt -135.42 177.45 2.22 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.409 -173.567 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 43.6 Cg_endo -74.76 -28.73 9.36 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 N-CA-C 107.514 -1.764 . . . . 0.0 107.514 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.676 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.8 OUTLIER -106.02 15.18 26.84 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.873 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.827 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -44.17 148.83 0.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.989 . . . . 0.0 109.507 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.934 ' HB2' HG23 ' A' ' 52' ' ' VAL . 1.3 mmt85 -162.03 155.93 21.51 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 117.436 -1.706 . . . . 0.0 113.293 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.829 HD12 ' HG3' ' A' ' 70' ' ' MET . 7.8 mt -114.73 98.32 6.79 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 174.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.541 ' HB3' ' N ' ' A' ' 24' ' ' MET . 60.7 m -28.85 -28.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.623 ' SG ' ' NE2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -39.76 -26.35 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.502 -1.373 . . . . 0.0 112.442 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.623 ' NE2' ' SG ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -125.74 0.25 7.42 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.208 -1.557 . . . . 0.0 112.934 -178.453 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.053 HG23 HG11 ' A' ' 60' ' ' VAL . 12.6 mm -78.64 99.97 3.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.366 -1.459 . . . . 0.0 107.518 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.995 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -81.92 130.88 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.208 -0.933 . . . . 0.0 110.578 -177.65 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.972 ' SD ' HG21 ' A' ' 97' ' ' ILE . 1.3 tpt -82.58 120.71 25.88 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.809 -0.557 . . . . 0.0 111.375 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.685 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -106.18 174.3 2.68 Favored Pre-proline 0 N--CA 1.494 1.767 0 C-N-CA 118.481 -1.288 . . . . 0.0 109.77 178.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 19' ' ' ASP . 44.3 Cg_endo -73.94 -10.51 23.08 Favored 'Trans proline' 0 C--N 1.292 -2.427 0 O-C-N 124.651 1.869 . . . . 0.0 110.074 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.62 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -92.48 -30.49 15.68 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.536 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.034 ' CD1' HG23 ' A' ' 60' ' ' VAL . 97.8 mt -90.07 25.04 2.26 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.865 0.841 . . . . 0.0 110.28 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -63.11 104.2 0.55 Allowed 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.287 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.662 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.99 18.43 2.6 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.333 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.116 HD13 ' CB ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -53.42 141.8 7.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.539 -0.977 . . . . 0.0 111.39 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.079 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.1 t -115.49 112.49 40.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -98.33 155.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.782 -1.199 . . . . 0.0 108.977 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -122.86 124.84 44.17 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.396 -0.815 . . . . 0.0 110.476 -178.413 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.577 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 63.4 t -99.22 137.4 20.39 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.879 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.674 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 57.2 Cg_endo -89.25 170.64 4.74 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 C-N-CA 121.809 1.673 . . . . 0.0 111.813 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.51 -16.36 27.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.735 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -111.09 75.08 0.9 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.522 ' NE2' HG13 ' A' ' 101' ' ' VAL . 18.3 mt-30 -98.94 56.75 1.07 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.327 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.602 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 1.6 p-90 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.787 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.736 ' O ' HG22 ' A' ' 97' ' ' ILE . 13.9 mtmt . . . . . 0 C--O 1.205 -1.253 0 CA-C-O 121.522 0.677 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.862 ' HA ' HG23 ' A' ' 97' ' ' ILE . 41.5 t -138.51 134.29 43.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 O-C-N 120.897 -1.127 . . . . 0.0 110.516 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 50.5 t -142.61 93.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.078 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.63 ' CD1' ' CD1' ' A' ' 32' ' ' ILE . 50.2 m-85 -69.67 162.45 27.68 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 109.464 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.614 HG22 ' HG2' ' A' ' 12' ' ' ARG . 87.3 t -127.89 168.56 20.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.096 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.621 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 6.1 p -103.12 -154.77 0.5 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 109.616 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.568 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -92.12 -29.84 16.3 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.017 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -91.93 -11.86 35.05 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.515 0.674 . . . . 0.0 109.251 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.5 7.23 18.67 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.234 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.578 HG22 ' NH2' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -71.64 131.12 42.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.355 -1.673 . . . . 0.0 107.451 178.446 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.614 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.77 173.47 7.19 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.124 0.964 . . . . 0.0 112.896 -177.437 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -134.44 -179.08 5.36 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.755 ' C ' HD23 ' A' ' 15' ' ' LEU . 37.0 mt-10 -151.78 112.93 4.28 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 117.844 -1.542 . . . . 0.0 110.729 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.953 HD11 ' HA ' ' A' ' 27' ' ' ALA . 3.9 mt -109.83 -151.11 0.47 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.482 1.134 . . . . 0.0 111.111 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.19 70.54 0.92 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.083 HG13 ' CG1' ' A' ' 21' ' ' VAL . 18.3 t -86.46 113.51 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.21 -170.8 2.89 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.87 0.843 . . . . 0.0 111.608 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.573 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 2.5 p30 -61.18 110.07 1.29 Allowed 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.769 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 112.19 -18.68 23.33 Favored Glycine 0 C--N 1.289 -2.029 0 C-N-CA 119.349 -1.405 . . . . 0.0 111.116 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.083 ' CG1' HG13 ' A' ' 17' ' ' VAL . 45.0 t -94.24 139.32 18.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 O-C-N 120.088 -1.831 . . . . 0.0 107.099 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.573 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -95.9 142.49 28.08 Favored 'General case' 0 C--N 1.275 -2.674 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.958 HD23 HG21 ' A' ' 17' ' ' VAL . 11.0 mt -49.67 -27.03 4.21 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.082 -1.447 . . . . 0.0 107.78 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.533 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -71.62 -17.31 62.28 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.832 0.825 . . . . 0.0 108.821 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.748 ' HG2' HG13 ' A' ' 21' ' ' VAL . 2.2 tp60 -89.7 -70.21 0.67 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.051 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -48.43 -49.67 34.28 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.301 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.953 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.76 -49.43 28.48 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.384 -1.448 . . . . 0.0 110.295 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -72.13 0.12 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.61 -0.681 . . . . 0.0 109.537 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.25 0.0 OUTLIER -103.58 -29.75 10.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.481 -0.762 . . . . 0.0 110.513 -179.773 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.845 ' CG ' HD22 ' A' ' 15' ' ' LEU . 9.0 m120 -97.73 -2.99 40.01 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.38 29.03 15.22 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.828 HD12 HD11 ' A' ' 15' ' ' LEU . 3.1 mt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.272 -1.134 . . . . 0.0 108.58 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.805 ' O ' HG13 ' A' ' 50' ' ' VAL . 25.8 p -86.84 25.4 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.438 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.099 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 7.3 t-80 -61.87 110.71 1.62 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.093 -1.005 . . . . 0.0 109.962 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.825 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -140.0 -169.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.624 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.825 ' N ' HG23 ' A' ' 50' ' ' VAL 0.258 62.0 m-85 -141.0 103.67 4.51 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.954 0.883 . . . . 0.0 111.041 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.044 ' HB ' HG22 ' A' ' 57' ' ' THR . 6.2 t -75.01 131.73 34.52 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 O-C-N 120.67 -1.268 . . . . 0.0 110.135 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.789 ' O ' HG23 ' A' ' 57' ' ' THR . 3.7 t30 -47.24 147.75 1.45 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.082 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.52 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.5 pt-20 -59.47 -8.74 1.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.212 -0.93 . . . . 0.0 111.966 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.587 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -96.69 10.01 39.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.701 -1.249 . . . . 0.0 110.725 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 1.128 ' CB ' HD13 ' A' ' 97' ' ' ILE . 91.0 m-85 -140.72 1.13 1.68 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.073 -1.017 . . . . 0.0 110.288 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 1.044 HG22 ' HB ' ' A' ' 52' ' ' VAL . 11.3 p -90.41 -40.81 11.84 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.946 -1.096 . . . . 0.0 108.465 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.26 -1.12 54.51 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.671 0.748 . . . . 0.0 110.592 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.009 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.256 0.2 OUTLIER -99.13 -47.09 5.34 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.618 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.995 HG22 ' O ' ' A' ' 89' ' ' ILE 0.327 1.0 OUTLIER -78.43 176.0 4.09 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.39 178.92 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.994 ' HD2' HG13 ' A' ' 60' ' ' VAL . 39.1 Cg_endo -72.7 103.27 1.53 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 CA-C-O 122.538 0.974 . . . . 0.0 111.314 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.512 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.26 73.09 1.8 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.052 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.92 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -37.76 161.26 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.337 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 66' ' ' ARG . 45.1 p-10 -86.95 -160.12 0.56 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.572 1.177 . . . . 0.0 113.125 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.0 pm0 -33.67 -27.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.477 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -53.17 -70.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.321 -1.487 . . . . 0.0 107.66 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.989 ' HG2' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -64.63 -30.67 71.69 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.801 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.989 HD12 ' HG2' ' A' ' 67' ' ' GLU . 1.2 mp -77.45 -16.66 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.176 -0.953 . . . . 0.0 110.853 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -90.61 -73.95 1.28 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.893 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -42.11 -29.12 0.22 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.599 -0.942 . . . . 0.0 108.566 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.01 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -80.01 -47.58 14.69 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 7.3 tp10 -64.12 -12.71 42.12 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.199 -0.938 . . . . 0.0 109.339 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.27 -18.33 27.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.362 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.01 HG22 ' O ' ' A' ' 71' ' ' LEU . 8.0 m -70.17 145.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.096 -1.003 . . . . 0.0 110.456 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.775 HG22 ' O ' ' A' ' 75' ' ' THR . 55.4 m -99.52 28.46 4.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.741 -0.6 . . . . 0.0 109.699 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.099 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -97.15 -148.81 0.32 Allowed 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.094 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.744 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.47 63.48 5.79 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 122.333 1.063 . . . . 0.0 110.918 -178.46 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.848 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.14 154.4 13.05 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 118.923 -2.36 . . . . 0.0 111.61 -177.303 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.651 ' HG3' ' CD2' ' A' ' 51' ' ' TYR 0.379 2.4 mmtt -133.86 177.31 2.31 Favored Pre-proline 0 C--N 1.289 -2.059 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.774 -173.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 42.0 Cg_endo -73.31 -25.57 15.44 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 N-CA-C 107.583 -1.737 . . . . 0.0 107.583 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.987 ' HB2' HG21 ' A' ' 57' ' ' THR . 8.2 p-10 -114.66 21.37 14.53 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.251 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.848 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -45.85 158.08 0.1 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.802 -1.186 . . . . 0.0 109.094 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.9 ' HB2' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -166.28 150.15 7.57 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 117.011 -1.876 . . . . 0.0 112.276 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.787 HD22 ' SG ' ' A' ' 48' ' ' CYS . 79.7 mt -104.67 102.83 12.41 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 24' ' ' MET . 1.9 t -24.05 -37.18 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.554 ' N ' ' O ' ' A' ' 84' ' ' LEU . 27.6 p -70.58 2.92 3.48 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.134 -1.604 . . . . 0.0 111.554 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.541 ' HG3' ' CB ' ' A' ' 67' ' ' GLU . 76.9 mm-40 -125.2 19.43 8.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.882 -1.136 . . . . 0.0 110.514 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.63 HG23 HG11 ' A' ' 60' ' ' VAL . 5.1 mm -120.34 100.49 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.105 -0.997 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.995 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -90.04 127.04 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.794 -1.191 . . . . 0.0 108.106 178.329 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.675 ' HE3' ' HA ' ' A' ' 90' ' ' MET . 26.3 mmm -82.73 137.42 34.41 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.334 -0.854 . . . . 0.0 110.626 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.737 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -114.7 170.27 5.66 Favored Pre-proline 0 C--N 1.291 -1.952 0 O-C-N 120.936 -1.102 . . . . 0.0 110.033 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 19' ' ' ASP . 40.6 Cg_endo -67.14 -10.31 28.14 Favored 'Trans proline' 0 C--N 1.292 -2.446 0 O-C-N 124.498 1.789 . . . . 0.0 110.859 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.604 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -92.57 -30.78 15.47 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 117.628 -1.629 . . . . 0.0 107.646 177.561 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.009 HD21 ' CB ' ' A' ' 59' ' ' LYS . 83.7 mt -89.8 28.53 1.33 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.096 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 34.8 p-10 -63.19 106.02 0.81 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 118.465 -1.294 . . . . 0.0 108.281 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.629 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.87 23.01 1.89 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.134 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -57.61 138.39 18.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.327 -1.102 . . . . 0.0 111.237 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.134 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.1 t -111.39 114.49 47.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.627 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -99.75 152.87 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.78 -1.2 . . . . 0.0 109.755 -178.902 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -123.06 128.59 50.35 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.318 -0.864 . . . . 0.0 110.71 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.621 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 64.9 t -101.45 134.69 20.11 Favored Pre-proline 0 C--N 1.292 -1.93 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.107 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.669 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 56.8 Cg_endo -87.79 175.67 4.29 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.512 2.141 . . . . 0.0 112.807 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -91.86 -17.05 25.83 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.601 0.715 . . . . 0.0 109.193 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.905 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.92 70.46 0.71 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.328 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.53 ' CG ' ' HG2' ' A' ' 102' ' ' PRO . 2.5 mt-30 -97.63 62.89 1.7 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 122.004 0.907 . . . . 0.0 110.219 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.668 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 5.8 p-90 . . . . . 0 C--N 1.294 -1.827 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.179 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.738 ' O ' HG22 ' A' ' 97' ' ' ILE . 6.9 mtmm . . . . . 0 C--O 1.21 -0.977 0 CA-C-O 121.999 0.904 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.923 ' HA ' HG23 ' A' ' 97' ' ' ILE . 53.8 t -140.77 135.35 34.01 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 O-C-N 121.351 -0.843 . . . . 0.0 111.024 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.757 HG13 ' HG3' ' A' ' 14' ' ' GLU . 20.8 t -142.49 90.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 C-N-CA 118.711 -1.196 . . . . 0.0 110.386 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.656 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 55.8 m-85 -69.57 136.16 50.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.448 -0.782 . . . . 0.0 109.817 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.567 HG22 ' CD ' ' A' ' 12' ' ' ARG . 62.2 t -100.03 167.69 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 O-C-N 120.723 -1.236 . . . . 0.0 109.297 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.586 ' HB3' HG22 ' A' ' 11' ' ' THR . 89.1 p -103.84 -155.92 0.55 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.103 -0.998 . . . . 0.0 109.246 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.612 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -87.7 -31.34 19.76 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -91.7 -6.65 51.63 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.364 0.602 . . . . 0.0 109.806 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.536 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.24 -23.46 12.56 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.76 129.11 28.81 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.691 -1.476 . . . . 0.0 108.223 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.567 ' CD ' HG22 ' A' ' 6' ' ' VAL . 20.8 mtt180 -121.73 -175.45 3.1 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 122.191 0.996 . . . . 0.0 112.65 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -133.76 179.7 6.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 177.634 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.757 ' HG3' HG13 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -151.78 111.15 3.94 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 117.704 -1.598 . . . . 0.0 110.972 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.998 HD21 ' CD1' ' A' ' 32' ' ' ILE . 7.6 mt -103.86 -157.04 0.59 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.527 1.156 . . . . 0.0 110.595 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -152.54 69.58 0.87 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.049 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.4 t -89.41 127.18 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.033 0.921 . . . . 0.0 109.783 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.23 177.05 6.71 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.21 1.005 . . . . 0.0 113.229 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.59 ' CB ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -53.14 120.63 6.16 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.222 177.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.651 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 106.54 -24.08 26.67 Favored Glycine 0 C--N 1.28 -2.53 0 C-N-CA 119.308 -1.425 . . . . 0.0 112.218 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.049 ' HB ' HG12 ' A' ' 17' ' ' VAL . 85.9 t -84.43 152.23 3.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.513 0 CA-C-N 120.286 2.043 . . . . 0.0 109.381 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.494 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -96.6 131.24 43.44 Favored 'General case' 0 C--N 1.274 -2.682 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.287 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.772 HD21 ' SD ' ' A' ' 90' ' ' MET . 7.5 mt -47.11 -26.99 1.23 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.47 -1.394 . . . . 0.0 108.707 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.585 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -73.74 -14.76 61.18 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.657 0.741 . . . . 0.0 109.445 -178.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 22' ' ' SER . 4.0 tt0 -90.2 -62.1 1.54 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.846 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -51.47 -55.65 17.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.128 -0.982 . . . . 0.0 110.385 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.981 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.62 -50.8 23.34 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.534 -1.353 . . . . 0.0 110.263 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.7 OUTLIER -66.92 -4.25 2.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.439 -0.788 . . . . 0.0 109.456 178.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 26' ' ' ALA 0.256 0.0 OUTLIER -103.44 -24.72 13.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.373 -0.829 . . . . 0.0 110.36 179.954 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.785 ' CG ' HD22 ' A' ' 15' ' ' LEU . 8.4 m120 -97.05 2.8 51.81 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.99 9.8 67.31 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.998 ' CD1' HD21 ' A' ' 15' ' ' LEU . 9.0 mt . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.439 -1.036 . . . . 0.0 108.757 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.629 0.728 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.71 ' SG ' HD13 ' A' ' 84' ' ' LEU . 25.9 p -89.92 29.96 1.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.659 -0.651 . . . . 0.0 109.678 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.334 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 7.0 t-160 -69.97 128.78 37.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.566 -0.709 . . . . 0.0 110.732 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.822 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.1 m -157.09 -172.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 O-C-N 121.297 -0.877 . . . . 0.0 109.468 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.822 ' N ' HG23 ' A' ' 50' ' ' VAL 0.252 81.4 m-85 -140.49 106.49 5.19 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.901 0.857 . . . . 0.0 110.823 178.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.128 ' HB ' HG22 ' A' ' 57' ' ' THR . 9.6 t -76.33 130.83 35.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.498 0 O-C-N 120.621 -1.299 . . . . 0.0 109.897 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.87 ' O ' HG23 ' A' ' 57' ' ' THR . 4.4 t30 -45.52 150.0 0.52 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.033 -1.042 . . . . 0.0 109.418 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 pt-20 -59.95 -8.46 2.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.255 -0.903 . . . . 0.0 111.888 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.58 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -97.24 9.15 43.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.671 -1.268 . . . . 0.0 110.779 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 1.1 ' CB ' HD13 ' A' ' 97' ' ' ILE . 90.5 m-85 -140.68 2.72 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 109.919 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 1.128 HG22 ' HB ' ' A' ' 52' ' ' VAL . 24.9 p -90.82 -40.48 11.76 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.979 -1.076 . . . . 0.0 108.375 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.55 -0.9 51.54 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.711 0.767 . . . . 0.0 110.664 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.055 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.26 0.0 OUTLIER -99.26 -47.95 5.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.479 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.064 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.334 0.9 OUTLIER -74.88 179.52 1.33 Allowed Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 113.529 -1.669 . . . . 0.0 106.751 178.585 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 1.064 ' HD2' HG13 ' A' ' 60' ' ' VAL . 36.9 Cg_endo -70.74 115.22 4.14 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 CA-C-O 122.951 1.146 . . . . 0.0 111.796 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.33 69.8 1.63 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.833 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -37.5 159.48 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.223 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -105.6 -154.79 0.52 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.201 -0.937 . . . . 0.0 111.362 -178.547 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 64' ' ' ASN . 6.2 pt-20 -31.98 -31.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.023 -0.423 . . . . 0.0 111.841 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 64' ' ' ASN . 3.5 mtm180 -52.84 -71.68 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.701 -1.25 . . . . 0.0 107.812 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.604 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 2.5 tm-20 -61.25 -48.65 80.5 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.349 -0.844 . . . . 0.0 109.321 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.552 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.1 mp -54.19 -16.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.367 -0.833 . . . . 0.0 110.421 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -89.23 -75.99 1.3 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.604 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.81 -40.27 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.272 -1.134 . . . . 0.0 108.486 178.549 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.0 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -65.3 -51.49 60.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.437 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -57.39 -22.4 42.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.951 -1.093 . . . . 0.0 108.646 178.326 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.53 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.79 -43.31 30.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.626 -0.671 . . . . 0.0 110.615 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.0 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.7 m -39.2 161.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.571 -0.705 . . . . 0.0 109.892 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.812 HG22 ' O ' ' A' ' 75' ' ' THR . 21.6 m -120.39 30.91 6.71 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.103 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.334 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -114.18 -166.5 1.11 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.701 -1.2 . . . . 0.0 112.493 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.75 63.27 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.616 -178.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.918 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.44 154.03 14.66 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 118.805 -2.434 . . . . 0.0 111.243 -177.003 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.532 ' CE ' ' HG3' ' A' ' 77' ' ' GLU 0.347 0.4 OUTLIER -131.43 179.65 1.3 Allowed Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.275 -174.794 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.429 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 45.7 Cg_endo -77.37 -27.94 6.05 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 N-CA-C 106.96 -1.977 . . . . 0.0 106.96 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.876 ' HB2' HG21 ' A' ' 57' ' ' THR . 19.3 p-10 -107.89 16.9 23.06 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.166 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.801 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -45.61 152.62 0.31 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.155 -0.966 . . . . 0.0 109.309 179.006 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.646 HH21 HG12 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -165.11 144.59 6.8 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.139 -1.424 . . . . 0.0 111.237 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.71 HD13 ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -97.62 109.3 22.08 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.585 ' SG ' ' N ' ' A' ' 24' ' ' MET . 7.2 t -28.68 -32.79 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' A' ' 84' ' ' LEU . 26.0 p -71.99 1.31 7.46 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.383 -1.448 . . . . 0.0 110.703 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 84' ' ' LEU . 33.2 mm-40 -125.22 20.49 8.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.994 -1.066 . . . . 0.0 110.52 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.584 ' CD1' ' NE ' ' A' ' 83' ' ' ARG . 6.8 mm -119.94 99.91 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.029 -1.044 . . . . 0.0 110.305 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.955 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -82.71 129.39 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.844 -1.16 . . . . 0.0 109.563 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.996 ' SD ' HG21 ' A' ' 97' ' ' ILE . 1.4 tpt -82.68 125.78 31.61 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.583 -0.698 . . . . 0.0 110.422 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.51 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 2.0 p -114.09 162.17 24.37 Favored Pre-proline 0 C--N 1.292 -1.913 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.903 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.59 ' HD3' ' CB ' ' A' ' 19' ' ' ASP . 37.9 Cg_endo -64.33 -13.69 39.71 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 O-C-N 124.658 1.873 . . . . 0.0 108.372 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.51 ' HG2' ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -84.76 -38.69 19.33 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.649 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.055 HD21 ' CB ' ' A' ' 59' ' ' LYS . 68.5 mt -90.5 31.09 1.06 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.725 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.59 107.19 1.09 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.922 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.638 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.93 22.32 1.98 Allowed Glycine 0 N--CA 1.498 2.799 0 O-C-N 120.817 -1.177 . . . . 0.0 110.328 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.104 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -59.0 140.67 17.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.634 -0.921 . . . . 0.0 111.497 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.104 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.2 t -114.75 111.47 36.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -98.89 154.83 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.631 -1.293 . . . . 0.0 109.764 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 1.3 m-20 -122.43 123.11 40.56 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.243 -0.911 . . . . 0.0 110.087 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.612 HG12 ' CE1' ' A' ' 8' ' ' HIS . 72.2 t -102.27 121.55 49.82 Favored Pre-proline 0 C--N 1.289 -2.063 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.3 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.752 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 53.6 Cg_endo -75.51 172.83 15.57 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.835 1.69 . . . . 0.0 112.048 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.51 -18.17 24.55 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.425 0.631 . . . . 0.0 109.371 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.713 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.95 73.51 0.82 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.46 ' CG ' ' HG2' ' A' ' 102' ' ' PRO . 1.2 mt-30 -98.63 56.26 1.11 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.266 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.591 ' OXT' ' CD2' ' A' ' 106' ' ' TRP . 1.5 p-90 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.852 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.648 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.941 0.401 . . . . 0.0 110.097 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.914 ' HA ' HG23 ' A' ' 97' ' ' ILE . 43.4 t -140.23 135.59 36.73 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 O-C-N 121.436 -0.79 . . . . 0.0 110.767 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 13' ' ' ARG . 39.2 t -141.81 91.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.77 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.661 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 42.3 m-85 -68.41 136.15 52.85 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 101' ' ' VAL . 98.7 t -98.91 163.82 2.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.6 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 81.9 p -98.59 -150.99 0.37 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.983 -1.073 . . . . 0.0 108.608 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.642 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -92.84 -30.53 15.4 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 119.763 -1.835 . . . . 0.0 107.815 178.22 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.506 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 3.1 p-10 -92.39 2.45 56.65 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.629 -0.67 . . . . 0.0 111.244 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 103.43 -8.39 52.15 Favored Glycine 0 N--CA 1.502 3.074 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.889 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -70.87 130.94 42.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.611 -1.523 . . . . 0.0 107.31 178.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -121.05 -172.33 2.38 Favored 'General case' 0 C--N 1.273 -2.758 0 O-C-N 120.862 -1.149 . . . . 0.0 112.567 -178.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.646 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.3 179.9 6.04 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 177.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.714 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 6.7 mt-10 -150.45 105.3 3.31 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.182 -1.574 . . . . 0.0 110.687 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.993 HD21 ' CD1' ' A' ' 32' ' ' ILE 0.256 8.4 mt -99.5 -156.2 0.54 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.889 0.852 . . . . 0.0 110.357 178.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -146.74 72.78 1.29 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.054 HG13 ' CG1' ' A' ' 21' ' ' VAL 0.255 14.7 t -86.5 120.15 35.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.505 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.56 -172.86 3.74 Favored 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.35 1.072 . . . . 0.0 111.969 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -68.65 117.1 9.94 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 177.18 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.583 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 112.8 -16.39 23.45 Favored Glycine 0 C--N 1.275 -2.855 0 C-N-CA 118.977 -1.582 . . . . 0.0 109.719 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.054 ' CG1' HG13 ' A' ' 17' ' ' VAL . 43.1 t -97.01 144.09 11.23 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.006 0 C-N-CA 117.144 -1.822 . . . . 0.0 108.564 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER -96.4 134.79 39.12 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.104 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.667 HD22 HG11 ' A' ' 3' ' ' VAL 0.27 7.6 mt -46.09 -30.1 1.76 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 123.833 1.778 . . . . 0.0 108.198 178.605 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.589 ' HB2' ' HB3' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -73.65 -12.28 60.69 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.721 -179.245 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.648 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.2 tt0 -95.52 -59.9 1.78 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.956 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -56.76 -49.43 75.29 Favored 'General case' 0 C--O 1.199 -1.559 0 C-N-CA 118.022 -1.471 . . . . 0.0 110.572 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.935 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.0 -53.43 12.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.611 -1.305 . . . . 0.0 109.802 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -3.76 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 121.352 0.596 . . . . 0.0 110.268 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 26' ' ' ALA 0.265 0.0 OUTLIER -105.44 -29.22 10.36 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.482 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.743 ' CG ' HD22 ' A' ' 15' ' ' LEU . 7.9 m120 -96.37 4.27 52.34 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.57 62.72 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 118.416 -1.85 . . . . 0.0 110.315 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.993 ' CD1' HD21 ' A' ' 15' ' ' LEU . 11.2 mt . . . . . 0 C--N 1.3 -1.577 0 O-C-N 121.492 -1.005 . . . . 0.0 108.652 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.4 p . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.286 0.565 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.7 ' SG ' HD13 ' A' ' 84' ' ' LEU . 23.8 p -91.78 29.97 1.45 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 110.886 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.227 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 11.7 t-160 -68.5 134.84 50.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.441 -1.412 . . . . 0.0 110.959 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.727 HG23 ' N ' ' A' ' 51' ' ' TYR . 2.0 m -159.74 179.89 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.641 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.727 ' N ' HG23 ' A' ' 50' ' ' VAL 0.275 65.8 m-85 -138.53 113.19 8.99 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 121.596 0.712 . . . . 0.0 110.959 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.005 ' HB ' HG22 ' A' ' 57' ' ' THR . 3.9 t -82.61 131.35 33.96 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 O-C-N 120.869 -1.144 . . . . 0.0 109.346 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.871 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -44.58 155.17 0.1 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.076 -1.049 . . . . 0.0 108.727 177.331 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -67.45 -1.07 4.3 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.839 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.626 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.45 5.31 48.16 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.564 -1.335 . . . . 0.0 111.393 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.879 ' CB ' HD13 ' A' ' 97' ' ' ILE . 70.6 m-85 -140.17 2.2 1.88 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.328 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 1.02 HG21 ' HB2' ' A' ' 81' ' ' ASN . 17.7 p -89.08 -30.28 18.78 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.318 -1.489 . . . . 0.0 107.748 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -107.8 20.74 18.39 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.015 -178.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.02 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.302 0.3 OUTLIER -125.93 -47.62 1.65 Allowed 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 124.455 2.074 . . . . 0.0 106.72 179.535 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.032 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.347 0.6 OUTLIER -75.68 -176.65 0.6 Allowed Pre-proline 0 C--N 1.273 -2.727 0 CA-C-N 113.093 -1.867 . . . . 0.0 107.153 179.244 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 1.032 ' HD2' HG13 ' A' ' 60' ' ' VAL . 37.5 Cg_endo -59.6 122.73 11.95 Favored 'Trans proline' 0 C--N 1.294 -2.307 0 CA-C-O 122.621 1.009 . . . . 0.0 111.354 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.473 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -70.77 67.93 0.4 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.041 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.561 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -37.34 151.89 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.143 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' A' ' 66' ' ' ARG . 48.7 p-10 -92.55 -164.21 1.15 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.033 0.92 . . . . 0.0 111.744 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 69' ' ' GLY . 24.6 pt-20 -55.56 -25.48 38.15 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.519 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.532 ' O ' ' HG2' ' A' ' 70' ' ' MET . 0.2 OUTLIER -55.71 -61.57 2.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 119.785 -1.822 . . . . 0.0 107.049 177.495 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 1.002 ' HA ' ' HE2' ' A' ' 70' ' ' MET . 1.0 OUTLIER -57.76 -49.41 76.67 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.701 -0.624 . . . . 0.0 109.922 177.196 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 58.0 mt -73.77 -0.9 2.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.058 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -94.25 -76.45 1.33 Allowed Glycine 0 C--O 1.202 -1.871 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . 1.002 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 1.6 ptt? -46.81 -25.81 0.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.02 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -74.56 -48.38 27.19 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.255 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.539 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -57.71 -16.01 9.63 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 119.972 -1.705 . . . . 0.0 108.328 177.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.585 ' O ' ' NE1' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -86.57 -30.34 21.94 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 120.509 -0.476 . . . . 0.0 112.033 -177.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.02 HG22 ' O ' ' A' ' 71' ' ' LEU . 22.3 m -48.83 170.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.789 HG22 ' O ' ' A' ' 75' ' ' THR . 23.5 m -120.15 16.93 12.41 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 109.534 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.227 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -105.76 -164.97 1.06 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.849 1.309 . . . . 0.0 113.589 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.811 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -52.39 61.8 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.573 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.877 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -56.34 154.21 8.56 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 114.911 -2.716 . . . . 0.0 110.142 -177.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.693 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.402 1.0 OUTLIER -135.19 174.34 4.71 Favored Pre-proline 0 C--N 1.277 -2.584 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.152 -173.704 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.94 -26.24 22.24 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 N-CA-C 107.782 -1.661 . . . . 0.0 107.782 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 1.02 ' HB2' HG21 ' A' ' 57' ' ' THR . 15.6 p-10 -110.27 16.29 21.79 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.716 0.769 . . . . 0.0 110.555 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.84 ' OG ' ' HG ' ' A' ' 78' ' ' LEU 0.256 0.5 OUTLIER -45.24 158.36 0.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.066 -1.021 . . . . 0.0 110.675 178.597 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.812 ' HD3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -168.56 153.26 6.1 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 117.475 -1.69 . . . . 0.0 114.315 -179.039 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.7 HD13 ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -105.94 88.65 2.86 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 24' ' ' MET . 1.5 t -12.32 -52.02 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.545 ' N ' ' O ' ' A' ' 84' ' ' LEU . 8.7 p -50.92 -9.65 0.06 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.084 -1.01 . . . . 0.0 111.636 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.435 ' HB3' ' CD ' ' A' ' 67' ' ' GLU . 1.1 mp0 -119.15 20.45 12.64 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 119.707 -1.871 . . . . 0.0 111.375 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.812 HD11 ' HD3' ' A' ' 83' ' ' ARG . 8.7 mm -118.91 117.64 55.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.71 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.926 ' O ' HG22 ' A' ' 60' ' ' VAL . 3.6 mm -100.21 131.69 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.451 -0.781 . . . . 0.0 109.364 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.891 ' SD ' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -82.04 129.71 34.87 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.36 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.732 ' OG1' ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -110.96 163.51 17.13 Favored Pre-proline 0 C--N 1.288 -2.072 0 C-N-CA 118.265 -1.374 . . . . 0.0 109.858 179.053 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.496 ' HD3' ' OD1' ' A' ' 19' ' ' ASP . 43.2 Cg_endo -65.18 -9.3 21.33 Favored 'Trans proline' 0 C--N 1.283 -2.883 0 O-C-N 124.641 1.864 . . . . 0.0 110.285 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.732 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.6 OUTLIER -93.69 -28.63 15.85 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 116.992 -1.883 . . . . 0.0 107.853 177.001 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.02 HD21 ' CB ' ' A' ' 59' ' ' LYS . 70.7 mt -91.71 33.94 1.01 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.09 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.452 ' O ' ' CG ' ' A' ' 95' ' ' ASP . 19.4 p-10 -64.29 103.72 0.67 Allowed 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.931 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.631 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 125.26 17.68 2.66 Favored Glycine 0 N--CA 1.504 3.212 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.716 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.039 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -51.07 144.3 2.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.322 0.582 . . . . 0.0 109.526 178.754 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.039 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.5 t -122.07 113.24 38.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.553 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -98.07 160.41 3.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 119.958 -1.714 . . . . 0.0 110.497 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.694 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -123.18 120.4 33.09 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 109.55 -178.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.6 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 76.5 t -96.27 126.95 42.08 Favored Pre-proline 0 C--N 1.291 -1.954 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.807 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.663 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 43.9 Cg_endo -79.65 166.04 22.08 Favored 'Trans proline' 0 C--N 1.295 -2.238 0 O-C-N 123.695 1.366 . . . . 0.0 110.797 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -89.42 -15.96 31.99 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.648 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.42 83.8 1.82 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.5 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.525 ' HG2' ' HG2' ' A' ' 102' ' ' PRO . 42.9 mt-30 -102.03 57.46 0.81 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.576 -1.25 . . . . 0.0 111.072 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.624 ' OXT' ' CG ' ' A' ' 106' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 O-C-N 121.244 -0.91 . . . . 0.0 110.601 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.939 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.211 -0.941 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.827 HG22 HG21 ' A' ' 97' ' ' ILE . 19.9 t -136.67 136.33 48.31 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.186 0 O-C-N 121.055 -1.028 . . . . 0.0 111.735 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 13' ' ' ARG . 59.9 t -141.3 89.89 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.696 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.677 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 29.5 m-85 -67.54 133.97 50.42 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 99' ' ' VAL . 61.9 t -99.58 172.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 120.956 -1.09 . . . . 0.0 109.576 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.559 ' HB3' HG22 ' A' ' 11' ' ' THR . 5.4 p -106.45 -145.78 0.39 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.243 -0.911 . . . . 0.0 109.623 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.575 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -96.28 -32.34 12.46 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.332 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -92.02 -8.19 46.74 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.848 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.82 -12.4 20.46 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.157 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.559 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -57.02 131.57 50.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.368 -1.666 . . . . 0.0 108.229 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -121.08 174.66 6.52 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 122.123 0.964 . . . . 0.0 112.957 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.669 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -129.13 178.84 6.13 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.017 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -151.93 109.76 3.66 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.041 -1.864 . . . . 0.0 111.289 178.441 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.96 HD11 ' HA ' ' A' ' 27' ' ' ALA . 3.6 mt -103.72 -157.98 0.64 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.449 1.119 . . . . 0.0 110.842 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 16' ' ' ASP . 27.2 t0 -149.5 67.91 1.02 Allowed 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.026 HG12 ' HB ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -88.85 124.62 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.108 0.956 . . . . 0.0 110.008 -177.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.05 179.81 5.86 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.243 1.021 . . . . 0.0 113.112 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.622 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -57.42 117.6 4.29 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.644 177.134 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.629 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 111.58 -25.06 14.02 Favored Glycine 0 C--N 1.286 -2.197 0 C-N-CA 119.425 -1.369 . . . . 0.0 111.381 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.026 ' HB ' HG12 ' A' ' 17' ' ' VAL . 91.2 t -85.63 149.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 120.082 1.941 . . . . 0.0 109.742 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -96.05 125.32 40.5 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.407 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.8 HD22 HG11 ' A' ' 3' ' ' VAL . 8.6 mt -41.77 -27.84 0.13 Allowed 'General case' 0 C--O 1.201 -1.461 0 O-C-N 121.084 -1.01 . . . . 0.0 109.258 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.527 ' SD ' ' HB3' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -59.32 -49.44 77.81 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 177.658 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 22' ' ' SER . 8.2 tt0 -57.98 -68.79 0.21 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.714 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.881 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.77 -55.95 7.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.971 -1.08 . . . . 0.0 111.052 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.96 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.65 -48.14 28.96 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.293 -1.504 . . . . 0.0 110.196 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -70.72 -1.46 2.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.502 179.19 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -102.05 -29.3 11.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 0.0 109.674 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.794 ' CG ' HD22 ' A' ' 15' ' ' LEU . 9.3 m120 -97.73 -3.15 39.71 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.79 32.98 9.43 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.119 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.867 HD12 HD11 ' A' ' 15' ' ' LEU . 5.2 mt . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.218 -1.166 . . . . 0.0 109.276 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.818 ' O ' HG13 ' A' ' 50' ' ' VAL . 28.6 p -101.24 29.93 4.45 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.716 -0.615 . . . . 0.0 110.243 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.002 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 2.0 t60 -65.47 104.24 0.96 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.523 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.91 HG11 ' SG ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -140.75 -173.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.454 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.716 ' CZ ' ' CE1' ' A' ' 49' ' ' HIS 0.275 84.2 m-85 -140.63 107.21 5.32 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 121.838 0.827 . . . . 0.0 110.617 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.073 ' HB ' HG22 ' A' ' 57' ' ' THR . 3.5 t -70.88 134.29 30.29 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 O-C-N 120.222 -1.549 . . . . 0.0 109.162 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.952 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -44.8 151.44 0.29 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.683 -1.207 . . . . 0.0 109.305 178.364 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -61.82 -8.51 4.97 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.216 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.611 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -92.64 5.06 52.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.019 -1.051 . . . . 0.0 111.379 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.926 ' HB3' HD12 ' A' ' 97' ' ' ILE . 42.0 m-85 -140.75 4.63 1.93 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.78 -1.2 . . . . 0.0 109.715 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 1.073 HG22 ' HB ' ' A' ' 52' ' ' VAL . 14.7 p -89.67 -33.16 16.73 Favored 'General case' 0 C--N 1.288 -2.066 0 O-C-N 120.746 -1.221 . . . . 0.0 108.023 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.25 -1.91 35.18 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.863 0.84 . . . . 0.0 109.968 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.062 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.268 1.5 mtpt -99.38 -48.64 4.72 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 123.07 1.414 . . . . 0.0 107.601 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.018 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.33 0.8 OUTLIER -72.09 -178.28 0.61 Allowed Pre-proline 0 C--N 1.288 -2.068 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.053 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 1.018 ' HD2' HG13 ' A' ' 60' ' ' VAL . 33.1 Cg_endo -67.61 128.0 17.33 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 CA-C-O 123.1 1.208 . . . . 0.0 111.922 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -73.23 69.4 1.08 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.107 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.496 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -38.02 157.94 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.594 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.479 ' C ' HD13 ' A' ' 68' ' ' ILE . 49.9 p30 -127.37 -149.7 0.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.762 -1.211 . . . . 0.0 112.48 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -36.45 -30.78 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.215 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.461 ' NH1' ' HG3' ' A' ' 66' ' ' ARG . 5.9 mtm-85 -53.79 -73.2 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.699 -1.251 . . . . 0.0 109.458 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.58 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -67.98 -38.82 83.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.094 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 0.5 OUTLIER -47.52 -19.83 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.22 -0.925 . . . . 0.0 109.618 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 67' ' ' GLU . . . -90.18 -70.13 1.22 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.588 ' HG3' ' HG ' ' A' ' 84' ' ' LEU . 1.0 OUTLIER -50.3 -30.26 11.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.847 -1.384 . . . . 0.0 108.384 178.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.036 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -74.13 -50.06 21.08 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.585 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -57.13 -18.4 14.85 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.727 -1.233 . . . . 0.0 108.39 178.282 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -83.54 -34.32 25.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.719 . . . . 0.0 111.533 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.036 HG22 ' O ' ' A' ' 71' ' ' LEU . 33.3 m -42.63 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.016 -1.052 . . . . 0.0 109.851 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 75' ' ' THR . 38.2 m -121.08 11.57 10.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.936 -1.102 . . . . 0.0 110.521 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.002 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -99.59 -154.87 0.48 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 123.041 1.4 . . . . 0.0 113.063 -177.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.757 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.252 0.0 OUTLIER -64.96 63.79 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.575 -178.384 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.921 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.03 145.05 37.64 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 115.078 -2.649 . . . . 0.0 110.529 -176.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.564 ' CE ' ' HG3' ' A' ' 77' ' ' GLU 0.362 0.1 OUTLIER -119.01 177.28 1.38 Allowed Pre-proline 0 C--N 1.288 -2.103 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.787 -175.238 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.456 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 42.7 Cg_endo -75.39 -25.2 11.5 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 N-CA-C 106.36 -2.208 . . . . 0.0 106.36 175.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.769 HD22 HG21 ' A' ' 57' ' ' THR . 14.6 p-10 -112.79 22.37 14.56 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.931 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.776 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -46.14 156.57 0.15 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.658 -1.276 . . . . 0.0 109.347 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.709 ' HB2' HG23 ' A' ' 52' ' ' VAL . 2.1 mmt85 -153.02 155.1 36.26 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.347 -1.341 . . . . 0.0 111.603 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.797 HD13 ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -111.84 100.72 9.15 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.91 ' SG ' HG11 ' A' ' 50' ' ' VAL . 88.2 m -30.37 -31.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.572 ' N ' ' O ' ' A' ' 84' ' ' LEU . 28.0 p -73.21 1.87 8.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.394 -1.442 . . . . 0.0 110.621 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' A' ' 84' ' ' LEU . 5.1 tp60 -126.29 -8.9 6.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.037 -1.04 . . . . 0.0 111.685 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.659 HD11 HH11 ' A' ' 83' ' ' ARG . 0.9 OUTLIER -89.87 118.84 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.769 -1.207 . . . . 0.0 110.39 -179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.86 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -102.65 135.01 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.074 -1.016 . . . . 0.0 109.607 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.804 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.0 tpt -83.61 121.15 26.85 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.702 -0.624 . . . . 0.0 110.66 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.698 HG23 HD12 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -95.83 -176.9 0.58 Allowed Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 117.879 -1.528 . . . . 0.0 109.172 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 46.1 Cg_endo -90.06 -8.04 4.23 Favored 'Trans proline' 0 C--N 1.284 -2.842 0 O-C-N 124.204 1.634 . . . . 0.0 108.883 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.565 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.9 pt-20 -91.96 -30.53 16.05 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.767 1.27 . . . . 0.0 107.577 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.062 HD21 ' CB ' ' A' ' 59' ' ' LYS . 62.6 mt -90.1 29.35 1.23 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.333 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 95' ' ' ASP . 17.9 p-10 -62.87 104.01 0.5 Allowed 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.932 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.609 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.37 22.88 2.02 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.051 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.939 HG22 ' O ' ' A' ' 2' ' ' LYS . 3.5 tt -63.12 161.3 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.462 1.125 . . . . 0.0 112.307 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.635 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 t -134.56 116.43 21.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -99.24 156.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.647 -1.283 . . . . 0.0 109.47 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.68 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.95 111.61 16.83 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.079 -1.013 . . . . 0.0 110.637 -178.666 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.535 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 58.7 t -91.83 127.94 47.93 Favored Pre-proline 0 C--N 1.288 -2.081 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.75 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.622 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 58.4 Cg_endo -79.06 -179.9 5.87 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.083 1.57 . . . . 0.0 112.715 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -91.01 -14.89 30.56 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.526 ' CB ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.37 82.66 1.63 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.512 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -98.64 50.54 0.98 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 117.381 -1.728 . . . . 0.0 110.478 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.598 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.117 -0.989 . . . . 0.0 109.888 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.792 ' O ' HG22 ' A' ' 97' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--O 1.207 -1.158 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.842 ' HA ' HG23 ' A' ' 97' ' ' ILE . 53.7 t -138.05 135.67 45.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 O-C-N 120.85 -1.156 . . . . 0.0 111.929 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 13' ' ' ARG . 47.5 t -143.18 92.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.717 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.664 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 34.6 m-85 -70.7 136.92 49.33 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.232 -0.917 . . . . 0.0 108.982 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.562 HG22 ' CD ' ' A' ' 12' ' ' ARG . 61.5 t -99.92 167.55 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 O-C-N 120.51 -1.369 . . . . 0.0 109.335 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.585 ' HB3' HG22 ' A' ' 11' ' ' THR . 91.2 p -103.17 -155.83 0.54 Allowed 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.15 -0.969 . . . . 0.0 109.014 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.6 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -88.51 -30.41 19.37 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -91.83 -6.08 52.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.38 0.609 . . . . 0.0 109.909 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.03 -24.65 11.5 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.71 129.55 29.95 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.671 -1.488 . . . . 0.0 108.453 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.562 ' CD ' HG22 ' A' ' 6' ' ' VAL . 1.6 mtm180 -121.53 -172.34 2.4 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-O 122.113 0.958 . . . . 0.0 112.514 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.624 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.73 -178.22 5.03 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.233 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.705 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 49.9 mt-10 -151.85 112.1 4.1 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 117.717 -1.593 . . . . 0.0 110.959 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.962 HD11 HD12 ' A' ' 32' ' ' ILE 0.254 6.5 mt -108.19 -153.38 0.5 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 122.573 1.178 . . . . 0.0 111.493 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.16 68.77 0.99 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.094 HG13 ' CG1' ' A' ' 21' ' ' VAL . 20.9 t -86.05 114.32 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.98 -170.57 2.84 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 122.098 0.951 . . . . 0.0 111.786 -177.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.514 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 2.1 p-10 -63.67 110.53 2.05 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.488 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 112.4 -16.83 24.21 Favored Glycine 0 C--N 1.286 -2.227 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.606 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.094 ' CG1' HG13 ' A' ' 17' ' ' VAL . 42.0 t -96.73 136.28 28.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 O-C-N 120.203 -1.763 . . . . 0.0 106.909 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.593 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -93.1 140.27 29.68 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.277 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.92 HD23 HG21 ' A' ' 17' ' ' VAL . 8.2 mt -47.96 -25.36 1.33 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.664 -1.273 . . . . 0.0 108.055 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.565 ' CB ' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -69.91 -29.68 66.92 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.316 -0.865 . . . . 0.0 108.667 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.618 ' CG ' HG13 ' A' ' 21' ' ' VAL . 23.6 tt0 -75.46 -70.84 0.4 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.045 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.79 -49.99 18.99 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.136 -1.426 . . . . 0.0 110.601 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.625 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.3 -41.55 19.31 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.211 -1.556 . . . . 0.0 110.796 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.68 2.1 2.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.32 -0.863 . . . . 0.0 109.646 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.261 0.0 OUTLIER -103.9 -30.38 10.37 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.4 1.095 . . . . 0.0 110.206 -179.817 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.769 ' CG ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -99.08 -6.48 28.35 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.714 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.28 32.79 15.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.962 HD12 HD11 ' A' ' 15' ' ' LEU . 4.0 mt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 0.0 109.166 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 105' ' ' GLN . 14.8 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.627 0.727 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.634 ' SG ' HD13 ' A' ' 84' ' ' LEU . 20.7 p -88.23 26.56 1.38 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.607 -0.683 . . . . 0.0 110.26 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.336 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 6.2 t-160 -70.26 125.49 26.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.431 -0.793 . . . . 0.0 109.899 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.824 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -153.37 -171.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.823 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.824 ' N ' HG23 ' A' ' 50' ' ' VAL 0.263 81.6 m-85 -140.81 113.27 8.04 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.734 0.778 . . . . 0.0 110.95 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.985 ' HB ' HG22 ' A' ' 57' ' ' THR . 5.6 t -80.39 132.44 31.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 O-C-N 120.426 -1.422 . . . . 0.0 109.796 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.905 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -43.88 158.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.544 -1.262 . . . . 0.0 108.772 177.168 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.18 1.53 7.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.759 -1.213 . . . . 0.0 110.144 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.594 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.06 5.59 46.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.792 ' CB ' HD13 ' A' ' 97' ' ' ILE . 57.7 m-85 -140.27 4.9 2.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.92 -1.112 . . . . 0.0 109.35 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.985 HG22 ' HB ' ' A' ' 52' ' ' VAL . 33.8 p -89.35 -39.67 13.28 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.26 -1.79 47.33 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.755 0.788 . . . . 0.0 110.661 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.052 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.26 0.8 OUTLIER -99.31 -47.68 5.08 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 123.207 1.48 . . . . 0.0 107.559 179.877 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.079 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.329 0.7 OUTLIER -78.31 -179.91 1.49 Allowed Pre-proline 0 C--N 1.286 -2.177 0 CA-C-N 113.624 -1.626 . . . . 0.0 107.921 179.811 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 1.079 ' HD2' HG13 ' A' ' 60' ' ' VAL . 37.9 Cg_endo -69.97 106.75 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 CA-C-O 122.655 1.023 . . . . 0.0 111.836 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.544 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -60.21 74.45 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.766 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 67' ' ' GLU . . . -36.78 153.2 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.951 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 66' ' ' ARG . 3.5 p30 -108.1 -159.75 0.7 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.165 -0.959 . . . . 0.0 111.858 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 7.4 pt-20 -29.68 -34.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.099 -0.375 . . . . 0.0 111.918 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 64' ' ' ASN . 5.7 mmt180 -53.09 -66.23 0.42 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 120.78 -1.2 . . . . 0.0 107.772 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 1.005 ' HG3' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -61.09 -49.08 78.78 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.14 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 1.005 HD12 ' HG3' ' A' ' 67' ' ' GLU . 1.1 mp -57.73 -12.69 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.337 -0.852 . . . . 0.0 111.183 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -89.91 -79.76 1.34 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.585 ' CE ' ' CG ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -43.88 -38.77 3.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -1.177 . . . . 0.0 108.846 179.216 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.995 ' O ' HG22 ' A' ' 74' ' ' VAL . 1.0 OUTLIER -64.99 -50.74 65.15 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.525 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -57.17 -22.19 38.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.224 -0.923 . . . . 0.0 108.844 178.553 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.53 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -80.18 -42.29 23.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.477 -0.764 . . . . 0.0 110.744 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.995 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.7 m -39.0 161.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.526 -0.734 . . . . 0.0 110.089 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 75' ' ' THR . 24.2 m -120.52 29.49 7.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 109.245 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.336 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -112.91 -166.38 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.45 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.6 63.36 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.493 -178.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.905 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.47 152.42 18.03 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 118.848 -2.407 . . . . 0.0 111.389 -176.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.526 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.35 0.0 OUTLIER -128.73 -175.97 0.49 Allowed Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.526 -174.824 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 47.0 Cg_endo -80.67 -30.0 2.03 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 N-CA-C 106.987 -1.967 . . . . 0.0 106.987 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.716 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.7 OUTLIER -105.28 13.21 30.81 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.381 178.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.808 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -44.27 147.54 0.54 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.221 -0.924 . . . . 0.0 109.702 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.775 ' C ' HD23 ' A' ' 84' ' ' LEU . 4.6 mtt180 -166.74 153.71 9.02 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 117.798 -1.561 . . . . 0.0 112.534 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.775 HD23 ' C ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -102.63 119.08 38.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 48' ' ' CYS . 28.8 p -33.53 -28.91 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.876 -0.515 . . . . 0.0 112.349 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.565 ' HA ' ' CB ' ' A' ' 24' ' ' MET . 31.8 p -77.17 8.16 4.3 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.551 -1.343 . . . . 0.0 111.075 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.585 ' CG ' ' CE ' ' A' ' 70' ' ' MET . 19.4 mm-40 -125.68 8.73 7.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.052 -1.03 . . . . 0.0 110.384 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.713 HD12 HG11 ' A' ' 60' ' ' VAL . 3.9 mm -120.5 119.72 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.969 -1.082 . . . . 0.0 111.47 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.894 ' O ' HG22 ' A' ' 60' ' ' VAL . 4.7 mm -102.06 131.36 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.085 -1.009 . . . . 0.0 108.967 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.769 ' HE3' ' HA ' ' A' ' 90' ' ' MET . 20.2 mmm -84.13 141.1 31.32 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.899 -1.126 . . . . 0.0 110.289 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.686 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -114.14 -175.43 0.32 Allowed Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.843 -1.16 . . . . 0.0 109.988 179.279 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 44.2 Cg_endo -84.98 -9.94 8.43 Favored 'Trans proline' 0 C--N 1.285 -2.8 0 O-C-N 123.705 1.371 . . . . 0.0 108.603 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.538 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.4 pt-20 -92.16 -35.12 14.03 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.052 HD21 ' CB ' ' A' ' 59' ' ' LYS . 55.7 mt -89.77 32.22 0.9 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.726 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.464 ' HA ' ' N ' ' A' ' 2' ' ' LYS . 6.8 p-10 -63.46 108.04 1.26 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 118.319 -1.352 . . . . 0.0 108.788 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.615 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.39 24.11 1.83 Allowed Glycine 0 N--CA 1.498 2.794 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.24 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.105 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -58.59 135.79 22.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.53 -0.983 . . . . 0.0 110.644 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.105 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.5 t -113.53 113.6 44.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -99.46 155.86 4.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.762 -1.211 . . . . 0.0 109.973 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.19 120.09 33.17 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.739 0.78 . . . . 0.0 109.842 -179.089 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.6 HG12 ' CE1' ' A' ' 8' ' ' HIS . 72.8 t -99.61 123.02 49.46 Favored Pre-proline 0 C--N 1.289 -2.06 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.3 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.755 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 55.8 Cg_endo -76.44 173.53 14.33 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.301 1.685 . . . . 0.0 112.21 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.463 ' OD1' ' CD2' ' A' ' 8' ' ' HIS . 1.3 t0 -91.57 -17.84 25.0 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.781 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.81 72.35 0.78 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.1 OUTLIER -98.42 56.02 1.13 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.285 -177.694 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.585 ' CD2' ' O ' ' A' ' 106' ' ' TRP . 1.7 p-90 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.886 -1.054 . . . . 0.0 109.807 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.59 ' O ' HG22 ' A' ' 97' ' ' ILE . 4.4 mmtt . . . . . 0 C--O 1.209 -1.029 0 CA-C-O 121.556 0.694 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.8 HG11 HD22 ' A' ' 23' ' ' LEU . 35.4 t -141.35 139.24 32.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 O-C-N 121.623 -0.673 . . . . 0.0 111.466 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.684 HG13 ' HG2' ' A' ' 14' ' ' GLU . 45.6 t -143.18 89.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.602 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 46.9 m-85 -67.63 156.67 36.29 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.368 -0.832 . . . . 0.0 109.463 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.555 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 86.3 t -122.36 170.1 12.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.25 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.597 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 12.0 p -105.45 -154.63 0.52 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.066 -1.021 . . . . 0.0 109.738 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.567 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.91 -30.25 17.0 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.522 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.68 -10.63 39.54 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.483 0.659 . . . . 0.0 109.428 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.531 ' O ' ' CD ' ' A' ' 12' ' ' ARG . . . 114.31 -4.33 23.53 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 120.297 -0.954 . . . . 0.0 110.758 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -63.77 130.18 43.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.557 -1.555 . . . . 0.0 107.847 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -121.08 175.67 5.96 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 122.245 1.022 . . . . 0.0 112.791 -177.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -132.83 179.31 6.24 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 177.253 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.684 ' HG2' HG13 ' A' ' 4' ' ' VAL . 42.0 mt-10 -151.57 108.1 3.48 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 117.54 -1.664 . . . . 0.0 110.954 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.898 HD21 ' CD1' ' A' ' 32' ' ' ILE . 4.9 mt -99.93 -164.19 1.1 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.804 1.288 . . . . 0.0 110.976 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -143.82 68.23 1.28 Allowed 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.051 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.1 t -88.06 125.41 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.908 0.861 . . . . 0.0 109.247 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 90' ' ' MET . . . -89.31 -176.98 5.26 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.746 1.26 . . . . 0.0 113.268 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 90' ' ' MET . 3.1 p-10 -62.12 118.26 7.11 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.569 177.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.509 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 111.9 -22.93 17.98 Favored Glycine 0 C--N 1.284 -2.34 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.593 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.051 ' HB ' HG12 ' A' ' 17' ' ' VAL . 80.9 t -88.94 149.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 119.818 1.809 . . . . 0.0 110.314 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 25' ' ' GLN . 1.6 p -96.14 128.64 43.22 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.8 HD22 HG11 ' A' ' 3' ' ' VAL . 8.0 mt -41.07 -31.22 0.17 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.201 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.509 ' O ' ' HB ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -68.84 -39.29 80.04 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 118.116 -1.434 . . . . 0.0 108.658 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.589 ' CG ' HG13 ' A' ' 21' ' ' VAL . 6.1 tt0 -56.83 -65.01 0.69 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.797 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -50.73 -56.02 13.92 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.683 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.679 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.0 -41.45 16.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.513 -1.367 . . . . 0.0 110.835 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -78.94 0.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.325 -0.859 . . . . 0.0 109.435 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.259 0.0 OUTLIER -104.03 -30.01 10.54 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.232 1.015 . . . . 0.0 110.333 -179.781 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.637 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -98.97 -2.66 36.84 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 24.97 44.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.898 ' CD1' HD21 ' A' ' 15' ' ' LEU . 4.4 mt . . . . . 0 C--N 1.302 -1.484 0 O-C-N 121.244 -1.151 . . . . 0.0 109.435 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.36 0.6 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.756 ' SG ' HD12 ' A' ' 84' ' ' LEU . 7.9 p -115.14 24.33 11.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.409 -0.807 . . . . 0.0 110.082 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.312 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 7.0 t-160 -65.11 122.97 18.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.493 -0.754 . . . . 0.0 110.297 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.816 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -148.42 -173.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.981 0.896 . . . . 0.0 109.89 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.816 ' N ' HG23 ' A' ' 50' ' ' VAL 0.27 75.6 m-85 -140.69 110.63 6.52 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.713 0.768 . . . . 0.0 110.855 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.979 ' HB ' HG22 ' A' ' 57' ' ' THR . 4.0 t -79.01 136.14 24.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 O-C-N 120.421 -1.425 . . . . 0.0 110.038 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.962 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -46.01 158.33 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.523 -1.271 . . . . 0.0 108.858 177.246 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' N ' ' OE2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -72.16 0.22 10.25 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.775 178.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.594 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.28 4.26 48.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.059 -1.026 . . . . 0.0 110.584 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.84 ' HB3' HD12 ' A' ' 97' ' ' ILE . 35.3 m-85 -140.19 6.72 2.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.06 . . . . 0.0 109.299 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.979 HG22 ' HB ' ' A' ' 52' ' ' VAL . 45.6 p -89.39 -39.86 13.13 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.9 -2.47 53.27 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.827 0.822 . . . . 0.0 110.335 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.084 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.261 0.0 OUTLIER -99.56 -47.88 4.95 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 122.971 1.367 . . . . 0.0 107.636 -179.961 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.076 HG11 HG23 ' A' ' 88' ' ' ILE 0.33 0.9 OUTLIER -77.54 177.97 2.4 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.113 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 1.038 ' HD2' HG13 ' A' ' 60' ' ' VAL . 38.2 Cg_endo -71.38 110.02 2.75 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 CA-C-O 122.565 0.985 . . . . 0.0 112.276 -176.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -60.21 70.95 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.108 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' PRO . . . -37.21 134.25 0.6 Allowed 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.88 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' ARG . 43.1 p-10 -88.76 -150.11 0.19 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.111 0.958 . . . . 0.0 112.252 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 64' ' ' ASN . 11.7 pt-20 -37.97 -26.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.573 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.517 ' HA ' ' NE ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -53.0 -70.91 0.08 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.752 -1.218 . . . . 0.0 108.025 179.57 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.67 ' HA ' ' HE3' ' A' ' 70' ' ' MET . 0.7 OUTLIER -67.38 -51.5 51.27 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 0.9 OUTLIER -44.65 -24.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.465 -0.772 . . . . 0.0 110.108 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.488 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -84.07 -83.08 0.97 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.137 -1.985 . . . . 0.0 108.137 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.67 ' HE3' ' HA ' ' A' ' 67' ' ' GLU . 1.7 ptt? -39.65 -40.52 0.92 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.578 -0.954 . . . . 0.0 108.934 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.0 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -61.71 -53.49 55.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.328 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.562 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 3.8 tp10 -56.22 -21.95 26.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.526 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.97 -45.65 23.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.648 -0.657 . . . . 0.0 110.377 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.0 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.3 m -38.94 159.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.556 -0.715 . . . . 0.0 109.733 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.81 HG22 ' O ' ' A' ' 75' ' ' THR . 20.5 m -120.56 34.53 5.18 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.075 -1.015 . . . . 0.0 108.96 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.312 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -115.88 -164.37 0.95 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.628 1.204 . . . . 0.0 112.649 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.751 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.251 0.0 OUTLIER -56.79 62.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.391 -178.843 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.929 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.11 153.65 14.38 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 118.845 -2.409 . . . . 0.0 111.081 -176.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.695 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.387 2.4 mmtt -131.93 177.48 2.22 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.151 -173.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.506 ' HD2' ' HD3' ' A' ' 79' ' ' LYS . 42.9 Cg_endo -73.4 -27.56 13.14 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 176.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.673 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.9 OUTLIER -109.38 13.88 23.94 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.041 179.362 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.75 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -45.04 147.29 0.7 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.954 -1.091 . . . . 0.0 109.649 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.746 ' CD ' HD11 ' A' ' 88' ' ' ILE . 1.1 mtt180 -167.47 163.11 14.84 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 117.765 -1.574 . . . . 0.0 113.01 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.782 ' N ' HD22 ' A' ' 84' ' ' LEU . 3.4 mm? -99.22 122.63 42.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 48' ' ' CYS . 1.9 p -42.92 -23.25 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.167 -0.958 . . . . 0.0 110.713 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 30.4 p -81.49 4.85 19.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.811 -1.181 . . . . 0.0 110.496 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.531 ' HG3' ' CE ' ' A' ' 70' ' ' MET . 18.7 mm-40 -125.22 9.0 7.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 110.827 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.076 HG23 HG11 ' A' ' 60' ' ' VAL . 30.1 mm -113.71 106.96 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.038 -1.039 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.024 ' O ' HG22 ' A' ' 60' ' ' VAL . 4.2 mm -84.88 131.52 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.976 -1.078 . . . . 0.0 110.046 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.669 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.8 tpt -82.62 113.74 20.52 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.359 -0.838 . . . . 0.0 110.823 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.902 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -91.5 -177.34 0.73 Allowed Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 117.516 -1.674 . . . . 0.0 108.642 178.386 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 46.9 Cg_endo -87.11 -12.61 4.82 Favored 'Trans proline' 0 C--N 1.287 -2.67 0 O-C-N 124.412 1.743 . . . . 0.0 108.651 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.541 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.1 pt-20 -85.2 -32.67 22.54 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.084 HD21 ' CB ' ' A' ' 59' ' ' LYS . 57.7 mt -89.33 36.54 0.83 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.68 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -62.3 99.82 0.15 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.036 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.579 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 120.67 29.52 1.54 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.268 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.84 HD12 ' HB3' ' A' ' 56' ' ' PHE . 9.5 tt -60.19 163.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.496 -1.591 . . . . 0.0 112.3 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.684 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.3 t -133.1 114.1 20.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.604 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -102.18 154.7 5.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 120.92 -1.113 . . . . 0.0 109.992 -178.382 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.635 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -122.63 122.91 39.94 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.764 0.792 . . . . 0.0 110.487 -178.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 73.6 t -98.45 136.33 20.88 Favored Pre-proline 0 C--N 1.289 -2.045 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.631 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.619 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 56.0 Cg_endo -89.76 173.59 3.58 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 121.716 1.61 . . . . 0.0 111.818 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 18.3 p-10 -91.2 -17.15 26.52 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.818 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.98 74.92 0.89 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.68 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.506 ' HG2' ' HG2' ' A' ' 102' ' ' PRO . 10.9 mt-30 -98.49 54.08 1.05 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.299 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.584 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 1.4 p-90 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.082 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.735 ' O ' HG22 ' A' ' 97' ' ' ILE . 11.3 mtmt . . . . . 0 C--O 1.206 -1.187 0 CA-C-O 121.547 0.689 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.864 ' HA ' HG23 ' A' ' 97' ' ' ILE . 44.9 t -137.94 135.01 45.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 O-C-N 121.119 -0.988 . . . . 0.0 111.024 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 13' ' ' ARG . 48.8 t -142.29 92.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.154 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.647 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 36.6 m-85 -70.87 137.3 49.25 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.502 -0.749 . . . . 0.0 109.326 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.57 HG22 ' CD ' ' A' ' 12' ' ' ARG . 74.7 t -99.86 166.49 2.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 O-C-N 120.807 -1.183 . . . . 0.0 109.035 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.586 ' HB3' HG22 ' A' ' 11' ' ' THR . 82.8 p -102.21 -154.88 0.5 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.066 -1.021 . . . . 0.0 108.925 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.594 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -89.52 -31.25 17.72 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.485 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 6.1 p-10 -92.01 -5.1 53.6 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.313 0.577 . . . . 0.0 109.792 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.4 -24.65 11.16 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.76 129.31 29.4 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.567 -1.549 . . . . 0.0 108.38 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.57 ' CD ' HG22 ' A' ' 6' ' ' VAL . 5.4 mtt180 -121.53 -172.47 2.43 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 122.187 0.994 . . . . 0.0 112.563 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.65 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -136.7 -178.85 5.36 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.719 ' C ' HD23 ' A' ' 15' ' ' LEU . 35.3 mt-10 -151.86 112.23 4.13 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 117.788 -1.565 . . . . 0.0 110.711 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.954 HD11 ' HA ' ' A' ' 27' ' ' ALA 0.253 3.5 mt -107.86 -152.3 0.48 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.464 1.126 . . . . 0.0 111.207 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -150.37 70.36 1.02 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.082 HG13 ' CG1' ' A' ' 21' ' ' VAL . 12.7 t -86.8 113.7 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.541 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.17 -169.89 2.58 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.03 0.919 . . . . 0.0 111.504 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.414 ' O ' ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -63.86 110.53 2.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.741 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 112.28 -17.2 24.24 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.558 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.082 ' CG1' HG13 ' A' ' 17' ' ' VAL . 42.9 t -95.58 137.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 O-C-N 120.134 -1.804 . . . . 0.0 107.358 178.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -95.56 144.03 26.36 Favored 'General case' 0 C--N 1.274 -2.69 0 C-N-CA 118.647 -1.221 . . . . 0.0 108.032 178.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.877 HD23 HG21 ' A' ' 17' ' ' VAL . 12.2 mt -49.81 -25.98 3.55 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.09 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.575 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -72.21 -18.67 61.82 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.618 ' CG ' HG13 ' A' ' 21' ' ' VAL . 24.7 tt0 -88.48 -71.96 0.56 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.06 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -47.2 -50.09 21.52 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.166 -1.413 . . . . 0.0 110.349 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.954 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.81 -48.21 30.69 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.354 -1.466 . . . . 0.0 110.361 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -72.97 0.55 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.594 -0.691 . . . . 0.0 109.627 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.34 -29.25 11.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.393 -0.817 . . . . 0.0 110.016 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.868 ' CG ' HD22 ' A' ' 15' ' ' LEU . 8.7 m120 -97.73 -0.97 44.46 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.72 22.39 43.21 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.934 HD12 HD11 ' A' ' 15' ' ' LEU . 4.9 mt . . . . . 0 C--N 1.301 -1.509 0 O-C-N 121.295 -1.121 . . . . 0.0 109.237 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.521 0.676 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.674 ' SG ' HD13 ' A' ' 84' ' ' LEU . 24.9 p -89.13 28.2 1.25 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.472 -0.767 . . . . 0.0 109.879 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.314 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 8.0 t-160 -70.32 126.55 29.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.379 -0.826 . . . . 0.0 110.14 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.803 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -156.14 -173.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.05 -1.031 . . . . 0.0 110.102 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.803 ' N ' HG23 ' A' ' 50' ' ' VAL 0.269 76.9 m-85 -140.92 109.9 6.12 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.656 0.741 . . . . 0.0 110.773 179.295 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.044 ' HB ' HG22 ' A' ' 57' ' ' THR . 4.1 t -76.58 131.64 34.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 O-C-N 120.225 -1.547 . . . . 0.0 110.773 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.809 ' O ' HG23 ' A' ' 57' ' ' THR . 3.7 t30 -47.82 146.28 2.46 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.608 -1.237 . . . . 0.0 108.668 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -59.0 -8.0 1.27 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.058 -1.026 . . . . 0.0 112.072 -178.393 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.57 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -94.76 8.1 43.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.469 -1.394 . . . . 0.0 110.532 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 1.095 ' CB ' HD13 ' A' ' 97' ' ' ILE . 87.3 m-85 -140.14 3.5 1.98 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 109.754 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 1.044 HG22 ' HB ' ' A' ' 52' ' ' VAL . 23.7 p -90.43 -40.54 11.98 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.1 -1.0 . . . . 0.0 108.467 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.92 -0.87 55.4 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.782 0.801 . . . . 0.0 110.438 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.025 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.259 0.2 OUTLIER -99.46 -48.17 4.87 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 123.199 1.476 . . . . 0.0 107.419 179.655 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.064 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.337 0.8 OUTLIER -77.36 -176.82 0.69 Allowed Pre-proline 0 C--N 1.289 -2.039 0 CA-C-N 113.602 -1.635 . . . . 0.0 107.225 179.31 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 1.064 ' HD2' HG13 ' A' ' 60' ' ' VAL . 35.5 Cg_endo -61.99 127.45 21.37 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 CA-C-O 122.885 1.119 . . . . 0.0 111.448 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.572 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -74.05 60.4 0.77 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.824 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 67' ' ' GLU . . . -38.43 107.29 0.06 Allowed 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.476 0.655 . . . . 0.0 109.915 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 66' ' ' ARG . 22.0 p-10 -87.73 -142.38 0.12 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.31 -0.869 . . . . 0.0 111.996 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 64' ' ' ASN . 15.7 pt-20 -29.14 -37.34 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 64' ' ' ASN . 4.3 mtm-85 -53.35 -70.37 0.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.872 -1.142 . . . . 0.0 108.99 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.637 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -59.78 -52.58 64.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 110.188 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.4 mp -45.54 -20.88 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.566 -0.709 . . . . 0.0 111.111 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -86.6 -80.21 1.19 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.593 ' HG3' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -44.06 -39.06 3.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -1.162 . . . . 0.0 108.653 178.728 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.053 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -63.41 -51.96 63.57 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.352 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.562 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -54.63 -24.21 20.5 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.273 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -71.23 -50.79 29.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.666 -0.647 . . . . 0.0 110.326 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.053 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.6 m -39.7 160.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.374 -0.828 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.791 HG22 ' O ' ' A' ' 75' ' ' THR . 20.9 m -120.66 35.27 4.93 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.033 -1.042 . . . . 0.0 109.26 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.314 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -114.98 -163.89 0.91 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.841 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.747 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.13 63.21 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.739 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.854 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.08 152.58 16.38 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 118.989 -2.32 . . . . 0.0 111.763 -177.177 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.689 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.392 1.5 mmtt -133.96 177.73 2.11 Favored Pre-proline 0 C--N 1.292 -1.926 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.662 -173.607 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 44.3 Cg_endo -75.93 -29.38 6.86 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 N-CA-C 107.329 -1.835 . . . . 0.0 107.329 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.709 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.6 OUTLIER -103.82 12.4 34.56 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.631 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.774 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -44.46 148.03 0.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.123 -0.986 . . . . 0.0 109.838 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.897 ' NE ' HD11 ' A' ' 88' ' ' ILE . 1.1 mtt180 -169.67 157.74 7.21 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.733 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.677 HD22 ' HA ' ' A' ' 49' ' ' HIS . 4.4 mt -106.97 116.09 31.32 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 24' ' ' MET . 7.4 p -35.35 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.575 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 4.5 p -65.41 -6.1 9.37 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.294 -1.504 . . . . 0.0 112.127 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.543 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . 35.1 tp60 -125.53 3.24 7.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.421 -1.424 . . . . 0.0 111.655 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.026 HG23 HG11 ' A' ' 60' ' ' VAL . 35.9 mm -100.99 103.4 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.753 -1.217 . . . . 0.0 110.312 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.992 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -90.17 128.63 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.073 -1.017 . . . . 0.0 108.465 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.691 ' HE3' ' HA ' ' A' ' 90' ' ' MET . 22.3 mmm -83.22 134.49 34.95 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.546 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.799 HG23 HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -112.15 170.67 5.03 Favored Pre-proline 0 C--N 1.291 -1.935 0 O-C-N 120.833 -1.167 . . . . 0.0 109.507 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 38.9 Cg_endo -65.86 -11.71 32.04 Favored 'Trans proline' 0 C--N 1.289 -2.58 0 O-C-N 124.525 1.803 . . . . 0.0 110.892 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.612 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.3 OUTLIER -92.37 -29.33 16.38 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 117.729 -1.588 . . . . 0.0 107.835 177.451 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.025 HD21 ' CB ' ' A' ' 59' ' ' LYS . 96.7 mt -89.96 27.48 1.58 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.707 0.765 . . . . 0.0 110.935 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.496 ' HA ' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -63.23 104.79 0.63 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.51 -1.276 . . . . 0.0 107.958 177.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.622 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.78 22.74 1.95 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.123 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -57.83 138.05 19.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.399 -1.059 . . . . 0.0 111.069 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.123 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.1 t -111.36 114.14 46.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.563 ' HB ' ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -98.81 155.17 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.732 -1.23 . . . . 0.0 109.209 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.664 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.93 120.32 33.08 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.358 -0.839 . . . . 0.0 110.251 -178.776 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 69.8 t -96.32 136.79 21.76 Favored Pre-proline 0 C--N 1.287 -2.115 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.789 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.68 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 57.3 Cg_endo -89.48 171.28 4.39 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.063 1.559 . . . . 0.0 111.585 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -91.2 -17.24 26.39 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.681 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.82 73.9 0.85 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.05 57.13 1.07 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.435 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.593 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 1.7 p-90 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.714 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.735 ' O ' HG22 ' A' ' 97' ' ' ILE . 9.1 mtmm . . . . . 0 C--O 1.211 -0.936 0 CA-C-O 121.828 0.823 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.945 ' HA ' HG23 ' A' ' 97' ' ' ILE . 56.0 t -141.17 135.04 31.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 O-C-N 121.152 -0.968 . . . . 0.0 110.983 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.756 HG13 ' HG3' ' A' ' 14' ' ' GLU . 23.6 t -142.6 89.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 118.732 -1.187 . . . . 0.0 110.415 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.656 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 46.2 m-85 -67.92 157.04 35.89 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.466 -0.772 . . . . 0.0 109.331 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 101' ' ' VAL . 99.7 t -122.54 169.98 13.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 O-C-N 121.178 -0.951 . . . . 0.0 109.291 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.595 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 9.9 p -102.61 -153.26 0.46 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.06 -1.025 . . . . 0.0 109.217 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.574 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -93.51 -29.44 15.53 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 178.093 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -91.81 -9.97 41.54 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.498 0.666 . . . . 0.0 109.452 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.529 ' O ' ' CD ' ' A' ' 12' ' ' ARG . . . 114.57 -5.69 22.83 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 120.3 -0.953 . . . . 0.0 111.145 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -63.54 130.56 44.87 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.288 -1.713 . . . . 0.0 107.924 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.539 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.74 176.08 5.7 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 122.257 1.027 . . . . 0.0 112.927 -177.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -133.02 178.9 6.53 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 177.599 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.756 ' HG3' HG13 ' A' ' 4' ' ' VAL . 46.2 mp0 -151.75 110.32 3.8 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 117.56 -1.656 . . . . 0.0 111.109 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.002 HD21 ' CD1' ' A' ' 32' ' ' ILE . 8.3 mt -103.17 -156.33 0.56 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.592 1.187 . . . . 0.0 110.618 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -153.02 70.35 0.87 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.061 HG12 ' HB ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -89.66 127.84 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.003 0.906 . . . . 0.0 109.627 -177.067 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.25 -179.27 5.84 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.259 1.028 . . . . 0.0 112.858 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -62.24 119.18 8.52 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.696 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 112.05 -22.14 19.01 Favored Glycine 0 C--N 1.288 -2.119 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.555 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.061 ' HB ' HG12 ' A' ' 17' ' ' VAL . 65.8 t -90.77 150.64 3.68 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.209 0 O-C-N 120.116 -1.814 . . . . 0.0 109.505 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.482 ' N ' HG12 ' A' ' 21' ' ' VAL . 1.2 p -96.61 132.14 42.54 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.781 HD22 HG11 ' A' ' 3' ' ' VAL . 7.9 mt -46.96 -28.44 1.62 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.705 -1.247 . . . . 0.0 108.436 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.553 ' CB ' ' O ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -73.91 -12.02 60.53 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.323 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.472 ' HB3' ' O ' ' A' ' 22' ' ' SER . 5.6 tt0 -91.84 -61.22 1.68 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.756 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -54.39 -55.53 27.72 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.375 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.927 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.42 -51.0 21.38 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.561 -1.337 . . . . 0.0 110.446 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -65.41 -5.61 2.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 109.333 179.009 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 26' ' ' ALA 0.256 0.0 OUTLIER -103.3 -24.0 13.55 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.731 0.777 . . . . 0.0 110.065 179.838 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.761 ' CG ' HD22 ' A' ' 15' ' ' LEU . 8.1 m120 -96.75 5.45 50.59 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.72 78.44 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.002 ' CD1' HD21 ' A' ' 15' ' ' LEU . 10.5 mt . . . . . 0 C--N 1.303 -1.444 0 O-C-N 121.317 -1.107 . . . . 0.0 109.213 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.444 0.64 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 1.023 ' HB2' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -107.06 14.73 26.02 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.475 -0.765 . . . . 0.0 109.66 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.291 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 11.5 t-160 -70.23 123.76 22.47 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.276 -0.89 . . . . 0.0 111.714 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.802 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.5 m -158.34 -174.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.729 0.776 . . . . 0.0 109.129 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.881 ' OH ' HD22 ' A' ' 78' ' ' LEU 0.252 68.0 m-85 -140.84 102.57 4.31 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.019 0.914 . . . . 0.0 110.66 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.076 ' HB ' HG22 ' A' ' 57' ' ' THR . 2.7 t -74.19 134.13 30.18 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 O-C-N 120.69 -1.256 . . . . 0.0 110.491 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.881 ' O ' HG23 ' A' ' 57' ' ' THR . 3.7 t30 -48.8 150.33 1.5 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.302 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.6 pt-20 -60.35 -8.1 2.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.246 -0.909 . . . . 0.0 111.909 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.578 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.78 9.41 43.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.628 -1.295 . . . . 0.0 110.758 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 1.121 ' CB ' HD13 ' A' ' 97' ' ' ILE . 88.0 m-85 -140.51 2.03 1.8 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.051 -1.03 . . . . 0.0 110.119 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 1.076 HG22 ' HB ' ' A' ' 52' ' ' VAL . 7.6 p -90.45 -40.21 12.16 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.015 -1.053 . . . . 0.0 108.36 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.39 -0.31 52.69 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.688 0.756 . . . . 0.0 110.699 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.046 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.265 1.1 mtpp -99.22 -48.49 4.81 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 123.303 1.525 . . . . 0.0 107.085 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.061 HG11 HD13 ' A' ' 88' ' ' ILE 0.334 0.9 OUTLIER -72.8 179.48 1.09 Allowed Pre-proline 0 C--N 1.288 -2.083 0 CA-C-N 113.436 -1.711 . . . . 0.0 106.472 178.431 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 1.046 ' HD2' HG13 ' A' ' 60' ' ' VAL . 36.6 Cg_endo -70.21 113.07 3.33 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 CA-C-O 122.834 1.098 . . . . 0.0 111.155 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.3 67.61 1.42 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.225 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.666 ' HB2' ' HG3' ' A' ' 87' ' ' GLN . . . -37.45 156.6 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.954 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 66' ' ' ARG . 5.9 p30 -92.37 -161.96 0.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.017 -1.052 . . . . 0.0 112.399 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 4.0 pt-20 -38.1 -24.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.987 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -52.76 -72.3 0.06 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.65 -1.281 . . . . 0.0 107.949 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.718 ' HA ' ' HE3' ' A' ' 70' ' ' MET . 0.5 OUTLIER -68.36 -40.88 81.33 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.554 -0.716 . . . . 0.0 109.298 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.635 HD12 ' CD ' ' A' ' 67' ' ' GLU . 1.1 mp -57.94 -16.89 7.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.111 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.51 ' HA2' ' OE1' ' A' ' 72' ' ' GLU . . . -97.01 -68.35 0.96 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.718 ' HE3' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -42.44 -38.9 2.04 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.126 -1.22 . . . . 0.0 108.065 179.463 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.121 HD11 ' CB ' ' A' ' 82' ' ' SER 0.261 0.0 OUTLIER -65.34 -50.51 65.31 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.883 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.515 ' OE2' ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -67.04 -29.84 69.75 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.515 ' N ' ' OE2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -61.11 -38.92 88.04 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.023 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.186 HG21 ' CD2' ' A' ' 49' ' ' HIS . 1.4 m -53.2 168.81 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 75' ' ' THR . 17.0 m -120.74 54.48 1.07 Allowed 'General case' 0 C--N 1.287 -2.145 0 O-C-N 120.483 -1.386 . . . . 0.0 110.014 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.291 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -126.17 -154.64 0.64 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 115.151 -2.62 . . . . 0.0 112.211 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.733 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.262 0.0 OUTLIER -63.88 60.38 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 122.702 1.239 . . . . 0.0 108.472 -179.558 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.009 HD13 ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -59.23 132.72 54.85 Favored 'General case' 0 C--N 1.288 -2.09 0 O-C-N 119.63 -1.919 . . . . 0.0 110.375 -177.09 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.546 ' CD ' ' HG3' ' A' ' 77' ' ' GLU 0.365 0.0 OUTLIER -116.01 -179.4 0.62 Allowed Pre-proline 0 C--N 1.291 -1.975 0 CA-C-N 112.666 -2.061 . . . . 0.0 111.798 -174.13 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -79.12 -28.79 3.58 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 N-CA-C 106.82 -2.031 . . . . 0.0 106.82 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.693 ' HB2' HG21 ' A' ' 57' ' ' THR . 14.8 p-10 -108.68 14.68 24.26 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.98 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 1.121 ' CB ' HD11 ' A' ' 71' ' ' LEU . 2.7 m -47.8 -175.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.537 -0.727 . . . . 0.0 109.68 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.601 ' HB2' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -174.89 169.27 3.47 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 116.434 -2.106 . . . . 0.0 114.72 178.473 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.023 HD13 ' HB2' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -115.72 103.12 10.37 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.661 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.596 ' SG ' ' HB3' ' A' ' 48' ' ' CYS . 0.7 OUTLIER -31.92 -31.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.819 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 84' ' ' LEU . 29.6 p -84.48 12.07 7.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.053 -1.654 . . . . 0.0 112.247 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.666 ' HG3' ' HB2' ' A' ' 63' ' ' ALA . 5.1 tp60 -126.33 21.62 7.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.588 -1.32 . . . . 0.0 111.836 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.061 HD13 HG11 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -120.12 105.15 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.736 -1.227 . . . . 0.0 110.678 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.945 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -90.76 132.39 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.923 -1.11 . . . . 0.0 109.37 179.085 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.984 ' SD ' HG21 ' A' ' 97' ' ' ILE . 1.3 tpt -82.83 117.56 22.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.653 -0.654 . . . . 0.0 111.348 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.754 HG23 HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -98.77 176.15 2.13 Favored Pre-proline 0 N--CA 1.496 1.849 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.779 178.525 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 45.3 Cg_endo -78.56 -9.0 16.09 Favored 'Trans proline' 0 C--N 1.293 -2.353 0 O-C-N 124.564 1.823 . . . . 0.0 110.262 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.612 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.6 OUTLIER -92.72 -29.72 15.91 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.046 HD21 ' CB ' ' A' ' 59' ' ' LYS . 85.9 mt -89.68 28.47 1.31 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.738 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.417 ' O ' ' CG ' ' A' ' 95' ' ' ASP . 17.9 p-10 -63.45 105.73 0.81 Allowed 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 118.513 -1.275 . . . . 0.0 108.621 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.666 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 125.04 16.99 2.83 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.523 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.121 HD13 ' CB ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -51.71 142.17 4.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.606 -0.938 . . . . 0.0 111.715 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.087 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.1 t -115.67 111.43 35.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.599 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -99.06 153.05 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 120.735 -1.228 . . . . 0.0 109.853 -178.542 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.675 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.76 127.88 49.74 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.791 -179.118 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 54.5 t -98.24 139.8 21.45 Favored Pre-proline 0 C--N 1.288 -2.07 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.722 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.6 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 56.2 Cg_endo -90.53 174.81 2.83 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.818 1.679 . . . . 0.0 111.886 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 11.1 p-10 -91.3 -17.72 25.48 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.905 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -111.34 67.86 0.65 Allowed 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -97.5 49.88 1.05 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.326 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.607 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 11.0 p-90 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.282 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.762 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.204 -1.318 0 CA-C-O 121.356 0.598 . . . . 0.0 110.057 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.933 HG22 ' CG2' ' A' ' 97' ' ' ILE . 44.8 t -134.39 133.07 55.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.843 0.83 . . . . 0.0 111.073 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 13' ' ' ARG . 56.4 t -142.29 89.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.531 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.681 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 40.9 m-85 -67.79 135.82 53.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.574 HG13 ' HG2' ' A' ' 12' ' ' ARG . 59.3 t -99.65 167.09 2.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 O-C-N 120.546 -1.346 . . . . 0.0 109.664 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.587 ' HB3' HG22 ' A' ' 11' ' ' THR . 89.6 p -102.3 -153.99 0.48 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 109.335 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.594 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -88.99 -33.09 17.31 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.477 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 10.5 p-10 -91.63 -3.88 55.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.736 -0.603 . . . . 0.0 109.883 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.11 -24.42 11.67 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.587 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.79 128.83 28.02 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.609 -1.524 . . . . 0.0 108.38 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.574 ' HG2' HG13 ' A' ' 6' ' ' VAL . 20.8 mtm180 -121.35 -171.77 2.28 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 122.162 0.982 . . . . 0.0 112.474 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.657 ' HE ' HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.36 -179.08 5.42 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 178.296 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -152.0 109.58 3.62 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 117.447 -1.701 . . . . 0.0 111.201 178.412 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.974 HD11 ' HA ' ' A' ' 27' ' ' ALA . 6.6 mt -105.06 -157.07 0.59 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.639 1.209 . . . . 0.0 110.583 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -153.27 70.81 0.87 Allowed 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.05 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.2 t -88.34 127.39 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.736 0.779 . . . . 0.0 109.592 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.0 -178.16 5.63 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.618 1.199 . . . . 0.0 112.987 -177.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.51 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 1.5 p30 -61.15 116.12 4.31 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.829 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.685 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 111.89 -20.86 21.57 Favored Glycine 0 C--N 1.287 -2.162 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.524 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.05 ' HB ' HG12 ' A' ' 17' ' ' VAL . 90.3 t -89.21 150.5 3.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 120.1 -1.823 . . . . 0.0 109.306 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 25' ' ' GLN . 1.6 p -96.01 125.61 40.67 Favored 'General case' 0 C--N 1.274 -2.684 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.752 ' CD2' HG21 ' A' ' 17' ' ' VAL . 4.4 mt -43.05 -24.33 0.07 Allowed 'General case' 0 C--O 1.203 -1.382 0 O-C-N 120.73 -1.231 . . . . 0.0 109.265 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.607 ' O ' ' HB ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -64.43 -47.58 78.58 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' SER . 10.5 tt0 -59.84 -65.51 0.67 Allowed 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.905 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.61 -60.04 2.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.911 -1.118 . . . . 0.0 110.581 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.974 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.72 -54.69 11.42 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.751 -1.218 . . . . 0.0 110.848 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -63.92 -6.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.544 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.254 0.0 OUTLIER -99.25 -25.97 14.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.303 -0.873 . . . . 0.0 109.817 179.708 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.797 ' CG ' HD22 ' A' ' 15' ' ' LEU . 8.1 m120 -96.93 3.93 51.84 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.81 72.81 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.971 ' CD1' HD21 ' A' ' 15' ' ' LEU . 9.0 mt . . . . . 0 C--N 1.302 -1.495 0 O-C-N 121.479 -1.012 . . . . 0.0 109.488 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.448 0.642 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.524 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 9.4 p -115.32 29.69 7.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.456 -0.777 . . . . 0.0 109.895 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.325 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 6.5 t-160 -70.21 125.98 28.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.745 . . . . 0.0 110.116 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.804 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -155.3 -173.66 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.0 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.804 ' N ' HG23 ' A' ' 50' ' ' VAL 0.269 82.9 m-85 -140.41 114.13 8.82 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.624 0.726 . . . . 0.0 110.754 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.019 ' HB ' HG22 ' A' ' 57' ' ' THR . 5.5 t -85.19 130.66 35.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 O-C-N 120.28 -1.513 . . . . 0.0 109.504 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.934 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -40.75 157.2 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.675 -1.265 . . . . 0.0 109.294 177.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.1 0.37 7.79 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.844 -1.16 . . . . 0.0 110.209 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.59 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.1 5.29 47.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.948 -1.095 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.831 ' CB ' HD13 ' A' ' 97' ' ' ILE . 55.0 m-85 -140.48 5.44 2.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.901 -1.124 . . . . 0.0 109.443 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 1.019 HG22 ' HB ' ' A' ' 52' ' ' VAL . 30.4 p -89.58 -38.02 14.27 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -2.45 44.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.828 0.823 . . . . 0.0 110.39 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.077 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.259 0.2 OUTLIER -99.21 -47.96 5.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 179.708 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.037 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.334 1.1 t -80.4 175.03 5.22 Favored Pre-proline 0 C--N 1.288 -2.071 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 177.403 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 1.037 ' HD2' HG13 ' A' ' 60' ' ' VAL . 38.3 Cg_endo -74.54 110.79 3.17 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 CA-C-O 122.877 1.115 . . . . 0.0 112.934 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.497 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -75.43 75.55 2.5 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.356 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.73 ' HB3' ' CB ' ' A' ' 67' ' ' GLU . . . -37.04 160.32 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.874 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 66' ' ' ARG . 6.1 p30 -96.99 -160.7 0.82 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.247 -0.908 . . . . 0.0 112.336 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -28.74 -39.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 122.025 -0.422 . . . . 0.0 112.074 -178.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 64' ' ' ASN . 3.6 mtt180 -53.19 -66.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.569 -1.332 . . . . 0.0 108.488 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.829 ' HA ' ' HE2' ' A' ' 70' ' ' MET . 0.8 OUTLIER -59.25 -35.13 73.14 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.579 -0.701 . . . . 0.0 109.86 178.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.7 mp -77.24 -9.04 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.224 -0.922 . . . . 0.0 110.278 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -84.23 -80.81 1.05 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.829 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.82 -36.56 2.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.164 -1.198 . . . . 0.0 108.728 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.994 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -64.62 -48.54 74.5 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.419 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.535 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 3.1 tp10 -61.36 -16.18 43.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.481 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -85.72 -40.51 16.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.695 -0.628 . . . . 0.0 110.459 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.994 HG22 ' O ' ' A' ' 71' ' ' LEU . 8.1 m -40.38 162.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.387 -0.821 . . . . 0.0 109.639 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 75' ' ' THR . 23.0 m -120.48 30.0 7.16 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.193 -0.942 . . . . 0.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.325 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -113.85 -167.96 1.28 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.755 -1.178 . . . . 0.0 112.465 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.738 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.14 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.819 -179.012 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.924 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.48 153.56 15.71 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 118.903 -2.373 . . . . 0.0 111.165 -177.16 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.535 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.347 0.0 OUTLIER -128.46 -178.18 0.75 Allowed Pre-proline 0 C--N 1.297 -1.703 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.329 -174.792 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 45.6 Cg_endo -78.75 -28.36 4.22 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 N-CA-C 106.985 -1.967 . . . . 0.0 106.985 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.6 ' CG ' HG21 ' A' ' 57' ' ' THR . 0.7 OUTLIER -108.11 16.24 23.5 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.089 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.826 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -43.72 149.37 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.922 -1.111 . . . . 0.0 108.932 -179.388 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.947 ' HB2' HG23 ' A' ' 52' ' ' VAL . 2.3 mmt85 -154.55 146.07 23.14 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.604 -1.638 . . . . 0.0 112.403 -177.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -103.67 88.71 3.13 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 177.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 24' ' ' MET . 5.7 t -17.03 -45.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.608 ' SG ' ' NE2' ' A' ' 87' ' ' GLN . 1.6 p -44.26 -19.31 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.611 -1.305 . . . . 0.0 112.236 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.608 ' NE2' ' SG ' ' A' ' 86' ' ' CYS . 13.5 mp0 -118.88 -4.72 10.64 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.254 -1.529 . . . . 0.0 112.081 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.634 HG23 HG11 ' A' ' 60' ' ' VAL . 3.2 mm -79.76 98.25 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.779 -1.201 . . . . 0.0 109.046 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.971 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -84.11 130.42 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.002 -1.061 . . . . 0.0 109.02 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.642 ' HE1' ' HB3' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -83.31 125.16 31.33 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.692 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.902 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -101.42 -177.67 0.58 Allowed Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 118.111 -1.436 . . . . 0.0 109.005 177.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.61 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 47.6 Cg_endo -89.07 -14.71 2.67 Favored 'Trans proline' 0 C--N 1.291 -2.453 0 O-C-N 124.483 1.781 . . . . 0.0 108.713 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.512 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.1 pt-20 -82.26 -31.47 30.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.077 HD21 ' CB ' ' A' ' 59' ' ' LYS . 52.4 mt -89.72 34.85 0.83 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.053 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -62.65 107.16 0.9 Allowed 'General case' 0 C--N 1.29 -2.013 0 O-C-N 120.365 -1.459 . . . . 0.0 109.092 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.444 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 122.24 25.67 1.98 Allowed Glycine 0 N--CA 1.497 2.761 0 O-C-N 120.835 -1.165 . . . . 0.0 110.71 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.117 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -59.1 135.97 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.971 -1.311 . . . . 0.0 110.6 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.117 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.4 t -115.77 111.74 36.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -99.5 156.5 3.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.88 -178.766 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.694 ' N ' ' O ' ' A' ' 51' ' ' TYR . 1.1 m-20 -122.9 125.95 46.34 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.306 -0.871 . . . . 0.0 110.413 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.589 HG12 ' CE1' ' A' ' 8' ' ' HIS . 56.1 t -103.61 130.31 23.75 Favored Pre-proline 0 C--N 1.289 -2.039 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.692 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.742 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 56.7 Cg_endo -84.23 173.84 8.55 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 124.296 1.682 . . . . 0.0 112.077 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.44 ' CG ' ' HB3' ' A' ' 8' ' ' HIS . 1.3 m-20 -91.34 -18.31 24.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.792 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.91 73.75 0.84 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.479 ' HG2' ' HD2' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -98.64 55.63 1.08 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 118.994 -1.083 . . . . 0.0 110.132 -177.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.582 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 1.4 p-90 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.92 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.809 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.202 -1.429 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.878 ' HA ' HG23 ' A' ' 97' ' ' ILE . 78.6 t -137.69 130.08 41.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 122.287 1.042 . . . . 0.0 110.711 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.659 HG13 ' HG2' ' A' ' 14' ' ' GLU . 85.8 t -141.42 96.5 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.917 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.294 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.675 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 21.6 m-85 -76.89 151.63 35.72 Favored 'General case' 0 C--O 1.201 -1.486 0 O-C-N 121.64 -0.663 . . . . 0.0 109.747 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 89.9 t -111.31 166.85 5.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 O-C-N 121.046 -1.034 . . . . 0.0 110.368 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 11' ' ' THR . 85.8 p -103.77 -157.21 0.6 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.131 -0.98 . . . . 0.0 109.261 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.545 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -91.04 -27.13 18.82 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.512 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -92.1 -8.23 46.37 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.734 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 113.47 -9.35 24.22 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.58 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.6 OUTLIER -66.54 136.17 55.25 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 119.914 -1.933 . . . . 0.0 108.758 179.599 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -120.5 179.66 4.25 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.251 1.024 . . . . 0.0 112.974 -176.799 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.667 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -134.58 173.27 11.84 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 179.589 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.669 ' C ' HD23 ' A' ' 15' ' ' LEU . 16.3 mt-10 -150.15 114.84 5.27 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 117.111 -1.836 . . . . 0.0 111.047 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.975 HD11 ' HA ' ' A' ' 27' ' ' ALA 0.28 4.6 mt -107.92 -154.03 0.52 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.462 1.125 . . . . 0.0 109.845 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.32 72.04 0.92 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.983 HG22 ' CB ' ' A' ' 26' ' ' ALA . 1.4 t -88.31 126.41 41.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-O 121.786 0.803 . . . . 0.0 109.022 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.629 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.44 -179.51 5.84 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.817 0.817 . . . . 0.0 112.777 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.68 ' HB3' ' CD ' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -56.75 112.44 1.3 Allowed 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.56 177.091 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.72 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 112.81 -21.54 18.31 Favored Glycine 0 C--N 1.282 -2.464 0 C-N-CA 118.702 -1.713 . . . . 0.0 113.003 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.94 ' HB ' HG12 ' A' ' 17' ' ' VAL . 66.7 t -86.2 147.87 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 120.677 2.239 . . . . 0.0 108.059 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -95.38 130.34 42.21 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.522 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.736 HD21 ' HG2' ' A' ' 90' ' ' MET . 11.0 mt -44.87 -25.79 0.34 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.015 -1.678 . . . . 0.0 109.782 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.552 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -67.41 -23.18 65.53 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.3 tt0 -88.09 -65.43 1.02 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.983 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.42 -49.86 17.51 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.281 -1.368 . . . . 0.0 111.383 178.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.975 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -55.2 -50.0 70.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.184 -1.573 . . . . 0.0 110.173 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.7 OUTLIER -67.32 -1.19 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.73 -1.231 . . . . 0.0 110.569 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . 0.265 0.0 OUTLIER -104.33 -31.15 9.68 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.311 1.053 . . . . 0.0 109.655 -178.665 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.717 ' CG ' HD22 ' A' ' 15' ' ' LEU . 9.3 m120 -95.82 4.16 53.1 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.17 12.58 63.2 Favored Glycine 0 N--CA 1.505 3.273 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.536 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.907 ' CD1' HD21 ' A' ' 15' ' ' LEU . 7.9 mt . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.564 -0.962 . . . . 0.0 109.681 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.683 0.754 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' ' 84' ' ' LEU . 6.8 p -99.68 30.04 3.82 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.616 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.305 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 9.0 t-160 -69.81 123.25 20.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.518 -0.739 . . . . 0.0 110.842 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.756 HG22 ' O ' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -155.32 -172.35 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 120.808 -1.182 . . . . 0.0 108.399 178.639 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.741 ' N ' HG23 ' A' ' 50' ' ' VAL 0.301 79.8 m-85 -139.78 109.13 6.14 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.351 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.001 ' HB ' HG22 ' A' ' 57' ' ' THR . 7.1 t -76.94 129.42 37.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 O-C-N 120.566 -1.334 . . . . 0.0 110.553 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.782 HD21 ' HB2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -42.75 146.22 0.39 Allowed 'General case' 0 C--N 1.307 -1.251 0 O-C-N 120.163 -1.586 . . . . 0.0 109.411 176.646 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.14 -9.48 0.92 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.361 -0.837 . . . . 0.0 111.956 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.631 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -92.15 7.77 40.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.041 -1.662 . . . . 0.0 112.281 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.782 ' HB2' HD21 ' A' ' 53' ' ' ASN . 77.1 m-85 -141.08 3.71 1.81 Allowed 'General case' 0 N--CA 1.516 2.857 0 O-C-N 120.535 -1.353 . . . . 0.0 108.759 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 1.027 HG21 ' HB2' ' A' ' 81' ' ' ASN . 17.0 p -89.4 -33.25 16.92 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.157 -0.965 . . . . 0.0 108.618 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.38 -1.76 24.67 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.94 0.876 . . . . 0.0 111.084 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.993 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.286 0.1 OUTLIER -97.63 -48.31 5.29 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 179.187 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.058 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.339 1.0 OUTLIER -77.44 177.75 2.52 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.699 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 1.058 ' HD2' HG13 ' A' ' 60' ' ' VAL . 32.5 Cg_endo -71.6 122.56 8.69 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 CA-C-O 122.632 1.013 . . . . 0.0 111.731 -177.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -77.17 73.57 3.75 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.36 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.625 ' HB1' ' HG2' ' A' ' 87' ' ' GLN . . . -37.71 157.59 0.01 OUTLIER 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.326 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.449 ' OD1' ' HB2' ' A' ' 66' ' ' ARG . 48.1 p30 -90.0 -168.7 2.2 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 123.157 1.456 . . . . 0.0 112.49 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -37.4 -30.43 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.237 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.482 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -55.28 -63.43 1.16 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.365 -1.459 . . . . 0.0 107.568 179.247 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.842 ' HA ' ' HE2' ' A' ' 70' ' ' MET . 8.0 tp10 -60.72 -41.0 94.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.823 -0.548 . . . . 0.0 110.421 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 65' ' ' GLU . 59.9 mt -79.75 -5.22 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.933 . . . . 0.0 110.906 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -86.93 -75.71 1.27 Allowed Glycine 0 N--CA 1.482 1.753 0 N-CA-C 107.629 -2.188 . . . . 0.0 107.629 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.842 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.52 -43.36 5.44 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.629 -1.228 . . . . 0.0 107.913 178.516 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.956 ' O ' HG22 ' A' ' 74' ' ' VAL 0.25 0.6 OUTLIER -56.96 -53.78 54.13 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.34 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -56.0 -24.94 41.92 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.707 -1.245 . . . . 0.0 108.358 178.369 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -74.05 -47.16 38.6 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.704 -179.362 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.956 HG22 ' O ' ' A' ' 71' ' ' LEU . 3.3 m -36.19 161.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 121.972 0.891 . . . . 0.0 111.186 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.83 HG22 ' O ' ' A' ' 75' ' ' THR . 30.2 m -118.45 25.9 9.97 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.456 -1.403 . . . . 0.0 109.973 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.305 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -103.46 -153.66 0.48 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.102 -1.624 . . . . 0.0 113.283 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.753 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.25 0.0 OUTLIER -71.05 63.15 0.31 Allowed 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.897 -178.41 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.774 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -57.39 154.97 9.86 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 116.218 -2.193 . . . . 0.0 110.317 -176.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.681 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.375 20.4 mmtt -134.02 178.89 1.55 Allowed Pre-proline 0 C--N 1.294 -1.831 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.253 -173.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 55.2 Cg_endo -77.3 -28.38 5.76 Favored 'Trans proline' 0 C--N 1.295 -2.27 0 N-CA-C 104.742 -2.83 . . . . 0.0 104.742 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 1.027 ' HB2' HG21 ' A' ' 57' ' ' THR . 13.3 p-10 -105.13 14.57 28.96 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.611 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.833 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -47.26 146.6 1.85 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.853 -1.155 . . . . 0.0 109.499 178.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.756 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 mmm-85 -169.1 122.8 0.81 Allowed 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 117.661 -1.616 . . . . 0.0 111.99 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -80.72 112.97 18.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.041 -1.662 . . . . 0.0 108.298 176.44 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 24' ' ' MET . 5.5 m -35.09 -23.55 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.552 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 9.7 p -64.08 -12.71 41.6 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 119.222 -2.174 . . . . 0.0 111.056 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.625 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -120.67 18.36 11.95 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.731 -1.188 . . . . 0.0 111.366 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 88' ' ' ILE . 3.5 mm -110.07 102.75 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.126 -0.984 . . . . 0.0 110.406 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -84.25 126.55 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 120.967 -1.083 . . . . 0.0 110.418 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.894 ' SD ' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -82.53 123.47 29.22 Favored 'General case' 0 C--O 1.2 -1.526 0 O-C-N 120.81 -1.181 . . . . 0.0 109.236 177.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.594 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -113.92 157.39 42.05 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.181 178.772 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.68 ' CD ' ' HB3' ' A' ' 19' ' ' ASP . 33.8 Cg_endo -58.06 -27.45 79.69 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 124.444 1.76 . . . . 0.0 109.07 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.594 ' HG2' ' HB ' ' A' ' 91' ' ' THR . 3.0 pt-20 -64.4 -42.85 95.86 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.176 176.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.001 HD13 HG23 ' A' ' 60' ' ' VAL . 50.8 mt -88.51 38.79 0.88 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.729 0.776 . . . . 0.0 112.469 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -64.6 111.1 2.57 Favored 'General case' 0 C--N 1.286 -2.185 0 O-C-N 119.867 -1.771 . . . . 0.0 109.167 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.676 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.44 21.69 2.2 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.176 -1.488 . . . . 0.0 110.425 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.146 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -60.34 136.98 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.054 -1.262 . . . . 0.0 110.297 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.146 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.5 t -117.15 113.2 42.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.576 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -101.16 156.67 4.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 120.262 -1.524 . . . . 0.0 109.886 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.624 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.48 130.05 52.65 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 122.571 1.177 . . . . 0.0 111.276 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 6' ' ' VAL . 87.2 t -104.89 136.65 19.13 Favored Pre-proline 0 C--N 1.283 -2.307 0 O-C-N 120.743 -1.223 . . . . 0.0 109.833 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.611 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 73.8 Cg_endo -92.61 166.85 2.75 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.807 1.671 . . . . 0.0 111.126 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -86.94 -18.09 31.59 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.706 0.765 . . . . 0.0 109.248 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.662 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -109.47 73.09 0.83 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.573 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.26 57.92 0.81 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.975 -1.078 . . . . 0.0 109.695 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.6 ' CD2' ' O ' ' A' ' 106' ' ' TRP . 3.3 p-90 . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.618 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.821 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.204 -1.318 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.965 HG22 HG21 ' A' ' 97' ' ' ILE . 40.4 t -135.47 135.83 51.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-O 121.748 0.785 . . . . 0.0 111.914 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 13' ' ' ARG . 47.4 t -142.67 88.5 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.496 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 46.4 m-85 -67.53 136.0 53.88 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.414 -0.804 . . . . 0.0 109.336 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.565 HG13 ' HG2' ' A' ' 12' ' ' ARG . 60.7 t -99.77 166.62 2.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 O-C-N 120.662 -1.274 . . . . 0.0 109.513 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.612 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 87.9 p -100.53 -155.28 0.5 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.141 -0.975 . . . . 0.0 109.029 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.615 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -89.7 -30.17 18.25 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.689 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.79 -6.18 52.21 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.388 0.613 . . . . 0.0 109.81 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.37 -24.92 10.91 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.593 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.71 129.16 28.77 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.689 -1.477 . . . . 0.0 108.237 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.565 ' HG2' HG13 ' A' ' 6' ' ' VAL . 2.5 mtm180 -121.42 -173.13 2.56 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-O 122.211 1.005 . . . . 0.0 112.528 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.599 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -134.94 -177.65 4.73 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 80.0 mt-10 -151.83 109.41 3.62 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.495 -1.682 . . . . 0.0 111.518 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.046 HD11 ' HA ' ' A' ' 27' ' ' ALA . 7.7 mt -106.63 -173.9 2.41 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.452 1.12 . . . . 0.0 110.889 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.62 68.86 1.44 Allowed 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.038 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.6 t -87.72 126.33 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.096 0.95 . . . . 0.0 109.311 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.514 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.29 178.47 6.33 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.124 0.964 . . . . 0.0 112.887 -177.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.584 ' HB3' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -52.21 129.94 29.21 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.215 1.007 . . . . 0.0 109.288 177.38 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.522 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 94.68 -20.93 46.07 Favored Glycine 0 C--N 1.276 -2.802 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.551 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.038 ' HB ' HG12 ' A' ' 17' ' ' VAL . 84.9 t -83.96 149.81 4.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 CA-C-N 120.843 2.322 . . . . 0.0 109.523 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -96.01 122.85 39.27 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.469 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.837 HD22 HG21 ' A' ' 17' ' ' VAL . 1.9 mt -46.33 -24.73 0.52 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.277 -1.514 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.553 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -70.33 -11.6 61.02 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.928 0.871 . . . . 0.0 108.756 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -97.83 -63.41 1.13 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.039 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.867 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -47.36 -58.96 3.55 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.975 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.046 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.76 -53.04 16.49 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.581 -1.324 . . . . 0.0 110.474 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -66.1 -3.52 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 109.526 179.091 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.442 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.255 0.0 OUTLIER -103.15 -24.99 13.54 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.833 0.825 . . . . 0.0 110.149 179.851 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.719 ' CG ' HD22 ' A' ' 15' ' ' LEU . 8.1 m120 -97.02 4.94 51.22 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.61 11.12 75.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.966 ' CD1' HD21 ' A' ' 15' ' ' LEU . 9.2 mt . . . . . 0 C--N 1.302 -1.492 0 O-C-N 121.364 -1.08 . . . . 0.0 109.309 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 105' ' ' GLN . 8.6 t . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.386 0.612 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.545 ' O ' HG13 ' A' ' 50' ' ' VAL . 25.4 p -88.64 26.41 1.5 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.476 -0.765 . . . . 0.0 110.12 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.323 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 6.1 t-160 -70.12 123.26 21.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.427 -0.796 . . . . 0.0 109.878 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.813 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -150.13 -170.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.095 -1.003 . . . . 0.0 109.807 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.838 ' CD1' ' HG3' ' A' ' 79' ' ' LYS . 75.2 m-85 -140.45 107.62 5.49 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.938 0.875 . . . . 0.0 110.762 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.015 ' HB ' HG22 ' A' ' 57' ' ' THR . 6.2 t -80.92 131.96 32.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 O-C-N 120.699 -1.251 . . . . 0.0 109.698 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.943 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -42.88 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.089 177.644 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -72.05 0.03 10.5 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.038 -1.039 . . . . 0.0 110.148 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.605 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.09 5.34 47.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.094 -1.004 . . . . 0.0 111.088 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.816 ' CB ' HD13 ' A' ' 97' ' ' ILE . 59.4 m-85 -140.62 5.12 1.99 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.762 -1.211 . . . . 0.0 109.415 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 1.026 HG21 ' HB2' ' A' ' 81' ' ' ASN . 35.3 p -89.74 -38.27 13.96 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -2.24 39.39 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.737 0.78 . . . . 0.0 110.76 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.059 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.262 0.1 OUTLIER -99.06 -47.46 5.22 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.659 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.083 HG23 HD13 ' A' ' 94' ' ' LEU 0.338 1.0 OUTLIER -78.25 176.76 3.3 Favored Pre-proline 0 C--N 1.285 -2.196 0 CA-C-N 113.371 -1.741 . . . . 0.0 106.392 178.312 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 1.019 ' HD2' HG13 ' A' ' 60' ' ' VAL . 39.9 Cg_endo -73.83 96.27 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 CA-C-O 122.59 0.996 . . . . 0.0 112.155 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.531 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -66.54 67.49 0.06 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.428 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.881 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . . . -37.17 152.93 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.281 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 66' ' ' ARG . 19.7 p-10 -88.17 -147.6 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.127 -0.983 . . . . 0.0 111.868 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 69' ' ' GLY . 17.7 pt-20 -28.98 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.193 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.503 ' HA ' ' NE ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -53.29 -70.5 0.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.807 -1.183 . . . . 0.0 108.982 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 1.071 ' HG2' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.26 -32.42 69.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.577 -0.702 . . . . 0.0 109.269 178.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 1.071 HD12 ' HG2' ' A' ' 67' ' ' GLU . 1.2 mp -77.64 -10.82 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 110.826 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -89.24 -79.27 1.32 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.693 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.27 -30.14 0.47 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -1.177 . . . . 0.0 108.668 179.535 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.997 ' O ' HG22 ' A' ' 74' ' ' VAL . 1.1 tm? -74.84 -50.73 16.08 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.567 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 8.1 tp10 -58.44 -22.72 55.39 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 108.777 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.513 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -80.99 -40.78 23.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.675 -0.641 . . . . 0.0 110.686 -179.487 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.997 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.7 m -40.06 162.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.436 -0.79 . . . . 0.0 109.754 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.823 HG22 ' O ' ' A' ' 75' ' ' THR . 21.7 m -120.63 32.38 6.02 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.114 -0.991 . . . . 0.0 108.965 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.323 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -115.27 -167.24 1.21 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.686 1.231 . . . . 0.0 112.728 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.761 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.19 62.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.996 -178.677 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.945 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.43 154.86 12.97 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 118.729 -2.482 . . . . 0.0 110.997 -177.729 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.838 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.382 0.5 OUTLIER -133.15 177.17 2.38 Favored Pre-proline 0 C--N 1.288 -2.077 0 CA-C-N 113.61 -1.632 . . . . 0.0 111.07 -173.79 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 41.0 Cg_endo -71.96 -25.91 19.19 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 N-CA-C 106.99 -1.965 . . . . 0.0 106.99 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 1.026 ' HB2' HG21 ' A' ' 57' ' ' THR . 13.6 p-10 -114.53 18.76 16.58 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.913 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.796 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -45.88 149.59 0.63 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.805 -1.185 . . . . 0.0 108.139 178.747 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.939 ' HB2' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -155.65 152.3 28.5 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.388 -1.725 . . . . 0.0 112.313 -178.675 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -106.43 103.29 12.71 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 24' ' ' MET . 5.7 t -27.82 -34.09 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.552 ' N ' ' O ' ' A' ' 84' ' ' LEU . 26.5 p -71.65 1.97 5.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.3 -1.5 . . . . 0.0 110.784 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.556 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 38.1 mm-40 -125.03 14.94 8.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.877 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.639 HG23 HG11 ' A' ' 60' ' ' VAL . 5.7 mm -116.46 99.0 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.272 -0.892 . . . . 0.0 110.285 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.99 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.7 mm -82.82 131.15 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.899 -1.125 . . . . 0.0 110.048 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.998 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.1 tpt -82.42 123.14 28.86 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.279 -0.888 . . . . 0.0 110.349 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.572 ' OG1' HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -113.22 159.33 35.36 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 118.151 -1.42 . . . . 0.0 110.319 179.29 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.584 ' CD ' ' HB3' ' A' ' 19' ' ' ASP . 37.2 Cg_endo -62.24 -14.23 37.08 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 O-C-N 124.481 1.779 . . . . 0.0 109.569 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.524 ' CG ' ' HB ' ' A' ' 91' ' ' THR . 1.8 pt-20 -82.52 -36.93 25.91 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.33 1.062 . . . . 0.0 108.42 177.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.083 HD13 HG23 ' A' ' 60' ' ' VAL . 50.3 mt -90.23 35.76 0.87 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.576 -178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 20.9 p30 -63.61 108.02 1.29 Allowed 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.823 177.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.617 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.36 23.79 1.88 Allowed Glycine 0 N--CA 1.496 2.695 0 O-C-N 120.755 -1.216 . . . . 0.0 110.7 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.115 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -59.62 136.83 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -1.087 . . . . 0.0 111.097 179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.115 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.5 t -115.76 110.31 31.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -100.0 154.99 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.834 -1.166 . . . . 0.0 110.039 -178.552 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.602 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.46 128.43 50.86 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.268 -0.895 . . . . 0.0 110.249 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.615 HG12 ' CE1' ' A' ' 8' ' ' HIS . 55.1 t -103.54 123.54 41.1 Favored Pre-proline 0 C--N 1.291 -1.972 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.669 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.738 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 54.8 Cg_endo -76.37 171.19 18.53 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.096 1.864 . . . . 0.0 111.949 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.5 -18.93 23.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.699 -0.626 . . . . 0.0 109.468 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.791 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -111.0 74.62 0.88 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 47' ' ' THR . 3.1 pt20 -98.81 56.1 1.07 Allowed 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.436 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.589 ' OXT' ' CD2' ' A' ' 106' ' ' TRP . 1.5 p-90 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.765 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.807 ' O ' HG22 ' A' ' 97' ' ' ILE . 4.1 mptt . . . . . 0 C--O 1.209 -1.072 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.917 ' HA ' HG23 ' A' ' 97' ' ' ILE . 65.4 t -140.56 134.05 33.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 O-C-N 121.382 -0.824 . . . . 0.0 110.959 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 45.9 t -142.7 90.2 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 C-N-CA 118.634 -1.226 . . . . 0.0 110.803 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 70.3 m-85 -67.64 134.65 51.53 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.674 -0.641 . . . . 0.0 109.464 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.535 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 97.3 t -99.62 169.36 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 O-C-N 120.113 -1.617 . . . . 0.0 109.717 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.593 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 95.9 p -104.46 -155.9 0.55 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 109.386 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.584 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.02 -29.69 18.25 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -91.83 -8.59 46.15 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.339 0.59 . . . . 0.0 109.713 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.21 -16.08 20.26 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -59.44 132.51 54.21 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.728 -1.454 . . . . 0.0 107.872 179.184 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.528 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.98 179.92 4.22 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 122.368 1.08 . . . . 0.0 113.02 -178.154 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 4' ' ' VAL 0.277 0.9 OUTLIER -127.25 179.03 5.66 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 178.682 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.693 ' C ' HD23 ' A' ' 15' ' ' LEU . 68.5 mt-10 -152.87 116.02 4.63 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 117.129 -1.828 . . . . 0.0 111.518 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.99 HD11 ' HA ' ' A' ' 27' ' ' ALA . 5.7 mt -112.63 -156.79 0.6 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.459 1.123 . . . . 0.0 110.194 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -153.08 68.24 0.81 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.035 HG12 ' HB ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -88.29 124.24 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.083 0.944 . . . . 0.0 109.463 -177.504 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -87.34 176.25 7.61 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.087 0.946 . . . . 0.0 112.851 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.582 ' HB3' HG22 ' A' ' 91' ' ' THR . 0.1 OUTLIER -51.02 127.85 19.95 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.318 1.056 . . . . 0.0 109.187 177.357 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.52 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 99.04 -23.82 34.84 Favored Glycine 0 C--N 1.276 -2.805 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.474 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.035 ' HB ' HG12 ' A' ' 17' ' ' VAL . 95.1 t -84.44 153.61 3.65 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.656 0 CA-C-N 120.61 2.205 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.527 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -96.98 134.71 39.99 Favored 'General case' 0 C--N 1.273 -2.728 0 C-N-CA 118.797 -1.161 . . . . 0.0 107.886 176.206 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.71 HD22 HG11 ' A' ' 3' ' ' VAL . 9.2 mt -50.24 -23.65 2.39 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.299 -1.501 . . . . 0.0 108.028 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.582 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -74.5 -15.0 60.89 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.599 -0.688 . . . . 0.0 109.211 179.175 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.55 ' CG ' HG13 ' A' ' 21' ' ' VAL . 3.7 tt0 -89.14 -63.5 1.28 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.853 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -56.04 -50.07 71.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.065 -1.022 . . . . 0.0 110.196 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.99 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.66 -48.66 28.89 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.527 -1.358 . . . . 0.0 109.706 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.504 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -70.78 -0.74 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.605 -0.684 . . . . 0.0 109.679 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.08 -27.18 12.73 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.813 0.816 . . . . 0.0 109.569 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.886 ' CG ' HD22 ' A' ' 15' ' ' LEU . 8.5 m120 -97.36 -0.72 45.91 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.68 21.47 36.83 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.843 HD11 HD21 ' A' ' 15' ' ' LEU . 2.1 mt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.392 -1.063 . . . . 0.0 109.66 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.533 0.682 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 11.3 p -115.18 28.53 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.48 -0.763 . . . . 0.0 109.625 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.097 ' HE1' ' HB3' ' A' ' 76' ' ' ALA . 6.8 t-160 -69.86 128.7 37.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.537 -0.727 . . . . 0.0 110.402 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.796 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -156.78 -174.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.971 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.796 ' N ' HG23 ' A' ' 50' ' ' VAL 0.272 81.9 m-85 -140.41 113.85 8.62 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.634 0.73 . . . . 0.0 110.323 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.033 ' HB ' HG22 ' A' ' 57' ' ' THR . 6.3 t -82.36 132.45 31.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 O-C-N 120.329 -1.482 . . . . 0.0 110.654 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.765 ' O ' HG23 ' A' ' 57' ' ' THR . 3.3 t30 -47.1 145.47 2.16 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.709 -1.244 . . . . 0.0 108.583 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.523 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -58.16 -8.37 1.07 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.159 -0.963 . . . . 0.0 112.077 -178.337 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.572 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -93.97 7.76 43.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.532 -1.355 . . . . 0.0 110.731 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 1.09 ' CB ' HD13 ' A' ' 97' ' ' ILE . 86.9 m-85 -140.54 4.65 1.97 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.125 -0.984 . . . . 0.0 109.622 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . 1.033 HG22 ' HB ' ' A' ' 52' ' ' VAL . 31.5 p -90.29 -41.19 11.68 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 120.946 -1.096 . . . . 0.0 108.068 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.34 -2.09 52.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.826 0.822 . . . . 0.0 110.56 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.057 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.255 0.1 OUTLIER -99.22 -47.77 5.07 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.531 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.071 HG23 HD13 ' A' ' 94' ' ' LEU 0.331 1.1 t -78.99 175.76 4.4 Favored Pre-proline 0 C--N 1.288 -2.065 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.186 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.987 ' HD2' HG13 ' A' ' 60' ' ' VAL . 40.0 Cg_endo -75.05 109.2 2.88 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 CA-C-O 122.702 1.042 . . . . 0.0 112.293 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.534 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -75.23 66.71 1.76 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.551 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.553 ' CB ' ' HG2' ' A' ' 87' ' ' GLN . . . -37.19 155.94 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.25 0.547 . . . . 0.0 110.226 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 66' ' ' ARG . 45.0 p-10 -96.06 -145.79 0.28 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.155 -0.966 . . . . 0.0 112.493 -177.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 64' ' ' ASN . 8.2 pt-20 -30.92 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.349 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 64' ' ' ASN . 2.3 mtm-85 -52.96 -71.2 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.608 -1.308 . . . . 0.0 108.365 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.866 ' HG3' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -62.89 -45.8 90.82 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 109.18 178.363 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.866 HD12 ' HG3' ' A' ' 67' ' ' GLU . 1.1 mp -55.77 -12.97 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.348 -0.845 . . . . 0.0 111.424 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -91.2 -78.41 1.37 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.566 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -45.37 -35.57 3.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.976 -1.308 . . . . 0.0 108.538 179.493 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.981 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.8 OUTLIER -67.77 -43.96 78.57 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 177.229 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.592 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -60.44 -25.79 66.24 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 108.699 178.168 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.579 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.94 -42.76 31.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.781 -0.574 . . . . 0.0 111.111 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.981 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.5 m -39.87 151.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.816 HG22 ' O ' ' A' ' 75' ' ' THR . 18.7 m -121.03 30.47 6.84 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.083 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.097 ' HB3' ' HE1' ' A' ' 49' ' ' HIS . . . -92.67 -82.5 0.33 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.492 -1.283 . . . . 0.0 113.344 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.721 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.288 0.0 OUTLIER -153.86 64.58 0.72 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 122.291 1.043 . . . . 0.0 108.683 -175.579 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.923 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -57.0 150.71 16.33 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 119.382 -2.074 . . . . 0.0 113.24 -173.62 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.536 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.36 0.0 OUTLIER -124.97 -174.14 0.32 Allowed Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.312 -174.889 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 46.6 Cg_endo -81.98 -28.86 1.87 Allowed 'Trans proline' 0 C--N 1.302 -1.92 0 N-CA-C 107.222 -1.876 . . . . 0.0 107.222 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.733 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.9 OUTLIER -107.47 15.33 24.97 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.113 179.416 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.824 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -44.65 146.68 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.952 -1.093 . . . . 0.0 109.611 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.925 ' HB2' HG23 ' A' ' 52' ' ' VAL . 30.7 mmm-85 -158.43 152.91 24.44 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.888 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.625 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -105.26 107.03 17.79 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 24' ' ' MET . 6.1 p -32.07 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.582 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 16.3 p -70.05 -1.24 9.31 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.425 -1.422 . . . . 0.0 111.03 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.553 ' HG2' ' CB ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -125.4 -1.92 7.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.91 -1.119 . . . . 0.0 110.938 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.674 HG23 HG11 ' A' ' 60' ' ' VAL . 3.2 mm -97.15 108.78 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.084 -1.01 . . . . 0.0 110.281 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.984 ' O ' HG22 ' A' ' 60' ' ' VAL . 2.9 mm -87.72 129.36 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.896 -1.128 . . . . 0.0 109.959 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . 1.011 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.4 tpt -83.03 122.94 28.97 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 121.42 -0.8 . . . . 0.0 110.379 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.754 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -114.11 159.22 37.14 Favored Pre-proline 0 C--N 1.292 -1.922 0 C-N-CA 118.233 -1.387 . . . . 0.0 109.682 178.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.754 ' HD2' HG22 ' A' ' 91' ' ' THR . 35.2 Cg_endo -58.66 -36.67 96.89 Favored 'Trans proline' 0 C--N 1.297 -2.149 0 O-C-N 124.334 1.702 . . . . 0.0 110.045 -178.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -58.9 -36.83 75.34 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.797 -1.161 . . . . 0.0 108.558 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.071 HD13 HG23 ' A' ' 60' ' ' VAL . 65.9 mt -90.59 35.12 0.88 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.937 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.473 ' HA ' ' N ' ' A' ' 2' ' ' LYS . 19.6 p-10 -63.75 107.03 1.09 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.575 -1.25 . . . . 0.0 109.391 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.615 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 123.75 19.83 2.69 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 120.458 -1.401 . . . . 0.0 110.733 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.1 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -55.77 140.33 13.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.228 -1.16 . . . . 0.0 111.119 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.1 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.0 t -115.53 112.15 38.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -98.61 156.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.786 -1.196 . . . . 0.0 109.346 -178.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.71 ' N ' ' O ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -122.85 124.21 42.75 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.742 0.782 . . . . 0.0 110.323 -178.74 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 68.2 t -100.32 135.55 20.24 Favored Pre-proline 0 C--N 1.289 -2.064 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.694 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 54.5 Cg_endo -88.9 176.09 3.39 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 121.765 1.643 . . . . 0.0 111.885 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -91.14 -20.45 21.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.572 -0.705 . . . . 0.0 109.36 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.606 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -110.76 77.86 1.07 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.768 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.5 ' HG2' ' HG2' ' A' ' 102' ' ' PRO . 12.9 mt-30 -98.34 52.07 1.02 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.72 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.632 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 3.0 p-90 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.18 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.769 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.205 -1.257 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.943 ' HA ' HG23 ' A' ' 97' ' ' ILE . 41.6 t -136.27 133.82 49.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 O-C-N 121.326 -0.859 . . . . 0.0 110.137 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 58.2 t -141.85 91.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.619 0 C-N-CA 118.804 -1.158 . . . . 0.0 110.411 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.658 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 40.8 m-85 -69.03 154.64 41.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.577 -0.702 . . . . 0.0 109.169 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.577 HG12 ' N ' ' A' ' 7' ' ' SER . 87.0 t -118.35 172.7 5.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.215 178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.615 ' HB3' HG22 ' A' ' 11' ' ' THR . 46.3 p -107.97 -158.4 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.104 -0.998 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.595 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -88.04 -29.67 20.51 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 178.366 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -91.76 -11.18 37.44 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.437 0.637 . . . . 0.0 109.575 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.29 -4.31 23.56 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.335 -0.936 . . . . 0.0 110.785 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.615 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -65.09 131.41 46.48 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.646 -1.502 . . . . 0.0 107.784 179.016 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -120.93 178.51 4.69 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 122.229 1.014 . . . . 0.0 112.905 -177.819 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.4 177.71 7.61 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.81 ' C ' HD23 ' A' ' 15' ' ' LEU . 9.2 mp0 -150.3 113.47 4.87 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.975 -1.49 . . . . 0.0 110.397 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.046 HD11 HD12 ' A' ' 32' ' ' ILE 0.262 2.8 mt -109.21 -151.53 0.47 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 122.603 1.192 . . . . 0.0 111.084 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -152.94 75.98 1.11 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.092 HG13 ' CG1' ' A' ' 21' ' ' VAL . 17.4 t -88.41 118.87 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.64 -175.4 4.66 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.595 -0.691 . . . . 0.0 110.892 -177.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -65.45 114.39 4.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.402 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.456 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 112.36 -15.84 24.82 Favored Glycine 0 C--N 1.288 -2.085 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.351 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.092 ' CG1' HG13 ' A' ' 17' ' ' VAL . 41.6 t -97.81 136.37 28.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 120.441 -1.623 . . . . 0.0 106.776 177.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -95.15 143.71 26.36 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.378 -1.329 . . . . 0.0 107.721 178.554 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.907 HD23 HG21 ' A' ' 17' ' ' VAL . 13.8 mt -47.04 -26.6 1.08 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.281 -1.367 . . . . 0.0 107.434 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.517 ' CB ' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -59.41 -39.27 82.91 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.362 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.607 ' CG ' HG13 ' A' ' 21' ' ' VAL . 28.1 tt0 -75.24 -72.37 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.796 -0.565 . . . . 0.0 110.532 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.068 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.6 -50.54 17.31 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 117.986 -1.486 . . . . 0.0 111.014 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.924 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.95 -46.02 31.77 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.343 -1.473 . . . . 0.0 110.443 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -74.08 0.57 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.555 -0.716 . . . . 0.0 109.654 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.18 -29.18 11.47 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.736 0.779 . . . . 0.0 109.687 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.907 ' CG ' HD22 ' A' ' 15' ' ' LEU . 8.5 m120 -97.56 -1.57 43.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.65 19.58 51.21 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.046 HD12 HD11 ' A' ' 15' ' ' LEU . 8.5 mt . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.306 -1.114 . . . . 0.0 109.434 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.568 0.699 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.75 ' SG ' HD13 ' A' ' 84' ' ' LEU . 25.4 p -88.38 29.98 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.636 -0.665 . . . . 0.0 110.048 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.352 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 9.0 t-160 -70.24 126.27 29.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.417 -0.802 . . . . 0.0 110.667 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.807 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.1 m -156.33 -174.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.251 -0.905 . . . . 0.0 109.99 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.807 ' N ' HG23 ' A' ' 50' ' ' VAL 0.254 78.2 m-85 -141.01 108.22 5.5 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.659 0.743 . . . . 0.0 110.669 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.029 ' HB ' HG22 ' A' ' 57' ' ' THR . 2.4 t -75.01 133.84 30.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 O-C-N 120.34 -1.475 . . . . 0.0 110.583 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.861 ' O ' HG23 ' A' ' 57' ' ' THR . 3.8 t30 -48.42 147.29 2.45 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.744 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.2 pt-20 -58.77 -8.41 1.32 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.169 -0.957 . . . . 0.0 111.972 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.573 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -96.01 7.91 45.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.475 -1.391 . . . . 0.0 111.057 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 1.13 ' CB ' HD13 ' A' ' 97' ' ' ILE . 87.7 m-85 -140.37 3.01 1.91 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.059 . . . . 0.0 109.898 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 1.029 HG22 ' HB ' ' A' ' 52' ' ' VAL . 3.2 p -90.55 -41.22 11.5 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -93.76 -0.94 55.67 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.737 0.779 . . . . 0.0 110.526 -178.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.034 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.253 1.2 mtpp -99.23 -46.91 5.38 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 123.135 1.445 . . . . 0.0 107.355 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.043 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.334 0.9 OUTLIER -74.86 -177.68 0.71 Allowed Pre-proline 0 C--N 1.287 -2.114 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.197 178.975 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 1.043 ' HD2' HG13 ' A' ' 60' ' ' VAL . 34.1 Cg_endo -61.59 122.34 10.91 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 CA-C-O 123.001 1.167 . . . . 0.0 111.941 -177.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.553 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -74.32 62.95 0.99 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.635 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.469 ' HB1' ' HG2' ' A' ' 87' ' ' GLN . . . -38.22 157.88 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.937 -0.477 . . . . 0.0 109.999 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 66' ' ' ARG . 29.8 p30 -118.0 -154.47 0.56 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.061 -1.024 . . . . 0.0 111.432 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 64' ' ' ASN . 4.3 pt-20 -31.24 -33.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.028 -0.42 . . . . 0.0 111.726 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -53.0 -71.05 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.773 -1.204 . . . . 0.0 108.195 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.885 ' HG3' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.7 -50.41 73.94 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 108.906 178.455 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.885 HD12 ' HG3' ' A' ' 67' ' ' GLU . 1.2 mp -51.52 -19.32 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 110.302 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -88.17 -75.69 1.28 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.67 ' HG3' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -45.04 -38.78 5.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -1.215 . . . . 0.0 108.674 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.039 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -65.74 -51.7 57.05 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.208 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 11.0 tp10 -55.39 -19.62 9.61 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.081 -1.012 . . . . 0.0 108.417 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -76.21 -46.98 25.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.604 -0.685 . . . . 0.0 110.552 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.039 HG22 ' O ' ' A' ' 71' ' ' LEU . 8.1 m -40.71 163.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.266 -0.896 . . . . 0.0 109.725 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.779 HG22 ' O ' ' A' ' 75' ' ' THR . 45.8 m -120.4 37.4 4.27 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.977 -1.077 . . . . 0.0 109.599 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.352 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -122.44 -167.78 1.62 Allowed 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.281 -1.368 . . . . 0.0 112.968 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.744 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -50.77 63.42 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.662 -178.754 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.865 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.42 153.65 15.35 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 118.767 -2.458 . . . . 0.0 111.809 -177.455 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.699 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.385 0.2 OUTLIER -133.96 176.86 2.57 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 113.294 -1.775 . . . . 0.0 111.308 -173.826 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 43.7 Cg_endo -75.34 -27.58 9.36 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 176.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.81 ' HB2' HG21 ' A' ' 57' ' ' THR . 15.5 p-10 -108.5 17.01 22.52 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.255 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.802 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -45.81 149.91 0.59 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.181 -0.949 . . . . 0.0 110.126 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.826 ' HB2' HG23 ' A' ' 52' ' ' VAL . 7.9 mmt85 -158.62 160.22 36.29 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.255 -1.378 . . . . 0.0 112.192 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.75 HD13 ' SG ' ' A' ' 48' ' ' CYS . 2.2 mt -112.85 114.98 27.75 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 24' ' ' MET . 12.6 p -30.67 -30.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.572 ' N ' ' O ' ' A' ' 84' ' ' LEU . 27.8 p -77.07 4.24 10.64 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.611 -1.306 . . . . 0.0 111.43 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.503 ' HG2' ' CB ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -125.34 11.94 8.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.819 -1.175 . . . . 0.0 111.357 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.007 HG23 HG11 ' A' ' 60' ' ' VAL . 21.4 mm -120.34 107.12 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.83 -1.169 . . . . 0.0 110.978 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.974 ' O ' HG22 ' A' ' 60' ' ' VAL . 3.9 mm -89.83 128.81 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.144 -0.973 . . . . 0.0 108.895 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.579 ' CE ' ' HB3' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -83.86 124.77 31.31 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.414 -0.804 . . . . 0.0 111.238 -178.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.831 HG23 HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -98.97 179.69 1.01 Allowed Pre-proline 0 C--N 1.295 -1.769 0 C-N-CA 117.673 -1.611 . . . . 0.0 109.181 177.721 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.558 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 45.6 Cg_endo -82.21 -12.88 10.33 Favored 'Trans proline' 0 C--N 1.289 -2.599 0 O-C-N 124.368 1.72 . . . . 0.0 108.705 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.553 ' HG2' ' OG1' ' A' ' 91' ' ' THR . 3.4 pt-20 -84.89 -33.69 22.73 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.034 HD21 ' CB ' ' A' ' 59' ' ' LYS . 66.1 mt -89.64 29.77 1.11 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.498 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -63.22 111.38 2.22 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 120.3 -1.5 . . . . 0.0 109.056 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.65 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 123.87 17.04 3.17 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.13 HD13 ' CB ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -53.75 141.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.377 -1.073 . . . . 0.0 111.668 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.08 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.0 t -117.46 113.63 43.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.592 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -99.41 155.41 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.838 -1.163 . . . . 0.0 109.773 -178.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.644 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.34 121.07 35.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.677 0.751 . . . . 0.0 109.783 -179.598 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.595 HG12 ' CE1' ' A' ' 8' ' ' HIS . 90.8 t -99.51 123.58 47.6 Favored Pre-proline 0 C--N 1.289 -2.025 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.432 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.766 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 52.6 Cg_endo -75.58 170.83 19.42 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.002 1.801 . . . . 0.0 112.028 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.424 ' CG ' ' HG2' ' A' ' 104' ' ' ARG . 11.6 p-10 -91.32 -17.45 25.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.677 -0.639 . . . . 0.0 109.402 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.797 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -110.75 70.89 0.73 Allowed 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.423 ' CD ' ' O ' ' A' ' 105' ' ' GLN . 0.0 OUTLIER -98.73 58.81 1.21 Allowed 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.466 -177.714 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.609 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 1.8 p-90 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.885 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.617 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.236 0.541 . . . . 0.0 110.345 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -87.55 147.79 25.17 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.172 -0.955 . . . . 0.0 110.472 179.231 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.921 ' HA ' HG23 ' A' ' 97' ' ' ILE . 54.9 t -140.99 135.59 33.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 121.121 -0.987 . . . . 0.0 110.902 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.594 HG13 ' HG2' ' A' ' 14' ' ' GLU . 47.3 t -142.4 90.96 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.804 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 73.1 m-85 -67.86 134.84 51.58 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 121.714 -0.616 . . . . 0.0 109.81 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.562 HG22 ' CD ' ' A' ' 12' ' ' ARG . 91.1 t -99.82 166.95 2.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 O-C-N 120.052 -1.655 . . . . 0.0 109.467 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.591 ' HB3' HG22 ' A' ' 11' ' ' THR . 86.1 p -101.8 -155.86 0.54 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.096 -1.003 . . . . 0.0 108.819 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.589 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.24 -29.83 17.93 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.8 -6.26 52.05 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.436 0.636 . . . . 0.0 109.878 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.38 -25.55 10.38 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.591 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.57 130.18 31.27 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.628 -1.513 . . . . 0.0 108.066 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.562 ' CD ' HG22 ' A' ' 6' ' ' VAL . 17.3 mtm-85 -121.26 -176.38 3.27 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 122.374 1.083 . . . . 0.0 112.883 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.587 ' O ' ' HA ' ' A' ' 4' ' ' VAL 0.28 0.2 OUTLIER -128.78 178.73 6.15 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.687 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 84.1 mt-10 -152.9 114.17 4.21 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 117.324 -1.751 . . . . 0.0 111.142 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.879 HD22 ' CG ' ' A' ' 30' ' ' ASN . 6.6 mt -108.71 -156.16 0.58 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.475 1.131 . . . . 0.0 110.095 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 1' ' ' SER . 0.7 OUTLIER -152.5 71.91 0.96 Allowed 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 177.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.003 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.4 t -89.14 127.58 41.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.866 0.841 . . . . 0.0 109.431 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.94 -175.06 4.47 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.675 1.226 . . . . 0.0 112.867 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.521 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 11.6 p30 -63.2 115.89 4.93 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.792 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.732 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 111.98 -22.39 18.74 Favored Glycine 0 C--N 1.287 -2.185 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.763 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.003 ' HB ' HG12 ' A' ' 17' ' ' VAL . 90.8 t -88.34 147.93 4.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 119.938 1.869 . . . . 0.0 109.746 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -96.63 131.79 42.93 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.751 HD22 HG11 ' A' ' 3' ' ' VAL . 8.8 mt -44.54 -26.11 0.33 Allowed 'General case' 0 C--O 1.201 -1.464 0 O-C-N 120.899 -1.126 . . . . 0.0 109.292 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.649 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -69.04 -42.4 76.37 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 118.206 -1.398 . . . . 0.0 107.77 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.563 ' CG ' HG13 ' A' ' 21' ' ' VAL . 6.8 tt0 -59.68 -70.8 0.15 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.744 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.759 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.97 -54.3 10.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.981 -1.075 . . . . 0.0 110.512 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.878 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.41 -51.15 20.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.787 -1.195 . . . . 0.0 110.098 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.018 HG23 ' HB2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -69.05 -1.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.622 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.12 -27.47 12.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.334 -0.853 . . . . 0.0 109.863 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.879 ' CG ' HD22 ' A' ' 15' ' ' LEU . 8.3 m120 -97.31 -0.8 45.89 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.11 21.17 33.68 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.849 HD11 HD21 ' A' ' 15' ' ' LEU . 1.8 mt -72.69 -62.75 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.221 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 1.018 ' HB2' HG23 ' A' ' 28' ' ' VAL . 13.2 m-30 -80.36 48.96 1.07 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.614 -0.679 . . . . 0.0 110.377 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -49.75 -20.66 0.88 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.434 -0.791 . . . . 0.0 110.469 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.919 HG12 HG21 ' A' ' 47' ' ' THR . 4.1 tt -66.91 179.0 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.158 -0.964 . . . . 0.0 110.1 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 36' ' ' VAL . 7.1 p -112.81 65.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.15 -0.969 . . . . 0.0 110.375 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 47' ' ' THR . . . -120.03 72.13 0.34 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 9.8 p30 -120.06 115.18 23.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -1.153 . . . . 0.0 110.344 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 42' ' ' SER . 23.1 p -100.03 25.0 7.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.187 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.07 50.06 40.61 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.37 19.83 9.37 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 11.1 m -92.62 0.63 57.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -1.106 . . . . 0.0 110.194 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.795 ' HB1' ' SD ' ' A' ' 70' ' ' MET . . . 53.14 60.1 3.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 110.264 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -139.63 24.77 2.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.371 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 2.1 p -129.9 -174.29 3.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.054 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.783 ' HB1' ' OXT' ' A' ' 106' ' ' TRP . . . -150.06 9.9 0.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.981 . . . . 0.0 110.955 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.919 HG21 HG12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -84.85 -18.79 33.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.917 -1.114 . . . . 0.0 109.86 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' VAL . 25.1 p -88.53 28.41 1.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.531 -0.731 . . . . 0.0 110.151 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.318 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 8.2 t-160 -70.21 126.37 29.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.433 -0.792 . . . . 0.0 110.219 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.812 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.3 m -156.39 -173.94 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-O 122.12 0.962 . . . . 0.0 110.246 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.812 ' N ' HG23 ' A' ' 50' ' ' VAL 0.268 77.1 m-85 -141.08 111.76 7.0 Favored 'General case' 0 C--O 1.197 -1.687 0 CA-C-O 121.557 0.694 . . . . 0.0 110.563 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.063 ' HB ' HG22 ' A' ' 57' ' ' THR . 2.4 t -78.4 131.46 34.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 O-C-N 120.31 -1.494 . . . . 0.0 110.689 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.838 ' O ' HG23 ' A' ' 57' ' ' THR . 3.4 t30 -47.44 146.67 1.96 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.495 -1.378 . . . . 0.0 108.778 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -58.71 -8.09 1.19 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.065 -1.022 . . . . 0.0 112.135 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.566 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -95.99 8.24 44.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.547 -1.345 . . . . 0.0 110.56 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 1.116 ' CB ' HD13 ' A' ' 97' ' ' ILE . 87.5 m-85 -140.16 3.77 2.0 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.23 -0.918 . . . . 0.0 109.846 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 1.063 HG22 ' HB ' ' A' ' 52' ' ' VAL . 8.7 p -90.45 -42.61 10.77 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.027 -1.046 . . . . 0.0 108.358 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -1.34 57.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.751 0.786 . . . . 0.0 110.486 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.033 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.259 0.1 OUTLIER -99.35 -46.79 5.39 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 123.073 1.416 . . . . 0.0 107.314 179.659 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.053 HG11 HG23 ' A' ' 88' ' ' ILE 0.338 1.0 OUTLIER -78.07 -179.8 1.43 Allowed Pre-proline 0 C--N 1.289 -2.06 0 CA-C-N 113.797 -1.547 . . . . 0.0 107.123 178.966 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 1.023 ' HD2' HG13 ' A' ' 60' ' ' VAL . 37.9 Cg_endo -68.39 107.54 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 CA-C-O 122.874 1.114 . . . . 0.0 112.42 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.632 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -75.46 71.54 2.41 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.016 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.613 ' HB1' ' OE1' ' A' ' 67' ' ' GLU . . . -38.65 170.92 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.604 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 66' ' ' ARG . 4.7 p30 -111.9 -164.25 0.9 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.91 -1.118 . . . . 0.0 112.543 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 68' ' ' ILE . 8.8 pt-20 -28.71 -39.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -52.9 -63.01 1.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.543 -1.348 . . . . 0.0 108.833 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.633 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -59.14 -30.06 67.86 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.52 -0.737 . . . . 0.0 110.5 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.564 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.8 mp -77.12 -8.87 12.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.434 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -88.17 -76.68 1.28 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.829 ' HG3' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -44.04 -40.29 4.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.165 -1.197 . . . . 0.0 108.481 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.058 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -64.67 -50.96 64.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.294 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 12.0 tp10 -56.91 -19.35 17.37 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.967 -1.083 . . . . 0.0 108.398 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -75.64 -47.88 24.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 110.156 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.058 HG22 ' O ' ' A' ' 71' ' ' LEU . 6.1 m -40.78 161.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 0.0 109.279 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.78 HG22 ' O ' ' A' ' 75' ' ' THR . 27.8 m -120.36 34.06 5.36 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 120.971 -1.081 . . . . 0.0 109.257 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.318 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -114.81 -165.19 0.99 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.595 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.748 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -54.05 63.26 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.167 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.84 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.35 153.02 16.37 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 118.842 -2.411 . . . . 0.0 111.67 -177.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.674 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.389 2.2 mmtt -135.42 177.45 2.22 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.409 -173.567 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 43.6 Cg_endo -74.76 -28.73 9.36 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 N-CA-C 107.514 -1.764 . . . . 0.0 107.514 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.676 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.8 OUTLIER -106.02 15.18 26.84 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.873 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.827 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -44.17 148.83 0.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.989 . . . . 0.0 109.507 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.934 ' HB2' HG23 ' A' ' 52' ' ' VAL . 1.3 mmt85 -162.03 155.93 21.51 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 117.436 -1.706 . . . . 0.0 113.293 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.829 HD12 ' HG3' ' A' ' 70' ' ' MET . 7.8 mt -114.73 98.32 6.79 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 174.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.541 ' HB3' ' N ' ' A' ' 24' ' ' MET . 60.7 m -28.85 -28.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.623 ' SG ' ' NE2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -39.76 -26.35 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.502 -1.373 . . . . 0.0 112.442 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.623 ' NE2' ' SG ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -125.74 0.25 7.42 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.208 -1.557 . . . . 0.0 112.934 -178.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.053 HG23 HG11 ' A' ' 60' ' ' VAL . 12.6 mm -78.64 99.97 3.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.366 -1.459 . . . . 0.0 107.518 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.995 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -81.92 130.88 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.208 -0.933 . . . . 0.0 110.578 -177.65 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.972 ' SD ' HG21 ' A' ' 97' ' ' ILE . 1.3 tpt -82.58 120.71 25.88 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.809 -0.557 . . . . 0.0 111.375 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.685 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -106.18 174.3 2.68 Favored Pre-proline 0 N--CA 1.494 1.767 0 C-N-CA 118.481 -1.288 . . . . 0.0 109.77 178.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 19' ' ' ASP . 44.3 Cg_endo -73.94 -10.51 23.08 Favored 'Trans proline' 0 C--N 1.292 -2.427 0 O-C-N 124.651 1.869 . . . . 0.0 110.074 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.62 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -92.48 -30.49 15.68 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.034 ' CD1' HG23 ' A' ' 60' ' ' VAL . 97.8 mt -90.07 25.04 2.26 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.865 0.841 . . . . 0.0 110.28 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.598 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 5.9 p-10 -63.11 104.2 0.55 Allowed 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.287 177.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.662 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.99 18.43 2.6 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.333 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.116 HD13 ' CB ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -53.42 141.8 7.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.539 -0.977 . . . . 0.0 111.39 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.079 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.1 t -115.49 112.49 40.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -98.33 155.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.782 -1.199 . . . . 0.0 108.977 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -122.86 124.84 44.17 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.396 -0.815 . . . . 0.0 110.476 -178.413 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.577 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 63.4 t -99.22 137.4 20.39 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.879 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.674 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 57.2 Cg_endo -89.25 170.64 4.74 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 C-N-CA 121.809 1.673 . . . . 0.0 111.813 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.51 -16.36 27.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.735 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -111.09 75.08 0.9 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.522 ' NE2' HG13 ' A' ' 101' ' ' VAL . 18.3 mt-30 -98.94 56.75 1.07 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.327 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.783 ' OXT' ' HB1' ' A' ' 46' ' ' ALA . 1.6 p-90 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.787 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.469 ' S2 ' ' HB3' ' A' ' 86' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 91' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.143 0.497 . . . . 0.0 110.225 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.736 ' O ' HG22 ' A' ' 97' ' ' ILE . 13.9 mtmt -69.7 148.12 49.67 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.139 -0.976 . . . . 0.0 109.873 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.862 ' HA ' HG23 ' A' ' 97' ' ' ILE . 41.5 t -138.51 134.29 43.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 O-C-N 120.897 -1.127 . . . . 0.0 110.516 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 50.5 t -142.61 93.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.078 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.63 ' CD1' ' CD1' ' A' ' 32' ' ' ILE . 50.2 m-85 -69.67 162.45 27.68 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 109.464 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.614 HG22 ' HG2' ' A' ' 12' ' ' ARG . 87.3 t -127.89 168.56 20.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.096 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.621 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 6.1 p -103.12 -154.77 0.5 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 109.616 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.568 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -92.12 -29.84 16.3 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.017 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -91.93 -11.86 35.05 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.515 0.674 . . . . 0.0 109.251 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.5 7.23 18.67 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.234 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.578 HG22 ' NH2' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -71.64 131.12 42.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.355 -1.673 . . . . 0.0 107.451 178.446 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.614 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.77 173.47 7.19 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.124 0.964 . . . . 0.0 112.896 -177.437 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -134.44 -179.08 5.36 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.755 ' C ' HD23 ' A' ' 15' ' ' LEU . 37.0 mt-10 -151.78 112.93 4.28 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 117.844 -1.542 . . . . 0.0 110.729 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.953 HD11 ' HA ' ' A' ' 27' ' ' ALA . 3.9 mt -109.83 -151.11 0.47 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.482 1.134 . . . . 0.0 111.111 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.19 70.54 0.92 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.083 HG13 ' CG1' ' A' ' 21' ' ' VAL . 18.3 t -86.46 113.51 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.21 -170.8 2.89 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.87 0.843 . . . . 0.0 111.608 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.573 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 2.5 p30 -61.18 110.07 1.29 Allowed 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.769 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 112.19 -18.68 23.33 Favored Glycine 0 C--N 1.289 -2.029 0 C-N-CA 119.349 -1.405 . . . . 0.0 111.116 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.083 ' CG1' HG13 ' A' ' 17' ' ' VAL . 45.0 t -94.24 139.32 18.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 O-C-N 120.088 -1.831 . . . . 0.0 107.099 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.573 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -95.9 142.49 28.08 Favored 'General case' 0 C--N 1.275 -2.674 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.958 HD23 HG21 ' A' ' 17' ' ' VAL . 11.0 mt -49.67 -27.03 4.21 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.082 -1.447 . . . . 0.0 107.78 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.533 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -71.62 -17.31 62.28 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.832 0.825 . . . . 0.0 108.821 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.748 ' HG2' HG13 ' A' ' 21' ' ' VAL . 2.2 tp60 -89.7 -70.21 0.67 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.051 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -48.43 -49.67 34.28 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.301 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.953 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.76 -49.43 28.48 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.384 -1.448 . . . . 0.0 110.295 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.524 HG21 ' OD2' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -72.13 0.12 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.61 -0.681 . . . . 0.0 109.537 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.25 0.0 OUTLIER -103.58 -29.75 10.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.481 -0.762 . . . . 0.0 110.513 -179.773 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.845 ' CG ' HD22 ' A' ' 15' ' ' LEU . 9.0 m120 -97.73 -2.99 40.01 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.38 29.03 15.22 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.828 HD12 HD11 ' A' ' 15' ' ' LEU . 3.1 mt -72.43 -60.13 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -1.134 . . . . 0.0 108.58 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.467 ' HB2' HG23 ' A' ' 28' ' ' VAL . 20.8 m-30 -81.05 46.48 0.91 Allowed 'General case' 0 C--N 1.288 -2.085 0 O-C-N 121.584 -0.698 . . . . 0.0 110.835 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 9.8 p-10 -55.93 -28.12 55.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.413 -0.804 . . . . 0.0 110.364 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 pt -66.94 161.05 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.12 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.439 ' H ' HG22 ' A' ' 36' ' ' VAL . 23.9 m -79.92 51.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.925 . . . . 0.0 110.13 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.545 ' CA ' ' HB ' ' A' ' 47' ' ' THR . . . -118.08 37.53 3.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.524 ' OD1' ' CE ' ' A' ' 24' ' ' MET . 2.5 t70 -120.16 121.93 39.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -1.179 . . . . 0.0 110.187 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.89 18.64 19.02 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.026 -1.046 . . . . 0.0 110.089 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.95 21.64 65.28 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.465 ' HA2' ' S1 ' ' A' ' 107' ' ' FES . . . 50.0 40.07 34.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -87.42 25.52 1.41 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -1.141 . . . . 0.0 110.31 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.926 ' HB1' ' HD2' ' A' ' 66' ' ' ARG . . . 42.86 36.59 0.89 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.206 -0.934 . . . . 0.0 110.146 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 p -140.09 30.24 2.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 110.177 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.521 ' O ' ' S2 ' ' A' ' 107' ' ' FES . 0.5 OUTLIER -161.42 -170.72 2.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.948 . . . . 0.0 110.669 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.786 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . . . -150.28 9.15 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.415 -1.428 . . . . 0.0 111.753 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.545 ' HB ' ' CA ' ' A' ' 37' ' ' GLY . 13.9 p -57.37 -20.09 27.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.761 -1.212 . . . . 0.0 107.944 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.805 ' O ' HG13 ' A' ' 50' ' ' VAL . 25.8 p -86.84 25.4 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.438 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.099 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 7.3 t-80 -61.87 110.71 1.62 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.093 -1.005 . . . . 0.0 109.962 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.825 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -140.0 -169.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.624 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.825 ' N ' HG23 ' A' ' 50' ' ' VAL 0.258 62.0 m-85 -141.0 103.67 4.51 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.954 0.883 . . . . 0.0 111.041 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.044 ' HB ' HG22 ' A' ' 57' ' ' THR . 6.2 t -75.01 131.73 34.52 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 O-C-N 120.67 -1.268 . . . . 0.0 110.135 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.789 ' O ' HG23 ' A' ' 57' ' ' THR . 3.7 t30 -47.24 147.75 1.45 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.082 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.52 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.5 pt-20 -59.47 -8.74 1.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.212 -0.93 . . . . 0.0 111.966 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.587 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -96.69 10.01 39.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.701 -1.249 . . . . 0.0 110.725 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 1.128 ' CB ' HD13 ' A' ' 97' ' ' ILE . 91.0 m-85 -140.72 1.13 1.68 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.073 -1.017 . . . . 0.0 110.288 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 1.044 HG22 ' HB ' ' A' ' 52' ' ' VAL . 11.3 p -90.41 -40.81 11.84 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.946 -1.096 . . . . 0.0 108.465 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.26 -1.12 54.51 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.671 0.748 . . . . 0.0 110.592 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.009 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.256 0.2 OUTLIER -99.13 -47.09 5.34 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.618 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.995 HG22 ' O ' ' A' ' 89' ' ' ILE 0.327 1.0 OUTLIER -78.43 176.0 4.09 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.39 178.92 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.994 ' HD2' HG13 ' A' ' 60' ' ' VAL . 39.1 Cg_endo -72.7 103.27 1.53 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 CA-C-O 122.538 0.974 . . . . 0.0 111.314 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.512 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.26 73.09 1.8 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.052 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.92 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -37.76 161.26 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.337 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 66' ' ' ARG . 45.1 p-10 -86.95 -160.12 0.56 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.572 1.177 . . . . 0.0 113.125 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.0 pm0 -33.67 -27.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.477 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.926 ' HD2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -53.17 -70.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.321 -1.487 . . . . 0.0 107.66 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.989 ' HG2' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -64.63 -30.67 71.69 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.801 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.989 HD12 ' HG2' ' A' ' 67' ' ' GLU . 1.2 mp -77.45 -16.66 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.176 -0.953 . . . . 0.0 110.853 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -90.61 -73.95 1.28 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.893 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -42.11 -29.12 0.22 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.599 -0.942 . . . . 0.0 108.566 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.01 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -80.01 -47.58 14.69 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 7.3 tp10 -64.12 -12.71 42.12 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.199 -0.938 . . . . 0.0 109.339 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.27 -18.33 27.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.362 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.01 HG22 ' O ' ' A' ' 71' ' ' LEU . 8.0 m -70.17 145.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.096 -1.003 . . . . 0.0 110.456 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.775 HG22 ' O ' ' A' ' 75' ' ' THR . 55.4 m -99.52 28.46 4.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.741 -0.6 . . . . 0.0 109.699 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.099 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -97.15 -148.81 0.32 Allowed 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.094 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.744 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.47 63.48 5.79 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 122.333 1.063 . . . . 0.0 110.918 -178.46 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.848 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.14 154.4 13.05 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 118.923 -2.36 . . . . 0.0 111.61 -177.303 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.651 ' HG3' ' CD2' ' A' ' 51' ' ' TYR 0.379 2.4 mmtt -133.86 177.31 2.31 Favored Pre-proline 0 C--N 1.289 -2.059 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.774 -173.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 42.0 Cg_endo -73.31 -25.57 15.44 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 N-CA-C 107.583 -1.737 . . . . 0.0 107.583 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.987 ' HB2' HG21 ' A' ' 57' ' ' THR . 8.2 p-10 -114.66 21.37 14.53 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.251 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.848 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -45.85 158.08 0.1 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.802 -1.186 . . . . 0.0 109.094 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.9 ' HB2' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -166.28 150.15 7.57 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 117.011 -1.876 . . . . 0.0 112.276 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.787 HD22 ' SG ' ' A' ' 48' ' ' CYS . 79.7 mt -104.67 102.83 12.41 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 24' ' ' MET . 1.9 t -24.05 -37.18 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.554 ' N ' ' O ' ' A' ' 84' ' ' LEU . 27.6 p -70.58 2.92 3.48 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.134 -1.604 . . . . 0.0 111.554 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.541 ' HG3' ' CB ' ' A' ' 67' ' ' GLU . 76.9 mm-40 -125.2 19.43 8.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.882 -1.136 . . . . 0.0 110.514 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.63 HG23 HG11 ' A' ' 60' ' ' VAL . 5.1 mm -120.34 100.49 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.105 -0.997 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.995 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -90.04 127.04 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.794 -1.191 . . . . 0.0 108.106 178.329 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.619 ' HE1' ' HB3' ' A' ' 94' ' ' LEU . 26.3 mmm -82.73 137.42 34.41 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.334 -0.854 . . . . 0.0 110.626 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.737 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -114.7 170.27 5.66 Favored Pre-proline 0 C--N 1.291 -1.952 0 O-C-N 120.936 -1.102 . . . . 0.0 110.033 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 19' ' ' ASP . 40.6 Cg_endo -67.14 -10.31 28.14 Favored 'Trans proline' 0 C--N 1.292 -2.446 0 O-C-N 124.498 1.789 . . . . 0.0 110.859 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.604 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -92.57 -30.78 15.47 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 117.628 -1.629 . . . . 0.0 107.646 177.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.009 HD21 ' CB ' ' A' ' 59' ' ' LYS . 83.7 mt -89.8 28.53 1.33 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.096 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 34.8 p-10 -63.19 106.02 0.81 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 118.465 -1.294 . . . . 0.0 108.281 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.629 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.87 23.01 1.89 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.134 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -57.61 138.39 18.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.327 -1.102 . . . . 0.0 111.237 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.134 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.1 t -111.39 114.49 47.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.627 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -99.75 152.87 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.78 -1.2 . . . . 0.0 109.755 -178.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -123.06 128.59 50.35 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.318 -0.864 . . . . 0.0 110.71 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.621 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 64.9 t -101.45 134.69 20.11 Favored Pre-proline 0 C--N 1.292 -1.93 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.107 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.669 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 56.8 Cg_endo -87.79 175.67 4.29 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.512 2.141 . . . . 0.0 112.807 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -91.86 -17.05 25.83 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.601 0.715 . . . . 0.0 109.193 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.905 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.92 70.46 0.71 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.328 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.53 ' CG ' ' HG2' ' A' ' 102' ' ' PRO . 2.5 mt-30 -97.63 62.89 1.7 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 122.004 0.907 . . . . 0.0 110.219 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.786 ' CZ2' ' HB3' ' A' ' 46' ' ' ALA . 5.8 p-90 . . . . . 0 C--N 1.294 -1.827 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.179 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.834 ' S2 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' A' ' 16' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.17 0.51 . . . . 0.0 110.344 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.738 ' O ' HG22 ' A' ' 97' ' ' ILE . 6.9 mtmm -84.85 146.4 27.33 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.999 0.904 . . . . 0.0 110.555 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.923 ' HA ' HG23 ' A' ' 97' ' ' ILE . 53.8 t -140.77 135.35 34.01 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 O-C-N 121.351 -0.843 . . . . 0.0 111.024 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.757 HG13 ' HG3' ' A' ' 14' ' ' GLU . 20.8 t -142.49 90.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 C-N-CA 118.711 -1.196 . . . . 0.0 110.386 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.656 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 55.8 m-85 -69.57 136.16 50.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.448 -0.782 . . . . 0.0 109.817 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.567 HG22 ' CD ' ' A' ' 12' ' ' ARG . 62.2 t -100.03 167.69 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 O-C-N 120.723 -1.236 . . . . 0.0 109.297 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.586 ' HB3' HG22 ' A' ' 11' ' ' THR . 89.1 p -103.84 -155.92 0.55 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.103 -0.998 . . . . 0.0 109.246 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.612 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -87.7 -31.34 19.76 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -91.7 -6.65 51.63 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.364 0.602 . . . . 0.0 109.806 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.536 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.24 -23.46 12.56 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.76 129.11 28.81 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.691 -1.476 . . . . 0.0 108.223 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.567 ' CD ' HG22 ' A' ' 6' ' ' VAL . 20.8 mtt180 -121.73 -175.45 3.1 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 122.191 0.996 . . . . 0.0 112.65 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -133.76 179.7 6.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 177.634 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.757 ' HG3' HG13 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -151.78 111.15 3.94 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 117.704 -1.598 . . . . 0.0 110.972 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.998 HD21 ' CD1' ' A' ' 32' ' ' ILE . 7.6 mt -103.86 -157.04 0.59 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.527 1.156 . . . . 0.0 110.595 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.571 ' HA ' ' O ' ' A' ' 1' ' ' SER . 62.0 t0 -152.54 69.58 0.87 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.049 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.4 t -89.41 127.18 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.033 0.921 . . . . 0.0 109.783 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.23 177.05 6.71 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.21 1.005 . . . . 0.0 113.229 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.59 ' CB ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -53.14 120.63 6.16 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.222 177.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.651 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 106.54 -24.08 26.67 Favored Glycine 0 C--N 1.28 -2.53 0 C-N-CA 119.308 -1.425 . . . . 0.0 112.218 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.049 ' HB ' HG12 ' A' ' 17' ' ' VAL . 85.9 t -84.43 152.23 3.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.513 0 CA-C-N 120.286 2.043 . . . . 0.0 109.381 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.494 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -96.6 131.24 43.44 Favored 'General case' 0 C--N 1.274 -2.682 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.287 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.772 HD21 ' SD ' ' A' ' 90' ' ' MET . 7.5 mt -47.11 -26.99 1.23 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.47 -1.394 . . . . 0.0 108.707 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.662 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -73.74 -14.76 61.18 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.657 0.741 . . . . 0.0 109.445 -178.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 22' ' ' SER . 4.0 tt0 -90.2 -62.1 1.54 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.846 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -51.47 -55.65 17.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.128 -0.982 . . . . 0.0 110.385 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.981 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.62 -50.8 23.34 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.534 -1.353 . . . . 0.0 110.263 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.095 HG23 ' CB ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -66.92 -4.25 2.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.439 -0.788 . . . . 0.0 109.456 178.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 26' ' ' ALA 0.256 0.0 OUTLIER -103.44 -24.72 13.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.373 -0.829 . . . . 0.0 110.36 179.954 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.785 ' CG ' HD22 ' A' ' 15' ' ' LEU . 8.4 m120 -97.05 2.8 51.81 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.99 9.8 67.31 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.998 ' CD1' HD21 ' A' ' 15' ' ' LEU . 9.0 mt -72.59 -59.13 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.439 -1.036 . . . . 0.0 108.757 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 1.095 ' CB ' HG23 ' A' ' 28' ' ' VAL . 6.9 m-30 -80.82 53.18 1.87 Allowed 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.567 0.699 . . . . 0.0 110.246 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -48.99 -22.55 0.89 Allowed 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.488 -0.757 . . . . 0.0 109.724 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 35' ' ' ILE . 3.3 tp -95.06 135.35 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.731 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.4 t -79.88 156.67 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.309 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG21 ' A' ' 47' ' ' THR . . . -79.84 -171.62 42.58 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' A' ' 45' ' ' CYS . 4.7 t0 -112.58 -26.44 8.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -1.124 . . . . 0.0 110.353 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 42' ' ' SER . 5.8 p -99.99 -15.12 18.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.108 -0.995 . . . . 0.0 110.404 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.75 43.98 94.34 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.42 1.53 80.98 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 39' ' ' CYS . 5.6 t -83.12 10.57 7.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.11 -1.23 . . . . 0.0 110.186 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.476 ' CB ' ' HG2' ' A' ' 66' ' ' ARG . . . 43.58 53.89 5.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 44' ' ' SER . 0.3 OUTLIER -140.03 16.33 2.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.375 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 1.1 p -130.05 -175.4 3.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.948 . . . . 0.0 110.216 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.532 ' HB3' ' CE3' ' A' ' 106' ' ' TRP . . . -143.99 9.31 1.49 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.29 -0.881 . . . . 0.0 110.411 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.591 HG21 ' HA2' ' A' ' 37' ' ' GLY . 15.1 t -71.37 -20.92 62.09 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.074 -1.016 . . . . 0.0 109.275 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.71 ' SG ' HD13 ' A' ' 84' ' ' LEU . 25.9 p -89.92 29.96 1.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.659 -0.651 . . . . 0.0 109.678 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.334 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 7.0 t-160 -69.97 128.78 37.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.566 -0.709 . . . . 0.0 110.732 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.822 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.1 m -157.09 -172.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 O-C-N 121.297 -0.877 . . . . 0.0 109.468 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.822 ' N ' HG23 ' A' ' 50' ' ' VAL 0.252 81.4 m-85 -140.49 106.49 5.19 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.901 0.857 . . . . 0.0 110.823 178.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.128 ' HB ' HG22 ' A' ' 57' ' ' THR . 9.6 t -76.33 130.83 35.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.498 0 O-C-N 120.621 -1.299 . . . . 0.0 109.897 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.87 ' O ' HG23 ' A' ' 57' ' ' THR . 4.4 t30 -45.52 150.0 0.52 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.033 -1.042 . . . . 0.0 109.418 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 pt-20 -59.95 -8.46 2.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.255 -0.903 . . . . 0.0 111.888 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.58 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -97.24 9.15 43.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.671 -1.268 . . . . 0.0 110.779 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 1.1 ' CB ' HD13 ' A' ' 97' ' ' ILE . 90.5 m-85 -140.68 2.72 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 109.919 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 1.128 HG22 ' HB ' ' A' ' 52' ' ' VAL . 24.9 p -90.82 -40.48 11.76 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.979 -1.076 . . . . 0.0 108.375 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.55 -0.9 51.54 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.711 0.767 . . . . 0.0 110.664 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.055 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.26 0.0 OUTLIER -99.26 -47.95 5.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.479 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.064 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.334 0.9 OUTLIER -74.88 179.52 1.33 Allowed Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 113.529 -1.669 . . . . 0.0 106.751 178.585 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 1.064 ' HD2' HG13 ' A' ' 60' ' ' VAL . 36.9 Cg_endo -70.74 115.22 4.14 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 CA-C-O 122.951 1.146 . . . . 0.0 111.796 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.33 69.8 1.63 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.833 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -37.5 159.48 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.223 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -105.6 -154.79 0.52 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.201 -0.937 . . . . 0.0 111.362 -178.547 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 64' ' ' ASN . 6.2 pt-20 -31.98 -31.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.023 -0.423 . . . . 0.0 111.841 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 64' ' ' ASN . 3.5 mtm180 -52.84 -71.68 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.701 -1.25 . . . . 0.0 107.812 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.604 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 2.5 tm-20 -61.25 -48.65 80.5 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.349 -0.844 . . . . 0.0 109.321 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.552 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.1 mp -54.19 -16.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.367 -0.833 . . . . 0.0 110.421 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -89.23 -75.99 1.3 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.642 ' SD ' ' S1 ' ' A' ' 107' ' ' FES . 0.0 OUTLIER -43.81 -40.27 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.272 -1.134 . . . . 0.0 108.486 178.549 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.0 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -65.3 -51.49 60.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.437 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -57.39 -22.4 42.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.951 -1.093 . . . . 0.0 108.646 178.326 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.53 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.79 -43.31 30.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.626 -0.671 . . . . 0.0 110.615 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.0 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.7 m -39.2 161.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.571 -0.705 . . . . 0.0 109.892 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.812 HG22 ' O ' ' A' ' 75' ' ' THR . 21.6 m -120.39 30.91 6.71 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.103 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.334 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -114.18 -166.5 1.11 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.701 -1.2 . . . . 0.0 112.493 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.75 63.27 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.616 -178.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.918 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.44 154.03 14.66 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 118.805 -2.434 . . . . 0.0 111.243 -177.003 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.532 ' CE ' ' HG3' ' A' ' 77' ' ' GLU 0.347 0.4 OUTLIER -131.43 179.65 1.3 Allowed Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.275 -174.794 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.429 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 45.7 Cg_endo -77.37 -27.94 6.05 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 N-CA-C 106.96 -1.977 . . . . 0.0 106.96 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.876 ' HB2' HG21 ' A' ' 57' ' ' THR . 19.3 p-10 -107.89 16.9 23.06 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.166 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.801 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -45.61 152.62 0.31 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.155 -0.966 . . . . 0.0 109.309 179.006 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.646 HH21 HG12 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -165.11 144.59 6.8 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.139 -1.424 . . . . 0.0 111.237 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.71 HD13 ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -97.62 109.3 22.08 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.585 ' SG ' ' N ' ' A' ' 24' ' ' MET . 7.2 t -28.68 -32.79 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' A' ' 84' ' ' LEU . 26.0 p -71.99 1.31 7.46 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.383 -1.448 . . . . 0.0 110.703 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.499 ' HG3' ' HE1' ' A' ' 70' ' ' MET . 33.2 mm-40 -125.22 20.49 8.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.994 -1.066 . . . . 0.0 110.52 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.584 ' CD1' ' NE ' ' A' ' 83' ' ' ARG . 6.8 mm -119.94 99.91 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.029 -1.044 . . . . 0.0 110.305 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.955 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -82.71 129.39 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.844 -1.16 . . . . 0.0 109.563 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.996 ' SD ' HG21 ' A' ' 97' ' ' ILE . 1.4 tpt -82.68 125.78 31.61 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.583 -0.698 . . . . 0.0 110.422 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.51 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 2.0 p -114.09 162.17 24.37 Favored Pre-proline 0 C--N 1.292 -1.913 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.903 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.59 ' HD3' ' CB ' ' A' ' 19' ' ' ASP . 37.9 Cg_endo -64.33 -13.69 39.71 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 O-C-N 124.658 1.873 . . . . 0.0 108.372 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.51 ' HG2' ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -84.76 -38.69 19.33 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.055 HD21 ' CB ' ' A' ' 59' ' ' LYS . 68.5 mt -90.5 31.09 1.06 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.725 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.498 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 6.3 p-10 -63.59 107.19 1.09 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.922 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.638 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.93 22.32 1.98 Allowed Glycine 0 N--CA 1.498 2.799 0 O-C-N 120.817 -1.177 . . . . 0.0 110.328 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.104 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -59.0 140.67 17.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.634 -0.921 . . . . 0.0 111.497 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.104 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.2 t -114.75 111.47 36.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -98.89 154.83 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.631 -1.293 . . . . 0.0 109.764 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 1.3 m-20 -122.43 123.11 40.56 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.243 -0.911 . . . . 0.0 110.087 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.612 HG12 ' CE1' ' A' ' 8' ' ' HIS . 72.2 t -102.27 121.55 49.82 Favored Pre-proline 0 C--N 1.289 -2.063 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.3 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.752 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 53.6 Cg_endo -75.51 172.83 15.57 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.835 1.69 . . . . 0.0 112.048 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.51 -18.17 24.55 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.425 0.631 . . . . 0.0 109.371 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.713 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.95 73.51 0.82 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.46 ' CG ' ' HG2' ' A' ' 102' ' ' PRO . 1.2 mt-30 -98.63 56.26 1.11 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.266 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.591 ' OXT' ' CD2' ' A' ' 106' ' ' TRP . 1.5 p-90 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.852 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.642 ' S1 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' A' ' 91' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.648 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -78.32 150.61 33.24 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.097 178.511 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.914 ' HA ' HG23 ' A' ' 97' ' ' ILE . 43.4 t -140.23 135.59 36.73 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 O-C-N 121.436 -0.79 . . . . 0.0 110.767 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 13' ' ' ARG . 39.2 t -141.81 91.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.77 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.661 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 42.3 m-85 -68.41 136.15 52.85 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 101' ' ' VAL . 98.7 t -98.91 163.82 2.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.6 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 81.9 p -98.59 -150.99 0.37 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.983 -1.073 . . . . 0.0 108.608 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.642 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -92.84 -30.53 15.4 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 119.763 -1.835 . . . . 0.0 107.815 178.22 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.506 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 3.1 p-10 -92.39 2.45 56.65 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.629 -0.67 . . . . 0.0 111.244 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 103.43 -8.39 52.15 Favored Glycine 0 N--CA 1.502 3.074 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.889 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -70.87 130.94 42.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.611 -1.523 . . . . 0.0 107.31 178.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -121.05 -172.33 2.38 Favored 'General case' 0 C--N 1.273 -2.758 0 O-C-N 120.862 -1.149 . . . . 0.0 112.567 -178.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.646 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.3 179.9 6.04 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 177.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.714 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 6.7 mt-10 -150.45 105.3 3.31 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.182 -1.574 . . . . 0.0 110.687 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.993 HD21 ' CD1' ' A' ' 32' ' ' ILE 0.256 8.4 mt -99.5 -156.2 0.54 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.889 0.852 . . . . 0.0 110.357 178.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -146.74 72.78 1.29 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.054 HG13 ' CG1' ' A' ' 21' ' ' VAL 0.255 14.7 t -86.5 120.15 35.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.505 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.56 -172.86 3.74 Favored 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.35 1.072 . . . . 0.0 111.969 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -68.65 117.1 9.94 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 177.18 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.583 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 112.8 -16.39 23.45 Favored Glycine 0 C--N 1.275 -2.855 0 C-N-CA 118.977 -1.582 . . . . 0.0 109.719 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.054 ' CG1' HG13 ' A' ' 17' ' ' VAL . 43.1 t -97.01 144.09 11.23 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.006 0 C-N-CA 117.144 -1.822 . . . . 0.0 108.564 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER -96.4 134.79 39.12 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.104 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.667 HD22 HG11 ' A' ' 3' ' ' VAL 0.27 7.6 mt -46.09 -30.1 1.76 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 123.833 1.778 . . . . 0.0 108.198 178.605 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.659 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -73.65 -12.28 60.69 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.721 -179.245 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.648 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.2 tt0 -95.52 -59.9 1.78 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.956 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -56.76 -49.43 75.29 Favored 'General case' 0 C--O 1.199 -1.559 0 C-N-CA 118.022 -1.471 . . . . 0.0 110.572 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.935 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.0 -53.43 12.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.611 -1.305 . . . . 0.0 109.802 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.932 HG23 ' HB3' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -63.52 -3.76 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 121.352 0.596 . . . . 0.0 110.268 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 26' ' ' ALA 0.265 0.0 OUTLIER -105.44 -29.22 10.36 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.482 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.743 ' CG ' HD22 ' A' ' 15' ' ' LEU . 7.9 m120 -96.37 4.27 52.34 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.57 62.72 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 118.416 -1.85 . . . . 0.0 110.315 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.993 ' CD1' HD21 ' A' ' 15' ' ' LEU . 11.2 mt -77.08 -60.83 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.492 -1.005 . . . . 0.0 108.652 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.932 ' HB3' HG23 ' A' ' 28' ' ' VAL . 3.8 m-30 -82.0 54.43 2.48 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 121.982 0.896 . . . . 0.0 110.571 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -46.97 -31.28 3.07 Favored 'General case' 0 C--N 1.271 -2.808 0 O-C-N 120.514 -1.366 . . . . 0.0 111.114 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.418 ' HA ' HD13 ' A' ' 35' ' ' ILE . 11.5 mm -69.46 130.78 34.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.834 ' O ' HG13 ' A' ' 36' ' ' VAL . 6.1 p -92.24 58.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.945 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.26 69.88 3.08 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -99.52 86.09 3.28 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 121.061 -1.259 . . . . 0.0 111.623 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 7.4 p -61.05 -9.15 3.98 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.0 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 53.77 46.13 68.09 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.728 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.34 28.76 62.29 Favored Glycine 0 N--CA 1.507 3.378 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 43' ' ' ALA . 45.8 t -99.82 12.98 35.31 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 118.046 0.923 . . . . 0.0 108.977 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 42' ' ' SER . . . 41.99 54.28 4.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.364 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.74 9.0 6.39 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.444 -0.902 . . . . 0.0 112.005 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -130.57 168.81 16.48 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 118.208 -1.397 . . . . 0.0 112.474 -178.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.522 ' O ' ' OXT' ' A' ' 106' ' ' TRP . . . -150.25 10.28 0.68 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.4 p -87.16 -4.35 59.11 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.031 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.7 ' SG ' HD13 ' A' ' 84' ' ' LEU . 23.8 p -91.78 29.97 1.45 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 110.886 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.227 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 11.7 t-160 -68.5 134.84 50.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.441 -1.412 . . . . 0.0 110.959 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.727 HG23 ' N ' ' A' ' 51' ' ' TYR . 2.0 m -159.74 179.89 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.641 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.727 ' N ' HG23 ' A' ' 50' ' ' VAL 0.275 65.8 m-85 -138.53 113.19 8.99 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 121.596 0.712 . . . . 0.0 110.959 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.005 ' HB ' HG22 ' A' ' 57' ' ' THR . 3.9 t -82.61 131.35 33.96 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 O-C-N 120.869 -1.144 . . . . 0.0 109.346 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.871 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -44.58 155.17 0.1 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.076 -1.049 . . . . 0.0 108.727 177.331 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -67.45 -1.07 4.3 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.839 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.626 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.45 5.31 48.16 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.564 -1.335 . . . . 0.0 111.393 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.879 ' CB ' HD13 ' A' ' 97' ' ' ILE . 70.6 m-85 -140.17 2.2 1.88 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.328 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 1.02 HG21 ' HB2' ' A' ' 81' ' ' ASN . 17.7 p -89.08 -30.28 18.78 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.318 -1.489 . . . . 0.0 107.748 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -107.8 20.74 18.39 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.015 -178.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.02 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.302 0.3 OUTLIER -125.93 -47.62 1.65 Allowed 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 124.455 2.074 . . . . 0.0 106.72 179.535 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.032 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.347 0.6 OUTLIER -75.68 -176.65 0.6 Allowed Pre-proline 0 C--N 1.273 -2.727 0 CA-C-N 113.093 -1.867 . . . . 0.0 107.153 179.244 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 1.032 ' HD2' HG13 ' A' ' 60' ' ' VAL . 37.5 Cg_endo -59.6 122.73 11.95 Favored 'Trans proline' 0 C--N 1.294 -2.307 0 CA-C-O 122.621 1.009 . . . . 0.0 111.354 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.473 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -70.77 67.93 0.4 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.041 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.561 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -37.34 151.89 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.143 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' A' ' 66' ' ' ARG . 48.7 p-10 -92.55 -164.21 1.15 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.033 0.92 . . . . 0.0 111.744 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 69' ' ' GLY . 24.6 pt-20 -55.56 -25.48 38.15 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.519 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.532 ' O ' ' HG2' ' A' ' 70' ' ' MET . 0.2 OUTLIER -55.71 -61.57 2.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 119.785 -1.822 . . . . 0.0 107.049 177.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 1.079 ' HA ' ' HE3' ' A' ' 70' ' ' MET . 1.0 OUTLIER -57.76 -49.41 76.67 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.701 -0.624 . . . . 0.0 109.922 177.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 58.0 mt -73.77 -0.9 2.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.058 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -94.25 -76.45 1.33 Allowed Glycine 0 C--O 1.202 -1.871 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . 1.079 ' HE3' ' HA ' ' A' ' 67' ' ' GLU . 1.6 ptt? -46.81 -25.81 0.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.02 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -74.56 -48.38 27.19 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.255 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.539 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -57.71 -16.01 9.63 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 119.972 -1.705 . . . . 0.0 108.328 177.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.585 ' O ' ' NE1' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -86.57 -30.34 21.94 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 120.509 -0.476 . . . . 0.0 112.033 -177.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.02 HG22 ' O ' ' A' ' 71' ' ' LEU . 22.3 m -48.83 170.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.789 HG22 ' O ' ' A' ' 75' ' ' THR . 23.5 m -120.15 16.93 12.41 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 109.534 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.227 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -105.76 -164.97 1.06 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.849 1.309 . . . . 0.0 113.589 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.811 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -52.39 61.8 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.573 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.877 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -56.34 154.21 8.56 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 114.911 -2.716 . . . . 0.0 110.142 -177.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.693 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.402 1.0 OUTLIER -135.19 174.34 4.71 Favored Pre-proline 0 C--N 1.277 -2.584 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.152 -173.704 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.94 -26.24 22.24 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 N-CA-C 107.782 -1.661 . . . . 0.0 107.782 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 1.02 ' HB2' HG21 ' A' ' 57' ' ' THR . 15.6 p-10 -110.27 16.29 21.79 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.716 0.769 . . . . 0.0 110.555 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.84 ' OG ' ' HG ' ' A' ' 78' ' ' LEU 0.256 0.5 OUTLIER -45.24 158.36 0.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.066 -1.021 . . . . 0.0 110.675 178.597 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.812 ' HD3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -168.56 153.26 6.1 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 117.475 -1.69 . . . . 0.0 114.315 -179.039 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.7 HD13 ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -105.94 88.65 2.86 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 24' ' ' MET . 1.5 t -12.32 -52.02 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.545 ' N ' ' O ' ' A' ' 84' ' ' LEU . 8.7 p -50.92 -9.65 0.06 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.084 -1.01 . . . . 0.0 111.636 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.435 ' HB3' ' CD ' ' A' ' 67' ' ' GLU . 1.1 mp0 -119.15 20.45 12.64 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 119.707 -1.871 . . . . 0.0 111.375 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.812 HD11 ' HD3' ' A' ' 83' ' ' ARG . 8.7 mm -118.91 117.64 55.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.71 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.926 ' O ' HG22 ' A' ' 60' ' ' VAL . 3.6 mm -100.21 131.69 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.451 -0.781 . . . . 0.0 109.364 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.891 ' SD ' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -82.04 129.71 34.87 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.36 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.732 ' OG1' ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -110.96 163.51 17.13 Favored Pre-proline 0 C--N 1.288 -2.072 0 C-N-CA 118.265 -1.374 . . . . 0.0 109.858 179.053 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.496 ' HD3' ' OD1' ' A' ' 19' ' ' ASP . 43.2 Cg_endo -65.18 -9.3 21.33 Favored 'Trans proline' 0 C--N 1.283 -2.883 0 O-C-N 124.641 1.864 . . . . 0.0 110.285 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.732 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.6 OUTLIER -93.69 -28.63 15.85 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 116.992 -1.883 . . . . 0.0 107.853 177.001 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.02 HD21 ' CB ' ' A' ' 59' ' ' LYS . 70.7 mt -91.71 33.94 1.01 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.09 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 19.4 p-10 -64.29 103.72 0.67 Allowed 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.931 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.631 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 125.26 17.68 2.66 Favored Glycine 0 N--CA 1.504 3.212 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.716 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.039 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -51.07 144.3 2.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.322 0.582 . . . . 0.0 109.526 178.754 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.039 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.5 t -122.07 113.24 38.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.553 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -98.07 160.41 3.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 119.958 -1.714 . . . . 0.0 110.497 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.694 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -123.18 120.4 33.09 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 109.55 -178.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.6 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 76.5 t -96.27 126.95 42.08 Favored Pre-proline 0 C--N 1.291 -1.954 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.807 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.663 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 43.9 Cg_endo -79.65 166.04 22.08 Favored 'Trans proline' 0 C--N 1.295 -2.238 0 O-C-N 123.695 1.366 . . . . 0.0 110.797 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -89.42 -15.96 31.99 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.648 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.42 83.8 1.82 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.5 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.525 ' HG2' ' HG2' ' A' ' 102' ' ' PRO . 42.9 mt-30 -102.03 57.46 0.81 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.576 -1.25 . . . . 0.0 111.072 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.624 ' OXT' ' CG ' ' A' ' 106' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 O-C-N 121.244 -0.91 . . . . 0.0 110.601 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.979 ' S1 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.622 ' CB ' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.356 0.598 . . . . 0.0 110.361 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.939 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -78.04 146.67 35.16 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.275 -0.89 . . . . 0.0 108.999 177.461 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.827 HG22 HG21 ' A' ' 97' ' ' ILE . 19.9 t -136.67 136.33 48.31 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.186 0 O-C-N 121.055 -1.028 . . . . 0.0 111.735 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 13' ' ' ARG . 59.9 t -141.3 89.89 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.696 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.677 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 29.5 m-85 -67.54 133.97 50.42 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 99' ' ' VAL . 61.9 t -99.58 172.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 120.956 -1.09 . . . . 0.0 109.576 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.559 ' HB3' HG22 ' A' ' 11' ' ' THR . 5.4 p -106.45 -145.78 0.39 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.243 -0.911 . . . . 0.0 109.623 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.575 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -96.28 -32.34 12.46 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.332 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -92.02 -8.19 46.74 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.848 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.82 -12.4 20.46 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.157 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.559 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -57.02 131.57 50.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.368 -1.666 . . . . 0.0 108.229 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -121.08 174.66 6.52 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 122.123 0.964 . . . . 0.0 112.957 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.669 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -129.13 178.84 6.13 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.017 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -151.93 109.76 3.66 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.041 -1.864 . . . . 0.0 111.289 178.441 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.96 HD11 ' HA ' ' A' ' 27' ' ' ALA . 3.6 mt -103.72 -157.98 0.64 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.449 1.119 . . . . 0.0 110.842 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 16' ' ' ASP . 27.2 t0 -149.5 67.91 1.02 Allowed 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.026 HG12 ' HB ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -88.85 124.62 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.108 0.956 . . . . 0.0 110.008 -177.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.05 179.81 5.86 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.243 1.021 . . . . 0.0 113.112 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.622 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -57.42 117.6 4.29 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.644 177.134 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.629 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 111.58 -25.06 14.02 Favored Glycine 0 C--N 1.286 -2.197 0 C-N-CA 119.425 -1.369 . . . . 0.0 111.381 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.026 ' HB ' HG12 ' A' ' 17' ' ' VAL . 91.2 t -85.63 149.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 120.082 1.941 . . . . 0.0 109.742 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -96.05 125.32 40.5 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.407 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.8 HD22 HG11 ' A' ' 3' ' ' VAL . 8.6 mt -41.77 -27.84 0.13 Allowed 'General case' 0 C--O 1.201 -1.461 0 O-C-N 121.084 -1.01 . . . . 0.0 109.258 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.547 ' HA ' ' HE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -59.32 -49.44 77.81 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 177.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 22' ' ' SER . 8.2 tt0 -57.98 -68.79 0.21 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.714 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.881 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.77 -55.95 7.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.971 -1.08 . . . . 0.0 111.052 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.96 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.65 -48.14 28.96 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.293 -1.504 . . . . 0.0 110.196 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -70.72 -1.46 2.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.502 179.19 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -102.05 -29.3 11.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 0.0 109.674 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.794 ' CG ' HD22 ' A' ' 15' ' ' LEU . 9.3 m120 -97.73 -3.15 39.71 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.455 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . 89.79 32.98 9.43 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.119 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.867 HD12 HD11 ' A' ' 15' ' ' LEU . 5.2 mt -80.42 -65.27 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -1.166 . . . . 0.0 109.276 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.667 ' CD1' HG22 ' A' ' 32' ' ' ILE . 19.7 m-85 -80.49 11.22 3.84 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.561 -0.712 . . . . 0.0 111.036 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 31' ' ' GLY . 41.8 p-10 -79.68 45.04 0.66 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.049 -1.032 . . . . 0.0 111.163 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.0 mt -100.58 -48.32 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.134 -0.979 . . . . 0.0 109.958 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.824 HG13 ' N ' ' A' ' 37' ' ' GLY . 2.2 p -117.22 -146.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.335 -0.853 . . . . 0.0 109.809 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.824 ' N ' HG13 ' A' ' 36' ' ' VAL . . . -90.16 -161.69 37.67 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -98.33 170.08 9.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.285 -1.127 . . . . 0.0 110.184 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -100.08 24.13 9.01 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.853 1.311 . . . . 0.0 109.003 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 41' ' ' GLY . . . 65.55 6.65 29.83 Favored Glycine 0 N--CA 1.495 2.63 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.438 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 46.61 22.35 1.05 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.334 -1.412 . . . . 0.0 109.847 177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 43' ' ' ALA . 4.7 p -91.81 22.99 3.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.877 -1.367 . . . . 0.0 111.316 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 42' ' ' SER . . . 44.05 26.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.142 -0.974 . . . . 0.0 109.256 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 42' ' ' SER . 5.5 t -125.75 18.04 8.0 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.485 -0.76 . . . . 0.0 109.556 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.465 ' O ' ' S2 ' ' A' ' 107' ' ' FES . 12.2 p -129.62 -174.06 3.19 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.993 0.902 . . . . 0.0 111.017 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.668 ' HB3' ' OXT' ' A' ' 106' ' ' TRP . . . -141.17 21.38 2.25 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 39' ' ' CYS . 3.0 m -55.19 -19.44 7.94 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.171 -1.011 . . . . 0.0 108.797 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.818 ' O ' HG13 ' A' ' 50' ' ' VAL . 28.6 p -101.24 29.93 4.45 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.716 -0.615 . . . . 0.0 110.243 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.002 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 2.0 t60 -65.47 104.24 0.96 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.523 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.91 HG11 ' SG ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -140.75 -173.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.454 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.716 ' CZ ' ' CE1' ' A' ' 49' ' ' HIS 0.275 84.2 m-85 -140.63 107.21 5.32 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 121.838 0.827 . . . . 0.0 110.617 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.073 ' HB ' HG22 ' A' ' 57' ' ' THR . 3.5 t -70.88 134.29 30.29 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 O-C-N 120.222 -1.549 . . . . 0.0 109.162 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.952 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -44.8 151.44 0.29 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.683 -1.207 . . . . 0.0 109.305 178.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -61.82 -8.51 4.97 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.216 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.611 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -92.64 5.06 52.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.019 -1.051 . . . . 0.0 111.379 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.926 ' HB3' HD12 ' A' ' 97' ' ' ILE . 42.0 m-85 -140.75 4.63 1.93 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.78 -1.2 . . . . 0.0 109.715 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 1.073 HG22 ' HB ' ' A' ' 52' ' ' VAL . 14.7 p -89.67 -33.16 16.73 Favored 'General case' 0 C--N 1.288 -2.066 0 O-C-N 120.746 -1.221 . . . . 0.0 108.023 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.25 -1.91 35.18 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.863 0.84 . . . . 0.0 109.968 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.062 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.268 1.5 mtpt -99.38 -48.64 4.72 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 123.07 1.414 . . . . 0.0 107.601 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.018 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.33 0.8 OUTLIER -72.09 -178.28 0.61 Allowed Pre-proline 0 C--N 1.288 -2.068 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.053 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 1.018 ' HD2' HG13 ' A' ' 60' ' ' VAL . 33.1 Cg_endo -67.61 128.0 17.33 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 CA-C-O 123.1 1.208 . . . . 0.0 111.922 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -73.23 69.4 1.08 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.107 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.496 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -38.02 157.94 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.594 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.479 ' C ' HD13 ' A' ' 68' ' ' ILE . 49.9 p30 -127.37 -149.7 0.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.762 -1.211 . . . . 0.0 112.48 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -36.45 -30.78 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.215 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.461 ' NH1' ' HG3' ' A' ' 66' ' ' ARG . 5.9 mtm-85 -53.79 -73.2 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.699 -1.251 . . . . 0.0 109.458 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.58 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -67.98 -38.82 83.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.094 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 0.5 OUTLIER -47.52 -19.83 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.22 -0.925 . . . . 0.0 109.618 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 67' ' ' GLU . . . -90.18 -70.13 1.22 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.588 ' HG3' ' HG ' ' A' ' 84' ' ' LEU . 1.0 OUTLIER -50.3 -30.26 11.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.847 -1.384 . . . . 0.0 108.384 178.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.036 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -74.13 -50.06 21.08 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.585 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -57.13 -18.4 14.85 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.727 -1.233 . . . . 0.0 108.39 178.282 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -83.54 -34.32 25.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.719 . . . . 0.0 111.533 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.036 HG22 ' O ' ' A' ' 71' ' ' LEU . 33.3 m -42.63 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.016 -1.052 . . . . 0.0 109.851 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 75' ' ' THR . 38.2 m -121.08 11.57 10.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.936 -1.102 . . . . 0.0 110.521 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.002 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -99.59 -154.87 0.48 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 123.041 1.4 . . . . 0.0 113.063 -177.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.757 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.252 0.0 OUTLIER -64.96 63.79 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.575 -178.384 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.921 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.03 145.05 37.64 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 115.078 -2.649 . . . . 0.0 110.529 -176.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.564 ' CE ' ' HG3' ' A' ' 77' ' ' GLU 0.362 0.1 OUTLIER -119.01 177.28 1.38 Allowed Pre-proline 0 C--N 1.288 -2.103 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.787 -175.238 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.456 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 42.7 Cg_endo -75.39 -25.2 11.5 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 N-CA-C 106.36 -2.208 . . . . 0.0 106.36 175.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.769 HD22 HG21 ' A' ' 57' ' ' THR . 14.6 p-10 -112.79 22.37 14.56 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.931 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.776 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -46.14 156.57 0.15 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.658 -1.276 . . . . 0.0 109.347 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.709 ' HB2' HG23 ' A' ' 52' ' ' VAL . 2.1 mmt85 -153.02 155.1 36.26 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.347 -1.341 . . . . 0.0 111.603 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.797 HD13 ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -111.84 100.72 9.15 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.91 ' SG ' HG11 ' A' ' 50' ' ' VAL . 88.2 m -30.37 -31.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.572 ' N ' ' O ' ' A' ' 84' ' ' LEU . 28.0 p -73.21 1.87 8.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.394 -1.442 . . . . 0.0 110.621 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' A' ' 84' ' ' LEU . 5.1 tp60 -126.29 -8.9 6.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.037 -1.04 . . . . 0.0 111.685 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.659 HD11 HH11 ' A' ' 83' ' ' ARG . 0.9 OUTLIER -89.87 118.84 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.769 -1.207 . . . . 0.0 110.39 -179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.86 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -102.65 135.01 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.074 -1.016 . . . . 0.0 109.607 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.804 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.0 tpt -83.61 121.15 26.85 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.702 -0.624 . . . . 0.0 110.66 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.698 HG23 HD12 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -95.83 -176.9 0.58 Allowed Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 117.879 -1.528 . . . . 0.0 109.172 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 46.1 Cg_endo -90.06 -8.04 4.23 Favored 'Trans proline' 0 C--N 1.284 -2.842 0 O-C-N 124.204 1.634 . . . . 0.0 108.883 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.565 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.9 pt-20 -91.96 -30.53 16.05 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.767 1.27 . . . . 0.0 107.577 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.062 HD21 ' CB ' ' A' ' 59' ' ' LYS . 62.6 mt -90.1 29.35 1.23 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.333 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.539 ' HA ' ' CB ' ' A' ' 1' ' ' SER . 17.9 p-10 -62.87 104.01 0.5 Allowed 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.932 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.609 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.37 22.88 2.02 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.051 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.939 HG22 ' O ' ' A' ' 2' ' ' LYS . 3.5 tt -63.12 161.3 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.462 1.125 . . . . 0.0 112.307 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.635 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 t -134.56 116.43 21.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -99.24 156.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.647 -1.283 . . . . 0.0 109.47 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.68 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.95 111.61 16.83 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.079 -1.013 . . . . 0.0 110.637 -178.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.535 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 58.7 t -91.83 127.94 47.93 Favored Pre-proline 0 C--N 1.288 -2.081 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.75 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.622 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 58.4 Cg_endo -79.06 -179.9 5.87 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.083 1.57 . . . . 0.0 112.715 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -91.01 -14.89 30.56 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.526 ' CB ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.37 82.66 1.63 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.512 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -98.64 50.54 0.98 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 117.381 -1.728 . . . . 0.0 110.478 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.668 ' OXT' ' HB3' ' A' ' 46' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.117 -0.989 . . . . 0.0 109.888 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.465 ' S2 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.61 ' CB ' ' O ' ' A' ' 91' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.179 0.514 . . . . 0.0 110.68 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.792 ' O ' HG22 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -62.08 148.85 42.89 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.842 ' HA ' HG23 ' A' ' 97' ' ' ILE . 53.7 t -138.05 135.67 45.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 O-C-N 120.85 -1.156 . . . . 0.0 111.929 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 13' ' ' ARG . 47.5 t -143.18 92.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.717 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.664 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 34.6 m-85 -70.7 136.92 49.33 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.232 -0.917 . . . . 0.0 108.982 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.562 HG22 ' CD ' ' A' ' 12' ' ' ARG . 61.5 t -99.92 167.55 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 O-C-N 120.51 -1.369 . . . . 0.0 109.335 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.585 ' HB3' HG22 ' A' ' 11' ' ' THR . 91.2 p -103.17 -155.83 0.54 Allowed 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.15 -0.969 . . . . 0.0 109.014 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.6 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -88.51 -30.41 19.37 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -91.83 -6.08 52.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.38 0.609 . . . . 0.0 109.909 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.03 -24.65 11.5 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.71 129.55 29.95 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.671 -1.488 . . . . 0.0 108.453 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.562 ' CD ' HG22 ' A' ' 6' ' ' VAL . 1.6 mtm180 -121.53 -172.34 2.4 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-O 122.113 0.958 . . . . 0.0 112.514 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.624 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.73 -178.22 5.03 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.233 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.705 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 49.9 mt-10 -151.85 112.1 4.1 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 117.717 -1.593 . . . . 0.0 110.959 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.962 HD11 HD12 ' A' ' 32' ' ' ILE 0.254 6.5 mt -108.19 -153.38 0.5 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 122.573 1.178 . . . . 0.0 111.493 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.16 68.77 0.99 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.094 HG13 ' CG1' ' A' ' 21' ' ' VAL . 20.9 t -86.05 114.32 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.98 -170.57 2.84 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 122.098 0.951 . . . . 0.0 111.786 -177.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.514 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 2.1 p-10 -63.67 110.53 2.05 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.488 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 112.4 -16.83 24.21 Favored Glycine 0 C--N 1.286 -2.227 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.606 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.094 ' CG1' HG13 ' A' ' 17' ' ' VAL . 42.0 t -96.73 136.28 28.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 O-C-N 120.203 -1.763 . . . . 0.0 106.909 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.593 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -93.1 140.27 29.68 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.277 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.92 HD23 HG21 ' A' ' 17' ' ' VAL . 8.2 mt -47.96 -25.36 1.33 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.664 -1.273 . . . . 0.0 108.055 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.608 ' HA ' ' HE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -69.91 -29.68 66.92 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.316 -0.865 . . . . 0.0 108.667 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.618 ' CG ' HG13 ' A' ' 21' ' ' VAL . 23.6 tt0 -75.46 -70.84 0.4 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.045 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.79 -49.99 18.99 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.136 -1.426 . . . . 0.0 110.601 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.625 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.3 -41.55 19.31 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.211 -1.556 . . . . 0.0 110.796 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.68 2.1 2.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.32 -0.863 . . . . 0.0 109.646 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.261 0.0 OUTLIER -103.9 -30.38 10.37 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.4 1.095 . . . . 0.0 110.206 -179.817 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.769 ' CG ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -99.08 -6.48 28.35 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.714 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.28 32.79 15.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.962 HD12 HD11 ' A' ' 15' ' ' LEU . 4.0 mt -72.75 -55.21 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 0.0 109.166 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.618 ' CD1' HG22 ' A' ' 32' ' ' ILE . 22.3 m-30 -81.25 55.97 2.72 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.735 0.779 . . . . 0.0 110.145 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 20.1 p-10 -49.25 -19.58 0.5 Allowed 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.725 -0.609 . . . . 0.0 110.693 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -66.81 167.43 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.974 -1.079 . . . . 0.0 109.866 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 t -103.35 51.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 110.452 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.985 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -120.14 70.45 0.36 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -120.15 118.53 30.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.112 -1.228 . . . . 0.0 110.342 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 23.2 p -100.13 22.24 11.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.21 -0.931 . . . . 0.0 110.153 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.05 39.99 97.74 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.02 34.36 23.41 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.501 ' O ' ' NH2' ' A' ' 66' ' ' ARG . 37.7 p -102.75 12.05 36.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 110.136 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.856 ' HB3' ' CZ ' ' A' ' 66' ' ' ARG . . . 55.88 60.13 3.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.132 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -135.93 7.01 3.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.312 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 1.8 p -134.15 -175.34 3.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.976 . . . . 0.0 110.318 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 106' ' ' TRP . . . -143.94 9.35 1.5 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 110.297 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.985 HG21 ' HA3' ' A' ' 37' ' ' GLY . 14.8 t -77.04 -15.55 59.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.06 -1.025 . . . . 0.0 109.437 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.634 ' SG ' HD13 ' A' ' 84' ' ' LEU . 20.7 p -88.23 26.56 1.38 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.607 -0.683 . . . . 0.0 110.26 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.336 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 6.2 t-160 -70.26 125.49 26.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.431 -0.793 . . . . 0.0 109.899 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.824 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -153.37 -171.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.823 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.824 ' N ' HG23 ' A' ' 50' ' ' VAL 0.263 81.6 m-85 -140.81 113.27 8.04 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.734 0.778 . . . . 0.0 110.95 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.985 ' HB ' HG22 ' A' ' 57' ' ' THR . 5.6 t -80.39 132.44 31.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 O-C-N 120.426 -1.422 . . . . 0.0 109.796 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.905 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -43.88 158.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.544 -1.262 . . . . 0.0 108.772 177.168 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.18 1.53 7.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.759 -1.213 . . . . 0.0 110.144 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.594 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.06 5.59 46.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.792 ' CB ' HD13 ' A' ' 97' ' ' ILE . 57.7 m-85 -140.27 4.9 2.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.92 -1.112 . . . . 0.0 109.35 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.985 HG22 ' HB ' ' A' ' 52' ' ' VAL . 33.8 p -89.35 -39.67 13.28 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.26 -1.79 47.33 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.755 0.788 . . . . 0.0 110.661 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.052 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.26 0.8 OUTLIER -99.31 -47.68 5.08 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 123.207 1.48 . . . . 0.0 107.559 179.877 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.079 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.329 0.7 OUTLIER -78.31 -179.91 1.49 Allowed Pre-proline 0 C--N 1.286 -2.177 0 CA-C-N 113.624 -1.626 . . . . 0.0 107.921 179.811 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 1.079 ' HD2' HG13 ' A' ' 60' ' ' VAL . 37.9 Cg_endo -69.97 106.75 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 CA-C-O 122.655 1.023 . . . . 0.0 111.836 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.544 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -60.21 74.45 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.766 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 67' ' ' GLU . . . -36.78 153.2 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.951 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 66' ' ' ARG . 3.5 p30 -108.1 -159.75 0.7 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.165 -0.959 . . . . 0.0 111.858 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 7.4 pt-20 -29.68 -34.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.099 -0.375 . . . . 0.0 111.918 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.856 ' CZ ' ' HB3' ' A' ' 43' ' ' ALA . 5.7 mmt180 -53.09 -66.23 0.42 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 120.78 -1.2 . . . . 0.0 107.772 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 1.005 ' HG3' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -61.09 -49.08 78.78 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.14 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 1.005 HD12 ' HG3' ' A' ' 67' ' ' GLU . 1.1 mp -57.73 -12.69 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.337 -0.852 . . . . 0.0 111.183 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -89.91 -79.76 1.34 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.703 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.88 -38.77 3.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -1.177 . . . . 0.0 108.846 179.216 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.995 ' O ' HG22 ' A' ' 74' ' ' VAL . 1.0 OUTLIER -64.99 -50.74 65.15 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.525 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -57.17 -22.19 38.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.224 -0.923 . . . . 0.0 108.844 178.553 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.53 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -80.18 -42.29 23.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.477 -0.764 . . . . 0.0 110.744 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.995 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.7 m -39.0 161.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.526 -0.734 . . . . 0.0 110.089 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 75' ' ' THR . 24.2 m -120.52 29.49 7.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 109.245 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.336 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -112.91 -166.38 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.45 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.6 63.36 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.493 -178.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.905 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.47 152.42 18.03 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 118.848 -2.407 . . . . 0.0 111.389 -176.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.526 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.35 0.0 OUTLIER -128.73 -175.97 0.49 Allowed Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.526 -174.824 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 47.0 Cg_endo -80.67 -30.0 2.03 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 N-CA-C 106.987 -1.967 . . . . 0.0 106.987 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.716 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.7 OUTLIER -105.28 13.21 30.81 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.381 178.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.808 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -44.27 147.54 0.54 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.221 -0.924 . . . . 0.0 109.702 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.775 ' C ' HD23 ' A' ' 84' ' ' LEU . 4.6 mtt180 -166.74 153.71 9.02 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 117.798 -1.561 . . . . 0.0 112.534 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.775 HD23 ' C ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -102.63 119.08 38.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 33' ' ' TYR . 28.8 p -33.53 -28.91 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.876 -0.515 . . . . 0.0 112.349 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.565 ' HA ' ' CB ' ' A' ' 24' ' ' MET . 31.8 p -77.17 8.16 4.3 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.551 -1.343 . . . . 0.0 111.075 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.585 ' CG ' ' CE ' ' A' ' 70' ' ' MET . 19.4 mm-40 -125.68 8.73 7.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.052 -1.03 . . . . 0.0 110.384 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.713 HD12 HG11 ' A' ' 60' ' ' VAL . 3.9 mm -120.5 119.72 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.969 -1.082 . . . . 0.0 111.47 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.894 ' O ' HG22 ' A' ' 60' ' ' VAL . 4.7 mm -102.06 131.36 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.085 -1.009 . . . . 0.0 108.967 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.652 ' HE3' ' HA ' ' A' ' 90' ' ' MET . 20.2 mmm -84.13 141.1 31.32 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.899 -1.126 . . . . 0.0 110.289 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.686 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -114.14 -175.43 0.32 Allowed Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.843 -1.16 . . . . 0.0 109.988 179.279 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 44.2 Cg_endo -84.98 -9.94 8.43 Favored 'Trans proline' 0 C--N 1.285 -2.8 0 O-C-N 123.705 1.371 . . . . 0.0 108.603 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.538 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.4 pt-20 -92.16 -35.12 14.03 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.052 HD21 ' CB ' ' A' ' 59' ' ' LYS . 55.7 mt -89.77 32.22 0.9 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.726 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.47 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 6.8 p-10 -63.46 108.04 1.26 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 118.319 -1.352 . . . . 0.0 108.788 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.615 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.39 24.11 1.83 Allowed Glycine 0 N--CA 1.498 2.794 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.24 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.105 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -58.59 135.79 22.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.53 -0.983 . . . . 0.0 110.644 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.105 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.5 t -113.53 113.6 44.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -99.46 155.86 4.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.762 -1.211 . . . . 0.0 109.973 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.19 120.09 33.17 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.739 0.78 . . . . 0.0 109.842 -179.089 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.6 HG12 ' CE1' ' A' ' 8' ' ' HIS . 72.8 t -99.61 123.02 49.46 Favored Pre-proline 0 C--N 1.289 -2.06 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.3 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.755 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 55.8 Cg_endo -76.44 173.53 14.33 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.301 1.685 . . . . 0.0 112.21 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.463 ' OD1' ' CD2' ' A' ' 8' ' ' HIS . 1.3 t0 -91.57 -17.84 25.0 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.781 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.81 72.35 0.78 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.1 OUTLIER -98.42 56.02 1.13 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.285 -177.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.619 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 1.7 p-90 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.886 -1.054 . . . . 0.0 109.807 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.471 ' S1 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.972 0.891 . . . . 0.0 110.851 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.651 ' H ' ' HA ' ' A' ' 95' ' ' ASP . 4.4 mmtt -98.81 149.64 22.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.556 0.694 . . . . 0.0 109.982 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.8 HG11 HD22 ' A' ' 23' ' ' LEU . 35.4 t -141.35 139.24 32.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 O-C-N 121.623 -0.673 . . . . 0.0 111.466 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.684 HG13 ' HG2' ' A' ' 14' ' ' GLU . 45.6 t -143.18 89.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.602 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 46.9 m-85 -67.63 156.67 36.29 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.368 -0.832 . . . . 0.0 109.463 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.555 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 86.3 t -122.36 170.1 12.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.25 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.597 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 12.0 p -105.45 -154.63 0.52 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.066 -1.021 . . . . 0.0 109.738 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.567 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.91 -30.25 17.0 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.522 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.68 -10.63 39.54 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.483 0.659 . . . . 0.0 109.428 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.531 ' O ' ' CD ' ' A' ' 12' ' ' ARG . . . 114.31 -4.33 23.53 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 120.297 -0.954 . . . . 0.0 110.758 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -63.77 130.18 43.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.557 -1.555 . . . . 0.0 107.847 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -121.08 175.67 5.96 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 122.245 1.022 . . . . 0.0 112.791 -177.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -132.83 179.31 6.24 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 177.253 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.684 ' HG2' HG13 ' A' ' 4' ' ' VAL . 42.0 mt-10 -151.57 108.1 3.48 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 117.54 -1.664 . . . . 0.0 110.954 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.898 HD21 ' CD1' ' A' ' 32' ' ' ILE . 4.9 mt -99.93 -164.19 1.1 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.804 1.288 . . . . 0.0 110.976 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 1' ' ' SER . 51.4 t0 -143.82 68.23 1.28 Allowed 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.051 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.1 t -88.06 125.41 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.908 0.861 . . . . 0.0 109.247 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.531 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -89.31 -176.98 5.26 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.746 1.26 . . . . 0.0 113.268 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 90' ' ' MET . 3.1 p-10 -62.12 118.26 7.11 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.569 177.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.509 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 111.9 -22.93 17.98 Favored Glycine 0 C--N 1.284 -2.34 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.593 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.051 ' HB ' HG12 ' A' ' 17' ' ' VAL . 80.9 t -88.94 149.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 119.818 1.809 . . . . 0.0 110.314 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 25' ' ' GLN . 1.6 p -96.14 128.64 43.22 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.8 HD22 HG11 ' A' ' 3' ' ' VAL . 8.0 mt -41.07 -31.22 0.17 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.201 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.644 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -68.84 -39.29 80.04 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 118.116 -1.434 . . . . 0.0 108.658 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.589 ' CG ' HG13 ' A' ' 21' ' ' VAL . 6.1 tt0 -56.83 -65.01 0.69 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.797 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -50.73 -56.02 13.92 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.683 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.679 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.0 -41.45 16.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.513 -1.367 . . . . 0.0 110.835 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -78.94 0.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.325 -0.859 . . . . 0.0 109.435 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.259 0.0 OUTLIER -104.03 -30.01 10.54 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.232 1.015 . . . . 0.0 110.333 -179.781 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.637 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -98.97 -2.66 36.84 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 24.97 44.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.898 ' CD1' HD21 ' A' ' 15' ' ' LEU . 4.4 mt -72.78 -51.64 26.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.244 -1.151 . . . . 0.0 109.435 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.665 ' CD1' HG22 ' A' ' 32' ' ' ILE . 15.2 m-30 -80.08 54.11 1.86 Allowed 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.766 0.793 . . . . 0.0 110.125 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -60.4 -7.29 1.95 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.726 -0.609 . . . . 0.0 111.201 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.556 ' N ' ' CD1' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -66.1 -149.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.852 -1.155 . . . . 0.0 110.278 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.821 ' CG2' HG21 ' A' ' 47' ' ' THR . 22.1 m -79.32 175.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.01 -1.056 . . . . 0.0 110.387 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.87 172.41 54.83 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.527 ' OD1' ' CE ' ' A' ' 24' ' ' MET . 8.0 p-10 -120.12 -141.27 0.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -1.064 . . . . 0.0 110.346 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 42' ' ' SER . 26.3 p -92.81 7.33 44.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.185 -0.947 . . . . 0.0 110.256 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.03 24.7 75.79 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.01 8.5 66.87 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 39' ' ' CYS . 4.1 m -84.63 7.79 19.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -1.142 . . . . 0.0 110.138 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.567 ' CB ' ' HD2' ' A' ' 66' ' ' ARG . . . 46.76 55.07 8.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.289 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 t -140.11 19.2 2.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.96 . . . . 0.0 110.389 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 38' ' ' ASP . 1.7 p -129.99 -173.49 3.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 110.404 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.684 ' HB1' ' OXT' ' A' ' 106' ' ' TRP . . . -144.01 9.78 1.51 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 110.199 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.821 HG21 ' CG2' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -82.07 7.93 12.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 110.028 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.756 ' SG ' HD12 ' A' ' 84' ' ' LEU . 7.9 p -115.14 24.33 11.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.409 -0.807 . . . . 0.0 110.082 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.312 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 7.0 t-160 -65.11 122.97 18.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.493 -0.754 . . . . 0.0 110.297 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.816 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -148.42 -173.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.981 0.896 . . . . 0.0 109.89 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.816 ' N ' HG23 ' A' ' 50' ' ' VAL 0.27 75.6 m-85 -140.69 110.63 6.52 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.713 0.768 . . . . 0.0 110.855 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.979 ' HB ' HG22 ' A' ' 57' ' ' THR . 4.0 t -79.01 136.14 24.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 O-C-N 120.421 -1.425 . . . . 0.0 110.038 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.962 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -46.01 158.33 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.523 -1.271 . . . . 0.0 108.858 177.246 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' N ' ' OE2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -72.16 0.22 10.25 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.775 178.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.594 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.28 4.26 48.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.059 -1.026 . . . . 0.0 110.584 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.84 ' HB3' HD12 ' A' ' 97' ' ' ILE . 35.3 m-85 -140.19 6.72 2.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.06 . . . . 0.0 109.299 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.979 HG22 ' HB ' ' A' ' 52' ' ' VAL . 45.6 p -89.39 -39.86 13.13 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.9 -2.47 53.27 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.827 0.822 . . . . 0.0 110.335 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.084 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.261 0.0 OUTLIER -99.56 -47.88 4.95 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 122.971 1.367 . . . . 0.0 107.636 -179.961 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.076 HG11 HG23 ' A' ' 88' ' ' ILE 0.33 0.9 OUTLIER -77.54 177.97 2.4 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.113 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 1.038 ' HD2' HG13 ' A' ' 60' ' ' VAL . 38.2 Cg_endo -71.38 110.02 2.75 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 CA-C-O 122.565 0.985 . . . . 0.0 112.276 -176.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -60.21 70.95 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.108 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' PRO . . . -37.21 134.25 0.6 Allowed 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.88 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' ARG . 43.1 p-10 -88.76 -150.11 0.19 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.111 0.958 . . . . 0.0 112.252 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 64' ' ' ASN . 11.7 pt-20 -37.97 -26.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.573 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.567 ' HD2' ' CB ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -53.0 -70.91 0.08 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.752 -1.218 . . . . 0.0 108.025 179.57 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.683 ' HA ' ' HE3' ' A' ' 70' ' ' MET . 0.7 OUTLIER -67.38 -51.5 51.27 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 0.9 OUTLIER -44.65 -24.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.465 -0.772 . . . . 0.0 110.108 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.488 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -84.07 -83.08 0.97 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.137 -1.985 . . . . 0.0 108.137 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.683 ' HE3' ' HA ' ' A' ' 67' ' ' GLU . 1.7 ptt? -39.65 -40.52 0.92 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.578 -0.954 . . . . 0.0 108.934 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.0 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -61.71 -53.49 55.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.328 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.562 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 3.8 tp10 -56.22 -21.95 26.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.526 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.97 -45.65 23.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.648 -0.657 . . . . 0.0 110.377 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.0 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.3 m -38.94 159.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.556 -0.715 . . . . 0.0 109.733 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.81 HG22 ' O ' ' A' ' 75' ' ' THR . 20.5 m -120.56 34.53 5.18 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.075 -1.015 . . . . 0.0 108.96 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.312 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -115.88 -164.37 0.95 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.628 1.204 . . . . 0.0 112.649 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.751 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.251 0.0 OUTLIER -56.79 62.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.391 -178.843 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.929 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.11 153.65 14.38 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 118.845 -2.409 . . . . 0.0 111.081 -176.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.695 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.387 2.4 mmtt -131.93 177.48 2.22 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.151 -173.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.506 ' HD2' ' HD3' ' A' ' 79' ' ' LYS . 42.9 Cg_endo -73.4 -27.56 13.14 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 176.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.673 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.9 OUTLIER -109.38 13.88 23.94 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.041 179.362 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.75 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -45.04 147.29 0.7 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.954 -1.091 . . . . 0.0 109.649 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.746 ' CD ' HD11 ' A' ' 88' ' ' ILE . 1.1 mtt180 -167.47 163.11 14.84 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 117.765 -1.574 . . . . 0.0 113.01 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.782 ' N ' HD22 ' A' ' 84' ' ' LEU . 3.4 mm? -99.22 122.63 42.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.539 ' CB ' ' OH ' ' A' ' 33' ' ' TYR . 1.9 p -42.92 -23.25 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.167 -0.958 . . . . 0.0 110.713 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 30.4 p -81.49 4.85 19.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.811 -1.181 . . . . 0.0 110.496 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.531 ' HG3' ' CE ' ' A' ' 70' ' ' MET . 18.7 mm-40 -125.22 9.0 7.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 110.827 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.076 HG23 HG11 ' A' ' 60' ' ' VAL . 30.1 mm -113.71 106.96 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.038 -1.039 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.024 ' O ' HG22 ' A' ' 60' ' ' VAL . 4.2 mm -84.88 131.52 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.976 -1.078 . . . . 0.0 110.046 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.669 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.8 tpt -82.62 113.74 20.52 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.359 -0.838 . . . . 0.0 110.823 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.902 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -91.5 -177.34 0.73 Allowed Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 117.516 -1.674 . . . . 0.0 108.642 178.386 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 46.9 Cg_endo -87.11 -12.61 4.82 Favored 'Trans proline' 0 C--N 1.287 -2.67 0 O-C-N 124.412 1.743 . . . . 0.0 108.651 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.541 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.1 pt-20 -85.2 -32.67 22.54 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.084 HD21 ' CB ' ' A' ' 59' ' ' LYS . 57.7 mt -89.33 36.54 0.83 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.68 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.651 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 12.8 p-10 -62.3 99.82 0.15 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.036 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.579 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 120.67 29.52 1.54 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.268 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.84 HD12 ' HB3' ' A' ' 56' ' ' PHE . 9.5 tt -60.19 163.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.496 -1.591 . . . . 0.0 112.3 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.684 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.3 t -133.1 114.1 20.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.604 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -102.18 154.7 5.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 120.92 -1.113 . . . . 0.0 109.992 -178.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.635 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -122.63 122.91 39.94 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.764 0.792 . . . . 0.0 110.487 -178.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 73.6 t -98.45 136.33 20.88 Favored Pre-proline 0 C--N 1.289 -2.045 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.631 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.619 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 56.0 Cg_endo -89.76 173.59 3.58 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 121.716 1.61 . . . . 0.0 111.818 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 18.3 p-10 -91.2 -17.15 26.52 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.818 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.98 74.92 0.89 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.68 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.506 ' HG2' ' HG2' ' A' ' 102' ' ' PRO . 10.9 mt-30 -98.49 54.08 1.05 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.299 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.684 ' OXT' ' HB1' ' A' ' 46' ' ' ALA . 1.4 p-90 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.082 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.574 ' S1 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.57 ' HB2' ' O ' ' A' ' 91' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.204 0.526 . . . . 0.0 110.22 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.735 ' O ' HG22 ' A' ' 97' ' ' ILE . 11.3 mtmt -69.99 149.47 47.69 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.248 -0.908 . . . . 0.0 110.175 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.864 ' HA ' HG23 ' A' ' 97' ' ' ILE . 44.9 t -137.94 135.01 45.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 O-C-N 121.119 -0.988 . . . . 0.0 111.024 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 13' ' ' ARG . 48.8 t -142.29 92.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.154 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.647 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 36.6 m-85 -70.87 137.3 49.25 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.502 -0.749 . . . . 0.0 109.326 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.57 HG22 ' CD ' ' A' ' 12' ' ' ARG . 74.7 t -99.86 166.49 2.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 O-C-N 120.807 -1.183 . . . . 0.0 109.035 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.586 ' HB3' HG22 ' A' ' 11' ' ' THR . 82.8 p -102.21 -154.88 0.5 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.066 -1.021 . . . . 0.0 108.925 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.594 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -89.52 -31.25 17.72 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.485 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 6.1 p-10 -92.01 -5.1 53.6 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.313 0.577 . . . . 0.0 109.792 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.4 -24.65 11.16 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.76 129.31 29.4 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.567 -1.549 . . . . 0.0 108.38 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.57 ' CD ' HG22 ' A' ' 6' ' ' VAL . 5.4 mtt180 -121.53 -172.47 2.43 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 122.187 0.994 . . . . 0.0 112.563 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.65 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -136.7 -178.85 5.36 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.719 ' C ' HD23 ' A' ' 15' ' ' LEU . 35.3 mt-10 -151.86 112.23 4.13 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 117.788 -1.565 . . . . 0.0 110.711 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.954 HD11 ' HA ' ' A' ' 27' ' ' ALA 0.253 3.5 mt -107.86 -152.3 0.48 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.464 1.126 . . . . 0.0 111.207 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -150.37 70.36 1.02 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.082 HG13 ' CG1' ' A' ' 21' ' ' VAL . 12.7 t -86.8 113.7 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.541 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.17 -169.89 2.58 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.03 0.919 . . . . 0.0 111.504 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.414 ' O ' ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -63.86 110.53 2.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.741 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 112.28 -17.2 24.24 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.558 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.082 ' CG1' HG13 ' A' ' 17' ' ' VAL . 42.9 t -95.58 137.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 O-C-N 120.134 -1.804 . . . . 0.0 107.358 178.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -95.56 144.03 26.36 Favored 'General case' 0 C--N 1.274 -2.69 0 C-N-CA 118.647 -1.221 . . . . 0.0 108.032 178.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.877 HD23 HG21 ' A' ' 17' ' ' VAL . 12.2 mt -49.81 -25.98 3.55 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.09 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.576 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -72.21 -18.67 61.82 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.618 ' CG ' HG13 ' A' ' 21' ' ' VAL . 24.7 tt0 -88.48 -71.96 0.56 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.06 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -47.2 -50.09 21.52 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.166 -1.413 . . . . 0.0 110.349 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.954 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.81 -48.21 30.69 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.354 -1.466 . . . . 0.0 110.361 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.617 HG23 ' HB2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -72.97 0.55 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.594 -0.691 . . . . 0.0 109.627 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.34 -29.25 11.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.393 -0.817 . . . . 0.0 110.016 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.868 ' CG ' HD22 ' A' ' 15' ' ' LEU . 8.7 m120 -97.73 -0.97 44.46 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.72 22.39 43.21 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.934 HD12 HD11 ' A' ' 15' ' ' LEU . 4.9 mt -72.64 -60.29 2.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.295 -1.121 . . . . 0.0 109.237 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.644 ' CE2' ' CB ' ' A' ' 27' ' ' ALA . 21.7 m-30 -80.79 50.73 1.4 Allowed 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.552 0.691 . . . . 0.0 110.58 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 13.3 p-10 -49.47 -21.45 0.93 Allowed 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.63 -0.669 . . . . 0.0 110.224 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 36' ' ' VAL . 23.0 mm -67.13 176.16 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 0.0 109.979 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.554 ' N ' HG22 ' A' ' 35' ' ' ILE . 86.6 t -95.63 80.35 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 110.369 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.6 ' CA ' HG21 ' A' ' 47' ' ' THR . . . -120.08 62.86 0.48 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -120.09 71.23 0.89 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -1.144 . . . . 0.0 110.317 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 19.6 p -88.36 24.99 1.76 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 110.198 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.41 33.05 86.19 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.93 22.55 4.6 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.52 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 84.0 p -89.91 11.0 21.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -1.153 . . . . 0.0 110.174 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 58.98 60.03 2.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 4.6 t -132.13 11.65 4.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 0.0 110.473 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 1.8 p -133.36 -173.64 3.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.124 -0.985 . . . . 0.0 110.338 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.733 ' HB1' ' OXT' ' A' ' 106' ' ' TRP . . . -148.5 9.63 0.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.873 . . . . 0.0 110.672 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.6 HG21 ' CA ' ' A' ' 37' ' ' GLY . 12.6 t -82.55 -16.62 47.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.874 -1.141 . . . . 0.0 109.702 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.674 ' SG ' HD13 ' A' ' 84' ' ' LEU . 24.9 p -89.13 28.2 1.25 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.472 -0.767 . . . . 0.0 109.879 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.314 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 8.0 t-160 -70.32 126.55 29.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.379 -0.826 . . . . 0.0 110.14 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.803 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -156.14 -173.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.05 -1.031 . . . . 0.0 110.102 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.803 ' N ' HG23 ' A' ' 50' ' ' VAL 0.269 76.9 m-85 -140.92 109.9 6.12 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.656 0.741 . . . . 0.0 110.773 179.295 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.044 ' HB ' HG22 ' A' ' 57' ' ' THR . 4.1 t -76.58 131.64 34.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 O-C-N 120.225 -1.547 . . . . 0.0 110.773 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.809 ' O ' HG23 ' A' ' 57' ' ' THR . 3.7 t30 -47.82 146.28 2.46 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.608 -1.237 . . . . 0.0 108.668 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -59.0 -8.0 1.27 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.058 -1.026 . . . . 0.0 112.072 -178.393 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.57 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -94.76 8.1 43.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.469 -1.394 . . . . 0.0 110.532 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 1.095 ' CB ' HD13 ' A' ' 97' ' ' ILE . 87.3 m-85 -140.14 3.5 1.98 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 109.754 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 1.044 HG22 ' HB ' ' A' ' 52' ' ' VAL . 23.7 p -90.43 -40.54 11.98 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.1 -1.0 . . . . 0.0 108.467 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.92 -0.87 55.4 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.782 0.801 . . . . 0.0 110.438 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.025 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.259 0.2 OUTLIER -99.46 -48.17 4.87 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 123.199 1.476 . . . . 0.0 107.419 179.655 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.064 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.337 0.8 OUTLIER -77.36 -176.82 0.69 Allowed Pre-proline 0 C--N 1.289 -2.039 0 CA-C-N 113.602 -1.635 . . . . 0.0 107.225 179.31 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 1.064 ' HD2' HG13 ' A' ' 60' ' ' VAL . 35.5 Cg_endo -61.99 127.45 21.37 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 CA-C-O 122.885 1.119 . . . . 0.0 111.448 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.572 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -74.05 60.4 0.77 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.824 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 67' ' ' GLU . . . -38.43 107.29 0.06 Allowed 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.476 0.655 . . . . 0.0 109.915 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 66' ' ' ARG . 22.0 p-10 -87.73 -142.38 0.12 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.31 -0.869 . . . . 0.0 111.996 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 64' ' ' ASN . 15.7 pt-20 -29.14 -37.34 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 64' ' ' ASN . 4.3 mtm-85 -53.35 -70.37 0.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.872 -1.142 . . . . 0.0 108.99 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.637 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -59.78 -52.58 64.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 110.188 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.4 mp -45.54 -20.88 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.566 -0.709 . . . . 0.0 111.111 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -86.6 -80.21 1.19 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.593 ' HG3' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -44.06 -39.06 3.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -1.162 . . . . 0.0 108.653 178.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.053 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -63.41 -51.96 63.57 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.352 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.562 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -54.63 -24.21 20.5 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.273 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -71.23 -50.79 29.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.666 -0.647 . . . . 0.0 110.326 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.053 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.6 m -39.7 160.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.374 -0.828 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.791 HG22 ' O ' ' A' ' 75' ' ' THR . 20.9 m -120.66 35.27 4.93 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.033 -1.042 . . . . 0.0 109.26 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.314 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -114.98 -163.89 0.91 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.841 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.747 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.13 63.21 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.739 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.854 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.08 152.58 16.38 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 118.989 -2.32 . . . . 0.0 111.763 -177.177 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.689 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.392 1.5 mmtt -133.96 177.73 2.11 Favored Pre-proline 0 C--N 1.292 -1.926 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.662 -173.607 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 44.3 Cg_endo -75.93 -29.38 6.86 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 N-CA-C 107.329 -1.835 . . . . 0.0 107.329 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.709 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.6 OUTLIER -103.82 12.4 34.56 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.631 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.774 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -44.46 148.03 0.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.123 -0.986 . . . . 0.0 109.838 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.897 ' NE ' HD11 ' A' ' 88' ' ' ILE . 1.1 mtt180 -169.67 157.74 7.21 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.733 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.677 HD22 ' HA ' ' A' ' 49' ' ' HIS . 4.4 mt -106.97 116.09 31.32 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.537 ' SG ' ' CE2' ' A' ' 33' ' ' TYR . 7.4 p -35.35 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.575 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 4.5 p -65.41 -6.1 9.37 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.294 -1.504 . . . . 0.0 112.127 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.543 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . 35.1 tp60 -125.53 3.24 7.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.421 -1.424 . . . . 0.0 111.655 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.026 HG23 HG11 ' A' ' 60' ' ' VAL . 35.9 mm -100.99 103.4 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.753 -1.217 . . . . 0.0 110.312 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.992 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -90.17 128.63 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.073 -1.017 . . . . 0.0 108.465 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.687 ' HE1' ' HB3' ' A' ' 94' ' ' LEU . 22.3 mmm -83.22 134.49 34.95 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.546 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.799 HG23 HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -112.15 170.67 5.03 Favored Pre-proline 0 C--N 1.291 -1.935 0 O-C-N 120.833 -1.167 . . . . 0.0 109.507 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 38.9 Cg_endo -65.86 -11.71 32.04 Favored 'Trans proline' 0 C--N 1.289 -2.58 0 O-C-N 124.525 1.803 . . . . 0.0 110.892 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.612 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.3 OUTLIER -92.37 -29.33 16.38 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 117.729 -1.588 . . . . 0.0 107.835 177.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.025 HD21 ' CB ' ' A' ' 59' ' ' LYS . 96.7 mt -89.96 27.48 1.58 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.707 0.765 . . . . 0.0 110.935 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.503 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -63.23 104.79 0.63 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.51 -1.276 . . . . 0.0 107.958 177.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.622 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.78 22.74 1.95 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.123 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -57.83 138.05 19.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.399 -1.059 . . . . 0.0 111.069 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.123 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.1 t -111.36 114.14 46.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.563 ' HB ' ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -98.81 155.17 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.732 -1.23 . . . . 0.0 109.209 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.664 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.93 120.32 33.08 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.358 -0.839 . . . . 0.0 110.251 -178.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 69.8 t -96.32 136.79 21.76 Favored Pre-proline 0 C--N 1.287 -2.115 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.789 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.68 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 57.3 Cg_endo -89.48 171.28 4.39 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.063 1.559 . . . . 0.0 111.585 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -91.2 -17.24 26.39 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.681 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.82 73.9 0.85 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.05 57.13 1.07 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.435 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.733 ' OXT' ' HB1' ' A' ' 46' ' ' ALA . 1.7 p-90 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.714 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.464 ' S1 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.588 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.085 0.469 . . . . 0.0 110.395 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.735 ' O ' HG22 ' A' ' 97' ' ' ILE . 9.1 mtmm -86.51 148.36 25.56 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.298 -0.876 . . . . 0.0 110.173 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.945 ' HA ' HG23 ' A' ' 97' ' ' ILE . 56.0 t -141.17 135.04 31.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 O-C-N 121.152 -0.968 . . . . 0.0 110.983 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.756 HG13 ' HG3' ' A' ' 14' ' ' GLU . 23.6 t -142.6 89.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 118.732 -1.187 . . . . 0.0 110.415 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.656 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 46.2 m-85 -67.92 157.04 35.89 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.466 -0.772 . . . . 0.0 109.331 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 101' ' ' VAL . 99.7 t -122.54 169.98 13.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 O-C-N 121.178 -0.951 . . . . 0.0 109.291 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.595 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 9.9 p -102.61 -153.26 0.46 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.06 -1.025 . . . . 0.0 109.217 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.574 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -93.51 -29.44 15.53 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 178.093 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -91.81 -9.97 41.54 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.498 0.666 . . . . 0.0 109.452 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.529 ' O ' ' CD ' ' A' ' 12' ' ' ARG . . . 114.57 -5.69 22.83 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 120.3 -0.953 . . . . 0.0 111.145 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -63.54 130.56 44.87 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.288 -1.713 . . . . 0.0 107.924 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.539 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.74 176.08 5.7 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 122.257 1.027 . . . . 0.0 112.927 -177.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -133.02 178.9 6.53 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 177.599 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.756 ' HG3' HG13 ' A' ' 4' ' ' VAL . 46.2 mp0 -151.75 110.32 3.8 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 117.56 -1.656 . . . . 0.0 111.109 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.002 HD21 ' CD1' ' A' ' 32' ' ' ILE . 8.3 mt -103.17 -156.33 0.56 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.592 1.187 . . . . 0.0 110.618 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 1' ' ' SER . 1.1 t0 -153.02 70.35 0.87 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.061 HG12 ' HB ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -89.66 127.84 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.003 0.906 . . . . 0.0 109.627 -177.067 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.25 -179.27 5.84 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.259 1.028 . . . . 0.0 112.858 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -62.24 119.18 8.52 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.696 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 112.05 -22.14 19.01 Favored Glycine 0 C--N 1.288 -2.119 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.555 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.061 ' HB ' HG12 ' A' ' 17' ' ' VAL . 65.8 t -90.77 150.64 3.68 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.209 0 O-C-N 120.116 -1.814 . . . . 0.0 109.505 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.482 ' N ' HG12 ' A' ' 21' ' ' VAL . 1.2 p -96.61 132.14 42.54 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.781 HD22 HG11 ' A' ' 3' ' ' VAL . 7.9 mt -46.96 -28.44 1.62 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.705 -1.247 . . . . 0.0 108.436 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.7 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -73.91 -12.02 60.53 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.323 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.472 ' HB3' ' O ' ' A' ' 22' ' ' SER . 5.6 tt0 -91.84 -61.22 1.68 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.756 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -54.39 -55.53 27.72 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.375 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.927 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.42 -51.0 21.38 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.561 -1.337 . . . . 0.0 110.446 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.067 HG23 ' CB ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -65.41 -5.61 2.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 109.333 179.009 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 26' ' ' ALA 0.256 0.0 OUTLIER -103.3 -24.0 13.55 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.731 0.777 . . . . 0.0 110.065 179.838 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.761 ' CG ' HD22 ' A' ' 15' ' ' LEU . 8.1 m120 -96.75 5.45 50.59 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.72 78.44 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.002 ' CD1' HD21 ' A' ' 15' ' ' LEU . 10.5 mt -72.63 -58.27 5.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.317 -1.107 . . . . 0.0 109.213 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 1.067 ' CB ' HG23 ' A' ' 28' ' ' VAL . 7.1 m-30 -80.59 50.51 1.33 Allowed 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.457 0.646 . . . . 0.0 110.489 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -49.52 -21.28 0.92 Allowed 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.533 -0.73 . . . . 0.0 110.242 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.558 HG22 ' H ' ' A' ' 36' ' ' VAL . 20.6 mm -70.45 177.1 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 36' ' ' VAL . 18.5 m -116.23 80.25 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.121 -0.987 . . . . 0.0 110.338 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.521 ' CA ' ' OG1' ' A' ' 47' ' ' THR . . . -120.22 54.58 0.65 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 3.6 p-10 -120.16 84.27 2.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -1.223 . . . . 0.0 110.436 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.3 p -86.73 20.1 2.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.106 -0.996 . . . . 0.0 110.229 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.2 34.59 40.8 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.62 21.8 5.06 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 29.9 t -80.44 1.23 30.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -1.161 . . . . 0.0 110.292 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 61.13 59.93 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.215 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.8 p -140.05 15.99 2.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.361 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 5.5 p -137.12 -169.3 2.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 110.355 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.643 ' CB ' ' CZ3' ' A' ' 106' ' ' TRP . . . -145.58 11.71 1.29 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.89 . . . . 0.0 110.26 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.521 ' OG1' ' CA ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -83.3 10.5 8.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 0.0 109.952 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 1.023 ' HB2' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -107.06 14.73 26.02 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.475 -0.765 . . . . 0.0 109.66 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.291 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 11.5 t-160 -70.23 123.76 22.47 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.276 -0.89 . . . . 0.0 111.714 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.802 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.5 m -158.34 -174.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.729 0.776 . . . . 0.0 109.129 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.881 ' OH ' HD22 ' A' ' 78' ' ' LEU 0.252 68.0 m-85 -140.84 102.57 4.31 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.019 0.914 . . . . 0.0 110.66 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.076 ' HB ' HG22 ' A' ' 57' ' ' THR . 2.7 t -74.19 134.13 30.18 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 O-C-N 120.69 -1.256 . . . . 0.0 110.491 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.881 ' O ' HG23 ' A' ' 57' ' ' THR . 3.7 t30 -48.8 150.33 1.5 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.302 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.6 pt-20 -60.35 -8.1 2.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.246 -0.909 . . . . 0.0 111.909 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.578 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.78 9.41 43.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.628 -1.295 . . . . 0.0 110.758 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 1.121 ' CB ' HD13 ' A' ' 97' ' ' ILE . 88.0 m-85 -140.51 2.03 1.8 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.051 -1.03 . . . . 0.0 110.119 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 1.076 HG22 ' HB ' ' A' ' 52' ' ' VAL . 7.6 p -90.45 -40.21 12.16 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.015 -1.053 . . . . 0.0 108.36 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.39 -0.31 52.69 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.688 0.756 . . . . 0.0 110.699 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.046 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.265 1.1 mtpp -99.22 -48.49 4.81 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 123.303 1.525 . . . . 0.0 107.085 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.061 HG11 HD13 ' A' ' 88' ' ' ILE 0.334 0.9 OUTLIER -72.8 179.48 1.09 Allowed Pre-proline 0 C--N 1.288 -2.083 0 CA-C-N 113.436 -1.711 . . . . 0.0 106.472 178.431 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 1.046 ' HD2' HG13 ' A' ' 60' ' ' VAL . 36.6 Cg_endo -70.21 113.07 3.33 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 CA-C-O 122.834 1.098 . . . . 0.0 111.155 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.3 67.61 1.42 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.225 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.666 ' HB2' ' HG3' ' A' ' 87' ' ' GLN . . . -37.45 156.6 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.954 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 66' ' ' ARG . 5.9 p30 -92.37 -161.96 0.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.017 -1.052 . . . . 0.0 112.399 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 4.0 pt-20 -38.1 -24.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.987 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -52.76 -72.3 0.06 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.65 -1.281 . . . . 0.0 107.949 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.718 ' HA ' ' HE3' ' A' ' 70' ' ' MET . 0.5 OUTLIER -68.36 -40.88 81.33 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.554 -0.716 . . . . 0.0 109.298 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.635 HD12 ' CD ' ' A' ' 67' ' ' GLU . 1.1 mp -57.94 -16.89 7.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.111 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.51 ' HA2' ' OE1' ' A' ' 72' ' ' GLU . . . -97.01 -68.35 0.96 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.718 ' HE3' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -42.44 -38.9 2.04 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.126 -1.22 . . . . 0.0 108.065 179.463 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.121 HD11 ' CB ' ' A' ' 82' ' ' SER 0.261 0.0 OUTLIER -65.34 -50.51 65.31 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.883 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.515 ' OE2' ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -67.04 -29.84 69.75 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.515 ' N ' ' OE2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -61.11 -38.92 88.04 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.023 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.186 HG21 ' CD2' ' A' ' 49' ' ' HIS . 1.4 m -53.2 168.81 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 75' ' ' THR . 17.0 m -120.74 54.48 1.07 Allowed 'General case' 0 C--N 1.287 -2.145 0 O-C-N 120.483 -1.386 . . . . 0.0 110.014 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.291 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -126.17 -154.64 0.64 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 115.151 -2.62 . . . . 0.0 112.211 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.733 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.262 0.0 OUTLIER -63.88 60.38 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 122.702 1.239 . . . . 0.0 108.472 -179.558 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.009 HD13 ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -59.23 132.72 54.85 Favored 'General case' 0 C--N 1.288 -2.09 0 O-C-N 119.63 -1.919 . . . . 0.0 110.375 -177.09 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.546 ' CD ' ' HG3' ' A' ' 77' ' ' GLU 0.365 0.0 OUTLIER -116.01 -179.4 0.62 Allowed Pre-proline 0 C--N 1.291 -1.975 0 CA-C-N 112.666 -2.061 . . . . 0.0 111.798 -174.13 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -79.12 -28.79 3.58 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 N-CA-C 106.82 -2.031 . . . . 0.0 106.82 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.693 ' HB2' HG21 ' A' ' 57' ' ' THR . 14.8 p-10 -108.68 14.68 24.26 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.98 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 1.121 ' CB ' HD11 ' A' ' 71' ' ' LEU . 2.7 m -47.8 -175.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.537 -0.727 . . . . 0.0 109.68 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.601 ' HB2' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -174.89 169.27 3.47 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 116.434 -2.106 . . . . 0.0 114.72 178.473 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.023 HD13 ' HB2' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -115.72 103.12 10.37 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.661 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.596 ' SG ' ' HB3' ' A' ' 48' ' ' CYS . 0.7 OUTLIER -31.92 -31.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.819 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 84' ' ' LEU . 29.6 p -84.48 12.07 7.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.053 -1.654 . . . . 0.0 112.247 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.666 ' HG3' ' HB2' ' A' ' 63' ' ' ALA . 5.1 tp60 -126.33 21.62 7.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.588 -1.32 . . . . 0.0 111.836 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.061 HD13 HG11 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -120.12 105.15 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.736 -1.227 . . . . 0.0 110.678 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.945 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -90.76 132.39 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.923 -1.11 . . . . 0.0 109.37 179.085 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.984 ' SD ' HG21 ' A' ' 97' ' ' ILE . 1.3 tpt -82.83 117.56 22.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.653 -0.654 . . . . 0.0 111.348 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.754 HG23 HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -98.77 176.15 2.13 Favored Pre-proline 0 N--CA 1.496 1.849 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.779 178.525 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 45.3 Cg_endo -78.56 -9.0 16.09 Favored 'Trans proline' 0 C--N 1.293 -2.353 0 O-C-N 124.564 1.823 . . . . 0.0 110.262 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.612 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.6 OUTLIER -92.72 -29.72 15.91 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.046 HD21 ' CB ' ' A' ' 59' ' ' LYS . 85.9 mt -89.68 28.47 1.31 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.738 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.595 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 17.9 p-10 -63.45 105.73 0.81 Allowed 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 118.513 -1.275 . . . . 0.0 108.621 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.666 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 125.04 16.99 2.83 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.523 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.121 HD13 ' CB ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -51.71 142.17 4.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.606 -0.938 . . . . 0.0 111.715 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.087 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.1 t -115.67 111.43 35.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.599 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -99.06 153.05 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 120.735 -1.228 . . . . 0.0 109.853 -178.542 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.675 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.76 127.88 49.74 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.791 -179.118 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 54.5 t -98.24 139.8 21.45 Favored Pre-proline 0 C--N 1.288 -2.07 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.722 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.6 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 56.2 Cg_endo -90.53 174.81 2.83 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.818 1.679 . . . . 0.0 111.886 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 11.1 p-10 -91.3 -17.72 25.48 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.905 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -111.34 67.86 0.65 Allowed 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -97.5 49.88 1.05 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.326 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.643 ' CZ3' ' CB ' ' A' ' 46' ' ' ALA . 11.0 p-90 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.282 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.662 ' S2 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 91' ' ' THR . 1.4 p . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.146 0.498 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.762 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -98.19 146.63 25.42 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.091 -1.006 . . . . 0.0 110.057 178.128 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.933 HG22 ' CG2' ' A' ' 97' ' ' ILE . 44.8 t -134.39 133.07 55.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.843 0.83 . . . . 0.0 111.073 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 13' ' ' ARG . 56.4 t -142.29 89.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.531 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.681 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 40.9 m-85 -67.79 135.82 53.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.574 HG13 ' HG2' ' A' ' 12' ' ' ARG . 59.3 t -99.65 167.09 2.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 O-C-N 120.546 -1.346 . . . . 0.0 109.664 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.587 ' HB3' HG22 ' A' ' 11' ' ' THR . 89.6 p -102.3 -153.99 0.48 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 109.335 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.594 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -88.99 -33.09 17.31 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.477 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 10.5 p-10 -91.63 -3.88 55.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.736 -0.603 . . . . 0.0 109.883 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.11 -24.42 11.67 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.587 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.79 128.83 28.02 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.609 -1.524 . . . . 0.0 108.38 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.574 ' HG2' HG13 ' A' ' 6' ' ' VAL . 20.8 mtm180 -121.35 -171.77 2.28 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 122.162 0.982 . . . . 0.0 112.474 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.657 ' HE ' HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.36 -179.08 5.42 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 178.296 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -152.0 109.58 3.62 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 117.447 -1.701 . . . . 0.0 111.201 178.412 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.974 HD11 ' HA ' ' A' ' 27' ' ' ALA . 6.6 mt -105.06 -157.07 0.59 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.639 1.209 . . . . 0.0 110.583 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -153.27 70.81 0.87 Allowed 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.05 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.2 t -88.34 127.39 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.736 0.779 . . . . 0.0 109.592 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.0 -178.16 5.63 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.618 1.199 . . . . 0.0 112.987 -177.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.51 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 1.5 p30 -61.15 116.12 4.31 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.829 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.685 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 111.89 -20.86 21.57 Favored Glycine 0 C--N 1.287 -2.162 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.524 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.05 ' HB ' HG12 ' A' ' 17' ' ' VAL . 90.3 t -89.21 150.5 3.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 120.1 -1.823 . . . . 0.0 109.306 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 25' ' ' GLN . 1.6 p -96.01 125.61 40.67 Favored 'General case' 0 C--N 1.274 -2.684 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.752 ' CD2' HG21 ' A' ' 17' ' ' VAL . 4.4 mt -43.05 -24.33 0.07 Allowed 'General case' 0 C--O 1.203 -1.382 0 O-C-N 120.73 -1.231 . . . . 0.0 109.265 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.684 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -64.43 -47.58 78.58 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' SER . 10.5 tt0 -59.84 -65.51 0.67 Allowed 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.905 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.61 -60.04 2.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.911 -1.118 . . . . 0.0 110.581 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.974 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.72 -54.69 11.42 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.751 -1.218 . . . . 0.0 110.848 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.947 HG23 ' CB ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -63.92 -6.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.544 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.254 0.0 OUTLIER -99.25 -25.97 14.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.303 -0.873 . . . . 0.0 109.817 179.708 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.797 ' CG ' HD22 ' A' ' 15' ' ' LEU . 8.1 m120 -96.93 3.93 51.84 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.81 72.81 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.971 ' CD1' HD21 ' A' ' 15' ' ' LEU . 9.0 mt -72.85 -56.41 9.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.479 -1.012 . . . . 0.0 109.488 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.947 ' CB ' HG23 ' A' ' 28' ' ' VAL . 7.0 m-30 -80.22 50.62 1.27 Allowed 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.459 0.647 . . . . 0.0 110.272 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -49.36 -21.48 0.88 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.474 -0.766 . . . . 0.0 110.272 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 pp -74.62 134.63 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 109.974 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 36' ' ' VAL . 10.8 p -112.14 55.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.952 . . . . 0.0 110.443 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 47' ' ' THR . . . -120.13 36.4 3.44 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.472 ' HB2' ' S1 ' ' A' ' 107' ' ' FES . 6.8 p-10 -101.07 158.23 16.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -1.151 . . . . 0.0 110.441 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 24.2 p -77.16 -9.16 58.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.31 -0.869 . . . . 0.0 110.233 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.15 35.71 26.37 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.07 4.72 71.45 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -83.63 4.32 28.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.209 -1.171 . . . . 0.0 110.209 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.484 ' HA ' ' S2 ' ' A' ' 107' ' ' FES . . . 42.26 49.0 4.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.318 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.5 p -140.07 24.48 2.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 110.581 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 2.1 p -130.12 -168.18 1.93 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.041 -1.037 . . . . 0.0 110.355 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.799 ' HB1' ' O ' ' A' ' 106' ' ' TRP . . . -149.44 9.86 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.935 . . . . 0.0 110.81 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 37' ' ' GLY . 15.0 p -83.31 4.05 28.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.004 -1.06 . . . . 0.0 109.995 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.524 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 9.4 p -115.32 29.69 7.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.456 -0.777 . . . . 0.0 109.895 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.325 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 6.5 t-160 -70.21 125.98 28.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.745 . . . . 0.0 110.116 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.804 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -155.3 -173.66 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.0 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.804 ' N ' HG23 ' A' ' 50' ' ' VAL 0.269 82.9 m-85 -140.41 114.13 8.82 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.624 0.726 . . . . 0.0 110.754 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.019 ' HB ' HG22 ' A' ' 57' ' ' THR . 5.5 t -85.19 130.66 35.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 O-C-N 120.28 -1.513 . . . . 0.0 109.504 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.934 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -40.75 157.2 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.675 -1.265 . . . . 0.0 109.294 177.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.1 0.37 7.79 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.844 -1.16 . . . . 0.0 110.209 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.59 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.1 5.29 47.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.948 -1.095 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.831 ' CB ' HD13 ' A' ' 97' ' ' ILE . 55.0 m-85 -140.48 5.44 2.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.901 -1.124 . . . . 0.0 109.443 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 1.019 HG22 ' HB ' ' A' ' 52' ' ' VAL . 30.4 p -89.58 -38.02 14.27 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -2.45 44.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.828 0.823 . . . . 0.0 110.39 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.077 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.259 0.2 OUTLIER -99.21 -47.96 5.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 179.708 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.037 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.334 1.1 t -80.4 175.03 5.22 Favored Pre-proline 0 C--N 1.288 -2.071 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 177.403 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 1.037 ' HD2' HG13 ' A' ' 60' ' ' VAL . 38.3 Cg_endo -74.54 110.79 3.17 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 CA-C-O 122.877 1.115 . . . . 0.0 112.934 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.497 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -75.43 75.55 2.5 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.356 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.73 ' HB3' ' CB ' ' A' ' 67' ' ' GLU . . . -37.04 160.32 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.874 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 66' ' ' ARG . 6.1 p30 -96.99 -160.7 0.82 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.247 -0.908 . . . . 0.0 112.336 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -28.74 -39.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 122.025 -0.422 . . . . 0.0 112.074 -178.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 64' ' ' ASN . 3.6 mtt180 -53.19 -66.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.569 -1.332 . . . . 0.0 108.488 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.829 ' HA ' ' HE2' ' A' ' 70' ' ' MET . 0.8 OUTLIER -59.25 -35.13 73.14 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.579 -0.701 . . . . 0.0 109.86 178.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.7 mp -77.24 -9.04 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.224 -0.922 . . . . 0.0 110.278 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -84.23 -80.81 1.05 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.829 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.82 -36.56 2.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.164 -1.198 . . . . 0.0 108.728 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.994 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -64.62 -48.54 74.5 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.419 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.535 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 3.1 tp10 -61.36 -16.18 43.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.481 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -85.72 -40.51 16.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.695 -0.628 . . . . 0.0 110.459 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.994 HG22 ' O ' ' A' ' 71' ' ' LEU . 8.1 m -40.38 162.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.387 -0.821 . . . . 0.0 109.639 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 75' ' ' THR . 23.0 m -120.48 30.0 7.16 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.193 -0.942 . . . . 0.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.325 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -113.85 -167.96 1.28 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.755 -1.178 . . . . 0.0 112.465 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.738 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.14 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.819 -179.012 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.924 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.48 153.56 15.71 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 118.903 -2.373 . . . . 0.0 111.165 -177.16 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.535 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.347 0.0 OUTLIER -128.46 -178.18 0.75 Allowed Pre-proline 0 C--N 1.297 -1.703 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.329 -174.792 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 45.6 Cg_endo -78.75 -28.36 4.22 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 N-CA-C 106.985 -1.967 . . . . 0.0 106.985 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.6 ' CG ' HG21 ' A' ' 57' ' ' THR . 0.7 OUTLIER -108.11 16.24 23.5 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.089 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.826 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -43.72 149.37 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.922 -1.111 . . . . 0.0 108.932 -179.388 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.947 ' HB2' HG23 ' A' ' 52' ' ' VAL . 2.3 mmt85 -154.55 146.07 23.14 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.604 -1.638 . . . . 0.0 112.403 -177.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -103.67 88.71 3.13 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 177.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 24' ' ' MET . 5.7 t -17.03 -45.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.608 ' SG ' ' NE2' ' A' ' 87' ' ' GLN . 1.6 p -44.26 -19.31 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.611 -1.305 . . . . 0.0 112.236 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.608 ' NE2' ' SG ' ' A' ' 86' ' ' CYS . 13.5 mp0 -118.88 -4.72 10.64 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.254 -1.529 . . . . 0.0 112.081 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.634 HG23 HG11 ' A' ' 60' ' ' VAL . 3.2 mm -79.76 98.25 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.779 -1.201 . . . . 0.0 109.046 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.971 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -84.11 130.42 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.002 -1.061 . . . . 0.0 109.02 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.642 ' HE1' ' HB3' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -83.31 125.16 31.33 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.692 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.902 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -101.42 -177.67 0.58 Allowed Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 118.111 -1.436 . . . . 0.0 109.005 177.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.61 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 47.6 Cg_endo -89.07 -14.71 2.67 Favored 'Trans proline' 0 C--N 1.291 -2.453 0 O-C-N 124.483 1.781 . . . . 0.0 108.713 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.512 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.1 pt-20 -82.26 -31.47 30.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.077 HD21 ' CB ' ' A' ' 59' ' ' LYS . 52.4 mt -89.72 34.85 0.83 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.053 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.582 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 6.7 p-10 -62.65 107.16 0.9 Allowed 'General case' 0 C--N 1.29 -2.013 0 O-C-N 120.365 -1.459 . . . . 0.0 109.092 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.444 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 122.24 25.67 1.98 Allowed Glycine 0 N--CA 1.497 2.761 0 O-C-N 120.835 -1.165 . . . . 0.0 110.71 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.117 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -59.1 135.97 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.971 -1.311 . . . . 0.0 110.6 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.117 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.4 t -115.77 111.74 36.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -99.5 156.5 3.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.88 -178.766 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.694 ' N ' ' O ' ' A' ' 51' ' ' TYR . 1.1 m-20 -122.9 125.95 46.34 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.306 -0.871 . . . . 0.0 110.413 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.589 HG12 ' CE1' ' A' ' 8' ' ' HIS . 56.1 t -103.61 130.31 23.75 Favored Pre-proline 0 C--N 1.289 -2.039 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.692 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.742 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 56.7 Cg_endo -84.23 173.84 8.55 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 124.296 1.682 . . . . 0.0 112.077 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.44 ' CG ' ' HB3' ' A' ' 8' ' ' HIS . 1.3 m-20 -91.34 -18.31 24.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.792 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.91 73.75 0.84 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.479 ' HG2' ' HD2' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -98.64 55.63 1.08 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 118.994 -1.083 . . . . 0.0 110.132 -177.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.799 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 1.4 p-90 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.92 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.484 ' S2 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.525 ' OG ' ' HG3' ' A' ' 90' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.498 1.966 0 CA-C-O 121.197 0.523 . . . . 0.0 110.521 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.809 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -73.34 144.06 46.65 Favored 'General case' 0 C--O 1.202 -1.429 0 O-C-N 120.682 -1.261 . . . . 0.0 109.073 179.119 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.878 ' HA ' HG23 ' A' ' 97' ' ' ILE . 78.6 t -137.69 130.08 41.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 122.287 1.042 . . . . 0.0 110.711 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.659 HG13 ' HG2' ' A' ' 14' ' ' GLU . 85.8 t -141.42 96.5 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.917 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.294 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.675 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 21.6 m-85 -76.89 151.63 35.72 Favored 'General case' 0 C--O 1.201 -1.486 0 O-C-N 121.64 -0.663 . . . . 0.0 109.747 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 89.9 t -111.31 166.85 5.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 O-C-N 121.046 -1.034 . . . . 0.0 110.368 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 11' ' ' THR . 85.8 p -103.77 -157.21 0.6 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.131 -0.98 . . . . 0.0 109.261 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.545 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -91.04 -27.13 18.82 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.512 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -92.1 -8.23 46.37 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.734 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 113.47 -9.35 24.22 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.58 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.6 OUTLIER -66.54 136.17 55.25 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 119.914 -1.933 . . . . 0.0 108.758 179.599 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -120.5 179.66 4.25 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.251 1.024 . . . . 0.0 112.974 -176.799 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.667 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -134.58 173.27 11.84 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 179.589 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.669 ' C ' HD23 ' A' ' 15' ' ' LEU . 16.3 mt-10 -150.15 114.84 5.27 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 117.111 -1.836 . . . . 0.0 111.047 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.975 HD11 ' HA ' ' A' ' 27' ' ' ALA 0.28 4.6 mt -107.92 -154.03 0.52 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.462 1.125 . . . . 0.0 109.845 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.32 72.04 0.92 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.983 HG22 ' CB ' ' A' ' 26' ' ' ALA . 1.4 t -88.31 126.41 41.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-O 121.786 0.803 . . . . 0.0 109.022 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.629 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.44 -179.51 5.84 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.817 0.817 . . . . 0.0 112.777 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.68 ' HB3' ' CD ' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -56.75 112.44 1.3 Allowed 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.56 177.091 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.72 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 112.81 -21.54 18.31 Favored Glycine 0 C--N 1.282 -2.464 0 C-N-CA 118.702 -1.713 . . . . 0.0 113.003 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.94 ' HB ' HG12 ' A' ' 17' ' ' VAL . 66.7 t -86.2 147.87 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 120.677 2.239 . . . . 0.0 108.059 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -95.38 130.34 42.21 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.522 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.736 HD21 ' HG2' ' A' ' 90' ' ' MET . 11.0 mt -44.87 -25.79 0.34 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.015 -1.678 . . . . 0.0 109.782 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.637 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -67.41 -23.18 65.53 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.3 tt0 -88.09 -65.43 1.02 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.983 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.42 -49.86 17.51 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.281 -1.368 . . . . 0.0 111.383 178.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.975 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -55.2 -50.0 70.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.184 -1.573 . . . . 0.0 110.173 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.862 HG23 ' CB ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -67.32 -1.19 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.73 -1.231 . . . . 0.0 110.569 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . 0.265 0.0 OUTLIER -104.33 -31.15 9.68 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.311 1.053 . . . . 0.0 109.655 -178.665 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.717 ' CG ' HD22 ' A' ' 15' ' ' LEU . 9.3 m120 -95.82 4.16 53.1 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.17 12.58 63.2 Favored Glycine 0 N--CA 1.505 3.273 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.536 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.907 ' CD1' HD21 ' A' ' 15' ' ' LEU . 7.9 mt -72.16 -58.34 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.564 -0.962 . . . . 0.0 109.681 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.862 ' CB ' HG23 ' A' ' 28' ' ' VAL . 6.1 m-30 -81.9 52.52 1.97 Allowed 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.3 -0.875 . . . . 0.0 109.902 178.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -49.06 -29.35 4.98 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.03 0.919 . . . . 0.0 109.448 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.563 ' O ' HG13 ' A' ' 35' ' ' ILE . 25.4 pt -82.78 100.53 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.526 0 O-C-N 120.362 -1.461 . . . . 0.0 108.354 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 36' ' ' VAL . 86.2 t -79.88 73.71 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 O-C-N 120.92 -1.112 . . . . 0.0 110.642 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' OG1' ' A' ' 47' ' ' THR . . . -120.42 44.65 1.34 Allowed Glycine 0 N--CA 1.504 3.232 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.57 169.88 11.34 Favored 'General case' 0 C--O 1.193 -1.884 0 O-C-N 121.697 -0.884 . . . . 0.0 110.085 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 6.9 p -100.5 -4.97 27.7 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-O 122.3 1.048 . . . . 0.0 109.896 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.62 30.83 68.24 Favored Glycine 0 N--CA 1.499 2.867 0 O-C-N 120.297 -1.502 . . . . 0.0 111.321 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.19 17.88 70.73 Favored Glycine 0 N--CA 1.502 3.092 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 39' ' ' CYS . 1.6 t -96.84 -1.43 46.07 Favored 'General case' 0 C--N 1.286 -2.158 0 O-C-N 119.599 -2.118 . . . . 0.0 109.181 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 52.76 55.47 8.97 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.286 -0.884 . . . . 0.0 110.341 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.04 30.73 1.8 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 120.605 -1.31 . . . . 0.0 110.136 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -141.04 175.31 9.72 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 119.527 -1.983 . . . . 0.0 111.739 -178.556 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.24 17.07 0.94 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.463 0.649 . . . . 0.0 110.469 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -89.19 -2.38 58.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.276 -1.515 . . . . 0.0 109.333 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' ' 84' ' ' LEU . 6.8 p -99.68 30.04 3.82 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.616 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.305 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 9.0 t-160 -69.81 123.25 20.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.518 -0.739 . . . . 0.0 110.842 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.756 HG22 ' O ' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -155.32 -172.35 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 120.808 -1.182 . . . . 0.0 108.399 178.639 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.741 ' N ' HG23 ' A' ' 50' ' ' VAL 0.301 79.8 m-85 -139.78 109.13 6.14 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.351 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.001 ' HB ' HG22 ' A' ' 57' ' ' THR . 7.1 t -76.94 129.42 37.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 O-C-N 120.566 -1.334 . . . . 0.0 110.553 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.782 HD21 ' HB2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -42.75 146.22 0.39 Allowed 'General case' 0 C--N 1.307 -1.251 0 O-C-N 120.163 -1.586 . . . . 0.0 109.411 176.646 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.14 -9.48 0.92 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.361 -0.837 . . . . 0.0 111.956 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.631 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -92.15 7.77 40.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.041 -1.662 . . . . 0.0 112.281 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.782 ' HB2' HD21 ' A' ' 53' ' ' ASN . 77.1 m-85 -141.08 3.71 1.81 Allowed 'General case' 0 N--CA 1.516 2.857 0 O-C-N 120.535 -1.353 . . . . 0.0 108.759 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 1.027 HG21 ' HB2' ' A' ' 81' ' ' ASN . 17.0 p -89.4 -33.25 16.92 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.157 -0.965 . . . . 0.0 108.618 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.38 -1.76 24.67 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.94 0.876 . . . . 0.0 111.084 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.993 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.286 0.1 OUTLIER -97.63 -48.31 5.29 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 179.187 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.058 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.339 1.0 OUTLIER -77.44 177.75 2.52 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.699 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 1.058 ' HD2' HG13 ' A' ' 60' ' ' VAL . 32.5 Cg_endo -71.6 122.56 8.69 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 CA-C-O 122.632 1.013 . . . . 0.0 111.731 -177.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -77.17 73.57 3.75 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.36 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.625 ' HB1' ' HG2' ' A' ' 87' ' ' GLN . . . -37.71 157.59 0.01 OUTLIER 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.326 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.449 ' OD1' ' HB2' ' A' ' 66' ' ' ARG . 48.1 p30 -90.0 -168.7 2.2 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 123.157 1.456 . . . . 0.0 112.49 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -37.4 -30.43 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.237 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.482 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -55.28 -63.43 1.16 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.365 -1.459 . . . . 0.0 107.568 179.247 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.818 ' HA ' ' HE2' ' A' ' 70' ' ' MET . 8.0 tp10 -60.72 -41.0 94.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.823 -0.548 . . . . 0.0 110.421 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 65' ' ' GLU . 59.9 mt -79.75 -5.22 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.933 . . . . 0.0 110.906 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -86.93 -75.71 1.27 Allowed Glycine 0 N--CA 1.482 1.753 0 N-CA-C 107.629 -2.188 . . . . 0.0 107.629 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.818 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.52 -43.36 5.44 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.629 -1.228 . . . . 0.0 107.913 178.516 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.956 ' O ' HG22 ' A' ' 74' ' ' VAL 0.25 0.6 OUTLIER -56.96 -53.78 54.13 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.34 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -56.0 -24.94 41.92 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.707 -1.245 . . . . 0.0 108.358 178.369 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -74.05 -47.16 38.6 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.704 -179.362 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.956 HG22 ' O ' ' A' ' 71' ' ' LEU . 3.3 m -36.19 161.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 121.972 0.891 . . . . 0.0 111.186 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.83 HG22 ' O ' ' A' ' 75' ' ' THR . 30.2 m -118.45 25.9 9.97 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.456 -1.403 . . . . 0.0 109.973 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.305 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -103.46 -153.66 0.48 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.102 -1.624 . . . . 0.0 113.283 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.753 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.25 0.0 OUTLIER -71.05 63.15 0.31 Allowed 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.897 -178.41 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.774 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -57.39 154.97 9.86 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 116.218 -2.193 . . . . 0.0 110.317 -176.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.681 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.375 20.4 mmtt -134.02 178.89 1.55 Allowed Pre-proline 0 C--N 1.294 -1.831 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.253 -173.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 55.2 Cg_endo -77.3 -28.38 5.76 Favored 'Trans proline' 0 C--N 1.295 -2.27 0 N-CA-C 104.742 -2.83 . . . . 0.0 104.742 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 1.027 ' HB2' HG21 ' A' ' 57' ' ' THR . 13.3 p-10 -105.13 14.57 28.96 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.611 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.833 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -47.26 146.6 1.85 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.853 -1.155 . . . . 0.0 109.499 178.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.756 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 mmm-85 -169.1 122.8 0.81 Allowed 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 117.661 -1.616 . . . . 0.0 111.99 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -80.72 112.97 18.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.041 -1.662 . . . . 0.0 108.298 176.44 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.537 ' HB2' ' OH ' ' A' ' 33' ' ' TYR . 5.5 m -35.09 -23.55 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.552 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 9.7 p -64.08 -12.71 41.6 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 119.222 -2.174 . . . . 0.0 111.056 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.625 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -120.67 18.36 11.95 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.731 -1.188 . . . . 0.0 111.366 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 88' ' ' ILE . 3.5 mm -110.07 102.75 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.126 -0.984 . . . . 0.0 110.406 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -84.25 126.55 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 120.967 -1.083 . . . . 0.0 110.418 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.894 ' SD ' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -82.53 123.47 29.22 Favored 'General case' 0 C--O 1.2 -1.526 0 O-C-N 120.81 -1.181 . . . . 0.0 109.236 177.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.594 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -113.92 157.39 42.05 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.181 178.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.68 ' CD ' ' HB3' ' A' ' 19' ' ' ASP . 33.8 Cg_endo -58.06 -27.45 79.69 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 124.444 1.76 . . . . 0.0 109.07 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.594 ' HG2' ' HB ' ' A' ' 91' ' ' THR . 3.0 pt-20 -64.4 -42.85 95.86 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.176 176.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.001 HD13 HG23 ' A' ' 60' ' ' VAL . 50.8 mt -88.51 38.79 0.88 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.729 0.776 . . . . 0.0 112.469 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.569 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 3.3 p-10 -64.6 111.1 2.57 Favored 'General case' 0 C--N 1.286 -2.185 0 O-C-N 119.867 -1.771 . . . . 0.0 109.167 177.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.676 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.44 21.69 2.2 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.176 -1.488 . . . . 0.0 110.425 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.146 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -60.34 136.98 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.054 -1.262 . . . . 0.0 110.297 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.146 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.5 t -117.15 113.2 42.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.576 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -101.16 156.67 4.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 120.262 -1.524 . . . . 0.0 109.886 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.624 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.48 130.05 52.65 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 122.571 1.177 . . . . 0.0 111.276 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 6' ' ' VAL . 87.2 t -104.89 136.65 19.13 Favored Pre-proline 0 C--N 1.283 -2.307 0 O-C-N 120.743 -1.223 . . . . 0.0 109.833 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.611 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 73.8 Cg_endo -92.61 166.85 2.75 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.807 1.671 . . . . 0.0 111.126 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -86.94 -18.09 31.59 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.706 0.765 . . . . 0.0 109.248 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.662 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -109.47 73.09 0.83 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.573 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.26 57.92 0.81 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.975 -1.078 . . . . 0.0 109.695 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.6 ' CD2' ' O ' ' A' ' 106' ' ' TRP . 3.3 p-90 . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.618 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.717 ' S2 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.331 0.586 . . . . 0.0 110.242 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.821 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -69.25 143.43 53.93 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.357 -0.84 . . . . 0.0 109.841 179.186 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.965 HG22 HG21 ' A' ' 97' ' ' ILE . 40.4 t -135.47 135.83 51.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-O 121.748 0.785 . . . . 0.0 111.914 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 13' ' ' ARG . 47.4 t -142.67 88.5 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.496 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 46.4 m-85 -67.53 136.0 53.88 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.414 -0.804 . . . . 0.0 109.336 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.565 HG13 ' HG2' ' A' ' 12' ' ' ARG . 60.7 t -99.77 166.62 2.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 O-C-N 120.662 -1.274 . . . . 0.0 109.513 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.612 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 87.9 p -100.53 -155.28 0.5 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.141 -0.975 . . . . 0.0 109.029 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.615 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -89.7 -30.17 18.25 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.689 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.79 -6.18 52.21 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.388 0.613 . . . . 0.0 109.81 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.37 -24.92 10.91 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.593 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.71 129.16 28.77 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.689 -1.477 . . . . 0.0 108.237 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.565 ' HG2' HG13 ' A' ' 6' ' ' VAL . 2.5 mtm180 -121.42 -173.13 2.56 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-O 122.211 1.005 . . . . 0.0 112.528 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.599 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -134.94 -177.65 4.73 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 80.0 mt-10 -151.83 109.41 3.62 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.495 -1.682 . . . . 0.0 111.518 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.046 HD11 ' HA ' ' A' ' 27' ' ' ALA . 7.7 mt -106.63 -173.9 2.41 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.452 1.12 . . . . 0.0 110.889 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.62 68.86 1.44 Allowed 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.038 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.6 t -87.72 126.33 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.096 0.95 . . . . 0.0 109.311 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.514 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.29 178.47 6.33 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.124 0.964 . . . . 0.0 112.887 -177.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.584 ' HB3' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -52.21 129.94 29.21 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.215 1.007 . . . . 0.0 109.288 177.38 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.522 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 94.68 -20.93 46.07 Favored Glycine 0 C--N 1.276 -2.802 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.551 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.038 ' HB ' HG12 ' A' ' 17' ' ' VAL . 84.9 t -83.96 149.81 4.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 CA-C-N 120.843 2.322 . . . . 0.0 109.523 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -96.01 122.85 39.27 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.469 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.837 HD22 HG21 ' A' ' 17' ' ' VAL . 1.9 mt -46.33 -24.73 0.52 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.277 -1.514 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.623 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -70.33 -11.6 61.02 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.928 0.871 . . . . 0.0 108.756 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -97.83 -63.41 1.13 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.039 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.867 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -47.36 -58.96 3.55 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.975 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.046 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.76 -53.04 16.49 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.581 -1.324 . . . . 0.0 110.474 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.093 HG23 ' CB ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -66.1 -3.52 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 109.526 179.091 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.442 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.255 0.0 OUTLIER -103.15 -24.99 13.54 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.833 0.825 . . . . 0.0 110.149 179.851 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.719 ' CG ' HD22 ' A' ' 15' ' ' LEU . 8.1 m120 -97.02 4.94 51.22 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.61 11.12 75.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.966 ' CD1' HD21 ' A' ' 15' ' ' LEU . 9.2 mt -72.79 -57.72 6.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.364 -1.08 . . . . 0.0 109.309 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 1.093 ' CB ' HG23 ' A' ' 28' ' ' VAL . 6.0 m-30 -80.58 30.88 0.29 Allowed 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.748 -0.595 . . . . 0.0 111.504 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -87.99 29.14 0.96 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.944 -1.098 . . . . 0.0 110.311 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.523 HG22 HG13 ' A' ' 36' ' ' VAL . 94.7 mt -107.0 -47.95 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 110.249 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.634 HG21 ' OG1' ' A' ' 47' ' ' THR . 35.0 m -120.06 174.77 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.553 ' O ' HG21 ' A' ' 47' ' ' THR . . . -104.68 139.16 14.5 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.448 ' OD2' ' SD ' ' A' ' 24' ' ' MET . 59.9 m-20 -104.55 177.35 4.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -1.187 . . . . 0.0 110.233 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 42' ' ' SER . 25.5 p -87.93 25.1 1.62 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 110.246 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.22 24.29 15.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.02 9.81 65.28 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 39' ' ' CYS . 1.5 t -81.4 8.21 9.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -1.164 . . . . 0.0 110.102 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB1' ' CZ ' ' A' ' 66' ' ' ARG . . . 44.86 54.07 7.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 110.359 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 42' ' ' SER . 0.9 OUTLIER -140.04 22.63 2.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 110.257 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -135.3 -175.97 4.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.925 . . . . 0.0 110.285 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.642 ' HB1' ' OXT' ' A' ' 106' ' ' TRP . . . -147.58 9.74 0.93 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.562 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.634 ' OG1' HG21 ' A' ' 36' ' ' VAL . 8.6 t -78.37 -14.96 59.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.02 -1.05 . . . . 0.0 109.907 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.545 ' O ' HG13 ' A' ' 50' ' ' VAL . 25.4 p -88.64 26.41 1.5 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.476 -0.765 . . . . 0.0 110.12 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.323 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 6.1 t-160 -70.12 123.26 21.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.427 -0.796 . . . . 0.0 109.878 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.813 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -150.13 -170.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.095 -1.003 . . . . 0.0 109.807 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.838 ' CD1' ' HG3' ' A' ' 79' ' ' LYS . 75.2 m-85 -140.45 107.62 5.49 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.938 0.875 . . . . 0.0 110.762 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.015 ' HB ' HG22 ' A' ' 57' ' ' THR . 6.2 t -80.92 131.96 32.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 O-C-N 120.699 -1.251 . . . . 0.0 109.698 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.943 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -42.88 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.089 177.644 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -72.05 0.03 10.5 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.038 -1.039 . . . . 0.0 110.148 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.605 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.09 5.34 47.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.094 -1.004 . . . . 0.0 111.088 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.816 ' CB ' HD13 ' A' ' 97' ' ' ILE . 59.4 m-85 -140.62 5.12 1.99 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.762 -1.211 . . . . 0.0 109.415 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 1.026 HG21 ' HB2' ' A' ' 81' ' ' ASN . 35.3 p -89.74 -38.27 13.96 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -2.24 39.39 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.737 0.78 . . . . 0.0 110.76 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.059 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.262 0.1 OUTLIER -99.06 -47.46 5.22 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.659 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.083 HG23 HD13 ' A' ' 94' ' ' LEU 0.338 1.0 OUTLIER -78.25 176.76 3.3 Favored Pre-proline 0 C--N 1.285 -2.196 0 CA-C-N 113.371 -1.741 . . . . 0.0 106.392 178.312 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 1.019 ' HD2' HG13 ' A' ' 60' ' ' VAL . 39.9 Cg_endo -73.83 96.27 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 CA-C-O 122.59 0.996 . . . . 0.0 112.155 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.531 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -66.54 67.49 0.06 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.428 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.881 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . . . -37.17 152.93 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.281 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 66' ' ' ARG . 19.7 p-10 -88.17 -147.6 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.127 -0.983 . . . . 0.0 111.868 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 69' ' ' GLY . 17.7 pt-20 -28.98 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.193 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.727 ' CZ ' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -53.29 -70.5 0.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.807 -1.183 . . . . 0.0 108.982 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 1.071 ' HG2' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.26 -32.42 69.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.577 -0.702 . . . . 0.0 109.269 178.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 1.071 HD12 ' HG2' ' A' ' 67' ' ' GLU . 1.2 mp -77.64 -10.82 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 110.826 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -89.24 -79.27 1.32 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.693 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.27 -30.14 0.47 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -1.177 . . . . 0.0 108.668 179.535 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.997 ' O ' HG22 ' A' ' 74' ' ' VAL . 1.1 tm? -74.84 -50.73 16.08 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.567 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 8.1 tp10 -58.44 -22.72 55.39 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 108.777 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.513 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -80.99 -40.78 23.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.675 -0.641 . . . . 0.0 110.686 -179.487 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.997 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.7 m -40.06 162.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.436 -0.79 . . . . 0.0 109.754 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.823 HG22 ' O ' ' A' ' 75' ' ' THR . 21.7 m -120.63 32.38 6.02 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.114 -0.991 . . . . 0.0 108.965 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.323 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -115.27 -167.24 1.21 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.686 1.231 . . . . 0.0 112.728 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.761 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.19 62.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.996 -178.677 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.945 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.43 154.86 12.97 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 118.729 -2.482 . . . . 0.0 110.997 -177.729 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.838 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.382 0.5 OUTLIER -133.15 177.17 2.38 Favored Pre-proline 0 C--N 1.288 -2.077 0 CA-C-N 113.61 -1.632 . . . . 0.0 111.07 -173.79 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 41.0 Cg_endo -71.96 -25.91 19.19 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 N-CA-C 106.99 -1.965 . . . . 0.0 106.99 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 1.026 ' HB2' HG21 ' A' ' 57' ' ' THR . 13.6 p-10 -114.53 18.76 16.58 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.913 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.796 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -45.88 149.59 0.63 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.805 -1.185 . . . . 0.0 108.139 178.747 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.939 ' HB2' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -155.65 152.3 28.5 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.388 -1.725 . . . . 0.0 112.313 -178.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -106.43 103.29 12.71 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 24' ' ' MET . 5.7 t -27.82 -34.09 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.552 ' N ' ' O ' ' A' ' 84' ' ' LEU . 26.5 p -71.65 1.97 5.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.3 -1.5 . . . . 0.0 110.784 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.556 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 38.1 mm-40 -125.03 14.94 8.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.877 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.639 HG23 HG11 ' A' ' 60' ' ' VAL . 5.7 mm -116.46 99.0 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.272 -0.892 . . . . 0.0 110.285 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.99 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.7 mm -82.82 131.15 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.899 -1.125 . . . . 0.0 110.048 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.998 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.1 tpt -82.42 123.14 28.86 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.279 -0.888 . . . . 0.0 110.349 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.572 ' OG1' HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -113.22 159.33 35.36 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 118.151 -1.42 . . . . 0.0 110.319 179.29 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.584 ' CD ' ' HB3' ' A' ' 19' ' ' ASP . 37.2 Cg_endo -62.24 -14.23 37.08 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 O-C-N 124.481 1.779 . . . . 0.0 109.569 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.524 ' CG ' ' HB ' ' A' ' 91' ' ' THR . 1.8 pt-20 -82.52 -36.93 25.91 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.33 1.062 . . . . 0.0 108.42 177.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.083 HD13 HG23 ' A' ' 60' ' ' VAL . 50.3 mt -90.23 35.76 0.87 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.576 -178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 20.9 p30 -63.61 108.02 1.29 Allowed 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.823 177.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.617 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.36 23.79 1.88 Allowed Glycine 0 N--CA 1.496 2.695 0 O-C-N 120.755 -1.216 . . . . 0.0 110.7 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.115 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -59.62 136.83 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -1.087 . . . . 0.0 111.097 179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.115 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.5 t -115.76 110.31 31.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -100.0 154.99 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.834 -1.166 . . . . 0.0 110.039 -178.552 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.602 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.46 128.43 50.86 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.268 -0.895 . . . . 0.0 110.249 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.615 HG12 ' CE1' ' A' ' 8' ' ' HIS . 55.1 t -103.54 123.54 41.1 Favored Pre-proline 0 C--N 1.291 -1.972 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.669 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.738 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 54.8 Cg_endo -76.37 171.19 18.53 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.096 1.864 . . . . 0.0 111.949 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.5 -18.93 23.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.699 -0.626 . . . . 0.0 109.468 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.791 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -111.0 74.62 0.88 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 47' ' ' THR . 3.1 pt20 -98.81 56.1 1.07 Allowed 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.436 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.642 ' OXT' ' HB1' ' A' ' 46' ' ' ALA . 1.5 p-90 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.765 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.446 ' S2 ' ' HB3' ' A' ' 38' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.587 ' OG ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.393 0.616 . . . . 0.0 110.467 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.807 ' O ' HG22 ' A' ' 97' ' ' ILE . 4.1 mptt -61.97 149.51 40.51 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.458 -0.776 . . . . 0.0 109.115 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.917 ' HA ' HG23 ' A' ' 97' ' ' ILE . 65.4 t -140.56 134.05 33.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 O-C-N 121.382 -0.824 . . . . 0.0 110.959 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 45.9 t -142.7 90.2 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 C-N-CA 118.634 -1.226 . . . . 0.0 110.803 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 70.3 m-85 -67.64 134.65 51.53 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.674 -0.641 . . . . 0.0 109.464 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.535 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 97.3 t -99.62 169.36 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 O-C-N 120.113 -1.617 . . . . 0.0 109.717 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.593 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 95.9 p -104.46 -155.9 0.55 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 109.386 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.584 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.02 -29.69 18.25 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -91.83 -8.59 46.15 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.339 0.59 . . . . 0.0 109.713 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.21 -16.08 20.26 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -59.44 132.51 54.21 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.728 -1.454 . . . . 0.0 107.872 179.184 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.528 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.98 179.92 4.22 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 122.368 1.08 . . . . 0.0 113.02 -178.154 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 4' ' ' VAL 0.277 0.9 OUTLIER -127.25 179.03 5.66 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 178.682 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.693 ' C ' HD23 ' A' ' 15' ' ' LEU . 68.5 mt-10 -152.87 116.02 4.63 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 117.129 -1.828 . . . . 0.0 111.518 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.99 HD11 ' HA ' ' A' ' 27' ' ' ALA . 5.7 mt -112.63 -156.79 0.6 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.459 1.123 . . . . 0.0 110.194 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -153.08 68.24 0.81 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.035 HG12 ' HB ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -88.29 124.24 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.083 0.944 . . . . 0.0 109.463 -177.504 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -87.34 176.25 7.61 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.087 0.946 . . . . 0.0 112.851 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.582 ' HB3' HG22 ' A' ' 91' ' ' THR . 0.1 OUTLIER -51.02 127.85 19.95 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.318 1.056 . . . . 0.0 109.187 177.357 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.52 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 99.04 -23.82 34.84 Favored Glycine 0 C--N 1.276 -2.805 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.474 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.035 ' HB ' HG12 ' A' ' 17' ' ' VAL . 95.1 t -84.44 153.61 3.65 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.656 0 CA-C-N 120.61 2.205 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.527 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -96.98 134.71 39.99 Favored 'General case' 0 C--N 1.273 -2.728 0 C-N-CA 118.797 -1.161 . . . . 0.0 107.886 176.206 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.71 HD22 HG11 ' A' ' 3' ' ' VAL . 9.2 mt -50.24 -23.65 2.39 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.299 -1.501 . . . . 0.0 108.028 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.634 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -74.5 -15.0 60.89 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.599 -0.688 . . . . 0.0 109.211 179.175 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.55 ' CG ' HG13 ' A' ' 21' ' ' VAL . 3.7 tt0 -89.14 -63.5 1.28 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.853 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -56.04 -50.07 71.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.065 -1.022 . . . . 0.0 110.196 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.99 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.66 -48.66 28.89 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.527 -1.358 . . . . 0.0 109.706 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.933 HG23 ' HB2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -70.78 -0.74 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.605 -0.684 . . . . 0.0 109.679 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.08 -27.18 12.73 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.813 0.816 . . . . 0.0 109.569 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.886 ' CG ' HD22 ' A' ' 15' ' ' LEU . 8.5 m120 -97.36 -0.72 45.91 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.68 21.47 36.83 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.843 HD11 HD21 ' A' ' 15' ' ' LEU . 2.1 mt -72.74 -68.06 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.392 -1.063 . . . . 0.0 109.66 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.933 ' HB2' HG23 ' A' ' 28' ' ' VAL . 21.8 m-85 -80.62 59.1 3.46 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.588 0.708 . . . . 0.0 110.595 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -66.48 48.93 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.024 0 O-C-N 121.573 -0.704 . . . . 0.0 110.619 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.675 HG13 HG21 ' A' ' 47' ' ' THR . 0.0 OUTLIER -107.55 158.56 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.301 -0.874 . . . . 0.0 109.771 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.4 t -112.75 -33.7 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.124 -0.985 . . . . 0.0 110.75 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.605 ' C ' HD11 ' A' ' 35' ' ' ILE . . . -79.87 72.38 2.59 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.512 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . 8.8 p-10 -120.22 169.43 10.26 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.234 -1.157 . . . . 0.0 110.179 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 18.0 p -100.03 -12.45 19.71 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.04 47.6 6.98 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . 66.77 8.83 49.98 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.543 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 5.2 t -79.98 -2.02 42.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -1.178 . . . . 0.0 110.205 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 60.06 53.78 4.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 0.0 110.275 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.07 11.69 2.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.578 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 1.9 p -129.92 -171.59 2.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.015 -1.053 . . . . 0.0 110.409 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.707 ' HB1' ' OXT' ' A' ' 106' ' ' TRP . . . -144.7 9.66 1.36 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 110.406 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.675 HG21 HG13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -81.36 6.43 14.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.114 -0.991 . . . . 0.0 109.88 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 11.3 p -115.18 28.53 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.48 -0.763 . . . . 0.0 109.625 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.097 ' HE1' ' HB3' ' A' ' 76' ' ' ALA . 6.8 t-160 -69.86 128.7 37.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.537 -0.727 . . . . 0.0 110.402 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.796 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -156.78 -174.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.971 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.796 ' N ' HG23 ' A' ' 50' ' ' VAL 0.272 81.9 m-85 -140.41 113.85 8.62 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.634 0.73 . . . . 0.0 110.323 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.033 ' HB ' HG22 ' A' ' 57' ' ' THR . 6.3 t -82.36 132.45 31.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 O-C-N 120.329 -1.482 . . . . 0.0 110.654 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.765 ' O ' HG23 ' A' ' 57' ' ' THR . 3.3 t30 -47.1 145.47 2.16 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.709 -1.244 . . . . 0.0 108.583 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.523 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -58.16 -8.37 1.07 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.159 -0.963 . . . . 0.0 112.077 -178.337 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.572 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -93.97 7.76 43.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.532 -1.355 . . . . 0.0 110.731 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 1.09 ' CB ' HD13 ' A' ' 97' ' ' ILE . 86.9 m-85 -140.54 4.65 1.97 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.125 -0.984 . . . . 0.0 109.622 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 1.033 HG22 ' HB ' ' A' ' 52' ' ' VAL . 31.5 p -90.29 -41.19 11.68 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 120.946 -1.096 . . . . 0.0 108.068 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.34 -2.09 52.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.826 0.822 . . . . 0.0 110.56 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.057 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.255 0.1 OUTLIER -99.22 -47.77 5.07 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.531 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.071 HG23 HD13 ' A' ' 94' ' ' LEU 0.331 1.1 t -78.99 175.76 4.4 Favored Pre-proline 0 C--N 1.288 -2.065 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.186 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.987 ' HD2' HG13 ' A' ' 60' ' ' VAL . 40.0 Cg_endo -75.05 109.2 2.88 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 CA-C-O 122.702 1.042 . . . . 0.0 112.293 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.534 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -75.23 66.71 1.76 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.551 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.553 ' CB ' ' HG2' ' A' ' 87' ' ' GLN . . . -37.19 155.94 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.25 0.547 . . . . 0.0 110.226 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 66' ' ' ARG . 45.0 p-10 -96.06 -145.79 0.28 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.155 -0.966 . . . . 0.0 112.493 -177.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 64' ' ' ASN . 8.2 pt-20 -30.92 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.349 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 64' ' ' ASN . 2.3 mtm-85 -52.96 -71.2 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.608 -1.308 . . . . 0.0 108.365 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.866 ' HG3' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -62.89 -45.8 90.82 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 109.18 178.363 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.866 HD12 ' HG3' ' A' ' 67' ' ' GLU . 1.1 mp -55.77 -12.97 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.348 -0.845 . . . . 0.0 111.424 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -91.2 -78.41 1.37 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.566 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -45.37 -35.57 3.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.976 -1.308 . . . . 0.0 108.538 179.493 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.981 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.8 OUTLIER -67.77 -43.96 78.57 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 177.229 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.592 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -60.44 -25.79 66.24 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 108.699 178.168 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.579 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.94 -42.76 31.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.781 -0.574 . . . . 0.0 111.111 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.981 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.5 m -39.87 151.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.816 HG22 ' O ' ' A' ' 75' ' ' THR . 18.7 m -121.03 30.47 6.84 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.083 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.097 ' HB3' ' HE1' ' A' ' 49' ' ' HIS . . . -92.67 -82.5 0.33 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.492 -1.283 . . . . 0.0 113.344 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.721 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.288 0.0 OUTLIER -153.86 64.58 0.72 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 122.291 1.043 . . . . 0.0 108.683 -175.579 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.923 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -57.0 150.71 16.33 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 119.382 -2.074 . . . . 0.0 113.24 -173.62 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.536 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.36 0.0 OUTLIER -124.97 -174.14 0.32 Allowed Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.312 -174.889 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 46.6 Cg_endo -81.98 -28.86 1.87 Allowed 'Trans proline' 0 C--N 1.302 -1.92 0 N-CA-C 107.222 -1.876 . . . . 0.0 107.222 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.733 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.9 OUTLIER -107.47 15.33 24.97 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.113 179.416 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.824 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -44.65 146.68 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.952 -1.093 . . . . 0.0 109.611 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.925 ' HB2' HG23 ' A' ' 52' ' ' VAL . 30.7 mmm-85 -158.43 152.91 24.44 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.888 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.625 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -105.26 107.03 17.79 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 24' ' ' MET . 6.1 p -32.07 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.582 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 16.3 p -70.05 -1.24 9.31 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.425 -1.422 . . . . 0.0 111.03 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.553 ' HG2' ' CB ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -125.4 -1.92 7.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.91 -1.119 . . . . 0.0 110.938 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.674 HG23 HG11 ' A' ' 60' ' ' VAL . 3.2 mm -97.15 108.78 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.084 -1.01 . . . . 0.0 110.281 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.984 ' O ' HG22 ' A' ' 60' ' ' VAL . 2.9 mm -87.72 129.36 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.896 -1.128 . . . . 0.0 109.959 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . 1.011 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.4 tpt -83.03 122.94 28.97 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 121.42 -0.8 . . . . 0.0 110.379 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.754 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -114.11 159.22 37.14 Favored Pre-proline 0 C--N 1.292 -1.922 0 C-N-CA 118.233 -1.387 . . . . 0.0 109.682 178.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.754 ' HD2' HG22 ' A' ' 91' ' ' THR . 35.2 Cg_endo -58.66 -36.67 96.89 Favored 'Trans proline' 0 C--N 1.297 -2.149 0 O-C-N 124.334 1.702 . . . . 0.0 110.045 -178.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -58.9 -36.83 75.34 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.797 -1.161 . . . . 0.0 108.558 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.071 HD13 HG23 ' A' ' 60' ' ' VAL . 65.9 mt -90.59 35.12 0.88 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.937 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.485 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 19.6 p-10 -63.75 107.03 1.09 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.575 -1.25 . . . . 0.0 109.391 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.615 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 123.75 19.83 2.69 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 120.458 -1.401 . . . . 0.0 110.733 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.1 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -55.77 140.33 13.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.228 -1.16 . . . . 0.0 111.119 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.1 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.0 t -115.53 112.15 38.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -98.61 156.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.786 -1.196 . . . . 0.0 109.346 -178.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.71 ' N ' ' O ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -122.85 124.21 42.75 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.742 0.782 . . . . 0.0 110.323 -178.74 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 68.2 t -100.32 135.55 20.24 Favored Pre-proline 0 C--N 1.289 -2.064 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.694 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 54.5 Cg_endo -88.9 176.09 3.39 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 121.765 1.643 . . . . 0.0 111.885 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -91.14 -20.45 21.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.572 -0.705 . . . . 0.0 109.36 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.606 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -110.76 77.86 1.07 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.768 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.5 ' HG2' ' HG2' ' A' ' 102' ' ' PRO . 12.9 mt-30 -98.34 52.07 1.02 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.72 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.707 ' OXT' ' HB1' ' A' ' 46' ' ' ALA . 3.0 p-90 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.18 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.487 ' S2 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.672 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.19 0.519 . . . . 0.0 110.437 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.769 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -79.21 142.18 36.5 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.257 178.041 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.943 ' HA ' HG23 ' A' ' 97' ' ' ILE . 41.6 t -136.27 133.82 49.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 O-C-N 121.326 -0.859 . . . . 0.0 110.137 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 58.2 t -141.85 91.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.619 0 C-N-CA 118.804 -1.158 . . . . 0.0 110.411 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.658 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 40.8 m-85 -69.03 154.64 41.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.577 -0.702 . . . . 0.0 109.169 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.577 HG12 ' N ' ' A' ' 7' ' ' SER . 87.0 t -118.35 172.7 5.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.215 178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.615 ' HB3' HG22 ' A' ' 11' ' ' THR . 46.3 p -107.97 -158.4 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.104 -0.998 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.595 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -88.04 -29.67 20.51 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 178.366 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -91.76 -11.18 37.44 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.437 0.637 . . . . 0.0 109.575 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.29 -4.31 23.56 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.335 -0.936 . . . . 0.0 110.785 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.615 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -65.09 131.41 46.48 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.646 -1.502 . . . . 0.0 107.784 179.016 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -120.93 178.51 4.69 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 122.229 1.014 . . . . 0.0 112.905 -177.819 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.4 177.71 7.61 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.81 ' C ' HD23 ' A' ' 15' ' ' LEU . 9.2 mp0 -150.3 113.47 4.87 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.975 -1.49 . . . . 0.0 110.397 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.046 HD11 HD12 ' A' ' 32' ' ' ILE 0.262 2.8 mt -109.21 -151.53 0.47 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 122.603 1.192 . . . . 0.0 111.084 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 1' ' ' SER . 12.4 t0 -152.94 75.98 1.11 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.092 HG13 ' CG1' ' A' ' 21' ' ' VAL . 17.4 t -88.41 118.87 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.64 -175.4 4.66 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.595 -0.691 . . . . 0.0 110.892 -177.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -65.45 114.39 4.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.402 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.456 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 112.36 -15.84 24.82 Favored Glycine 0 C--N 1.288 -2.085 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.351 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.092 ' CG1' HG13 ' A' ' 17' ' ' VAL . 41.6 t -97.81 136.37 28.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 120.441 -1.623 . . . . 0.0 106.776 177.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -95.15 143.71 26.36 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.378 -1.329 . . . . 0.0 107.721 178.554 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.907 HD23 HG21 ' A' ' 17' ' ' VAL . 13.8 mt -47.04 -26.6 1.08 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.281 -1.367 . . . . 0.0 107.434 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.637 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -59.41 -39.27 82.91 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.362 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.607 ' CG ' HG13 ' A' ' 21' ' ' VAL . 28.1 tt0 -75.24 -72.37 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.796 -0.565 . . . . 0.0 110.532 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.068 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.6 -50.54 17.31 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 117.986 -1.486 . . . . 0.0 111.014 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.924 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.95 -46.02 31.77 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.343 -1.473 . . . . 0.0 110.443 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.704 HG23 ' HB2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -74.08 0.57 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.555 -0.716 . . . . 0.0 109.654 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.18 -29.18 11.47 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.736 0.779 . . . . 0.0 109.687 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.907 ' CG ' HD22 ' A' ' 15' ' ' LEU . 8.5 m120 -97.56 -1.57 43.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.65 19.58 51.21 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.046 HD12 HD11 ' A' ' 15' ' ' LEU . 8.5 mt -72.7 -57.37 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -1.114 . . . . 0.0 109.434 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.737 ' CD2' ' HB3' ' A' ' 27' ' ' ALA . 20.0 m-30 -81.16 56.01 2.7 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.533 0.682 . . . . 0.0 110.52 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.42 47.13 0.21 Allowed 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.651 -0.655 . . . . 0.0 110.443 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.56 HG23 ' N ' ' A' ' 36' ' ' VAL . 2.7 tp -86.87 -169.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.868 . . . . 0.0 109.73 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.56 ' N ' HG23 ' A' ' 35' ' ' ILE . 72.1 t -80.08 -90.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 110.191 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.522 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -119.12 155.93 15.89 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' OD1' ' S1 ' ' A' ' 107' ' ' FES . 0.4 OUTLIER -119.51 -175.15 2.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -1.111 . . . . 0.0 110.054 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 24.5 p -99.77 7.44 45.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.232 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 53.65 35.25 51.65 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.19 18.7 78.05 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 39' ' ' CYS . 12.1 t -87.12 13.12 9.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -1.129 . . . . 0.0 110.133 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 42' ' ' SER . . . 43.53 55.27 5.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 110.084 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.8 p -137.82 12.62 2.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.327 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -135.72 179.55 6.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.11 -0.993 . . . . 0.0 110.326 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.699 ' HB3' ' CZ3' ' A' ' 106' ' ' TRP . . . -147.66 9.9 0.93 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 0.0 110.52 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -16.88 62.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.059 -1.026 . . . . 0.0 109.407 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.75 ' SG ' HD13 ' A' ' 84' ' ' LEU . 25.4 p -88.38 29.98 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.636 -0.665 . . . . 0.0 110.048 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.352 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 9.0 t-160 -70.24 126.27 29.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.417 -0.802 . . . . 0.0 110.667 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.807 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.1 m -156.33 -174.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.251 -0.905 . . . . 0.0 109.99 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.807 ' N ' HG23 ' A' ' 50' ' ' VAL 0.254 78.2 m-85 -141.01 108.22 5.5 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.659 0.743 . . . . 0.0 110.669 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.029 ' HB ' HG22 ' A' ' 57' ' ' THR . 2.4 t -75.01 133.84 30.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 O-C-N 120.34 -1.475 . . . . 0.0 110.583 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.861 ' O ' HG23 ' A' ' 57' ' ' THR . 3.8 t30 -48.42 147.29 2.45 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.744 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.2 pt-20 -58.77 -8.41 1.32 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.169 -0.957 . . . . 0.0 111.972 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.573 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -96.01 7.91 45.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.475 -1.391 . . . . 0.0 111.057 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 1.13 ' CB ' HD13 ' A' ' 97' ' ' ILE . 87.7 m-85 -140.37 3.01 1.91 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.059 . . . . 0.0 109.898 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 1.029 HG22 ' HB ' ' A' ' 52' ' ' VAL . 3.2 p -90.55 -41.22 11.5 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -93.76 -0.94 55.67 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.737 0.779 . . . . 0.0 110.526 -178.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.034 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.253 1.2 mtpp -99.23 -46.91 5.38 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 123.135 1.445 . . . . 0.0 107.355 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.043 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.334 0.9 OUTLIER -74.86 -177.68 0.71 Allowed Pre-proline 0 C--N 1.287 -2.114 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.197 178.975 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 1.043 ' HD2' HG13 ' A' ' 60' ' ' VAL . 34.1 Cg_endo -61.59 122.34 10.91 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 CA-C-O 123.001 1.167 . . . . 0.0 111.941 -177.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.553 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -74.32 62.95 0.99 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.635 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.469 ' HB1' ' HG2' ' A' ' 87' ' ' GLN . . . -38.22 157.88 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.937 -0.477 . . . . 0.0 109.999 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 66' ' ' ARG . 29.8 p30 -118.0 -154.47 0.56 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.061 -1.024 . . . . 0.0 111.432 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 64' ' ' ASN . 4.3 pt-20 -31.24 -33.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.028 -0.42 . . . . 0.0 111.726 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -53.0 -71.05 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.773 -1.204 . . . . 0.0 108.195 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.885 ' HG3' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.7 -50.41 73.94 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 108.906 178.455 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.885 HD12 ' HG3' ' A' ' 67' ' ' GLU . 1.2 mp -51.52 -19.32 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 110.302 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -88.17 -75.69 1.28 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.67 ' HG3' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -45.04 -38.78 5.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -1.215 . . . . 0.0 108.674 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.039 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -65.74 -51.7 57.05 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.208 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 11.0 tp10 -55.39 -19.62 9.61 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.081 -1.012 . . . . 0.0 108.417 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -76.21 -46.98 25.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.604 -0.685 . . . . 0.0 110.552 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.039 HG22 ' O ' ' A' ' 71' ' ' LEU . 8.1 m -40.71 163.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.266 -0.896 . . . . 0.0 109.725 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.779 HG22 ' O ' ' A' ' 75' ' ' THR . 45.8 m -120.4 37.4 4.27 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.977 -1.077 . . . . 0.0 109.599 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.352 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -122.44 -167.78 1.62 Allowed 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.281 -1.368 . . . . 0.0 112.968 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.744 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -50.77 63.42 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.662 -178.754 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.865 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.42 153.65 15.35 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 118.767 -2.458 . . . . 0.0 111.809 -177.455 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.699 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.385 0.2 OUTLIER -133.96 176.86 2.57 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 113.294 -1.775 . . . . 0.0 111.308 -173.826 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 43.7 Cg_endo -75.34 -27.58 9.36 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 176.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.81 ' HB2' HG21 ' A' ' 57' ' ' THR . 15.5 p-10 -108.5 17.01 22.52 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.255 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.802 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -45.81 149.91 0.59 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.181 -0.949 . . . . 0.0 110.126 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.826 ' HB2' HG23 ' A' ' 52' ' ' VAL . 7.9 mmt85 -158.62 160.22 36.29 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.255 -1.378 . . . . 0.0 112.192 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.75 HD13 ' SG ' ' A' ' 48' ' ' CYS . 2.2 mt -112.85 114.98 27.75 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.531 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 12.6 p -30.67 -30.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.572 ' N ' ' O ' ' A' ' 84' ' ' LEU . 27.8 p -77.07 4.24 10.64 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.611 -1.306 . . . . 0.0 111.43 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.503 ' HG2' ' CB ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -125.34 11.94 8.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.819 -1.175 . . . . 0.0 111.357 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.007 HG23 HG11 ' A' ' 60' ' ' VAL . 21.4 mm -120.34 107.12 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.83 -1.169 . . . . 0.0 110.978 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.974 ' O ' HG22 ' A' ' 60' ' ' VAL . 3.9 mm -89.83 128.81 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.144 -0.973 . . . . 0.0 108.895 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.672 ' HG3' ' HB2' ' A' ' 1' ' ' SER . 0.0 OUTLIER -83.86 124.77 31.31 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.414 -0.804 . . . . 0.0 111.238 -178.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.831 HG23 HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -98.97 179.69 1.01 Allowed Pre-proline 0 C--N 1.295 -1.769 0 C-N-CA 117.673 -1.611 . . . . 0.0 109.181 177.721 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.558 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 45.6 Cg_endo -82.21 -12.88 10.33 Favored 'Trans proline' 0 C--N 1.289 -2.599 0 O-C-N 124.368 1.72 . . . . 0.0 108.705 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.553 ' HG2' ' OG1' ' A' ' 91' ' ' THR . 3.4 pt-20 -84.89 -33.69 22.73 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.034 HD21 ' CB ' ' A' ' 59' ' ' LYS . 66.1 mt -89.64 29.77 1.11 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.498 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.435 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 5.7 p-10 -63.22 111.38 2.22 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 120.3 -1.5 . . . . 0.0 109.056 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.65 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 123.87 17.04 3.17 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.13 HD13 ' CB ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -53.75 141.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.377 -1.073 . . . . 0.0 111.668 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.08 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.0 t -117.46 113.63 43.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.592 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -99.41 155.41 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.838 -1.163 . . . . 0.0 109.773 -178.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.644 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.34 121.07 35.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.677 0.751 . . . . 0.0 109.783 -179.598 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.595 HG12 ' CE1' ' A' ' 8' ' ' HIS . 90.8 t -99.51 123.58 47.6 Favored Pre-proline 0 C--N 1.289 -2.025 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.432 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.766 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 52.6 Cg_endo -75.58 170.83 19.42 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.002 1.801 . . . . 0.0 112.028 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.424 ' CG ' ' HG2' ' A' ' 104' ' ' ARG . 11.6 p-10 -91.32 -17.45 25.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.677 -0.639 . . . . 0.0 109.402 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.797 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -110.75 70.89 0.73 Allowed 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.423 ' CD ' ' O ' ' A' ' 105' ' ' GLN . 0.0 OUTLIER -98.73 58.81 1.21 Allowed 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.466 -177.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.699 ' CZ3' ' HB3' ' A' ' 46' ' ' ALA . 1.8 p-90 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.885 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.406 ' S1 ' ' OD1' ' A' ' 38' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 121.931 0.872 . . . . 0.0 110.472 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.921 ' HA ' HG23 ' A' ' 97' ' ' ILE . 54.9 t -140.99 135.59 33.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 121.121 -0.987 . . . . 0.0 110.902 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.594 HG13 ' HG2' ' A' ' 14' ' ' GLU . 47.3 t -142.4 90.96 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.804 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 73.1 m-85 -67.86 134.84 51.58 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 121.714 -0.616 . . . . 0.0 109.81 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.562 HG22 ' CD ' ' A' ' 12' ' ' ARG . 91.1 t -99.82 166.95 2.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 O-C-N 120.052 -1.655 . . . . 0.0 109.467 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.591 ' HB3' HG22 ' A' ' 11' ' ' THR . 86.1 p -101.8 -155.86 0.54 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.096 -1.003 . . . . 0.0 108.819 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.589 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.24 -29.83 17.93 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.8 -6.26 52.05 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.436 0.636 . . . . 0.0 109.878 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.38 -25.55 10.38 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.591 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.57 130.18 31.27 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.628 -1.513 . . . . 0.0 108.066 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.562 ' CD ' HG22 ' A' ' 6' ' ' VAL . 17.3 mtm-85 -121.26 -176.38 3.27 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 122.374 1.083 . . . . 0.0 112.883 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.587 ' O ' ' HA ' ' A' ' 4' ' ' VAL 0.28 0.2 OUTLIER -128.78 178.73 6.15 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.687 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 84.1 mt-10 -152.9 114.17 4.21 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 117.324 -1.751 . . . . 0.0 111.142 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.879 HD22 ' CG ' ' A' ' 30' ' ' ASN . 6.6 mt -108.71 -156.16 0.58 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.475 1.131 . . . . 0.0 110.095 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.5 71.91 0.96 Allowed 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.003 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.4 t -89.14 127.58 41.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.866 0.841 . . . . 0.0 109.431 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.94 -175.06 4.47 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.675 1.226 . . . . 0.0 112.867 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.521 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 11.6 p30 -63.2 115.89 4.93 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.792 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.732 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 111.98 -22.39 18.74 Favored Glycine 0 C--N 1.287 -2.185 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.763 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.003 ' HB ' HG12 ' A' ' 17' ' ' VAL . 90.8 t -88.34 147.93 4.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 119.938 1.869 . . . . 0.0 109.746 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -96.63 131.79 42.93 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.751 HD22 HG11 ' A' ' 3' ' ' VAL . 8.8 mt -44.54 -26.11 0.33 Allowed 'General case' 0 C--O 1.201 -1.464 0 O-C-N 120.899 -1.126 . . . . 0.0 109.292 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.6 ' O ' ' HB ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -69.04 -42.4 76.37 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 118.206 -1.398 . . . . 0.0 107.77 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.563 ' CG ' HG13 ' A' ' 21' ' ' VAL . 1.5 tt0 -59.68 -70.8 0.15 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.744 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.759 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.97 -54.3 10.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.981 -1.075 . . . . 0.0 110.512 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.878 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.41 -51.15 20.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.787 -1.195 . . . . 0.0 110.098 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.6 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -69.05 -1.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.622 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.12 -27.47 12.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.334 -0.853 . . . . 0.0 109.863 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.879 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.5 m-80 -97.31 -0.8 45.89 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.11 21.17 33.68 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.849 HD11 HD21 ' A' ' 15' ' ' LEU . 1.8 mt . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.221 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.505 0.669 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' VAL . 25.1 p -88.53 28.41 1.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.531 -0.731 . . . . 0.0 110.151 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.118 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 4.0 t60 -70.21 126.37 29.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.433 -0.792 . . . . 0.0 110.219 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.812 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.3 m -156.39 -173.94 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-O 122.12 0.962 . . . . 0.0 110.246 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.812 ' N ' HG23 ' A' ' 50' ' ' VAL 0.268 77.1 m-85 -141.08 111.76 7.0 Favored 'General case' 0 C--O 1.197 -1.687 0 CA-C-O 121.557 0.694 . . . . 0.0 110.563 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.063 ' HB ' HG22 ' A' ' 57' ' ' THR . 2.4 t -78.4 131.46 34.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 O-C-N 120.31 -1.494 . . . . 0.0 110.689 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.838 ' O ' HG23 ' A' ' 57' ' ' THR . 3.4 t30 -47.44 146.67 1.96 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.495 -1.378 . . . . 0.0 108.778 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -58.71 -8.09 1.19 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.065 -1.022 . . . . 0.0 112.135 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.566 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -95.99 8.24 44.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.547 -1.345 . . . . 0.0 110.56 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 1.116 ' CB ' HD13 ' A' ' 97' ' ' ILE . 87.5 m-85 -140.16 3.77 2.0 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.23 -0.918 . . . . 0.0 109.846 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 1.063 HG22 ' HB ' ' A' ' 52' ' ' VAL . 8.7 p -90.45 -42.61 10.77 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.027 -1.046 . . . . 0.0 108.358 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -1.34 57.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.751 0.786 . . . . 0.0 110.486 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.033 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.259 0.1 OUTLIER -99.35 -46.79 5.39 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 123.073 1.416 . . . . 0.0 107.314 179.659 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.053 HG11 HG23 ' A' ' 88' ' ' ILE 0.338 1.0 OUTLIER -78.07 -179.8 1.43 Allowed Pre-proline 0 C--N 1.289 -2.06 0 CA-C-N 113.797 -1.547 . . . . 0.0 107.123 178.966 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 1.023 ' HD2' HG13 ' A' ' 60' ' ' VAL . 37.9 Cg_endo -68.39 107.54 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 CA-C-O 122.874 1.114 . . . . 0.0 112.42 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.632 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -75.46 71.54 2.41 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.016 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.613 ' HB1' ' OE1' ' A' ' 67' ' ' GLU . . . -38.65 170.92 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.604 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -111.9 -164.25 0.9 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.91 -1.118 . . . . 0.0 112.543 -178.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 68' ' ' ILE . 8.8 pt-20 -28.71 -39.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -52.9 -63.01 1.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.543 -1.348 . . . . 0.0 108.833 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.633 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -59.14 -30.06 67.86 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.52 -0.737 . . . . 0.0 110.5 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.564 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.8 mp -77.12 -8.87 12.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.434 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -88.17 -76.68 1.28 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.829 ' HG3' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -44.04 -40.29 4.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.165 -1.197 . . . . 0.0 108.481 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.058 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -64.67 -50.96 64.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 12.0 tp10 -56.91 -19.35 17.37 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.967 -1.083 . . . . 0.0 108.398 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -75.64 -47.88 24.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 110.156 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.058 HG22 ' O ' ' A' ' 71' ' ' LEU . 6.1 m -40.78 161.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 0.0 109.279 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.78 HG22 ' O ' ' A' ' 75' ' ' THR . 27.8 m -120.36 34.06 5.36 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 120.971 -1.081 . . . . 0.0 109.257 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.118 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -114.81 -165.19 0.99 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.595 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.748 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -54.05 63.26 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.167 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.84 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.35 153.02 16.37 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 118.842 -2.411 . . . . 0.0 111.67 -177.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.674 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.389 2.2 mmtt -135.42 177.45 2.22 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.409 -173.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 43.6 Cg_endo -74.76 -28.73 9.36 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 N-CA-C 107.514 -1.764 . . . . 0.0 107.514 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.676 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.8 OUTLIER -106.02 15.18 26.84 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.873 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.827 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -44.17 148.83 0.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.989 . . . . 0.0 109.507 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.934 ' HB2' HG23 ' A' ' 52' ' ' VAL . 1.3 mmt85 -162.03 155.93 21.51 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 117.436 -1.706 . . . . 0.0 113.293 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.829 HD12 ' HG3' ' A' ' 70' ' ' MET . 7.8 mt -114.73 98.32 6.79 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 174.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.541 ' HB3' ' N ' ' A' ' 24' ' ' MET . 60.7 m -28.85 -28.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -39.76 -26.35 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.502 -1.373 . . . . 0.0 112.442 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.594 ' NE2' ' CG ' ' A' ' 67' ' ' GLU . 8.8 pm0 -125.74 0.25 7.42 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.208 -1.557 . . . . 0.0 112.934 -178.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.053 HG23 HG11 ' A' ' 60' ' ' VAL . 12.6 mm -78.64 99.97 3.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.366 -1.459 . . . . 0.0 107.518 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.995 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -81.92 130.88 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.208 -0.933 . . . . 0.0 110.578 -177.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.972 ' SD ' HG21 ' A' ' 97' ' ' ILE . 1.3 tpt -82.58 120.71 25.88 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.809 -0.557 . . . . 0.0 111.375 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.685 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -106.18 174.3 2.68 Favored Pre-proline 0 N--CA 1.494 1.767 0 C-N-CA 118.481 -1.288 . . . . 0.0 109.77 178.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 19' ' ' ASP . 44.3 Cg_endo -73.94 -10.51 23.08 Favored 'Trans proline' 0 C--N 1.292 -2.427 0 O-C-N 124.651 1.869 . . . . 0.0 110.074 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.62 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -92.48 -30.49 15.68 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.034 ' CD1' HG23 ' A' ' 60' ' ' VAL . 97.8 mt -90.07 25.04 2.26 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.865 0.841 . . . . 0.0 110.28 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -63.11 104.2 0.55 Allowed 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.287 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.662 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.99 18.43 2.6 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.333 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.116 HD13 ' CB ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -53.42 141.8 7.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.539 -0.977 . . . . 0.0 111.39 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.079 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.1 t -115.49 112.49 40.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -98.33 155.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.782 -1.199 . . . . 0.0 108.977 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -122.86 124.84 44.17 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.396 -0.815 . . . . 0.0 110.476 -178.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.577 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 63.4 t -99.22 137.4 20.39 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.879 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.69 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 57.2 Cg_endo -89.25 170.64 4.74 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 C-N-CA 121.809 1.673 . . . . 0.0 111.813 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.51 -16.36 27.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.735 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -111.09 75.08 0.9 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.522 ' NE2' HG13 ' A' ' 101' ' ' VAL . 18.3 mt-30 -98.94 56.75 1.07 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.327 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.602 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 1.6 p-90 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.787 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.736 ' O ' HG22 ' A' ' 97' ' ' ILE . 13.9 mtmt . . . . . 0 C--O 1.205 -1.253 0 CA-C-O 121.522 0.677 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.862 ' HA ' HG23 ' A' ' 97' ' ' ILE . 41.5 t -138.51 134.29 43.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 O-C-N 120.897 -1.127 . . . . 0.0 110.516 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 50.5 t -142.61 93.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.078 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.63 ' CD1' ' CD1' ' A' ' 32' ' ' ILE . 50.2 m-85 -69.67 162.45 27.68 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 109.464 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.614 HG22 ' HG2' ' A' ' 12' ' ' ARG . 87.3 t -127.89 168.56 20.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.096 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.621 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 6.1 p -103.12 -154.77 0.5 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 109.616 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.568 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -92.12 -29.84 16.3 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -91.93 -11.86 35.05 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.515 0.674 . . . . 0.0 109.251 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.5 7.23 18.67 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.234 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.578 HG22 ' NH2' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -71.64 131.12 42.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.355 -1.673 . . . . 0.0 107.451 178.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.614 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.77 173.47 7.19 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.124 0.964 . . . . 0.0 112.896 -177.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -134.44 -179.08 5.36 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.755 ' C ' HD23 ' A' ' 15' ' ' LEU . 37.0 mt-10 -151.78 112.93 4.28 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 117.844 -1.542 . . . . 0.0 110.729 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.953 HD11 ' HA ' ' A' ' 27' ' ' ALA . 3.9 mt -109.83 -151.11 0.47 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.482 1.134 . . . . 0.0 111.111 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.19 70.54 0.92 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.083 HG13 ' CG1' ' A' ' 21' ' ' VAL . 18.3 t -86.46 113.51 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.21 -170.8 2.89 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.87 0.843 . . . . 0.0 111.608 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.573 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 2.5 p30 -61.18 110.07 1.29 Allowed 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.769 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 112.19 -18.68 23.33 Favored Glycine 0 C--N 1.289 -2.029 0 C-N-CA 119.349 -1.405 . . . . 0.0 111.116 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.083 ' CG1' HG13 ' A' ' 17' ' ' VAL . 45.0 t -94.24 139.32 18.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 O-C-N 120.088 -1.831 . . . . 0.0 107.099 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.573 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -95.9 142.49 28.08 Favored 'General case' 0 C--N 1.275 -2.674 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.958 HD23 HG21 ' A' ' 17' ' ' VAL . 11.0 mt -49.67 -27.03 4.21 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.082 -1.447 . . . . 0.0 107.78 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.533 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -71.62 -17.31 62.28 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.832 0.825 . . . . 0.0 108.821 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.748 ' HG2' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -89.7 -70.21 0.67 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.051 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -48.43 -49.67 34.28 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.301 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.953 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.76 -49.43 28.48 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.384 -1.448 . . . . 0.0 110.295 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -72.13 0.12 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.61 -0.681 . . . . 0.0 109.537 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.25 0.0 OUTLIER -103.58 -29.75 10.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.481 -0.762 . . . . 0.0 110.513 -179.773 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.845 ' CG ' HD22 ' A' ' 15' ' ' LEU . 4.1 m-80 -97.73 -2.99 40.01 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.38 29.03 15.22 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.828 HD12 HD11 ' A' ' 15' ' ' LEU . 3.1 mt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.272 -1.134 . . . . 0.0 108.58 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.805 ' O ' HG13 ' A' ' 50' ' ' VAL . 25.8 p -86.84 25.4 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.438 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.899 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 13.5 t60 -61.87 110.71 1.62 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.093 -1.005 . . . . 0.0 109.962 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.825 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -140.0 -169.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.624 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.825 ' N ' HG23 ' A' ' 50' ' ' VAL 0.258 62.0 m-85 -141.0 103.67 4.51 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.954 0.883 . . . . 0.0 111.041 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.044 ' HB ' HG22 ' A' ' 57' ' ' THR . 6.2 t -75.01 131.73 34.52 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 O-C-N 120.67 -1.268 . . . . 0.0 110.135 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.789 ' O ' HG23 ' A' ' 57' ' ' THR . 3.7 t30 -47.24 147.75 1.45 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.082 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.52 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.5 pt-20 -59.47 -8.74 1.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.212 -0.93 . . . . 0.0 111.966 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.587 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -96.69 10.01 39.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.701 -1.249 . . . . 0.0 110.725 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 1.128 ' CB ' HD13 ' A' ' 97' ' ' ILE . 91.0 m-85 -140.72 1.13 1.68 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.073 -1.017 . . . . 0.0 110.288 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 1.044 HG22 ' HB ' ' A' ' 52' ' ' VAL . 11.3 p -90.41 -40.81 11.84 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.946 -1.096 . . . . 0.0 108.465 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.26 -1.12 54.51 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.671 0.748 . . . . 0.0 110.592 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.009 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.256 0.2 OUTLIER -99.13 -47.09 5.34 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.618 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.995 HG22 ' O ' ' A' ' 89' ' ' ILE 0.327 1.0 OUTLIER -78.43 176.0 4.09 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.39 178.92 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.994 ' HD2' HG13 ' A' ' 60' ' ' VAL . 39.1 Cg_endo -72.7 103.27 1.53 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 CA-C-O 122.538 0.974 . . . . 0.0 111.314 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.512 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.26 73.09 1.8 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.052 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.92 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -37.76 161.26 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.337 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 66' ' ' ARG . 45.1 p-10 -86.95 -160.12 0.56 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.572 1.177 . . . . 0.0 113.125 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.0 pm0 -33.67 -27.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.477 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -53.17 -70.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.321 -1.487 . . . . 0.0 107.66 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.989 ' HG2' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -64.63 -30.67 71.69 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.801 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.989 HD12 ' HG2' ' A' ' 67' ' ' GLU . 1.2 mp -77.45 -16.66 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.176 -0.953 . . . . 0.0 110.853 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -90.61 -73.95 1.28 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.893 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -42.11 -29.12 0.22 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.599 -0.942 . . . . 0.0 108.566 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.01 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -80.01 -47.58 14.69 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 7.3 tp10 -64.12 -12.71 42.12 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.199 -0.938 . . . . 0.0 109.339 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.27 -18.33 27.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.362 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.01 HG22 ' O ' ' A' ' 71' ' ' LEU . 8.0 m -70.17 145.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.096 -1.003 . . . . 0.0 110.456 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.775 HG22 ' O ' ' A' ' 75' ' ' THR . 55.4 m -99.52 28.46 4.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.741 -0.6 . . . . 0.0 109.699 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.905 ' HB2' ' HB3' ' A' ' 104' ' ' ARG . . . -97.15 -148.81 0.32 Allowed 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.094 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.744 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.47 63.48 5.79 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 122.333 1.063 . . . . 0.0 110.918 -178.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.848 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.14 154.4 13.05 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 118.923 -2.36 . . . . 0.0 111.61 -177.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.651 ' HG3' ' CD2' ' A' ' 51' ' ' TYR 0.379 2.4 mmtt -133.86 177.31 2.31 Favored Pre-proline 0 C--N 1.289 -2.059 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.774 -173.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 42.0 Cg_endo -73.31 -25.57 15.44 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 N-CA-C 107.583 -1.737 . . . . 0.0 107.583 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.987 ' HB2' HG21 ' A' ' 57' ' ' THR . 8.2 p-10 -114.66 21.37 14.53 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.251 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.848 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -45.85 158.08 0.1 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.802 -1.186 . . . . 0.0 109.094 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.9 ' HB2' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -166.28 150.15 7.57 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 117.011 -1.876 . . . . 0.0 112.276 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.787 HD22 ' SG ' ' A' ' 48' ' ' CYS . 79.7 mt -104.67 102.83 12.41 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 24' ' ' MET . 1.9 t -24.05 -37.18 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.554 ' N ' ' O ' ' A' ' 84' ' ' LEU . 27.6 p -70.58 2.92 3.48 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.134 -1.604 . . . . 0.0 111.554 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.541 ' HG3' ' CB ' ' A' ' 67' ' ' GLU . 76.9 mm-40 -125.2 19.43 8.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.882 -1.136 . . . . 0.0 110.514 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.63 HG23 HG11 ' A' ' 60' ' ' VAL . 5.1 mm -120.34 100.49 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.105 -0.997 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.995 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -90.04 127.04 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.794 -1.191 . . . . 0.0 108.106 178.329 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.675 ' HE3' ' HA ' ' A' ' 90' ' ' MET . 26.3 mmm -82.73 137.42 34.41 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.334 -0.854 . . . . 0.0 110.626 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.737 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -114.7 170.27 5.66 Favored Pre-proline 0 C--N 1.291 -1.952 0 O-C-N 120.936 -1.102 . . . . 0.0 110.033 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 19' ' ' ASP . 40.6 Cg_endo -67.14 -10.31 28.14 Favored 'Trans proline' 0 C--N 1.292 -2.446 0 O-C-N 124.498 1.789 . . . . 0.0 110.859 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.604 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -92.57 -30.78 15.47 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 117.628 -1.629 . . . . 0.0 107.646 177.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.009 HD21 ' CB ' ' A' ' 59' ' ' LYS . 83.7 mt -89.8 28.53 1.33 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.096 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 34.8 p-10 -63.19 106.02 0.81 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 118.465 -1.294 . . . . 0.0 108.281 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.629 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.87 23.01 1.89 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.134 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -57.61 138.39 18.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.327 -1.102 . . . . 0.0 111.237 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.134 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.1 t -111.39 114.49 47.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.627 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -99.75 152.87 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.78 -1.2 . . . . 0.0 109.755 -178.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -123.06 128.59 50.35 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.318 -0.864 . . . . 0.0 110.71 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.621 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 64.9 t -101.45 134.69 20.11 Favored Pre-proline 0 C--N 1.292 -1.93 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.107 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.736 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 56.8 Cg_endo -87.79 175.67 4.29 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.512 2.141 . . . . 0.0 112.807 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -91.86 -17.05 25.83 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.601 0.715 . . . . 0.0 109.193 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.905 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.92 70.46 0.71 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.53 ' CG ' ' HG2' ' A' ' 102' ' ' PRO . 2.5 mt-30 -97.63 62.89 1.7 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 122.004 0.907 . . . . 0.0 110.219 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.668 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 5.8 p-90 . . . . . 0 C--N 1.294 -1.827 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.179 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.738 ' O ' HG22 ' A' ' 97' ' ' ILE . 6.9 mtmm . . . . . 0 C--O 1.21 -0.977 0 CA-C-O 121.999 0.904 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.923 ' HA ' HG23 ' A' ' 97' ' ' ILE . 53.8 t -140.77 135.35 34.01 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 O-C-N 121.351 -0.843 . . . . 0.0 111.024 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.757 HG13 ' HG3' ' A' ' 14' ' ' GLU . 20.8 t -142.49 90.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 C-N-CA 118.711 -1.196 . . . . 0.0 110.386 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.656 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 55.8 m-85 -69.57 136.16 50.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.448 -0.782 . . . . 0.0 109.817 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.567 HG22 ' CD ' ' A' ' 12' ' ' ARG . 62.2 t -100.03 167.69 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 O-C-N 120.723 -1.236 . . . . 0.0 109.297 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.586 ' HB3' HG22 ' A' ' 11' ' ' THR . 89.1 p -103.84 -155.92 0.55 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.103 -0.998 . . . . 0.0 109.246 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.612 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -87.7 -31.34 19.76 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -91.7 -6.65 51.63 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.364 0.602 . . . . 0.0 109.806 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.536 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.24 -23.46 12.56 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.76 129.11 28.81 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.691 -1.476 . . . . 0.0 108.223 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.567 ' CD ' HG22 ' A' ' 6' ' ' VAL . 20.8 mtt180 -121.73 -175.45 3.1 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 122.191 0.996 . . . . 0.0 112.65 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -133.76 179.7 6.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 177.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.757 ' HG3' HG13 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -151.78 111.15 3.94 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 117.704 -1.598 . . . . 0.0 110.972 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.998 HD21 ' CD1' ' A' ' 32' ' ' ILE . 7.6 mt -103.86 -157.04 0.59 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.527 1.156 . . . . 0.0 110.595 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -152.54 69.58 0.87 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.049 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.4 t -89.41 127.18 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.033 0.921 . . . . 0.0 109.783 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.23 177.05 6.71 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.21 1.005 . . . . 0.0 113.229 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.59 ' CB ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -53.14 120.63 6.16 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.222 177.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.651 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 106.54 -24.08 26.67 Favored Glycine 0 C--N 1.28 -2.53 0 C-N-CA 119.308 -1.425 . . . . 0.0 112.218 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.049 ' HB ' HG12 ' A' ' 17' ' ' VAL . 85.9 t -84.43 152.23 3.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.513 0 CA-C-N 120.286 2.043 . . . . 0.0 109.381 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.494 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -96.6 131.24 43.44 Favored 'General case' 0 C--N 1.274 -2.682 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.772 HD21 ' SD ' ' A' ' 90' ' ' MET . 7.5 mt -47.11 -26.99 1.23 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.47 -1.394 . . . . 0.0 108.707 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.585 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -73.74 -14.76 61.18 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.657 0.741 . . . . 0.0 109.445 -178.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 22' ' ' SER . 0.7 OUTLIER -90.2 -62.1 1.54 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 177.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.846 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -51.47 -55.65 17.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.128 -0.982 . . . . 0.0 110.385 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.981 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.62 -50.8 23.34 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.534 -1.353 . . . . 0.0 110.263 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.7 OUTLIER -66.92 -4.25 2.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.439 -0.788 . . . . 0.0 109.456 178.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 26' ' ' ALA 0.256 0.0 OUTLIER -103.44 -24.72 13.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.373 -0.829 . . . . 0.0 110.36 179.954 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.785 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.8 m-80 -97.05 2.8 51.81 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.99 9.8 67.31 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.998 ' CD1' HD21 ' A' ' 15' ' ' LEU . 9.0 mt . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.439 -1.036 . . . . 0.0 108.757 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.629 0.728 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.71 ' SG ' HD13 ' A' ' 84' ' ' LEU . 25.9 p -89.92 29.96 1.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.659 -0.651 . . . . 0.0 109.678 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.134 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 5.9 t60 -69.97 128.78 37.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.566 -0.709 . . . . 0.0 110.732 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.822 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.1 m -157.09 -172.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 O-C-N 121.297 -0.877 . . . . 0.0 109.468 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.822 ' N ' HG23 ' A' ' 50' ' ' VAL 0.252 81.4 m-85 -140.49 106.49 5.19 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.901 0.857 . . . . 0.0 110.823 178.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.128 ' HB ' HG22 ' A' ' 57' ' ' THR . 9.6 t -76.33 130.83 35.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.498 0 O-C-N 120.621 -1.299 . . . . 0.0 109.897 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.87 ' O ' HG23 ' A' ' 57' ' ' THR . 4.4 t30 -45.52 150.0 0.52 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.033 -1.042 . . . . 0.0 109.418 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 pt-20 -59.95 -8.46 2.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.255 -0.903 . . . . 0.0 111.888 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.58 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -97.24 9.15 43.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.671 -1.268 . . . . 0.0 110.779 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 1.1 ' CB ' HD13 ' A' ' 97' ' ' ILE . 90.5 m-85 -140.68 2.72 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 109.919 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 1.128 HG22 ' HB ' ' A' ' 52' ' ' VAL . 24.9 p -90.82 -40.48 11.76 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.979 -1.076 . . . . 0.0 108.375 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.55 -0.9 51.54 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.711 0.767 . . . . 0.0 110.664 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.055 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.26 0.0 OUTLIER -99.26 -47.95 5.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.479 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.064 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.334 0.9 OUTLIER -74.88 179.52 1.33 Allowed Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 113.529 -1.669 . . . . 0.0 106.751 178.585 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 1.064 ' HD2' HG13 ' A' ' 60' ' ' VAL . 36.9 Cg_endo -70.74 115.22 4.14 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 CA-C-O 122.951 1.146 . . . . 0.0 111.796 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.33 69.8 1.63 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.833 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -37.5 159.48 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.223 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -105.6 -154.79 0.52 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.201 -0.937 . . . . 0.0 111.362 -178.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 64' ' ' ASN . 6.2 pt-20 -31.98 -31.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.023 -0.423 . . . . 0.0 111.841 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 64' ' ' ASN . 3.5 mtm180 -52.84 -71.68 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.701 -1.25 . . . . 0.0 107.812 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.604 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 2.5 tm-20 -61.25 -48.65 80.5 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.349 -0.844 . . . . 0.0 109.321 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.552 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.1 mp -54.19 -16.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.367 -0.833 . . . . 0.0 110.421 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -89.23 -75.99 1.3 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.604 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.81 -40.27 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.272 -1.134 . . . . 0.0 108.486 178.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.0 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -65.3 -51.49 60.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -57.39 -22.4 42.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.951 -1.093 . . . . 0.0 108.646 178.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.53 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.79 -43.31 30.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.626 -0.671 . . . . 0.0 110.615 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.0 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.7 m -39.2 161.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.571 -0.705 . . . . 0.0 109.892 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.812 HG22 ' O ' ' A' ' 75' ' ' THR . 21.6 m -120.39 30.91 6.71 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.103 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.134 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -114.18 -166.5 1.11 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.701 -1.2 . . . . 0.0 112.493 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.75 63.27 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.616 -178.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.918 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.44 154.03 14.66 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 118.805 -2.434 . . . . 0.0 111.243 -177.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.532 ' CE ' ' HG3' ' A' ' 77' ' ' GLU 0.347 0.4 OUTLIER -131.43 179.65 1.3 Allowed Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.275 -174.794 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.429 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 45.7 Cg_endo -77.37 -27.94 6.05 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 N-CA-C 106.96 -1.977 . . . . 0.0 106.96 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.876 ' HB2' HG21 ' A' ' 57' ' ' THR . 19.3 p-10 -107.89 16.9 23.06 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.166 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.801 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -45.61 152.62 0.31 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.155 -0.966 . . . . 0.0 109.309 179.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.646 HH21 HG12 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -165.11 144.59 6.8 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.139 -1.424 . . . . 0.0 111.237 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.71 HD13 ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -97.62 109.3 22.08 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.585 ' SG ' ' N ' ' A' ' 24' ' ' MET . 7.2 t -28.68 -32.79 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' A' ' 84' ' ' LEU . 26.0 p -71.99 1.31 7.46 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.383 -1.448 . . . . 0.0 110.703 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 84' ' ' LEU . 33.2 mm-40 -125.22 20.49 8.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.994 -1.066 . . . . 0.0 110.52 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.584 ' CD1' ' NE ' ' A' ' 83' ' ' ARG . 6.8 mm -119.94 99.91 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.029 -1.044 . . . . 0.0 110.305 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.955 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -82.71 129.39 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.844 -1.16 . . . . 0.0 109.563 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.996 ' SD ' HG21 ' A' ' 97' ' ' ILE . 1.4 tpt -82.68 125.78 31.61 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.583 -0.698 . . . . 0.0 110.422 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.51 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 2.0 p -114.09 162.17 24.37 Favored Pre-proline 0 C--N 1.292 -1.913 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.903 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.59 ' HD3' ' CB ' ' A' ' 19' ' ' ASP . 37.9 Cg_endo -64.33 -13.69 39.71 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 O-C-N 124.658 1.873 . . . . 0.0 108.372 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.51 ' HG2' ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -84.76 -38.69 19.33 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.055 HD21 ' CB ' ' A' ' 59' ' ' LYS . 68.5 mt -90.5 31.09 1.06 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.725 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.59 107.19 1.09 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.922 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.638 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.93 22.32 1.98 Allowed Glycine 0 N--CA 1.498 2.799 0 O-C-N 120.817 -1.177 . . . . 0.0 110.328 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.104 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -59.0 140.67 17.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.634 -0.921 . . . . 0.0 111.497 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.104 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.2 t -114.75 111.47 36.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -98.89 154.83 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.631 -1.293 . . . . 0.0 109.764 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 1.3 m-20 -122.43 123.11 40.56 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.243 -0.911 . . . . 0.0 110.087 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.612 HG12 ' CE1' ' A' ' 8' ' ' HIS . 72.2 t -102.27 121.55 49.82 Favored Pre-proline 0 C--N 1.289 -2.063 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.3 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.657 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 53.6 Cg_endo -75.51 172.83 15.57 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.835 1.69 . . . . 0.0 112.048 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.51 -18.17 24.55 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.425 0.631 . . . . 0.0 109.371 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.713 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.95 73.51 0.82 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.46 ' CG ' ' HG2' ' A' ' 102' ' ' PRO . 1.2 mt-30 -98.63 56.26 1.11 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.266 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.591 ' OXT' ' CD2' ' A' ' 106' ' ' TRP . 1.5 p-90 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.852 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.648 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.941 0.401 . . . . 0.0 110.097 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.914 ' HA ' HG23 ' A' ' 97' ' ' ILE . 43.4 t -140.23 135.59 36.73 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 O-C-N 121.436 -0.79 . . . . 0.0 110.767 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 13' ' ' ARG . 39.2 t -141.81 91.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.77 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.661 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 42.3 m-85 -68.41 136.15 52.85 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 101' ' ' VAL . 98.7 t -98.91 163.82 2.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.6 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 81.9 p -98.59 -150.99 0.37 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.983 -1.073 . . . . 0.0 108.608 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.642 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -92.84 -30.53 15.4 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 119.763 -1.835 . . . . 0.0 107.815 178.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.506 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 3.1 p-10 -92.39 2.45 56.65 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.629 -0.67 . . . . 0.0 111.244 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 103.43 -8.39 52.15 Favored Glycine 0 N--CA 1.502 3.074 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.889 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -70.87 130.94 42.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.611 -1.523 . . . . 0.0 107.31 178.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -121.05 -172.33 2.38 Favored 'General case' 0 C--N 1.273 -2.758 0 O-C-N 120.862 -1.149 . . . . 0.0 112.567 -178.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.646 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.3 179.9 6.04 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 177.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.714 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 6.7 mt-10 -150.45 105.3 3.31 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.182 -1.574 . . . . 0.0 110.687 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.993 HD21 ' CD1' ' A' ' 32' ' ' ILE 0.256 8.4 mt -99.5 -156.2 0.54 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.889 0.852 . . . . 0.0 110.357 178.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -146.74 72.78 1.29 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.054 HG13 ' CG1' ' A' ' 21' ' ' VAL 0.255 14.7 t -86.5 120.15 35.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.56 -172.86 3.74 Favored 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.35 1.072 . . . . 0.0 111.969 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -68.65 117.1 9.94 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 177.18 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.583 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 112.8 -16.39 23.45 Favored Glycine 0 C--N 1.275 -2.855 0 C-N-CA 118.977 -1.582 . . . . 0.0 109.719 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.054 ' CG1' HG13 ' A' ' 17' ' ' VAL . 43.1 t -97.01 144.09 11.23 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.006 0 C-N-CA 117.144 -1.822 . . . . 0.0 108.564 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER -96.4 134.79 39.12 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.667 HD22 HG11 ' A' ' 3' ' ' VAL 0.27 7.6 mt -46.09 -30.1 1.76 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 123.833 1.778 . . . . 0.0 108.198 178.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.589 ' HB2' ' HB3' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -73.65 -12.28 60.69 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.721 -179.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.648 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.2 tt0 -95.52 -59.9 1.78 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.956 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -56.76 -49.43 75.29 Favored 'General case' 0 C--O 1.199 -1.559 0 C-N-CA 118.022 -1.471 . . . . 0.0 110.572 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.935 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.0 -53.43 12.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.611 -1.305 . . . . 0.0 109.802 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -3.76 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 121.352 0.596 . . . . 0.0 110.268 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 26' ' ' ALA 0.265 0.0 OUTLIER -105.44 -29.22 10.36 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.482 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.743 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.3 m-80 -96.37 4.27 52.34 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.57 62.72 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 118.416 -1.85 . . . . 0.0 110.315 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.993 ' CD1' HD21 ' A' ' 15' ' ' LEU . 11.2 mt . . . . . 0 C--N 1.3 -1.577 0 O-C-N 121.492 -1.005 . . . . 0.0 108.652 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.4 p . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.286 0.565 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.7 ' SG ' HD13 ' A' ' 84' ' ' LEU . 23.8 p -91.78 29.97 1.45 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 110.886 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.027 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 5.3 t60 -68.5 134.84 50.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.441 -1.412 . . . . 0.0 110.959 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.727 HG23 ' N ' ' A' ' 51' ' ' TYR . 2.0 m -159.74 179.89 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.641 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.727 ' N ' HG23 ' A' ' 50' ' ' VAL 0.275 65.8 m-85 -138.53 113.19 8.99 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 121.596 0.712 . . . . 0.0 110.959 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.005 ' HB ' HG22 ' A' ' 57' ' ' THR . 3.9 t -82.61 131.35 33.96 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 O-C-N 120.869 -1.144 . . . . 0.0 109.346 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.871 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -44.58 155.17 0.1 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.076 -1.049 . . . . 0.0 108.727 177.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -67.45 -1.07 4.3 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.839 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.626 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.45 5.31 48.16 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.564 -1.335 . . . . 0.0 111.393 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.879 ' CB ' HD13 ' A' ' 97' ' ' ILE . 70.6 m-85 -140.17 2.2 1.88 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.328 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 1.02 HG21 ' HB2' ' A' ' 81' ' ' ASN . 17.7 p -89.08 -30.28 18.78 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.318 -1.489 . . . . 0.0 107.748 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -107.8 20.74 18.39 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.015 -178.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.02 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.302 0.3 OUTLIER -125.93 -47.62 1.65 Allowed 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 124.455 2.074 . . . . 0.0 106.72 179.535 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.032 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.347 0.6 OUTLIER -75.68 -176.65 0.6 Allowed Pre-proline 0 C--N 1.273 -2.727 0 CA-C-N 113.093 -1.867 . . . . 0.0 107.153 179.244 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 1.032 ' HD2' HG13 ' A' ' 60' ' ' VAL . 37.5 Cg_endo -59.6 122.73 11.95 Favored 'Trans proline' 0 C--N 1.294 -2.307 0 CA-C-O 122.621 1.009 . . . . 0.0 111.354 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.473 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -70.77 67.93 0.4 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.041 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.561 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -37.34 151.89 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.143 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' A' ' 66' ' ' ARG . 48.7 p-10 -92.55 -164.21 1.15 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.033 0.92 . . . . 0.0 111.744 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 69' ' ' GLY . 24.6 pt-20 -55.56 -25.48 38.15 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.519 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.532 ' O ' ' HG2' ' A' ' 70' ' ' MET . 0.2 OUTLIER -55.71 -61.57 2.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 119.785 -1.822 . . . . 0.0 107.049 177.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 1.002 ' HA ' ' HE2' ' A' ' 70' ' ' MET . 1.0 OUTLIER -57.76 -49.41 76.67 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.701 -0.624 . . . . 0.0 109.922 177.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 58.0 mt -73.77 -0.9 2.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.058 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -94.25 -76.45 1.33 Allowed Glycine 0 C--O 1.202 -1.871 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 1.002 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 1.6 ptt? -46.81 -25.81 0.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.02 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -74.56 -48.38 27.19 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.539 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -57.71 -16.01 9.63 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 119.972 -1.705 . . . . 0.0 108.328 177.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.585 ' O ' ' NE1' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -86.57 -30.34 21.94 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 120.509 -0.476 . . . . 0.0 112.033 -177.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.02 HG22 ' O ' ' A' ' 71' ' ' LEU . 22.3 m -48.83 170.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.789 HG22 ' O ' ' A' ' 75' ' ' THR . 23.5 m -120.15 16.93 12.41 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 109.534 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.027 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -105.76 -164.97 1.06 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.849 1.309 . . . . 0.0 113.589 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.811 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -52.39 61.8 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.573 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.877 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -56.34 154.21 8.56 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 114.911 -2.716 . . . . 0.0 110.142 -177.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.693 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.402 1.0 OUTLIER -135.19 174.34 4.71 Favored Pre-proline 0 C--N 1.277 -2.584 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.152 -173.704 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.94 -26.24 22.24 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 N-CA-C 107.782 -1.661 . . . . 0.0 107.782 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 1.02 ' HB2' HG21 ' A' ' 57' ' ' THR . 15.6 p-10 -110.27 16.29 21.79 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.716 0.769 . . . . 0.0 110.555 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.84 ' OG ' ' HG ' ' A' ' 78' ' ' LEU 0.256 0.5 OUTLIER -45.24 158.36 0.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.066 -1.021 . . . . 0.0 110.675 178.597 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.812 ' HD3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -168.56 153.26 6.1 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 117.475 -1.69 . . . . 0.0 114.315 -179.039 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.7 HD13 ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -105.94 88.65 2.86 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 24' ' ' MET . 1.5 t -12.32 -52.02 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.545 ' N ' ' O ' ' A' ' 84' ' ' LEU . 8.7 p -50.92 -9.65 0.06 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.084 -1.01 . . . . 0.0 111.636 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.435 ' HB3' ' CD ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -119.15 20.45 12.64 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 119.707 -1.871 . . . . 0.0 111.375 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.812 HD11 ' HD3' ' A' ' 83' ' ' ARG . 8.7 mm -118.91 117.64 55.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.71 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.926 ' O ' HG22 ' A' ' 60' ' ' VAL . 3.6 mm -100.21 131.69 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.451 -0.781 . . . . 0.0 109.364 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.891 ' SD ' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -82.04 129.71 34.87 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.36 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.732 ' OG1' ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -110.96 163.51 17.13 Favored Pre-proline 0 C--N 1.288 -2.072 0 C-N-CA 118.265 -1.374 . . . . 0.0 109.858 179.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.496 ' HD3' ' OD1' ' A' ' 19' ' ' ASP . 43.2 Cg_endo -65.18 -9.3 21.33 Favored 'Trans proline' 0 C--N 1.283 -2.883 0 O-C-N 124.641 1.864 . . . . 0.0 110.285 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.732 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.6 OUTLIER -93.69 -28.63 15.85 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 116.992 -1.883 . . . . 0.0 107.853 177.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.02 HD21 ' CB ' ' A' ' 59' ' ' LYS . 70.7 mt -91.71 33.94 1.01 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.09 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.452 ' O ' ' CG ' ' A' ' 95' ' ' ASP . 19.4 p-10 -64.29 103.72 0.67 Allowed 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.931 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.631 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 125.26 17.68 2.66 Favored Glycine 0 N--CA 1.504 3.212 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.716 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.039 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -51.07 144.3 2.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.322 0.582 . . . . 0.0 109.526 178.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.039 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.5 t -122.07 113.24 38.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.553 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -98.07 160.41 3.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 119.958 -1.714 . . . . 0.0 110.497 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.694 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -123.18 120.4 33.09 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 109.55 -178.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.6 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 76.5 t -96.27 126.95 42.08 Favored Pre-proline 0 C--N 1.291 -1.954 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.807 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.663 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 43.9 Cg_endo -79.65 166.04 22.08 Favored 'Trans proline' 0 C--N 1.295 -2.238 0 O-C-N 123.695 1.366 . . . . 0.0 110.797 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -89.42 -15.96 31.99 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.648 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.42 83.8 1.82 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.525 ' HG2' ' HG2' ' A' ' 102' ' ' PRO . 42.9 mt-30 -102.03 57.46 0.81 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.576 -1.25 . . . . 0.0 111.072 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.624 ' OXT' ' CG ' ' A' ' 106' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 O-C-N 121.244 -0.91 . . . . 0.0 110.601 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.939 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.211 -0.941 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.827 HG22 HG21 ' A' ' 97' ' ' ILE . 19.9 t -136.67 136.33 48.31 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.186 0 O-C-N 121.055 -1.028 . . . . 0.0 111.735 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 13' ' ' ARG . 59.9 t -141.3 89.89 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.696 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.677 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 29.5 m-85 -67.54 133.97 50.42 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 99' ' ' VAL . 61.9 t -99.58 172.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 120.956 -1.09 . . . . 0.0 109.576 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.559 ' HB3' HG22 ' A' ' 11' ' ' THR . 5.4 p -106.45 -145.78 0.39 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.243 -0.911 . . . . 0.0 109.623 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.575 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -96.28 -32.34 12.46 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -92.02 -8.19 46.74 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.848 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.82 -12.4 20.46 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.157 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.559 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -57.02 131.57 50.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.368 -1.666 . . . . 0.0 108.229 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -121.08 174.66 6.52 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 122.123 0.964 . . . . 0.0 112.957 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.669 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -129.13 178.84 6.13 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -151.93 109.76 3.66 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.041 -1.864 . . . . 0.0 111.289 178.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.96 HD11 ' HA ' ' A' ' 27' ' ' ALA . 3.6 mt -103.72 -157.98 0.64 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.449 1.119 . . . . 0.0 110.842 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 16' ' ' ASP . 27.2 t0 -149.5 67.91 1.02 Allowed 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.026 HG12 ' HB ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -88.85 124.62 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.108 0.956 . . . . 0.0 110.008 -177.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.05 179.81 5.86 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.243 1.021 . . . . 0.0 113.112 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.622 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -57.42 117.6 4.29 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.644 177.134 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.629 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 111.58 -25.06 14.02 Favored Glycine 0 C--N 1.286 -2.197 0 C-N-CA 119.425 -1.369 . . . . 0.0 111.381 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.026 ' HB ' HG12 ' A' ' 17' ' ' VAL . 91.2 t -85.63 149.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 120.082 1.941 . . . . 0.0 109.742 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -96.05 125.32 40.5 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.8 HD22 HG11 ' A' ' 3' ' ' VAL . 8.6 mt -41.77 -27.84 0.13 Allowed 'General case' 0 C--O 1.201 -1.461 0 O-C-N 121.084 -1.01 . . . . 0.0 109.258 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.527 ' SD ' ' HB3' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -59.32 -49.44 77.81 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 177.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.5 tt0 -57.98 -68.79 0.21 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.714 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.881 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.77 -55.95 7.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.971 -1.08 . . . . 0.0 111.052 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.96 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.65 -48.14 28.96 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.293 -1.504 . . . . 0.0 110.196 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -70.72 -1.46 2.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.502 179.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -102.05 -29.3 11.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 0.0 109.674 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.794 ' CG ' HD22 ' A' ' 15' ' ' LEU . 4.5 m-80 -97.73 -3.15 39.71 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.79 32.98 9.43 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.119 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.867 HD12 HD11 ' A' ' 15' ' ' LEU . 5.2 mt . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.218 -1.166 . . . . 0.0 109.276 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.818 ' O ' HG13 ' A' ' 50' ' ' VAL . 28.6 p -101.24 29.93 4.45 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.716 -0.615 . . . . 0.0 110.243 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.002 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 2.0 t60 -65.47 104.24 0.96 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.523 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.91 HG11 ' SG ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -140.75 -173.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.454 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.716 ' CZ ' ' CE1' ' A' ' 49' ' ' HIS 0.275 84.2 m-85 -140.63 107.21 5.32 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 121.838 0.827 . . . . 0.0 110.617 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.073 ' HB ' HG22 ' A' ' 57' ' ' THR . 3.5 t -70.88 134.29 30.29 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 O-C-N 120.222 -1.549 . . . . 0.0 109.162 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.952 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -44.8 151.44 0.29 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.683 -1.207 . . . . 0.0 109.305 178.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -61.82 -8.51 4.97 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.216 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.611 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -92.64 5.06 52.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.019 -1.051 . . . . 0.0 111.379 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.926 ' HB3' HD12 ' A' ' 97' ' ' ILE . 42.0 m-85 -140.75 4.63 1.93 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.78 -1.2 . . . . 0.0 109.715 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 1.073 HG22 ' HB ' ' A' ' 52' ' ' VAL . 14.7 p -89.67 -33.16 16.73 Favored 'General case' 0 C--N 1.288 -2.066 0 O-C-N 120.746 -1.221 . . . . 0.0 108.023 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.25 -1.91 35.18 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.863 0.84 . . . . 0.0 109.968 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.062 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.268 1.5 mtpt -99.38 -48.64 4.72 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 123.07 1.414 . . . . 0.0 107.601 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.018 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.33 0.8 OUTLIER -72.09 -178.28 0.61 Allowed Pre-proline 0 C--N 1.288 -2.068 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.053 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 1.018 ' HD2' HG13 ' A' ' 60' ' ' VAL . 33.1 Cg_endo -67.61 128.0 17.33 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 CA-C-O 123.1 1.208 . . . . 0.0 111.922 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -73.23 69.4 1.08 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.107 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.496 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -38.02 157.94 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.594 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.479 ' C ' HD13 ' A' ' 68' ' ' ILE . 49.9 p30 -127.37 -149.7 0.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.762 -1.211 . . . . 0.0 112.48 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -36.45 -30.78 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.215 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.461 ' NH1' ' HG3' ' A' ' 66' ' ' ARG . 5.9 mtm-85 -53.79 -73.2 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.699 -1.251 . . . . 0.0 109.458 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.58 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -67.98 -38.82 83.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.094 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 0.5 OUTLIER -47.52 -19.83 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.22 -0.925 . . . . 0.0 109.618 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 67' ' ' GLU . . . -90.18 -70.13 1.22 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.588 ' HG3' ' HG ' ' A' ' 84' ' ' LEU . 1.0 OUTLIER -50.3 -30.26 11.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.847 -1.384 . . . . 0.0 108.384 178.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.036 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -74.13 -50.06 21.08 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.585 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -57.13 -18.4 14.85 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.727 -1.233 . . . . 0.0 108.39 178.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -83.54 -34.32 25.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.719 . . . . 0.0 111.533 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.036 HG22 ' O ' ' A' ' 71' ' ' LEU . 33.3 m -42.63 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.016 -1.052 . . . . 0.0 109.851 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 75' ' ' THR . 38.2 m -121.08 11.57 10.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.936 -1.102 . . . . 0.0 110.521 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.002 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -99.59 -154.87 0.48 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 123.041 1.4 . . . . 0.0 113.063 -177.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.757 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.252 0.0 OUTLIER -64.96 63.79 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.575 -178.384 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.921 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.03 145.05 37.64 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 115.078 -2.649 . . . . 0.0 110.529 -176.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.564 ' CE ' ' HG3' ' A' ' 77' ' ' GLU 0.362 0.1 OUTLIER -119.01 177.28 1.38 Allowed Pre-proline 0 C--N 1.288 -2.103 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.787 -175.238 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.456 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 42.7 Cg_endo -75.39 -25.2 11.5 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 N-CA-C 106.36 -2.208 . . . . 0.0 106.36 175.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.769 HD22 HG21 ' A' ' 57' ' ' THR . 14.6 p-10 -112.79 22.37 14.56 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.931 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.776 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -46.14 156.57 0.15 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.658 -1.276 . . . . 0.0 109.347 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.709 ' HB2' HG23 ' A' ' 52' ' ' VAL . 2.1 mmt85 -153.02 155.1 36.26 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.347 -1.341 . . . . 0.0 111.603 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.797 HD13 ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -111.84 100.72 9.15 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.91 ' SG ' HG11 ' A' ' 50' ' ' VAL . 88.2 m -30.37 -31.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.572 ' N ' ' O ' ' A' ' 84' ' ' LEU . 28.0 p -73.21 1.87 8.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.394 -1.442 . . . . 0.0 110.621 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' A' ' 84' ' ' LEU . 1.2 tp-100 -126.29 -8.9 6.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.037 -1.04 . . . . 0.0 111.685 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.659 HD11 HH11 ' A' ' 83' ' ' ARG . 0.9 OUTLIER -89.87 118.84 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.769 -1.207 . . . . 0.0 110.39 -179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.86 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -102.65 135.01 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.074 -1.016 . . . . 0.0 109.607 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.804 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.0 tpt -83.61 121.15 26.85 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.702 -0.624 . . . . 0.0 110.66 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.698 HG23 HD12 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -95.83 -176.9 0.58 Allowed Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 117.879 -1.528 . . . . 0.0 109.172 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 46.1 Cg_endo -90.06 -8.04 4.23 Favored 'Trans proline' 0 C--N 1.284 -2.842 0 O-C-N 124.204 1.634 . . . . 0.0 108.883 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.565 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.9 pt-20 -91.96 -30.53 16.05 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.767 1.27 . . . . 0.0 107.577 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.062 HD21 ' CB ' ' A' ' 59' ' ' LYS . 62.6 mt -90.1 29.35 1.23 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.333 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 95' ' ' ASP . 17.9 p-10 -62.87 104.01 0.5 Allowed 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.932 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.609 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.37 22.88 2.02 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.051 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.939 HG22 ' O ' ' A' ' 2' ' ' LYS . 3.5 tt -63.12 161.3 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.462 1.125 . . . . 0.0 112.307 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.635 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 t -134.56 116.43 21.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -99.24 156.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.647 -1.283 . . . . 0.0 109.47 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.68 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.95 111.61 16.83 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.079 -1.013 . . . . 0.0 110.637 -178.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.535 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 58.7 t -91.83 127.94 47.93 Favored Pre-proline 0 C--N 1.288 -2.081 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.75 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.622 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 58.4 Cg_endo -79.06 -179.9 5.87 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.083 1.57 . . . . 0.0 112.715 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -91.01 -14.89 30.56 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.526 ' CB ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.37 82.66 1.63 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.458 ' NE2' ' CG1' ' A' ' 101' ' ' VAL . 3.7 tt0 -98.64 50.54 0.98 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 117.381 -1.728 . . . . 0.0 110.478 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.598 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.117 -0.989 . . . . 0.0 109.888 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.792 ' O ' HG22 ' A' ' 97' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--O 1.207 -1.158 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.842 ' HA ' HG23 ' A' ' 97' ' ' ILE . 53.7 t -138.05 135.67 45.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 O-C-N 120.85 -1.156 . . . . 0.0 111.929 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 13' ' ' ARG . 47.5 t -143.18 92.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.717 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.664 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 34.6 m-85 -70.7 136.92 49.33 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.232 -0.917 . . . . 0.0 108.982 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.562 HG22 ' CD ' ' A' ' 12' ' ' ARG . 61.5 t -99.92 167.55 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 O-C-N 120.51 -1.369 . . . . 0.0 109.335 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.585 ' HB3' HG22 ' A' ' 11' ' ' THR . 91.2 p -103.17 -155.83 0.54 Allowed 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.15 -0.969 . . . . 0.0 109.014 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.6 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -88.51 -30.41 19.37 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -91.83 -6.08 52.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.38 0.609 . . . . 0.0 109.909 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.03 -24.65 11.5 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.71 129.55 29.95 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.671 -1.488 . . . . 0.0 108.453 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.562 ' CD ' HG22 ' A' ' 6' ' ' VAL . 1.6 mtm180 -121.53 -172.34 2.4 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-O 122.113 0.958 . . . . 0.0 112.514 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.624 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.73 -178.22 5.03 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.705 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 49.9 mt-10 -151.85 112.1 4.1 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 117.717 -1.593 . . . . 0.0 110.959 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.962 HD11 HD12 ' A' ' 32' ' ' ILE 0.254 6.5 mt -108.19 -153.38 0.5 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 122.573 1.178 . . . . 0.0 111.493 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.16 68.77 0.99 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.094 HG13 ' CG1' ' A' ' 21' ' ' VAL . 20.9 t -86.05 114.32 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.98 -170.57 2.84 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 122.098 0.951 . . . . 0.0 111.786 -177.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.514 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 2.1 p-10 -63.67 110.53 2.05 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.488 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 112.4 -16.83 24.21 Favored Glycine 0 C--N 1.286 -2.227 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.606 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.094 ' CG1' HG13 ' A' ' 17' ' ' VAL . 42.0 t -96.73 136.28 28.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 O-C-N 120.203 -1.763 . . . . 0.0 106.909 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.593 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -93.1 140.27 29.68 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.277 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.92 HD23 HG21 ' A' ' 17' ' ' VAL . 8.2 mt -47.96 -25.36 1.33 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.664 -1.273 . . . . 0.0 108.055 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.565 ' CB ' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -69.91 -29.68 66.92 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.316 -0.865 . . . . 0.0 108.667 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.618 ' CG ' HG13 ' A' ' 21' ' ' VAL . 3.5 tt0 -75.46 -70.84 0.4 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.045 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.79 -49.99 18.99 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.136 -1.426 . . . . 0.0 110.601 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.625 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.3 -41.55 19.31 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.211 -1.556 . . . . 0.0 110.796 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.68 2.1 2.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.32 -0.863 . . . . 0.0 109.646 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.261 0.0 OUTLIER -103.9 -30.38 10.37 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.4 1.095 . . . . 0.0 110.206 -179.817 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.769 ' CG ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -99.08 -6.48 28.35 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.28 32.79 15.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.962 HD12 HD11 ' A' ' 15' ' ' LEU . 4.0 mt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 0.0 109.166 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 105' ' ' GLN . 14.8 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.627 0.727 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.634 ' SG ' HD13 ' A' ' 84' ' ' LEU . 20.7 p -88.23 26.56 1.38 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.607 -0.683 . . . . 0.0 110.26 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.136 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 4.5 t60 -70.26 125.49 26.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.431 -0.793 . . . . 0.0 109.899 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.824 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -153.37 -171.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.823 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.824 ' N ' HG23 ' A' ' 50' ' ' VAL 0.263 81.6 m-85 -140.81 113.27 8.04 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.734 0.778 . . . . 0.0 110.95 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.985 ' HB ' HG22 ' A' ' 57' ' ' THR . 5.6 t -80.39 132.44 31.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 O-C-N 120.426 -1.422 . . . . 0.0 109.796 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.905 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -43.88 158.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.544 -1.262 . . . . 0.0 108.772 177.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.18 1.53 7.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.759 -1.213 . . . . 0.0 110.144 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.594 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.06 5.59 46.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.792 ' CB ' HD13 ' A' ' 97' ' ' ILE . 57.7 m-85 -140.27 4.9 2.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.92 -1.112 . . . . 0.0 109.35 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.985 HG22 ' HB ' ' A' ' 52' ' ' VAL . 33.8 p -89.35 -39.67 13.28 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.26 -1.79 47.33 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.755 0.788 . . . . 0.0 110.661 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.052 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.26 0.8 OUTLIER -99.31 -47.68 5.08 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 123.207 1.48 . . . . 0.0 107.559 179.877 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.079 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.329 0.7 OUTLIER -78.31 -179.91 1.49 Allowed Pre-proline 0 C--N 1.286 -2.177 0 CA-C-N 113.624 -1.626 . . . . 0.0 107.921 179.811 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 1.079 ' HD2' HG13 ' A' ' 60' ' ' VAL . 37.9 Cg_endo -69.97 106.75 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 CA-C-O 122.655 1.023 . . . . 0.0 111.836 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.544 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -60.21 74.45 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.766 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 67' ' ' GLU . . . -36.78 153.2 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.951 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 66' ' ' ARG . 1.1 p-10 -108.1 -159.75 0.7 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.165 -0.959 . . . . 0.0 111.858 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 7.4 pt-20 -29.68 -34.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.099 -0.375 . . . . 0.0 111.918 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 64' ' ' ASN . 5.7 mmt180 -53.09 -66.23 0.42 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 120.78 -1.2 . . . . 0.0 107.772 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 1.005 ' HG3' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -61.09 -49.08 78.78 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 1.005 HD12 ' HG3' ' A' ' 67' ' ' GLU . 1.1 mp -57.73 -12.69 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.337 -0.852 . . . . 0.0 111.183 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -89.91 -79.76 1.34 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.585 ' CE ' ' CG ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -43.88 -38.77 3.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -1.177 . . . . 0.0 108.846 179.216 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.995 ' O ' HG22 ' A' ' 74' ' ' VAL . 1.0 OUTLIER -64.99 -50.74 65.15 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -57.17 -22.19 38.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.224 -0.923 . . . . 0.0 108.844 178.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.53 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -80.18 -42.29 23.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.477 -0.764 . . . . 0.0 110.744 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.995 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.7 m -39.0 161.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.526 -0.734 . . . . 0.0 110.089 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 75' ' ' THR . 24.2 m -120.52 29.49 7.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 109.245 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.136 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -112.91 -166.38 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.45 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.6 63.36 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.493 -178.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.905 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.47 152.42 18.03 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 118.848 -2.407 . . . . 0.0 111.389 -176.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.526 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.35 0.0 OUTLIER -128.73 -175.97 0.49 Allowed Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.526 -174.824 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 47.0 Cg_endo -80.67 -30.0 2.03 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 N-CA-C 106.987 -1.967 . . . . 0.0 106.987 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.716 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.7 OUTLIER -105.28 13.21 30.81 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.381 178.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.808 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -44.27 147.54 0.54 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.221 -0.924 . . . . 0.0 109.702 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.775 ' C ' HD23 ' A' ' 84' ' ' LEU . 4.6 mtt180 -166.74 153.71 9.02 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 117.798 -1.561 . . . . 0.0 112.534 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.775 HD23 ' C ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -102.63 119.08 38.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 48' ' ' CYS . 28.8 p -33.53 -28.91 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.876 -0.515 . . . . 0.0 112.349 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.565 ' HA ' ' CB ' ' A' ' 24' ' ' MET . 31.8 p -77.17 8.16 4.3 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.551 -1.343 . . . . 0.0 111.075 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.585 ' CG ' ' CE ' ' A' ' 70' ' ' MET . 19.4 mm-40 -125.68 8.73 7.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.052 -1.03 . . . . 0.0 110.384 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.713 HD12 HG11 ' A' ' 60' ' ' VAL . 3.9 mm -120.5 119.72 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.969 -1.082 . . . . 0.0 111.47 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.894 ' O ' HG22 ' A' ' 60' ' ' VAL . 4.7 mm -102.06 131.36 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.085 -1.009 . . . . 0.0 108.967 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.769 ' HE3' ' HA ' ' A' ' 90' ' ' MET . 20.2 mmm -84.13 141.1 31.32 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.899 -1.126 . . . . 0.0 110.289 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.686 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -114.14 -175.43 0.32 Allowed Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.843 -1.16 . . . . 0.0 109.988 179.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 44.2 Cg_endo -84.98 -9.94 8.43 Favored 'Trans proline' 0 C--N 1.285 -2.8 0 O-C-N 123.705 1.371 . . . . 0.0 108.603 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.538 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.4 pt-20 -92.16 -35.12 14.03 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.052 HD21 ' CB ' ' A' ' 59' ' ' LYS . 55.7 mt -89.77 32.22 0.9 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.726 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.464 ' HA ' ' N ' ' A' ' 2' ' ' LYS . 6.8 p-10 -63.46 108.04 1.26 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 118.319 -1.352 . . . . 0.0 108.788 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.615 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.39 24.11 1.83 Allowed Glycine 0 N--CA 1.498 2.794 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.24 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.105 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -58.59 135.79 22.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.53 -0.983 . . . . 0.0 110.644 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.105 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.5 t -113.53 113.6 44.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -99.46 155.86 4.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.762 -1.211 . . . . 0.0 109.973 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.19 120.09 33.17 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.739 0.78 . . . . 0.0 109.842 -179.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.6 HG12 ' CE1' ' A' ' 8' ' ' HIS . 72.8 t -99.61 123.02 49.46 Favored Pre-proline 0 C--N 1.289 -2.06 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.3 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.666 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 55.8 Cg_endo -76.44 173.53 14.33 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.301 1.685 . . . . 0.0 112.21 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.463 ' OD1' ' CD2' ' A' ' 8' ' ' HIS . 1.3 t0 -91.57 -17.84 25.0 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.781 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.81 72.35 0.78 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.1 OUTLIER -98.42 56.02 1.13 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.285 -177.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.585 ' CD2' ' O ' ' A' ' 106' ' ' TRP . 1.7 p-90 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.886 -1.054 . . . . 0.0 109.807 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.59 ' O ' HG22 ' A' ' 97' ' ' ILE . 4.4 mmtt . . . . . 0 C--O 1.209 -1.029 0 CA-C-O 121.556 0.694 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.8 HG11 HD22 ' A' ' 23' ' ' LEU . 35.4 t -141.35 139.24 32.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 O-C-N 121.623 -0.673 . . . . 0.0 111.466 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.684 HG13 ' HG2' ' A' ' 14' ' ' GLU . 45.6 t -143.18 89.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.602 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 46.9 m-85 -67.63 156.67 36.29 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.368 -0.832 . . . . 0.0 109.463 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.555 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 86.3 t -122.36 170.1 12.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.25 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.597 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 12.0 p -105.45 -154.63 0.52 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.066 -1.021 . . . . 0.0 109.738 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.567 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.91 -30.25 17.0 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.68 -10.63 39.54 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.483 0.659 . . . . 0.0 109.428 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.531 ' O ' ' CD ' ' A' ' 12' ' ' ARG . . . 114.31 -4.33 23.53 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 120.297 -0.954 . . . . 0.0 110.758 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -63.77 130.18 43.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.557 -1.555 . . . . 0.0 107.847 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -121.08 175.67 5.96 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 122.245 1.022 . . . . 0.0 112.791 -177.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -132.83 179.31 6.24 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 177.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.684 ' HG2' HG13 ' A' ' 4' ' ' VAL . 42.0 mt-10 -151.57 108.1 3.48 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 117.54 -1.664 . . . . 0.0 110.954 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.898 HD21 ' CD1' ' A' ' 32' ' ' ILE . 4.9 mt -99.93 -164.19 1.1 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.804 1.288 . . . . 0.0 110.976 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -143.82 68.23 1.28 Allowed 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.051 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.1 t -88.06 125.41 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.908 0.861 . . . . 0.0 109.247 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 90' ' ' MET . . . -89.31 -176.98 5.26 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.746 1.26 . . . . 0.0 113.268 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 90' ' ' MET . 3.1 p-10 -62.12 118.26 7.11 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.569 177.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.509 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 111.9 -22.93 17.98 Favored Glycine 0 C--N 1.284 -2.34 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.593 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.051 ' HB ' HG12 ' A' ' 17' ' ' VAL . 80.9 t -88.94 149.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 119.818 1.809 . . . . 0.0 110.314 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 25' ' ' GLN . 1.6 p -96.14 128.64 43.22 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.8 HD22 HG11 ' A' ' 3' ' ' VAL . 8.0 mt -41.07 -31.22 0.17 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.201 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.509 ' O ' ' HB ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -68.84 -39.29 80.04 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 118.116 -1.434 . . . . 0.0 108.658 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.589 ' CG ' HG13 ' A' ' 21' ' ' VAL . 1.4 tt0 -56.83 -65.01 0.69 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.797 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -50.73 -56.02 13.92 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.683 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.679 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.0 -41.45 16.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.513 -1.367 . . . . 0.0 110.835 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -78.94 0.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.325 -0.859 . . . . 0.0 109.435 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.259 0.0 OUTLIER -104.03 -30.01 10.54 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.232 1.015 . . . . 0.0 110.333 -179.781 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.637 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -98.97 -2.66 36.84 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 24.97 44.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.898 ' CD1' HD21 ' A' ' 15' ' ' LEU . 4.4 mt . . . . . 0 C--N 1.302 -1.484 0 O-C-N 121.244 -1.151 . . . . 0.0 109.435 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.36 0.6 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.756 ' SG ' HD12 ' A' ' 84' ' ' LEU . 7.9 p -115.14 24.33 11.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.409 -0.807 . . . . 0.0 110.082 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.112 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 6.5 t60 -65.11 122.97 18.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.493 -0.754 . . . . 0.0 110.297 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.816 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -148.42 -173.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.981 0.896 . . . . 0.0 109.89 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.816 ' N ' HG23 ' A' ' 50' ' ' VAL 0.27 75.6 m-85 -140.69 110.63 6.52 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.713 0.768 . . . . 0.0 110.855 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.979 ' HB ' HG22 ' A' ' 57' ' ' THR . 4.0 t -79.01 136.14 24.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 O-C-N 120.421 -1.425 . . . . 0.0 110.038 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.962 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -46.01 158.33 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.523 -1.271 . . . . 0.0 108.858 177.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' N ' ' OE2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -72.16 0.22 10.25 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.775 178.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.594 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.28 4.26 48.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.059 -1.026 . . . . 0.0 110.584 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.84 ' HB3' HD12 ' A' ' 97' ' ' ILE . 35.3 m-85 -140.19 6.72 2.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.06 . . . . 0.0 109.299 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.979 HG22 ' HB ' ' A' ' 52' ' ' VAL . 45.6 p -89.39 -39.86 13.13 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.9 -2.47 53.27 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.827 0.822 . . . . 0.0 110.335 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.084 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.261 0.0 OUTLIER -99.56 -47.88 4.95 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 122.971 1.367 . . . . 0.0 107.636 -179.961 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.076 HG11 HG23 ' A' ' 88' ' ' ILE 0.33 0.9 OUTLIER -77.54 177.97 2.4 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.113 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 1.038 ' HD2' HG13 ' A' ' 60' ' ' VAL . 38.2 Cg_endo -71.38 110.02 2.75 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 CA-C-O 122.565 0.985 . . . . 0.0 112.276 -176.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -60.21 70.95 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.108 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' PRO . . . -37.21 134.25 0.6 Allowed 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.88 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' ARG . 43.1 p-10 -88.76 -150.11 0.19 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.111 0.958 . . . . 0.0 112.252 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 64' ' ' ASN . 11.7 pt-20 -37.97 -26.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.573 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.517 ' HA ' ' NE ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -53.0 -70.91 0.08 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.752 -1.218 . . . . 0.0 108.025 179.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.67 ' HA ' ' HE3' ' A' ' 70' ' ' MET . 0.7 OUTLIER -67.38 -51.5 51.27 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 0.9 OUTLIER -44.65 -24.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.465 -0.772 . . . . 0.0 110.108 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.488 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -84.07 -83.08 0.97 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.137 -1.985 . . . . 0.0 108.137 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.67 ' HE3' ' HA ' ' A' ' 67' ' ' GLU . 1.7 ptt? -39.65 -40.52 0.92 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.578 -0.954 . . . . 0.0 108.934 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.0 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -61.71 -53.49 55.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.562 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 3.8 tp10 -56.22 -21.95 26.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.526 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.97 -45.65 23.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.648 -0.657 . . . . 0.0 110.377 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.0 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.3 m -38.94 159.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.556 -0.715 . . . . 0.0 109.733 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.81 HG22 ' O ' ' A' ' 75' ' ' THR . 20.5 m -120.56 34.53 5.18 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.075 -1.015 . . . . 0.0 108.96 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.112 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -115.88 -164.37 0.95 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.628 1.204 . . . . 0.0 112.649 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.751 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.251 0.0 OUTLIER -56.79 62.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.391 -178.843 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.929 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.11 153.65 14.38 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 118.845 -2.409 . . . . 0.0 111.081 -176.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.695 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.387 2.4 mmtt -131.93 177.48 2.22 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.151 -173.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.506 ' HD2' ' HD3' ' A' ' 79' ' ' LYS . 42.9 Cg_endo -73.4 -27.56 13.14 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 176.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.673 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.9 OUTLIER -109.38 13.88 23.94 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.041 179.362 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.75 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -45.04 147.29 0.7 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.954 -1.091 . . . . 0.0 109.649 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.746 ' CD ' HD11 ' A' ' 88' ' ' ILE . 1.1 mtt180 -167.47 163.11 14.84 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 117.765 -1.574 . . . . 0.0 113.01 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.782 ' N ' HD22 ' A' ' 84' ' ' LEU . 3.4 mm? -99.22 122.63 42.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 48' ' ' CYS . 1.9 p -42.92 -23.25 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.167 -0.958 . . . . 0.0 110.713 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 30.4 p -81.49 4.85 19.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.811 -1.181 . . . . 0.0 110.496 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.531 ' HG3' ' CE ' ' A' ' 70' ' ' MET . 18.7 mm-40 -125.22 9.0 7.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 110.827 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.076 HG23 HG11 ' A' ' 60' ' ' VAL . 30.1 mm -113.71 106.96 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.038 -1.039 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.024 ' O ' HG22 ' A' ' 60' ' ' VAL . 4.2 mm -84.88 131.52 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.976 -1.078 . . . . 0.0 110.046 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.669 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.8 tpt -82.62 113.74 20.52 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.359 -0.838 . . . . 0.0 110.823 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.902 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -91.5 -177.34 0.73 Allowed Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 117.516 -1.674 . . . . 0.0 108.642 178.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 46.9 Cg_endo -87.11 -12.61 4.82 Favored 'Trans proline' 0 C--N 1.287 -2.67 0 O-C-N 124.412 1.743 . . . . 0.0 108.651 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.541 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.1 pt-20 -85.2 -32.67 22.54 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.084 HD21 ' CB ' ' A' ' 59' ' ' LYS . 57.7 mt -89.33 36.54 0.83 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.68 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -62.3 99.82 0.15 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.036 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.579 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 120.67 29.52 1.54 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.268 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.84 HD12 ' HB3' ' A' ' 56' ' ' PHE . 9.5 tt -60.19 163.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.496 -1.591 . . . . 0.0 112.3 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.684 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.3 t -133.1 114.1 20.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.604 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -102.18 154.7 5.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 120.92 -1.113 . . . . 0.0 109.992 -178.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.635 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -122.63 122.91 39.94 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.764 0.792 . . . . 0.0 110.487 -178.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 73.6 t -98.45 136.33 20.88 Favored Pre-proline 0 C--N 1.289 -2.045 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.631 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.672 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 56.0 Cg_endo -89.76 173.59 3.58 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 121.716 1.61 . . . . 0.0 111.818 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 18.3 p-10 -91.2 -17.15 26.52 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.818 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.98 74.92 0.89 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.506 ' HG2' ' HG2' ' A' ' 102' ' ' PRO . 10.9 mt-30 -98.49 54.08 1.05 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.299 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.584 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 1.4 p-90 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.082 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.735 ' O ' HG22 ' A' ' 97' ' ' ILE . 11.3 mtmt . . . . . 0 C--O 1.206 -1.187 0 CA-C-O 121.547 0.689 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.864 ' HA ' HG23 ' A' ' 97' ' ' ILE . 44.9 t -137.94 135.01 45.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 O-C-N 121.119 -0.988 . . . . 0.0 111.024 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 13' ' ' ARG . 48.8 t -142.29 92.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.154 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.647 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 36.6 m-85 -70.87 137.3 49.25 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.502 -0.749 . . . . 0.0 109.326 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.57 HG22 ' CD ' ' A' ' 12' ' ' ARG . 74.7 t -99.86 166.49 2.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 O-C-N 120.807 -1.183 . . . . 0.0 109.035 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.586 ' HB3' HG22 ' A' ' 11' ' ' THR . 82.8 p -102.21 -154.88 0.5 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.066 -1.021 . . . . 0.0 108.925 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.594 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -89.52 -31.25 17.72 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.485 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 6.1 p-10 -92.01 -5.1 53.6 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.313 0.577 . . . . 0.0 109.792 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.4 -24.65 11.16 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.76 129.31 29.4 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.567 -1.549 . . . . 0.0 108.38 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.57 ' CD ' HG22 ' A' ' 6' ' ' VAL . 5.4 mtt180 -121.53 -172.47 2.43 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 122.187 0.994 . . . . 0.0 112.563 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.65 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -136.7 -178.85 5.36 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.719 ' C ' HD23 ' A' ' 15' ' ' LEU . 35.3 mt-10 -151.86 112.23 4.13 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 117.788 -1.565 . . . . 0.0 110.711 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.954 HD11 ' HA ' ' A' ' 27' ' ' ALA 0.253 3.5 mt -107.86 -152.3 0.48 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.464 1.126 . . . . 0.0 111.207 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -150.37 70.36 1.02 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.082 HG13 ' CG1' ' A' ' 21' ' ' VAL . 12.7 t -86.8 113.7 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.541 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.17 -169.89 2.58 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.03 0.919 . . . . 0.0 111.504 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.414 ' O ' ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -63.86 110.53 2.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.741 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 112.28 -17.2 24.24 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.558 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.082 ' CG1' HG13 ' A' ' 17' ' ' VAL . 42.9 t -95.58 137.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 O-C-N 120.134 -1.804 . . . . 0.0 107.358 178.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -95.56 144.03 26.36 Favored 'General case' 0 C--N 1.274 -2.69 0 C-N-CA 118.647 -1.221 . . . . 0.0 108.032 178.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.877 HD23 HG21 ' A' ' 17' ' ' VAL . 12.2 mt -49.81 -25.98 3.55 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.09 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.575 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -72.21 -18.67 61.82 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.618 ' CG ' HG13 ' A' ' 21' ' ' VAL . 3.7 tt0 -88.48 -71.96 0.56 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.06 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -47.2 -50.09 21.52 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.166 -1.413 . . . . 0.0 110.349 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.954 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.81 -48.21 30.69 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.354 -1.466 . . . . 0.0 110.361 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -72.97 0.55 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.594 -0.691 . . . . 0.0 109.627 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.34 -29.25 11.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.393 -0.817 . . . . 0.0 110.016 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.868 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.9 m-80 -97.73 -0.97 44.46 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.72 22.39 43.21 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.934 HD12 HD11 ' A' ' 15' ' ' LEU . 4.9 mt . . . . . 0 C--N 1.301 -1.509 0 O-C-N 121.295 -1.121 . . . . 0.0 109.237 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.521 0.676 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.674 ' SG ' HD13 ' A' ' 84' ' ' LEU . 24.9 p -89.13 28.2 1.25 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.472 -0.767 . . . . 0.0 109.879 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.114 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 3.6 t60 -70.32 126.55 29.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.379 -0.826 . . . . 0.0 110.14 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.803 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -156.14 -173.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.05 -1.031 . . . . 0.0 110.102 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.803 ' N ' HG23 ' A' ' 50' ' ' VAL 0.269 76.9 m-85 -140.92 109.9 6.12 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.656 0.741 . . . . 0.0 110.773 179.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.044 ' HB ' HG22 ' A' ' 57' ' ' THR . 4.1 t -76.58 131.64 34.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 O-C-N 120.225 -1.547 . . . . 0.0 110.773 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.809 ' O ' HG23 ' A' ' 57' ' ' THR . 3.7 t30 -47.82 146.28 2.46 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.608 -1.237 . . . . 0.0 108.668 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -59.0 -8.0 1.27 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.058 -1.026 . . . . 0.0 112.072 -178.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.57 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -94.76 8.1 43.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.469 -1.394 . . . . 0.0 110.532 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 1.095 ' CB ' HD13 ' A' ' 97' ' ' ILE . 87.3 m-85 -140.14 3.5 1.98 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 109.754 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 1.044 HG22 ' HB ' ' A' ' 52' ' ' VAL . 23.7 p -90.43 -40.54 11.98 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.1 -1.0 . . . . 0.0 108.467 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.92 -0.87 55.4 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.782 0.801 . . . . 0.0 110.438 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.025 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.259 0.2 OUTLIER -99.46 -48.17 4.87 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 123.199 1.476 . . . . 0.0 107.419 179.655 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.064 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.337 0.8 OUTLIER -77.36 -176.82 0.69 Allowed Pre-proline 0 C--N 1.289 -2.039 0 CA-C-N 113.602 -1.635 . . . . 0.0 107.225 179.31 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 1.064 ' HD2' HG13 ' A' ' 60' ' ' VAL . 35.5 Cg_endo -61.99 127.45 21.37 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 CA-C-O 122.885 1.119 . . . . 0.0 111.448 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.572 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -74.05 60.4 0.77 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.824 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 67' ' ' GLU . . . -38.43 107.29 0.06 Allowed 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.476 0.655 . . . . 0.0 109.915 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.518 ' ND2' ' HG2' ' A' ' 65' ' ' GLU . 0.1 OUTLIER -87.73 -142.38 0.12 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.31 -0.869 . . . . 0.0 111.996 -178.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.518 ' HG2' ' ND2' ' A' ' 64' ' ' ASN . 15.7 pt-20 -29.14 -37.34 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 64' ' ' ASN . 4.3 mtm-85 -53.35 -70.37 0.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.872 -1.142 . . . . 0.0 108.99 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.637 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -59.78 -52.58 64.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 110.188 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.4 mp -45.54 -20.88 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.566 -0.709 . . . . 0.0 111.111 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -86.6 -80.21 1.19 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.593 ' HG3' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -44.06 -39.06 3.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -1.162 . . . . 0.0 108.653 178.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.053 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -63.41 -51.96 63.57 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.562 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -54.63 -24.21 20.5 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -71.23 -50.79 29.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.666 -0.647 . . . . 0.0 110.326 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.053 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.6 m -39.7 160.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.374 -0.828 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.791 HG22 ' O ' ' A' ' 75' ' ' THR . 20.9 m -120.66 35.27 4.93 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.033 -1.042 . . . . 0.0 109.26 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.114 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -114.98 -163.89 0.91 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.841 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.747 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.13 63.21 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.739 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.854 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.08 152.58 16.38 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 118.989 -2.32 . . . . 0.0 111.763 -177.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.689 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.392 1.5 mmtt -133.96 177.73 2.11 Favored Pre-proline 0 C--N 1.292 -1.926 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.662 -173.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 44.3 Cg_endo -75.93 -29.38 6.86 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 N-CA-C 107.329 -1.835 . . . . 0.0 107.329 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.709 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.6 OUTLIER -103.82 12.4 34.56 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.631 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.774 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -44.46 148.03 0.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.123 -0.986 . . . . 0.0 109.838 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.897 ' NE ' HD11 ' A' ' 88' ' ' ILE . 1.1 mtt180 -169.67 157.74 7.21 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.733 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.677 HD22 ' HA ' ' A' ' 49' ' ' HIS . 4.4 mt -106.97 116.09 31.32 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 24' ' ' MET . 7.4 p -35.35 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.575 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 4.5 p -65.41 -6.1 9.37 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.294 -1.504 . . . . 0.0 112.127 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.543 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . 6.5 tp-100 -125.53 3.24 7.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.421 -1.424 . . . . 0.0 111.655 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.026 HG23 HG11 ' A' ' 60' ' ' VAL . 35.9 mm -100.99 103.4 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.753 -1.217 . . . . 0.0 110.312 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.992 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -90.17 128.63 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.073 -1.017 . . . . 0.0 108.465 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.691 ' HE3' ' HA ' ' A' ' 90' ' ' MET . 22.3 mmm -83.22 134.49 34.95 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.546 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.799 HG23 HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -112.15 170.67 5.03 Favored Pre-proline 0 C--N 1.291 -1.935 0 O-C-N 120.833 -1.167 . . . . 0.0 109.507 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 38.9 Cg_endo -65.86 -11.71 32.04 Favored 'Trans proline' 0 C--N 1.289 -2.58 0 O-C-N 124.525 1.803 . . . . 0.0 110.892 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.612 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.3 OUTLIER -92.37 -29.33 16.38 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 117.729 -1.588 . . . . 0.0 107.835 177.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.025 HD21 ' CB ' ' A' ' 59' ' ' LYS . 96.7 mt -89.96 27.48 1.58 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.707 0.765 . . . . 0.0 110.935 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.496 ' HA ' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -63.23 104.79 0.63 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.51 -1.276 . . . . 0.0 107.958 177.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.622 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.78 22.74 1.95 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.123 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -57.83 138.05 19.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.399 -1.059 . . . . 0.0 111.069 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.123 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.1 t -111.36 114.14 46.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.563 ' HB ' ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -98.81 155.17 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.732 -1.23 . . . . 0.0 109.209 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.664 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.93 120.32 33.08 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.358 -0.839 . . . . 0.0 110.251 -178.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 69.8 t -96.32 136.79 21.76 Favored Pre-proline 0 C--N 1.287 -2.115 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.789 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.675 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 57.3 Cg_endo -89.48 171.28 4.39 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.063 1.559 . . . . 0.0 111.585 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -91.2 -17.24 26.39 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.681 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.82 73.9 0.85 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.05 57.13 1.07 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.435 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.593 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 1.7 p-90 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.714 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.735 ' O ' HG22 ' A' ' 97' ' ' ILE . 9.1 mtmm . . . . . 0 C--O 1.211 -0.936 0 CA-C-O 121.828 0.823 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.945 ' HA ' HG23 ' A' ' 97' ' ' ILE . 56.0 t -141.17 135.04 31.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 O-C-N 121.152 -0.968 . . . . 0.0 110.983 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.756 HG13 ' HG3' ' A' ' 14' ' ' GLU . 23.6 t -142.6 89.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 118.732 -1.187 . . . . 0.0 110.415 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.656 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 46.2 m-85 -67.92 157.04 35.89 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.466 -0.772 . . . . 0.0 109.331 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 101' ' ' VAL . 99.7 t -122.54 169.98 13.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 O-C-N 121.178 -0.951 . . . . 0.0 109.291 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.595 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 9.9 p -102.61 -153.26 0.46 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.06 -1.025 . . . . 0.0 109.217 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.574 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -93.51 -29.44 15.53 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 178.093 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -91.81 -9.97 41.54 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.498 0.666 . . . . 0.0 109.452 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.529 ' O ' ' CD ' ' A' ' 12' ' ' ARG . . . 114.57 -5.69 22.83 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 120.3 -0.953 . . . . 0.0 111.145 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -63.54 130.56 44.87 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.288 -1.713 . . . . 0.0 107.924 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.539 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.74 176.08 5.7 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 122.257 1.027 . . . . 0.0 112.927 -177.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -133.02 178.9 6.53 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 177.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.756 ' HG3' HG13 ' A' ' 4' ' ' VAL . 46.2 mp0 -151.75 110.32 3.8 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 117.56 -1.656 . . . . 0.0 111.109 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.002 HD21 ' CD1' ' A' ' 32' ' ' ILE . 8.3 mt -103.17 -156.33 0.56 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.592 1.187 . . . . 0.0 110.618 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -153.02 70.35 0.87 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.061 HG12 ' HB ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -89.66 127.84 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.003 0.906 . . . . 0.0 109.627 -177.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.25 -179.27 5.84 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.259 1.028 . . . . 0.0 112.858 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -62.24 119.18 8.52 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.696 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 112.05 -22.14 19.01 Favored Glycine 0 C--N 1.288 -2.119 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.555 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.061 ' HB ' HG12 ' A' ' 17' ' ' VAL . 65.8 t -90.77 150.64 3.68 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.209 0 O-C-N 120.116 -1.814 . . . . 0.0 109.505 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.482 ' N ' HG12 ' A' ' 21' ' ' VAL . 1.2 p -96.61 132.14 42.54 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.781 HD22 HG11 ' A' ' 3' ' ' VAL . 7.9 mt -46.96 -28.44 1.62 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.705 -1.247 . . . . 0.0 108.436 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.553 ' CB ' ' O ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -73.91 -12.02 60.53 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.323 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.472 ' HB3' ' O ' ' A' ' 22' ' ' SER . 1.0 OUTLIER -91.84 -61.22 1.68 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.756 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -54.39 -55.53 27.72 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.375 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.927 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.42 -51.0 21.38 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.561 -1.337 . . . . 0.0 110.446 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -65.41 -5.61 2.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 109.333 179.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 26' ' ' ALA 0.256 0.0 OUTLIER -103.3 -24.0 13.55 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.731 0.777 . . . . 0.0 110.065 179.838 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.761 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.6 m-80 -96.75 5.45 50.59 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.72 78.44 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.002 ' CD1' HD21 ' A' ' 15' ' ' LEU . 10.5 mt . . . . . 0 C--N 1.303 -1.444 0 O-C-N 121.317 -1.107 . . . . 0.0 109.213 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.444 0.64 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 1.023 ' HB2' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -107.06 14.73 26.02 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.475 -0.765 . . . . 0.0 109.66 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.091 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 13.4 t60 -70.23 123.76 22.47 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.276 -0.89 . . . . 0.0 111.714 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.802 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.5 m -158.34 -174.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.729 0.776 . . . . 0.0 109.129 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.881 ' OH ' HD22 ' A' ' 78' ' ' LEU 0.252 68.0 m-85 -140.84 102.57 4.31 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.019 0.914 . . . . 0.0 110.66 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.076 ' HB ' HG22 ' A' ' 57' ' ' THR . 2.7 t -74.19 134.13 30.18 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 O-C-N 120.69 -1.256 . . . . 0.0 110.491 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.881 ' O ' HG23 ' A' ' 57' ' ' THR . 3.7 t30 -48.8 150.33 1.5 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.302 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.6 pt-20 -60.35 -8.1 2.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.246 -0.909 . . . . 0.0 111.909 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.578 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.78 9.41 43.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.628 -1.295 . . . . 0.0 110.758 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 1.121 ' CB ' HD13 ' A' ' 97' ' ' ILE . 88.0 m-85 -140.51 2.03 1.8 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.051 -1.03 . . . . 0.0 110.119 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 1.076 HG22 ' HB ' ' A' ' 52' ' ' VAL . 7.6 p -90.45 -40.21 12.16 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.015 -1.053 . . . . 0.0 108.36 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.39 -0.31 52.69 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.688 0.756 . . . . 0.0 110.699 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.046 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.265 1.1 mtpp -99.22 -48.49 4.81 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 123.303 1.525 . . . . 0.0 107.085 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.061 HG11 HD13 ' A' ' 88' ' ' ILE 0.334 0.9 OUTLIER -72.8 179.48 1.09 Allowed Pre-proline 0 C--N 1.288 -2.083 0 CA-C-N 113.436 -1.711 . . . . 0.0 106.472 178.431 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 1.046 ' HD2' HG13 ' A' ' 60' ' ' VAL . 36.6 Cg_endo -70.21 113.07 3.33 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 CA-C-O 122.834 1.098 . . . . 0.0 111.155 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.3 67.61 1.42 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.225 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.666 ' HB2' ' HG3' ' A' ' 87' ' ' GLN . . . -37.45 156.6 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.954 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 66' ' ' ARG . 2.3 p-10 -92.37 -161.96 0.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.017 -1.052 . . . . 0.0 112.399 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 4.0 pt-20 -38.1 -24.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.987 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -52.76 -72.3 0.06 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.65 -1.281 . . . . 0.0 107.949 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.937 ' HA ' ' HE3' ' A' ' 70' ' ' MET . 0.5 OUTLIER -68.36 -40.88 81.33 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.554 -0.716 . . . . 0.0 109.298 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.635 HD12 ' CD ' ' A' ' 67' ' ' GLU . 1.1 mp -57.94 -16.89 7.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.111 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.51 ' HA2' ' OE1' ' A' ' 72' ' ' GLU . . . -97.01 -68.35 0.96 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.937 ' HE3' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -42.44 -38.9 2.04 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.126 -1.22 . . . . 0.0 108.065 179.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.121 HD11 ' CB ' ' A' ' 82' ' ' SER 0.261 0.0 OUTLIER -65.34 -50.51 65.31 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.883 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.515 ' OE2' ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -67.04 -29.84 69.75 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.515 ' N ' ' OE2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -61.11 -38.92 88.04 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.023 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.082 HG21 ' CE1' ' A' ' 49' ' ' HIS . 1.4 m -53.2 168.81 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 75' ' ' THR . 17.0 m -120.74 54.48 1.07 Allowed 'General case' 0 C--N 1.287 -2.145 0 O-C-N 120.483 -1.386 . . . . 0.0 110.014 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.091 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -126.17 -154.64 0.64 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 115.151 -2.62 . . . . 0.0 112.211 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.733 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.262 0.0 OUTLIER -63.88 60.38 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 122.702 1.239 . . . . 0.0 108.472 -179.558 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.009 HD13 ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -59.23 132.72 54.85 Favored 'General case' 0 C--N 1.288 -2.09 0 O-C-N 119.63 -1.919 . . . . 0.0 110.375 -177.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.546 ' CD ' ' HG3' ' A' ' 77' ' ' GLU 0.365 0.0 OUTLIER -116.01 -179.4 0.62 Allowed Pre-proline 0 C--N 1.291 -1.975 0 CA-C-N 112.666 -2.061 . . . . 0.0 111.798 -174.13 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -79.12 -28.79 3.58 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 N-CA-C 106.82 -2.031 . . . . 0.0 106.82 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.693 ' HB2' HG21 ' A' ' 57' ' ' THR . 14.8 p-10 -108.68 14.68 24.26 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.98 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 1.121 ' CB ' HD11 ' A' ' 71' ' ' LEU . 2.7 m -47.8 -175.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.537 -0.727 . . . . 0.0 109.68 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.601 ' HB2' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -174.89 169.27 3.47 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 116.434 -2.106 . . . . 0.0 114.72 178.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.023 HD13 ' HB2' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -115.72 103.12 10.37 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.596 ' SG ' ' HB3' ' A' ' 48' ' ' CYS . 0.7 OUTLIER -31.92 -31.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 84' ' ' LEU . 29.6 p -84.48 12.07 7.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.053 -1.654 . . . . 0.0 112.247 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.666 ' HG3' ' HB2' ' A' ' 63' ' ' ALA . 1.5 tp-100 -126.33 21.62 7.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.588 -1.32 . . . . 0.0 111.836 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.061 HD13 HG11 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -120.12 105.15 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.736 -1.227 . . . . 0.0 110.678 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.945 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -90.76 132.39 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.923 -1.11 . . . . 0.0 109.37 179.085 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.984 ' SD ' HG21 ' A' ' 97' ' ' ILE . 1.3 tpt -82.83 117.56 22.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.653 -0.654 . . . . 0.0 111.348 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.754 HG23 HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -98.77 176.15 2.13 Favored Pre-proline 0 N--CA 1.496 1.849 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.779 178.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 45.3 Cg_endo -78.56 -9.0 16.09 Favored 'Trans proline' 0 C--N 1.293 -2.353 0 O-C-N 124.564 1.823 . . . . 0.0 110.262 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.612 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.6 OUTLIER -92.72 -29.72 15.91 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.046 HD21 ' CB ' ' A' ' 59' ' ' LYS . 85.9 mt -89.68 28.47 1.31 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.738 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.417 ' O ' ' CG ' ' A' ' 95' ' ' ASP . 17.9 p-10 -63.45 105.73 0.81 Allowed 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 118.513 -1.275 . . . . 0.0 108.621 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.666 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 125.04 16.99 2.83 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.523 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.121 HD13 ' CB ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -51.71 142.17 4.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.606 -0.938 . . . . 0.0 111.715 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.087 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.1 t -115.67 111.43 35.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.599 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -99.06 153.05 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 120.735 -1.228 . . . . 0.0 109.853 -178.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.675 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.76 127.88 49.74 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.791 -179.118 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 54.5 t -98.24 139.8 21.45 Favored Pre-proline 0 C--N 1.288 -2.07 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.722 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.7 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 56.2 Cg_endo -90.53 174.81 2.83 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.818 1.679 . . . . 0.0 111.886 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 11.1 p-10 -91.3 -17.72 25.48 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.905 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -111.34 67.86 0.65 Allowed 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -97.5 49.88 1.05 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.326 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.607 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 11.0 p-90 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.282 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.762 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.204 -1.318 0 CA-C-O 121.356 0.598 . . . . 0.0 110.057 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.933 HG22 ' CG2' ' A' ' 97' ' ' ILE . 44.8 t -134.39 133.07 55.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.843 0.83 . . . . 0.0 111.073 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 13' ' ' ARG . 56.4 t -142.29 89.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.531 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.681 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 40.9 m-85 -67.79 135.82 53.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.574 HG13 ' HG2' ' A' ' 12' ' ' ARG . 59.3 t -99.65 167.09 2.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 O-C-N 120.546 -1.346 . . . . 0.0 109.664 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.587 ' HB3' HG22 ' A' ' 11' ' ' THR . 89.6 p -102.3 -153.99 0.48 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 109.335 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.594 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -88.99 -33.09 17.31 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.477 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 10.5 p-10 -91.63 -3.88 55.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.736 -0.603 . . . . 0.0 109.883 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.11 -24.42 11.67 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.587 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.79 128.83 28.02 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.609 -1.524 . . . . 0.0 108.38 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.574 ' HG2' HG13 ' A' ' 6' ' ' VAL . 20.8 mtm180 -121.35 -171.77 2.28 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 122.162 0.982 . . . . 0.0 112.474 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.657 ' HE ' HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.36 -179.08 5.42 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 178.296 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -152.0 109.58 3.62 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 117.447 -1.701 . . . . 0.0 111.201 178.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.974 HD11 ' HA ' ' A' ' 27' ' ' ALA . 6.6 mt -105.06 -157.07 0.59 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.639 1.209 . . . . 0.0 110.583 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -153.27 70.81 0.87 Allowed 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.05 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.2 t -88.34 127.39 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.736 0.779 . . . . 0.0 109.592 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.0 -178.16 5.63 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.618 1.199 . . . . 0.0 112.987 -177.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.51 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 1.5 p30 -61.15 116.12 4.31 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.829 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.685 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 111.89 -20.86 21.57 Favored Glycine 0 C--N 1.287 -2.162 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.524 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.05 ' HB ' HG12 ' A' ' 17' ' ' VAL . 90.3 t -89.21 150.5 3.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 120.1 -1.823 . . . . 0.0 109.306 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 25' ' ' GLN . 1.6 p -96.01 125.61 40.67 Favored 'General case' 0 C--N 1.274 -2.684 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.752 ' CD2' HG21 ' A' ' 17' ' ' VAL . 4.4 mt -43.05 -24.33 0.07 Allowed 'General case' 0 C--O 1.203 -1.382 0 O-C-N 120.73 -1.231 . . . . 0.0 109.265 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.607 ' O ' ' HB ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -64.43 -47.58 78.58 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.9 tt0 -59.84 -65.51 0.67 Allowed 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.905 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.61 -60.04 2.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.911 -1.118 . . . . 0.0 110.581 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.974 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.72 -54.69 11.42 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.751 -1.218 . . . . 0.0 110.848 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -63.92 -6.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.544 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.254 0.0 OUTLIER -99.25 -25.97 14.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.303 -0.873 . . . . 0.0 109.817 179.708 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.797 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.5 m-80 -96.93 3.93 51.84 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.81 72.81 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.971 ' CD1' HD21 ' A' ' 15' ' ' LEU . 9.0 mt . . . . . 0 C--N 1.302 -1.495 0 O-C-N 121.479 -1.012 . . . . 0.0 109.488 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.448 0.642 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.524 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 9.4 p -115.32 29.69 7.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.456 -0.777 . . . . 0.0 109.895 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.125 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 4.7 t60 -70.21 125.98 28.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.745 . . . . 0.0 110.116 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.804 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -155.3 -173.66 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.0 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.804 ' N ' HG23 ' A' ' 50' ' ' VAL 0.269 82.9 m-85 -140.41 114.13 8.82 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.624 0.726 . . . . 0.0 110.754 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.019 ' HB ' HG22 ' A' ' 57' ' ' THR . 5.5 t -85.19 130.66 35.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 O-C-N 120.28 -1.513 . . . . 0.0 109.504 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.934 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -40.75 157.2 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.675 -1.265 . . . . 0.0 109.294 177.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.1 0.37 7.79 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.844 -1.16 . . . . 0.0 110.209 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.59 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.1 5.29 47.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.948 -1.095 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.831 ' CB ' HD13 ' A' ' 97' ' ' ILE . 55.0 m-85 -140.48 5.44 2.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.901 -1.124 . . . . 0.0 109.443 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 1.019 HG22 ' HB ' ' A' ' 52' ' ' VAL . 30.4 p -89.58 -38.02 14.27 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -2.45 44.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.828 0.823 . . . . 0.0 110.39 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.077 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.259 0.2 OUTLIER -99.21 -47.96 5.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 179.708 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.037 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.334 1.1 t -80.4 175.03 5.22 Favored Pre-proline 0 C--N 1.288 -2.071 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 177.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 1.037 ' HD2' HG13 ' A' ' 60' ' ' VAL . 38.3 Cg_endo -74.54 110.79 3.17 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 CA-C-O 122.877 1.115 . . . . 0.0 112.934 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.497 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -75.43 75.55 2.5 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.356 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.73 ' HB3' ' CB ' ' A' ' 67' ' ' GLU . . . -37.04 160.32 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.874 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -96.99 -160.7 0.82 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.247 -0.908 . . . . 0.0 112.336 -178.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -28.74 -39.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 122.025 -0.422 . . . . 0.0 112.074 -178.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 64' ' ' ASN . 3.6 mtt180 -53.19 -66.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.569 -1.332 . . . . 0.0 108.488 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.787 ' HA ' ' HE2' ' A' ' 70' ' ' MET . 0.8 OUTLIER -59.25 -35.13 73.14 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.579 -0.701 . . . . 0.0 109.86 178.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.7 mp -77.24 -9.04 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.224 -0.922 . . . . 0.0 110.278 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -84.23 -80.81 1.05 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.787 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.82 -36.56 2.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.164 -1.198 . . . . 0.0 108.728 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.994 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -64.62 -48.54 74.5 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.535 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 3.1 tp10 -61.36 -16.18 43.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.481 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -85.72 -40.51 16.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.695 -0.628 . . . . 0.0 110.459 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.994 HG22 ' O ' ' A' ' 71' ' ' LEU . 8.1 m -40.38 162.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.387 -0.821 . . . . 0.0 109.639 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 75' ' ' THR . 23.0 m -120.48 30.0 7.16 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.193 -0.942 . . . . 0.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.125 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -113.85 -167.96 1.28 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.755 -1.178 . . . . 0.0 112.465 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.738 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.14 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.819 -179.012 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.924 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.48 153.56 15.71 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 118.903 -2.373 . . . . 0.0 111.165 -177.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.535 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.347 0.0 OUTLIER -128.46 -178.18 0.75 Allowed Pre-proline 0 C--N 1.297 -1.703 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.329 -174.792 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 45.6 Cg_endo -78.75 -28.36 4.22 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 N-CA-C 106.985 -1.967 . . . . 0.0 106.985 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.6 ' CG ' HG21 ' A' ' 57' ' ' THR . 0.7 OUTLIER -108.11 16.24 23.5 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.089 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.826 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -43.72 149.37 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.922 -1.111 . . . . 0.0 108.932 -179.388 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.947 ' HB2' HG23 ' A' ' 52' ' ' VAL . 2.3 mmt85 -154.55 146.07 23.14 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.604 -1.638 . . . . 0.0 112.403 -177.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -103.67 88.71 3.13 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 177.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 24' ' ' MET . 5.7 t -17.03 -45.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.578 ' N ' ' O ' ' A' ' 84' ' ' LEU . 1.6 p -44.26 -19.31 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.611 -1.305 . . . . 0.0 112.236 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.559 ' HB3' ' HB2' ' A' ' 63' ' ' ALA . 1.3 mp0 -118.88 -4.72 10.64 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.254 -1.529 . . . . 0.0 112.081 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.634 HG23 HG11 ' A' ' 60' ' ' VAL . 3.2 mm -79.76 98.25 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.779 -1.201 . . . . 0.0 109.046 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.971 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -84.11 130.42 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.002 -1.061 . . . . 0.0 109.02 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.642 ' HE1' ' HB3' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -83.31 125.16 31.33 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.692 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.902 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -101.42 -177.67 0.58 Allowed Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 118.111 -1.436 . . . . 0.0 109.005 177.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.61 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 47.6 Cg_endo -89.07 -14.71 2.67 Favored 'Trans proline' 0 C--N 1.291 -2.453 0 O-C-N 124.483 1.781 . . . . 0.0 108.713 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.512 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.1 pt-20 -82.26 -31.47 30.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.077 HD21 ' CB ' ' A' ' 59' ' ' LYS . 52.4 mt -89.72 34.85 0.83 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.053 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -62.65 107.16 0.9 Allowed 'General case' 0 C--N 1.29 -2.013 0 O-C-N 120.365 -1.459 . . . . 0.0 109.092 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.444 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 122.24 25.67 1.98 Allowed Glycine 0 N--CA 1.497 2.761 0 O-C-N 120.835 -1.165 . . . . 0.0 110.71 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.117 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -59.1 135.97 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.971 -1.311 . . . . 0.0 110.6 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.117 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.4 t -115.77 111.74 36.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -99.5 156.5 3.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.88 -178.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.694 ' N ' ' O ' ' A' ' 51' ' ' TYR . 1.1 m-20 -122.9 125.95 46.34 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.306 -0.871 . . . . 0.0 110.413 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.589 HG12 ' CE1' ' A' ' 8' ' ' HIS . 56.1 t -103.61 130.31 23.75 Favored Pre-proline 0 C--N 1.289 -2.039 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.692 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.653 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 56.7 Cg_endo -84.23 173.84 8.55 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 124.296 1.682 . . . . 0.0 112.077 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.44 ' CG ' ' HB3' ' A' ' 8' ' ' HIS . 1.3 m-20 -91.34 -18.31 24.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.792 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.91 73.75 0.84 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.479 ' HG2' ' HD2' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -98.64 55.63 1.08 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 118.994 -1.083 . . . . 0.0 110.132 -177.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.582 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 1.4 p-90 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.92 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.809 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.202 -1.429 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.878 ' HA ' HG23 ' A' ' 97' ' ' ILE . 78.6 t -137.69 130.08 41.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 122.287 1.042 . . . . 0.0 110.711 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.659 HG13 ' HG2' ' A' ' 14' ' ' GLU . 85.8 t -141.42 96.5 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.917 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.294 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.675 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 21.6 m-85 -76.89 151.63 35.72 Favored 'General case' 0 C--O 1.201 -1.486 0 O-C-N 121.64 -0.663 . . . . 0.0 109.747 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 89.9 t -111.31 166.85 5.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 O-C-N 121.046 -1.034 . . . . 0.0 110.368 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 11' ' ' THR . 85.8 p -103.77 -157.21 0.6 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.131 -0.98 . . . . 0.0 109.261 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.545 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -91.04 -27.13 18.82 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -92.1 -8.23 46.37 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.734 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 113.47 -9.35 24.22 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.58 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.6 OUTLIER -66.54 136.17 55.25 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 119.914 -1.933 . . . . 0.0 108.758 179.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -120.5 179.66 4.25 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.251 1.024 . . . . 0.0 112.974 -176.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.667 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -134.58 173.27 11.84 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 179.589 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.669 ' C ' HD23 ' A' ' 15' ' ' LEU . 16.3 mt-10 -150.15 114.84 5.27 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 117.111 -1.836 . . . . 0.0 111.047 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.975 HD11 ' HA ' ' A' ' 27' ' ' ALA 0.28 4.6 mt -107.92 -154.03 0.52 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.462 1.125 . . . . 0.0 109.845 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.32 72.04 0.92 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.983 HG22 ' CB ' ' A' ' 26' ' ' ALA . 1.4 t -88.31 126.41 41.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-O 121.786 0.803 . . . . 0.0 109.022 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.629 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.44 -179.51 5.84 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.817 0.817 . . . . 0.0 112.777 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.68 ' HB3' ' CD ' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -56.75 112.44 1.3 Allowed 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.56 177.091 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.72 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 112.81 -21.54 18.31 Favored Glycine 0 C--N 1.282 -2.464 0 C-N-CA 118.702 -1.713 . . . . 0.0 113.003 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.94 ' HB ' HG12 ' A' ' 17' ' ' VAL . 66.7 t -86.2 147.87 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 120.677 2.239 . . . . 0.0 108.059 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -95.38 130.34 42.21 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.736 HD21 ' HG2' ' A' ' 90' ' ' MET . 11.0 mt -44.87 -25.79 0.34 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.015 -1.678 . . . . 0.0 109.782 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.552 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -67.41 -23.18 65.53 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.3 tt0 -88.09 -65.43 1.02 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.983 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.42 -49.86 17.51 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.281 -1.368 . . . . 0.0 111.383 178.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.975 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -55.2 -50.0 70.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.184 -1.573 . . . . 0.0 110.173 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.7 OUTLIER -67.32 -1.19 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.73 -1.231 . . . . 0.0 110.569 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . 0.265 0.0 OUTLIER -104.33 -31.15 9.68 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.311 1.053 . . . . 0.0 109.655 -178.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.717 ' CG ' HD22 ' A' ' 15' ' ' LEU . 6.8 m-80 -95.82 4.16 53.1 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.17 12.58 63.2 Favored Glycine 0 N--CA 1.505 3.273 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.536 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.907 ' CD1' HD21 ' A' ' 15' ' ' LEU . 7.9 mt . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.564 -0.962 . . . . 0.0 109.681 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.683 0.754 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' ' 84' ' ' LEU . 6.8 p -99.68 30.04 3.82 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.616 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.105 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 5.3 t60 -69.81 123.25 20.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.518 -0.739 . . . . 0.0 110.842 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.756 HG22 ' O ' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -155.32 -172.35 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 120.808 -1.182 . . . . 0.0 108.399 178.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.741 ' N ' HG23 ' A' ' 50' ' ' VAL 0.301 79.8 m-85 -139.78 109.13 6.14 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.351 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.001 ' HB ' HG22 ' A' ' 57' ' ' THR . 7.1 t -76.94 129.42 37.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 O-C-N 120.566 -1.334 . . . . 0.0 110.553 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.782 HD21 ' HB2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -42.75 146.22 0.39 Allowed 'General case' 0 C--N 1.307 -1.251 0 O-C-N 120.163 -1.586 . . . . 0.0 109.411 176.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.14 -9.48 0.92 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.361 -0.837 . . . . 0.0 111.956 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.631 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -92.15 7.77 40.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.041 -1.662 . . . . 0.0 112.281 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.782 ' HB2' HD21 ' A' ' 53' ' ' ASN . 77.1 m-85 -141.08 3.71 1.81 Allowed 'General case' 0 N--CA 1.516 2.857 0 O-C-N 120.535 -1.353 . . . . 0.0 108.759 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 1.027 HG21 ' HB2' ' A' ' 81' ' ' ASN . 17.0 p -89.4 -33.25 16.92 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.157 -0.965 . . . . 0.0 108.618 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.38 -1.76 24.67 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.94 0.876 . . . . 0.0 111.084 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.993 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.286 0.1 OUTLIER -97.63 -48.31 5.29 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 179.187 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.058 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.339 1.0 OUTLIER -77.44 177.75 2.52 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.699 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 1.058 ' HD2' HG13 ' A' ' 60' ' ' VAL . 32.5 Cg_endo -71.6 122.56 8.69 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 CA-C-O 122.632 1.013 . . . . 0.0 111.731 -177.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -77.17 73.57 3.75 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.36 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.625 ' HB1' ' HG2' ' A' ' 87' ' ' GLN . . . -37.71 157.59 0.01 OUTLIER 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.326 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.449 ' OD1' ' HB2' ' A' ' 66' ' ' ARG . 48.1 p30 -90.0 -168.7 2.2 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 123.157 1.456 . . . . 0.0 112.49 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -37.4 -30.43 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.237 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.482 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -55.28 -63.43 1.16 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.365 -1.459 . . . . 0.0 107.568 179.247 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.842 ' HA ' ' HE2' ' A' ' 70' ' ' MET . 8.0 tp10 -60.72 -41.0 94.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.823 -0.548 . . . . 0.0 110.421 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 65' ' ' GLU . 59.9 mt -79.75 -5.22 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.933 . . . . 0.0 110.906 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -86.93 -75.71 1.27 Allowed Glycine 0 N--CA 1.482 1.753 0 N-CA-C 107.629 -2.188 . . . . 0.0 107.629 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.842 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.52 -43.36 5.44 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.629 -1.228 . . . . 0.0 107.913 178.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.956 ' O ' HG22 ' A' ' 74' ' ' VAL 0.25 0.6 OUTLIER -56.96 -53.78 54.13 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.34 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -56.0 -24.94 41.92 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.707 -1.245 . . . . 0.0 108.358 178.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -74.05 -47.16 38.6 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.704 -179.362 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.956 HG22 ' O ' ' A' ' 71' ' ' LEU . 3.3 m -36.19 161.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 121.972 0.891 . . . . 0.0 111.186 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.83 HG22 ' O ' ' A' ' 75' ' ' THR . 30.2 m -118.45 25.9 9.97 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.456 -1.403 . . . . 0.0 109.973 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.105 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -103.46 -153.66 0.48 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.102 -1.624 . . . . 0.0 113.283 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.753 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.25 0.0 OUTLIER -71.05 63.15 0.31 Allowed 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.897 -178.41 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.774 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -57.39 154.97 9.86 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 116.218 -2.193 . . . . 0.0 110.317 -176.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.681 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.375 20.4 mmtt -134.02 178.89 1.55 Allowed Pre-proline 0 C--N 1.294 -1.831 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.253 -173.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 55.2 Cg_endo -77.3 -28.38 5.76 Favored 'Trans proline' 0 C--N 1.295 -2.27 0 N-CA-C 104.742 -2.83 . . . . 0.0 104.742 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 1.027 ' HB2' HG21 ' A' ' 57' ' ' THR . 13.3 p-10 -105.13 14.57 28.96 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.611 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.833 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -47.26 146.6 1.85 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.853 -1.155 . . . . 0.0 109.499 178.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.756 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 mmm-85 -169.1 122.8 0.81 Allowed 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 117.661 -1.616 . . . . 0.0 111.99 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -80.72 112.97 18.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.041 -1.662 . . . . 0.0 108.298 176.44 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 24' ' ' MET . 5.5 m -35.09 -23.55 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.552 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 9.7 p -64.08 -12.71 41.6 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 119.222 -2.174 . . . . 0.0 111.056 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.625 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -120.67 18.36 11.95 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.731 -1.188 . . . . 0.0 111.366 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 88' ' ' ILE . 3.5 mm -110.07 102.75 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.126 -0.984 . . . . 0.0 110.406 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -84.25 126.55 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 120.967 -1.083 . . . . 0.0 110.418 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.894 ' SD ' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -82.53 123.47 29.22 Favored 'General case' 0 C--O 1.2 -1.526 0 O-C-N 120.81 -1.181 . . . . 0.0 109.236 177.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.594 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -113.92 157.39 42.05 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.181 178.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.68 ' CD ' ' HB3' ' A' ' 19' ' ' ASP . 33.8 Cg_endo -58.06 -27.45 79.69 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 124.444 1.76 . . . . 0.0 109.07 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.594 ' HG2' ' HB ' ' A' ' 91' ' ' THR . 3.0 pt-20 -64.4 -42.85 95.86 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.176 176.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.001 HD13 HG23 ' A' ' 60' ' ' VAL . 50.8 mt -88.51 38.79 0.88 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.729 0.776 . . . . 0.0 112.469 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -64.6 111.1 2.57 Favored 'General case' 0 C--N 1.286 -2.185 0 O-C-N 119.867 -1.771 . . . . 0.0 109.167 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.676 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.44 21.69 2.2 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.176 -1.488 . . . . 0.0 110.425 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.146 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -60.34 136.98 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.054 -1.262 . . . . 0.0 110.297 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.146 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.5 t -117.15 113.2 42.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.576 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -101.16 156.67 4.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 120.262 -1.524 . . . . 0.0 109.886 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.624 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.48 130.05 52.65 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 122.571 1.177 . . . . 0.0 111.276 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 6' ' ' VAL . 87.2 t -104.89 136.65 19.13 Favored Pre-proline 0 C--N 1.283 -2.307 0 O-C-N 120.743 -1.223 . . . . 0.0 109.833 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.611 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 73.8 Cg_endo -92.61 166.85 2.75 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.807 1.671 . . . . 0.0 111.126 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -86.94 -18.09 31.59 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.706 0.765 . . . . 0.0 109.248 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.662 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -109.47 73.09 0.83 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.26 57.92 0.81 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.975 -1.078 . . . . 0.0 109.695 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.6 ' CD2' ' O ' ' A' ' 106' ' ' TRP . 3.3 p-90 . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.618 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.821 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.204 -1.318 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.965 HG22 HG21 ' A' ' 97' ' ' ILE . 40.4 t -135.47 135.83 51.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-O 121.748 0.785 . . . . 0.0 111.914 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 13' ' ' ARG . 47.4 t -142.67 88.5 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.496 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 46.4 m-85 -67.53 136.0 53.88 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.414 -0.804 . . . . 0.0 109.336 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.565 HG13 ' HG2' ' A' ' 12' ' ' ARG . 60.7 t -99.77 166.62 2.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 O-C-N 120.662 -1.274 . . . . 0.0 109.513 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.612 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 87.9 p -100.53 -155.28 0.5 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.141 -0.975 . . . . 0.0 109.029 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.615 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -89.7 -30.17 18.25 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.79 -6.18 52.21 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.388 0.613 . . . . 0.0 109.81 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.37 -24.92 10.91 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.593 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.71 129.16 28.77 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.689 -1.477 . . . . 0.0 108.237 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.565 ' HG2' HG13 ' A' ' 6' ' ' VAL . 2.5 mtm180 -121.42 -173.13 2.56 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-O 122.211 1.005 . . . . 0.0 112.528 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.599 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -134.94 -177.65 4.73 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 80.0 mt-10 -151.83 109.41 3.62 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.495 -1.682 . . . . 0.0 111.518 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.046 HD11 ' HA ' ' A' ' 27' ' ' ALA . 7.7 mt -106.63 -173.9 2.41 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.452 1.12 . . . . 0.0 110.889 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.62 68.86 1.44 Allowed 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.038 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.6 t -87.72 126.33 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.096 0.95 . . . . 0.0 109.311 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.514 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.29 178.47 6.33 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.124 0.964 . . . . 0.0 112.887 -177.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.584 ' HB3' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -52.21 129.94 29.21 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.215 1.007 . . . . 0.0 109.288 177.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.522 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 94.68 -20.93 46.07 Favored Glycine 0 C--N 1.276 -2.802 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.551 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.038 ' HB ' HG12 ' A' ' 17' ' ' VAL . 84.9 t -83.96 149.81 4.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 CA-C-N 120.843 2.322 . . . . 0.0 109.523 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -96.01 122.85 39.27 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.837 HD22 HG21 ' A' ' 17' ' ' VAL . 1.9 mt -46.33 -24.73 0.52 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.277 -1.514 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.553 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -70.33 -11.6 61.02 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.928 0.871 . . . . 0.0 108.756 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -97.83 -63.41 1.13 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.039 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.867 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -47.36 -58.96 3.55 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.975 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.046 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.76 -53.04 16.49 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.581 -1.324 . . . . 0.0 110.474 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -66.1 -3.52 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 109.526 179.091 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.442 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.255 0.0 OUTLIER -103.15 -24.99 13.54 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.833 0.825 . . . . 0.0 110.149 179.851 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.719 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.6 m-80 -97.02 4.94 51.22 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.61 11.12 75.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.966 ' CD1' HD21 ' A' ' 15' ' ' LEU . 9.2 mt . . . . . 0 C--N 1.302 -1.492 0 O-C-N 121.364 -1.08 . . . . 0.0 109.309 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 105' ' ' GLN . 8.6 t . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.386 0.612 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.545 ' O ' HG13 ' A' ' 50' ' ' VAL . 25.4 p -88.64 26.41 1.5 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.476 -0.765 . . . . 0.0 110.12 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.123 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 5.7 t60 -70.12 123.26 21.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.427 -0.796 . . . . 0.0 109.878 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.813 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -150.13 -170.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.095 -1.003 . . . . 0.0 109.807 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.838 ' CD1' ' HG3' ' A' ' 79' ' ' LYS . 75.2 m-85 -140.45 107.62 5.49 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.938 0.875 . . . . 0.0 110.762 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.015 ' HB ' HG22 ' A' ' 57' ' ' THR . 6.2 t -80.92 131.96 32.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 O-C-N 120.699 -1.251 . . . . 0.0 109.698 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.943 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -42.88 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.089 177.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -72.05 0.03 10.5 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.038 -1.039 . . . . 0.0 110.148 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.605 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.09 5.34 47.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.094 -1.004 . . . . 0.0 111.088 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.816 ' CB ' HD13 ' A' ' 97' ' ' ILE . 59.4 m-85 -140.62 5.12 1.99 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.762 -1.211 . . . . 0.0 109.415 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 1.026 HG21 ' HB2' ' A' ' 81' ' ' ASN . 35.3 p -89.74 -38.27 13.96 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -2.24 39.39 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.737 0.78 . . . . 0.0 110.76 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.059 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.262 0.1 OUTLIER -99.06 -47.46 5.22 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.659 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.083 HG23 HD13 ' A' ' 94' ' ' LEU 0.338 1.0 OUTLIER -78.25 176.76 3.3 Favored Pre-proline 0 C--N 1.285 -2.196 0 CA-C-N 113.371 -1.741 . . . . 0.0 106.392 178.312 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 1.019 ' HD2' HG13 ' A' ' 60' ' ' VAL . 39.9 Cg_endo -73.83 96.27 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 CA-C-O 122.59 0.996 . . . . 0.0 112.155 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.531 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -66.54 67.49 0.06 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.428 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.881 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . . . -37.17 152.93 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.281 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -88.17 -147.6 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.127 -0.983 . . . . 0.0 111.868 -178.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 69' ' ' GLY . 17.7 pt-20 -28.98 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.193 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.503 ' HA ' ' NE ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -53.29 -70.5 0.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.807 -1.183 . . . . 0.0 108.982 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 1.071 ' HG2' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.26 -32.42 69.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.577 -0.702 . . . . 0.0 109.269 178.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 1.071 HD12 ' HG2' ' A' ' 67' ' ' GLU . 1.2 mp -77.64 -10.82 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 110.826 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -89.24 -79.27 1.32 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.693 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.27 -30.14 0.47 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -1.177 . . . . 0.0 108.668 179.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.997 ' O ' HG22 ' A' ' 74' ' ' VAL . 1.1 tm? -74.84 -50.73 16.08 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.567 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 8.1 tp10 -58.44 -22.72 55.39 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 108.777 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.513 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -80.99 -40.78 23.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.675 -0.641 . . . . 0.0 110.686 -179.487 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.997 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.7 m -40.06 162.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.436 -0.79 . . . . 0.0 109.754 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.823 HG22 ' O ' ' A' ' 75' ' ' THR . 21.7 m -120.63 32.38 6.02 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.114 -0.991 . . . . 0.0 108.965 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.123 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -115.27 -167.24 1.21 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.686 1.231 . . . . 0.0 112.728 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.761 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.19 62.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.996 -178.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.945 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.43 154.86 12.97 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 118.729 -2.482 . . . . 0.0 110.997 -177.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.838 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.382 0.5 OUTLIER -133.15 177.17 2.38 Favored Pre-proline 0 C--N 1.288 -2.077 0 CA-C-N 113.61 -1.632 . . . . 0.0 111.07 -173.79 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 41.0 Cg_endo -71.96 -25.91 19.19 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 N-CA-C 106.99 -1.965 . . . . 0.0 106.99 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 1.026 ' HB2' HG21 ' A' ' 57' ' ' THR . 13.6 p-10 -114.53 18.76 16.58 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.913 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.796 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -45.88 149.59 0.63 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.805 -1.185 . . . . 0.0 108.139 178.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.939 ' HB2' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -155.65 152.3 28.5 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.388 -1.725 . . . . 0.0 112.313 -178.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -106.43 103.29 12.71 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 24' ' ' MET . 5.7 t -27.82 -34.09 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.552 ' N ' ' O ' ' A' ' 84' ' ' LEU . 26.5 p -71.65 1.97 5.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.3 -1.5 . . . . 0.0 110.784 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.556 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 38.1 mm-40 -125.03 14.94 8.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.877 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.639 HG23 HG11 ' A' ' 60' ' ' VAL . 5.7 mm -116.46 99.0 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.272 -0.892 . . . . 0.0 110.285 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.99 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.7 mm -82.82 131.15 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.899 -1.125 . . . . 0.0 110.048 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.998 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.1 tpt -82.42 123.14 28.86 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.279 -0.888 . . . . 0.0 110.349 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.572 ' OG1' HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -113.22 159.33 35.36 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 118.151 -1.42 . . . . 0.0 110.319 179.29 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.584 ' CD ' ' HB3' ' A' ' 19' ' ' ASP . 37.2 Cg_endo -62.24 -14.23 37.08 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 O-C-N 124.481 1.779 . . . . 0.0 109.569 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.524 ' CG ' ' HB ' ' A' ' 91' ' ' THR . 1.8 pt-20 -82.52 -36.93 25.91 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.33 1.062 . . . . 0.0 108.42 177.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.083 HD13 HG23 ' A' ' 60' ' ' VAL . 50.3 mt -90.23 35.76 0.87 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.576 -178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 20.9 p30 -63.61 108.02 1.29 Allowed 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.823 177.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.617 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.36 23.79 1.88 Allowed Glycine 0 N--CA 1.496 2.695 0 O-C-N 120.755 -1.216 . . . . 0.0 110.7 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.115 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -59.62 136.83 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -1.087 . . . . 0.0 111.097 179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.115 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.5 t -115.76 110.31 31.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -100.0 154.99 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.834 -1.166 . . . . 0.0 110.039 -178.552 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.602 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.46 128.43 50.86 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.268 -0.895 . . . . 0.0 110.249 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.615 HG12 ' CE1' ' A' ' 8' ' ' HIS . 55.1 t -103.54 123.54 41.1 Favored Pre-proline 0 C--N 1.291 -1.972 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.669 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.682 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 54.8 Cg_endo -76.37 171.19 18.53 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.096 1.864 . . . . 0.0 111.949 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.5 -18.93 23.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.699 -0.626 . . . . 0.0 109.468 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.791 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -111.0 74.62 0.88 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 47' ' ' THR . 3.1 pt20 -98.81 56.1 1.07 Allowed 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.436 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.589 ' OXT' ' CD2' ' A' ' 106' ' ' TRP . 1.5 p-90 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.765 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.807 ' O ' HG22 ' A' ' 97' ' ' ILE . 4.1 mptt . . . . . 0 C--O 1.209 -1.072 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.917 ' HA ' HG23 ' A' ' 97' ' ' ILE . 65.4 t -140.56 134.05 33.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 O-C-N 121.382 -0.824 . . . . 0.0 110.959 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 45.9 t -142.7 90.2 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 C-N-CA 118.634 -1.226 . . . . 0.0 110.803 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 70.3 m-85 -67.64 134.65 51.53 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.674 -0.641 . . . . 0.0 109.464 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.535 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 97.3 t -99.62 169.36 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 O-C-N 120.113 -1.617 . . . . 0.0 109.717 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.593 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 95.9 p -104.46 -155.9 0.55 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 109.386 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.584 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.02 -29.69 18.25 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -91.83 -8.59 46.15 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.339 0.59 . . . . 0.0 109.713 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.21 -16.08 20.26 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -59.44 132.51 54.21 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.728 -1.454 . . . . 0.0 107.872 179.184 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.528 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.98 179.92 4.22 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 122.368 1.08 . . . . 0.0 113.02 -178.154 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 4' ' ' VAL 0.277 0.9 OUTLIER -127.25 179.03 5.66 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 178.682 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.693 ' C ' HD23 ' A' ' 15' ' ' LEU . 68.5 mt-10 -152.87 116.02 4.63 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 117.129 -1.828 . . . . 0.0 111.518 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.99 HD11 ' HA ' ' A' ' 27' ' ' ALA . 5.7 mt -112.63 -156.79 0.6 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.459 1.123 . . . . 0.0 110.194 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -153.08 68.24 0.81 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.035 HG12 ' HB ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -88.29 124.24 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.083 0.944 . . . . 0.0 109.463 -177.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -87.34 176.25 7.61 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.087 0.946 . . . . 0.0 112.851 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.582 ' HB3' HG22 ' A' ' 91' ' ' THR . 0.1 OUTLIER -51.02 127.85 19.95 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.318 1.056 . . . . 0.0 109.187 177.357 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.52 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 99.04 -23.82 34.84 Favored Glycine 0 C--N 1.276 -2.805 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.474 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.035 ' HB ' HG12 ' A' ' 17' ' ' VAL . 95.1 t -84.44 153.61 3.65 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.656 0 CA-C-N 120.61 2.205 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.527 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -96.98 134.71 39.99 Favored 'General case' 0 C--N 1.273 -2.728 0 C-N-CA 118.797 -1.161 . . . . 0.0 107.886 176.206 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.71 HD22 HG11 ' A' ' 3' ' ' VAL . 9.2 mt -50.24 -23.65 2.39 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.299 -1.501 . . . . 0.0 108.028 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.582 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -74.5 -15.0 60.89 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.599 -0.688 . . . . 0.0 109.211 179.175 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.55 ' CG ' HG13 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -89.14 -63.5 1.28 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.853 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -56.04 -50.07 71.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.065 -1.022 . . . . 0.0 110.196 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.99 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.66 -48.66 28.89 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.527 -1.358 . . . . 0.0 109.706 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.504 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -70.78 -0.74 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.605 -0.684 . . . . 0.0 109.679 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.08 -27.18 12.73 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.813 0.816 . . . . 0.0 109.569 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.886 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.7 m-80 -97.36 -0.72 45.91 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.68 21.47 36.83 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.843 HD11 HD21 ' A' ' 15' ' ' LEU . 2.1 mt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.392 -1.063 . . . . 0.0 109.66 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.533 0.682 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 11.3 p -115.18 28.53 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.48 -0.763 . . . . 0.0 109.625 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.89 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 5.2 t60 -69.86 128.7 37.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.537 -0.727 . . . . 0.0 110.402 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.796 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -156.78 -174.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.971 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.796 ' N ' HG23 ' A' ' 50' ' ' VAL 0.272 81.9 m-85 -140.41 113.85 8.62 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.634 0.73 . . . . 0.0 110.323 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.033 ' HB ' HG22 ' A' ' 57' ' ' THR . 6.3 t -82.36 132.45 31.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 O-C-N 120.329 -1.482 . . . . 0.0 110.654 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.765 ' O ' HG23 ' A' ' 57' ' ' THR . 3.3 t30 -47.1 145.47 2.16 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.709 -1.244 . . . . 0.0 108.583 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.523 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -58.16 -8.37 1.07 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.159 -0.963 . . . . 0.0 112.077 -178.337 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.572 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -93.97 7.76 43.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.532 -1.355 . . . . 0.0 110.731 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 1.09 ' CB ' HD13 ' A' ' 97' ' ' ILE . 86.9 m-85 -140.54 4.65 1.97 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.125 -0.984 . . . . 0.0 109.622 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 1.033 HG22 ' HB ' ' A' ' 52' ' ' VAL . 31.5 p -90.29 -41.19 11.68 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 120.946 -1.096 . . . . 0.0 108.068 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.34 -2.09 52.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.826 0.822 . . . . 0.0 110.56 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.057 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.255 0.1 OUTLIER -99.22 -47.77 5.07 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.531 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.071 HG23 HD13 ' A' ' 94' ' ' LEU 0.331 1.1 t -78.99 175.76 4.4 Favored Pre-proline 0 C--N 1.288 -2.065 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.186 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.987 ' HD2' HG13 ' A' ' 60' ' ' VAL . 40.0 Cg_endo -75.05 109.2 2.88 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 CA-C-O 122.702 1.042 . . . . 0.0 112.293 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.534 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -75.23 66.71 1.76 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.551 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.553 ' CB ' ' HG2' ' A' ' 87' ' ' GLN . . . -37.19 155.94 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.25 0.547 . . . . 0.0 110.226 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 66' ' ' ARG . 45.0 p-10 -96.06 -145.79 0.28 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.155 -0.966 . . . . 0.0 112.493 -177.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 64' ' ' ASN . 8.2 pt-20 -30.92 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.349 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 64' ' ' ASN . 2.3 mtm-85 -52.96 -71.2 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.608 -1.308 . . . . 0.0 108.365 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.866 ' HG3' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -62.89 -45.8 90.82 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 109.18 178.363 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.866 HD12 ' HG3' ' A' ' 67' ' ' GLU . 1.1 mp -55.77 -12.97 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.348 -0.845 . . . . 0.0 111.424 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -91.2 -78.41 1.37 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.566 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -45.37 -35.57 3.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.976 -1.308 . . . . 0.0 108.538 179.493 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.981 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.8 OUTLIER -67.77 -43.96 78.57 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 177.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.592 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -60.44 -25.79 66.24 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 108.699 178.168 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.579 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.94 -42.76 31.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.781 -0.574 . . . . 0.0 111.111 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.981 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.5 m -39.87 151.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.816 HG22 ' O ' ' A' ' 75' ' ' THR . 18.7 m -121.03 30.47 6.84 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.083 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.89 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -92.67 -82.5 0.33 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.492 -1.283 . . . . 0.0 113.344 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.721 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.288 0.0 OUTLIER -153.86 64.58 0.72 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 122.291 1.043 . . . . 0.0 108.683 -175.579 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.923 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -57.0 150.71 16.33 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 119.382 -2.074 . . . . 0.0 113.24 -173.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.536 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.36 0.0 OUTLIER -124.97 -174.14 0.32 Allowed Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.312 -174.889 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 46.6 Cg_endo -81.98 -28.86 1.87 Allowed 'Trans proline' 0 C--N 1.302 -1.92 0 N-CA-C 107.222 -1.876 . . . . 0.0 107.222 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.733 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.9 OUTLIER -107.47 15.33 24.97 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.113 179.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.824 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -44.65 146.68 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.952 -1.093 . . . . 0.0 109.611 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.925 ' HB2' HG23 ' A' ' 52' ' ' VAL . 30.7 mmm-85 -158.43 152.91 24.44 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.888 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.625 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -105.26 107.03 17.79 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 24' ' ' MET . 6.1 p -32.07 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.582 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 16.3 p -70.05 -1.24 9.31 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.425 -1.422 . . . . 0.0 111.03 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.553 ' HG2' ' CB ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -125.4 -1.92 7.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.91 -1.119 . . . . 0.0 110.938 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.674 HG23 HG11 ' A' ' 60' ' ' VAL . 3.2 mm -97.15 108.78 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.084 -1.01 . . . . 0.0 110.281 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.984 ' O ' HG22 ' A' ' 60' ' ' VAL . 2.9 mm -87.72 129.36 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.896 -1.128 . . . . 0.0 109.959 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 1.011 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.4 tpt -83.03 122.94 28.97 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 121.42 -0.8 . . . . 0.0 110.379 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.754 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -114.11 159.22 37.14 Favored Pre-proline 0 C--N 1.292 -1.922 0 C-N-CA 118.233 -1.387 . . . . 0.0 109.682 178.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.754 ' HD2' HG22 ' A' ' 91' ' ' THR . 35.2 Cg_endo -58.66 -36.67 96.89 Favored 'Trans proline' 0 C--N 1.297 -2.149 0 O-C-N 124.334 1.702 . . . . 0.0 110.045 -178.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -58.9 -36.83 75.34 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.797 -1.161 . . . . 0.0 108.558 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.071 HD13 HG23 ' A' ' 60' ' ' VAL . 65.9 mt -90.59 35.12 0.88 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.937 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.473 ' HA ' ' N ' ' A' ' 2' ' ' LYS . 19.6 p-10 -63.75 107.03 1.09 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.575 -1.25 . . . . 0.0 109.391 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.615 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 123.75 19.83 2.69 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 120.458 -1.401 . . . . 0.0 110.733 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.1 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -55.77 140.33 13.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.228 -1.16 . . . . 0.0 111.119 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.1 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.0 t -115.53 112.15 38.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -98.61 156.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.786 -1.196 . . . . 0.0 109.346 -178.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.71 ' N ' ' O ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -122.85 124.21 42.75 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.742 0.782 . . . . 0.0 110.323 -178.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 68.2 t -100.32 135.55 20.24 Favored Pre-proline 0 C--N 1.289 -2.064 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.694 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 54.5 Cg_endo -88.9 176.09 3.39 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 121.765 1.643 . . . . 0.0 111.885 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -91.14 -20.45 21.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.572 -0.705 . . . . 0.0 109.36 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.606 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -110.76 77.86 1.07 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.5 ' HG2' ' HG2' ' A' ' 102' ' ' PRO . 12.9 mt-30 -98.34 52.07 1.02 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.72 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.632 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 3.0 p-90 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.18 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.769 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.205 -1.257 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.943 ' HA ' HG23 ' A' ' 97' ' ' ILE . 41.6 t -136.27 133.82 49.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 O-C-N 121.326 -0.859 . . . . 0.0 110.137 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 58.2 t -141.85 91.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.619 0 C-N-CA 118.804 -1.158 . . . . 0.0 110.411 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.658 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 40.8 m-85 -69.03 154.64 41.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.577 -0.702 . . . . 0.0 109.169 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.577 HG12 ' N ' ' A' ' 7' ' ' SER . 87.0 t -118.35 172.7 5.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.215 178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.615 ' HB3' HG22 ' A' ' 11' ' ' THR . 46.3 p -107.97 -158.4 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.104 -0.998 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.595 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -88.04 -29.67 20.51 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 178.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -91.76 -11.18 37.44 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.437 0.637 . . . . 0.0 109.575 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.29 -4.31 23.56 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.335 -0.936 . . . . 0.0 110.785 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.615 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -65.09 131.41 46.48 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.646 -1.502 . . . . 0.0 107.784 179.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -120.93 178.51 4.69 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 122.229 1.014 . . . . 0.0 112.905 -177.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.4 177.71 7.61 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.81 ' C ' HD23 ' A' ' 15' ' ' LEU . 9.2 mp0 -150.3 113.47 4.87 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.975 -1.49 . . . . 0.0 110.397 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.046 HD11 HD12 ' A' ' 32' ' ' ILE 0.262 2.8 mt -109.21 -151.53 0.47 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 122.603 1.192 . . . . 0.0 111.084 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -152.94 75.98 1.11 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.092 HG13 ' CG1' ' A' ' 21' ' ' VAL . 17.4 t -88.41 118.87 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.64 -175.4 4.66 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.595 -0.691 . . . . 0.0 110.892 -177.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -65.45 114.39 4.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.456 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 112.36 -15.84 24.82 Favored Glycine 0 C--N 1.288 -2.085 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.351 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.092 ' CG1' HG13 ' A' ' 17' ' ' VAL . 41.6 t -97.81 136.37 28.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 120.441 -1.623 . . . . 0.0 106.776 177.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -95.15 143.71 26.36 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.378 -1.329 . . . . 0.0 107.721 178.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.907 HD23 HG21 ' A' ' 17' ' ' VAL . 13.8 mt -47.04 -26.6 1.08 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.281 -1.367 . . . . 0.0 107.434 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.517 ' CB ' ' HA ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -59.41 -39.27 82.91 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.362 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.607 ' CG ' HG13 ' A' ' 21' ' ' VAL . 4.8 tt0 -75.24 -72.37 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.796 -0.565 . . . . 0.0 110.532 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.068 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.6 -50.54 17.31 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 117.986 -1.486 . . . . 0.0 111.014 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.924 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.95 -46.02 31.77 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.343 -1.473 . . . . 0.0 110.443 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -74.08 0.57 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.555 -0.716 . . . . 0.0 109.654 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.18 -29.18 11.47 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.736 0.779 . . . . 0.0 109.687 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.907 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.8 m-80 -97.56 -1.57 43.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.65 19.58 51.21 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.046 HD12 HD11 ' A' ' 15' ' ' LEU . 8.5 mt . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.306 -1.114 . . . . 0.0 109.434 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.568 0.699 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.75 ' SG ' HD13 ' A' ' 84' ' ' LEU . 25.4 p -88.38 29.98 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.636 -0.665 . . . . 0.0 110.048 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.152 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 4.1 t60 -70.24 126.27 29.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.417 -0.802 . . . . 0.0 110.667 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.807 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.1 m -156.33 -174.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.251 -0.905 . . . . 0.0 109.99 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.807 ' N ' HG23 ' A' ' 50' ' ' VAL 0.254 78.2 m-85 -141.01 108.22 5.5 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.659 0.743 . . . . 0.0 110.669 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.029 ' HB ' HG22 ' A' ' 57' ' ' THR . 2.4 t -75.01 133.84 30.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 O-C-N 120.34 -1.475 . . . . 0.0 110.583 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.861 ' O ' HG23 ' A' ' 57' ' ' THR . 3.8 t30 -48.42 147.29 2.45 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.744 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.2 pt-20 -58.77 -8.41 1.32 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.169 -0.957 . . . . 0.0 111.972 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.573 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -96.01 7.91 45.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.475 -1.391 . . . . 0.0 111.057 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 1.13 ' CB ' HD13 ' A' ' 97' ' ' ILE . 87.7 m-85 -140.37 3.01 1.91 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.059 . . . . 0.0 109.898 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 1.029 HG22 ' HB ' ' A' ' 52' ' ' VAL . 3.2 p -90.55 -41.22 11.5 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -93.76 -0.94 55.67 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.737 0.779 . . . . 0.0 110.526 -178.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.034 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.253 1.2 mtpp -99.23 -46.91 5.38 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 123.135 1.445 . . . . 0.0 107.355 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.043 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.334 0.9 OUTLIER -74.86 -177.68 0.71 Allowed Pre-proline 0 C--N 1.287 -2.114 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.197 178.975 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 1.043 ' HD2' HG13 ' A' ' 60' ' ' VAL . 34.1 Cg_endo -61.59 122.34 10.91 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 CA-C-O 123.001 1.167 . . . . 0.0 111.941 -177.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.553 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -74.32 62.95 0.99 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.635 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.469 ' HB1' ' HG2' ' A' ' 87' ' ' GLN . . . -38.22 157.88 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.937 -0.477 . . . . 0.0 109.999 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 66' ' ' ARG . 29.8 p30 -118.0 -154.47 0.56 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.061 -1.024 . . . . 0.0 111.432 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 64' ' ' ASN . 4.3 pt-20 -31.24 -33.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.028 -0.42 . . . . 0.0 111.726 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -53.0 -71.05 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.773 -1.204 . . . . 0.0 108.195 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.885 ' HG3' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.7 -50.41 73.94 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 108.906 178.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.885 HD12 ' HG3' ' A' ' 67' ' ' GLU . 1.2 mp -51.52 -19.32 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 110.302 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -88.17 -75.69 1.28 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.67 ' HG3' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -45.04 -38.78 5.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -1.215 . . . . 0.0 108.674 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.039 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -65.74 -51.7 57.05 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.208 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 11.0 tp10 -55.39 -19.62 9.61 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.081 -1.012 . . . . 0.0 108.417 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -76.21 -46.98 25.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.604 -0.685 . . . . 0.0 110.552 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.039 HG22 ' O ' ' A' ' 71' ' ' LEU . 8.1 m -40.71 163.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.266 -0.896 . . . . 0.0 109.725 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.779 HG22 ' O ' ' A' ' 75' ' ' THR . 45.8 m -120.4 37.4 4.27 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.977 -1.077 . . . . 0.0 109.599 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.152 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -122.44 -167.78 1.62 Allowed 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.281 -1.368 . . . . 0.0 112.968 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.744 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -50.77 63.42 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.662 -178.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.865 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.42 153.65 15.35 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 118.767 -2.458 . . . . 0.0 111.809 -177.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.699 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.385 0.2 OUTLIER -133.96 176.86 2.57 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 113.294 -1.775 . . . . 0.0 111.308 -173.826 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 43.7 Cg_endo -75.34 -27.58 9.36 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 176.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.81 ' HB2' HG21 ' A' ' 57' ' ' THR . 15.5 p-10 -108.5 17.01 22.52 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.255 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.802 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -45.81 149.91 0.59 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.181 -0.949 . . . . 0.0 110.126 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.826 ' HB2' HG23 ' A' ' 52' ' ' VAL . 7.9 mmt85 -158.62 160.22 36.29 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.255 -1.378 . . . . 0.0 112.192 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.75 HD13 ' SG ' ' A' ' 48' ' ' CYS . 2.2 mt -112.85 114.98 27.75 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 24' ' ' MET . 12.6 p -30.67 -30.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.572 ' N ' ' O ' ' A' ' 84' ' ' LEU . 27.8 p -77.07 4.24 10.64 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.611 -1.306 . . . . 0.0 111.43 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.503 ' HG2' ' CB ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -125.34 11.94 8.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.819 -1.175 . . . . 0.0 111.357 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.007 HG23 HG11 ' A' ' 60' ' ' VAL . 21.4 mm -120.34 107.12 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.83 -1.169 . . . . 0.0 110.978 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.974 ' O ' HG22 ' A' ' 60' ' ' VAL . 3.9 mm -89.83 128.81 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.144 -0.973 . . . . 0.0 108.895 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.579 ' CE ' ' HB3' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -83.86 124.77 31.31 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.414 -0.804 . . . . 0.0 111.238 -178.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.831 HG23 HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -98.97 179.69 1.01 Allowed Pre-proline 0 C--N 1.295 -1.769 0 C-N-CA 117.673 -1.611 . . . . 0.0 109.181 177.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.558 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 45.6 Cg_endo -82.21 -12.88 10.33 Favored 'Trans proline' 0 C--N 1.289 -2.599 0 O-C-N 124.368 1.72 . . . . 0.0 108.705 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.553 ' HG2' ' OG1' ' A' ' 91' ' ' THR . 3.4 pt-20 -84.89 -33.69 22.73 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.034 HD21 ' CB ' ' A' ' 59' ' ' LYS . 66.1 mt -89.64 29.77 1.11 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.498 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -63.22 111.38 2.22 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 120.3 -1.5 . . . . 0.0 109.056 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.65 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 123.87 17.04 3.17 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.13 HD13 ' CB ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -53.75 141.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.377 -1.073 . . . . 0.0 111.668 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.08 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.0 t -117.46 113.63 43.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.592 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -99.41 155.41 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.838 -1.163 . . . . 0.0 109.773 -178.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.644 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.34 121.07 35.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.677 0.751 . . . . 0.0 109.783 -179.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.595 HG12 ' CE1' ' A' ' 8' ' ' HIS . 90.8 t -99.51 123.58 47.6 Favored Pre-proline 0 C--N 1.289 -2.025 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.432 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.684 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 52.6 Cg_endo -75.58 170.83 19.42 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.002 1.801 . . . . 0.0 112.028 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.424 ' CG ' ' HG2' ' A' ' 104' ' ' ARG . 11.6 p-10 -91.32 -17.45 25.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.677 -0.639 . . . . 0.0 109.402 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.797 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -110.75 70.89 0.73 Allowed 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.423 ' CD ' ' O ' ' A' ' 105' ' ' GLN . 0.0 OUTLIER -98.73 58.81 1.21 Allowed 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.466 -177.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.609 ' NE1' ' HA ' ' A' ' 74' ' ' VAL . 1.8 p-90 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.885 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.617 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.236 0.541 . . . . 0.0 110.345 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -87.55 147.79 25.17 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.172 -0.955 . . . . 0.0 110.472 179.231 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.921 ' HA ' HG23 ' A' ' 97' ' ' ILE . 54.9 t -140.99 135.59 33.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 121.121 -0.987 . . . . 0.0 110.902 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.594 HG13 ' HG2' ' A' ' 14' ' ' GLU . 47.3 t -142.4 90.96 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.804 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 73.1 m-85 -67.86 134.84 51.58 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 121.714 -0.616 . . . . 0.0 109.81 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.562 HG22 ' CD ' ' A' ' 12' ' ' ARG . 91.1 t -99.82 166.95 2.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 O-C-N 120.052 -1.655 . . . . 0.0 109.467 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.591 ' HB3' HG22 ' A' ' 11' ' ' THR . 86.1 p -101.8 -155.86 0.54 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.096 -1.003 . . . . 0.0 108.819 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.589 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.24 -29.83 17.93 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.8 -6.26 52.05 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.436 0.636 . . . . 0.0 109.878 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.38 -25.55 10.38 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.591 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.57 130.18 31.27 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.628 -1.513 . . . . 0.0 108.066 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.562 ' CD ' HG22 ' A' ' 6' ' ' VAL . 17.3 mtm-85 -121.26 -176.38 3.27 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 122.374 1.083 . . . . 0.0 112.883 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.587 ' O ' ' HA ' ' A' ' 4' ' ' VAL 0.28 0.2 OUTLIER -128.78 178.73 6.15 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.687 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 84.1 mt-10 -152.9 114.17 4.21 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 117.324 -1.751 . . . . 0.0 111.142 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.879 HD22 ' CG ' ' A' ' 30' ' ' ASN . 6.6 mt -108.71 -156.16 0.58 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.475 1.131 . . . . 0.0 110.095 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 1' ' ' SER . 0.7 OUTLIER -152.5 71.91 0.96 Allowed 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 177.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.003 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.4 t -89.14 127.58 41.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.866 0.841 . . . . 0.0 109.431 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.94 -175.06 4.47 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.675 1.226 . . . . 0.0 112.867 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.521 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 11.6 p30 -63.2 115.89 4.93 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.792 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.732 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 111.98 -22.39 18.74 Favored Glycine 0 C--N 1.287 -2.185 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.763 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.003 ' HB ' HG12 ' A' ' 17' ' ' VAL . 90.8 t -88.34 147.93 4.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 119.938 1.869 . . . . 0.0 109.746 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -96.63 131.79 42.93 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.751 HD22 HG11 ' A' ' 3' ' ' VAL . 8.8 mt -44.54 -26.11 0.33 Allowed 'General case' 0 C--O 1.201 -1.464 0 O-C-N 120.899 -1.126 . . . . 0.0 109.292 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.649 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -69.04 -42.4 76.37 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 118.206 -1.398 . . . . 0.0 107.77 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.563 ' CG ' HG13 ' A' ' 21' ' ' VAL . 1.5 tt0 -59.68 -70.8 0.15 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.744 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.759 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.97 -54.3 10.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.981 -1.075 . . . . 0.0 110.512 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.878 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.41 -51.15 20.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.787 -1.195 . . . . 0.0 110.098 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.018 HG23 ' HB2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -69.05 -1.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.622 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.12 -27.47 12.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.334 -0.853 . . . . 0.0 109.863 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.879 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.5 m-80 -97.31 -0.8 45.89 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.11 21.17 33.68 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.849 HD11 HD21 ' A' ' 15' ' ' LEU . 1.8 mt -72.69 -62.75 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.221 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 1.018 ' HB2' HG23 ' A' ' 28' ' ' VAL . 13.2 m-30 -80.36 48.96 1.07 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.614 -0.679 . . . . 0.0 110.377 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -49.75 -20.66 0.88 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.434 -0.791 . . . . 0.0 110.469 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.919 HG12 HG21 ' A' ' 47' ' ' THR . 4.1 tt -66.91 179.0 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.158 -0.964 . . . . 0.0 110.1 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 36' ' ' VAL . 7.1 p -112.81 65.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.15 -0.969 . . . . 0.0 110.375 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 47' ' ' THR . . . -120.03 72.13 0.34 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 9.8 p30 -120.06 115.18 23.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -1.153 . . . . 0.0 110.344 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 42' ' ' SER . 23.1 p -100.03 25.0 7.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.187 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.07 50.06 40.61 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.37 19.83 9.37 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 11.1 m -92.62 0.63 57.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -1.106 . . . . 0.0 110.194 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.795 ' HB1' ' SD ' ' A' ' 70' ' ' MET . . . 53.14 60.1 3.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 110.264 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -139.63 24.77 2.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.371 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 2.1 p -129.9 -174.29 3.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.054 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.783 ' HB1' ' OXT' ' A' ' 106' ' ' TRP . . . -150.06 9.9 0.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.981 . . . . 0.0 110.955 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.919 HG21 HG12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -84.85 -18.79 33.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.917 -1.114 . . . . 0.0 109.86 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' VAL . 25.1 p -88.53 28.41 1.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.531 -0.731 . . . . 0.0 110.151 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.118 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 4.0 t60 -70.21 126.37 29.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.433 -0.792 . . . . 0.0 110.219 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.812 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.3 m -156.39 -173.94 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-O 122.12 0.962 . . . . 0.0 110.246 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.812 ' N ' HG23 ' A' ' 50' ' ' VAL 0.268 77.1 m-85 -141.08 111.76 7.0 Favored 'General case' 0 C--O 1.197 -1.687 0 CA-C-O 121.557 0.694 . . . . 0.0 110.563 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.063 ' HB ' HG22 ' A' ' 57' ' ' THR . 2.4 t -78.4 131.46 34.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 O-C-N 120.31 -1.494 . . . . 0.0 110.689 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.838 ' O ' HG23 ' A' ' 57' ' ' THR . 3.4 t30 -47.44 146.67 1.96 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.495 -1.378 . . . . 0.0 108.778 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -58.71 -8.09 1.19 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.065 -1.022 . . . . 0.0 112.135 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.566 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -95.99 8.24 44.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.547 -1.345 . . . . 0.0 110.56 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 1.116 ' CB ' HD13 ' A' ' 97' ' ' ILE . 87.5 m-85 -140.16 3.77 2.0 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.23 -0.918 . . . . 0.0 109.846 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 1.063 HG22 ' HB ' ' A' ' 52' ' ' VAL . 8.7 p -90.45 -42.61 10.77 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.027 -1.046 . . . . 0.0 108.358 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -1.34 57.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.751 0.786 . . . . 0.0 110.486 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.033 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.259 0.1 OUTLIER -99.35 -46.79 5.39 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 123.073 1.416 . . . . 0.0 107.314 179.659 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.053 HG11 HG23 ' A' ' 88' ' ' ILE 0.338 1.0 OUTLIER -78.07 -179.8 1.43 Allowed Pre-proline 0 C--N 1.289 -2.06 0 CA-C-N 113.797 -1.547 . . . . 0.0 107.123 178.966 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 1.023 ' HD2' HG13 ' A' ' 60' ' ' VAL . 37.9 Cg_endo -68.39 107.54 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 CA-C-O 122.874 1.114 . . . . 0.0 112.42 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.632 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -75.46 71.54 2.41 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.016 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.613 ' HB1' ' OE1' ' A' ' 67' ' ' GLU . . . -38.65 170.92 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.604 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -111.9 -164.25 0.9 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.91 -1.118 . . . . 0.0 112.543 -178.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 68' ' ' ILE . 8.8 pt-20 -28.71 -39.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -52.9 -63.01 1.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.543 -1.348 . . . . 0.0 108.833 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.633 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -59.14 -30.06 67.86 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.52 -0.737 . . . . 0.0 110.5 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.564 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.8 mp -77.12 -8.87 12.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.434 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -88.17 -76.68 1.28 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.829 ' HG3' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -44.04 -40.29 4.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.165 -1.197 . . . . 0.0 108.481 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.058 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -64.67 -50.96 64.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 12.0 tp10 -56.91 -19.35 17.37 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.967 -1.083 . . . . 0.0 108.398 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -75.64 -47.88 24.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 110.156 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.058 HG22 ' O ' ' A' ' 71' ' ' LEU . 6.1 m -40.78 161.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 0.0 109.279 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.78 HG22 ' O ' ' A' ' 75' ' ' THR . 27.8 m -120.36 34.06 5.36 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 120.971 -1.081 . . . . 0.0 109.257 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.118 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -114.81 -165.19 0.99 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.595 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.748 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -54.05 63.26 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.167 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.84 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.35 153.02 16.37 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 118.842 -2.411 . . . . 0.0 111.67 -177.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.674 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.389 2.2 mmtt -135.42 177.45 2.22 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.409 -173.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 43.6 Cg_endo -74.76 -28.73 9.36 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 N-CA-C 107.514 -1.764 . . . . 0.0 107.514 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.676 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.8 OUTLIER -106.02 15.18 26.84 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.873 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.827 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -44.17 148.83 0.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.989 . . . . 0.0 109.507 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.934 ' HB2' HG23 ' A' ' 52' ' ' VAL . 1.3 mmt85 -162.03 155.93 21.51 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 117.436 -1.706 . . . . 0.0 113.293 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.829 HD12 ' HG3' ' A' ' 70' ' ' MET . 7.8 mt -114.73 98.32 6.79 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 174.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.541 ' HB3' ' N ' ' A' ' 24' ' ' MET . 60.7 m -28.85 -28.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -39.76 -26.35 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.502 -1.373 . . . . 0.0 112.442 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.594 ' NE2' ' CG ' ' A' ' 67' ' ' GLU . 8.8 pm0 -125.74 0.25 7.42 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.208 -1.557 . . . . 0.0 112.934 -178.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.053 HG23 HG11 ' A' ' 60' ' ' VAL . 12.6 mm -78.64 99.97 3.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.366 -1.459 . . . . 0.0 107.518 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.995 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -81.92 130.88 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.208 -0.933 . . . . 0.0 110.578 -177.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.972 ' SD ' HG21 ' A' ' 97' ' ' ILE . 1.3 tpt -82.58 120.71 25.88 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.809 -0.557 . . . . 0.0 111.375 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.685 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -106.18 174.3 2.68 Favored Pre-proline 0 N--CA 1.494 1.767 0 C-N-CA 118.481 -1.288 . . . . 0.0 109.77 178.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 19' ' ' ASP . 44.3 Cg_endo -73.94 -10.51 23.08 Favored 'Trans proline' 0 C--N 1.292 -2.427 0 O-C-N 124.651 1.869 . . . . 0.0 110.074 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.62 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -92.48 -30.49 15.68 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.034 ' CD1' HG23 ' A' ' 60' ' ' VAL . 97.8 mt -90.07 25.04 2.26 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.865 0.841 . . . . 0.0 110.28 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.598 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 5.9 p-10 -63.11 104.2 0.55 Allowed 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.287 177.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.662 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.99 18.43 2.6 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.333 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.116 HD13 ' CB ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -53.42 141.8 7.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.539 -0.977 . . . . 0.0 111.39 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.079 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.1 t -115.49 112.49 40.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -98.33 155.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.782 -1.199 . . . . 0.0 108.977 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -122.86 124.84 44.17 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.396 -0.815 . . . . 0.0 110.476 -178.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.577 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 63.4 t -99.22 137.4 20.39 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.879 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.69 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 57.2 Cg_endo -89.25 170.64 4.74 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 C-N-CA 121.809 1.673 . . . . 0.0 111.813 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.51 -16.36 27.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.735 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -111.09 75.08 0.9 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.522 ' NE2' HG13 ' A' ' 101' ' ' VAL . 18.3 mt-30 -98.94 56.75 1.07 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.327 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.783 ' OXT' ' HB1' ' A' ' 46' ' ' ALA . 1.6 p-90 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.787 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.469 ' S2 ' ' HB3' ' A' ' 86' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 91' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.143 0.497 . . . . 0.0 110.225 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.736 ' O ' HG22 ' A' ' 97' ' ' ILE . 13.9 mtmt -69.7 148.12 49.67 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.139 -0.976 . . . . 0.0 109.873 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.862 ' HA ' HG23 ' A' ' 97' ' ' ILE . 41.5 t -138.51 134.29 43.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 O-C-N 120.897 -1.127 . . . . 0.0 110.516 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 50.5 t -142.61 93.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.078 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.63 ' CD1' ' CD1' ' A' ' 32' ' ' ILE . 50.2 m-85 -69.67 162.45 27.68 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 109.464 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.614 HG22 ' HG2' ' A' ' 12' ' ' ARG . 87.3 t -127.89 168.56 20.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.096 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.621 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 6.1 p -103.12 -154.77 0.5 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 109.616 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.568 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -92.12 -29.84 16.3 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -91.93 -11.86 35.05 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.515 0.674 . . . . 0.0 109.251 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.5 7.23 18.67 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.234 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.578 HG22 ' NH2' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -71.64 131.12 42.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.355 -1.673 . . . . 0.0 107.451 178.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.614 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.77 173.47 7.19 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.124 0.964 . . . . 0.0 112.896 -177.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -134.44 -179.08 5.36 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.755 ' C ' HD23 ' A' ' 15' ' ' LEU . 37.0 mt-10 -151.78 112.93 4.28 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 117.844 -1.542 . . . . 0.0 110.729 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.953 HD11 ' HA ' ' A' ' 27' ' ' ALA . 3.9 mt -109.83 -151.11 0.47 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.482 1.134 . . . . 0.0 111.111 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.19 70.54 0.92 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.083 HG13 ' CG1' ' A' ' 21' ' ' VAL . 18.3 t -86.46 113.51 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.21 -170.8 2.89 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.87 0.843 . . . . 0.0 111.608 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.573 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 2.5 p30 -61.18 110.07 1.29 Allowed 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.769 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 112.19 -18.68 23.33 Favored Glycine 0 C--N 1.289 -2.029 0 C-N-CA 119.349 -1.405 . . . . 0.0 111.116 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.083 ' CG1' HG13 ' A' ' 17' ' ' VAL . 45.0 t -94.24 139.32 18.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 O-C-N 120.088 -1.831 . . . . 0.0 107.099 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.573 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -95.9 142.49 28.08 Favored 'General case' 0 C--N 1.275 -2.674 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.958 HD23 HG21 ' A' ' 17' ' ' VAL . 11.0 mt -49.67 -27.03 4.21 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.082 -1.447 . . . . 0.0 107.78 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.533 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -71.62 -17.31 62.28 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.832 0.825 . . . . 0.0 108.821 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.748 ' HG2' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -89.7 -70.21 0.67 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.051 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -48.43 -49.67 34.28 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.301 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.953 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.76 -49.43 28.48 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.384 -1.448 . . . . 0.0 110.295 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.524 HG21 ' OD2' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -72.13 0.12 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.61 -0.681 . . . . 0.0 109.537 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.25 0.0 OUTLIER -103.58 -29.75 10.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.481 -0.762 . . . . 0.0 110.513 -179.773 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.845 ' CG ' HD22 ' A' ' 15' ' ' LEU . 4.1 m-80 -97.73 -2.99 40.01 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.38 29.03 15.22 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.828 HD12 HD11 ' A' ' 15' ' ' LEU . 3.1 mt -72.43 -60.13 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -1.134 . . . . 0.0 108.58 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.467 ' HB2' HG23 ' A' ' 28' ' ' VAL . 20.8 m-30 -81.05 46.48 0.91 Allowed 'General case' 0 C--N 1.288 -2.085 0 O-C-N 121.584 -0.698 . . . . 0.0 110.835 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 9.8 p-10 -55.93 -28.12 55.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.413 -0.804 . . . . 0.0 110.364 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 pt -66.94 161.05 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.12 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.439 ' H ' HG22 ' A' ' 36' ' ' VAL . 23.9 m -79.92 51.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.925 . . . . 0.0 110.13 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.545 ' CA ' ' HB ' ' A' ' 47' ' ' THR . . . -118.08 37.53 3.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.524 ' OD1' ' CE ' ' A' ' 24' ' ' MET . 2.5 t70 -120.16 121.93 39.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -1.179 . . . . 0.0 110.187 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.89 18.64 19.02 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.026 -1.046 . . . . 0.0 110.089 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.95 21.64 65.28 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.465 ' HA2' ' S1 ' ' A' ' 107' ' ' FES . . . 50.0 40.07 34.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -87.42 25.52 1.41 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -1.141 . . . . 0.0 110.31 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.926 ' HB1' ' HD2' ' A' ' 66' ' ' ARG . . . 42.86 36.59 0.89 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.206 -0.934 . . . . 0.0 110.146 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 p -140.09 30.24 2.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 110.177 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.521 ' O ' ' S2 ' ' A' ' 107' ' ' FES . 0.5 OUTLIER -161.42 -170.72 2.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.948 . . . . 0.0 110.669 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.786 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . . . -150.28 9.15 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.415 -1.428 . . . . 0.0 111.753 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.545 ' HB ' ' CA ' ' A' ' 37' ' ' GLY . 13.9 p -57.37 -20.09 27.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.761 -1.212 . . . . 0.0 107.944 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.805 ' O ' HG13 ' A' ' 50' ' ' VAL . 25.8 p -86.84 25.4 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.438 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.899 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 13.5 t60 -61.87 110.71 1.62 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.093 -1.005 . . . . 0.0 109.962 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.825 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -140.0 -169.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.624 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.825 ' N ' HG23 ' A' ' 50' ' ' VAL 0.258 62.0 m-85 -141.0 103.67 4.51 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.954 0.883 . . . . 0.0 111.041 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.044 ' HB ' HG22 ' A' ' 57' ' ' THR . 6.2 t -75.01 131.73 34.52 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 O-C-N 120.67 -1.268 . . . . 0.0 110.135 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.789 ' O ' HG23 ' A' ' 57' ' ' THR . 3.7 t30 -47.24 147.75 1.45 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.082 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.52 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.5 pt-20 -59.47 -8.74 1.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.212 -0.93 . . . . 0.0 111.966 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.587 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -96.69 10.01 39.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.701 -1.249 . . . . 0.0 110.725 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 1.128 ' CB ' HD13 ' A' ' 97' ' ' ILE . 91.0 m-85 -140.72 1.13 1.68 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.073 -1.017 . . . . 0.0 110.288 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 1.044 HG22 ' HB ' ' A' ' 52' ' ' VAL . 11.3 p -90.41 -40.81 11.84 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.946 -1.096 . . . . 0.0 108.465 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.26 -1.12 54.51 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.671 0.748 . . . . 0.0 110.592 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.009 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.256 0.2 OUTLIER -99.13 -47.09 5.34 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.618 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.995 HG22 ' O ' ' A' ' 89' ' ' ILE 0.327 1.0 OUTLIER -78.43 176.0 4.09 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.39 178.92 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.994 ' HD2' HG13 ' A' ' 60' ' ' VAL . 39.1 Cg_endo -72.7 103.27 1.53 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 CA-C-O 122.538 0.974 . . . . 0.0 111.314 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.512 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.26 73.09 1.8 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.052 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.92 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -37.76 161.26 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.337 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 66' ' ' ARG . 45.1 p-10 -86.95 -160.12 0.56 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.572 1.177 . . . . 0.0 113.125 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.0 pm0 -33.67 -27.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.477 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.926 ' HD2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -53.17 -70.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.321 -1.487 . . . . 0.0 107.66 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.989 ' HG2' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -64.63 -30.67 71.69 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.801 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.989 HD12 ' HG2' ' A' ' 67' ' ' GLU . 1.2 mp -77.45 -16.66 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.176 -0.953 . . . . 0.0 110.853 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -90.61 -73.95 1.28 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.893 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -42.11 -29.12 0.22 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.599 -0.942 . . . . 0.0 108.566 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.01 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -80.01 -47.58 14.69 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 7.3 tp10 -64.12 -12.71 42.12 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.199 -0.938 . . . . 0.0 109.339 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.27 -18.33 27.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.362 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.01 HG22 ' O ' ' A' ' 71' ' ' LEU . 8.0 m -70.17 145.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.096 -1.003 . . . . 0.0 110.456 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.775 HG22 ' O ' ' A' ' 75' ' ' THR . 55.4 m -99.52 28.46 4.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.741 -0.6 . . . . 0.0 109.699 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.905 ' HB2' ' HB3' ' A' ' 104' ' ' ARG . . . -97.15 -148.81 0.32 Allowed 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.094 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.744 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.47 63.48 5.79 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 122.333 1.063 . . . . 0.0 110.918 -178.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.848 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -58.14 154.4 13.05 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 118.923 -2.36 . . . . 0.0 111.61 -177.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.651 ' HG3' ' CD2' ' A' ' 51' ' ' TYR 0.379 2.4 mmtt -133.86 177.31 2.31 Favored Pre-proline 0 C--N 1.289 -2.059 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.774 -173.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 42.0 Cg_endo -73.31 -25.57 15.44 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 N-CA-C 107.583 -1.737 . . . . 0.0 107.583 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.987 ' HB2' HG21 ' A' ' 57' ' ' THR . 8.2 p-10 -114.66 21.37 14.53 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.251 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.848 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -45.85 158.08 0.1 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.802 -1.186 . . . . 0.0 109.094 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.9 ' HB2' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -166.28 150.15 7.57 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 117.011 -1.876 . . . . 0.0 112.276 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.787 HD22 ' SG ' ' A' ' 48' ' ' CYS . 79.7 mt -104.67 102.83 12.41 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 24' ' ' MET . 1.9 t -24.05 -37.18 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.554 ' N ' ' O ' ' A' ' 84' ' ' LEU . 27.6 p -70.58 2.92 3.48 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.134 -1.604 . . . . 0.0 111.554 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.541 ' HG3' ' CB ' ' A' ' 67' ' ' GLU . 76.9 mm-40 -125.2 19.43 8.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.882 -1.136 . . . . 0.0 110.514 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.63 HG23 HG11 ' A' ' 60' ' ' VAL . 5.1 mm -120.34 100.49 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.105 -0.997 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.995 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -90.04 127.04 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.794 -1.191 . . . . 0.0 108.106 178.329 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.619 ' HE1' ' HB3' ' A' ' 94' ' ' LEU . 26.3 mmm -82.73 137.42 34.41 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.334 -0.854 . . . . 0.0 110.626 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.737 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -114.7 170.27 5.66 Favored Pre-proline 0 C--N 1.291 -1.952 0 O-C-N 120.936 -1.102 . . . . 0.0 110.033 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 19' ' ' ASP . 40.6 Cg_endo -67.14 -10.31 28.14 Favored 'Trans proline' 0 C--N 1.292 -2.446 0 O-C-N 124.498 1.789 . . . . 0.0 110.859 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.604 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -92.57 -30.78 15.47 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 117.628 -1.629 . . . . 0.0 107.646 177.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.009 HD21 ' CB ' ' A' ' 59' ' ' LYS . 83.7 mt -89.8 28.53 1.33 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.096 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 34.8 p-10 -63.19 106.02 0.81 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 118.465 -1.294 . . . . 0.0 108.281 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.629 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.87 23.01 1.89 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.134 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -57.61 138.39 18.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.327 -1.102 . . . . 0.0 111.237 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.134 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.1 t -111.39 114.49 47.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.627 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -99.75 152.87 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.78 -1.2 . . . . 0.0 109.755 -178.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -123.06 128.59 50.35 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.318 -0.864 . . . . 0.0 110.71 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.621 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 64.9 t -101.45 134.69 20.11 Favored Pre-proline 0 C--N 1.292 -1.93 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.107 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.736 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 56.8 Cg_endo -87.79 175.67 4.29 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.512 2.141 . . . . 0.0 112.807 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -91.86 -17.05 25.83 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.601 0.715 . . . . 0.0 109.193 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.905 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.92 70.46 0.71 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.53 ' CG ' ' HG2' ' A' ' 102' ' ' PRO . 2.5 mt-30 -97.63 62.89 1.7 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 122.004 0.907 . . . . 0.0 110.219 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.786 ' CZ2' ' HB3' ' A' ' 46' ' ' ALA . 5.8 p-90 . . . . . 0 C--N 1.294 -1.827 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.179 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.834 ' S2 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' A' ' 16' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.17 0.51 . . . . 0.0 110.344 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.738 ' O ' HG22 ' A' ' 97' ' ' ILE . 6.9 mtmm -84.85 146.4 27.33 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.999 0.904 . . . . 0.0 110.555 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.923 ' HA ' HG23 ' A' ' 97' ' ' ILE . 53.8 t -140.77 135.35 34.01 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 O-C-N 121.351 -0.843 . . . . 0.0 111.024 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.757 HG13 ' HG3' ' A' ' 14' ' ' GLU . 20.8 t -142.49 90.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 C-N-CA 118.711 -1.196 . . . . 0.0 110.386 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.656 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 55.8 m-85 -69.57 136.16 50.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.448 -0.782 . . . . 0.0 109.817 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.567 HG22 ' CD ' ' A' ' 12' ' ' ARG . 62.2 t -100.03 167.69 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 O-C-N 120.723 -1.236 . . . . 0.0 109.297 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.586 ' HB3' HG22 ' A' ' 11' ' ' THR . 89.1 p -103.84 -155.92 0.55 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.103 -0.998 . . . . 0.0 109.246 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.612 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -87.7 -31.34 19.76 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -91.7 -6.65 51.63 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.364 0.602 . . . . 0.0 109.806 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.536 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.24 -23.46 12.56 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.76 129.11 28.81 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.691 -1.476 . . . . 0.0 108.223 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.567 ' CD ' HG22 ' A' ' 6' ' ' VAL . 20.8 mtt180 -121.73 -175.45 3.1 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 122.191 0.996 . . . . 0.0 112.65 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -133.76 179.7 6.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 177.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.757 ' HG3' HG13 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -151.78 111.15 3.94 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 117.704 -1.598 . . . . 0.0 110.972 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.998 HD21 ' CD1' ' A' ' 32' ' ' ILE . 7.6 mt -103.86 -157.04 0.59 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.527 1.156 . . . . 0.0 110.595 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.571 ' HA ' ' O ' ' A' ' 1' ' ' SER . 62.0 t0 -152.54 69.58 0.87 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.049 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.4 t -89.41 127.18 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.033 0.921 . . . . 0.0 109.783 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.23 177.05 6.71 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.21 1.005 . . . . 0.0 113.229 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.59 ' CB ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -53.14 120.63 6.16 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.222 177.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.651 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 106.54 -24.08 26.67 Favored Glycine 0 C--N 1.28 -2.53 0 C-N-CA 119.308 -1.425 . . . . 0.0 112.218 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.049 ' HB ' HG12 ' A' ' 17' ' ' VAL . 85.9 t -84.43 152.23 3.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.513 0 CA-C-N 120.286 2.043 . . . . 0.0 109.381 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.494 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -96.6 131.24 43.44 Favored 'General case' 0 C--N 1.274 -2.682 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.772 HD21 ' SD ' ' A' ' 90' ' ' MET . 7.5 mt -47.11 -26.99 1.23 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.47 -1.394 . . . . 0.0 108.707 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.662 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -73.74 -14.76 61.18 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.657 0.741 . . . . 0.0 109.445 -178.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 22' ' ' SER . 0.7 OUTLIER -90.2 -62.1 1.54 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 177.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.846 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -51.47 -55.65 17.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.128 -0.982 . . . . 0.0 110.385 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.981 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.62 -50.8 23.34 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.534 -1.353 . . . . 0.0 110.263 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.095 HG23 ' CB ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -66.92 -4.25 2.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.439 -0.788 . . . . 0.0 109.456 178.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 26' ' ' ALA 0.256 0.0 OUTLIER -103.44 -24.72 13.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.373 -0.829 . . . . 0.0 110.36 179.954 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.785 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.8 m-80 -97.05 2.8 51.81 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.99 9.8 67.31 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.998 ' CD1' HD21 ' A' ' 15' ' ' LEU . 9.0 mt -72.59 -59.13 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.439 -1.036 . . . . 0.0 108.757 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 1.095 ' CB ' HG23 ' A' ' 28' ' ' VAL . 6.9 m-30 -80.82 53.18 1.87 Allowed 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.567 0.699 . . . . 0.0 110.246 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -48.99 -22.55 0.89 Allowed 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.488 -0.757 . . . . 0.0 109.724 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 35' ' ' ILE . 3.3 tp -95.06 135.35 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.731 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.4 t -79.88 156.67 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.309 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG21 ' A' ' 47' ' ' THR . . . -79.84 -171.62 42.58 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' A' ' 45' ' ' CYS . 4.7 t0 -112.58 -26.44 8.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -1.124 . . . . 0.0 110.353 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 42' ' ' SER . 5.8 p -99.99 -15.12 18.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.108 -0.995 . . . . 0.0 110.404 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.75 43.98 94.34 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.42 1.53 80.98 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 39' ' ' CYS . 5.6 t -83.12 10.57 7.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.11 -1.23 . . . . 0.0 110.186 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.476 ' CB ' ' HG2' ' A' ' 66' ' ' ARG . . . 43.58 53.89 5.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 44' ' ' SER . 0.3 OUTLIER -140.03 16.33 2.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.375 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 1.1 p -130.05 -175.4 3.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.948 . . . . 0.0 110.216 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.532 ' HB3' ' CE3' ' A' ' 106' ' ' TRP . . . -143.99 9.31 1.49 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.29 -0.881 . . . . 0.0 110.411 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.591 HG21 ' HA2' ' A' ' 37' ' ' GLY . 15.1 t -71.37 -20.92 62.09 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.074 -1.016 . . . . 0.0 109.275 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.71 ' SG ' HD13 ' A' ' 84' ' ' LEU . 25.9 p -89.92 29.96 1.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.659 -0.651 . . . . 0.0 109.678 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.134 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 5.9 t60 -69.97 128.78 37.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.566 -0.709 . . . . 0.0 110.732 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.822 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.1 m -157.09 -172.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 O-C-N 121.297 -0.877 . . . . 0.0 109.468 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.822 ' N ' HG23 ' A' ' 50' ' ' VAL 0.252 81.4 m-85 -140.49 106.49 5.19 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.901 0.857 . . . . 0.0 110.823 178.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.128 ' HB ' HG22 ' A' ' 57' ' ' THR . 9.6 t -76.33 130.83 35.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.498 0 O-C-N 120.621 -1.299 . . . . 0.0 109.897 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.87 ' O ' HG23 ' A' ' 57' ' ' THR . 4.4 t30 -45.52 150.0 0.52 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.033 -1.042 . . . . 0.0 109.418 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 pt-20 -59.95 -8.46 2.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.255 -0.903 . . . . 0.0 111.888 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.58 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -97.24 9.15 43.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.671 -1.268 . . . . 0.0 110.779 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 1.1 ' CB ' HD13 ' A' ' 97' ' ' ILE . 90.5 m-85 -140.68 2.72 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 109.919 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 1.128 HG22 ' HB ' ' A' ' 52' ' ' VAL . 24.9 p -90.82 -40.48 11.76 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.979 -1.076 . . . . 0.0 108.375 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.55 -0.9 51.54 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.711 0.767 . . . . 0.0 110.664 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.055 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.26 0.0 OUTLIER -99.26 -47.95 5.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.479 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.064 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.334 0.9 OUTLIER -74.88 179.52 1.33 Allowed Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 113.529 -1.669 . . . . 0.0 106.751 178.585 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 1.064 ' HD2' HG13 ' A' ' 60' ' ' VAL . 36.9 Cg_endo -70.74 115.22 4.14 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 CA-C-O 122.951 1.146 . . . . 0.0 111.796 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.33 69.8 1.63 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.833 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -37.5 159.48 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.223 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -105.6 -154.79 0.52 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.201 -0.937 . . . . 0.0 111.362 -178.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 64' ' ' ASN . 6.2 pt-20 -31.98 -31.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.023 -0.423 . . . . 0.0 111.841 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 64' ' ' ASN . 3.5 mtm180 -52.84 -71.68 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.701 -1.25 . . . . 0.0 107.812 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.604 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 2.5 tm-20 -61.25 -48.65 80.5 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.349 -0.844 . . . . 0.0 109.321 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.552 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.1 mp -54.19 -16.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.367 -0.833 . . . . 0.0 110.421 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -89.23 -75.99 1.3 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.642 ' SD ' ' S1 ' ' A' ' 107' ' ' FES . 0.0 OUTLIER -43.81 -40.27 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.272 -1.134 . . . . 0.0 108.486 178.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.0 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -65.3 -51.49 60.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -57.39 -22.4 42.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.951 -1.093 . . . . 0.0 108.646 178.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.53 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.79 -43.31 30.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.626 -0.671 . . . . 0.0 110.615 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.0 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.7 m -39.2 161.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.571 -0.705 . . . . 0.0 109.892 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.812 HG22 ' O ' ' A' ' 75' ' ' THR . 21.6 m -120.39 30.91 6.71 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.103 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.134 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -114.18 -166.5 1.11 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.701 -1.2 . . . . 0.0 112.493 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.75 63.27 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.616 -178.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.918 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.44 154.03 14.66 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 118.805 -2.434 . . . . 0.0 111.243 -177.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.532 ' CE ' ' HG3' ' A' ' 77' ' ' GLU 0.347 0.4 OUTLIER -131.43 179.65 1.3 Allowed Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.275 -174.794 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.429 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 45.7 Cg_endo -77.37 -27.94 6.05 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 N-CA-C 106.96 -1.977 . . . . 0.0 106.96 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.876 ' HB2' HG21 ' A' ' 57' ' ' THR . 19.3 p-10 -107.89 16.9 23.06 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.166 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.801 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -45.61 152.62 0.31 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.155 -0.966 . . . . 0.0 109.309 179.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.646 HH21 HG12 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -165.11 144.59 6.8 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.139 -1.424 . . . . 0.0 111.237 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.71 HD13 ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -97.62 109.3 22.08 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.585 ' SG ' ' N ' ' A' ' 24' ' ' MET . 7.2 t -28.68 -32.79 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' A' ' 84' ' ' LEU . 26.0 p -71.99 1.31 7.46 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.383 -1.448 . . . . 0.0 110.703 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.499 ' HG3' ' HE1' ' A' ' 70' ' ' MET . 33.2 mm-40 -125.22 20.49 8.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.994 -1.066 . . . . 0.0 110.52 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.584 ' CD1' ' NE ' ' A' ' 83' ' ' ARG . 6.8 mm -119.94 99.91 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.029 -1.044 . . . . 0.0 110.305 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.955 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -82.71 129.39 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.844 -1.16 . . . . 0.0 109.563 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.996 ' SD ' HG21 ' A' ' 97' ' ' ILE . 1.4 tpt -82.68 125.78 31.61 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.583 -0.698 . . . . 0.0 110.422 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.51 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 2.0 p -114.09 162.17 24.37 Favored Pre-proline 0 C--N 1.292 -1.913 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.903 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.59 ' HD3' ' CB ' ' A' ' 19' ' ' ASP . 37.9 Cg_endo -64.33 -13.69 39.71 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 O-C-N 124.658 1.873 . . . . 0.0 108.372 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.51 ' HG2' ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -84.76 -38.69 19.33 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.055 HD21 ' CB ' ' A' ' 59' ' ' LYS . 68.5 mt -90.5 31.09 1.06 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.725 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.498 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 6.3 p-10 -63.59 107.19 1.09 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.922 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.638 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.93 22.32 1.98 Allowed Glycine 0 N--CA 1.498 2.799 0 O-C-N 120.817 -1.177 . . . . 0.0 110.328 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.104 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -59.0 140.67 17.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.634 -0.921 . . . . 0.0 111.497 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.104 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.2 t -114.75 111.47 36.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -98.89 154.83 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.631 -1.293 . . . . 0.0 109.764 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 1.3 m-20 -122.43 123.11 40.56 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.243 -0.911 . . . . 0.0 110.087 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.612 HG12 ' CE1' ' A' ' 8' ' ' HIS . 72.2 t -102.27 121.55 49.82 Favored Pre-proline 0 C--N 1.289 -2.063 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.3 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.657 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 53.6 Cg_endo -75.51 172.83 15.57 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.835 1.69 . . . . 0.0 112.048 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.51 -18.17 24.55 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.425 0.631 . . . . 0.0 109.371 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.713 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.95 73.51 0.82 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.46 ' CG ' ' HG2' ' A' ' 102' ' ' PRO . 1.2 mt-30 -98.63 56.26 1.11 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.266 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.591 ' OXT' ' CD2' ' A' ' 106' ' ' TRP . 1.5 p-90 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.852 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.642 ' S1 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' A' ' 91' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.648 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -78.32 150.61 33.24 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.097 178.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.914 ' HA ' HG23 ' A' ' 97' ' ' ILE . 43.4 t -140.23 135.59 36.73 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 O-C-N 121.436 -0.79 . . . . 0.0 110.767 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 13' ' ' ARG . 39.2 t -141.81 91.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.77 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.661 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 42.3 m-85 -68.41 136.15 52.85 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 101' ' ' VAL . 98.7 t -98.91 163.82 2.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.6 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 81.9 p -98.59 -150.99 0.37 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.983 -1.073 . . . . 0.0 108.608 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.642 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -92.84 -30.53 15.4 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 119.763 -1.835 . . . . 0.0 107.815 178.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.506 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 3.1 p-10 -92.39 2.45 56.65 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.629 -0.67 . . . . 0.0 111.244 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 103.43 -8.39 52.15 Favored Glycine 0 N--CA 1.502 3.074 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.889 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -70.87 130.94 42.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.611 -1.523 . . . . 0.0 107.31 178.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -121.05 -172.33 2.38 Favored 'General case' 0 C--N 1.273 -2.758 0 O-C-N 120.862 -1.149 . . . . 0.0 112.567 -178.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.646 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.3 179.9 6.04 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 177.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.714 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 6.7 mt-10 -150.45 105.3 3.31 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.182 -1.574 . . . . 0.0 110.687 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.993 HD21 ' CD1' ' A' ' 32' ' ' ILE 0.256 8.4 mt -99.5 -156.2 0.54 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.889 0.852 . . . . 0.0 110.357 178.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -146.74 72.78 1.29 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.054 HG13 ' CG1' ' A' ' 21' ' ' VAL 0.255 14.7 t -86.5 120.15 35.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.56 -172.86 3.74 Favored 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.35 1.072 . . . . 0.0 111.969 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -68.65 117.1 9.94 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 177.18 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.583 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 112.8 -16.39 23.45 Favored Glycine 0 C--N 1.275 -2.855 0 C-N-CA 118.977 -1.582 . . . . 0.0 109.719 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.054 ' CG1' HG13 ' A' ' 17' ' ' VAL . 43.1 t -97.01 144.09 11.23 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.006 0 C-N-CA 117.144 -1.822 . . . . 0.0 108.564 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER -96.4 134.79 39.12 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.667 HD22 HG11 ' A' ' 3' ' ' VAL 0.27 7.6 mt -46.09 -30.1 1.76 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 123.833 1.778 . . . . 0.0 108.198 178.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.659 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -73.65 -12.28 60.69 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.721 -179.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.648 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.2 tt0 -95.52 -59.9 1.78 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.956 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -56.76 -49.43 75.29 Favored 'General case' 0 C--O 1.199 -1.559 0 C-N-CA 118.022 -1.471 . . . . 0.0 110.572 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.935 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.0 -53.43 12.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.611 -1.305 . . . . 0.0 109.802 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.932 HG23 ' HB3' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -63.52 -3.76 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 121.352 0.596 . . . . 0.0 110.268 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 26' ' ' ALA 0.265 0.0 OUTLIER -105.44 -29.22 10.36 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.482 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.743 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.3 m-80 -96.37 4.27 52.34 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.57 62.72 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 118.416 -1.85 . . . . 0.0 110.315 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.993 ' CD1' HD21 ' A' ' 15' ' ' LEU . 11.2 mt -77.08 -60.83 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.492 -1.005 . . . . 0.0 108.652 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.932 ' HB3' HG23 ' A' ' 28' ' ' VAL . 3.8 m-30 -82.0 54.43 2.48 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 121.982 0.896 . . . . 0.0 110.571 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -46.97 -31.28 3.07 Favored 'General case' 0 C--N 1.271 -2.808 0 O-C-N 120.514 -1.366 . . . . 0.0 111.114 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.418 ' HA ' HD13 ' A' ' 35' ' ' ILE . 11.5 mm -69.46 130.78 34.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.834 ' O ' HG13 ' A' ' 36' ' ' VAL . 6.1 p -92.24 58.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.945 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.26 69.88 3.08 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -99.52 86.09 3.28 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 121.061 -1.259 . . . . 0.0 111.623 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 7.4 p -61.05 -9.15 3.98 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.0 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 53.77 46.13 68.09 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.728 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.34 28.76 62.29 Favored Glycine 0 N--CA 1.507 3.378 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 43' ' ' ALA . 45.8 t -99.82 12.98 35.31 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 118.046 0.923 . . . . 0.0 108.977 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 42' ' ' SER . . . 41.99 54.28 4.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.364 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.74 9.0 6.39 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.444 -0.902 . . . . 0.0 112.005 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -130.57 168.81 16.48 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 118.208 -1.397 . . . . 0.0 112.474 -178.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.522 ' O ' ' OXT' ' A' ' 106' ' ' TRP . . . -150.25 10.28 0.68 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.4 p -87.16 -4.35 59.11 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.031 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.7 ' SG ' HD13 ' A' ' 84' ' ' LEU . 23.8 p -91.78 29.97 1.45 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 110.886 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.027 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 5.3 t60 -68.5 134.84 50.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.441 -1.412 . . . . 0.0 110.959 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.727 HG23 ' N ' ' A' ' 51' ' ' TYR . 2.0 m -159.74 179.89 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.641 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.727 ' N ' HG23 ' A' ' 50' ' ' VAL 0.275 65.8 m-85 -138.53 113.19 8.99 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 121.596 0.712 . . . . 0.0 110.959 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.005 ' HB ' HG22 ' A' ' 57' ' ' THR . 3.9 t -82.61 131.35 33.96 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 O-C-N 120.869 -1.144 . . . . 0.0 109.346 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.871 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -44.58 155.17 0.1 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.076 -1.049 . . . . 0.0 108.727 177.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -67.45 -1.07 4.3 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.839 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.626 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.45 5.31 48.16 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.564 -1.335 . . . . 0.0 111.393 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.879 ' CB ' HD13 ' A' ' 97' ' ' ILE . 70.6 m-85 -140.17 2.2 1.88 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.328 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 1.02 HG21 ' HB2' ' A' ' 81' ' ' ASN . 17.7 p -89.08 -30.28 18.78 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.318 -1.489 . . . . 0.0 107.748 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -107.8 20.74 18.39 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.015 -178.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.02 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.302 0.3 OUTLIER -125.93 -47.62 1.65 Allowed 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 124.455 2.074 . . . . 0.0 106.72 179.535 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.032 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.347 0.6 OUTLIER -75.68 -176.65 0.6 Allowed Pre-proline 0 C--N 1.273 -2.727 0 CA-C-N 113.093 -1.867 . . . . 0.0 107.153 179.244 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 1.032 ' HD2' HG13 ' A' ' 60' ' ' VAL . 37.5 Cg_endo -59.6 122.73 11.95 Favored 'Trans proline' 0 C--N 1.294 -2.307 0 CA-C-O 122.621 1.009 . . . . 0.0 111.354 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.473 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -70.77 67.93 0.4 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.041 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.561 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -37.34 151.89 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.143 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' A' ' 66' ' ' ARG . 48.7 p-10 -92.55 -164.21 1.15 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.033 0.92 . . . . 0.0 111.744 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 69' ' ' GLY . 24.6 pt-20 -55.56 -25.48 38.15 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.519 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.532 ' O ' ' HG2' ' A' ' 70' ' ' MET . 0.2 OUTLIER -55.71 -61.57 2.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 119.785 -1.822 . . . . 0.0 107.049 177.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 1.014 ' HA ' ' HE2' ' A' ' 70' ' ' MET . 1.0 OUTLIER -57.76 -49.41 76.67 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.701 -0.624 . . . . 0.0 109.922 177.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 58.0 mt -73.77 -0.9 2.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.058 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -94.25 -76.45 1.33 Allowed Glycine 0 C--O 1.202 -1.871 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 1.014 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 1.6 ptt? -46.81 -25.81 0.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.02 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -74.56 -48.38 27.19 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.539 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -57.71 -16.01 9.63 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 119.972 -1.705 . . . . 0.0 108.328 177.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.585 ' O ' ' NE1' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -86.57 -30.34 21.94 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 120.509 -0.476 . . . . 0.0 112.033 -177.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.02 HG22 ' O ' ' A' ' 71' ' ' LEU . 22.3 m -48.83 170.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.789 HG22 ' O ' ' A' ' 75' ' ' THR . 23.5 m -120.15 16.93 12.41 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 109.534 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.027 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -105.76 -164.97 1.06 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.849 1.309 . . . . 0.0 113.589 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.811 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -52.39 61.8 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.573 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.877 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -56.34 154.21 8.56 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 114.911 -2.716 . . . . 0.0 110.142 -177.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.693 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.402 1.0 OUTLIER -135.19 174.34 4.71 Favored Pre-proline 0 C--N 1.277 -2.584 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.152 -173.704 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.94 -26.24 22.24 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 N-CA-C 107.782 -1.661 . . . . 0.0 107.782 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 1.02 ' HB2' HG21 ' A' ' 57' ' ' THR . 15.6 p-10 -110.27 16.29 21.79 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.716 0.769 . . . . 0.0 110.555 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.84 ' OG ' ' HG ' ' A' ' 78' ' ' LEU 0.256 0.5 OUTLIER -45.24 158.36 0.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.066 -1.021 . . . . 0.0 110.675 178.597 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.812 ' HD3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -168.56 153.26 6.1 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 117.475 -1.69 . . . . 0.0 114.315 -179.039 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.7 HD13 ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -105.94 88.65 2.86 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 24' ' ' MET . 1.5 t -12.32 -52.02 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.545 ' N ' ' O ' ' A' ' 84' ' ' LEU . 8.7 p -50.92 -9.65 0.06 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.084 -1.01 . . . . 0.0 111.636 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.435 ' HB3' ' CD ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -119.15 20.45 12.64 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 119.707 -1.871 . . . . 0.0 111.375 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.812 HD11 ' HD3' ' A' ' 83' ' ' ARG . 8.7 mm -118.91 117.64 55.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.71 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.926 ' O ' HG22 ' A' ' 60' ' ' VAL . 3.6 mm -100.21 131.69 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.451 -0.781 . . . . 0.0 109.364 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.891 ' SD ' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -82.04 129.71 34.87 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.36 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.732 ' OG1' ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -110.96 163.51 17.13 Favored Pre-proline 0 C--N 1.288 -2.072 0 C-N-CA 118.265 -1.374 . . . . 0.0 109.858 179.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.496 ' HD3' ' OD1' ' A' ' 19' ' ' ASP . 43.2 Cg_endo -65.18 -9.3 21.33 Favored 'Trans proline' 0 C--N 1.283 -2.883 0 O-C-N 124.641 1.864 . . . . 0.0 110.285 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.732 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.6 OUTLIER -93.69 -28.63 15.85 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 116.992 -1.883 . . . . 0.0 107.853 177.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.02 HD21 ' CB ' ' A' ' 59' ' ' LYS . 70.7 mt -91.71 33.94 1.01 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.09 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 19.4 p-10 -64.29 103.72 0.67 Allowed 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.931 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.631 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 125.26 17.68 2.66 Favored Glycine 0 N--CA 1.504 3.212 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.716 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.039 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -51.07 144.3 2.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.322 0.582 . . . . 0.0 109.526 178.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.039 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.5 t -122.07 113.24 38.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.553 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -98.07 160.41 3.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 119.958 -1.714 . . . . 0.0 110.497 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.694 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -123.18 120.4 33.09 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 109.55 -178.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.6 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 76.5 t -96.27 126.95 42.08 Favored Pre-proline 0 C--N 1.291 -1.954 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.807 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.663 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 43.9 Cg_endo -79.65 166.04 22.08 Favored 'Trans proline' 0 C--N 1.295 -2.238 0 O-C-N 123.695 1.366 . . . . 0.0 110.797 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -89.42 -15.96 31.99 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.648 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.42 83.8 1.82 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.525 ' HG2' ' HG2' ' A' ' 102' ' ' PRO . 42.9 mt-30 -102.03 57.46 0.81 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.576 -1.25 . . . . 0.0 111.072 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.624 ' OXT' ' CG ' ' A' ' 106' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 O-C-N 121.244 -0.91 . . . . 0.0 110.601 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.979 ' S1 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.622 ' CB ' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.356 0.598 . . . . 0.0 110.361 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.939 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -78.04 146.67 35.16 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.275 -0.89 . . . . 0.0 108.999 177.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.827 HG22 HG21 ' A' ' 97' ' ' ILE . 19.9 t -136.67 136.33 48.31 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.186 0 O-C-N 121.055 -1.028 . . . . 0.0 111.735 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 13' ' ' ARG . 59.9 t -141.3 89.89 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.696 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.677 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 29.5 m-85 -67.54 133.97 50.42 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 99' ' ' VAL . 61.9 t -99.58 172.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 120.956 -1.09 . . . . 0.0 109.576 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.559 ' HB3' HG22 ' A' ' 11' ' ' THR . 5.4 p -106.45 -145.78 0.39 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.243 -0.911 . . . . 0.0 109.623 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.575 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -96.28 -32.34 12.46 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -92.02 -8.19 46.74 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.848 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.82 -12.4 20.46 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.157 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.559 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -57.02 131.57 50.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.368 -1.666 . . . . 0.0 108.229 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -121.08 174.66 6.52 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 122.123 0.964 . . . . 0.0 112.957 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.669 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -129.13 178.84 6.13 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -151.93 109.76 3.66 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.041 -1.864 . . . . 0.0 111.289 178.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.96 HD11 ' HA ' ' A' ' 27' ' ' ALA . 3.6 mt -103.72 -157.98 0.64 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.449 1.119 . . . . 0.0 110.842 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 16' ' ' ASP . 27.2 t0 -149.5 67.91 1.02 Allowed 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.026 HG12 ' HB ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -88.85 124.62 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.108 0.956 . . . . 0.0 110.008 -177.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.05 179.81 5.86 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.243 1.021 . . . . 0.0 113.112 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.622 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -57.42 117.6 4.29 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.644 177.134 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.629 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 111.58 -25.06 14.02 Favored Glycine 0 C--N 1.286 -2.197 0 C-N-CA 119.425 -1.369 . . . . 0.0 111.381 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.026 ' HB ' HG12 ' A' ' 17' ' ' VAL . 91.2 t -85.63 149.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 120.082 1.941 . . . . 0.0 109.742 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -96.05 125.32 40.5 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.8 HD22 HG11 ' A' ' 3' ' ' VAL . 8.6 mt -41.77 -27.84 0.13 Allowed 'General case' 0 C--O 1.201 -1.461 0 O-C-N 121.084 -1.01 . . . . 0.0 109.258 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.547 ' HA ' ' HE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -59.32 -49.44 77.81 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 177.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.5 tt0 -57.98 -68.79 0.21 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.714 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.881 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.77 -55.95 7.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.971 -1.08 . . . . 0.0 111.052 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.96 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.65 -48.14 28.96 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.293 -1.504 . . . . 0.0 110.196 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -70.72 -1.46 2.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.502 179.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -102.05 -29.3 11.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 0.0 109.674 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.794 ' CG ' HD22 ' A' ' 15' ' ' LEU . 4.5 m-80 -97.73 -3.15 39.71 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.455 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . 89.79 32.98 9.43 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.119 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.867 HD12 HD11 ' A' ' 15' ' ' LEU . 5.2 mt -80.42 -65.27 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -1.166 . . . . 0.0 109.276 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.667 ' CD1' HG22 ' A' ' 32' ' ' ILE . 19.7 m-85 -80.49 11.22 3.84 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.561 -0.712 . . . . 0.0 111.036 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 31' ' ' GLY . 41.8 p-10 -79.68 45.04 0.66 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.049 -1.032 . . . . 0.0 111.163 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.0 mt -100.58 -48.32 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.134 -0.979 . . . . 0.0 109.958 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.824 HG13 ' N ' ' A' ' 37' ' ' GLY . 2.2 p -117.22 -146.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.335 -0.853 . . . . 0.0 109.809 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.824 ' N ' HG13 ' A' ' 36' ' ' VAL . . . -90.16 -161.69 37.67 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -98.33 170.08 9.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.285 -1.127 . . . . 0.0 110.184 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -100.08 24.13 9.01 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.853 1.311 . . . . 0.0 109.003 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 41' ' ' GLY . . . 65.55 6.65 29.83 Favored Glycine 0 N--CA 1.495 2.63 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.438 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 46.61 22.35 1.05 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.334 -1.412 . . . . 0.0 109.847 177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 43' ' ' ALA . 4.7 p -91.81 22.99 3.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.877 -1.367 . . . . 0.0 111.316 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 42' ' ' SER . . . 44.05 26.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.142 -0.974 . . . . 0.0 109.256 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 42' ' ' SER . 5.5 t -125.75 18.04 8.0 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.485 -0.76 . . . . 0.0 109.556 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.465 ' O ' ' S2 ' ' A' ' 107' ' ' FES . 12.2 p -129.62 -174.06 3.19 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.993 0.902 . . . . 0.0 111.017 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.668 ' HB3' ' OXT' ' A' ' 106' ' ' TRP . . . -141.17 21.38 2.25 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 39' ' ' CYS . 3.0 m -55.19 -19.44 7.94 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.171 -1.011 . . . . 0.0 108.797 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.818 ' O ' HG13 ' A' ' 50' ' ' VAL . 28.6 p -101.24 29.93 4.45 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.716 -0.615 . . . . 0.0 110.243 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.002 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 2.0 t60 -65.47 104.24 0.96 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.523 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.91 HG11 ' SG ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -140.75 -173.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.454 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.716 ' CZ ' ' CE1' ' A' ' 49' ' ' HIS 0.275 84.2 m-85 -140.63 107.21 5.32 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 121.838 0.827 . . . . 0.0 110.617 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.073 ' HB ' HG22 ' A' ' 57' ' ' THR . 3.5 t -70.88 134.29 30.29 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 O-C-N 120.222 -1.549 . . . . 0.0 109.162 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.952 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -44.8 151.44 0.29 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.683 -1.207 . . . . 0.0 109.305 178.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -61.82 -8.51 4.97 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.216 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.611 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -92.64 5.06 52.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.019 -1.051 . . . . 0.0 111.379 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.926 ' HB3' HD12 ' A' ' 97' ' ' ILE . 42.0 m-85 -140.75 4.63 1.93 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.78 -1.2 . . . . 0.0 109.715 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 1.073 HG22 ' HB ' ' A' ' 52' ' ' VAL . 14.7 p -89.67 -33.16 16.73 Favored 'General case' 0 C--N 1.288 -2.066 0 O-C-N 120.746 -1.221 . . . . 0.0 108.023 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.25 -1.91 35.18 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.863 0.84 . . . . 0.0 109.968 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.062 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.268 1.5 mtpt -99.38 -48.64 4.72 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 123.07 1.414 . . . . 0.0 107.601 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.018 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.33 0.8 OUTLIER -72.09 -178.28 0.61 Allowed Pre-proline 0 C--N 1.288 -2.068 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.053 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 1.018 ' HD2' HG13 ' A' ' 60' ' ' VAL . 33.1 Cg_endo -67.61 128.0 17.33 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 CA-C-O 123.1 1.208 . . . . 0.0 111.922 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -73.23 69.4 1.08 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.107 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.496 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -38.02 157.94 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.594 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.479 ' C ' HD13 ' A' ' 68' ' ' ILE . 49.9 p30 -127.37 -149.7 0.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.762 -1.211 . . . . 0.0 112.48 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -36.45 -30.78 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.215 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.461 ' NH1' ' HG3' ' A' ' 66' ' ' ARG . 5.9 mtm-85 -53.79 -73.2 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.699 -1.251 . . . . 0.0 109.458 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.58 ' HA ' ' CE ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -67.98 -38.82 83.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.094 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 0.5 OUTLIER -47.52 -19.83 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.22 -0.925 . . . . 0.0 109.618 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 67' ' ' GLU . . . -90.18 -70.13 1.22 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.588 ' HG3' ' HG ' ' A' ' 84' ' ' LEU . 1.0 OUTLIER -50.3 -30.26 11.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.847 -1.384 . . . . 0.0 108.384 178.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.036 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -74.13 -50.06 21.08 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.585 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -57.13 -18.4 14.85 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.727 -1.233 . . . . 0.0 108.39 178.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -83.54 -34.32 25.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.55 -0.719 . . . . 0.0 111.533 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.036 HG22 ' O ' ' A' ' 71' ' ' LEU . 33.3 m -42.63 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.016 -1.052 . . . . 0.0 109.851 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 75' ' ' THR . 38.2 m -121.08 11.57 10.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.936 -1.102 . . . . 0.0 110.521 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.002 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -99.59 -154.87 0.48 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 123.041 1.4 . . . . 0.0 113.063 -177.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.757 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.252 0.0 OUTLIER -64.96 63.79 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.575 -178.384 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.921 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.03 145.05 37.64 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 115.078 -2.649 . . . . 0.0 110.529 -176.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.564 ' CE ' ' HG3' ' A' ' 77' ' ' GLU 0.362 0.1 OUTLIER -119.01 177.28 1.38 Allowed Pre-proline 0 C--N 1.288 -2.103 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.787 -175.238 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.456 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 42.7 Cg_endo -75.39 -25.2 11.5 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 N-CA-C 106.36 -2.208 . . . . 0.0 106.36 175.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.769 HD22 HG21 ' A' ' 57' ' ' THR . 14.6 p-10 -112.79 22.37 14.56 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.931 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.776 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -46.14 156.57 0.15 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.658 -1.276 . . . . 0.0 109.347 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.709 ' HB2' HG23 ' A' ' 52' ' ' VAL . 2.1 mmt85 -153.02 155.1 36.26 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.347 -1.341 . . . . 0.0 111.603 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.797 HD13 ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -111.84 100.72 9.15 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.91 ' SG ' HG11 ' A' ' 50' ' ' VAL . 88.2 m -30.37 -31.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.572 ' N ' ' O ' ' A' ' 84' ' ' LEU . 28.0 p -73.21 1.87 8.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.394 -1.442 . . . . 0.0 110.621 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' A' ' 84' ' ' LEU . 1.2 tp-100 -126.29 -8.9 6.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.037 -1.04 . . . . 0.0 111.685 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.659 HD11 HH11 ' A' ' 83' ' ' ARG . 0.9 OUTLIER -89.87 118.84 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.769 -1.207 . . . . 0.0 110.39 -179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.86 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -102.65 135.01 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.074 -1.016 . . . . 0.0 109.607 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.804 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.0 tpt -83.61 121.15 26.85 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.702 -0.624 . . . . 0.0 110.66 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.698 HG23 HD12 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -95.83 -176.9 0.58 Allowed Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 117.879 -1.528 . . . . 0.0 109.172 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 46.1 Cg_endo -90.06 -8.04 4.23 Favored 'Trans proline' 0 C--N 1.284 -2.842 0 O-C-N 124.204 1.634 . . . . 0.0 108.883 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.565 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.9 pt-20 -91.96 -30.53 16.05 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.767 1.27 . . . . 0.0 107.577 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.062 HD21 ' CB ' ' A' ' 59' ' ' LYS . 62.6 mt -90.1 29.35 1.23 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.333 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.539 ' HA ' ' CB ' ' A' ' 1' ' ' SER . 17.9 p-10 -62.87 104.01 0.5 Allowed 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.932 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.609 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.37 22.88 2.02 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.051 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.939 HG22 ' O ' ' A' ' 2' ' ' LYS . 3.5 tt -63.12 161.3 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.462 1.125 . . . . 0.0 112.307 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.635 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 t -134.56 116.43 21.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -99.24 156.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.647 -1.283 . . . . 0.0 109.47 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.68 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.95 111.61 16.83 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.079 -1.013 . . . . 0.0 110.637 -178.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.535 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 58.7 t -91.83 127.94 47.93 Favored Pre-proline 0 C--N 1.288 -2.081 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.75 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.622 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 58.4 Cg_endo -79.06 -179.9 5.87 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.083 1.57 . . . . 0.0 112.715 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -91.01 -14.89 30.56 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.526 ' CB ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.37 82.66 1.63 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.458 ' NE2' ' CG1' ' A' ' 101' ' ' VAL . 3.7 tt0 -98.64 50.54 0.98 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 117.381 -1.728 . . . . 0.0 110.478 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.668 ' OXT' ' HB3' ' A' ' 46' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.117 -0.989 . . . . 0.0 109.888 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.465 ' S2 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.61 ' CB ' ' O ' ' A' ' 91' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.179 0.514 . . . . 0.0 110.68 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.792 ' O ' HG22 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -62.08 148.85 42.89 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.842 ' HA ' HG23 ' A' ' 97' ' ' ILE . 53.7 t -138.05 135.67 45.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 O-C-N 120.85 -1.156 . . . . 0.0 111.929 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 13' ' ' ARG . 47.5 t -143.18 92.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.717 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.664 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 34.6 m-85 -70.7 136.92 49.33 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.232 -0.917 . . . . 0.0 108.982 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.562 HG22 ' CD ' ' A' ' 12' ' ' ARG . 61.5 t -99.92 167.55 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 O-C-N 120.51 -1.369 . . . . 0.0 109.335 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.585 ' HB3' HG22 ' A' ' 11' ' ' THR . 91.2 p -103.17 -155.83 0.54 Allowed 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.15 -0.969 . . . . 0.0 109.014 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.6 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -88.51 -30.41 19.37 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -91.83 -6.08 52.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.38 0.609 . . . . 0.0 109.909 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.03 -24.65 11.5 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.71 129.55 29.95 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.671 -1.488 . . . . 0.0 108.453 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.562 ' CD ' HG22 ' A' ' 6' ' ' VAL . 1.6 mtm180 -121.53 -172.34 2.4 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-O 122.113 0.958 . . . . 0.0 112.514 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.624 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.73 -178.22 5.03 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.705 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 49.9 mt-10 -151.85 112.1 4.1 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 117.717 -1.593 . . . . 0.0 110.959 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.962 HD11 HD12 ' A' ' 32' ' ' ILE 0.254 6.5 mt -108.19 -153.38 0.5 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 122.573 1.178 . . . . 0.0 111.493 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.16 68.77 0.99 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.094 HG13 ' CG1' ' A' ' 21' ' ' VAL . 20.9 t -86.05 114.32 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.98 -170.57 2.84 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 122.098 0.951 . . . . 0.0 111.786 -177.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.514 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 2.1 p-10 -63.67 110.53 2.05 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.488 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 112.4 -16.83 24.21 Favored Glycine 0 C--N 1.286 -2.227 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.606 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.094 ' CG1' HG13 ' A' ' 17' ' ' VAL . 42.0 t -96.73 136.28 28.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 O-C-N 120.203 -1.763 . . . . 0.0 106.909 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.593 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -93.1 140.27 29.68 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.277 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.92 HD23 HG21 ' A' ' 17' ' ' VAL . 8.2 mt -47.96 -25.36 1.33 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.664 -1.273 . . . . 0.0 108.055 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.608 ' HA ' ' HE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -69.91 -29.68 66.92 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.316 -0.865 . . . . 0.0 108.667 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.618 ' CG ' HG13 ' A' ' 21' ' ' VAL . 3.5 tt0 -75.46 -70.84 0.4 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.045 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.79 -49.99 18.99 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.136 -1.426 . . . . 0.0 110.601 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.625 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.3 -41.55 19.31 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.211 -1.556 . . . . 0.0 110.796 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.68 2.1 2.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.32 -0.863 . . . . 0.0 109.646 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.261 0.0 OUTLIER -103.9 -30.38 10.37 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.4 1.095 . . . . 0.0 110.206 -179.817 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.769 ' CG ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -99.08 -6.48 28.35 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.28 32.79 15.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.962 HD12 HD11 ' A' ' 15' ' ' LEU . 4.0 mt -72.75 -55.21 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 0.0 109.166 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.618 ' CD1' HG22 ' A' ' 32' ' ' ILE . 22.3 m-30 -81.25 55.97 2.72 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.735 0.779 . . . . 0.0 110.145 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 20.1 p-10 -49.25 -19.58 0.5 Allowed 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.725 -0.609 . . . . 0.0 110.693 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -66.81 167.43 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.974 -1.079 . . . . 0.0 109.866 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 t -103.35 51.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 110.452 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.985 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -120.14 70.45 0.36 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -120.15 118.53 30.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.112 -1.228 . . . . 0.0 110.342 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 23.2 p -100.13 22.24 11.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.21 -0.931 . . . . 0.0 110.153 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.05 39.99 97.74 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.02 34.36 23.41 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.501 ' O ' ' NH2' ' A' ' 66' ' ' ARG . 37.7 p -102.75 12.05 36.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 110.136 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.856 ' HB3' ' CZ ' ' A' ' 66' ' ' ARG . . . 55.88 60.13 3.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.132 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -135.93 7.01 3.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.312 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 1.8 p -134.15 -175.34 3.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.976 . . . . 0.0 110.318 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 106' ' ' TRP . . . -143.94 9.35 1.5 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 110.297 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.985 HG21 ' HA3' ' A' ' 37' ' ' GLY . 14.8 t -77.04 -15.55 59.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.06 -1.025 . . . . 0.0 109.437 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.634 ' SG ' HD13 ' A' ' 84' ' ' LEU . 20.7 p -88.23 26.56 1.38 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.607 -0.683 . . . . 0.0 110.26 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.136 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 4.5 t60 -70.26 125.49 26.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.431 -0.793 . . . . 0.0 109.899 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.824 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -153.37 -171.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.823 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.824 ' N ' HG23 ' A' ' 50' ' ' VAL 0.263 81.6 m-85 -140.81 113.27 8.04 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.734 0.778 . . . . 0.0 110.95 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.985 ' HB ' HG22 ' A' ' 57' ' ' THR . 5.6 t -80.39 132.44 31.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 O-C-N 120.426 -1.422 . . . . 0.0 109.796 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.905 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -43.88 158.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.544 -1.262 . . . . 0.0 108.772 177.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.18 1.53 7.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.759 -1.213 . . . . 0.0 110.144 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.594 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.06 5.59 46.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.792 ' CB ' HD13 ' A' ' 97' ' ' ILE . 57.7 m-85 -140.27 4.9 2.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.92 -1.112 . . . . 0.0 109.35 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.985 HG22 ' HB ' ' A' ' 52' ' ' VAL . 33.8 p -89.35 -39.67 13.28 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.26 -1.79 47.33 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.755 0.788 . . . . 0.0 110.661 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.052 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.26 0.8 OUTLIER -99.31 -47.68 5.08 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 123.207 1.48 . . . . 0.0 107.559 179.877 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.079 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.329 0.7 OUTLIER -78.31 -179.91 1.49 Allowed Pre-proline 0 C--N 1.286 -2.177 0 CA-C-N 113.624 -1.626 . . . . 0.0 107.921 179.811 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 1.079 ' HD2' HG13 ' A' ' 60' ' ' VAL . 37.9 Cg_endo -69.97 106.75 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 CA-C-O 122.655 1.023 . . . . 0.0 111.836 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.544 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -60.21 74.45 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.766 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 67' ' ' GLU . . . -36.78 153.2 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.951 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 66' ' ' ARG . 1.1 p-10 -108.1 -159.75 0.7 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.165 -0.959 . . . . 0.0 111.858 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 7.4 pt-20 -29.68 -34.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.099 -0.375 . . . . 0.0 111.918 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.856 ' CZ ' ' HB3' ' A' ' 43' ' ' ALA . 5.7 mmt180 -53.09 -66.23 0.42 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 120.78 -1.2 . . . . 0.0 107.772 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 1.005 ' HG3' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -61.09 -49.08 78.78 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 1.005 HD12 ' HG3' ' A' ' 67' ' ' GLU . 1.1 mp -57.73 -12.69 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.337 -0.852 . . . . 0.0 111.183 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -89.91 -79.76 1.34 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.703 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.88 -38.77 3.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -1.177 . . . . 0.0 108.846 179.216 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.995 ' O ' HG22 ' A' ' 74' ' ' VAL . 1.0 OUTLIER -64.99 -50.74 65.15 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -57.17 -22.19 38.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.224 -0.923 . . . . 0.0 108.844 178.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.53 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -80.18 -42.29 23.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.477 -0.764 . . . . 0.0 110.744 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.995 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.7 m -39.0 161.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.526 -0.734 . . . . 0.0 110.089 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 75' ' ' THR . 24.2 m -120.52 29.49 7.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 109.245 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.136 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -112.91 -166.38 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.45 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.6 63.36 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.493 -178.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.905 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.47 152.42 18.03 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 118.848 -2.407 . . . . 0.0 111.389 -176.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.526 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.35 0.0 OUTLIER -128.73 -175.97 0.49 Allowed Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.526 -174.824 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 47.0 Cg_endo -80.67 -30.0 2.03 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 N-CA-C 106.987 -1.967 . . . . 0.0 106.987 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.716 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.7 OUTLIER -105.28 13.21 30.81 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.381 178.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.808 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -44.27 147.54 0.54 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.221 -0.924 . . . . 0.0 109.702 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.775 ' C ' HD23 ' A' ' 84' ' ' LEU . 4.6 mtt180 -166.74 153.71 9.02 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 117.798 -1.561 . . . . 0.0 112.534 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.775 HD23 ' C ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -102.63 119.08 38.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 33' ' ' TYR . 28.8 p -33.53 -28.91 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.876 -0.515 . . . . 0.0 112.349 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.565 ' HA ' ' CB ' ' A' ' 24' ' ' MET . 31.8 p -77.17 8.16 4.3 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.551 -1.343 . . . . 0.0 111.075 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.585 ' CG ' ' CE ' ' A' ' 70' ' ' MET . 19.4 mm-40 -125.68 8.73 7.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.052 -1.03 . . . . 0.0 110.384 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.713 HD12 HG11 ' A' ' 60' ' ' VAL . 3.9 mm -120.5 119.72 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.969 -1.082 . . . . 0.0 111.47 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.894 ' O ' HG22 ' A' ' 60' ' ' VAL . 4.7 mm -102.06 131.36 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.085 -1.009 . . . . 0.0 108.967 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.652 ' HE3' ' HA ' ' A' ' 90' ' ' MET . 20.2 mmm -84.13 141.1 31.32 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.899 -1.126 . . . . 0.0 110.289 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.686 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -114.14 -175.43 0.32 Allowed Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.843 -1.16 . . . . 0.0 109.988 179.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 44.2 Cg_endo -84.98 -9.94 8.43 Favored 'Trans proline' 0 C--N 1.285 -2.8 0 O-C-N 123.705 1.371 . . . . 0.0 108.603 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.538 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.4 pt-20 -92.16 -35.12 14.03 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.052 HD21 ' CB ' ' A' ' 59' ' ' LYS . 55.7 mt -89.77 32.22 0.9 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.726 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.47 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 6.8 p-10 -63.46 108.04 1.26 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 118.319 -1.352 . . . . 0.0 108.788 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.615 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.39 24.11 1.83 Allowed Glycine 0 N--CA 1.498 2.794 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.24 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.105 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -58.59 135.79 22.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.53 -0.983 . . . . 0.0 110.644 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.105 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.5 t -113.53 113.6 44.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -99.46 155.86 4.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.762 -1.211 . . . . 0.0 109.973 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.19 120.09 33.17 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.739 0.78 . . . . 0.0 109.842 -179.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.6 HG12 ' CE1' ' A' ' 8' ' ' HIS . 72.8 t -99.61 123.02 49.46 Favored Pre-proline 0 C--N 1.289 -2.06 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.3 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.666 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 55.8 Cg_endo -76.44 173.53 14.33 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.301 1.685 . . . . 0.0 112.21 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.463 ' OD1' ' CD2' ' A' ' 8' ' ' HIS . 1.3 t0 -91.57 -17.84 25.0 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.781 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.81 72.35 0.78 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' THR . 0.1 OUTLIER -98.42 56.02 1.13 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.285 -177.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.619 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 1.7 p-90 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.886 -1.054 . . . . 0.0 109.807 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.471 ' S1 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.972 0.891 . . . . 0.0 110.851 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.651 ' H ' ' HA ' ' A' ' 95' ' ' ASP . 4.4 mmtt -98.81 149.64 22.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.556 0.694 . . . . 0.0 109.982 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.8 HG11 HD22 ' A' ' 23' ' ' LEU . 35.4 t -141.35 139.24 32.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 O-C-N 121.623 -0.673 . . . . 0.0 111.466 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.684 HG13 ' HG2' ' A' ' 14' ' ' GLU . 45.6 t -143.18 89.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.602 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 46.9 m-85 -67.63 156.67 36.29 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.368 -0.832 . . . . 0.0 109.463 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.555 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 86.3 t -122.36 170.1 12.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.25 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.597 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 12.0 p -105.45 -154.63 0.52 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.066 -1.021 . . . . 0.0 109.738 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.567 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.91 -30.25 17.0 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.68 -10.63 39.54 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.483 0.659 . . . . 0.0 109.428 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.531 ' O ' ' CD ' ' A' ' 12' ' ' ARG . . . 114.31 -4.33 23.53 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 120.297 -0.954 . . . . 0.0 110.758 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -63.77 130.18 43.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.557 -1.555 . . . . 0.0 107.847 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -121.08 175.67 5.96 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 122.245 1.022 . . . . 0.0 112.791 -177.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -132.83 179.31 6.24 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 177.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.684 ' HG2' HG13 ' A' ' 4' ' ' VAL . 42.0 mt-10 -151.57 108.1 3.48 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 117.54 -1.664 . . . . 0.0 110.954 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.898 HD21 ' CD1' ' A' ' 32' ' ' ILE . 4.9 mt -99.93 -164.19 1.1 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.804 1.288 . . . . 0.0 110.976 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 1' ' ' SER . 51.4 t0 -143.82 68.23 1.28 Allowed 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.051 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.1 t -88.06 125.41 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.908 0.861 . . . . 0.0 109.247 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.531 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -89.31 -176.98 5.26 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.746 1.26 . . . . 0.0 113.268 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 90' ' ' MET . 3.1 p-10 -62.12 118.26 7.11 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.569 177.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.509 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 111.9 -22.93 17.98 Favored Glycine 0 C--N 1.284 -2.34 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.593 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.051 ' HB ' HG12 ' A' ' 17' ' ' VAL . 80.9 t -88.94 149.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 119.818 1.809 . . . . 0.0 110.314 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 25' ' ' GLN . 1.6 p -96.14 128.64 43.22 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.8 HD22 HG11 ' A' ' 3' ' ' VAL . 8.0 mt -41.07 -31.22 0.17 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.201 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.644 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -68.84 -39.29 80.04 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 118.116 -1.434 . . . . 0.0 108.658 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.589 ' CG ' HG13 ' A' ' 21' ' ' VAL . 1.4 tt0 -56.83 -65.01 0.69 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.797 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -50.73 -56.02 13.92 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.683 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.679 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.0 -41.45 16.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.513 -1.367 . . . . 0.0 110.835 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -78.94 0.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.325 -0.859 . . . . 0.0 109.435 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.259 0.0 OUTLIER -104.03 -30.01 10.54 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.232 1.015 . . . . 0.0 110.333 -179.781 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.637 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -98.97 -2.66 36.84 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 24.97 44.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.898 ' CD1' HD21 ' A' ' 15' ' ' LEU . 4.4 mt -72.78 -51.64 26.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.244 -1.151 . . . . 0.0 109.435 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.665 ' CD1' HG22 ' A' ' 32' ' ' ILE . 15.2 m-30 -80.08 54.11 1.86 Allowed 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.766 0.793 . . . . 0.0 110.125 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -60.4 -7.29 1.95 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.726 -0.609 . . . . 0.0 111.201 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.556 ' N ' ' CD1' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -66.1 -149.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.852 -1.155 . . . . 0.0 110.278 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.821 ' CG2' HG21 ' A' ' 47' ' ' THR . 22.1 m -79.32 175.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.01 -1.056 . . . . 0.0 110.387 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.87 172.41 54.83 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.527 ' OD1' ' CE ' ' A' ' 24' ' ' MET . 8.0 p-10 -120.12 -141.27 0.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -1.064 . . . . 0.0 110.346 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 42' ' ' SER . 26.3 p -92.81 7.33 44.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.185 -0.947 . . . . 0.0 110.256 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.03 24.7 75.79 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.01 8.5 66.87 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 39' ' ' CYS . 4.1 m -84.63 7.79 19.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -1.142 . . . . 0.0 110.138 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.567 ' CB ' ' HD2' ' A' ' 66' ' ' ARG . . . 46.76 55.07 8.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.289 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 t -140.11 19.2 2.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.96 . . . . 0.0 110.389 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 38' ' ' ASP . 1.7 p -129.99 -173.49 3.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 110.404 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.684 ' HB1' ' OXT' ' A' ' 106' ' ' TRP . . . -144.01 9.78 1.51 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 110.199 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.821 HG21 ' CG2' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -82.07 7.93 12.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 110.028 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.756 ' SG ' HD12 ' A' ' 84' ' ' LEU . 7.9 p -115.14 24.33 11.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.409 -0.807 . . . . 0.0 110.082 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.112 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 6.5 t60 -65.11 122.97 18.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.493 -0.754 . . . . 0.0 110.297 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.816 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -148.42 -173.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.981 0.896 . . . . 0.0 109.89 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.816 ' N ' HG23 ' A' ' 50' ' ' VAL 0.27 75.6 m-85 -140.69 110.63 6.52 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.713 0.768 . . . . 0.0 110.855 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.979 ' HB ' HG22 ' A' ' 57' ' ' THR . 4.0 t -79.01 136.14 24.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 O-C-N 120.421 -1.425 . . . . 0.0 110.038 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.962 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -46.01 158.33 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.523 -1.271 . . . . 0.0 108.858 177.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' N ' ' OE2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -72.16 0.22 10.25 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.775 178.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.594 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.28 4.26 48.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.059 -1.026 . . . . 0.0 110.584 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.84 ' HB3' HD12 ' A' ' 97' ' ' ILE . 35.3 m-85 -140.19 6.72 2.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.06 . . . . 0.0 109.299 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.979 HG22 ' HB ' ' A' ' 52' ' ' VAL . 45.6 p -89.39 -39.86 13.13 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.9 -2.47 53.27 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.827 0.822 . . . . 0.0 110.335 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.084 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.261 0.0 OUTLIER -99.56 -47.88 4.95 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 122.971 1.367 . . . . 0.0 107.636 -179.961 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.076 HG11 HG23 ' A' ' 88' ' ' ILE 0.33 0.9 OUTLIER -77.54 177.97 2.4 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.113 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 1.038 ' HD2' HG13 ' A' ' 60' ' ' VAL . 38.2 Cg_endo -71.38 110.02 2.75 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 CA-C-O 122.565 0.985 . . . . 0.0 112.276 -176.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -60.21 70.95 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.108 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' PRO . . . -37.21 134.25 0.6 Allowed 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.88 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' ARG . 43.1 p-10 -88.76 -150.11 0.19 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.111 0.958 . . . . 0.0 112.252 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 64' ' ' ASN . 11.7 pt-20 -37.97 -26.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.573 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.567 ' HD2' ' CB ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -53.0 -70.91 0.08 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.752 -1.218 . . . . 0.0 108.025 179.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.683 ' HA ' ' HE3' ' A' ' 70' ' ' MET . 0.7 OUTLIER -67.38 -51.5 51.27 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 0.9 OUTLIER -44.65 -24.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.465 -0.772 . . . . 0.0 110.108 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.488 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -84.07 -83.08 0.97 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.137 -1.985 . . . . 0.0 108.137 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.683 ' HE3' ' HA ' ' A' ' 67' ' ' GLU . 1.7 ptt? -39.65 -40.52 0.92 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.578 -0.954 . . . . 0.0 108.934 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.0 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -61.71 -53.49 55.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.562 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 3.8 tp10 -56.22 -21.95 26.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.526 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.97 -45.65 23.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.648 -0.657 . . . . 0.0 110.377 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.0 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.3 m -38.94 159.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.556 -0.715 . . . . 0.0 109.733 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.81 HG22 ' O ' ' A' ' 75' ' ' THR . 20.5 m -120.56 34.53 5.18 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.075 -1.015 . . . . 0.0 108.96 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.112 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -115.88 -164.37 0.95 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.628 1.204 . . . . 0.0 112.649 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.751 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.251 0.0 OUTLIER -56.79 62.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.391 -178.843 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.929 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.11 153.65 14.38 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 118.845 -2.409 . . . . 0.0 111.081 -176.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.695 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.387 2.4 mmtt -131.93 177.48 2.22 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.151 -173.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.506 ' HD2' ' HD3' ' A' ' 79' ' ' LYS . 42.9 Cg_endo -73.4 -27.56 13.14 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 176.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.673 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.9 OUTLIER -109.38 13.88 23.94 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.041 179.362 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.75 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -45.04 147.29 0.7 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.954 -1.091 . . . . 0.0 109.649 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.746 ' CD ' HD11 ' A' ' 88' ' ' ILE . 1.1 mtt180 -167.47 163.11 14.84 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 117.765 -1.574 . . . . 0.0 113.01 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.782 ' N ' HD22 ' A' ' 84' ' ' LEU . 3.4 mm? -99.22 122.63 42.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.539 ' CB ' ' OH ' ' A' ' 33' ' ' TYR . 1.9 p -42.92 -23.25 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.167 -0.958 . . . . 0.0 110.713 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 30.4 p -81.49 4.85 19.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.811 -1.181 . . . . 0.0 110.496 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.531 ' HG3' ' CE ' ' A' ' 70' ' ' MET . 18.7 mm-40 -125.22 9.0 7.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 110.827 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.076 HG23 HG11 ' A' ' 60' ' ' VAL . 30.1 mm -113.71 106.96 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.038 -1.039 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.024 ' O ' HG22 ' A' ' 60' ' ' VAL . 4.2 mm -84.88 131.52 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.976 -1.078 . . . . 0.0 110.046 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.669 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.8 tpt -82.62 113.74 20.52 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.359 -0.838 . . . . 0.0 110.823 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.902 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -91.5 -177.34 0.73 Allowed Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 117.516 -1.674 . . . . 0.0 108.642 178.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 46.9 Cg_endo -87.11 -12.61 4.82 Favored 'Trans proline' 0 C--N 1.287 -2.67 0 O-C-N 124.412 1.743 . . . . 0.0 108.651 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.541 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.1 pt-20 -85.2 -32.67 22.54 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.084 HD21 ' CB ' ' A' ' 59' ' ' LYS . 57.7 mt -89.33 36.54 0.83 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.68 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.651 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 12.8 p-10 -62.3 99.82 0.15 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.036 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.579 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 120.67 29.52 1.54 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.268 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.84 HD12 ' HB3' ' A' ' 56' ' ' PHE . 9.5 tt -60.19 163.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.496 -1.591 . . . . 0.0 112.3 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.684 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.3 t -133.1 114.1 20.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.604 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -102.18 154.7 5.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 120.92 -1.113 . . . . 0.0 109.992 -178.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.635 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -122.63 122.91 39.94 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.764 0.792 . . . . 0.0 110.487 -178.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 73.6 t -98.45 136.33 20.88 Favored Pre-proline 0 C--N 1.289 -2.045 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.631 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.672 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 56.0 Cg_endo -89.76 173.59 3.58 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 121.716 1.61 . . . . 0.0 111.818 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 18.3 p-10 -91.2 -17.15 26.52 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.818 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.98 74.92 0.89 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.506 ' HG2' ' HG2' ' A' ' 102' ' ' PRO . 10.9 mt-30 -98.49 54.08 1.05 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.299 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.684 ' OXT' ' HB1' ' A' ' 46' ' ' ALA . 1.4 p-90 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.082 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.574 ' S1 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.57 ' HB2' ' O ' ' A' ' 91' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.204 0.526 . . . . 0.0 110.22 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.735 ' O ' HG22 ' A' ' 97' ' ' ILE . 11.3 mtmt -69.99 149.47 47.69 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.248 -0.908 . . . . 0.0 110.175 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.864 ' HA ' HG23 ' A' ' 97' ' ' ILE . 44.9 t -137.94 135.01 45.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 O-C-N 121.119 -0.988 . . . . 0.0 111.024 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 13' ' ' ARG . 48.8 t -142.29 92.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.154 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.647 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 36.6 m-85 -70.87 137.3 49.25 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.502 -0.749 . . . . 0.0 109.326 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.57 HG22 ' CD ' ' A' ' 12' ' ' ARG . 74.7 t -99.86 166.49 2.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 O-C-N 120.807 -1.183 . . . . 0.0 109.035 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.586 ' HB3' HG22 ' A' ' 11' ' ' THR . 82.8 p -102.21 -154.88 0.5 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.066 -1.021 . . . . 0.0 108.925 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.594 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -89.52 -31.25 17.72 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.485 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 6.1 p-10 -92.01 -5.1 53.6 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.313 0.577 . . . . 0.0 109.792 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.4 -24.65 11.16 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.76 129.31 29.4 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.567 -1.549 . . . . 0.0 108.38 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.57 ' CD ' HG22 ' A' ' 6' ' ' VAL . 5.4 mtt180 -121.53 -172.47 2.43 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 122.187 0.994 . . . . 0.0 112.563 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.65 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -136.7 -178.85 5.36 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.719 ' C ' HD23 ' A' ' 15' ' ' LEU . 35.3 mt-10 -151.86 112.23 4.13 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 117.788 -1.565 . . . . 0.0 110.711 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.954 HD11 ' HA ' ' A' ' 27' ' ' ALA 0.253 3.5 mt -107.86 -152.3 0.48 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.464 1.126 . . . . 0.0 111.207 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -150.37 70.36 1.02 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.082 HG13 ' CG1' ' A' ' 21' ' ' VAL . 12.7 t -86.8 113.7 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.541 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -90.17 -169.89 2.58 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.03 0.919 . . . . 0.0 111.504 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.414 ' O ' ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -63.86 110.53 2.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.741 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 112.28 -17.2 24.24 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.558 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.082 ' CG1' HG13 ' A' ' 17' ' ' VAL . 42.9 t -95.58 137.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 O-C-N 120.134 -1.804 . . . . 0.0 107.358 178.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -95.56 144.03 26.36 Favored 'General case' 0 C--N 1.274 -2.69 0 C-N-CA 118.647 -1.221 . . . . 0.0 108.032 178.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.877 HD23 HG21 ' A' ' 17' ' ' VAL . 12.2 mt -49.81 -25.98 3.55 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.09 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.576 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -72.21 -18.67 61.82 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.618 ' CG ' HG13 ' A' ' 21' ' ' VAL . 3.7 tt0 -88.48 -71.96 0.56 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.06 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -47.2 -50.09 21.52 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.166 -1.413 . . . . 0.0 110.349 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.954 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.81 -48.21 30.69 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.354 -1.466 . . . . 0.0 110.361 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.617 HG23 ' HB2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -72.97 0.55 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.594 -0.691 . . . . 0.0 109.627 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.34 -29.25 11.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.393 -0.817 . . . . 0.0 110.016 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.868 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.9 m-80 -97.73 -0.97 44.46 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.72 22.39 43.21 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.934 HD12 HD11 ' A' ' 15' ' ' LEU . 4.9 mt -72.64 -60.29 2.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.295 -1.121 . . . . 0.0 109.237 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.644 ' CE2' ' CB ' ' A' ' 27' ' ' ALA . 21.7 m-30 -80.79 50.73 1.4 Allowed 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.552 0.691 . . . . 0.0 110.58 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 13.3 p-10 -49.47 -21.45 0.93 Allowed 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.63 -0.669 . . . . 0.0 110.224 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 36' ' ' VAL . 23.0 mm -67.13 176.16 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 0.0 109.979 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.554 ' N ' HG22 ' A' ' 35' ' ' ILE . 86.6 t -95.63 80.35 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 110.369 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.6 ' CA ' HG21 ' A' ' 47' ' ' THR . . . -120.08 62.86 0.48 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -120.09 71.23 0.89 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -1.144 . . . . 0.0 110.317 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 19.6 p -88.36 24.99 1.76 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 110.198 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.41 33.05 86.19 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.93 22.55 4.6 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.52 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 84.0 p -89.91 11.0 21.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -1.153 . . . . 0.0 110.174 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 58.98 60.03 2.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 4.6 t -132.13 11.65 4.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 0.0 110.473 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 1.8 p -133.36 -173.64 3.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.124 -0.985 . . . . 0.0 110.338 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.733 ' HB1' ' OXT' ' A' ' 106' ' ' TRP . . . -148.5 9.63 0.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.873 . . . . 0.0 110.672 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.6 HG21 ' CA ' ' A' ' 37' ' ' GLY . 12.6 t -82.55 -16.62 47.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.874 -1.141 . . . . 0.0 109.702 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.674 ' SG ' HD13 ' A' ' 84' ' ' LEU . 24.9 p -89.13 28.2 1.25 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.472 -0.767 . . . . 0.0 109.879 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.114 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 3.6 t60 -70.32 126.55 29.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.379 -0.826 . . . . 0.0 110.14 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.803 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -156.14 -173.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.05 -1.031 . . . . 0.0 110.102 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.803 ' N ' HG23 ' A' ' 50' ' ' VAL 0.269 76.9 m-85 -140.92 109.9 6.12 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.656 0.741 . . . . 0.0 110.773 179.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.044 ' HB ' HG22 ' A' ' 57' ' ' THR . 4.1 t -76.58 131.64 34.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 O-C-N 120.225 -1.547 . . . . 0.0 110.773 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.809 ' O ' HG23 ' A' ' 57' ' ' THR . 3.7 t30 -47.82 146.28 2.46 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.608 -1.237 . . . . 0.0 108.668 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -59.0 -8.0 1.27 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.058 -1.026 . . . . 0.0 112.072 -178.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.57 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -94.76 8.1 43.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.469 -1.394 . . . . 0.0 110.532 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 1.095 ' CB ' HD13 ' A' ' 97' ' ' ILE . 87.3 m-85 -140.14 3.5 1.98 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 109.754 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 1.044 HG22 ' HB ' ' A' ' 52' ' ' VAL . 23.7 p -90.43 -40.54 11.98 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.1 -1.0 . . . . 0.0 108.467 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.92 -0.87 55.4 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.782 0.801 . . . . 0.0 110.438 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.025 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.259 0.2 OUTLIER -99.46 -48.17 4.87 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 123.199 1.476 . . . . 0.0 107.419 179.655 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.064 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.337 0.8 OUTLIER -77.36 -176.82 0.69 Allowed Pre-proline 0 C--N 1.289 -2.039 0 CA-C-N 113.602 -1.635 . . . . 0.0 107.225 179.31 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 1.064 ' HD2' HG13 ' A' ' 60' ' ' VAL . 35.5 Cg_endo -61.99 127.45 21.37 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 CA-C-O 122.885 1.119 . . . . 0.0 111.448 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.572 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -74.05 60.4 0.77 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.824 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 67' ' ' GLU . . . -38.43 107.29 0.06 Allowed 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.476 0.655 . . . . 0.0 109.915 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.518 ' ND2' ' HG2' ' A' ' 65' ' ' GLU . 0.1 OUTLIER -87.73 -142.38 0.12 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.31 -0.869 . . . . 0.0 111.996 -178.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.518 ' HG2' ' ND2' ' A' ' 64' ' ' ASN . 15.7 pt-20 -29.14 -37.34 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 64' ' ' ASN . 4.3 mtm-85 -53.35 -70.37 0.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.872 -1.142 . . . . 0.0 108.99 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.637 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -59.78 -52.58 64.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 110.188 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.4 mp -45.54 -20.88 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.566 -0.709 . . . . 0.0 111.111 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -86.6 -80.21 1.19 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.593 ' HG3' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -44.06 -39.06 3.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -1.162 . . . . 0.0 108.653 178.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.053 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -63.41 -51.96 63.57 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.562 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -54.63 -24.21 20.5 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -71.23 -50.79 29.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.666 -0.647 . . . . 0.0 110.326 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.053 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.6 m -39.7 160.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.374 -0.828 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.791 HG22 ' O ' ' A' ' 75' ' ' THR . 20.9 m -120.66 35.27 4.93 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.033 -1.042 . . . . 0.0 109.26 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.114 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -114.98 -163.89 0.91 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.841 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.747 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.13 63.21 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.739 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.854 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.08 152.58 16.38 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 118.989 -2.32 . . . . 0.0 111.763 -177.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.689 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.392 1.5 mmtt -133.96 177.73 2.11 Favored Pre-proline 0 C--N 1.292 -1.926 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.662 -173.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 44.3 Cg_endo -75.93 -29.38 6.86 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 N-CA-C 107.329 -1.835 . . . . 0.0 107.329 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.709 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.6 OUTLIER -103.82 12.4 34.56 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.631 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.774 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -44.46 148.03 0.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.123 -0.986 . . . . 0.0 109.838 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.897 ' NE ' HD11 ' A' ' 88' ' ' ILE . 1.1 mtt180 -169.67 157.74 7.21 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.733 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.677 HD22 ' HA ' ' A' ' 49' ' ' HIS . 4.4 mt -106.97 116.09 31.32 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.537 ' SG ' ' CE2' ' A' ' 33' ' ' TYR . 7.4 p -35.35 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.575 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 4.5 p -65.41 -6.1 9.37 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.294 -1.504 . . . . 0.0 112.127 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.543 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . 6.5 tp-100 -125.53 3.24 7.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.421 -1.424 . . . . 0.0 111.655 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.026 HG23 HG11 ' A' ' 60' ' ' VAL . 35.9 mm -100.99 103.4 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.753 -1.217 . . . . 0.0 110.312 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.992 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -90.17 128.63 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.073 -1.017 . . . . 0.0 108.465 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.687 ' HE1' ' HB3' ' A' ' 94' ' ' LEU . 22.3 mmm -83.22 134.49 34.95 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.546 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.799 HG23 HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -112.15 170.67 5.03 Favored Pre-proline 0 C--N 1.291 -1.935 0 O-C-N 120.833 -1.167 . . . . 0.0 109.507 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 38.9 Cg_endo -65.86 -11.71 32.04 Favored 'Trans proline' 0 C--N 1.289 -2.58 0 O-C-N 124.525 1.803 . . . . 0.0 110.892 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.612 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.3 OUTLIER -92.37 -29.33 16.38 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 117.729 -1.588 . . . . 0.0 107.835 177.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.025 HD21 ' CB ' ' A' ' 59' ' ' LYS . 96.7 mt -89.96 27.48 1.58 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.707 0.765 . . . . 0.0 110.935 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.503 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -63.23 104.79 0.63 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.51 -1.276 . . . . 0.0 107.958 177.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.622 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.78 22.74 1.95 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.123 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -57.83 138.05 19.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.399 -1.059 . . . . 0.0 111.069 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.123 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.1 t -111.36 114.14 46.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.563 ' HB ' ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -98.81 155.17 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.732 -1.23 . . . . 0.0 109.209 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.664 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.93 120.32 33.08 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.358 -0.839 . . . . 0.0 110.251 -178.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 69.8 t -96.32 136.79 21.76 Favored Pre-proline 0 C--N 1.287 -2.115 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.789 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.675 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 57.3 Cg_endo -89.48 171.28 4.39 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.063 1.559 . . . . 0.0 111.585 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -91.2 -17.24 26.39 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.681 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.82 73.9 0.85 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.05 57.13 1.07 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.435 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.733 ' OXT' ' HB1' ' A' ' 46' ' ' ALA . 1.7 p-90 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.714 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.464 ' S1 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.588 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.085 0.469 . . . . 0.0 110.395 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.735 ' O ' HG22 ' A' ' 97' ' ' ILE . 9.1 mtmm -86.51 148.36 25.56 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.298 -0.876 . . . . 0.0 110.173 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.945 ' HA ' HG23 ' A' ' 97' ' ' ILE . 56.0 t -141.17 135.04 31.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 O-C-N 121.152 -0.968 . . . . 0.0 110.983 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.756 HG13 ' HG3' ' A' ' 14' ' ' GLU . 23.6 t -142.6 89.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 118.732 -1.187 . . . . 0.0 110.415 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.656 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 46.2 m-85 -67.92 157.04 35.89 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.466 -0.772 . . . . 0.0 109.331 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 101' ' ' VAL . 99.7 t -122.54 169.98 13.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 O-C-N 121.178 -0.951 . . . . 0.0 109.291 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.595 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 9.9 p -102.61 -153.26 0.46 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.06 -1.025 . . . . 0.0 109.217 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.574 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -93.51 -29.44 15.53 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 178.093 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -91.81 -9.97 41.54 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.498 0.666 . . . . 0.0 109.452 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.529 ' O ' ' CD ' ' A' ' 12' ' ' ARG . . . 114.57 -5.69 22.83 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 120.3 -0.953 . . . . 0.0 111.145 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -63.54 130.56 44.87 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.288 -1.713 . . . . 0.0 107.924 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.539 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.74 176.08 5.7 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 122.257 1.027 . . . . 0.0 112.927 -177.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -133.02 178.9 6.53 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 177.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.756 ' HG3' HG13 ' A' ' 4' ' ' VAL . 46.2 mp0 -151.75 110.32 3.8 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 117.56 -1.656 . . . . 0.0 111.109 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.002 HD21 ' CD1' ' A' ' 32' ' ' ILE . 8.3 mt -103.17 -156.33 0.56 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.592 1.187 . . . . 0.0 110.618 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 1' ' ' SER . 1.1 t0 -153.02 70.35 0.87 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.061 HG12 ' HB ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -89.66 127.84 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.003 0.906 . . . . 0.0 109.627 -177.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.25 -179.27 5.84 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.259 1.028 . . . . 0.0 112.858 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -62.24 119.18 8.52 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.696 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 112.05 -22.14 19.01 Favored Glycine 0 C--N 1.288 -2.119 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.555 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.061 ' HB ' HG12 ' A' ' 17' ' ' VAL . 65.8 t -90.77 150.64 3.68 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.209 0 O-C-N 120.116 -1.814 . . . . 0.0 109.505 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.482 ' N ' HG12 ' A' ' 21' ' ' VAL . 1.2 p -96.61 132.14 42.54 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.781 HD22 HG11 ' A' ' 3' ' ' VAL . 7.9 mt -46.96 -28.44 1.62 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.705 -1.247 . . . . 0.0 108.436 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.7 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -73.91 -12.02 60.53 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.323 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.472 ' HB3' ' O ' ' A' ' 22' ' ' SER . 1.0 OUTLIER -91.84 -61.22 1.68 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.756 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -54.39 -55.53 27.72 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.375 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.927 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.42 -51.0 21.38 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.561 -1.337 . . . . 0.0 110.446 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.067 HG23 ' CB ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -65.41 -5.61 2.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 109.333 179.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 26' ' ' ALA 0.256 0.0 OUTLIER -103.3 -24.0 13.55 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.731 0.777 . . . . 0.0 110.065 179.838 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.761 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.6 m-80 -96.75 5.45 50.59 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.72 78.44 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.002 ' CD1' HD21 ' A' ' 15' ' ' LEU . 10.5 mt -72.63 -58.27 5.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.317 -1.107 . . . . 0.0 109.213 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 1.067 ' CB ' HG23 ' A' ' 28' ' ' VAL . 7.1 m-30 -80.59 50.51 1.33 Allowed 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.457 0.646 . . . . 0.0 110.489 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -49.52 -21.28 0.92 Allowed 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.533 -0.73 . . . . 0.0 110.242 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.558 HG22 ' H ' ' A' ' 36' ' ' VAL . 20.6 mm -70.45 177.1 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 36' ' ' VAL . 18.5 m -116.23 80.25 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.121 -0.987 . . . . 0.0 110.338 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.521 ' CA ' ' OG1' ' A' ' 47' ' ' THR . . . -120.22 54.58 0.65 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 3.6 p-10 -120.16 84.27 2.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -1.223 . . . . 0.0 110.436 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.3 p -86.73 20.1 2.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.106 -0.996 . . . . 0.0 110.229 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.2 34.59 40.8 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.62 21.8 5.06 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 29.9 t -80.44 1.23 30.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -1.161 . . . . 0.0 110.292 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 61.13 59.93 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.215 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.8 p -140.05 15.99 2.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.361 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 5.5 p -137.12 -169.3 2.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 110.355 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.643 ' CB ' ' CZ3' ' A' ' 106' ' ' TRP . . . -145.58 11.71 1.29 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.89 . . . . 0.0 110.26 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.521 ' OG1' ' CA ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -83.3 10.5 8.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 0.0 109.952 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 1.023 ' HB2' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -107.06 14.73 26.02 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.475 -0.765 . . . . 0.0 109.66 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.091 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 13.4 t60 -70.23 123.76 22.47 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.276 -0.89 . . . . 0.0 111.714 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.802 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.5 m -158.34 -174.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.729 0.776 . . . . 0.0 109.129 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.881 ' OH ' HD22 ' A' ' 78' ' ' LEU 0.252 68.0 m-85 -140.84 102.57 4.31 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.019 0.914 . . . . 0.0 110.66 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.076 ' HB ' HG22 ' A' ' 57' ' ' THR . 2.7 t -74.19 134.13 30.18 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 O-C-N 120.69 -1.256 . . . . 0.0 110.491 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.881 ' O ' HG23 ' A' ' 57' ' ' THR . 3.7 t30 -48.8 150.33 1.5 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.302 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.6 pt-20 -60.35 -8.1 2.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.246 -0.909 . . . . 0.0 111.909 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.578 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -98.78 9.41 43.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.628 -1.295 . . . . 0.0 110.758 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 1.121 ' CB ' HD13 ' A' ' 97' ' ' ILE . 88.0 m-85 -140.51 2.03 1.8 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.051 -1.03 . . . . 0.0 110.119 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 1.076 HG22 ' HB ' ' A' ' 52' ' ' VAL . 7.6 p -90.45 -40.21 12.16 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.015 -1.053 . . . . 0.0 108.36 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.39 -0.31 52.69 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.688 0.756 . . . . 0.0 110.699 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.046 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.265 1.1 mtpp -99.22 -48.49 4.81 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 123.303 1.525 . . . . 0.0 107.085 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.061 HG11 HD13 ' A' ' 88' ' ' ILE 0.334 0.9 OUTLIER -72.8 179.48 1.09 Allowed Pre-proline 0 C--N 1.288 -2.083 0 CA-C-N 113.436 -1.711 . . . . 0.0 106.472 178.431 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 1.046 ' HD2' HG13 ' A' ' 60' ' ' VAL . 36.6 Cg_endo -70.21 113.07 3.33 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 CA-C-O 122.834 1.098 . . . . 0.0 111.155 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -74.3 67.61 1.42 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.225 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.666 ' HB2' ' HG3' ' A' ' 87' ' ' GLN . . . -37.45 156.6 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.954 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 66' ' ' ARG . 2.3 p-10 -92.37 -161.96 0.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.017 -1.052 . . . . 0.0 112.399 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 4.0 pt-20 -38.1 -24.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.987 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -52.76 -72.3 0.06 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.65 -1.281 . . . . 0.0 107.949 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.937 ' HA ' ' HE3' ' A' ' 70' ' ' MET . 0.5 OUTLIER -68.36 -40.88 81.33 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.554 -0.716 . . . . 0.0 109.298 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.635 HD12 ' CD ' ' A' ' 67' ' ' GLU . 1.1 mp -57.94 -16.89 7.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.111 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.51 ' HA2' ' OE1' ' A' ' 72' ' ' GLU . . . -97.01 -68.35 0.96 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.937 ' HE3' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -42.44 -38.9 2.04 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.126 -1.22 . . . . 0.0 108.065 179.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.121 HD11 ' CB ' ' A' ' 82' ' ' SER 0.261 0.0 OUTLIER -65.34 -50.51 65.31 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.883 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.515 ' OE2' ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -67.04 -29.84 69.75 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.515 ' N ' ' OE2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -61.11 -38.92 88.04 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.023 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.082 HG21 ' CE1' ' A' ' 49' ' ' HIS . 1.4 m -53.2 168.81 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 75' ' ' THR . 17.0 m -120.74 54.48 1.07 Allowed 'General case' 0 C--N 1.287 -2.145 0 O-C-N 120.483 -1.386 . . . . 0.0 110.014 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.091 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -126.17 -154.64 0.64 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 115.151 -2.62 . . . . 0.0 112.211 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.733 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.262 0.0 OUTLIER -63.88 60.38 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 122.702 1.239 . . . . 0.0 108.472 -179.558 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.009 HD13 ' OG ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -59.23 132.72 54.85 Favored 'General case' 0 C--N 1.288 -2.09 0 O-C-N 119.63 -1.919 . . . . 0.0 110.375 -177.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.546 ' CD ' ' HG3' ' A' ' 77' ' ' GLU 0.365 0.0 OUTLIER -116.01 -179.4 0.62 Allowed Pre-proline 0 C--N 1.291 -1.975 0 CA-C-N 112.666 -2.061 . . . . 0.0 111.798 -174.13 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -79.12 -28.79 3.58 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 N-CA-C 106.82 -2.031 . . . . 0.0 106.82 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.693 ' HB2' HG21 ' A' ' 57' ' ' THR . 14.8 p-10 -108.68 14.68 24.26 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.98 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 1.121 ' CB ' HD11 ' A' ' 71' ' ' LEU . 2.7 m -47.8 -175.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.537 -0.727 . . . . 0.0 109.68 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.601 ' HB2' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -174.89 169.27 3.47 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 116.434 -2.106 . . . . 0.0 114.72 178.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.023 HD13 ' HB2' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -115.72 103.12 10.37 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.596 ' SG ' ' HB3' ' A' ' 48' ' ' CYS . 0.7 OUTLIER -31.92 -31.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 84' ' ' LEU . 29.6 p -84.48 12.07 7.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.053 -1.654 . . . . 0.0 112.247 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.666 ' HG3' ' HB2' ' A' ' 63' ' ' ALA . 1.5 tp-100 -126.33 21.62 7.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.588 -1.32 . . . . 0.0 111.836 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.061 HD13 HG11 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -120.12 105.15 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.736 -1.227 . . . . 0.0 110.678 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.945 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -90.76 132.39 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.923 -1.11 . . . . 0.0 109.37 179.085 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.984 ' SD ' HG21 ' A' ' 97' ' ' ILE . 1.3 tpt -82.83 117.56 22.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.653 -0.654 . . . . 0.0 111.348 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.754 HG23 HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -98.77 176.15 2.13 Favored Pre-proline 0 N--CA 1.496 1.849 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.779 178.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 45.3 Cg_endo -78.56 -9.0 16.09 Favored 'Trans proline' 0 C--N 1.293 -2.353 0 O-C-N 124.564 1.823 . . . . 0.0 110.262 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.612 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 0.6 OUTLIER -92.72 -29.72 15.91 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.046 HD21 ' CB ' ' A' ' 59' ' ' LYS . 85.9 mt -89.68 28.47 1.31 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.738 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.595 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 17.9 p-10 -63.45 105.73 0.81 Allowed 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 118.513 -1.275 . . . . 0.0 108.621 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.666 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 125.04 16.99 2.83 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.523 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.121 HD13 ' CB ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -51.71 142.17 4.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.606 -0.938 . . . . 0.0 111.715 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.087 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.1 t -115.67 111.43 35.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.599 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -99.06 153.05 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 120.735 -1.228 . . . . 0.0 109.853 -178.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.675 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.76 127.88 49.74 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.791 -179.118 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 54.5 t -98.24 139.8 21.45 Favored Pre-proline 0 C--N 1.288 -2.07 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.722 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.7 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 56.2 Cg_endo -90.53 174.81 2.83 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.818 1.679 . . . . 0.0 111.886 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 11.1 p-10 -91.3 -17.72 25.48 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.905 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -111.34 67.86 0.65 Allowed 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -97.5 49.88 1.05 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.326 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.643 ' CZ3' ' CB ' ' A' ' 46' ' ' ALA . 11.0 p-90 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.282 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.662 ' S2 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 91' ' ' THR . 1.4 p . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.146 0.498 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.762 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -98.19 146.63 25.42 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.091 -1.006 . . . . 0.0 110.057 178.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.933 HG22 ' CG2' ' A' ' 97' ' ' ILE . 44.8 t -134.39 133.07 55.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.843 0.83 . . . . 0.0 111.073 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 13' ' ' ARG . 56.4 t -142.29 89.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.531 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.681 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 40.9 m-85 -67.79 135.82 53.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.574 HG13 ' HG2' ' A' ' 12' ' ' ARG . 59.3 t -99.65 167.09 2.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 O-C-N 120.546 -1.346 . . . . 0.0 109.664 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.587 ' HB3' HG22 ' A' ' 11' ' ' THR . 89.6 p -102.3 -153.99 0.48 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 109.335 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.594 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -88.99 -33.09 17.31 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.477 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 10.5 p-10 -91.63 -3.88 55.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.736 -0.603 . . . . 0.0 109.883 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.11 -24.42 11.67 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.587 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.79 128.83 28.02 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.609 -1.524 . . . . 0.0 108.38 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.574 ' HG2' HG13 ' A' ' 6' ' ' VAL . 20.8 mtm180 -121.35 -171.77 2.28 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 122.162 0.982 . . . . 0.0 112.474 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.657 ' HE ' HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.36 -179.08 5.42 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 178.296 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -152.0 109.58 3.62 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 117.447 -1.701 . . . . 0.0 111.201 178.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.974 HD11 ' HA ' ' A' ' 27' ' ' ALA . 6.6 mt -105.06 -157.07 0.59 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.639 1.209 . . . . 0.0 110.583 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -153.27 70.81 0.87 Allowed 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.05 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.2 t -88.34 127.39 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.736 0.779 . . . . 0.0 109.592 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.0 -178.16 5.63 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.618 1.199 . . . . 0.0 112.987 -177.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.51 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 1.5 p30 -61.15 116.12 4.31 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.829 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.685 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 111.89 -20.86 21.57 Favored Glycine 0 C--N 1.287 -2.162 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.524 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.05 ' HB ' HG12 ' A' ' 17' ' ' VAL . 90.3 t -89.21 150.5 3.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 120.1 -1.823 . . . . 0.0 109.306 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 25' ' ' GLN . 1.6 p -96.01 125.61 40.67 Favored 'General case' 0 C--N 1.274 -2.684 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.752 ' CD2' HG21 ' A' ' 17' ' ' VAL . 4.4 mt -43.05 -24.33 0.07 Allowed 'General case' 0 C--O 1.203 -1.382 0 O-C-N 120.73 -1.231 . . . . 0.0 109.265 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.684 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -64.43 -47.58 78.58 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.9 tt0 -59.84 -65.51 0.67 Allowed 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.905 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.61 -60.04 2.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.911 -1.118 . . . . 0.0 110.581 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.974 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.72 -54.69 11.42 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.751 -1.218 . . . . 0.0 110.848 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.947 HG23 ' CB ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -63.92 -6.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.544 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.254 0.0 OUTLIER -99.25 -25.97 14.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.303 -0.873 . . . . 0.0 109.817 179.708 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.797 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.5 m-80 -96.93 3.93 51.84 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.81 72.81 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.971 ' CD1' HD21 ' A' ' 15' ' ' LEU . 9.0 mt -72.85 -56.41 9.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.479 -1.012 . . . . 0.0 109.488 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.947 ' CB ' HG23 ' A' ' 28' ' ' VAL . 7.0 m-30 -80.22 50.62 1.27 Allowed 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.459 0.647 . . . . 0.0 110.272 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -49.36 -21.48 0.88 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.474 -0.766 . . . . 0.0 110.272 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 pp -74.62 134.63 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 109.974 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 36' ' ' VAL . 10.8 p -112.14 55.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.952 . . . . 0.0 110.443 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 47' ' ' THR . . . -120.13 36.4 3.44 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.472 ' HB2' ' S1 ' ' A' ' 107' ' ' FES . 6.8 p-10 -101.07 158.23 16.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -1.151 . . . . 0.0 110.441 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 24.2 p -77.16 -9.16 58.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.31 -0.869 . . . . 0.0 110.233 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.15 35.71 26.37 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.07 4.72 71.45 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -83.63 4.32 28.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.209 -1.171 . . . . 0.0 110.209 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.484 ' HA ' ' S2 ' ' A' ' 107' ' ' FES . . . 42.26 49.0 4.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.318 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.5 p -140.07 24.48 2.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 110.581 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 2.1 p -130.12 -168.18 1.93 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.041 -1.037 . . . . 0.0 110.355 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.799 ' HB1' ' O ' ' A' ' 106' ' ' TRP . . . -149.44 9.86 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.935 . . . . 0.0 110.81 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 37' ' ' GLY . 15.0 p -83.31 4.05 28.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.004 -1.06 . . . . 0.0 109.995 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.524 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 9.4 p -115.32 29.69 7.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.456 -0.777 . . . . 0.0 109.895 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.125 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 4.7 t60 -70.21 125.98 28.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.745 . . . . 0.0 110.116 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.804 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -155.3 -173.66 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.0 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.804 ' N ' HG23 ' A' ' 50' ' ' VAL 0.269 82.9 m-85 -140.41 114.13 8.82 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.624 0.726 . . . . 0.0 110.754 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.019 ' HB ' HG22 ' A' ' 57' ' ' THR . 5.5 t -85.19 130.66 35.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 O-C-N 120.28 -1.513 . . . . 0.0 109.504 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.934 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -40.75 157.2 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.675 -1.265 . . . . 0.0 109.294 177.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.1 0.37 7.79 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.844 -1.16 . . . . 0.0 110.209 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.59 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.1 5.29 47.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.948 -1.095 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.831 ' CB ' HD13 ' A' ' 97' ' ' ILE . 55.0 m-85 -140.48 5.44 2.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.901 -1.124 . . . . 0.0 109.443 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 1.019 HG22 ' HB ' ' A' ' 52' ' ' VAL . 30.4 p -89.58 -38.02 14.27 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -2.45 44.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.828 0.823 . . . . 0.0 110.39 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.077 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.259 0.2 OUTLIER -99.21 -47.96 5.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 179.708 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.037 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.334 1.1 t -80.4 175.03 5.22 Favored Pre-proline 0 C--N 1.288 -2.071 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 177.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 1.037 ' HD2' HG13 ' A' ' 60' ' ' VAL . 38.3 Cg_endo -74.54 110.79 3.17 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 CA-C-O 122.877 1.115 . . . . 0.0 112.934 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.497 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -75.43 75.55 2.5 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.356 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.73 ' HB3' ' CB ' ' A' ' 67' ' ' GLU . . . -37.04 160.32 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.874 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -96.99 -160.7 0.82 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.247 -0.908 . . . . 0.0 112.336 -178.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -28.74 -39.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 122.025 -0.422 . . . . 0.0 112.074 -178.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 64' ' ' ASN . 3.6 mtt180 -53.19 -66.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.569 -1.332 . . . . 0.0 108.488 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.787 ' HA ' ' HE2' ' A' ' 70' ' ' MET . 0.8 OUTLIER -59.25 -35.13 73.14 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.579 -0.701 . . . . 0.0 109.86 178.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.7 mp -77.24 -9.04 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.224 -0.922 . . . . 0.0 110.278 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -84.23 -80.81 1.05 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.787 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.82 -36.56 2.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.164 -1.198 . . . . 0.0 108.728 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.994 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -64.62 -48.54 74.5 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.535 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 3.1 tp10 -61.36 -16.18 43.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.481 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -85.72 -40.51 16.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.695 -0.628 . . . . 0.0 110.459 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.994 HG22 ' O ' ' A' ' 71' ' ' LEU . 8.1 m -40.38 162.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.387 -0.821 . . . . 0.0 109.639 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 75' ' ' THR . 23.0 m -120.48 30.0 7.16 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.193 -0.942 . . . . 0.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.125 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -113.85 -167.96 1.28 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.755 -1.178 . . . . 0.0 112.465 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.738 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.14 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.819 -179.012 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.924 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.48 153.56 15.71 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 118.903 -2.373 . . . . 0.0 111.165 -177.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.535 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.347 0.0 OUTLIER -128.46 -178.18 0.75 Allowed Pre-proline 0 C--N 1.297 -1.703 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.329 -174.792 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 45.6 Cg_endo -78.75 -28.36 4.22 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 N-CA-C 106.985 -1.967 . . . . 0.0 106.985 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.6 ' CG ' HG21 ' A' ' 57' ' ' THR . 0.7 OUTLIER -108.11 16.24 23.5 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.089 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.826 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -43.72 149.37 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.922 -1.111 . . . . 0.0 108.932 -179.388 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.947 ' HB2' HG23 ' A' ' 52' ' ' VAL . 2.3 mmt85 -154.55 146.07 23.14 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.604 -1.638 . . . . 0.0 112.403 -177.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -103.67 88.71 3.13 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 177.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 24' ' ' MET . 5.7 t -17.03 -45.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.578 ' N ' ' O ' ' A' ' 84' ' ' LEU . 1.6 p -44.26 -19.31 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.611 -1.305 . . . . 0.0 112.236 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.559 ' HB3' ' HB2' ' A' ' 63' ' ' ALA . 1.3 mp0 -118.88 -4.72 10.64 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.254 -1.529 . . . . 0.0 112.081 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.634 HG23 HG11 ' A' ' 60' ' ' VAL . 3.2 mm -79.76 98.25 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.779 -1.201 . . . . 0.0 109.046 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.971 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -84.11 130.42 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.002 -1.061 . . . . 0.0 109.02 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.642 ' HE1' ' HB3' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -83.31 125.16 31.33 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.692 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.902 HG23 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -101.42 -177.67 0.58 Allowed Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 118.111 -1.436 . . . . 0.0 109.005 177.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.61 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 47.6 Cg_endo -89.07 -14.71 2.67 Favored 'Trans proline' 0 C--N 1.291 -2.453 0 O-C-N 124.483 1.781 . . . . 0.0 108.713 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.512 ' CG ' ' HG ' ' A' ' 94' ' ' LEU . 2.1 pt-20 -82.26 -31.47 30.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.077 HD21 ' CB ' ' A' ' 59' ' ' LYS . 52.4 mt -89.72 34.85 0.83 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.053 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.582 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 6.7 p-10 -62.65 107.16 0.9 Allowed 'General case' 0 C--N 1.29 -2.013 0 O-C-N 120.365 -1.459 . . . . 0.0 109.092 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.444 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 122.24 25.67 1.98 Allowed Glycine 0 N--CA 1.497 2.761 0 O-C-N 120.835 -1.165 . . . . 0.0 110.71 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.117 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -59.1 135.97 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.971 -1.311 . . . . 0.0 110.6 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.117 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.4 t -115.77 111.74 36.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -99.5 156.5 3.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.88 -178.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.694 ' N ' ' O ' ' A' ' 51' ' ' TYR . 1.1 m-20 -122.9 125.95 46.34 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.306 -0.871 . . . . 0.0 110.413 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.589 HG12 ' CE1' ' A' ' 8' ' ' HIS . 56.1 t -103.61 130.31 23.75 Favored Pre-proline 0 C--N 1.289 -2.039 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.692 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.653 ' CG ' ' CD2' ' A' ' 49' ' ' HIS . 56.7 Cg_endo -84.23 173.84 8.55 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 124.296 1.682 . . . . 0.0 112.077 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.44 ' CG ' ' HB3' ' A' ' 8' ' ' HIS . 1.3 m-20 -91.34 -18.31 24.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.792 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -110.91 73.75 0.84 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.479 ' HG2' ' HD2' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -98.64 55.63 1.08 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 118.994 -1.083 . . . . 0.0 110.132 -177.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.799 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 1.4 p-90 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.92 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.484 ' S2 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.525 ' OG ' ' HG3' ' A' ' 90' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.498 1.966 0 CA-C-O 121.197 0.523 . . . . 0.0 110.521 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.809 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -73.34 144.06 46.65 Favored 'General case' 0 C--O 1.202 -1.429 0 O-C-N 120.682 -1.261 . . . . 0.0 109.073 179.119 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.878 ' HA ' HG23 ' A' ' 97' ' ' ILE . 78.6 t -137.69 130.08 41.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 122.287 1.042 . . . . 0.0 110.711 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.659 HG13 ' HG2' ' A' ' 14' ' ' GLU . 85.8 t -141.42 96.5 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.917 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.294 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.675 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 21.6 m-85 -76.89 151.63 35.72 Favored 'General case' 0 C--O 1.201 -1.486 0 O-C-N 121.64 -0.663 . . . . 0.0 109.747 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 89.9 t -111.31 166.85 5.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 O-C-N 121.046 -1.034 . . . . 0.0 110.368 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 11' ' ' THR . 85.8 p -103.77 -157.21 0.6 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.131 -0.98 . . . . 0.0 109.261 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.545 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -91.04 -27.13 18.82 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -92.1 -8.23 46.37 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.734 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 113.47 -9.35 24.22 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.58 ' O ' ' N ' ' A' ' 7' ' ' SER . 0.6 OUTLIER -66.54 136.17 55.25 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 119.914 -1.933 . . . . 0.0 108.758 179.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -120.5 179.66 4.25 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.251 1.024 . . . . 0.0 112.974 -176.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.667 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -134.58 173.27 11.84 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 179.589 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.669 ' C ' HD23 ' A' ' 15' ' ' LEU . 16.3 mt-10 -150.15 114.84 5.27 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 117.111 -1.836 . . . . 0.0 111.047 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.975 HD11 ' HA ' ' A' ' 27' ' ' ALA 0.28 4.6 mt -107.92 -154.03 0.52 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.462 1.125 . . . . 0.0 109.845 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.32 72.04 0.92 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.983 HG22 ' CB ' ' A' ' 26' ' ' ALA . 1.4 t -88.31 126.41 41.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-O 121.786 0.803 . . . . 0.0 109.022 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.629 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.44 -179.51 5.84 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.817 0.817 . . . . 0.0 112.777 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.68 ' HB3' ' CD ' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -56.75 112.44 1.3 Allowed 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.56 177.091 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.72 ' H ' HG23 ' A' ' 89' ' ' ILE . . . 112.81 -21.54 18.31 Favored Glycine 0 C--N 1.282 -2.464 0 C-N-CA 118.702 -1.713 . . . . 0.0 113.003 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.94 ' HB ' HG12 ' A' ' 17' ' ' VAL . 66.7 t -86.2 147.87 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 120.677 2.239 . . . . 0.0 108.059 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -95.38 130.34 42.21 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.736 HD21 ' HG2' ' A' ' 90' ' ' MET . 11.0 mt -44.87 -25.79 0.34 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.015 -1.678 . . . . 0.0 109.782 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.637 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -67.41 -23.18 65.53 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.3 tt0 -88.09 -65.43 1.02 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.983 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.42 -49.86 17.51 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.281 -1.368 . . . . 0.0 111.383 178.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.975 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -55.2 -50.0 70.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.184 -1.573 . . . . 0.0 110.173 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.862 HG23 ' CB ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -67.32 -1.19 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.73 -1.231 . . . . 0.0 110.569 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . 0.265 0.0 OUTLIER -104.33 -31.15 9.68 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.311 1.053 . . . . 0.0 109.655 -178.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.717 ' CG ' HD22 ' A' ' 15' ' ' LEU . 6.8 m-80 -95.82 4.16 53.1 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.17 12.58 63.2 Favored Glycine 0 N--CA 1.505 3.273 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.536 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.907 ' CD1' HD21 ' A' ' 15' ' ' LEU . 7.9 mt -72.16 -58.34 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.564 -0.962 . . . . 0.0 109.681 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.862 ' CB ' HG23 ' A' ' 28' ' ' VAL . 6.1 m-30 -81.9 52.52 1.97 Allowed 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.3 -0.875 . . . . 0.0 109.902 178.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -49.06 -29.35 4.98 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.03 0.919 . . . . 0.0 109.448 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.563 ' O ' HG13 ' A' ' 35' ' ' ILE . 25.4 pt -82.78 100.53 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.526 0 O-C-N 120.362 -1.461 . . . . 0.0 108.354 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 36' ' ' VAL . 86.2 t -79.88 73.71 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 O-C-N 120.92 -1.112 . . . . 0.0 110.642 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' OG1' ' A' ' 47' ' ' THR . . . -120.42 44.65 1.34 Allowed Glycine 0 N--CA 1.504 3.232 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.57 169.88 11.34 Favored 'General case' 0 C--O 1.193 -1.884 0 O-C-N 121.697 -0.884 . . . . 0.0 110.085 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 6.9 p -100.5 -4.97 27.7 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-O 122.3 1.048 . . . . 0.0 109.896 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.62 30.83 68.24 Favored Glycine 0 N--CA 1.499 2.867 0 O-C-N 120.297 -1.502 . . . . 0.0 111.321 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.19 17.88 70.73 Favored Glycine 0 N--CA 1.502 3.092 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 39' ' ' CYS . 1.6 t -96.84 -1.43 46.07 Favored 'General case' 0 C--N 1.286 -2.158 0 O-C-N 119.599 -2.118 . . . . 0.0 109.181 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 52.76 55.47 8.97 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.286 -0.884 . . . . 0.0 110.341 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.04 30.73 1.8 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 120.605 -1.31 . . . . 0.0 110.136 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -141.04 175.31 9.72 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 119.527 -1.983 . . . . 0.0 111.739 -178.556 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.24 17.07 0.94 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.463 0.649 . . . . 0.0 110.469 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -89.19 -2.38 58.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.276 -1.515 . . . . 0.0 109.333 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' ' 84' ' ' LEU . 6.8 p -99.68 30.04 3.82 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.616 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.105 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 5.3 t60 -69.81 123.25 20.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.518 -0.739 . . . . 0.0 110.842 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.756 HG22 ' O ' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -155.32 -172.35 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 120.808 -1.182 . . . . 0.0 108.399 178.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.741 ' N ' HG23 ' A' ' 50' ' ' VAL 0.301 79.8 m-85 -139.78 109.13 6.14 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.351 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.001 ' HB ' HG22 ' A' ' 57' ' ' THR . 7.1 t -76.94 129.42 37.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 O-C-N 120.566 -1.334 . . . . 0.0 110.553 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.782 HD21 ' HB2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -42.75 146.22 0.39 Allowed 'General case' 0 C--N 1.307 -1.251 0 O-C-N 120.163 -1.586 . . . . 0.0 109.411 176.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.14 -9.48 0.92 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.361 -0.837 . . . . 0.0 111.956 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.631 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -92.15 7.77 40.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.041 -1.662 . . . . 0.0 112.281 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.782 ' HB2' HD21 ' A' ' 53' ' ' ASN . 77.1 m-85 -141.08 3.71 1.81 Allowed 'General case' 0 N--CA 1.516 2.857 0 O-C-N 120.535 -1.353 . . . . 0.0 108.759 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 1.027 HG21 ' HB2' ' A' ' 81' ' ' ASN . 17.0 p -89.4 -33.25 16.92 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.157 -0.965 . . . . 0.0 108.618 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.38 -1.76 24.67 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.94 0.876 . . . . 0.0 111.084 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.993 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.286 0.1 OUTLIER -97.63 -48.31 5.29 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 179.187 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.058 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.339 1.0 OUTLIER -77.44 177.75 2.52 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.699 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 1.058 ' HD2' HG13 ' A' ' 60' ' ' VAL . 32.5 Cg_endo -71.6 122.56 8.69 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 CA-C-O 122.632 1.013 . . . . 0.0 111.731 -177.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -77.17 73.57 3.75 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.36 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.625 ' HB1' ' HG2' ' A' ' 87' ' ' GLN . . . -37.71 157.59 0.01 OUTLIER 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.326 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.449 ' OD1' ' HB2' ' A' ' 66' ' ' ARG . 48.1 p30 -90.0 -168.7 2.2 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 123.157 1.456 . . . . 0.0 112.49 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -37.4 -30.43 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.237 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.482 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -55.28 -63.43 1.16 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.365 -1.459 . . . . 0.0 107.568 179.247 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.818 ' HA ' ' HE2' ' A' ' 70' ' ' MET . 8.0 tp10 -60.72 -41.0 94.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.823 -0.548 . . . . 0.0 110.421 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 65' ' ' GLU . 59.9 mt -79.75 -5.22 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.933 . . . . 0.0 110.906 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -86.93 -75.71 1.27 Allowed Glycine 0 N--CA 1.482 1.753 0 N-CA-C 107.629 -2.188 . . . . 0.0 107.629 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.818 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.52 -43.36 5.44 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.629 -1.228 . . . . 0.0 107.913 178.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.956 ' O ' HG22 ' A' ' 74' ' ' VAL 0.25 0.6 OUTLIER -56.96 -53.78 54.13 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.34 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -56.0 -24.94 41.92 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.707 -1.245 . . . . 0.0 108.358 178.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -74.05 -47.16 38.6 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.704 -179.362 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.956 HG22 ' O ' ' A' ' 71' ' ' LEU . 3.3 m -36.19 161.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 121.972 0.891 . . . . 0.0 111.186 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.83 HG22 ' O ' ' A' ' 75' ' ' THR . 30.2 m -118.45 25.9 9.97 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.456 -1.403 . . . . 0.0 109.973 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.105 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -103.46 -153.66 0.48 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.102 -1.624 . . . . 0.0 113.283 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.753 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.25 0.0 OUTLIER -71.05 63.15 0.31 Allowed 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.897 -178.41 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.774 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -57.39 154.97 9.86 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 116.218 -2.193 . . . . 0.0 110.317 -176.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.681 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.375 20.4 mmtt -134.02 178.89 1.55 Allowed Pre-proline 0 C--N 1.294 -1.831 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.253 -173.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 55.2 Cg_endo -77.3 -28.38 5.76 Favored 'Trans proline' 0 C--N 1.295 -2.27 0 N-CA-C 104.742 -2.83 . . . . 0.0 104.742 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 1.027 ' HB2' HG21 ' A' ' 57' ' ' THR . 13.3 p-10 -105.13 14.57 28.96 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.611 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.833 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -47.26 146.6 1.85 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.853 -1.155 . . . . 0.0 109.499 178.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.756 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 mmm-85 -169.1 122.8 0.81 Allowed 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 117.661 -1.616 . . . . 0.0 111.99 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -80.72 112.97 18.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.041 -1.662 . . . . 0.0 108.298 176.44 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.537 ' HB2' ' OH ' ' A' ' 33' ' ' TYR . 5.5 m -35.09 -23.55 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.552 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 9.7 p -64.08 -12.71 41.6 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 119.222 -2.174 . . . . 0.0 111.056 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.625 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -120.67 18.36 11.95 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.731 -1.188 . . . . 0.0 111.366 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 88' ' ' ILE . 3.5 mm -110.07 102.75 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.126 -0.984 . . . . 0.0 110.406 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -84.25 126.55 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 120.967 -1.083 . . . . 0.0 110.418 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.894 ' SD ' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -82.53 123.47 29.22 Favored 'General case' 0 C--O 1.2 -1.526 0 O-C-N 120.81 -1.181 . . . . 0.0 109.236 177.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.594 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -113.92 157.39 42.05 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.181 178.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.68 ' CD ' ' HB3' ' A' ' 19' ' ' ASP . 33.8 Cg_endo -58.06 -27.45 79.69 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 124.444 1.76 . . . . 0.0 109.07 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.594 ' HG2' ' HB ' ' A' ' 91' ' ' THR . 3.0 pt-20 -64.4 -42.85 95.86 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.176 176.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.001 HD13 HG23 ' A' ' 60' ' ' VAL . 50.8 mt -88.51 38.79 0.88 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.729 0.776 . . . . 0.0 112.469 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.569 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 3.3 p-10 -64.6 111.1 2.57 Favored 'General case' 0 C--N 1.286 -2.185 0 O-C-N 119.867 -1.771 . . . . 0.0 109.167 177.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.676 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.44 21.69 2.2 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.176 -1.488 . . . . 0.0 110.425 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.146 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -60.34 136.98 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.054 -1.262 . . . . 0.0 110.297 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.146 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.5 t -117.15 113.2 42.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.576 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -101.16 156.67 4.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 120.262 -1.524 . . . . 0.0 109.886 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.624 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.48 130.05 52.65 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 122.571 1.177 . . . . 0.0 111.276 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 6' ' ' VAL . 87.2 t -104.89 136.65 19.13 Favored Pre-proline 0 C--N 1.283 -2.307 0 O-C-N 120.743 -1.223 . . . . 0.0 109.833 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.611 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 73.8 Cg_endo -92.61 166.85 2.75 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.807 1.671 . . . . 0.0 111.126 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -86.94 -18.09 31.59 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.706 0.765 . . . . 0.0 109.248 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.662 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -109.47 73.09 0.83 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.26 57.92 0.81 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.975 -1.078 . . . . 0.0 109.695 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.6 ' CD2' ' O ' ' A' ' 106' ' ' TRP . 3.3 p-90 . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.618 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.717 ' S2 ' ' SD ' ' A' ' 70' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.331 0.586 . . . . 0.0 110.242 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.821 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -69.25 143.43 53.93 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.357 -0.84 . . . . 0.0 109.841 179.186 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.965 HG22 HG21 ' A' ' 97' ' ' ILE . 40.4 t -135.47 135.83 51.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-O 121.748 0.785 . . . . 0.0 111.914 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 13' ' ' ARG . 47.4 t -142.67 88.5 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.496 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 46.4 m-85 -67.53 136.0 53.88 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.414 -0.804 . . . . 0.0 109.336 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.565 HG13 ' HG2' ' A' ' 12' ' ' ARG . 60.7 t -99.77 166.62 2.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 O-C-N 120.662 -1.274 . . . . 0.0 109.513 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.612 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 87.9 p -100.53 -155.28 0.5 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.141 -0.975 . . . . 0.0 109.029 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.615 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -89.7 -30.17 18.25 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.79 -6.18 52.21 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.388 0.613 . . . . 0.0 109.81 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' A' ' 12' ' ' ARG . . . 114.37 -24.92 10.91 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.593 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -52.71 129.16 28.77 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.689 -1.477 . . . . 0.0 108.237 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.565 ' HG2' HG13 ' A' ' 6' ' ' VAL . 2.5 mtm180 -121.42 -173.13 2.56 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-O 122.211 1.005 . . . . 0.0 112.528 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.599 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -134.94 -177.65 4.73 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 80.0 mt-10 -151.83 109.41 3.62 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.495 -1.682 . . . . 0.0 111.518 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.046 HD11 ' HA ' ' A' ' 27' ' ' ALA . 7.7 mt -106.63 -173.9 2.41 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.452 1.12 . . . . 0.0 110.889 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.62 68.86 1.44 Allowed 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.038 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.6 t -87.72 126.33 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.096 0.95 . . . . 0.0 109.311 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.514 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.29 178.47 6.33 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.124 0.964 . . . . 0.0 112.887 -177.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.584 ' HB3' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -52.21 129.94 29.21 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.215 1.007 . . . . 0.0 109.288 177.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.522 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 94.68 -20.93 46.07 Favored Glycine 0 C--N 1.276 -2.802 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.551 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.038 ' HB ' HG12 ' A' ' 17' ' ' VAL . 84.9 t -83.96 149.81 4.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 CA-C-N 120.843 2.322 . . . . 0.0 109.523 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -96.01 122.85 39.27 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.837 HD22 HG21 ' A' ' 17' ' ' VAL . 1.9 mt -46.33 -24.73 0.52 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.277 -1.514 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.623 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -70.33 -11.6 61.02 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.928 0.871 . . . . 0.0 108.756 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -97.83 -63.41 1.13 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.039 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.867 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -47.36 -58.96 3.55 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.975 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.046 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.76 -53.04 16.49 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.581 -1.324 . . . . 0.0 110.474 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.093 HG23 ' CB ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -66.1 -3.52 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 109.526 179.091 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.442 ' HB3' ' O ' ' A' ' 26' ' ' ALA 0.255 0.0 OUTLIER -103.15 -24.99 13.54 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.833 0.825 . . . . 0.0 110.149 179.851 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.719 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.6 m-80 -97.02 4.94 51.22 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.61 11.12 75.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.966 ' CD1' HD21 ' A' ' 15' ' ' LEU . 9.2 mt -72.79 -57.72 6.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.364 -1.08 . . . . 0.0 109.309 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 1.093 ' CB ' HG23 ' A' ' 28' ' ' VAL . 6.0 m-30 -80.58 30.88 0.29 Allowed 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.748 -0.595 . . . . 0.0 111.504 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -87.99 29.14 0.96 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.944 -1.098 . . . . 0.0 110.311 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.523 HG22 HG13 ' A' ' 36' ' ' VAL . 94.7 mt -107.0 -47.95 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 110.249 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.634 HG21 ' OG1' ' A' ' 47' ' ' THR . 35.0 m -120.06 174.77 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.553 ' O ' HG21 ' A' ' 47' ' ' THR . . . -104.68 139.16 14.5 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.448 ' OD2' ' SD ' ' A' ' 24' ' ' MET . 59.9 m-20 -104.55 177.35 4.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -1.187 . . . . 0.0 110.233 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 42' ' ' SER . 25.5 p -87.93 25.1 1.62 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 110.246 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.22 24.29 15.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.02 9.81 65.28 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 39' ' ' CYS . 1.5 t -81.4 8.21 9.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -1.164 . . . . 0.0 110.102 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB1' ' CZ ' ' A' ' 66' ' ' ARG . . . 44.86 54.07 7.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 110.359 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 42' ' ' SER . 0.9 OUTLIER -140.04 22.63 2.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 110.257 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -135.3 -175.97 4.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.925 . . . . 0.0 110.285 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.642 ' HB1' ' OXT' ' A' ' 106' ' ' TRP . . . -147.58 9.74 0.93 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.562 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.634 ' OG1' HG21 ' A' ' 36' ' ' VAL . 8.6 t -78.37 -14.96 59.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.02 -1.05 . . . . 0.0 109.907 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.545 ' O ' HG13 ' A' ' 50' ' ' VAL . 25.4 p -88.64 26.41 1.5 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.476 -0.765 . . . . 0.0 110.12 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.123 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 5.7 t60 -70.12 123.26 21.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.427 -0.796 . . . . 0.0 109.878 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.813 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -150.13 -170.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.095 -1.003 . . . . 0.0 109.807 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.838 ' CD1' ' HG3' ' A' ' 79' ' ' LYS . 75.2 m-85 -140.45 107.62 5.49 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.938 0.875 . . . . 0.0 110.762 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.015 ' HB ' HG22 ' A' ' 57' ' ' THR . 6.2 t -80.92 131.96 32.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 O-C-N 120.699 -1.251 . . . . 0.0 109.698 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.943 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -42.88 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.089 177.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -72.05 0.03 10.5 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.038 -1.039 . . . . 0.0 110.148 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.605 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -99.09 5.34 47.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.094 -1.004 . . . . 0.0 111.088 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.816 ' CB ' HD13 ' A' ' 97' ' ' ILE . 59.4 m-85 -140.62 5.12 1.99 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.762 -1.211 . . . . 0.0 109.415 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 1.026 HG21 ' HB2' ' A' ' 81' ' ' ASN . 35.3 p -89.74 -38.27 13.96 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -2.24 39.39 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.737 0.78 . . . . 0.0 110.76 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.059 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.262 0.1 OUTLIER -99.06 -47.46 5.22 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.659 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.083 HG23 HD13 ' A' ' 94' ' ' LEU 0.338 1.0 OUTLIER -78.25 176.76 3.3 Favored Pre-proline 0 C--N 1.285 -2.196 0 CA-C-N 113.371 -1.741 . . . . 0.0 106.392 178.312 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 1.019 ' HD2' HG13 ' A' ' 60' ' ' VAL . 39.9 Cg_endo -73.83 96.27 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 CA-C-O 122.59 0.996 . . . . 0.0 112.155 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.531 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -66.54 67.49 0.06 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.428 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.881 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . . . -37.17 152.93 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.281 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -88.17 -147.6 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.127 -0.983 . . . . 0.0 111.868 -178.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 69' ' ' GLY . 17.7 pt-20 -28.98 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.193 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.727 ' CZ ' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -53.29 -70.5 0.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.807 -1.183 . . . . 0.0 108.982 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 1.071 ' HG2' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.26 -32.42 69.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.577 -0.702 . . . . 0.0 109.269 178.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 1.071 HD12 ' HG2' ' A' ' 67' ' ' GLU . 1.2 mp -77.64 -10.82 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 110.826 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 65' ' ' GLU . . . -89.24 -79.27 1.32 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.693 ' HE2' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -43.27 -30.14 0.47 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -1.177 . . . . 0.0 108.668 179.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.997 ' O ' HG22 ' A' ' 74' ' ' VAL . 1.1 tm? -74.84 -50.73 16.08 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.567 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 8.1 tp10 -58.44 -22.72 55.39 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 108.777 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.513 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -80.99 -40.78 23.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.675 -0.641 . . . . 0.0 110.686 -179.487 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.997 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.7 m -40.06 162.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.436 -0.79 . . . . 0.0 109.754 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.823 HG22 ' O ' ' A' ' 75' ' ' THR . 21.7 m -120.63 32.38 6.02 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.114 -0.991 . . . . 0.0 108.965 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.123 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -115.27 -167.24 1.21 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.686 1.231 . . . . 0.0 112.728 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.761 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -55.19 62.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.996 -178.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.945 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.43 154.86 12.97 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 118.729 -2.482 . . . . 0.0 110.997 -177.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.838 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.382 0.5 OUTLIER -133.15 177.17 2.38 Favored Pre-proline 0 C--N 1.288 -2.077 0 CA-C-N 113.61 -1.632 . . . . 0.0 111.07 -173.79 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 41.0 Cg_endo -71.96 -25.91 19.19 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 N-CA-C 106.99 -1.965 . . . . 0.0 106.99 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 1.026 ' HB2' HG21 ' A' ' 57' ' ' THR . 13.6 p-10 -114.53 18.76 16.58 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.913 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.796 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -45.88 149.59 0.63 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.805 -1.185 . . . . 0.0 108.139 178.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.939 ' HB2' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -155.65 152.3 28.5 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.388 -1.725 . . . . 0.0 112.313 -178.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -106.43 103.29 12.71 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 24' ' ' MET . 5.7 t -27.82 -34.09 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.552 ' N ' ' O ' ' A' ' 84' ' ' LEU . 26.5 p -71.65 1.97 5.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.3 -1.5 . . . . 0.0 110.784 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.556 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 38.1 mm-40 -125.03 14.94 8.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.877 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.639 HG23 HG11 ' A' ' 60' ' ' VAL . 5.7 mm -116.46 99.0 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.272 -0.892 . . . . 0.0 110.285 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.99 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.7 mm -82.82 131.15 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.899 -1.125 . . . . 0.0 110.048 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.998 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.1 tpt -82.42 123.14 28.86 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.279 -0.888 . . . . 0.0 110.349 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.572 ' OG1' HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -113.22 159.33 35.36 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 118.151 -1.42 . . . . 0.0 110.319 179.29 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.584 ' CD ' ' HB3' ' A' ' 19' ' ' ASP . 37.2 Cg_endo -62.24 -14.23 37.08 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 O-C-N 124.481 1.779 . . . . 0.0 109.569 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.524 ' CG ' ' HB ' ' A' ' 91' ' ' THR . 1.8 pt-20 -82.52 -36.93 25.91 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.33 1.062 . . . . 0.0 108.42 177.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.083 HD13 HG23 ' A' ' 60' ' ' VAL . 50.3 mt -90.23 35.76 0.87 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.576 -178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 20.9 p30 -63.61 108.02 1.29 Allowed 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.823 177.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.617 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 124.36 23.79 1.88 Allowed Glycine 0 N--CA 1.496 2.695 0 O-C-N 120.755 -1.216 . . . . 0.0 110.7 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.115 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -59.62 136.83 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -1.087 . . . . 0.0 111.097 179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.115 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.5 t -115.76 110.31 31.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -100.0 154.99 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.834 -1.166 . . . . 0.0 110.039 -178.552 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.602 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -122.46 128.43 50.86 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.268 -0.895 . . . . 0.0 110.249 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.615 HG12 ' CE1' ' A' ' 8' ' ' HIS . 55.1 t -103.54 123.54 41.1 Favored Pre-proline 0 C--N 1.291 -1.972 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.669 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.682 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 54.8 Cg_endo -76.37 171.19 18.53 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.096 1.864 . . . . 0.0 111.949 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.5 -18.93 23.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.699 -0.626 . . . . 0.0 109.468 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.791 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -111.0 74.62 0.88 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 47' ' ' THR . 3.1 pt20 -98.81 56.1 1.07 Allowed 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.436 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.642 ' OXT' ' HB1' ' A' ' 46' ' ' ALA . 1.5 p-90 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.765 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.446 ' S2 ' ' HB3' ' A' ' 38' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.587 ' OG ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.393 0.616 . . . . 0.0 110.467 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.807 ' O ' HG22 ' A' ' 97' ' ' ILE . 4.1 mptt -61.97 149.51 40.51 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.458 -0.776 . . . . 0.0 109.115 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.917 ' HA ' HG23 ' A' ' 97' ' ' ILE . 65.4 t -140.56 134.05 33.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 O-C-N 121.382 -0.824 . . . . 0.0 110.959 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 45.9 t -142.7 90.2 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 C-N-CA 118.634 -1.226 . . . . 0.0 110.803 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 70.3 m-85 -67.64 134.65 51.53 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.674 -0.641 . . . . 0.0 109.464 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.535 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 97.3 t -99.62 169.36 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 O-C-N 120.113 -1.617 . . . . 0.0 109.717 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.593 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 95.9 p -104.46 -155.9 0.55 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 109.386 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.584 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -90.02 -29.69 18.25 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -91.83 -8.59 46.15 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.339 0.59 . . . . 0.0 109.713 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.21 -16.08 20.26 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -59.44 132.51 54.21 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.728 -1.454 . . . . 0.0 107.872 179.184 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.528 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -120.98 179.92 4.22 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 122.368 1.08 . . . . 0.0 113.02 -178.154 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 4' ' ' VAL 0.277 0.9 OUTLIER -127.25 179.03 5.66 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 178.682 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.693 ' C ' HD23 ' A' ' 15' ' ' LEU . 68.5 mt-10 -152.87 116.02 4.63 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 117.129 -1.828 . . . . 0.0 111.518 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.99 HD11 ' HA ' ' A' ' 27' ' ' ALA . 5.7 mt -112.63 -156.79 0.6 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.459 1.123 . . . . 0.0 110.194 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -153.08 68.24 0.81 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.035 HG12 ' HB ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -88.29 124.24 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.083 0.944 . . . . 0.0 109.463 -177.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -87.34 176.25 7.61 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.087 0.946 . . . . 0.0 112.851 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.582 ' HB3' HG22 ' A' ' 91' ' ' THR . 0.1 OUTLIER -51.02 127.85 19.95 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.318 1.056 . . . . 0.0 109.187 177.357 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.52 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 99.04 -23.82 34.84 Favored Glycine 0 C--N 1.276 -2.805 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.474 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.035 ' HB ' HG12 ' A' ' 17' ' ' VAL . 95.1 t -84.44 153.61 3.65 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.656 0 CA-C-N 120.61 2.205 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.527 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -96.98 134.71 39.99 Favored 'General case' 0 C--N 1.273 -2.728 0 C-N-CA 118.797 -1.161 . . . . 0.0 107.886 176.206 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.71 HD22 HG11 ' A' ' 3' ' ' VAL . 9.2 mt -50.24 -23.65 2.39 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.299 -1.501 . . . . 0.0 108.028 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.634 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -74.5 -15.0 60.89 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.599 -0.688 . . . . 0.0 109.211 179.175 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.55 ' CG ' HG13 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -89.14 -63.5 1.28 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.853 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -56.04 -50.07 71.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.065 -1.022 . . . . 0.0 110.196 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.99 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.66 -48.66 28.89 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.527 -1.358 . . . . 0.0 109.706 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.933 HG23 ' HB2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -70.78 -0.74 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.605 -0.684 . . . . 0.0 109.679 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.08 -27.18 12.73 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.813 0.816 . . . . 0.0 109.569 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.886 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.7 m-80 -97.36 -0.72 45.91 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.68 21.47 36.83 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.843 HD11 HD21 ' A' ' 15' ' ' LEU . 2.1 mt -72.74 -68.06 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.392 -1.063 . . . . 0.0 109.66 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.933 ' HB2' HG23 ' A' ' 28' ' ' VAL . 21.8 m-85 -80.62 59.1 3.46 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.588 0.708 . . . . 0.0 110.595 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -66.48 48.93 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.024 0 O-C-N 121.573 -0.704 . . . . 0.0 110.619 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.675 HG13 HG21 ' A' ' 47' ' ' THR . 0.0 OUTLIER -107.55 158.56 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.301 -0.874 . . . . 0.0 109.771 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.4 t -112.75 -33.7 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.124 -0.985 . . . . 0.0 110.75 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.605 ' C ' HD11 ' A' ' 35' ' ' ILE . . . -79.87 72.38 2.59 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.512 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . 8.8 p-10 -120.22 169.43 10.26 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.234 -1.157 . . . . 0.0 110.179 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 18.0 p -100.03 -12.45 19.71 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.04 47.6 6.98 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . 66.77 8.83 49.98 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.543 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 5.2 t -79.98 -2.02 42.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -1.178 . . . . 0.0 110.205 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 60.06 53.78 4.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 0.0 110.275 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.07 11.69 2.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.578 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 1.9 p -129.92 -171.59 2.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.015 -1.053 . . . . 0.0 110.409 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.707 ' HB1' ' OXT' ' A' ' 106' ' ' TRP . . . -144.7 9.66 1.36 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 110.406 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.675 HG21 HG13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -81.36 6.43 14.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.114 -0.991 . . . . 0.0 109.88 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 11.3 p -115.18 28.53 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.48 -0.763 . . . . 0.0 109.625 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.89 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 5.2 t60 -69.86 128.7 37.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.537 -0.727 . . . . 0.0 110.402 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.796 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -156.78 -174.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.971 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.796 ' N ' HG23 ' A' ' 50' ' ' VAL 0.272 81.9 m-85 -140.41 113.85 8.62 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.634 0.73 . . . . 0.0 110.323 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.033 ' HB ' HG22 ' A' ' 57' ' ' THR . 6.3 t -82.36 132.45 31.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 O-C-N 120.329 -1.482 . . . . 0.0 110.654 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.765 ' O ' HG23 ' A' ' 57' ' ' THR . 3.3 t30 -47.1 145.47 2.16 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.709 -1.244 . . . . 0.0 108.583 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.523 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -58.16 -8.37 1.07 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.159 -0.963 . . . . 0.0 112.077 -178.337 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.572 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -93.97 7.76 43.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.532 -1.355 . . . . 0.0 110.731 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 1.09 ' CB ' HD13 ' A' ' 97' ' ' ILE . 86.9 m-85 -140.54 4.65 1.97 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.125 -0.984 . . . . 0.0 109.622 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 1.033 HG22 ' HB ' ' A' ' 52' ' ' VAL . 31.5 p -90.29 -41.19 11.68 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 120.946 -1.096 . . . . 0.0 108.068 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.34 -2.09 52.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.826 0.822 . . . . 0.0 110.56 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.057 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.255 0.1 OUTLIER -99.22 -47.77 5.07 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.531 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.071 HG23 HD13 ' A' ' 94' ' ' LEU 0.331 1.1 t -78.99 175.76 4.4 Favored Pre-proline 0 C--N 1.288 -2.065 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.186 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.987 ' HD2' HG13 ' A' ' 60' ' ' VAL . 40.0 Cg_endo -75.05 109.2 2.88 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 CA-C-O 122.702 1.042 . . . . 0.0 112.293 -176.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.534 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -75.23 66.71 1.76 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.551 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.553 ' CB ' ' HG2' ' A' ' 87' ' ' GLN . . . -37.19 155.94 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.25 0.547 . . . . 0.0 110.226 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 66' ' ' ARG . 45.0 p-10 -96.06 -145.79 0.28 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.155 -0.966 . . . . 0.0 112.493 -177.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 64' ' ' ASN . 8.2 pt-20 -30.92 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.349 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 64' ' ' ASN . 2.3 mtm-85 -52.96 -71.2 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.608 -1.308 . . . . 0.0 108.365 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.866 ' HG3' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -62.89 -45.8 90.82 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 109.18 178.363 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.866 HD12 ' HG3' ' A' ' 67' ' ' GLU . 1.1 mp -55.77 -12.97 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.348 -0.845 . . . . 0.0 111.424 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -91.2 -78.41 1.37 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.566 ' CE ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -45.37 -35.57 3.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.976 -1.308 . . . . 0.0 108.538 179.493 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.981 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.8 OUTLIER -67.77 -43.96 78.57 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 177.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.592 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -60.44 -25.79 66.24 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 108.699 178.168 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.579 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -77.94 -42.76 31.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.781 -0.574 . . . . 0.0 111.111 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.981 HG22 ' O ' ' A' ' 71' ' ' LEU . 4.5 m -39.87 151.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.816 HG22 ' O ' ' A' ' 75' ' ' THR . 18.7 m -121.03 30.47 6.84 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.083 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.89 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -92.67 -82.5 0.33 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.492 -1.283 . . . . 0.0 113.344 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.721 ' CG ' ' O ' ' A' ' 77' ' ' GLU 0.288 0.0 OUTLIER -153.86 64.58 0.72 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 122.291 1.043 . . . . 0.0 108.683 -175.579 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.923 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -57.0 150.71 16.33 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 119.382 -2.074 . . . . 0.0 113.24 -173.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.536 ' HD2' ' O ' ' A' ' 77' ' ' GLU 0.36 0.0 OUTLIER -124.97 -174.14 0.32 Allowed Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.312 -174.889 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 46.6 Cg_endo -81.98 -28.86 1.87 Allowed 'Trans proline' 0 C--N 1.302 -1.92 0 N-CA-C 107.222 -1.876 . . . . 0.0 107.222 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.733 ' HB2' HG21 ' A' ' 57' ' ' THR . 0.9 OUTLIER -107.47 15.33 24.97 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.113 179.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.824 ' OG ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -44.65 146.68 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.952 -1.093 . . . . 0.0 109.611 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.925 ' HB2' HG23 ' A' ' 52' ' ' VAL . 30.7 mmm-85 -158.43 152.91 24.44 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.888 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.625 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -105.26 107.03 17.79 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 24' ' ' MET . 6.1 p -32.07 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.582 ' HA ' ' HB3' ' A' ' 24' ' ' MET . 16.3 p -70.05 -1.24 9.31 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.425 -1.422 . . . . 0.0 111.03 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.553 ' HG2' ' CB ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -125.4 -1.92 7.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.91 -1.119 . . . . 0.0 110.938 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.674 HG23 HG11 ' A' ' 60' ' ' VAL . 3.2 mm -97.15 108.78 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.084 -1.01 . . . . 0.0 110.281 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.984 ' O ' HG22 ' A' ' 60' ' ' VAL . 2.9 mm -87.72 129.36 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.896 -1.128 . . . . 0.0 109.959 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 1.011 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.4 tpt -83.03 122.94 28.97 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 121.42 -0.8 . . . . 0.0 110.379 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.754 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -114.11 159.22 37.14 Favored Pre-proline 0 C--N 1.292 -1.922 0 C-N-CA 118.233 -1.387 . . . . 0.0 109.682 178.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.754 ' HD2' HG22 ' A' ' 91' ' ' THR . 35.2 Cg_endo -58.66 -36.67 96.89 Favored 'Trans proline' 0 C--N 1.297 -2.149 0 O-C-N 124.334 1.702 . . . . 0.0 110.045 -178.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -58.9 -36.83 75.34 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.797 -1.161 . . . . 0.0 108.558 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.071 HD13 HG23 ' A' ' 60' ' ' VAL . 65.9 mt -90.59 35.12 0.88 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.937 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.485 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 19.6 p-10 -63.75 107.03 1.09 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.575 -1.25 . . . . 0.0 109.391 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.615 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 123.75 19.83 2.69 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 120.458 -1.401 . . . . 0.0 110.733 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.1 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -55.77 140.33 13.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.228 -1.16 . . . . 0.0 111.119 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.1 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.0 t -115.53 112.15 38.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -98.61 156.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.786 -1.196 . . . . 0.0 109.346 -178.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.71 ' N ' ' O ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -122.85 124.21 42.75 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.742 0.782 . . . . 0.0 110.323 -178.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 68.2 t -100.32 135.55 20.24 Favored Pre-proline 0 C--N 1.289 -2.064 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.694 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 54.5 Cg_endo -88.9 176.09 3.39 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 121.765 1.643 . . . . 0.0 111.885 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -91.14 -20.45 21.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.572 -0.705 . . . . 0.0 109.36 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.606 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -110.76 77.86 1.07 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.5 ' HG2' ' HG2' ' A' ' 102' ' ' PRO . 12.9 mt-30 -98.34 52.07 1.02 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.72 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.707 ' OXT' ' HB1' ' A' ' 46' ' ' ALA . 3.0 p-90 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.18 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.487 ' S2 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.672 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.19 0.519 . . . . 0.0 110.437 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.769 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -79.21 142.18 36.5 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.257 178.041 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.943 ' HA ' HG23 ' A' ' 97' ' ' ILE . 41.6 t -136.27 133.82 49.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 O-C-N 121.326 -0.859 . . . . 0.0 110.137 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 58.2 t -141.85 91.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.619 0 C-N-CA 118.804 -1.158 . . . . 0.0 110.411 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.658 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 40.8 m-85 -69.03 154.64 41.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.577 -0.702 . . . . 0.0 109.169 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.577 HG12 ' N ' ' A' ' 7' ' ' SER . 87.0 t -118.35 172.7 5.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.215 178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.615 ' HB3' HG22 ' A' ' 11' ' ' THR . 46.3 p -107.97 -158.4 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.104 -0.998 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.595 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -88.04 -29.67 20.51 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 178.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -91.76 -11.18 37.44 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.437 0.637 . . . . 0.0 109.575 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 114.29 -4.31 23.56 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.335 -0.936 . . . . 0.0 110.785 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.615 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.6 OUTLIER -65.09 131.41 46.48 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.646 -1.502 . . . . 0.0 107.784 179.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -120.93 178.51 4.69 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 122.229 1.014 . . . . 0.0 112.905 -177.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -135.4 177.71 7.61 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.81 ' C ' HD23 ' A' ' 15' ' ' LEU . 9.2 mp0 -150.3 113.47 4.87 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.975 -1.49 . . . . 0.0 110.397 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.046 HD11 HD12 ' A' ' 32' ' ' ILE 0.262 2.8 mt -109.21 -151.53 0.47 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 122.603 1.192 . . . . 0.0 111.084 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 1' ' ' SER . 12.4 t0 -152.94 75.98 1.11 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.092 HG13 ' CG1' ' A' ' 21' ' ' VAL . 17.4 t -88.41 118.87 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -89.64 -175.4 4.66 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.595 -0.691 . . . . 0.0 110.892 -177.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -65.45 114.39 4.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.456 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . 112.36 -15.84 24.82 Favored Glycine 0 C--N 1.288 -2.085 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.351 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.092 ' CG1' HG13 ' A' ' 17' ' ' VAL . 41.6 t -97.81 136.37 28.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 120.441 -1.623 . . . . 0.0 106.776 177.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -95.15 143.71 26.36 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.378 -1.329 . . . . 0.0 107.721 178.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.907 HD23 HG21 ' A' ' 17' ' ' VAL . 13.8 mt -47.04 -26.6 1.08 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.281 -1.367 . . . . 0.0 107.434 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.637 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -59.41 -39.27 82.91 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.362 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.607 ' CG ' HG13 ' A' ' 21' ' ' VAL . 4.8 tt0 -75.24 -72.37 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.796 -0.565 . . . . 0.0 110.532 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.068 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -46.6 -50.54 17.31 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 117.986 -1.486 . . . . 0.0 111.014 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.924 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -47.95 -46.02 31.77 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.343 -1.473 . . . . 0.0 110.443 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.704 HG23 ' HB2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -74.08 0.57 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.555 -0.716 . . . . 0.0 109.654 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -103.18 -29.18 11.47 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.736 0.779 . . . . 0.0 109.687 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.907 ' CG ' HD22 ' A' ' 15' ' ' LEU . 3.8 m-80 -97.56 -1.57 43.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.65 19.58 51.21 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.046 HD12 HD11 ' A' ' 15' ' ' LEU . 8.5 mt -72.7 -57.37 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -1.114 . . . . 0.0 109.434 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.737 ' CD2' ' HB3' ' A' ' 27' ' ' ALA . 20.0 m-30 -81.16 56.01 2.7 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.533 0.682 . . . . 0.0 110.52 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.42 47.13 0.21 Allowed 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.651 -0.655 . . . . 0.0 110.443 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.56 HG23 ' N ' ' A' ' 36' ' ' VAL . 2.7 tp -86.87 -169.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.868 . . . . 0.0 109.73 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.56 ' N ' HG23 ' A' ' 35' ' ' ILE . 72.1 t -80.08 -90.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 110.191 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.522 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -119.12 155.93 15.89 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' OD1' ' S1 ' ' A' ' 107' ' ' FES . 0.4 OUTLIER -119.51 -175.15 2.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -1.111 . . . . 0.0 110.054 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 24.5 p -99.77 7.44 45.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.232 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 53.65 35.25 51.65 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.19 18.7 78.05 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 39' ' ' CYS . 12.1 t -87.12 13.12 9.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -1.129 . . . . 0.0 110.133 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 42' ' ' SER . . . 43.53 55.27 5.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 110.084 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.8 p -137.82 12.62 2.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.327 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -135.72 179.55 6.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.11 -0.993 . . . . 0.0 110.326 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.699 ' HB3' ' CZ3' ' A' ' 106' ' ' TRP . . . -147.66 9.9 0.93 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 0.0 110.52 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -16.88 62.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.059 -1.026 . . . . 0.0 109.407 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.75 ' SG ' HD13 ' A' ' 84' ' ' LEU . 25.4 p -88.38 29.98 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.636 -0.665 . . . . 0.0 110.048 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.152 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 4.1 t60 -70.24 126.27 29.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.417 -0.802 . . . . 0.0 110.667 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.807 HG23 ' N ' ' A' ' 51' ' ' TYR . 1.1 m -156.33 -174.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.251 -0.905 . . . . 0.0 109.99 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.807 ' N ' HG23 ' A' ' 50' ' ' VAL 0.254 78.2 m-85 -141.01 108.22 5.5 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.659 0.743 . . . . 0.0 110.669 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.029 ' HB ' HG22 ' A' ' 57' ' ' THR . 2.4 t -75.01 133.84 30.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 O-C-N 120.34 -1.475 . . . . 0.0 110.583 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.861 ' O ' HG23 ' A' ' 57' ' ' THR . 3.8 t30 -48.42 147.29 2.45 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.744 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.2 pt-20 -58.77 -8.41 1.32 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.169 -0.957 . . . . 0.0 111.972 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.573 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -96.01 7.91 45.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.475 -1.391 . . . . 0.0 111.057 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 1.13 ' CB ' HD13 ' A' ' 97' ' ' ILE . 87.7 m-85 -140.37 3.01 1.91 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.059 . . . . 0.0 109.898 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 1.029 HG22 ' HB ' ' A' ' 52' ' ' VAL . 3.2 p -90.55 -41.22 11.5 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -93.76 -0.94 55.67 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.737 0.779 . . . . 0.0 110.526 -178.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.034 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.253 1.2 mtpp -99.23 -46.91 5.38 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 123.135 1.445 . . . . 0.0 107.355 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.043 HG13 ' HD2' ' A' ' 61' ' ' PRO 0.334 0.9 OUTLIER -74.86 -177.68 0.71 Allowed Pre-proline 0 C--N 1.287 -2.114 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.197 178.975 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 1.043 ' HD2' HG13 ' A' ' 60' ' ' VAL . 34.1 Cg_endo -61.59 122.34 10.91 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 CA-C-O 123.001 1.167 . . . . 0.0 111.941 -177.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.553 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -74.32 62.95 0.99 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.635 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.469 ' HB1' ' HG2' ' A' ' 87' ' ' GLN . . . -38.22 157.88 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.937 -0.477 . . . . 0.0 109.999 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 66' ' ' ARG . 29.8 p30 -118.0 -154.47 0.56 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.061 -1.024 . . . . 0.0 111.432 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 64' ' ' ASN . 4.3 pt-20 -31.24 -33.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.028 -0.42 . . . . 0.0 111.726 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -53.0 -71.05 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.773 -1.204 . . . . 0.0 108.195 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.885 ' HG3' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -59.7 -50.41 73.94 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 108.906 178.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.885 HD12 ' HG3' ' A' ' 67' ' ' GLU . 1.2 mp -51.52 -19.32 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 110.302 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -88.17 -75.69 1.28 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.67 ' HG3' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -45.04 -38.78 5.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -1.215 . . . . 0.0 108.674 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.039 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -65.74 -51.7 57.05 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.208 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 11.0 tp10 -55.39 -19.62 9.61 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.081 -1.012 . . . . 0.0 108.417 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -76.21 -46.98 25.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.604 -0.685 . . . . 0.0 110.552 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.039 HG22 ' O ' ' A' ' 71' ' ' LEU . 8.1 m -40.71 163.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.266 -0.896 . . . . 0.0 109.725 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.779 HG22 ' O ' ' A' ' 75' ' ' THR . 45.8 m -120.4 37.4 4.27 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.977 -1.077 . . . . 0.0 109.599 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.152 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -122.44 -167.78 1.62 Allowed 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.281 -1.368 . . . . 0.0 112.968 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.744 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -50.77 63.42 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.662 -178.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.865 HD11 ' CD2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -58.42 153.65 15.35 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 118.767 -2.458 . . . . 0.0 111.809 -177.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.699 ' HG3' ' CD1' ' A' ' 51' ' ' TYR 0.385 0.2 OUTLIER -133.96 176.86 2.57 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 113.294 -1.775 . . . . 0.0 111.308 -173.826 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 43.7 Cg_endo -75.34 -27.58 9.36 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 176.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.81 ' HB2' HG21 ' A' ' 57' ' ' THR . 15.5 p-10 -108.5 17.01 22.52 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.255 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.802 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -45.81 149.91 0.59 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.181 -0.949 . . . . 0.0 110.126 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.826 ' HB2' HG23 ' A' ' 52' ' ' VAL . 7.9 mmt85 -158.62 160.22 36.29 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.255 -1.378 . . . . 0.0 112.192 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.75 HD13 ' SG ' ' A' ' 48' ' ' CYS . 2.2 mt -112.85 114.98 27.75 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.531 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 12.6 p -30.67 -30.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.572 ' N ' ' O ' ' A' ' 84' ' ' LEU . 27.8 p -77.07 4.24 10.64 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.611 -1.306 . . . . 0.0 111.43 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.503 ' HG2' ' CB ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -125.34 11.94 8.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.819 -1.175 . . . . 0.0 111.357 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.007 HG23 HG11 ' A' ' 60' ' ' VAL . 21.4 mm -120.34 107.12 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.83 -1.169 . . . . 0.0 110.978 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.974 ' O ' HG22 ' A' ' 60' ' ' VAL . 3.9 mm -89.83 128.81 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.144 -0.973 . . . . 0.0 108.895 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.672 ' HG3' ' HB2' ' A' ' 1' ' ' SER . 0.0 OUTLIER -83.86 124.77 31.31 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.414 -0.804 . . . . 0.0 111.238 -178.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.831 HG23 HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -98.97 179.69 1.01 Allowed Pre-proline 0 C--N 1.295 -1.769 0 C-N-CA 117.673 -1.611 . . . . 0.0 109.181 177.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.558 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 45.6 Cg_endo -82.21 -12.88 10.33 Favored 'Trans proline' 0 C--N 1.289 -2.599 0 O-C-N 124.368 1.72 . . . . 0.0 108.705 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.553 ' HG2' ' OG1' ' A' ' 91' ' ' THR . 3.4 pt-20 -84.89 -33.69 22.73 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.034 HD21 ' CB ' ' A' ' 59' ' ' LYS . 66.1 mt -89.64 29.77 1.11 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.498 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.435 ' HA ' ' H ' ' A' ' 2' ' ' LYS . 5.7 p-10 -63.22 111.38 2.22 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 120.3 -1.5 . . . . 0.0 109.056 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.65 ' N ' ' HB2' ' A' ' 2' ' ' LYS . . . 123.87 17.04 3.17 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.13 HD13 ' CB ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -53.75 141.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.377 -1.073 . . . . 0.0 111.668 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.08 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.0 t -117.46 113.63 43.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.592 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -99.41 155.41 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.838 -1.163 . . . . 0.0 109.773 -178.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.644 ' HB2' ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -122.34 121.07 35.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.677 0.751 . . . . 0.0 109.783 -179.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.595 HG12 ' CE1' ' A' ' 8' ' ' HIS . 90.8 t -99.51 123.58 47.6 Favored Pre-proline 0 C--N 1.289 -2.025 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.432 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.684 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 52.6 Cg_endo -75.58 170.83 19.42 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.002 1.801 . . . . 0.0 112.028 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.424 ' CG ' ' HG2' ' A' ' 104' ' ' ARG . 11.6 p-10 -91.32 -17.45 25.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.677 -0.639 . . . . 0.0 109.402 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.797 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -110.75 70.89 0.73 Allowed 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.423 ' CD ' ' O ' ' A' ' 105' ' ' GLN . 0.0 OUTLIER -98.73 58.81 1.21 Allowed 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.466 -177.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.699 ' CZ3' ' HB3' ' A' ' 46' ' ' ALA . 1.8 p-90 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.885 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.406 ' S1 ' ' OD1' ' A' ' 38' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_